<SEC-DOCUMENT>0001193125-24-067332.txt : 20240314
<SEC-HEADER>0001193125-24-067332.hdr.sgml : 20240314
<ACCEPTANCE-DATETIME>20240314060705
ACCESSION NUMBER:		0001193125-24-067332
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		27
CONFORMED PERIOD OF REPORT:	20240307
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240314
DATE AS OF CHANGE:		20240314

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEW YORK COMMUNITY BANCORP, INC.
		CENTRAL INDEX KEY:			0000910073
		STANDARD INDUSTRIAL CLASSIFICATION:	SAVINGS INSTITUTIONS, NOT FEDERALLY CHARTERED [6036]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				061377322
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31565
		FILM NUMBER:		24747815

	BUSINESS ADDRESS:	
		STREET 1:		102 DUFFY AVENUE
		CITY:			HICKSVILLE
		STATE:			NY
		ZIP:			11801
		BUSINESS PHONE:		5166834100

	MAIL ADDRESS:	
		STREET 1:		102 DUFFY AVENUE
		CITY:			HICKSVILLE
		STATE:			NY
		ZIP:			11801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NEW YORK COMMUNITY BANCORP INC
		DATE OF NAME CHANGE:	20001128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QUEENS COUNTY BANCORP INC
		DATE OF NAME CHANGE:	19930802
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d763888d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nycb="http://www.mynycb.com/20240307" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-621">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-03-07_to_2024-03-07">0000910073</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_CurrentFiscalYearEndDate_duration_2024-03-07_to_2024-03-07" name="dei:CurrentFiscalYearEndDate" contextRef="duration_2024-03-07_to_2024-03-07">--12-31</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="nycb-20240307.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-03-07_to_2024-03-07"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000910073</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-03-07</xbrli:startDate> <xbrli:endDate>2024-03-07</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000910073</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-03-07</xbrli:startDate> <xbrli:endDate>2024-03-07</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_nycb-BifurcatedOptionNotesUnitSecuritiesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000910073</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nycb:BifurcatedOptionNotesUnitSecuritiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-03-07</xbrli:startDate> <xbrli:endDate>2024-03-07</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_nycb-FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000910073</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nycb:FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-03-07</xbrli:startDate> <xbrli:endDate>2024-03-07</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D. C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-657">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-03-07_to_2024-03-07" format="ixt:datemonthdayyearen" id="ixv-658">March&#160;7, 2024</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-659">NEW YORK COMMUNITY BANCORP, INC.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-03-07_to_2024-03-07" format="ixt-sec:stateprovnameen" id="ixv-660">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-661">1-31565</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-662">06-1377322</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or other jurisdiction<br/>of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br/>Identification No.)</span></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-663">102 Duffy Avenue</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-664">Hicksville</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-03-07_to_2024-03-07" format="ixt-sec:stateprovnameen" id="ixv-665">New York</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-666">11801</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-667">(516)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-668">683-4100</ix:nonNumeric></span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-03-07_to_2024-03-07" format="ixt-sec:boolballotbox" id="ixv-669">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-03-07_to_2024-03-07" format="ixt-sec:boolballotbox" id="ixv-670">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-03-07_to_2024-03-07" format="ixt-sec:boolballotbox" id="ixv-671">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-03-07_to_2024-03-07" format="ixt-sec:boolballotbox" id="ixv-672">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title&#160;of&#160;each&#160;class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name&#160;of&#160;each&#160;exchange<br/>on which&#160;registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" id="ixv-673">Common Stock, par value $0.01 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" id="ixv-674">NYCB</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" format="ixt-sec:exchnameen" id="ixv-675">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_nycb-BifurcatedOptionNotesUnitSecuritiesMember" id="ixv-676">Bifurcated Option Note Unit Securities SM</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_nycb-BifurcatedOptionNotesUnitSecuritiesMember" id="ixv-677">NYCB PU</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_nycb-BifurcatedOptionNotesUnitSecuritiesMember" format="ixt-sec:exchnameen" id="ixv-678">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_nycb-FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember" id="ixv-158"><span style="white-space:nowrap"><span style="white-space:nowrap">Fixed-to-Floating</span></span> Rate Series A Noncumulative Perpetual Preferred Stock, $0.01 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_nycb-FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember" id="ixv-679">NYCB PA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_nycb-FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember" format="ixt-sec:exchnameen" id="ixv-680">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company &#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-03-07_to_2024-03-07" format="ixt-sec:boolballotbox" id="ixv-681">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#8194;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;1.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Investment Agreements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;7, 2024, New York Community Bancorp, Inc. (&#8220;NYCB&#8221; or the &#8220;Company&#8221;) entered into separate investment agreements with (a)&#160;affiliates of funds managed by Liberty 77 Capital L.P. (&#8220;Liberty&#8221;), (b) affiliates of funds managed by Hudson Bay Capital Management, LP (&#8220;Hudson Bay&#8221;), (c) affiliates of funds managed by Reverence Capital Partners L.P. (&#8220;Reverence&#8221;) and (d)&#160;certain other investors (the &#8220;Other Investors&#8221; and, collectively with Liberty, Reverence and Hudson Bay, the &#8220;Investors&#8221;, and the investment agreements entered into with each of the Investors on March&#160;7, 2024, collectively, the &#8220;Original Investment Agreements&#8221;). On March&#160;11, 2024, NYCB entered into separate amendments to the Original Investment Agreements with Liberty (such agreement, as amended, the &#8220;Liberty Investment Agreement&#8221;), Hudson Bay (such agreements, as amended, the &#8220;Hudson Bay Investment Agreements&#8221;) and Reverence (such agreement, as amended, the &#8220;Reverence Investment Agreement&#8221; and, collectively with the Liberty Investment Agreement, the Hudson Bay Investment Agreements and the Original Investment Agreements of the Other Investors, the &#8220;Investment Agreements&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Investment Agreements, on the terms and subject to the conditions set forth therein, at the closing of the transactions contemplated by the Investment Agreements on March&#160;11, 2024 (the &#8220;Closing&#8221;), the Investors invested an aggregate of approximately $1.05&#160;billion in the Company in exchange for the sale and issuance of: (a) 76,630,965 shares of common stock, par value $0.01 per share, of NYCB (the &#8220;Common Stock&#8221;) at a purchase price per share of $2.00; (b) 192,062 shares of a new series of preferred stock, par value $0.01 per share, of NYCB designated as Series B Noncumulative Convertible Preferred Stock (the &#8220;Series B Preferred Stock&#8221;), at a price per share of $2,000 and each share of which is automatically convertible into 1,000 shares of Common Stock (or, in certain limited circumstances, one share of Series C Preferred Stock (as defined below)) in the event of a transfer by the holder thereof consistent with the rules and limitations of Regulation Y of the Bank Holding Company Act of 1956, as amended (the &#8220;BHCA&#8221;), subject to certain limitations (a &#8220;Reg Y Transfer&#8221;), and all of which shares of Series B Preferred Stock represent the right (on an as converted basis) to receive approximately 192&#160;million shares of our Common Stock; (c) 256,307 shares of a new series of preferred stock, par value $0.01 per share, of NYCB designated as Series C Noncumulative Convertible Preferred Stock (the &#8220;Series C Preferred Stock&#8221;, together with the Series B Preferred Stock, the &#8220;Preferred Stock&#8221;), at a price per share of $2,000 and each share of which is (i)&#160;convertible prior to the receipt of the Requisite Stockholder Approvals (as defined below) at the option of certain holders into 1,000 shares Common Stock up to a limit of 22% of total shares of Series C Preferred Stock held at the Closing and (ii)&#160;automatically convertible into 1,000 shares of Common Stock upon the occurrence of certain events (as described below under &#8220;Certificates of Designations &#8211; Series C Preferred Stock&#8221;), and all of which shares of Series C Preferred Stock represent the right (on an as converted basis) to receive approximately 256&#160;million shares of Common Stock; and <span style="white-space:nowrap">(d)&#160;net-settled</span> warrants (the &#8220;Issued Warrants&#8221;), which are not exercisable for 180 days after the Closing, affording the holder thereof the right, until the seven-year anniversary of the issuance of such Issued Warrant, to purchase for $2,500 per share, shares of a new class of <span style="white-space:nowrap">non-voting,</span> common-equivalent preferred stock of the Company (the &#8220;Series D NVCE Stock&#8221;), each share of which is convertible into 1,000 shares of Common Stock (or, in certain limited circumstances, one share of Series C Preferred Stock) in a Reg Y Transfer, and all of which shares of Series D NVCE Stock, upon issuance, will represent the right (on an as converted basis) to receive 315&#160;million shares of Common Stock (clauses (a)&#160;through (d), collectively referred to herein as the &#8220;Investment&#8221;). </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Requisite Stockholder Approvals </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Investment, the Company plans to submit to its stockholders for their (a)&#160;adoption and approval amendments to its Amended and Restated Certificate of Incorporation (the &#8220;Certificate of Incorporation&#8221;) to: (i)&#160;effect at least a <span style="white-space:nowrap">1-3</span> reverse stock split of Common Stock (the &#8220;COI Reverse Stock Split Amendment&#8221;), for among other reasons, to make the bid price more attractive to a broader group of institutional and retail investors; (ii)&#160;increase the number of authorized shares of Common Stock to at least 1,700,000,000 (or, in the event of the approval of the Certificate of Incorporation Reverse Stock Split Amendment, at least 566,670,000) (the &#8220;COI Authorized Share Amendment&#8221;); and (iii)&#160;exempt certain of the Investors and their respective affiliates from the application of a provision of the Certificate of Incorporation that prohibits any person who beneficially owns, directly or indirectly, more than 10% of the then-outstanding shares of Common Stock from voting any such shares of Common Stock in excess of such 10% threshold (the &#8220;COI Exemption Amendment&#8221; and, collectively with the COI Reverse Stock Split Amendment and the COI Authorized Share Amendment, the &#8220;COI Amendments&#8221;); and (b)&#160;approval of the issuance of shares of Common Stock that is 20% or more of the total voting power of the Company&#8217;s securities (the &#8220;Share Issuance&#8221;) in accordance with the rules of the New York Stock Exchange (the &#8220;NYSE&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The requisite vote of our stockholders necessary to duly and validly (a)&#160;adopt and approve the COI Reverse Stock Split Amendment and the COI Authorized Share Amendment requires the affirmative vote of a majority of votes cast by the holders of shares of Common Stock, at a duly held meeting of the Company&#8217;s stockholders, (b)&#160;adopt and approve the COI Exemption Amendment requires the affirmative vote of the holders of a majority of the outstanding shares of Common Stock entitled to vote on the COI Exemption Amendment and (c)&#160;approve the Share Issuance requires the affirmative vote of a majority of votes cast by holders of shares of the Common Stock at a duly convened meeting of stockholders of the Company at which a quorum is present (collectively, other than the COI Reverse Stock Split Amendment, the &#8220;Requisite Stockholder Vote&#8221;; the approval of the Company&#8217;s stockholders of the COI Authorized Share Amendment and the Share Issuance, the &#8220;Requisite Stockholder Approvals&#8221;). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Indemnification </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Investment Agreements, NYCB and each Investor agrees to indemnify the other and their respective affiliates from and against all losses (subject to certain exceptions) directly resulting from (a)&#160;any inaccuracy in or breach of any representation or warranty of such party set forth in the applicable Investment Agreement or (b)&#160;such party&#8217;s breach of any of its agreements or covenants in the applicable Investment Agreement, in each case, subject certain limitations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Additional Investor Rights and Covenants </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Liberty, Hudson Bay and Reverence have each agreed in their Investment Agreements not to convert certain shares of Series B Preferred Stock or Series C Preferred Stock prior to receipt of the Requisite Stockholder Vote. If the Company is not able to obtain the Requisite Stockholder Vote on or before September&#160;9, 2024, the Company will be required to issue to the Investors cash-settled warrants (the &#8220;Incentive Warrants&#8221; and, together with the Issued Warrants, the &#8220;Warrants&#8221;), which would become exercisable 60 days after their issuance if the Requisite Stockholder Votes still have not been obtained at such time. If, however, the Requisite Stockholder Votes are received prior to the expiration of such <span style="white-space:nowrap">60-day</span> period after issuance, the Incentive Warrants will be cancelled. The Incentive Warrants provide the holder thereof the right, until the <span style="white-space:nowrap">ten-year</span> anniversary of the issuance of such warrant, to receive from the Company cash in an amount equal to: (i)&#160;from issuance thereof until (and including) November&#160;7, 2024, 160% of such holder&#8217;s investment in the Company in the Investment; (ii) on (and including) November&#160;8, 2024 until (and including) January&#160;6, 2025, 180% of such holder&#8217;s investment in the Company in the Investment; (iii) on (and including) January&#160;7, 2025 until (and including) March&#160;8, 2025, 200% of such holder&#8217;s investment in the Company in the Investment; and (iv) from and after March&#160;9, 2025, 220% of such holder&#8217;s investment in the Company in the Investment, in each case, net of the exercise price (which would be the amount of such holder&#8217;s investment in the Company in the Investment). The maximum coverage of the Incentive Warrants shall not exceed 220%. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, pursuant to the Liberty Investment Agreement, the Reverence Investment Agreement, and Hudson Bay Investment Agreements, after receipt of antitrust clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the &#8220;HSR Act&#8221;), each of Liberty, Reverence and Hudson Bay have the right at its option to exchange a certain amount of its shares of Series B Preferred Stock into Series C Preferred Stock in a manner that complies with applicable banking laws and regulations, including the rules and limitations of Regulation Y of the BHCA, or with the terms of any <span style="white-space:nowrap">non-objection</span> received by the Federal Reserve Board under the Change in Bank Control Act of 1978, as amended. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the Closing, Liberty became entitled to nominate two representatives to be elected to the Board of Directors of NYCB (the &#8220;NYCB Board&#8221;), subject to (a)&#160;the receipt of certain regulatory approvals, consents or <span style="white-space:nowrap">non-objections</span> and the completion of any applicable waiting periods and (b)&#160;satisfaction of certain eligibility requirements (collectively, &#8220;Eligibility Requirements&#8221;), so long as Liberty and its affiliates beneficially own at least the lesser of (i) 2.5% of the outstanding shares of Common Stock (on an <span style="white-space:nowrap">as-converted</span> basis) or (ii) 25% of the shares of Common Stock (on an <span style="white-space:nowrap">as-converted</span> basis) that Liberty beneficially owns immediately following the Closing. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Reverence Investment Agreement, at the Closing, Reverence became entitled to nominate one representative to be elected to the NYCB Board, subject to Eligibility Requirements, so long as Reverence and its affiliates beneficially own at least (i) 2.5% of the outstanding shares of Common Stock (on an <span style="white-space:nowrap">as-converted</span> basis) or (ii) 25% of the shares of Common Stock (on an <span style="white-space:nowrap">as-converted</span> basis) that Reverence acquired in the Investment. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Certain Other Terms and Conditions of the Investment Agreements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Investment Agreements contain customary representations, warranties and agreements of each party. The Closing was conditioned on, among other things, (a)&#160;the receipt of funding by NYCB (in the aggregate) of at least $600&#160;million pursuant to the Investment Agreements, (b)&#160;there being no further action required to authorize for listing on the NYSE the shares of Common Stock (i)&#160;issued under each Investment Agreement and (ii)&#160;to be issued upon the conversion of the Series C Preferred Stock issued in the Investment and (c)&#160;other customary closing conditions. On March&#160;11, 2024, the conditions to closing in the Investment Agreements were satisfied and the Investment was completed. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Certificates of Designations </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;11, 2024, in connection with the Closing, NYCB filed (a)&#160;a Certificate of Designations with the Secretary of State of the State of Delaware (the &#8220;DE Secretary&#8221;) to create, out of NYCB&#8217;s authorized but unissued preferred stock, the Series B Preferred Stock, (b)&#160;a Certificate of Designations with the DE Secretary to create, out of NYCB&#8217;s authorized but unissued preferred stock, the Series C Preferred Stock, and (c)&#160;a Certificate of Designations with the DE Secretary to create, out of NYCB&#8217;s authorized but unissued preferred stock, the Series D NVCE Stock (collectively, the &#8220;Certificates of Designations&#8221;). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Series B Preferred Stock </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each share of Series B Preferred Stock will automatically convert into 1,000 shares of Common Stock in a Reg Y Transfer, unless such conversion would require the expiration of any applicable waiting period under the HSR Act or receipt of the Requisite Stockholder Approvals, in which case, such shares of Series B Preferred Stock would convert into shares of Series C Preferred Stock. The conversion rate applicable to the Series B Preferred Stock is subject to certain customary anti-dilution adjustments. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of Series B Preferred Stock generally do not have voting rights, except with respect to certain protective matters such as amendments to the Company Certificate of Incorporation or the Certificate of Designations with respect to the Series B Preferred Stock that significantly and adversely affect the preferences, rights, privileges or powers of the Series B Preferred Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the period of time between the Closing and the receipt of the Requisite Stockholder Approvals, the Certificate of Designations with respect to the Series B Preferred Stock provides for quarterly <span style="white-space:nowrap">non-cumulative</span> cash dividends at an annual rate of 13%, as and if declared by the Board. The NYCB Board cannot declare or pay any cash dividend or make cash distributions in respect of any parity Company preferred stock or the Common Stock unless the NYCB Board declares and pays to the holders of Series B Preferred Stock a dividend at the same time. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Certificate of Designations with respect to the Series B Preferred Stock also provides for a per share liquidation preference equal to the Base Price of $2,000 per share. With respect to such liquidation preference, the Series B Preferred Stock ranks pari passu with the Company&#8217;s Series A Preferred Stock and Series C Preferred Stock, and ranks senior to the Common Stock and Series D NVCE Stock. Following the satisfaction of the liquidation preference, the Series B Preferred Stock participates with the Common Stock on an <span style="white-space:nowrap">as-converted</span> basis in a liquidation, dissolution or winding up of the Company. Upon the occurrence of a Reorganization Event (as defined in the Certificate of Designations with respect to the Series B Preferred Stock), the Series B Preferred Stock is entitled to a liquidation preference equal to two times the liquidation preference discussed above. Under these circumstances, the Series B Preferred Stock ranks pari passu with the Company&#8217;s Series A Preferred Stock and Series C Preferred Stock, but senior to the Common Stock and Series D NVCE Stock. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From and after receipt of the Requisite Stockholder Approvals, the foregoing dividend rights and liquidation preferences cease to apply and the holders of Series B Preferred Stock are thereafter entitled to receive dividends at the same time and on the same terms as the holders of Common Stock in an amount equal to the product of the conversion rate then in effect and the per share dividend amount being paid in respect of each share of Common Stock, and shall rank as equal to the Common Stock in any liquidation of the Company. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Series C Preferred Stock </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each share of Series C Preferred Stock will automatically convert into 1,000 shares of Common Stock in a Reg Y Transfer, unless such conversion would require the expiration of any applicable waiting period under the HSR Act or the Requisite Stockholder Approvals, in which case only the maximum number of shares of Series C Preferred Stock that can convert into Common Stock without receipt of the applicable Requisite Stockholder Approval or expiration of any applicable waiting period under the HSR Act will convert into shares of Common Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, upon the expiration or termination of any applicable waiting period (or extension thereof) under the HSR Act applicable to the conversion of shares of Series C Preferred Stock into Common Stock, the maximum number of shares of Series C Preferred Stock that can convert into shares of Common Stock without requiring NYCB stockholder approval will automatically convert into 1,000 shares of Common Stock for each converting share of Series C Preferred Stock. Until receipt of the Requisite Stockholder Approvals, such holders have the right to convert their shares of Series C Preferred Stock into Common Stock, subject to a limit of 22% of the total shares of Series C Preferred Stock held by such holder at the Closing. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon receipt of the Requisite Stockholder Approvals, the remaining shares Series C Preferred Stock will automatically convert into 1,000 shares of Common Stock for each converting share of Series C Preferred Stock. The Certificate of Designations with respect to the Series C Preferred Stock also provides for other automatic conversion scenarios under circumstances where the Requisite Stockholder Approvals are not obtained at the same time or one or both of the Requisite Stockholder Approvals are obtained before the expiration of the applicable waiting period under the HSR Act. The conversion rate applicable to the Series C Preferred Stock is subject to certain customary anti-dilution adjustments. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of Series C Preferred Stock generally do not have voting rights, except with respect to certain protective matters such as amendments to the Company Certificate of Incorporation or the Certificate of Designations with respect to the Series C Preferred Stock that significantly and adversely affect the preferences, rights, privileges or powers of the Series C Preferred Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Certificate of Designations with respect to the Series C Preferred Stock provides for quarterly <span style="white-space:nowrap">non-cumulative</span> cash dividends at an annual rate of 13%, as and if declared by the NYCB Board. The NYCB Board cannot declare or pay any cash dividend or make cash distributions in respect of any parity Company preferred stock or the Common Stock unless the NYCB Board declares and pays to the holders of Series C Preferred Stock a dividend at the same time. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Certificate of Designations with respect to the Series C Preferred Stock also provides for a per share liquidation preference equal to the Base Price of $2,000 per share. With respect to such liquidation preference, the Series C Preferred Stock ranks pari passu with the Company&#8217;s Series A Preferred Stock and Series B Preferred Stock, and ranks senior to the Common Stock and Series D NVCE Stock. Following the satisfaction of the liquidation preference, the Series C Preferred Stock participates with the Common Stock on an <span style="white-space:nowrap">as-converted</span> basis in a liquidation, dissolution or winding up of the Company. Upon the occurrence of a Reorganization Event (as defined in the Certificate of Designations with respect to the Series C Preferred Stock), the Series C Preferred Stock is entitled to a liquidation preference equal to two times the liquidation preference discussed above. Under these circumstances, the Series C Preferred Stock ranks pari passu with the Series A Preferred Stock and Series B Preferred Stock, but senior to the Company&#8217;s Common Stock and Series D NVCE Stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Series D NVCE Stock </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has not issued any shares of Series D NVCE Stock. The Series D NVCE Stock is issuable only upon exercise of the Issued Warrants, as described below. </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each share of Series D NVCE Stock will automatically convert into 1,000 shares of Common Stock in a Reg Y Transfer, unless such conversion would require the expiration of any applicable waiting period under the HSR Act or the receipt of the Requisite Stockholder Approvals, in which case, only the maximum number of shares of Series D NVCE Stock that can convert into Common Stock without receipt of the Requisite Stockholder Approvals or expiration of any applicable waiting period under the HSR Act will convert into shares of Common Stock. The conversion rate applicable to the Series D NVCE Stock is subject to certain customary anti-dilution adjustments. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of Series D NVCE Stock generally do not have voting rights, except with respect to certain protective matters such as amendments to the Certificate of Incorporation or the Certificate of Designations with respect to the Series D NVCE Stock that significantly and adversely affect the preferences, rights, privileges or powers of the Series D NVCE Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of Series D NVCE Stock are entitled to receive dividends at the same time and on the same terms as the holders of Common Stock in an amount equal to the product of the conversion rate then in effect and the per share dividend amount being paid in respect of each share of Common Stock. The NYCB Board cannot declare or pay any cash dividend or make cash distributions in respect of the Common Stock unless the NYCB Board declares and pays to the holders of Series D NVCE Stock at the same time and on the same terms as the holders of Common Stock, the dividend to which the shares of Series D NVCE Stock are entitled. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of any liquidation, dissolution or winding up of the affairs of the Company, holders of the Series D NVCE Stock are entitled to receive, in preference to the holders of the Common Stock, an amount per share equal to $0.0001. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither NYCB nor any holders will have redemption rights with respect to either series of Preferred Stock or the Series D NVCE Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, notwithstanding anything to the contrary set forth in their respective Investment Agreements, the Certificates of Designations or the Issued Warrants, certain Investors are restricted from converting, exchanging or exercising its Preferred Stock, Series D NVCE Stock and/or Issued Warrants to the extent such conversion, exchange or exercise would result in such Investor together with its affiliates beneficially owning in excess of 9.99% of the shares of Common Stock then outstanding. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Registration Rights Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;11, 2024, NYCB entered into a Registration Rights Agreement with each Investor (the &#8220;Registration Rights Agreement&#8221;), pursuant to which NYCB will provide customary registration rights to the Investors and their affiliates and certain permitted transferees with respect to, among other things, (a)&#160;the shares of Common Stock purchased under the Investment Agreements, (b)&#160;shares of Common Stock issued upon the conversion of shares of the Preferred Stock and exercise of the Issued Warrants purchased under the Investment Agreements, (c)&#160;if the Requisite Stockholder Votes are not received on or before 120 days after the Closing, the shares of Preferred Stock and (d)&#160;the Warrants. Under the Registration Rights Agreement, the Investors are entitled to customary shelf registration rights (which will initially be on a Form <span style="white-space:nowrap">S-1</span> and the Company will use commercially reasonable efforts to promptly convert the shelf registration statement on Form <span style="white-space:nowrap">S-1</span> into a shelf registration statement on Form <span style="white-space:nowrap">S-3,</span> subject to certain limitations as set forth in the Registration Rights Agreement) and customary piggyback registration rights, in each case, subject to certain limitations as set forth in the Registration Rights Agreement. Liberty and Reverence will additionally be entitled to request a certain number of marketed and unmarketed underwritten shelf takedowns and shall have the right to select the managing underwriter to administer any underwritten shelf takedowns provided the selection is reasonably acceptable to the Company. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Issued Warrants </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;11, 2024, pursuant to the Investment Agreements, NYCB issued the Issued Warrants to purchase (in the aggregate) approximately 315,000 shares of Series D NVCE Stock, each at an exercise price of $2,500 per share, subject to customary anti-dilution adjustments provided under the Issued Warrants. On and following September&#160;10, 2024, and prior to 5:00 pm (New York City time) on March&#160;11, 2031, the Issued Warrants may be exercised, on a net share settlement basis, by the holder thereof. Prior to September&#160;10, 2024, the Investors (and certain affiliates of the Investors) are prohibited from (a)&#160;transferring, selling or disposing of any shares of Common Stock or Preferred Stock or the Issued Warrant issued pursuant to an applicable Investment Agreement (subject to certain exceptions, such as certain transfers to affiliates), or (b)&#160;effecting or entering any short sale or similar hedge of any shares of Common Stock or Preferred Stock or the Issued Warrant (subject to certain exceptions). Failure to comply with the foregoing restrictions will result in the applicable holder of the Issued Warrant automatically forfeiting such warrant. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Exhibits </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing descriptions of the Liberty Investment Agreement, Hudson Bay Investment Agreements, Reverence Investment Agreement, Certificates of Designations of the Series B Preferred Stock, Series C Preferred Stock, Series D NVCE Stock, Registration Rights Agreement, Issued Warrant and Incentive Warrant, (collectively, the &#8220;Transaction Agreements&#8221;) and the transactions contemplated thereby are not complete and are subject to and qualified in their entirety by reference to the full text of such agreements, copies of which are attached to this Current Report on Form <span style="white-space:nowrap">8-K</span> as Exhibit&#160;3.1, Exhibit 3.2, Exhibit 3.3, Exhibit&#160;3.4, Exhibit&#160;4.1, Exhibit&#160;10.1, Exhibit&#160;10.2, Exhibit&#160;10.3 and Exhibit&#160;10.4, respectively, and are incorporated herein by reference. The Investment Agreements entered into with the other Investors are substantially similar in all material respects to the Investment Agreements attached to this Current Report on Form <span style="white-space:nowrap">8-K</span> (however, such Investment Agreements of the other Investors omit the corporate governance provisions contained in the Investment Agreements attached hereto). </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;3.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Unregistered Sales of Equity Securities </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information set forth in Item 1.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated by reference into this Item 3.02. The issuances pursuant to the Investment Agreements of shares of Common Stock, Preferred Stock, and Warrants are exempt from registration under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), by virtue of the exemption provided by Section&#160;4(a)(2) of the Securities Act. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.02. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Resignation of Directors </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the completion of the Investment, Thomas Cangemi, James Carpenter, Leslie Dunn, Lawrence Rosano Jr, Ronald Rosenfeld and Robert Wann (the &#8220;Resigning Directors&#8221;) resigned as members of the NYCB Board, effective as of March&#160;11, 2024. The resignations of the Resigning Directors were not the result, in whole or in part, of any disagreement with NYCB or NYCB&#8217;s management relating to NYCB&#8217;s operations, policies or practices. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Investment, on March&#160;7, 2024, David Treadwell gave notice to NYCB of his intention to resign as a member of the NYCB Board, effective upon the qualification of his successor. Mr.&#160;Treadwell continues to serve as a member of the NYCB Board and will do so until a successor is qualified as a member of the NYCB Board. The resignation of Mr.&#160;Treadwell was not the result, in whole or in part, of any disagreement with NYCB or NYCB&#8217;s management relating to NYCB&#8217;s operations, policies or practices. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Investment, on March&#160;7, 2024, Lawrence Savarese gave notice to NYCB of his intention to resign as a member of the NYCB Board, effective immediately following the filing of NYCB&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the fiscal year ended December&#160;31, 2023 (the &#8220;2023 Form <span style="white-space:nowrap">10-K&#8221;).</span> Mr.&#160;Savarese continues to serve as a member of the NYCB Board and will do so until the 2023 Form <span style="white-space:nowrap">10-K</span> is filed. The resignation of Mr.&#160;Savarese was not the result, in whole or in part, of any disagreement with NYCB or NYCB&#8217;s management relating to NYCB&#8217;s operations, policies or practices. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Continued Service of Directors </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The six directors of NYCB as of immediately prior to the completion of the Investment that continue to serve on the Board are as follows: Alessandro P. DiNello, Marshall J. Lux, Larry J. Savarese, Peter Schoels, David L. Treadwell and Jennifer R. Whip. As noted above, Messrs. Savarese and Treadwell provided notice of an intent to resign subject to certain events. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Newly Appointed Directors </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the completion of the Investment, Former Treasury Secretary Steven Mnuchin, Joseph Otting, Milton Berlinski, and Allen Puwalski (the &#8220;New Directors&#8221;) were appointed to the NYCB Board, effective March&#160;11, 2024. The New Directors were appointed to the NYCB Board to fill the vacancies resulting from the resignations of the Resigning Directors, and the size of NYCB Board was set at ten directors. The NYCB Board continues to be divided into three classes, with Mr.&#160;Mnuchin and Mr.&#160;Otting appointed to the term of the NYCB Board that expires at the 2026 annual meeting of stockholders, Mr.&#160;Allen Puwalski appointed to the term of the NYCB Board that expires at the 2025 annual meeting of stockholders and Mr.&#160;Berlinski appointed to the term of the NYCB Board that expires at the 2024 annual meeting of stockholders. </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;DiNello will remain the Executive Chairman of the NYCB Board until April&#160;1, 2024. Mr.&#160;Mnuchin was appointed to the newly created position of Lead Independent Director of the NYCB Board. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Board Committee Assignments </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the completion of the Investment, the membership of committees of the NYCB Board have been reconstituted as follows: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Audit Committee</span>: Mr.&#160;Savarese (Chair), Mr.&#160;Lux, Mr.&#160;Puwalski, Ms.&#160;Whip </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Compensation Committee</span>: Mr.&#160;Berlinski (Chair), Mr.&#160;Mnuchin, Mr.&#160;Puwalski, Mr.&#160;Schoels </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Executive Committee: Mr.&#160;DiNello (Chair), Mr.&#160;Mnuchin, Mr.&#160;Otting </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Nominating and Corporate Governance Committee</span>: Mr.&#160;Mnuchin (Chair), Mr.&#160;Berlinski, Mr.&#160;Schoels, Ms.&#160;Whip </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Risk Assessment Committee</span>: Mr.&#160;Puwalski (Chair), Mr.&#160;Lux, Mr.&#160;Treadwell, Ms.&#160;Whip </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Technology Committee</span>: Mr.&#160;Lux (Chair), Mr.&#160;DiNello, Mr.&#160;Otting, Ms.&#160;Whip </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Appointment of Joseph Otting as President and Chief Executive Officer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the Employment Agreement Term Sheet between the Company and Joseph Otting, filed as Exhibit 10.1 to the Form <span style="white-space:nowrap">8-K</span> filed on March&#160;8, 2024 with the SEC (the &#8220;Otting Term Sheet&#8221;), Joseph Otting will assume the role of President and Chief Executive Officer of the Company as of April&#160;1, 2024. The disclosure under Item 5.02 thereto, as well as the Otting Term Sheet, is incorporated by reference hereto. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joseph M. Otting, age 66, is an American businessman and government official. He served as the 31st Comptroller of the Currency from November 2017 to 2020, and has since served as Lead Director and Chairman of the Audit Committee for Black Knight, Inc. from June 2020 until September 2023, as Chairman of the Board of Directors of Andalusian Credit Company, LLC since August 2023, on the Board of Directors and as Chair of the Audit and Risk Committee for Blockchain.com since November 2022, and on the Board of Directors to Talino Ventures since August 2022. In the nonprofit space, he has served on the Governing Board of Operation Hope since September 2020 and a director on OASIS Center International&#8217;s board since October 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to becoming Comptroller of the Currency, Mr.&#160;Otting was an executive in the banking industry. He served as President of CIT Bank and <span style="white-space:nowrap">Co-President</span> of CIT Group from August 2015 to December 2015. Mr.&#160;Otting previously was President, Chief Executive Officer, and a member of the Board of Directors of OneWest Bank, N.A. Prior to joining OneWest Bank, he served as Vice Chairman of U.S. Bancorp, where he managed the Commercial Banking Group and served on the Bancorp&#8217;s executive management committee. He also served as a member of U.S. Bank&#8217;s main subsidiary banks&#8217; Board of Directors. From 1994 to 2001, Mr.&#160;Otting was with Union Bank of California, where he was Executive Vice President and Group Head of Commercial Banking. Before joining Union Bank, he was with Bank of America and held positions in branch management, preferred banking, and commercial lending. Mr.&#160;Otting has played significant roles in charitable and community development organizations. He has served as a board member for the California Chamber of Commerce, the Killebrew-Thompson Memorial foundation, the Associated Oregon Industries, the Oregon Business Council, the Portland Business Alliance, the Minnesota Chamber of Commerce, and Blue Cross Blue Shield of Oregon. He was also a member of the Financial Services Roundtable, the Los Angeles Chamber of Commerce, and the Board and Executive Committee of the Los Angeles Economic Development Corporation. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Otting holds a bachelor of arts in management from the University of Northern Iowa and is a graduate of the School of Credit and Financial Management, which was held at Dartmouth College in Hanover, New Hampshire. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic"><span style="white-space:nowrap">Non-Participation</span> of Directors and Officers in the Investment </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No directors or officers of NYCB prior to the Closing gave consideration for, received shares pursuant to, or participated in any compensatory manner in the Investment. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.03</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Investment and the director resignations and appointments described in Item 5.02 above, on March&#160;10, 2024, the bylaws of the Company were amended (the &#8220;Bylaws Amendment&#8221;) to reflect certain governance matters, including (i)&#160;the removal of Article IX of the bylaws of the Company (including removal of the position of the Presiding Director), (ii)&#160;the establishment of the position of the Lead Independent Director and (iii)&#160;that the position of the Executive Chairman of the Board shall cease to exist on April&#160;1, 2024 and its replacement with the position of the Chairman of the Board, which Bylaws Amendment was implemented through an amendment and restatement of the Company&#8217;s bylaws (the &#8220;Amended and Restated Bylaws&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing summary of the Bylaws Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amended and Restated Bylaws, a copy of which (marked to show changes from the prior version) is filed as Exhibit&#160;3.1 to this Current Report and is incorporated herein by reference. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;7.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;11, 2024, the Company issued a press release announcing the completion of the Investment. A copy of the press release is attached hereto as Exhibit 99.1. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Description&#160;of&#160;Exhibit</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;3.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d763888dex31.htm">Amended and Restated Bylaws</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;3.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d763888dex32.htm">Certificate of Designations for Series B Noncumulative Convertible Preferred Stock</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;3.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d763888dex33.htm">Certificate of Designations for Series C Noncumulative Convertible Preferred Stock</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;3.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d763888dex34.htm">Certificate of Designations for Series D NVCE Stock</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d763888dex41.htm">Form of Issued Warrant </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d763888dex101.htm">Liberty Investment Agreement, dated March&#160;7, 2024 (and as amended on March&#160;11, 2024), by and between NYCB and Liberty* </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d763888dex102.htm">Form of Hudson Bay Investment Agreements, dated March&#160;7, 2024 (and as amended on March&#160;11, 2024), by and between NYCB and Hudson Bay* </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d763888dex103.htm">Reverence Investment Agreement, dated March&#160;7, 2024 (and as amended on March&#160;11, 2024), by and between NYCB and Reverence.* </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d763888dex104.htm">Registration Rights Agreement, dated March&#160;11, 2024, by and between NYCB and the Investors.* </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d763888dex991.htm">Press Release of NYCB, dated March&#160;11, 2024 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pursuant to Item 601(a)(5) of Regulation <span style="white-space:nowrap">S-K,</span> certain schedules and similar attachments have been omitted. The registrant hereby agrees to furnish a copy of any omitted schedule or similar attachment to the SEC upon request. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cautionary Note Regarding Forward-Looking Statements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing disclosures may include <span style="white-space:nowrap">forward-looking</span> statements within the meaning of the federal securities laws by the Company pertaining to such matters as our goals, intentions, and expectations regarding the convertibility of the shares of preferred stock and exercisability of the warrants issued in connection with the Investment; the Company&#8217;s seeking (and the Company&#8217;s ability to obtain) approval of its stockholders of any necessary amendments of the Company&#8217;s organizational documents or approvals of the issuance of shares of common stock or preferred stock in connection with the Investment; receipt of any required regulatory approvals or <span style="white-space:nowrap">non-objections</span> in connection with the Investment; revenues, earnings, loan production, asset quality, capital levels, and acquisitions, among other matters; our estimates of future costs and benefits of the actions we may take; our assessments of </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
probable losses on loans; our assessments of interest rate and other market risks; and our ability to achieve our financial and other strategic goals, including those related to our merger with Flagstar Bancorp, Inc., which was completed on December&#160;1, 2022, the purchase and assumption of certain assets and liabilities of Signature Bridge Bank beginning March&#160;20, 2023 (the &#8220;Signature Transaction&#8221;), and our transition to a $100&#160;billion plus bank. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">Forward-looking</span> statements are typically identified by such words as &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;outlook,&#8221; &#8220;estimate,&#8221; &#8220;forecast,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; and other similar words and expressions, and are subject to numerous assumptions, risks, and uncertainties, which change over time. Additionally, <span style="white-space:nowrap">forward-looking</span> statements speak only as of the date they are made; the Company does not assume any duty, and does not undertake, to update our <span style="white-space:nowrap">forward-looking</span> statements. Furthermore, because <span style="white-space:nowrap">forward-looking</span> statements are subject to assumptions and uncertainties, actual results or future events could differ, possibly materially, from those anticipated in our statements, and our future performance could differ materially from our historical results. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our <span style="white-space:nowrap">forward-looking</span> statements are subject to the following principal risks and uncertainties: general economic conditions and trends, either nationally or locally; conditions in the securities markets; changes in interest rates; changes in deposit flows, and in the demand for deposit, loan, and investment products and other financial services; changes in real estate values; changes in the quality or composition of our loan or investment portfolios; changes in future allowance for credit losses requirements under relevant accounting and regulatory requirements; the ability to pay future dividends at currently expected rates; changes in our capital management and balance sheet strategies and our ability to successfully implement such strategies; changes in competitive pressures among financial institutions or from <span style="white-space:nowrap">non-financial</span> institutions; changes in legislation, regulations, and policies; the success of our blockchain and fintech activities, investments and strategic partnerships; the restructuring of our mortgage business; the impact of failures or disruptions in or breaches of the Company&#8217;s operational or security systems, data or infrastructure, or those of third parties, including as a result of cyberattacks or campaigns; the impact of natural disasters, extreme weather events, military conflict (including the Russia/Ukraine conflict, the conflict in Israel and surrounding areas, the possible expansion of such conflicts and potential geopolitical consequences), terrorism or other geopolitical events; and a variety of other matters which, by their nature, are subject to significant uncertainties and/or are beyond our control. Our forward-looking statements are also subject to the following principal risks and uncertainties with respect to our merger with Flagstar Bancorp, which was completed on December&#160;1, 2022, and the Signature Transaction; the possibility that the anticipated benefits of the transactions will not be realized when expected or at all; the possibility of increased legal and compliance costs, including with respect to any litigation or regulatory actions related to the business practices of acquired companies or the combined business; diversion of management&#8217;s attention from ongoing business operations and opportunities; the possibility that the Company may be unable to achieve expected synergies and operating efficiencies in or as a result of the transactions within the expected timeframes or at all; and revenues following the transactions may be lower than expected. Additionally, there can be no assurance that the Community Benefits Agreement entered into with NCRC, which was contingent upon the closing of the Company&#8217;s merger with Flagstar Bancorp, Inc., will achieve the results or outcome originally expected or anticipated by us as a result of changes to our business strategy, performance of the U.S. economy, or changes to the laws and regulations affecting us, our customers, communities we serve, and the U.S. economy (including, but not limited to, tax laws and regulations). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">More information regarding some of these factors is provided in the Risk Factors section of our Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2022, Quarterly Reports on Form <span style="white-space:nowrap">10-Q</span> for the quarters ended March&#160;31, 2023, June&#160;30, 2023, and September&#160;30, 2023 and in other SEC reports we file. Our <span style="white-space:nowrap">forward-looking</span> statements may also be subject to other risks and uncertainties, including those we may discuss in this Amendment, during investor presentations, or in our other SEC filings, which are accessible on our website and at the SEC&#8217;s website, www.sec.gov. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Important Information and Where You Can Find It </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K</span> may be deemed to be solicitation material in respect of a charter amendment and other approvals by the stockholders of the Company. In connection with the Requisite Stockholder Approvals, NYCB will file with the SEC a preliminary proxy statement and a definitive proxy statement, which will be sent to the stockholders of NYCB, seeking certain approvals related to the issuances of shares of common stock issued under each Investment Agreement and to be issued upon the conversion of shares of the preferred stock issued under the Investment Agreements. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">INVESTORS AND SECURITY HOLDERS OF NYCB AND THEIR RESPECTIVE AFFILIATES ARE URGED TO READ, WHEN AVAILABLE, THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH THE TRANSACTION, AS WELL AS ANY </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT NYCB AND THE TRANSACTION.&#160;Investors and security holders will be able to obtain a free copy of the proxy statement, as well as other relevant documents filed with the SEC containing information about NYCB, without charge, at the SEC&#8217;s website (http://www.sec.gov). Copies of documents filed with the SEC by NYCB can also be obtained, without charge, by directing a request to Investor Relations, New York Community Bancorp, Inc.,&#160;102 Duffy Avenue, Hicksville, New York 11801 or by telephone <span style="white-space:nowrap"><span style="white-space:nowrap">(516-683-4420).</span></span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Participants in the Solicitation of Proxies in Connection with Proposed Transaction </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NYCB and certain of their respective directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in respect of the Requisite Stockholder Approvals under the rules of the SEC.&#160;Information regarding NYCB&#8217;s directors and executive officers is available in its definitive proxy statement for its 2023 annual stockholders meeting, which was filed with the SEC on&#160;April 21, 2023, and certain of its Current Reports on Form <span style="white-space:nowrap">8-K.</span> Other information regarding the participants in the solicitation of proxies in respect of such stockholder approvals and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement and other relevant materials to be filed with the SEC. Free copies of these documents, when available, may be obtained as described in the preceding paragraph. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Not an Offer of Securities </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in this Current Report on Form <span style="white-space:nowrap">8-K</span> is for informational purposes only and shall not constitute, or form a part of, an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities. The securities that are the subject of the private placement have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the U.S. absent registration or an applicable exemption from registration requirements. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:47%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:46%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">NEW&#160;YORK&#160;COMMUNITY&#160;BANCORP,&#160;INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt" colspan="3"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">Date: March&#160;14 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Salvatore J. DiMartino</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Salvatore J. DiMartino</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-style:italic">Executive Vice President and Director of Investor Relations</span></td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>d763888dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT 3.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NEW YORK COMMUNITY BANCORP, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BYLAWS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Amended and
Restated as of<FONT STYLE="font-family:Times New Roman" COLOR="#ff0000"><STRIKE> February&nbsp;8</STRIKE></FONT><FONT STYLE="font-family:Times New Roman" COLOR="#0000ff"><U STYLE="border-bottom:1pt double; padding-bottom:1pt">March 10</U></FONT>,
2024) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE I - STOCKHOLDERS </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;1. Annual Meeting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An annual
meeting of the stockholders, for the election of Directors to succeed those whose terms expire and for the transaction of such other business as may properly come before the meeting, shall be held at such place, on such date, and at such time as the
Board of Directors shall each year fix, which date shall be within thirteen (13)&nbsp;months subsequent to the later of the date of incorporation or the last annual meeting of stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;2. Special Meetings. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
the rights of the holders of any class or series of preferred stock of the Corporation, special meetings of stockholders of the Corporation may be called only by the Board of Directors pursuant to a resolution adopted by a majority of the Whole
Board. The term &#147;Whole Board&#148; shall mean the total number of Directors which the Corporation would have if there were no vacancies on the Board of Directors (hereinafter the &#147;Whole Board&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;3. Notice of Meetings. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Written
notice of the place, date, and time of all meetings of the stockholders shall be given, not less than ten (10)&nbsp;nor more than sixty (60)&nbsp;days before the date on which the meeting is to be held, to each stockholder entitled to vote at such
meeting, except as otherwise provided herein or required by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When a meeting is adjourned to another place, date, or time, written
notice need not be given of the adjourned meeting if the place, date, and time thereof are announced at the meeting at which the adjournment is taken; provided, however, that if the date of any adjourned meeting is more than thirty (30)&nbsp;days
after the date for which the meeting was originally noticed, or if a new record date is fixed for the adjourned meeting, written notice of the place, date, and time of the adjourned meeting shall be given in conformity herewith. At any adjourned
meeting, any business may be transacted which might have been transacted at the original meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;4. Quorum. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any meeting of the stockholders, the holders of a majority of all of the shares of the stock entitled to vote at the meeting, present in
person or by proxy (after giving effect to the provisions of Article FOURTH of the Corporation&#146;s Certificate of Incorporation), shall constitute a quorum for all purposes, unless or except to the extent that the presence of a larger number may
be required by law. Where a separate vote by a class or classes is required, a majority of the shares of such class or classes present in person or represented by proxy (after giving effect to the provisions of Article FOURTH of the
Corporation&#146;s Certificate of Incorporation) shall constitute a quorum entitled to take action with respect to that vote on that matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a quorum shall fail to attend any meeting, the Chief Executive Officer or the holders of a majority of the shares of stock entitled to vote
who are present, in person or by proxy, may adjourn the meeting to another place, date, or time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;5. Organization. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Chairman of the Board of the Corporation or, in the absence of a Chairman of the Board or at his or her delegation, the Chief Executive
Officer of the Corporation shall call to order any meeting of the stockholders and preside over the meeting (such person, the &#147;Chairman of the Meeting&#148;). In the absence of the Secretary of the Corporation, the secretary of the meeting
shall be such person as the Chairman of the Meeting appoints.GGGGG </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;6. Conduct of Business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Chairman of the Meeting of any meeting of stockholders shall determine the order of business and the procedures at the meeting,
including such regulation of the manner of voting and the conduct of discussion as seem to him or her in order. The date and time of the opening and closing of the polls for each matter upon which the stockholders will vote at the meeting shall be
announced at the meeting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) At any annual meeting of the stockholders, only such business shall be conducted as shall have been brought
before the meeting (i)&nbsp;by or at the direction of the Board of Directors or (ii)&nbsp;by any stockholder of the Corporation who is entitled to vote with respect thereto and who complies with the notice procedures set forth in this
Section&nbsp;6(b) or, in the case of a director nomination, Section&nbsp;6(c) or Section&nbsp;8 of this Article I of these Bylaws. For business to be properly brought before an annual meeting by a stockholder under this Section&nbsp;6(b), the
business must relate to a proper subject matter for stockholder action and the stockholder must have given timely notice thereof in writing to the Secretary of the Corporation. To be timely, a stockholder&#146;s notice must be delivered or mailed to
and received at the principal executive office of the Corporation not less than ninety (90)&nbsp;days prior to the date of the annual meeting; provided, however, that in the event that less than one hundred (100)&nbsp;days&#146; notice or prior
public disclosure of the date of the meeting is given or made to stockholders, notice by the stockholder to be timely must be received not later than the close of business on the tenth day following the day on which such notice of the date of the
annual meeting was mailed or such public disclosure was made. A stockholder&#146;s notice to the Secretary shall set forth as to each matter such stockholder proposes to bring before the annual meeting (i)&nbsp;a brief description of the business
desired to be brought before the annual meeting and the reasons for conducting such business at the annual meeting, (ii)&nbsp;the name and address, as they appear on the Corporation&#146;s books, of the stockholder proposing such business,
(iii)&nbsp;the class and number of shares of the Corporation&#146;s capital stock that are beneficially owned by such stockholder, (iv)&nbsp;any material interest of such stockholder in such business, and (v)&nbsp;whether and the extent to which any
hedging derivative or other transaction is in place or has been entered into within the prior six months preceding the date of delivery of the stockholder&#146;s notice by or for the benefit of such stockholder with respect to the Corporation or its
subsidiaries or any of their respective securities, debt instruments or credit ratings, the effect or intent of which transaction is to give rise to gain or loss as a result of changes in the trading price of such securities or debt instruments or
changes in the credit ratings for the Corporation, its subsidiaries or any of their respective securities or debt instruments (or, more generally, changes in the perceived creditworthiness of the Corporation or its subsidiaries), or to increase or
decrease the voting power of such stockholder, and if so, a summary of the material terms thereof. Notwithstanding anything in these Bylaws to the contrary, no business shall be brought before or conducted at an annual meeting except in accordance
with the provisions of this Section&nbsp;6(b) (or, in the case of a director nomination, Section&nbsp;6(c) or Section&nbsp;8 of this Article 1 of these Bylaws). The Chairman of the Meeting shall, if the facts so warrant, determine and declare to the
meeting that business was not properly brought before the meeting in accordance with the provisions of this Section&nbsp;6(b) and, if he or she should so determine, he or she shall so declare to the meeting and any such business so determined to be
not properly brought before the meeting shall not be transacted. At any special meeting of the stockholders, only such business shall be conducted as shall have been brought before the meeting by or at the direction of a majority of the Whole Board
of Directors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Only persons who are nominated in accordance with the procedures set forth in these Bylaws shall be eligible for
election as Directors. Nominations of persons for election to the Board of Directors of the Corporation may be made at a meeting of stockholders at which Directors are to be elected only (i)&nbsp;by or at the direction of the Board of Directors or
(ii)&nbsp;by any stockholder of the Corporation entitled to vote for the election of Directors at the meeting who complies with the notice procedures set forth in this Section&nbsp;6(c) or Section&nbsp;8 of this Article 1 of these Bylaws. Such
nominations, other than those made by or at the direction of the Board of Directors, shall be made by timely notice in writing to the Secretary of the Corporation. To be timely under this Section&nbsp;6(c), a stockholder&#146;s notice shall be
delivered or mailed to and received at the principal executive office of the Corporation not less than ninety (90)&nbsp;days prior to the date of the meeting; provided, however, that in the event that less than one hundred (100)&nbsp;days&#146;
notice or prior disclosure of the date of the meeting is given or made to stockholders, notice by the stockholder to be timely must be so received not later than the close of business on the 10th day following the day on which such notice of the
date of the meeting was mailed or such public disclosure was made. Such stockholder&#146;s notice shall set forth (i)&nbsp;as to each person whom such stockholder proposes to nominate for election or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">re-election as a Director, all information relating to such person that is required to be disclosed in
solicitations of proxies for election of Directors, or is otherwise required, in each case pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended (including such person&#146;s written consent to being named in the proxy
statement as a nominee and to serving as a Director if elected); and (ii)&nbsp;as to the stockholder giving the notice (f)&nbsp;the name and address, as they appear on the Corporation&#146;s books, of such stockholder, (y)&nbsp;the class and number
of shares of the Corporation&#146;s capital stock that are beneficially owned by such stockholder, and (z)&nbsp;whether and the extent to which any hedging, derivative or other transaction is in place or has been entered into within the prior six
months preceding the date of delivery of the stockholder&#146;s notice by or for the benefit of such stockholder with respect to the Corporation or its subsidiaries or any of their respective securities, debt instruments or credit ratings, the
effect or intent of which transaction is to give rise to gain or loss as a result of changes in the trading price of such securities or debt instruments or changes in the credit ratings for the Corporation, its subsidiaries or any of their
respective securities or debt instruments (or, more generally, changes in the perceived creditworthiness of the Corporation or its subsidiaries), or to increase or decrease the voting power of such stockholder, and if so, a summary of the material
terms thereof. At the request of the Board of Directors, any person nominated by the Board of Directors for election as a Director shall furnish to the Secretary of the Corporation that information required to be set forth in a stockholder&#146;s
notice of nomination which pertains to the nominee. No person shall be eligible for election by stockholders as a Director of the Corporation unless nominated by the Board of Directors or nominated in accordance with the provisions of this
Section&nbsp;6(c) or Section&nbsp;8 of this Article 1 of these Bylaws. The Chairman of the Meeting shall, if the facts so warrant, determine that a nomination was not made in accordance with such sections and, if he or she shall so determine, he or
she shall so declare to the meeting and the defective nomination shall be disregarded. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7. Proxies and Voting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A stockholder may execute a writing authorizing another person or persons to act for such stockholder as proxy. Execution may be accomplished
by the stockholder or such stockholder&#146;s authorized officer, director, employee or agent signing such writing or causing such person&#146;s signature to be affixed to such writing by any reasonable means including, but not limited to, by
facsimile signature. A stockholder may authorize another person or persons to act for such stockholder as proxy by transmitting or authorizing the transmission of a telegram, cablegram, or other means of electronic transmission to the person who
will be the holder of the proxy or to a profit solicitation firm, proxy support service organization or like agent duly authorized by the person who will be the holder of the proxy to receive such transmission, provided that any such telegram,
cablegram or other means of electronic transmission must either set forth or be submitted with information from which it can be determined that the telegram, cablegram or other electronic transmission was authorized by stockholder. Any copy,
facsimile telecommunication or other reliable reproduction of the writing or transmission created pursuant to this paragraph may be substituted or used in lieu of the original writing or transmission for any and all purposes for which the original
writing or transmission could be used, provided that such copy, facsimile telecommunication or other reproduction shall be a complete reproduction of the entire original writing or transmission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All voting, including the election of Directors but excepting where otherwise required by law or by the governing documents of the
Corporation, may be made by a voice vote; provided, however, that upon demand therefore by a stockholder entitled to vote his or her proxy, a stock vote shall be taken. Every stock vote shall be taken by ballot, each of which shall state the name of
the stockholder or proxy voting and such other information as may be required under the procedures established for the meeting. The Board of Directors shall, in advance of any meeting of stockholders, appoint one or more inspectors to act at the
meeting and make a written report thereof. The Board of Directors may designate one or more persons as alternate inspectors to replace any inspector who fails to act. If no inspector or alternate is able to act at a meeting of stockholders, the
Chairman of the Meeting shall appoint one or more inspectors to act at the meeting. Each inspector, before entering upon the discharge of his duties, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality
and according to the best of his ability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in the Certificate of Incorporation with respect to directors to
be elected by the holders of any class or series of preferred stock of the Corporation and in these Bylaws with respect to the filling of vacancies on the Board of Directors, each director shall be elected by a majority of the votes cast with
respect to such director at any meeting of stockholders duly called and at which a quorum is present and directors are to be elected; <U>provided</U>, however, that the directors shall be elected by a plurality of the votes cast at a meeting of the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">stockholders duly called and at which a quorum is present and directors are to be elected if, in connection
with such meeting (i)&nbsp;the Secretary of the Corporation shall have received one or more notices that a stockholder has nominated or proposes to nominate a person or persons for election as a director, which notice(s) purports to be in compliance
with the advance notice requirements set forth in Section&nbsp;6 or Section&nbsp;8 of this Article I of the Bylaws or applicable rules promulgated by the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended,
irrespective of whether the Board of Directors thereafter determines that any such notice(s) is (are) not in compliance with such requirements, and (ii)&nbsp;as of the fourteenth (14th)&nbsp;day preceding the date on which notice of such meeting of
the stockholders is first mailed or otherwise given in accordance with applicable law to the stockholders of the Corporation, such nomination or proposed nomination has not been withdrawn by such stockholder and would thereby cause the number of
nominees and proposed nominees to elect the number of directors to be elected at such meeting, as determined by the Secretary of the Corporation, irrespective of whether such nomination or proposed nomination is thereafter withdrawn by such
stockholder (a &#147;Contested Election&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the directors are to be elected by a plurality of the votes cast pursuant to the
provisions of the immediately preceding sentence, stockholders shall not be permitted to vote &#147;against&#148; any one or more nominees but shall only be permitted to vote &#147;for&#148; one or more nominees or withhold their votes with respect
to one or more nominees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes hereof, a majority of the votes cast means the number of votes cast &#147;for&#148; a director
nominee must elect the number of votes cast &#147;against&#148; that director nominee, with abstentions and broker non-votes not counted as a vote cast either &#147;for&#148; or &#147;against&#148; that director nominee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, in any election of directors of the Corporation which is not a Contested Election, an incumbent director does not receive a majority of
the votes cast, such incumbent director shall promptly following certification of the election results tender an irrevocable resignation as a director, subject to acceptance or rejection thereof or other action with respect thereto by the Board, for
consideration by the Nominating and Corporate Governance Committee of the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance
Committee will promptly consider any such tendered resignation and will make recommendation to the Board of Directors as to whether such tendered resignation should be accepted or rejected, or whether other action should be taken with respect to
such tendered resignation. Any incumbent director whose tendered resignation is under consideration may not participate in any deliberation or vote of the Nominating and Corporate Governance Committee or the Board of Directors regarding such
tendered resignation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee in making its recommendation, and the Board of Directors in
making its decision as to whether to accept or reject such recommendation, may each consider any factors they deem relevant, including, without limitation, the incumbent director&#146;s qualifications and past and expected future contributions to
the Corporation, the overall composition of the Board of Directors and whether accepting the tendered resignation would cause the Corporation to fail to satisfy any applicable law, rule or regulation (including, without limitation, New York Stock
Exchange listing requirements and federal securities laws and regulations), in deciding whether to accept, reject or take other action with respect to any such tendered resignation and in accordance with such policies and procedures adopted by the
Committee and/or the Board of Directors for such purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Within one hundred twenty (120)&nbsp;days after the date on which
certification of the stockholder vote on the election of directors is made, the Board of Directors will publicly disclose its decision and rationale regarding whether to accept, reject or take other action with respect to the tendered resignation in
a press release, a periodic or current report filed with the Securities and Exchange Commission or by other public announcement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any
incumbent director fails to tender his or her resignation as required pursuant to this Section&nbsp;7 of Article I, the Nominating and Corporate Governance Committee shall nevertheless assess the appropriateness of such director&#146;s continued
service as a director and shall recommend to the Board of Directors the action to be taken with respect to such director as if the director had tendered his or her resignation. Should the Board of Directors determine that it would have accepted the
resignation of such director if it had been tendered as required pursuant to this Section&nbsp;7 of Article I, then the term of such director shall be deemed to expire on the day that is one hundred twenty (120)&nbsp;days following certification of
the stockholder vote and the Board of Directors will publicly disclose its decision and rationale in a press release, a periodic or current report filed with the Securities and Exchange Commission or by other public announcement within one hundred
twenty (120)&nbsp;days after certification of the stockholder vote. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise required by law, the Certificate of Incorporation or these Bylaws, all
matters shall be determined by a majority of the votes cast affirmatively or negatively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;8. Stockholder Nominations Included in the
Corporation&#146;s Proxy Materials. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subject to the provisions of this Section&nbsp;8(a) if expressly requested in the relevant
Nomination Notice (as defined below), the Corporation shall include in its proxy statement for any annual meeting of stockholders: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the
name of any person nominated for election (the &#147;Stockholder Nominee&#148;) by any Eligible Holder (as defined below) or group of up to twenty (20)&nbsp;Eligible Holders that has (individually and collectively, in the case of a group) satisfied
all applicable conditions and complied with all applicable procedures set forth in this Section&nbsp;8 (such Eligible Holder or group being a &#147;Nominating Stockholder&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) disclosure about the Stockholder Nominee and the Nominating Stockholder required under the rules of the Securities and Exchange Commission
or other applicable law to be included in the proxy statement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) any statement included by the Nominating Stockholder in the
Nomination Notice for inclusion in the proxy statement in support of the Stockholder Nominee&#146;s election to the Board of Directors (subject, without limitation, to Section&nbsp;8(f)(ii)), if such statement does not exceed 500 words; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) any other information that the Corporation or the Board of Directors determines, in their discretion, to include in the proxy statement
relating to the nomination of the Stockholder Nominee, including, without limitation, any statement in opposition to the nomination and any of the information provided pursuant to this Section. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The name of any Stockholder Nominee included in the proxy statement pursuant to Section&nbsp;8(a) for an annual meeting of stockholders
shall be included on any ballot relating to the election of directors distributed at such annual meeting and shall be set forth on a form of proxy (or other format through which the Corporation permits proxies to be submitted) distributed by the
Corporation in connection with election of directors at such annual meeting so as to permit shareholders to vote on the election of such Stockholder Nominee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Maximum Number of Stockholder Nominees. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Corporation shall not be required to include in the proxy statement for an annual meeting of stockholders more Stockholder Nominees
than that number of directors constituting twenty percent (20%), but no less than two (2), of the total number of directors of the Corporation on the last day on which a Nomination Notice may be submitted pursuant to this Section&nbsp;8(c) (rounded
down to the nearest whole number) (the &#147;Maximum Number&#148;). The Maximum Number for a particular annual meeting shall be reduced by: (1)&nbsp;Stockholder Nominees who are subsequently withdrawn, cease to satisfy the requirements of this
Section&nbsp;8 or become unwilling to serve; (2)&nbsp;Stockholder Nominees that the Board of Directors itself decides to nominate for election at such annual meeting; and (3)&nbsp;the number of incumbent directors who had been Stockholder Nominees
at any of the preceding three annual meetings and whose reelection at the upcoming annual meeting is being recommended by the Board of Directors. In the event that one or more vacancies for any reason occurs on the Board of Directors after the
deadline set forth in Section&nbsp;8(e) below but before the date of the annual meeting and the Board of Directors resolves to reduce the size of the board in connection therewith, the Maximum Number shall be calculated based on the number of
directors in office as so reduced. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) If the number of Stockholder Nominees pursuant to this Section&nbsp;8(c) for any annual
meeting of stockholders exceeds the Maximum Number then, promptly upon notice from the Corporation, each Nominating Stockholder will select one Stockholder Nominee for inclusion in the proxy statement until the Maximum Number is reached, going in
order of the amount (largest to smallest) of the ownership disclosed in each Nominating Stockholder&#146;s Nomination Notice, with the process repeated if the Maximum Number is not reached after each Nominating Stockholder has selected one
Stockholder Nominee. If, after the deadline for submitting a Nomination Notice as set forth in Section&nbsp;8(e), a Nominating Stockholder becomes ineligible or withdraws its nomination or a Stockholder Nominee becomes unwilling to serve on the
Board of Directors, whether before or after the mailing of definitive proxy statement, then the nomination shall be disregarded, and the Corporation: (1)&nbsp;shall not be required to include in its proxy statement or on any ballot or form of proxy
the disregarded Stockholder Nominee or any successor or replacement nominee proposed by the Nominating Stockholder or by any other Nominating Stockholder, and (2)&nbsp;may otherwise communicate to its stockholders, including without limitation by
amending or supplementing its proxy statement or ballot or form of proxy, that the Stockholder Nominee will not be included as a Stockholder Nominee in the proxy statement or on any ballot or form of proxy and will not be voted on at the annual
meeting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Eligibility of Nominating Stockholder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) An &#147;Eligible Holder&#148; is a person who has either (1)&nbsp;been a record holder of the shares of common stock used to satisfy the
eligibility requirements in this Section&nbsp;8(d) continuously for the relevant three-year period, or (2)&nbsp;provides to the Secretary of the Corporation, within the time period referred to in Section&nbsp;8(e), evidence of continuous ownership
of such shares for such three-year period from one or more securities intermediaries in a form that the Board of Directors or its designee, acting in good faith, determines would be deemed acceptable for purposes of a shareholder proposal under Rule
14a-8(b)(2) under the Securities Exchange Act of 1934 (the &#147;Exchange Act&#148;) (or any successor rule). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) An Eligible Holder or
group of up to twenty (20)&nbsp;Eligible Holders may submit a nomination in accordance with this Section&nbsp;8(d) only if the person or group (in the aggregate) has continuously been a holder of full voting rights in and ownership of at least the
Minimum Number (as defined below) of shares of the Corporation&#146;s common stock throughout the three (3)&nbsp;year period preceding and including the date of submission of the Nomination Notice, and continues to hold full voting rights in and
ownership of at least the Minimum Number through the date of the annual meeting. Two or more funds that are (1)&nbsp;under common management and investment control, (2)&nbsp;under common management and funded primarily by a single employer or
(3)&nbsp;a &#147;group of investment companies,&#148; as such term is defined in Section&nbsp;12(d)(1)(G)(ii) of the Investment Company Act of 1940, as amended, shall be treated as one Eligible Holder if such Eligible Holder shall provide together
with the Nomination Notice documentation reasonably satisfactory to the Corporation that demonstrates that the funds meet the criteria set forth in (1), (2) or (3)&nbsp;hereof. For the avoidance of doubt, in the event of a nomination by a group of
Eligible Holders, any and all requirements and obligations for an individual Eligible Holder that are set forth in this Section&nbsp;8(d), including the minimum holding period, shall apply to each member of such group; provided, however, that the
Minimum Number shall apply to the ownership of the group in the aggregate. Should any stockholder cease to satisfy the eligibility requirements in this Section&nbsp;8(d), as determined by the Board of Directors, or withdraw from a group of Eligible
Holders at any time prior to the annual meeting of stockholders, the group of Eligible Stockholders shall only be deemed to own the shares held by the remaining members of the group. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) The &#147;Minimum Number&#148; of shares of the Corporation&#146;s common stock means three percent (3%)&nbsp;of the number of
outstanding shares of common stock as of the most recent date for which such amount is given in any filing by the Corporation with the Securities and Exchange Commission (&#147;SEC&#148;) prior to the submission of the Nomination Notice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) For purposes of this Section&nbsp;8, an Eligible Holder &#147;owns&#148; only those
outstanding shares of the Corporation as to which the Eligible Holder possesses both: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the full voting and investment rights pertaining to the shares; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the full economic interest in (including the opportunity for profit and risk of loss on) such shares;
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that the number of shares calculated in accordance with clauses (1)&nbsp;and (2)&nbsp;shall not include any shares:
(i)&nbsp;purchased or sold by such Eligible Holder or any of its affiliates in any transaction that has not been settled or closed; (ii)&nbsp;sold short by such Eligible Holder; (iii)&nbsp;borrowed by such Eligible Holder or any of its affiliates
for any purpose or purchased by such Eligible Holder or any of its affiliates pursuant to an agreement to resell or subject to any other obligation to resell to another person; or (iv)&nbsp;subject to any option, warrant, forward contract, swap,
contract of sale, other derivative or similar agreement entered into by such Eligible Holder or any of its affiliates, whether any such instrument or agreement is to be settled with shares or with cash based on the notional amount or value of
outstanding shares of the Corporation, in any such case which instrument or agreement has, or is intended to have, the purpose or effect of: (i)&nbsp;reducing in any manner, to any extent or at any time in the future, such Eligible Holder&#146;s or
any of its affiliates&#146; full right to vote or direct the voting of any such shares; and/or (ii)&nbsp;hedging, offsetting, or altering to any degree, gain or loss arising from the full economic ownership of such shares by such Eligible Holder or
any of its affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An Eligible Holder &#147;owns&#148; shares held in the name of a nominee or other intermediary so long as the
Eligible Holder retains the right to instruct how the shares are voted with respect to the election of directors and possesses the full economic interest in the shares. An Eligible Holder&#146;s ownership of shares shall be deemed to continue during
any period in which the Eligible Holder has delegated any voting power by means of a proxy, power of attorney, or other similar instrument or arrangement that is revocable at any time by the Eligible Holder. An Eligible Holder&#146;s ownership of
shares shall be deemed to continue during any period in which the Eligible Holder has loaned such shares provided that the Eligible Holder has the power to recall such loaned shares on five (5)&nbsp;business days&#146; notice, has recalled such
loaned shares as of the date of the Nomination Notice and continues to hold such shares through the date of the annual meeting. The terms &#147;owned,&#148; &#147;owning&#148; and other variations of the word &#147;own&#148; shall have correlative
meanings. Whether outstanding shares of the Corporation are &#147;owned&#148; for these purposes shall be determined by the Board. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) No
person shall be permitted to be in more than one group constituting a Nominating Stockholder, and if any person appears as a member of more than one group, it shall be deemed to be a member of the group that has the largest net long position as
reflected in the Nomination Notice. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Nomination Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To nominate a Stockholder Nominee, the Nominating Stockholder must, no earlier than 150 calendar days and no later than 120 calendar days
before the anniversary of the date that the Corporation mailed its proxy statement for the prior year&#146;s annual meeting, submit to the Secretary of the Corporation at the principal executive office of the Corporation all of the following
information and documents (collectively, the &#147;Nomination Notice&#148;); provided, however, that if (and only if) the annual meeting is not scheduled to be held within a period that commences 30 days before such anniversary date and ends 30 days
after such anniversary date (an annual meeting date outside such period being referred to herein as an &#147;Other Meeting Date&#148;), the Nomination Notice shall be given in the manner provided herein by the later of the close of business on
(i)&nbsp;the date that is 180 days prior to such Other Meeting Date or (ii)&nbsp;the tenth day following the date such Other Meeting Date is first publicly announced or disclosed: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) A Schedule 14N (or any successor form) relating to the Stockholder Nominee, completed and filed with the SEC by the Nominating Stockholder
as applicable, in accordance with SEC rules; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) A written notice, in a form deemed satisfactory by the Board of Directors or its
designee, acting in good faith, of the nomination of such Stockholder Nominee that includes the following additional information, agreements, representations and warranties by the Nominating Stockholder (including each group member): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the information required with respect to the nomination of directors pursuant to Section&nbsp;6(c) of these
By-laws; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the details of any relationship that existed within the past five (5)&nbsp;years and that would have been
described pursuant to Item&#8201;6(e) of Schedule 14N (or any successor item) if it existed on the date of submission of the Schedule 14N; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a representation and warranty that the Nominating Stockholder did not acquire, and is not holding, securities
of the Corporation for the purpose or with the effect of influencing or changing control of the Corporation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a representation and warranty that the Stockholder Nominee&#146;s candidacy or, if elected, Board membership
would not violate applicable state or federal law or the rules of any stock exchange on which the Corporation&#146;s securities are traded; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a representation and warranty that the Stockholder Nominee: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">a. does not have any direct or indirect relationship with the Corporation other than those relationships that have been deemed
categorically immaterial pursuant to the Corporation&#146;s policy on director independence as most recently published on its website and otherwise qualifies as independent under the rules of the primary stock exchange on which the
Corporation&#146;s securities are traded; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">b. meets the audit committee independence requirements under the rules of any
stock exchange on which the Corporation&#146;s securities are traded; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">c. is a &#147;non-employee director&#148; for the
purposes of Rule 16b-3 under the Exchange Act (or any successor rule); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">d. is an &#147;outside director&#148; for the
purposes of Section&nbsp;162(m) of the Internal Revenue Code (or any successor provision); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">e. meets the director
qualifications set forth in Article II of these By-Laws; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">f. is not and has not been subject to any event specified in
Item&#8201;401(f) of Regulation S-K (or any successor rule), without reference to whether the event is material to an evaluation of the ability or integrity of the Nominee or whether the event occurred in the ten-year time period referenced in such
Item; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">g. does not serve as a director of more than four other entities other than the Corporation; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">h. is not and has not been, within the past three years, an officer or director of a competitor as defined in Section&nbsp;8
of the Clayton Antitrust Act of 1914. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a representation and warranty that the Nominating Stockholder satisfies the eligibility requirements set forth
in Section&nbsp;8(d) and has provided evidence of ownership to the extent required by Section&nbsp;8(d)(i); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a representation and warranty that the Nominating Stockholder intends to continue to satisfy the eligibility
requirements described in Section&nbsp;8(d) through the date of the annual meeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">details of any position of the Stockholder Nominee as an officer or director of any competitor (that is, any
entity that produces products or provides services that compete with or are alternatives to the principal products produced or services provided by the Corporation or its affiliates) of the Corporation, within the five (5)&nbsp;years preceding the
submission of the Nomination Notice; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a representation and warranty that the Nominating Stockholder will not engage in a &#147;solicitation&#148;
within the meaning of Rule 14a-1(l) (without reference to the exception in Section&nbsp;14a-(I)(2)(iv)) (or any successor rules) with respect to the annual meeting, other than with respect to the Stockholder Nominee; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if desired, a statement for inclusion in the proxy statement in support of the Stockholder Nominee&#146;s
election to the Board of Directors, provided that such statement shall not exceed 500 words; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of a nomination by a group, the designation by all group members of one group member that is
authorized to act on behalf of all group members with respect to matters relating to the nomination, including withdrawal of the nomination; and </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) an executed agreement, in a form deemed satisfactory by the Board of Directors or its designee, acting in good faith, pursuant to which
the Nominating Stockholder (including each group member) agrees: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to comply with all applicable laws, rules and regulations in connection with the nomination and election;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to assume all liability stemming from an action, suit or proceeding concerning any actual or alleged legal or
regulatory violation arising out of any communication by the Nominating Stockholder with the Corporation, its stockholders or any other person in connection with the nomination or election of directors, including, without limitation, the Nomination
Notice; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to indemnify and hold harmless (jointly with all other group members, in the case of a group member) the
Corporation and each of its directors, officers and employees individually against any liability, loss, damages, expenses or other costs (including attorneys&#146; fees) incurred in connection with any threatened or pending action, suit or
proceeding, whether legal, administrative or investigative, against the Corporation or any of its directors, officers or employees arising out of or relating to a failure or alleged failure of the Nominating Stockholder to comply with, or, any
breach or alleged breach of, its obligations, agreements or representations under this Section&nbsp;8(e); and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the event that any information included in the Nomination Notice, or any other communications by the
Nominating Stockholder (including with respect to any group member), with the Corporation, its stockholders or any other person in connection with the nomination or election ceases to be true and accurate in all material respects (or due to a
subsequent development omits a material fact necessary to make the statements made not misleading), or that the Nominating Stockholder (including any group member) has failed to continue to satisfy the eligibility requirements described in
Section&nbsp;8(d), to promptly (and in any event within 48 hours of discovering such misstatement or omission) notify the Corporation and any other recipient of such communication of the misstatement or omission in such previously provided
information and of the information that is required to correct the misstatement or omission. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) an executed agreement,
in a form deemed satisfactory by the Board of Directors or its designee, acting in good faith, by the Stockholder Nominee: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to provide to the Corporation such other information, including completion of the Corporation&#146;s director
questionnaire, as it may reasonably request; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that the Stockholder Nominee has read and agrees, if elected, to serve as a member of the Board of Directors,
to adhere to the Corporation&#146;s Corporate Governance Guidelines, Code of Professional Conduct, Code of Business Conduct and Ethics, and any other Corporation policies and guidelines applicable to directors; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that the Stockholder Nominee is not and will not become a party to any compensatory, payment or other financial
agreement, arrangement or understanding with any person or entity in connection with service or action as a director of the Corporation, or any agreement, arrangement or understanding with any person or entity as to how the Stockholder Nominee would
vote or act on any issue or question as a director, in each case that has not been disclosed to the Corporation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
information and documents required by this Section&nbsp;8(e) shall be (i)&nbsp;provided with respect to and executed by each group member, in the case of information applicable to group members; and (ii)&nbsp;provided with respect to the persons
specified in Instruction 1 to Item&#8201;6(c) and (d)&nbsp;of Schedule 14N (or any successor item) in the case of a Nominating Stockholder or group member that is an entity. The Nomination Notice shall be deemed submitted on the date on which all of
the information and documents referred to in this Section&nbsp;8(e) (other than such information and documents contemplated to be provided after the date the Nomination Notice is provided) have been provided to the Secretary of the Corporation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Exceptions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)
Notwithstanding anything to the contrary contained in this Section&nbsp;8, the Corporation may omit from its proxy statement any Stockholder Nominee, and such nomination shall be disregarded and no vote on such Stockholder Nominee will occur,
notwithstanding that proxies in respect of such vote may have been received by the Corporation, if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Corporation receives a notice pursuant to Section&nbsp;6(c) of Article I of these Bylaws that a stockholder
intends to nominate a candidate for director at the annual meeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Nominating Stockholder or the designated lead group member, as applicable, or any qualified representative
thereof, does not appear at the meeting of stockholders to present the nomination submitted pursuant to this Section&nbsp;8; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Board of Directors, acting in good faith, determines that such Stockholder Nominee&#146;s nomination or
election to the Board of Directors would result in the Corporation violating or failing to be in compliance with the Corporation&#146;s Bylaws or certificate of incorporation or any applicable law, rule or regulation to which the Corporation is
subject, including any rules or regulations of any stock exchange on which the Corporation&#146;s securities are traded; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Stockholder Nominee was nominated for election to the Board of Directors pursuant to this Section&nbsp;8 at
one of the Corporation&#146;s two preceding annual meetings of stockholders and received a vote of less than 25% of the shares of common stock entitled to vote for such Nominee; or the Corporation is notified, or the Board of Directors acting in
good faith determines, that a Nominating Stockholder has failed to continue to satisfy the eligibility requirements described in Section&nbsp;8(d), any of the representations and warranties made in the Nomination Notice ceases to be true and
accurate in all material respects (or omits a material fact necessary to make the statements made not misleading), the Stockholder Nominee becomes unwilling or unable to serve on the Board of Directors or any material violation or breach occurs of
the obligations, agreements, representations or warranties of the Nominating Stockholder or the Stockholder Nominee under this Section&nbsp;8. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Notwithstanding anything to the contrary contained in this Section&nbsp;8, the Corporation may omit from its proxy statement, or may
supplement or correct, any information, including all or any portion of the statement in support of the Stockholder Nominee included in the Nomination Notice, if the Board of Directors in good faith determines that: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such information is not true in all material respects or omits a material statement necessary to make the
statements made not misleading; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such information directly or indirectly impugns the character, integrity or personal reputation of, or directly
or indirectly makes charges concerning improper, illegal or immoral conduct or associations, without factual foundation, with respect to, any person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">or the inclusion of such information in the proxy statement would otherwise violate the SEC proxy rules or any
other applicable law, rule or regulation. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;9. Stock List. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A complete list of stockholders entitled to vote at any meeting of stockholders, arranged in alphabetical order for each class of stock and
showing the address of each such stockholder and the number of shares registered in his or her name, shall be open to the examination of any such stockholder, for any purpose germane to the meeting, during ordinary business hours for a period of at
least ten (10)&nbsp;days prior to the meeting, either at a place within the city where the meeting is to be held, which place shall be specified in the notice of the meeting, or, if not so specified, at the place where the meeting is to be held.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The stock list shall also be kept at the place of the meeting during the whole time thereof and shall be open to the examination of any
such stockholder who is present. This list shall presumptively determine the identity of the stockholders entitled to vote at the meeting and the number of shares held by each of them. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;10. Consent of Stockholders in Lieu of Meeting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the rights of the holders of any class or series of preferred stock of the Corporation, any action required or permitted to be taken
by the stockholders of the Corporation must be effected at an annual or special meeting of stockholders of the Corporation and may not be effected by any consent in writing by such stockholders. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE II - BOARD DF DIRECTORS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.
General Powers, Number, and Term of Office. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The business and affairs of the Corporation shall be under the direction of its Board of
Directors.<FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE> Subject to Article IX,
the</STRIKE></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#0000ff"><U STYLE="border-bottom:1pt double; padding-bottom:1pt">The</U></FONT><FONT STYLE="font-family:Times New Roman"> number of Directors who shall constitute
the Whole Board shall be such number as the majority of the Whole Board shall from time to time have designated, which number shall be no less than nine (9)&nbsp;and no more than eighteen (18).</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE> Subject to Article IX, Section&nbsp;3(c), immediately following the expiration of the Specified Period the</STRIKE></FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#0000ff"><U STYLE="border-bottom:1pt double; padding-bottom:1pt">The</U></FONT><FONT STYLE="font-family:Times New Roman"> Board of Directors shall elect a Chairman of the Board from among
its members</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE> and, thereafter, annually
elect</STRIKE></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#0000ff"><U STYLE="border-bottom:1pt double; padding-bottom:1pt">. Prior to April&nbsp;1, 2024, (a)&nbsp;the Chairman of the Board shall be an &#147;Executive
Chairman&#148;; (b)&nbsp;the Executive Chairman shall be the most senior executive officer of the Corporation with commensurate authority;
and</U></FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#0000ff"><U STYLE="border-bottom:1pt double; padding-bottom:1pt"> (c) Mr.&nbsp;Alessandro&nbsp;P. DiNello shall serve as the Executive Chairman. In addition to</U></FONT><FONT
STYLE="font-family:Times New Roman"> a Chairman of the Board</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#0000ff"><U STYLE="border-bottom:1pt double; padding-bottom:1pt">, the Board of Directors may elect a Lead
Independent Director</U></FONT><FONT STYLE="font-family:Times New Roman"> from among its members. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Directors, other than those
who may be elected by the holders of any class or series of Preferred Stock, shall be divided, with respect to the time for which they severally hold office, into three classes, with the term of office of the first class to expire at the first
annual meeting of stockholders; the term of office of the second class to expire at the annual meeting of stockholders one year thereafter; and the term of office of the third class to expire at the annual meeting of stockholders two years
thereafter, with each Director to hold office until his or her successor shall have been duly elected and qualified. At each annual meeting of stockholders, Directors elected to succeed those Directors whose terms then expire shall be elected for a
term of office to expire at the third succeeding annual meeting of stockholders after their election, with each Director to hold office until his or her successor shall have been duly elected and qualified. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;2. Vacancies and Newly Created Directorships. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the rights of the holders of any class or series of Preferred Stock, and unless the Board of Directors otherwise determines, newly
created directorships resulting from any increase in the authorized number of Directors or any vacancies in the Board of Directors resulting from death, resignation, retirement, disqualification, removal from office, or other cause may be filled
only by a majority vote of the Directors then in office, though less than a quorum, and Directors so chosen shall hold office for a term expiring at the annual meeting of stockholders at which the term of office of the class to which they have been
elected expires and until such Director&#146;s successor shall have been duly elected and qualified. No decrease in the number of authorized Directors constituting the Board shall shorten the term of any incumbent Director. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;3. Regular Meetings. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Regular
meetings of the Board of Directors shall be held at such place or places, on such date or dates, and at such time or times as shall have been established by the Board of Directors and publicized among all Directors. A notice of each regular meeting
shall not be required. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;4. Special Meetings. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Special meetings of the Board of Directors may be called by one-half (1/2)&nbsp;of the Directors then in office (rounded up to the nearest
whole number), or by a Chairman of the Board or the Chief Executive Officer, and shall be held in such place, on such date, and at such time as they, or he or she, shall fix. Notice of the place, date and time of each such special meeting shall be
given to each Director, unless waived by such Director, by mailing written notice not less than five (5)&nbsp;days before the meeting or by telegraphing or telexing, or by facsimile transmission of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the same or by hand, not less than twenty-four (24)&nbsp;hours before the meeting in the case of a meeting
to be held at a location within twenty-five (25)&nbsp;miles of the Corporation&#146;s executive offices and not less than forty-eight (48)&nbsp;hours before the meeting in the case of a meeting to be held at a location beyond twenty-five
(25)&nbsp;miles of the Corporation&#146;s executive offices. No special meeting shall be held at a location beyond seventy-five (75)&nbsp;miles of the Corporation&#146;s executive offices. Unless otherwise indicated in the notice thereof, any and
all business may be transacted at a special meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;5. Quorum. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any meeting of the Board of Directors, a majority of the Whole Board shall constitute a quorum for all purposes. If a quorum shall fail to
attend any meeting, a majority of those present may adjourn the meeting to another place, date, or time, without further notice or waiver thereof. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;6. Participation in Meetings By Conference Telephone. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Members of the Board of Directors, or of any committee thereof, may participate in a meeting of such Board or committee by means of conference
telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other, and such participation shall constitute presence in person at such meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7. Conduct of Business. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any
meeting of the Board of Directors, business shall be transacted in such order and manner as a Chairman of the Board or, in the absence of a Chairman of the Board or at his or her delegation, the Chief Executive Officer or the Board of Directors may
from time to time determine, and all matters shall be determined by the vote of a majority of the Directors present, except as otherwise provided herein or required by law. The Board of Directors may take action without a meeting if all members
thereof consent thereto in writing, and the writing or writings are filed with the minutes of proceedings of the Board of Directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.
Compensation of Directors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Directors, as such, may receive, pursuant to resolution of the Board of Directors, fixed fees and other
compensation for their services as Directors, including, without limitation, their services as members of committees of the Board of Directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;9. Retirement of Directors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No
person may be elected, appointed, or nominated as a Director of the Corporation after December&nbsp;31 of the year in which such person attains the age of 75; provided, however, that the Board of Directors, by a written resolution approved by a
majority of the disinterested members of the Whole Board of Directors, may exclude an incumbent director from such age limitation. Notwithstanding the limitation of this provision, a director shall be able to complete a term in which he or she
attains the age of 75. Vacancies on the Board of Directors created by operation of this provision may be filled in accordance with these Bylaws. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE III &#150; COMMITTEES </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.
Committees of the Board of Directors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors, by a vote of a majority of the Whole Board of Directors, may, from time to
time, designate committees of the Board, with such lawfully delegable powers and duties as it thereby confers, to serve at the pleasure of a majority of the Whole Board, and shall, for these committees and any others provided for herein, elect a
Director or Directors to serve as the member or members, designating, if it desires, other Directors as alternate members who may replace any absent or disqualified member at any meeting of the committee. The Board of Directors, by a resolution
adopted by a majority of the Whole Board, may terminate any committee previously established. Any committee so designated by resolution adopted by a majority of the Whole Board, may exercise the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">power and authority of the Board of Directors to declare a dividend, to authorize the issuance of stock, or
to adopt a certificate of ownership and merger pursuant to Section&nbsp;253 of the Delaware General Corporation Law if the resolution which designates the committee or a supplemental resolution of the Board of Directors shall so provide. In the
absence or disqualification of any member of any committee and any alternate member in his or her place, the member or members of the committee present at the meeting and not disqualified from voting, whether or not he or she or they constitute a
quorum, may by unanimous vote appoint another member of the Board of Directors to act at the meeting in the place of the absent or disqualified member. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;2. Conduct of Business. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each
committee may determine the procedural rules for meeting and conducting its business and shall act in accordance therewith, except as otherwise provided herein or required by law or the Board of Directors. Adequate provision shall be made for notice
to members of all meetings; a majority of the members shall constitute a quorum unless the committee shall consist of one (1)&nbsp;or two (2)&nbsp;members, in which event one (1)&nbsp;member shall constitute a quorum; and all matters shall be
determined by a majority vote of the members present. Action may be taken by any committee without a meeting if all members thereof consent thereto in writing, and the writing or writings are filed with the minutes of the proceedings of such
committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;3. Nominating and Corporate Governance Committee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors, by resolution adopted by a majority of the Whole Board, shall appoint a Nominating and Corporate Governance Committee
of the Board, consisting of not less than three (3)&nbsp;members of the Board of Directors. The Nominating and Corporate Governance Committee shall have authority (a)&nbsp;to review any nominations for election to the Board of Directors made by a
stockholder of the Corporation pursuant to Section 6(c)(ii) of Article I of these Bylaws in order to determine compliance with such Bylaw and (b)&nbsp;to recommend to the Whole Board nominees for election to the Board of Directors to replace those
Directors whose terms expire at the annual meeting of stockholders next ensuing. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE IV - OFFICERS </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;1. Generally. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Board of
Directors, as soon as may be practicable after the annual meeting of stockholders, shall choose one or more Chairmen of the Board; a Chief Executive Officer; a President; one or more Vice Presidents (which may have the designation &#147;Senior
Executive&#148;, &#147;Executive&#148; or &#147;Senior&#148; before &#147;Vice President&#148;); and a Secretary, and from time to time may choose such other Officers as it may deem proper. The Chairmen of the Board shall be chosen from among the
Directors. Any number of offices may be held by the same person. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The term of office of all Officers shall be until such Officers&#146;
resignation or removal and any Officer may be removed from office at any time by the affirmative vote of a majority of the authorized number of Directors then constituting the Board of Directors. The removal of the current Chairman of the Board or
Chief Executive Officer and President from such office or any action to materially modify, amend or breach the employment agreement of such person, or terminate such person&#146;s employment, shall require the affirmative vote of 75% of all of the
Directors of the Corporation. This Section&nbsp;1(b) of Article IV of these Bylaws may not be amended, altered or repealed by the Board of Directors except pursuant to a resolution adopted by 75% of all of the Directors of the Corporation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) All Officers chosen by the Board of Directors or a Chairman of the Board shall each have such powers and duties as generally pertain to
their respective Offices, subject to the specific provisions of this ARTICLE IV. Such Officers shall also have such powers and duties as, from time to time, may be conferred by the Board of Directors or by any committee thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;2. Chairman of the Board of Directors. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Chairman of the Board shall, subject to the provisions of these Bylaws and to the direction of the Board of Directors, serve in a general
executive capacity. A Chairman of the Board shall perform all duties and have all powers which are delegated to him or her by the Board of Directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;3. Chief Executive Officer and President. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Chief Executive Officer and President shall have general responsibility for the management and control of the business and affairs of the
Corporation and shall perform all duties and have all powers that are commonly incident to the office of Chief Executive Officer and President or that are delegated to him or her by the Board of Directors. The Chief Executive Officer and President
shall have power to sign all stock certificates, contracts and other instruments of the Corporation that are authorized and shall have general supervision of all of the other Officers (other than a Chairman of the Board), employees and agents of the
Corporation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;4. Vice President. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Vice Presidents shall perform the duties and exercise the powers usually incident to their respective offices and/or such other duties and
powers as may be properly assigned to them by the Board of Directors. A Vice President or Vice Presidents may be designated as &#147;Senior Executive Vice President&#148;, &#147;Executive Vice President&#148; or &#147;Senior Vice President&#148;.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;5. Secretary. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Secretary
or Assistant Secretary shall issue notices of meetings, shall keep their minutes, shall have charge of the seal and the corporate books, and shall perform such other duties and exercise such other powers as are usually incident to such office and/or
such other duties and powers as are properly assigned thereto by the Board of Directors. Subject to the direction of the Board of Directors, the Secretary shall have the power to sign all stock certificates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;6. Chief Financial Officer. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Chief Financial Officer of the Corporation shall have the responsibility for maintaining the financial records of the Corporation. He or she shall make such disbursements of the funds of the Corporation as are authorized and shall render, from time
to time, an account of all such transactions and of the financial condition of the Corporation. The Chief Financial Officer shall also perform such other duties as the Board of Directors may from time to time prescribe. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;7. Assistant Secretaries and Other Officers. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors may appoint one or more Assistant Secretaries and such other Officers who shall have such powers and shall perform such
duties as are provided in these Bylaws or as may be assigned to them by the Board of Directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;8. Action with Respect to Securities of
Other Corporations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise directed by the Board of Directors, a Chairman of the Board or any Officer of the Corporation
authorized by the Chief Executive Officer shall have power to vote and otherwise act on behalf of the Corporation, in person or by proxy, at any meeting of stockholders of, or with respect to any action of stockholders of, any other corporation in
which this Corporation may hold securities, and otherwise to exercise any and all rights and powers which this Corporation may possess by reason of its ownership of securities in such other corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE V - STOCK </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;1. Certificates of Stock. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each
stockholder shall be entitled to a certificate signed by, or in the name of the Corporation by, a Chairman of the Board or the Chief Executive Officer, and by the Secretary or an Assistant Secretary, or any Treasurer or Assistant Treasurer,
certifying the number of shares owned by him or her. Any or all of the signatures on the certificate may be by facsimile. Notwithstanding the foregoing, the Board of Directors of the Corporation may provide by resolution or resolutions that some or
all of any or all classes or series of its stock shall be uncertificated shares. Any such resolution shall not apply to shares represented by a certificate until such certificate is surrendered to the Corporation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;2. Transfers of Stock. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Transfers
of stock shall be made only upon the transfer books of the Corporation kept at an office of the Corporation or by transfer agents designated to transfer shares of the stock of the Corporation. Except where a certificate is issued in accordance with
Section&nbsp;4 of Article V of these Bylaws, an outstanding certificate for the number of shares involved shall be surrendered for cancellation before a new certificate is issued therefore. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;3. Record Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order that the
Corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders, or to receive payment of any dividend or other distribution or allotment of any rights, or to exercise any rights in respect of any change,
conversion, or exchange of stock or for the purpose of any other lawful action, the Board of Directors may fix a record date, which record date shall not precede the date on which the resolution fixing the record date is adopted and which record
date shall not be more than sixty (60)&nbsp;days nor less than ten (10)&nbsp;days before the date of any meeting of stockholders, nor more than sixty (60)&nbsp;days prior to the time for such other action as hereinbefore described; provided,
however, that if no record date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on
which notice is given or, if notice is waived, at the close of business on the next day preceding the day on which the meeting is held, and, for determining stockholders entitled to receive payment of any dividend or other distribution or allotment
or rights or to exercise any rights of change, conversion, or exchange of stock, or for any other purpose, the record date shall be at the close of business on the day on which the Board of Directors adopts a resolution relating thereto. A
determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; provided, however, that the Board of Directors may fix a new record date for the adjourned meeting.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;4. Lost, Stolen, or Destroyed Certificates. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of the loss, theft, or destruction of any certificate of stock, another may be issued in its place pursuant to such regulations as
the Board of Directors may establish concerning proof of such loss, theft, or destruction and concerning the giving of a satisfactory bond or bonds of indemnity. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;5. Regulations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The issue,
transfer, conversion, and registration of certificates of stock shall be governed by such other regulations as the Board of Directors may establish. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VI - NOTICES </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;1. Notices.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise specifically provided herein or required by law, all notices required to be given to any stockholder, Director,
Officer, employee, or agent shall be in writing and may in every instance be effectively given by hand delivery to the recipient thereof, by depositing such notice in the mails, postage paid, or by sending such notice by prepaid telegram or mailgram
or other courier. Any such notice shall be addressed to such stockholder, Director, Officer, employee or agent at his or her last known address as the same appears on the books of the Corporation. The time when such notice is received, if hand
delivered, or dispatched, if delivered through the mails or by telegram or mailgram or other courier, shall be the time of the giving of the notice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;2. Waivers. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A written waiver of any notice, signed by a stockholder, Director, Officer, employee, or agent, whether before or after the time of the event
for which notice is to be given, shall be deemed equivalent to the notice required to be given to such stockholder, Director, Officer, employee, or agent. Neither the business nor the purpose of any meeting need be specified in such a waiver. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VII - MISCELLANEOUS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.
Facsimile Signatures. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the provisions for use of facsimile signatures specifically authorized elsewhere in these Bylaws,
facsimile signatures of any Officer or Officers of the Corporation may be used whenever and as authorized by the Board of Directors or a committee thereof designated by the Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;2. Corporate Seal. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of
Directors may provide a suitable seal, containing the name of the Corporation, which seal shall be in the charge of the Secretary. If and when so directed by the Board of Directors or a designated committee thereof, duplicates of the seal may be
kept and used by the Chief Financial Officer or by an Assistant Secretary or an assistant to the Chief Financial Officer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;3. Reliance Upon
Books, Reports, and Records. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Director, each member of any committee designated by the Board of Directors, and each Officer of the
Corporation shall, in the performance of his or her duties, be fully protected in relying in good faith upon the books of account or other records of the Corporation and upon such information, opinions, reports, or statements presented to the
Corporation by any of its Officers or employees, or committees of the Board of Directors so designated, or by lawyers, accountants, agents, or any other person as to matters which such Director or committee member or Officer reasonably believes are
within such other person&#146;s professional or expert competence and who has been selected with reasonable care by or on behalf of the Corporation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;4. Fiscal Year. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fiscal year of
the Corporation shall be as fixed by the Board of Directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;5. Time Periods. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In applying any provision of these Bylaws which requires that an act be done or not be done a specified number of days prior to an event, or
that an act be done during a period of a specified number of days prior to an event, calendar days shall be used, the day of the doing of the act shall be excluded, and the day of the event shall be included. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VIII - AMENDMENTS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Board of Directors, by a resolution adopted by a majority of the Whole Board, may, except as otherwise expressly provided herein, amend, alter, or repeal these Bylaws at any meeting of the Board, provided notice of the proposed change was given not
less than two days prior to the meeting. The stockholders shall also have power to amend, alter, or repeal these Bylaws at any meeting of stockholders provided notice of the proposed change was given in the notice of the meeting; provided, however,
that, notwithstanding any other provisions of the Bylaws or any provision of law which might otherwise permit a lesser vote or no vote, but in addition to any affirmative vote of the holders of any particular class or series of the voting stock
required by law, the Certificate of Incorporation, any Preferred Stock Designation, or these Bylaws, the affirmative votes of the holders of at least 80% of the voting power (taking into account the provisions of Article FOURTH of the Certificate of
Incorporation) of all the then-outstanding shares of the Voting Stock voting together as a single class, shall be required to alter, amend, or repeal any provisions of these Bylaws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>ARTICLE IX
- CERTAIN GOVERNANCE MATTERS</STRIKE></FONT><FONT STYLE="font-family:Times New Roman"> </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>Section&nbsp;1. Interpretation; Definitions.</STRIKE></FONT><FONT STYLE="font-family:Times New Roman"> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>(a) The provisions of this Article IX shall apply
notwithstanding anything to the contrary set forth in these Bylaws. In the event of any inconsistency between any provision of this Article IX and any other provision of these Bylaws, such provision of this Article IX shall control.</STRIKE></FONT><FONT
STYLE="font-family:Times New Roman"> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>(b) The
following definitions shall apply to this Article IX and otherwise as applicable in these</STRIKE></FONT><FONT STYLE="font-family:Times New Roman">
</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>Bylaws:</STRIKE></FONT><FONT STYLE="font-family:Times New Roman"> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>(i) &#147;Designated Exchange&#148; shall mean the primary
stock exchange on which the Corporation&#146;s common stock is listed.</STRIKE></FONT><FONT STYLE="font-family:Times New Roman"> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>(ii) &#147;Entire Board of Directors&#148; shall mean the total number of directors which the Corporation would have if there were no vacancies.</STRIKE></FONT><FONT
STYLE="font-family:Times New Roman"> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>(iii)
&#147;Bank&#148; shall mean Flagstar, National Association, a wholly owned subsidiary of</STRIKE></FONT><FONT STYLE="font-family:Times New Roman"> </FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>the
Corporation.</STRIKE></FONT><FONT STYLE="font-family:Times New Roman"> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>(iv) &#147;Specified Period&#148; shall mean the period beginning on February&nbsp;7, 2004 and ending on February&nbsp;7, 2026.</STRIKE></FONT><FONT
STYLE="font-family:Times New Roman"> </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>Section&nbsp;2. Executive
Chairman; CEO; Presiding Director.</STRIKE></FONT><FONT STYLE="font-family:Times New Roman"> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>(a) Effective as of the February&nbsp;7, 2024, (i)&nbsp;Mr.&nbsp;Alessandro&nbsp;P. DiNello shall serve as the Executive Chairman of the Board of Directors and
(ii)&nbsp;Mr.&nbsp;Thomas&nbsp;R. Cangemi shall serve as the President and Chief Executive Officer of the Corporation and shall report directly to the Executive Chairman. The Executive Chairman shall be the most senior executive officer of the
Corporation with commensurate authority.</STRIKE></FONT><FONT STYLE="font-family:Times New Roman"> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>(b) During the Specified Period, (i)&nbsp;any removal of Mr.&nbsp;Alessandro&nbsp;P. DiNello serving in the capacity set forth in subsection (a)&nbsp;above from, or failure
to appoint, re-elect or re-nominate any him to such position, or (ii)&nbsp;any amendment or modification to any employment or similar agreement with him to the extent such amendment or modification would adversely affect him, shall, in each case,
require the affirmative vote of at least three-fourths (75%)&nbsp;of the Entire Board of Directors.</STRIKE></FONT><FONT STYLE="font-family:Times New Roman"> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>(c) During the Specified Period, the Presiding Director of
the Board of Directors of the Corporation shall be an independent director chosen from among the Legacy NYCB Directors by majority vote of the Legacy NYCB Directors and shall initially be, as of the Effective Time, Mr.&nbsp;Hanif Dahya. The
Presiding Director shall qualify as an independent director under the rules of the Designated Exchange.</STRIKE></FONT><FONT STYLE="font-family:Times New Roman"> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>(d) The Corporation shall cause the Bank, effective as of
February&nbsp;7, 2024, to appoint (i)&nbsp;Mr.&nbsp;Alessandro&nbsp;P. DiNello as the Executive Chairman of the Board of Directors of the Bank as long as he serves as the Executive Chairman of the Board of Directors of the Corporation and
(ii)&nbsp;Mr.&nbsp;Thomas&nbsp;R. Cangemi as President and Chief Executive Officer of the Bank as long as he serves as the President and Chief Executive Officer of the Corporation and who shall report directly to the Executive Chairman. The
Executive Chairman shall be the most senior executive officer of the Bank with commensurate authority. During the Specified Period, but subject to Mr.&nbsp;Alessandro&nbsp;P. DiNello holding the qualifying position at the Corporation, the
Corporation shall cause the Bank not to (A)&nbsp;remove Mr.&nbsp;Alessandro&nbsp;P. DiNello serving in the capacity set forth in the immediately preceding sentence, or fail to appoint, re-elect or re-nominate Mr.&nbsp;Alessandro&nbsp;P. DiNello to
serve in such capacity, or (B)&nbsp;amend or modify</STRIKE></FONT><FONT STYLE="font-family:Times New Roman"> </FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>any employment or similar agreement with
Mr.&nbsp;Alessandro&nbsp;P. DiNello to the extent such amendment or modification would adversely affect him, in each case, except with the affirmative vote of at least three-fourths (75%)&nbsp;of the Entire Board of Directors.</STRIKE></FONT><FONT
STYLE="font-family:Times New Roman"> </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>(e) During
the Specified Period, the Corporation may not exercise its authority, in its capacity as sole shareholder of the Bank, to (and the Corporation shall cause the Bank not to) modify, amend or repeal any of the provisions of the bylaws of the Bank
relating to the duties, authority or reporting relationships of the Executive Chairman of the Bank, in each case, without the affirmative vote of at least three-fourths (75%)&nbsp;of the Entire Board of Directors.</STRIKE></FONT><FONT
STYLE="font-family:Times New Roman"> </FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>Section&nbsp;3.
Amendments.</STRIKE></FONT><FONT STYLE="font-family:Times New Roman"> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="font-family:Times New Roman; font-size:10pt" COLOR="#ff0000"><STRIKE>During the Specified Period, the provisions of (a)&nbsp;this Article IX, and (b)&nbsp;any other provision of these Bylaws that sets forth the authority and responsibility of
the Executive Chairman may be modified, amended or repealed, and any Bylaw provision or other resolution inconsistent with this Article IX may be adopted, by the Board of Directors only by (and any such modification, amendment, repeal or
inconsistent Bylaw provisions and other resolutions may be proposed or recommended by the Board of Directors for adoption by the shareholders of the Corporation only by) an affirmative vote of at least three-fourths (75%)&nbsp;of the Entire Board of
Directors.</STRIKE></FONT><FONT STYLE="font-family:Times New Roman"> </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>d763888dex32.htm
<DESCRIPTION>EX-3.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT 3.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXECUTION VERSION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF DESIGNATIONS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SERIES B
NONCUMULATIVE CONVERTIBLE PREFERRED STOCK </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NEW YORK COMMUNITY BANCORP, INC. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NEW YORK
COMMUNITY BANCORP, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware (the &#147;<U>Corporation</U>&#148;), in accordance with the provisions of Sections 103, 141 and 151 thereof, does hereby
certify that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the provisions of the Amended and Restated Certificate of Incorporation, as amended, and the Amended and
Restated Bylaws of the Corporation and applicable law, the Board of Directors of the Corporation (the &#147;<U>Board</U>&#148;), duly adopted the following resolution on March&nbsp;6, 2024, creating a series of Preferred Stock of the Corporation
designated as &#147;Series B Noncumulative Convertible Preferred Stock&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">RESOLVED, that pursuant to the Delaware General Corporation
Law (the &#147;<U>DGCL</U>&#148;), the Charter and the Amended and Restated Bylaws of the Corporation, the Board hereby establishes a series of Preferred Stock, par value $0.01 per share, of the Corporation and fixes and determines the designation,
powers, preferences, redemption rights, qualifications, privileges, limitations, restrictions and special or relative rights thereof as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;I. Designation and Amount. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A series of Preferred Stock designated as the &#147;Series B Noncumulative Convertible Preferred Stock&#148; (&#147;<U>Series B Preferred
Stock</U>&#148;) is hereby established. The total number of authorized shares of Series B Preferred Stock shall be 267,062. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;II.</B> <B>Definitions</B><B>.</B> As used herein, the following terms shall have the following meanings, unless
the context otherwise requires: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Adjustment Event</U>&#148; has the meaning specified in
<U>Section</U><U></U><U>&nbsp;VIII(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; means, with respect to any Person, any other Person that,
directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, such specified Person (as used in this definition, the term &#147;control&#148; means the possession, directly or indirectly, of
the power to direct or cause the direction of the management or policies of a Person, whether through ownership of voting securities, by contract or otherwise). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Applicable Conversion Rate</U>&#148; means, for each share of Series B Preferred Stock, the number of shares of Common Stock equal to
the product of (a)&nbsp;one thousand (1,000) <I>multiplied by</I> (b)&nbsp;the quotient of (i)&nbsp;the Base Price <I>divided by</I> (ii)&nbsp;the then-applicable Conversion Price, subject to adjustment pursuant to <U>Section VIII</U> for any
applicable event occurring subsequent to the initial determination of the Applicable Conversion Rate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Base Price</U>&#148; means
$2.00. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>BHC Act</U>&#148; means the Bank Holding Company Act of 1956 (as amended) and its
implementing regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Board</U>&#148; means the Board of Directors of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means any day, other than a Saturday, Sunday or other day on which banking institutions in the city of New
York, New York are required or authorized by Law to be closed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Certificate of Designations</U>&#148; means this Certificate of
Designations of Series B Preferred Stock of the Corporation, dated March&nbsp;11, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Charter</U>&#148; means the Amended and
Restated Certificate of Incorporation of the Corporation, as amended, supplemented and/or restated from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Charter
Amendment Approval</U>&#148; means the approval of the proposal to amend the Charter in a manner to increase the total authorized number of shares of Common Stock to at least 1,700,000,000 by the affirmative vote of a majority of votes cast by the
holders of shares of Common Stock, at the meeting of the Corporation&#146;s stockholders at which a vote is taken with respect to such Charter amendment proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Class</U><U></U><U>&nbsp;of Voting Security</U>&#148; shall be interpreted in a manner consistent with how &#147;class of voting
shares&#148; is defined in 12 C.F.R. Section&nbsp;225.2(q)(3) or any successor provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing</U>&#148; has the meaning set
forth in the Investment Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Date</U>&#148; means the date that any shares of Series B Preferred Stock are first
issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Price</U>&#148; of the Common Stock (or other relevant capital stock or equity interest) on any date of
determination means the closing sale price or, if no closing sale price is reported, the last reported sale price of the shares of the Common Stock (or other relevant capital stock or equity interest) on the NYSE on such date. If the Common Stock
(or other relevant capital stock or equity interest) is not traded on the NYSE on any date of determination, the Closing Price of the Common Stock (or other relevant capital stock or equity interest) on such date of determination means the closing
sale price as reported in the composite transactions for the principal U.S. national or regional securities exchange on which the Common Stock (or other relevant capital stock or equity interest) is so listed or quoted, or, if no closing sale price
is reported, the last reported sale price on the principal U.S. national or regional securities exchange on which the Common Stock (or other relevant capital stock or equity interest) is so listed or quoted, or if the Common Stock (or other relevant
capital stock or equity interest) is not so listed or quoted on a U.S. national or regional securities exchange, the last quoted bid price for the Common Stock (or other relevant capital stock or equity interest) in the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market as reported by OTC Markets Group Inc. or a similar organization, or, if that bid price is not available, the market price of the Common Stock (or other
relevant capital stock or equity interest) on that date as determined by a nationally recognized independent investment banking firm retained by the Corporation for this purpose. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Certificate of Designations, all references herein to the &#147;Closing
Price&#148; and &#147;last reported sale price&#148; of the Common Stock (or other relevant capital stock or equity interest) on the NYSE shall be such closing sale price and last reported sale price as reflected on the website of the NYSE
(http://www.nyse.com) and as reported by Bloomberg Professional service; <U>provided</U> that in the event that there is a discrepancy between the closing sale price or last reported sale price as reflected on the website of the NYSE and as reported
by Bloomberg Professional service, the closing sale price and last reported sale price on the website of the NYSE shall govern. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Common Stock</U>&#148; means the common stock, $0.01 par value per share, of the Corporation authorized by the Corporation on or
after the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Conversion Date</U>&#148; means the date on which any shares of Series B Preferred Stock shall become
convertible into any shares of Common Stock or Series C Preferred Stock, as applicable, pursuant to <U>Section</U><U></U><U>&nbsp;III</U>; <U>provided</U>, <U>however</U>, that if a Conversion Date would otherwise occur on or after an <FONT
STYLE="white-space:nowrap">Ex-Date</FONT> for an issuance, dividend or distribution that results in an adjustment of the Conversion Price pursuant to <U>Section</U><U></U><U>&nbsp;VIII</U> and on or before the Record Date for such issuance, dividend
or distribution, such Conversion Date shall instead occur on the first calendar day after the Record Date for such issuance, dividend or distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Conversion Price</U>&#148; means, for each share of Series B Preferred Stock, the Base Price, as the same may be adjusted from time
to time in accordance with the terms of this Certificate of Designations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Convertible Transfer</U>&#148; means a transfer by the
Holder that is both (i)&nbsp;to a Person who is not an affiliate of the Holder for purposes of the BHC Act and (ii) (A)&nbsp;to the Corporation; (B)&nbsp;in a widespread public distribution; (C)&nbsp;in which no transferee (or group of associated
transferees) would receive 2% or more of the outstanding securities of any Class&nbsp;of Voting Securities of the Corporation; or (D)&nbsp;to a purchaser that would control more than 50% of every Class&nbsp;of Voting Securities of the Corporation
without any transfer from the Holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Corporation</U>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Current Market Price</U>&#148; means, on any date, the average of the daily Closing Price per share of the Common Stock or other
securities on each of the five consecutive Trading Days preceding the earlier of the day before the date of the issuance, dividend or distribution in question and the day before the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> with respect to the
issuance or distribution, giving rise to an adjustment to the Conversion Price pursuant to <U>Section</U><U></U><U>&nbsp;VIII</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>DGCL</U>&#148; means the Delaware General Corporation Law, as amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Dividend Parity Stock</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;IV(c)</U> with respect to dividends prior
to the receipt of the Stockholder Approvals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Dividend Payment Date</U>&#148; means, with respect to the period between Closing
and the Stockholder Approvals Date, March&nbsp;17, June&nbsp;17, September&nbsp;17 and December&nbsp;17 of each year, commencing June&nbsp;17, 2024; provided, however, that if any such date is not a Business Day, then such date shall nevertheless be
a Dividend Payment Date but dividends on the Series B Preferred </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Stock, when, as and if declared, shall be paid on the next succeeding Business Day (without adjustment in the amount of the dividend per share of Series B Preferred Stock). Each Dividend Payment
Date &#147;relates&#148; to the Dividend Period most recently ending before such Dividend Payment Date, and vice versa (with the words &#147;related&#148; and &#147;relating&#148; having correlative meanings). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Dividend Period</U>&#148; means, with respect to the period between Closing and the Stockholder Approvals Date, each period from and
including a Dividend Payment Date (except that the initial Dividend Period shall commence on the Original Issue Date) and continuing to, but excluding, the next succeeding Dividend Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Dividend Rate</U>&#148; means, with respect to dividends for the period between Closing and the Stockholder Approvals Date, 13%. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Dividend Record Date</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;IV(a)</U> with respect to dividends for the
period between Closing and the Stockholder Approvals Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Property</U>&#148; means the Preferred Exchange Property or
the NVCE Exchange Property, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Ex-Date</FONT></U>&#148; means, when used with
respect to any issuance, dividend or distribution giving rise to an adjustment to the Conversion Price pursuant to <U>Section</U><U></U><U>&nbsp;VIII</U>, the first date on which the applicable Common Stock or other securities trade without the
right to receive the issuance, dividend or distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Federal Reserve Board</U>&#148; means the Board of Governors of the
Federal Reserve System. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Government Entity</U>&#148; means any (a)&nbsp;federal, state, local, municipal, foreign or other
government; (b)&nbsp;governmental entity of any nature (including any governmental agency, branch, department, official, committee or entity and any court or other tribunal), whether foreign or domestic; or (c)&nbsp;body exercising or entitled to
exercise any administrative, executive, judicial, legislative, police, regulatory, or taxing authority or power of any nature, whether foreign or domestic, including any arbitral tribunal and self-regulatory organizations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Holder</U>&#148; means the Person in whose name any shares of Series B Preferred Stock are registered, which may be treated by the
Corporation as the absolute owner of such shares of Series B Preferred Stock for the purpose of making payment and settling conversion and for all other purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR Act</U>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR Amount</U>&#148; means, with respect to any conversion or exchange of Series B Preferred Stock hereunder held by a particular
Holder, the sum of (a)&nbsp;the product of $2.73 and the aggregate number of shares of Common Stock purchased by the Holder at the Closing, <U>plus</U> (b)&nbsp;the product of $2.73 and the number of shares of Common Stock being issued to such
Holder upon any such conversion of Series C Preferred Stock held by such Holder <U>plus</U> (c)&nbsp;the product of $2.73 and the number of shares of Common Stock issued upon any prior conversion of Series C Preferred Stock held by such Holder. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR Approvals</U>&#148; means, with respect to the shares of Series B Preferred
Stock of any Holder, the expiration or termination of any applicable waiting period (or extension thereof) under the HSR Act with respect to such Holder&#146;s acquisition or ownership of Common Stock upon conversion or exchange of such shares of
Series B Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR Threshold</U>&#148; means $119.5&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Investment Agreement(s)</U>&#148; means the investment agreement(s), by and between the Corporation and the investor parties thereto,
dated as of March 7, 2024 (as amended, supplemented or restated from time to time). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Junior Stock</U>&#148; means, prior to the
Stockholder Approvals Date, the Common Stock and any other class or series of stock of the Corporation that ranks junior to the Series B Preferred Stock either or both as to the payment of dividends and/or as to the distribution of assets on any
liquidation, dissolution or winding up of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Law</U>&#148; means, with respect to any Person, any legal,
regulatory and administrative laws, statutes, rules, Orders and regulations applicable to such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liens</U>&#148; means any
and all liens, charges, security interests, options, claims, mortgages, pledges, proxies, voting trusts or agreements, obligations, understandings or arrangements, or other restrictions on title or transfer of any nature whatsoever. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liquidation Preference</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;VII(a)(i)(1)</U> with respect to the
period between Closing and the Stockholder Approvals Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>NVCE Exchange Property</U>&#148; has the meaning specified in
<U>Section</U><U></U><U>&nbsp;VIII(i)(ii)(1)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>NYSE</U>&#148; means the New York Stock Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>NYSE Limit</U>&#148; means a number of shares of Common Stock equal to 19.9% of the shares of Common Stock outstanding immediately
prior to the execution of the Investment Agreement(s). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>NYSE Share Issuance Amount</U>&#148; means (a)&nbsp;the total number of
shares of Common Stock issued upon conversion or exchange of any shares of Series B Preferred Stock <I>plus</I> (b)&nbsp;the total number of shares of Common Stock issued at the Closing <I>plus</I> (c)&nbsp;the total number of shares of Common Stock
issued upon conversion of any shares of Series C Preferred Stock <I>plus</I> (d)&nbsp;the total number of shares of Common Stock issued upon conversion of any shares of Series D NVCE Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Order</U>&#148; means any applicable order, injunction, judgment, decree, ruling, or writ of any Government Entity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means an individual, corporation, partnership, limited
partnership, limited liability company, syndicate, person (including a &#147;person&#148; as defined in Sections 13(d)(3) and 14(d) of the Exchange Act), trust, association or entity or government, political subdivision, agency or instrumentality of
a government. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permanent Warrant</U>&#148; has the meaning set forth in the Investment Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Preferred Exchange Property</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;VIII(i)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Preferred Stock</U>&#148; has the meaning set forth in the Charter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Record Date</U>&#148; means, with respect to any dividend, distribution or other transaction or event in which the holders of the
Common Stock have the right to receive any cash, securities or other property or in which the Common Stock is exchanged for or converted into any combination of cash, securities or other property, the date fixed for determination of holders of the
Common Stock entitled to receive such cash, securities or other property (whether such date is fixed by the Board or a duly authorized committee of the Board or by Law, contract or otherwise). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reorganization Event</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;VIII(i)(iii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series A Preferred Stock</U>&#148; means the Corporation&#146;s
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Series A Noncumulative Perpetual Preferred Stock, par value $0.01 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series B NVCE Dividend Amount</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;V(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series B Preferred Liquidation Amount</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;VII(a)(i)</U> and applies
solely during the period between Closing and the Stockholder Approvals Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series B Preferred Stock</U>&#148; has the meaning
specified in <U>Section</U><U></U><U>&nbsp;I</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series C Preferred Stock</U>&#148; means the Series C Noncumulative
Convertible Preferred Stock, par value $0.01 per share, of the Corporation, issued pursuant to the Investment Agreement(s). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series D NVCE Stock</U>&#148; means the Series D <FONT STYLE="white-space:nowrap">Non-Voting</FONT> Common Equivalent Stock, par
value $0.01 per share, of the Corporation, issuable upon conversion of a Permanent Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Share Issuance Approval</U>&#148;
means the approval, by the affirmative vote of a majority of votes cast by holders of shares of Common Stock at the meeting of the Corporation&#146;s stockholders at which a vote is taken with respect to such issuance, that is required under
applicable NYSE rules as a result of the NYSE Share Issuance Amount exceeding the NYSE Limit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Stockholder Approvals</U>&#148;
means the Charter Amendment Approval and Share Issuance Approval. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Stockholder Approvals Date</U>&#148; means the day that is the second Business Day
after the date on which the Stockholder Approvals are obtained; <U>provided</U>, that, if the Charter Amendment Approval and the Share Issuance Approval are not obtained on the same date, the Stockholder Approvals Date shall mean the day that is the
second Business Day after the later of the two approvals are obtained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subject Series B Share</U>&#148; means a share of Series
B Preferred Stock that is automatically converted pursuant to <U>Section</U><U></U><U>&nbsp;III(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trading Day</U>&#148;
means a day on which the shares of Common Stock: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) are not suspended from trading on any national or regional securities
exchange or association or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market at the close of business; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) have traded at least once on the national or regional securities exchange or association or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market that is the primary market for the trading of the Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;III. Conversion. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Conversion upon Convertible Transfer</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The shares of Series B Preferred Stock shall not be convertible into any other class of capital stock of the Corporation, except in
accordance with this <U>Section</U><U></U><U>&nbsp;III</U>. On the terms and in the manner set forth in this <U>Section</U><U></U><U>&nbsp;III</U>, upon the consummation of any Convertible Transfer of shares of Series B Preferred Stock, each
outstanding share of Series B Preferred Stock subject to such Convertible Transfer (each, a &#147;<U>Subject Series B Share</U>&#148;) shall automatically convert into a number of shares of Common Stock equal to the Applicable Conversion Rate;
<U>provided</U> that, if at that time of the Convertible Transfer, (A)&nbsp;the HSR Approvals and/or the Stockholder Approvals is required for the conversion of the Subject Series B Shares into Common Stock and (B)&nbsp;the HSR Approvals or the
Stockholder Approvals, as applicable, has not yet been obtained, then (1)&nbsp;the maximum number of Subject Series B Shares that can convert into Common Stock without receipt of the HSR Approvals or Stockholder Approvals, as applicable, shall so
convert into Common Stock based on the Applicable Conversion Rate and (2)&nbsp;each other Subject Series B Share shall automatically convert into one share of the Series C Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) On the Conversion Date, the Corporation shall effect the conversion of the Subject Series B Shares by delivering the shares of Common
Stock or Series C Preferred Stock, as applicable, so converted pursuant to <U>Section</U><U></U><U>&nbsp;III(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The shares of
Common Stock or Series C Preferred Stock, as applicable, issuable upon conversion of the Subject Series B Shares pursuant to <U>Section</U><U></U><U>&nbsp;III(a)</U> shall be allocated among the applicable Holders in such Convertible Transfer on a
<I>pro rata </I>basis of the aggregate dollar amount invested by the Holders on the Closing Date; <U>provided</U> <U>that</U> such allocation shall be subject to any adjustment required to be made so as to not cause, in the event that HSR Approvals
have not been obtained, any Holder&#146;s HSR Amount to exceed the HSR Threshold. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Prior to the close of business on any applicable Conversion Date, the shares of Common
Stock or Series C Preferred Stock, as applicable, issuable upon conversion of any shares of Series B Preferred Stock pursuant to <U>Section</U><U></U><U>&nbsp;III(a)</U> shall not be deemed outstanding for any purpose, and the Holders shall have no
rights with respect to the Common Stock and Series C Preferred Stock, as applicable (including voting rights, rights to respond to tender offers for the Common Stock or Series C Preferred Stock, as applicable, and rights to receive any dividends or
other distributions on the Common Stock or Series C Preferred Stock, as applicable) by virtue of holding shares of Series B Preferred Stock, except as otherwise expressly set forth in this Certificate of Designations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Effective immediately prior to the close of business on any applicable Conversion Date, the rights of the Holders with respect to the
shares of the Series B Preferred Stock so converted shall cease and the Persons entitled to receive shares of Common Stock or Series C Preferred Stock, as applicable, upon the conversion of such shares of Series B Preferred Stock shall be treated
for all purposes as having become the record and beneficial owners of such shares of Common Stock or Series C Preferred Stock, as applicable. In the event that the Holders shall not by written notice to the Corporation designate the name in which
shares of Common Stock or Series C Preferred Stock, as applicable, and/or cash, securities or other property (including payments of cash in lieu of fractional shares) to be issued or paid upon conversion of shares of Series B Preferred Stock should
be registered or paid or the manner in which such shares should be delivered, the Corporation shall be entitled to register and deliver such shares, and make such payment, in the name of the Holders and in the manner shown on the records of the
Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) No fractional shares of Common Stock or Series C Preferred Stock, as applicable, shall be issued upon any conversion of
shares of Series B Preferred Stock. If more than one share of Series B Preferred Stock shall be surrendered for conversion at any one time by the same Holder, the number of full shares of Common Stock issuable upon conversion thereof shall be
computed on the basis of the aggregate number of shares of Series B Preferred Stock so surrendered. Instead of any fractional shares of Common Stock that would otherwise be issuable upon conversion of any Subject Series B Share, the Corporation
shall pay an amount in cash (rounded to the nearest cent) equal to the fractional share of Common Stock, that otherwise would be issuable hereunder, <I>multiplied by</I> the Closing Price of the Common Stock determined as of the second Trading Day
immediately preceding the applicable Conversion Date, in the case of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) All shares of Common Stock or Series C Preferred
Stock, as applicable, which may be issued upon conversion of the shares of Series B Preferred Stock will, upon issuance by the Corporation, be duly authorized, validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT>
free and clear of all Liens (other than transfer restrictions imposed under applicable securities Laws) and not issued in violation of any preemptive right or Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Effective immediately prior to the Conversion Date, dividends or distributions shall no longer be declared on any Subject Series B Shares
and such shares shall cease to be outstanding, in each case, subject to the rights of a Holder to receive any declared and unpaid dividends or distributions on such shares and any other payments to which they are otherwise entitled pursuant to
<U>Section</U><U></U><U>&nbsp;IV</U> or <U>Section</U><U></U><U>&nbsp;VIII</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;IV. Dividend Rights Prior to the Stockholder Approvals Date. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The provisions of this <U>Section IV</U> shall only apply to dividends declared and payable prior to the Stockholder Approvals Date.
Holders shall be entitled to receive, when, as and if declared by the Board (or a duly authorized committee of the Board), on each Dividend Payment Date, out of funds legally available therefor, <FONT STYLE="white-space:nowrap">non-cumulative</FONT>
cash dividends on the Series B Preferred Liquidation Amount per share of Series B Preferred Stock at a rate per annum equal to the Dividend Rate on each Dividend Payment Date for each Dividend Period. Such dividends shall be payable in arrears (as
provided below in this <U>Section</U><U></U><U>&nbsp;IV(a)</U>), but only when, as and if declared by the Board (or a duly authorized committee of the Board). Dividends on the Series B Preferred Stock shall not be cumulative; Holders shall not be
entitled to receive any dividends not declared by the Board (or a duly authorized committee of the Board) and no interest, or sum of money in lieu of interest, shall be payable in respect of any dividend not so declared. Dividends on the Series B
Preferred Stock shall not be declared or set aside for payment if and to the extent such dividends would cause the Corporation to fail to comply with the capital adequacy rules of the Federal Reserve Board (or, as and if applicable, the capital
adequacy rules or regulations of any successor appropriate federal banking agency) applicable to the Corporation. Dividends that are payable on the Series B Preferred Stock on any Dividend Payment Date will be payable to Holders as they appear on
the stock register of the Corporation on the applicable record date, which shall be the 15th calendar day before such Dividend Payment Date or such other record date fixed by the Board (or a duly authorized committee of the Board) that is not more
than 60 nor less than 10 days prior to such Dividend Payment Date (each, a &#147;<U>Dividend Record Date</U>&#148;). Any such day that is a Dividend Record Date shall be a Dividend Record Date whether or not such day is a Business Day. Dividends
payable on the Series B Preferred Stock shall be computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months. The Corporation&#146;s determination of any
dividend rate and its calculation of the amount of dividends for any Dividend Period will be maintained on file at the Corporation&#146;s principal offices and will be available to any Holder upon request and will be final and binding in the absence
of manifest error. Holders shall not be entitled to any dividends, whether payable in cash, securities or other property, other than dividends (if any) declared and payable on the Series B Preferred Stock as specified in this
<U>Section</U><U></U><U>&nbsp;IV</U> (subject to the other provisions of this Certificate of Designations); provided, that the foregoing shall not limit or modify the rights of any Holder to receive any dividend or other distribution pursuant to
<U>Section</U><U></U><U>&nbsp;VIII</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) So long as any share of Series B Preferred Stock remains outstanding, no dividend shall be
declared or paid on the Common Stock or any other shares of Junior Stock (other than any dividend in connection with the implementation of a shareholders&#146; rights plan or the redemption or repurchase of any rights under any such plan), unless
full dividends for the last preceding Dividend Period on all outstanding shares of Series B Preferred Stock have been declared and paid (or declared and a sum sufficient for the payment thereof has been set aside). The Corporation and its
subsidiaries shall not purchase, redeem or otherwise acquire, directly or indirectly, for consideration any shares of Common Stock or other Junior Stock (other than (A)&nbsp;as a result of a reclassification of such Junior Stock for or into other
Junior Stock, (B)&nbsp;the exchange or conversion of one share of such Junior Stock for or into another share of such Junior Stock, (C)&nbsp;purchases, redemptions or other acquisitions of shares of Junior Stock in connection with any employment
contract, benefit plan or other similar arrangement with or for the benefit of employees, officers, directors or consultants, (D)&nbsp;the purchase of fractional interests in shares </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of Junior Stock pursuant to the conversion or exchange provisions of such securities or the security being converted or exchanged) nor shall the Corporation pay or make available any monies for a
sinking fund for the redemption of any shares of Common Stock or any other shares of Junior Stock during a Dividend Period, unless the full dividends for the most recently completed Dividend Period on all outstanding shares of Series B Preferred
Stock have been declared and paid (or declared and a sum sufficient for the payment thereof has been set aside). The foregoing provision shall not restrict the ability of the Corporation or any affiliate of the Corporation to engage in any
market-making transactions in Junior Stock in the ordinary course of business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) When dividends are not paid in full upon the shares of
Series B Preferred Stock and other equity securities ranking on a parity, which, for avoidance of doubt, includes the Series A Preferred Stock and the Series C Preferred Stock, with the Series B Preferred Stock as to payment of dividends
(&#147;<U>Dividend Parity Stock</U>&#148;), all dividends declared and unpaid for payment on a dividend payment date with respect to the Series B Preferred Stock and the Dividend Parity Stock shall be shared ratably by the Holders and holders of any
Dividend Parity Stock, in proportion to the respective amounts of the declared and unpaid dividends relating to the current dividend period. To the extent a dividend period with respect to any Dividend Parity Stock coincides with more than one
Dividend Period with respect to the Series B Preferred Stock, for purposes of the immediately preceding sentence the Board shall treat such dividend period as two or more consecutive dividend periods, none of which coincides with more than one
Dividend Period with respect to the Series B Preferred Stock, or shall treat such dividend period(s) with respect to any Dividend Parity Stock and Dividend Period(s) with respect to the Series B Preferred Stock for purposes of the immediately
preceding sentence in any other manner that it deems to be fair and equitable in order to achieve ratable payments of dividends on such Dividend Parity Stock and the Series B Preferred Stock. To the extent a Dividend Period with respect to the
Series B Preferred Stock coincides with more than one dividend period with respect to any Dividend Parity Stock, for purposes of the first sentence of this paragraph the Board shall treat such Dividend Period as two or more consecutive Dividend
Periods, none of which coincides with more than one dividend period with respect to such Dividend Parity Stock, or shall treat such Dividend Period(s) with respect to the Series B Preferred Stock and dividend period(s) with respect to any Dividend
Parity Stock for purposes of the first sentence of this paragraph in any other manner that it deems to be fair and equitable in order to achieve ratable payments of dividends on the Series B Preferred Stock and such Dividend Parity Stock. The term
&#147;<U>dividend period</U>&#148; as used in this paragraph means such dividend periods as are provided for in the terms of any Dividend Parity Stock and, in the case of shares of Series B Preferred Stock, Dividend Periods applicable to shares of
Series B Preferred Stock; and the term &#147;<U>dividend payment dates</U>&#148; as used in this paragraph means such dividend payment dates as are provided for in the terms of any Dividend Parity Stock and, in the case of shares of Series B
Preferred Stock, Dividend Payment Dates applicable to shares of Series B Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Subject to the foregoing, such dividends
(payable in cash, securities or other property) as may be determined by the Board (or a duly authorized committee of the Board) may be declared and paid on any securities, including Common Stock, any other Junior Stock and any Dividend Parity Stock,
from time to time out of any funds legally available for such payment. In the event such dividends are declared and paid, the Holders shall be entitled to receive the greater of the (i)&nbsp;dividends that would be due to the Holders on an <FONT
STYLE="white-space:nowrap">as-converted</FONT> basis or (ii)&nbsp;dividends such Holder receives on its shares of Series B Preferred Stock during the same period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding any provision in this Certificate of Designations to the contrary,
Holders shall not be entitled to receive any dividends or distributions on any shares of Series B Preferred Stock on or after the applicable Conversion Date (if prior to the Stockholder Approvals Date) in respect of such shares of Series B Preferred
Stock that have been converted as provided herein, except to the extent that any such dividends or distributions have been declared by the Board or any duly authorized committee of the Board and the Record Date for such dividend occurs prior to such
applicable Conversion Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;V. Dividend Rights after the Stockholder Approvals Date. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The provisions of this <U>Section V</U> shall only apply to dividends declared and payable after the Stockholder Approvals Date. From and
after the Stockholder Approvals Date to (but excluding) the applicable Conversion Date, (i)&nbsp;the Holders shall be entitled to receive, when, as and if declared by the Board or any duly authorized committee of the Board (but only out of assets
legally available therefor under the DGCL) all cash dividends or distributions (including regular quarterly dividends or distributions) declared and paid or made in respect of the shares of Common Stock, at the same time and on the same terms as
holders of Common Stock, in an amount per share of Series B Preferred Stock equal to the product of (x)&nbsp;the Applicable Conversion Rate then in effect and (y)&nbsp;any per share dividend or distribution, as applicable, declared and paid or made
in respect of each share of Common Stock (the &#147;<U>Series B NVCE Dividend Amount</U>&#148;), and (ii)&nbsp;the Board or any duly authorized committee thereof may not declare and pay any cash dividend or make any cash distribution in respect of
Common Stock unless the Board or any duly authorized committee of the Board declares and pays to the Holders, at the same time and on the same terms as holders of Common Stock, the Series B NVCE Dividend Amount per share of Series B Preferred Stock.
Notwithstanding any provision in this <U>Section</U><U></U><U>&nbsp;V(a)</U>&nbsp;to the contrary, no Holder of a share of Series B Preferred Stock shall be entitled to receive any dividend or distribution made with respect to the Common Stock where
the Record Date for determination of holders of Common Stock entitled to receive such dividend or distribution occurs prior to the Stockholder Approvals Date or the date of issuance of such share of Series B Preferred Stock. The foregoing shall not
limit or modify the rights of any Holder to receive any dividend or other distribution pursuant to <U>Section</U><U></U><U>&nbsp;VIII</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each dividend or distribution declared and paid pursuant to <U>Section</U><U></U><U>&nbsp;V(a)</U> will be payable to Holders of record of
shares of Series B Preferred Stock as they appear in the records of the Corporation at the close of business on the same day as the Record Date for the corresponding dividend or distribution to the holders of shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except as set forth in this Certificate of Designations, the Corporation shall have no obligation to pay, and the holders of shares of
Series B Preferred Stock shall have no right to receive, dividends or distributions at any time, including with respect to dividends or distributions with respect to Common Stock or any other class or series of authorized Preferred Stock. To the
extent the Corporation declares dividends or distributions on the Series B Preferred Stock and on any Common Stock and the Series D NVCE Stock, but does not make full payment of such declared dividends or distributions, the Corporation will allocate
the dividend payments </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
on a <I>pro rata</I> basis among the holders of the shares of Series B Preferred Stock and the holders of any Common Stock and Series D NVCE Stock then outstanding. For purposes of calculating
the allocation of partial dividend payments, the Corporation will allocate dividend payments on a <I>pro rata</I> basis among the Holders and the holders of any Common Stock and Series D NVCE Stock so that the amount of dividends or distributions
paid per share on the shares of Series B Preferred Stock and such Common Stock and Series D NVCE Stock shall in all cases bear to each other the same ratio that payable dividends or distributions per share on the shares of the Series B Preferred
Stock and such Common Stock and Series D NVCE Stock (but without, in the case of any noncumulative Preferred Stock, accumulation of dividends or distributions for prior dividend periods) bear to each other. The foregoing right shall not be
cumulative and shall not in any way create any claim or right in favor of Holders in the event that dividends or distributions have not been declared or paid in respect of any prior calendar quarter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) No interest or sum of money in lieu of interest will be payable in respect of any dividend payment or payments on shares of Series B
Preferred Stock that may be in arrears. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Following the Stockholder Approvals Date, Holders shall not be entitled to any dividends or
distributions, whether payable in cash, securities or other property, other than dividends or distributions (if any) declared and payable on shares of Series B Preferred Stock as specified in this Certificate of Designations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Notwithstanding any provision in this Certificate of Designations to the contrary, Holders shall not be entitled to receive any dividends
or distributions on any shares of Series B Preferred Stock on or after the applicable Conversion Date (if such date is after the Stockholder Approvals Date) in respect of such shares of Series B Preferred Stock that have been converted as provided
herein, except to the extent that any such dividends or distributions have been declared by the Board or any duly authorized committee of the Board and the Record Date for such dividend occurs prior to such applicable Conversion Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;VI. Voting. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding any stated or statutory voting rights, except as set forth in <U>Section</U><U></U><U>&nbsp;VI(b)</U>, the Holders shall
not be entitled to vote (in their capacity as Holders) on any matter submitted to a vote of the stockholders of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) So
long as any shares of Series B Preferred Stock are outstanding, the Corporation shall not, without the written consent or affirmative vote, given in person or by proxy, at a meeting called for that purpose by holders of at least a majority of the
outstanding shares of Series B Preferred Stock, voting as a single and separate class, amend, alter or repeal (including by merger, consolidation or otherwise, and whether in a single transaction or a series of related transactions, other than a
Reorganization Event pursuant to which the Series B Preferred Stock is treated in accordance with <U>Section</U><U></U><U>&nbsp;VIII(i)</U>) any provision of (i)&nbsp;this Certificate of Designations or (ii)&nbsp;the Charter, in either case, that
would alter, modify or change the preferences, rights, privileges or powers of the Series B Preferred Stock so as to, or in a manner that would, significantly and adversely affect the preferences, rights, privileges or powers of the Series B
Preferred Stock; <U>provided</U><I>, </I>that any such amendment or alteration to any provision of this Certificate of Designations or the Charter that alters, modifies or changes the preferences, rights,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
privileges or powers of a particular Holder so as to, or in a manner that would, significantly and adversely affect the preferences, rights, privileges or powers of such Holder in a manner
disproportionate from any other Holder shall require the prior written consent of such significantly and adversely affected Holder; <U>provided</U><I>, </I><U>further</U>, that neither (x)&nbsp;any increase in the amount of the authorized or issued
Series B Preferred Stock or any securities convertible into Series B Preferred Stock nor (y)&nbsp;the creation and issuance, or an increase in the authorized or issued amount, of any series of Preferred Stock, or any securities convertible into
Preferred Stock, ranking equal with and/or junior to the Series B Preferred Stock with respect to the payment of dividends (whether such dividends are cumulative or <FONT STYLE="white-space:nowrap">non-cumulative)</FONT> and/or the distribution of
assets upon the Corporation&#146;s liquidation, dissolution or winding up, in either case, will, in and of itself, be deemed to significantly and adversely affect the preferences, rights, privileges or powers of the Series B Preferred Stock or any
Holder and the Holders will have no right to vote their shares of Series B Preferred Stock or consent to such action solely by reason of such an increase, creation or issuance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding the foregoing, the Corporation shall not, without the written consent or affirmative vote, given in person or by proxy, at
a meeting called for that purpose by the unanimous consent of the holders of the outstanding shares of Series B Preferred Stock, amend, alter or repeal (including by merger, consolidation or otherwise, and whether in a single transaction or a series
of related transactions, other than a Reorganization Event pursuant to which the Series B Preferred Stock is treated in accordance with <U>Section</U><U></U><U>&nbsp;VIII(i)</U>) the definitions of Applicable Conversion Rate, Base Price, Conversion
Price, Dividend Rate or, if prior to the Stockholder Approvals Date, Series B Preferred Liquidation Amount under this Certificate of Designations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding the foregoing, the Holders shall not have any voting rights set out in <U>Section</U><U></U><U>&nbsp;VI(b)</U> if, at or
prior to the effective time of the act with respect to which such vote would otherwise be required, all outstanding shares of Series B Preferred Stock shall have been converted into shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;VII. Rank; Liquidation. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The following provisions apply during the period between Closing and the Stockholder Approvals Date: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) In the event of any liquidation, dissolution or winding up of the affairs of the Corporation, whether voluntary or involuntary, holders of
the Series B Preferred Stock shall be entitled to receive, out of the assets of the Corporation, or proceeds thereof (whether capital or surplus), available for distribution to stockholders of the Corporation, and after satisfaction of all
liabilities and obligations to creditors of the Corporation and subject to the rights of any securities ranking senior to the Series B Preferred Stock, before any distribution of such assets or proceeds is made to or set aside for the holders of
Common Stock, in full an amount per share equal to the Base Price multiplied by the Applicable Conversion Rate, together with an amount equal to all dividends (if any) that have been declared but not paid prior to the date of payment of such
distribution (but without any amount in respect of dividends that have not been declared prior to such payment date) (the &#147;<U>Series B Preferred Liquidation Amount</U>&#148;). The rights of the Series B Preferred Stock pursuant to this
<U>Section</U><U></U><U>&nbsp;VII(a)</U> shall rank <I>pari passu</I> with the rights of the Series A Preferred Stock and Series C Preferred Stock. Thereafter, the Series B Preferred Stock will participate with the Common Stock on an <FONT
STYLE="white-space:nowrap">as-converted</FONT> basis as if Series B Preferred Stock was converted immediately prior to such liquidation, dissolution or winding up. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) If in any distribution described in
<U>Section</U><U></U><U>&nbsp;VII(a)</U> above the assets of the Corporation or proceeds thereof are not sufficient to pay the Liquidation Preferences (as defined below) in full to all holders of the Series B Preferred Stock and all holders of any
stock of the Corporation ranking equally with the Series B Preferred Stock as to such distribution, the amounts paid to the holders of the Series B Preferred Stock and to the holders of all such other stock shall be paid pro rata in accordance with
the respective aggregate Liquidation Preferences of the holders of the Series B Preferred Stock and the holders of all such other stock. In any such distribution, the &#147;<U>Liquidation Preference</U>&#148; of any holder of stock of the
Corporation shall mean the amount otherwise payable to such holder in such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an amount equal to any declared but unpaid dividends (and,
in the case of any holder of stock other than the Series B Preferred Stock and on which dividends accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not declared, as applicable). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) After the Stockholder Approvals Date, the Series B Preferred Stock shall, consistent with the requirements of 12 C.F.R.
Section&nbsp;217.20(b)(1) (or any successor regulation) with respect to common equity tier 1 capital, rank equally with, and have identical rights, preferences and privileges as, the Common Stock with respect to dividends or distributions (including
regular quarterly dividends) declared by the Board and rights upon any liquidation, dissolution, winding up or similar proceeding of the Corporation, as provided in the Charter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) For purposes of this <U>Section</U><U></U><U>&nbsp;VII</U>, the sale, conveyance, exchange or transfer (for cash, shares of stock,
securities or other consideration) of all or substantially all of the property and assets of the Corporation shall not be deemed a voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Corporation, nor shall the
merger, consolidation or any other business combination transaction of the Corporation into or with any other corporation or Person or the merger, consolidation or any other business combination of any other corporation or Person into or with the
Corporation be deemed to be a voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;VIII. Adjustments. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Conversion Price shall be subject to the adjustments described in this <U>Section</U><U></U><U>&nbsp;VIII</U> (each such event set
forth in <U>clauses (b)</U>&nbsp;through <U>(j)</U>, an &#147;<U>Adjustment Event</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Stock Dividends and
Distributions</U>. If the Corporation pays dividends or other distributions on the Common Stock in shares of Common Stock, then the Conversion Price will be adjusted by multiplying the Conversion Price in effect at 5:00 p.m., New York City time on
the Trading Day immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such dividend or distribution by the following fraction: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB> =</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately prior to <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such dividend or distribution.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP> =</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the sum of (x)&nbsp;the number of shares of Common Stock outstanding immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such dividend or distribution, <I>plus</I> (y)&nbsp;the total number of shares of
Common Stock issued in such dividend or distribution.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The adjustment pursuant to this <U>clause (b)</U>&nbsp;shall become effective at 9:00 a.m., New York City time
on the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such dividend or distribution. For the purposes of this <U>clause (b)</U>, the number of shares of Common Stock at the time outstanding shall not include shares held in treasury by the
Corporation. If any dividend or distribution described in this <U>clause (b)</U>&nbsp;is declared but not so paid or made, the Conversion Price shall be readjusted, effective as of the date the Board publicly announces its decision not to make such
dividend or distribution, to such Conversion Price that would be in effect if such dividend or distribution had not been declared. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)
<U>Subdivisions, Splits and Combinations of Common Stock</U>. If the Corporation subdivides, splits or combines the shares of Common Stock, then the Conversion Price will be adjusted by multiplying the Conversion Price in effect at 5:00 p.m., New
York City time on the Trading Day immediately prior to the effective date of such share subdivision, split or combination by the following fraction: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0 </SUB>=</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately prior to the effective date of such share subdivision, split or combination.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">OS<SUP STYLE="font-size:75%; vertical-align:top">1 </SUP>=</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately after the opening of business on the effective date of such share subdivision, split or combination.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The adjustment pursuant to this clause (c)&nbsp;shall become effective at 9:00 a.m., New York City time on the
effective date of such subdivision, split or combination. For the purposes of this clause (c), the number of shares of Common Stock at the time outstanding shall not include shares held in treasury by the Corporation. If any subdivision, split or
combination described in this clause (c)&nbsp;is announced but the outstanding shares of Common Stock are not subdivided, split or combined, the Conversion Price shall be readjusted, effective as of the date the Board publicly announces its decision
not to subdivide, split or combine the outstanding shares of Common Stock, to such Conversion Price that would be in effect if such subdivision, split or combination had not been announced. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Issuance of Stock Purchase Rights</U>. If the Corporation issues to all or
substantially all holders of the shares of Common Stock rights or warrants (other than rights or warrants issued pursuant to a dividend reinvestment plan or share purchase plan or other similar plans) entitling them, for a period of up to 45 days
from the date of issuance of such rights or warrants, to subscribe for or purchase the shares of Common Stock at less than the Current Market Price on the date immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such
issuance, then the Conversion Price will be adjusted by multiplying the Conversion Price in effect at 5:00 p.m., New York City time on the Trading Day immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such issuance by the
following fraction: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="7%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB> + Y</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB> + X</TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB> =</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">X =</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the total number of shares of Common Stock issuable pursuant to such rights or warrants.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">Y =</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock equal to the aggregate price payable to exercise such rights or warrants divided by the Current Market Price on the date immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Date</FONT>
for the issuance of such rights or warrants.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any adjustment pursuant to this <U>Section</U><U></U><U>&nbsp;VIII(d)</U> shall become effective immediately prior to 9:00
a.m., New York City time, on the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such issuance. For the purposes of this <U>Section</U><U></U><U>&nbsp;VIII(d)</U>, the number of shares of Common Stock at the time outstanding shall not include
shares held in treasury by the Corporation. The Corporation shall not issue any such rights or warrants in respect of shares of the Common Stock held in treasury by the Corporation. In the event that such rights or warrants described in this
<U>Section</U><U></U><U>&nbsp;VIII(d)</U> are not so issued, the Conversion Price shall be readjusted, effective as of the date the Board publicly announces its decision not to issue such rights or warrants, to the Conversion Price that would then
be in effect if such issuance had not been declared. To the extent that such rights or warrants are not exercised prior to their expiration or shares of Common Stock are otherwise not delivered pursuant to such rights or warrants upon the exercise
of such rights or warrants, the Conversion Price shall be readjusted to such Conversion Price that would then be in effect had the adjustment made upon the issuance of such rights or warrants been made on the basis of the delivery of only the number
of shares of Common Stock actually delivered. In determining the aggregate offering price payable for such shares of Common Stock, there shall be taken into account any consideration received for such rights or warrants and the value of such
consideration (if other than cash, to be reasonably determined by the Board). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Debt or Asset Distributions</U>. If the Corporation
distributes to all or substantially all holders of shares of Common Stock evidences of indebtedness, shares of capital stock, securities, cash or other assets (excluding any dividend or distribution referred to in clause (b)&nbsp;above, any dividend
or distribution paid exclusively in cash, any consideration payable in connection with a tender or exchange offer made by the Corporation or any of its subsidiaries, and any dividend of shares of capital stock of any class or series, or similar
equity interests, of or relating to a subsidiary or other business unit in the case of certain <FONT STYLE="white-space:nowrap">spin-off</FONT> transactions as described below), then the Conversion Price will be adjusted by multiplying the
Conversion Price in effect at 5:00 p.m., New York City time on the Trading Day immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution by the following fraction: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="7%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0&nbsp;</SUB>&#8196;&#150;&#8196;FMV</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP ALIGN="center">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&nbsp;=</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the Current Market Price per share of Common Stock on such date.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">FMV&nbsp;=</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the fair market value of the portion of the distribution applicable to one share of Common Stock on such date as reasonably determined by the Board; provided that, if &#147;FMV&#148; as set forth above is equal to or greater than
&#147;SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#148; as set forth above, in lieu of the foregoing adjustment, adequate provision shall be made so that each Holder shall receive on the date on which such distribution is made to
holders of Common Stock, for each share of Series B Preferred Stock, the amount of such distribution such Holder would have received had such holder owned a number of shares of Common Stock equal to the Applicable Conversion Rate on the <FONT
STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In a <FONT STYLE="white-space:nowrap">&#147;spin-off&#148;,</FONT> where the Corporation makes a distribution
to all holders of shares of Common Stock consisting of capital stock of any class or series, or similar equity interests of, or relating to, a subsidiary or other business unit, if a Holder did not participate in such distribution with respect to
such shares of Series B Preferred Stock as provided for in (x)&nbsp;prior to the Stockholder Approvals Date, <U>Section</U><U></U><U>&nbsp;IV</U> or (y)&nbsp;after the Stockholder Approvals Date, <U>Section V</U>, the Conversion Price with respect
to such share held by such Holder will be adjusted on the 15<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Trading Day after the effective date of the distribution by multiplying such Conversion Price in effect immediately prior to such 15<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP> Trading Day by the following fraction: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="7%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">MP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP ALIGN="center">MP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>+&nbsp;MP<SUB STYLE="font-size:75%; vertical-align:bottom">s</SUB></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">MP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&nbsp;=</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the average of the Closing Prices of the Common Stock over the first 10 Trading Days commencing on and including the fifth Trading Day following the effective date of such distribution.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">MP<SUB STYLE="font-size:75%; vertical-align:bottom">s</SUB> =</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the average of the Closing Prices of the capital stock or equity interests representing the portion of the distribution applicable to one share of Common Stock over the first 10 Trading Days commencing on and including the fifth
Trading Day following the effective date of such distribution, or, if not traded on a national or regional securities exchange or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, the fair
market value of the capital stock or equity interests representing the portion of the distribution applicable to one share of Common Stock on such date as reasonably determined by the Board.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any adjustment pursuant to this <U>clause (e)</U>&nbsp;shall become effective immediately prior to 9:00 a.m.,
New York City time, on the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution. In the event that such distribution described in this <U>clause (e)</U>&nbsp;is not so paid or made, the Conversion Price shall be readjusted,
effective as of the date the Board publicly announces its decision not to pay or make such dividend or distribution, to the Conversion Price that would then be in effect if such dividend or distribution had not been declared. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Cash Distributions</U>. If the Corporation makes a distribution consisting
exclusively of cash to all holders of Common Stock, excluding any (i)(x) prior to the Stockholder Approvals Date, regular quarterly cash dividend on the Common Stock not in excess of $0.05 per share, which per share amount shall be adjusted
accordingly in the event that the Corporation subdivides, splits or combines the shares of Common Stock and (y)&nbsp;after the Stockholder Approvals Date, cash dividend on the Common Stock to the extent a corresponding cash dividend is paid on the
Series B Preferred Stock pursuant to <U>Section</U><U></U><U>&nbsp;V(a),</U> (ii) cash that is distributed in a Reorganization Event or as part of a <FONT STYLE="white-space:nowrap">&#147;spin-off&#148;</FONT> referred to in <U>clause
(e)</U>&nbsp;above, (iii) dividend or distribution in connection with the Corporation&#146;s liquidation, dissolution or <FONT STYLE="white-space:nowrap">winding-up,</FONT> and (iv)&nbsp;consideration payable in connection with a tender or exchange
offer made by the Corporation or any of its subsidiaries, then in each event, the Conversion Price in effect immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution will be multiplied by the following fraction:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="7%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0&nbsp;</SUB>&#150;&#8196;DIV</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP ALIGN="center">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB> =</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the Closing Price per share of Common Stock on the Trading Day immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Date.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">DIV =</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the amount per share of Common Stock of the cash distribution, as determined pursuant to the introduction to this <U>clause (f)</U>.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that any distribution described in this <U>clause</U><U></U><U>&nbsp;(f)</U> is not so made, the
Conversion Price shall be readjusted, effective as of the date the Board publicly announces its decision not to pay such distribution, to the Conversion Price which would then be in effect if such distribution had not been declared. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if &#147;DIV&#148; as set forth above is equal to or greater than &#147;SP<SUB
STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#148; as set forth above, in lieu of the foregoing adjustment, adequate provision shall be made so that each Holder shall have the right to receive on the date on which the relevant cash dividend
or distribution is distributed to holders of Common Stock, for each share of Series B Preferred Stock, the amount of cash such Holder would have received had such holder owned a number of shares of Common Stock equal to the Applicable Conversion
Rate on the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Self-Tender Offers and Exchange Offers</U>. If
the Corporation or any of its subsidiaries successfully completes a tender or exchange offer for the Common Stock where the cash and the value of any other consideration included in the payment per share of the Common Stock exceeds the Closing Price
per share of the Common Stock on the Trading Day immediately succeeding the expiration of the tender or exchange offer, then the Conversion Price will be adjusted by multiplying the Conversion Price in effect at 5:00 p.m., New York City time prior
to the commencement of the offer by the following fraction: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="10%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&nbsp;x&nbsp;SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP ALIGN="center">AC&nbsp;+&nbsp;(SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&nbsp;x&nbsp;OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP>)</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB> =</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the Closing Price per share of Common Stock on the Trading Day immediately succeeding the commencement of the tender or exchange offer.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB> =</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately prior to the expiration of the tender or exchange offer, including any shares validly tendered and not withdrawn.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP> =</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately after the expiration of the tender or exchange offer (after giving effect to such tender offer or exchange offer).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">AC =</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the aggregate cash and fair market value of the other consideration payable in the tender or exchange offer, as reasonably determined by the Board.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any adjustment made pursuant to this clause (g)&nbsp;shall become effective immediately prior to 9:00 a.m.,
New York City time, on the Trading Day immediately following the expiration of the tender or exchange offer. In the event that the Corporation or one of its subsidiaries is obligated to purchase shares of Common Stock pursuant to any such tender
offer or exchange offer, but the Corporation or such subsidiary is permanently prevented by applicable law from effecting any such purchases, or all such purchases are rescinded, then the Conversion Price shall be readjusted to be such Conversion
Price that would then be in effect if such tender offer or exchange offer had not been made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Rights Plans</U>. To the extent that
the Corporation has a rights plan in effect with respect to the Common Stock on any Conversion Date, upon conversion of any shares of the Series B Preferred Stock, the Holders will receive, in addition to the shares of Common Stock, the rights under
the rights plan, unless, prior to such Conversion Date, the rights have separated from the shares of Common Stock, in which case the Conversion Price will be adjusted at the time of separation as if the Corporation had made a distribution to all
holders of Common Stock as described in <U>clause (e)</U>&nbsp;above, subject to readjustment in the event of the expiration, termination or redemption of such rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Reorganization Events</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Upon the occurrence of a Reorganization Event prior to an applicable Conversion Date, if such date is prior to the Stockholder Approvals
Date, each share of Series B Preferred Stock outstanding immediately prior to such Reorganization Event shall, without the consent of any Holders, be entitled to receive, out of the assets of the Corporation or proceeds thereof (whether capital or
surplus) available for distribution to stockholders of the Corporation, and after satisfaction of all liabilities and obligations to creditors of the Corporation and subject to the rights of any securities ranking senior to the Series B Preferred
Stock, before any distribution of such assets or proceeds is made to or set aside for the holders of Common Stock and any other Junior Stock, in full, the greater of the (1)&nbsp;amount per share equal to two times the Series B Preferred Liquidation
Amount or (2)&nbsp;amount equal to the distribution amount of such assets or proceeds of the Corporation as was receivable by a holder of the number of shares of Common Stock into which such share of Series B Preferred Stock was convertible
immediately prior to such Reorganization Event (such payment, the &#147;<U>Preferred Exchange Property</U>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) Upon the occurrence of a Reorganization Event prior to an applicable Conversion Date, if such date is after the Stockholder
Approvals Date, each share of Series B Preferred Stock outstanding immediately prior to such Reorganization Event shall, without the consent of Holders, automatically convert into the types and amounts of securities, cash, and other property that is
or was receivable in such Reorganization Event by a holder (other than the counterparty to the Reorganization Event or an Affiliate of such other party) of the number of shares of Common Stock into which such share of Series B Preferred Stock was
convertible immediately prior to such Reorganization Event in exchange for such shares of Series B Preferred Stock (such securities, cash, and other property, the &#147;<U>NVCE Exchange Property</U>&#148;); <U>provided</U> <U>that</U>, to the extent
receipt of any NVCE Exchange Property would be prohibited by Law or would require the Holder to obtain any consent, authorization, approval, license or permit of any Governmental Entity to acquire or hold the NVCE Exchange Property, then the portion
of the Series B Preferred Stock of such Holder that such Holder is prohibited by Law or requires such action to acquire or hold shall instead either (A)&nbsp;convert into a substantially identical <FONT STYLE="white-space:nowrap">non-voting</FONT>
security (with commensurate voting powers and conversion rights as the Series B Preferred Stock hereunder) of the entity surviving such Reorganization Event or other entity in which holders of shares of Common Stock receive securities in connection
with such Reorganization Event or (B)&nbsp;if proper provision is not made to give effect to the foregoing <U>subclause (A)</U>, remain outstanding without any alterations to the terms thereof and be convertible into the NVCE Exchange Property. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) In the event that holders of the shares of the Common Stock have the opportunity to elect the form of consideration to be
received in such Reorganization Event, the Corporation shall ensure that the Holders of the Series B Preferred Stock have the same opportunity to elect the form of consideration in accordance with the same procedures and pro ration mechanics that
apply to the election to be made by the holders of the Common Stock. The amount of NVCE Exchange Property receivable upon conversion of any Series B Preferred Stock shall be determined based upon the Conversion Price in effect on the date on which
such Reorganization Event is consummated. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) The Corporation shall not enter into any definitive agreement for a
transaction constituting a Reorganization Event unless such definitive agreement provides for the conversion of the Series B Preferred Stock into the Exchange Property in a manner that is consistent with and gives effect to this
<U>Section</U><U></U><U>&nbsp;VIII(j)(ii).</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) A &#147;<U>Reorganization Event</U>&#148; shall mean: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) any consolidation, merger, conversion or other similar business combination of the Corporation with or into another Person,
in each case, pursuant to which all or substantially all of the Common Stock outstanding will be converted into cash, securities, or other property of the Corporation or another Person; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) any sale, transfer, lease, or conveyance to another Person of all or
substantially all of the property and assets of the Corporation and its subsidiaries, taken as a whole, in each case pursuant to which all of the Common Stock outstanding will be converted into cash, securities, or other property of the Corporation
or another Person; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) any reclassification of the Common Stock into securities other than the Common Stock; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(4) any statutory exchange of all of the outstanding shares of Common Stock for securities of another Person (other than in
connection with a merger or acquisition). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) The provisions of this <U>Section</U><U></U><U>&nbsp;VIII(i)</U> shall similarly apply to
successive Reorganization Events or any series of transactions that results in a Reorganization Event and the provisions of <U>Section</U><U></U><U>&nbsp;VIII(i)</U> shall apply to any shares of capital stock of the Corporation (or any successor)
received by the holders of the Common Stock in any such Reorganization Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) The Corporation (or any successor) shall, at least
twenty days prior to the occurrence of any Reorganization Event, provide written notice to the Holders of the anticipated occurrence of such event and of the type and amount of the cash, securities or other property that constitutes the Exchange
Property; <U>provided</U>, that no such notice shall be required if the anticipated occurrence of any Reorganization Event is disclosed in any registration statement, prospectus, report, schedule or proxy statement filed with or furnished by the
Corporation to the U.S. Securities and Exchange Commission. Failure to deliver such notice shall not affect the operation of this <U>Section</U><U></U><U>&nbsp;VIII</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) No adjustment to the Conversion Price shall be made with respect to a share of Series B Preferred Stock if the Holder thereof has
participated in the transaction that would otherwise give rise to an adjustment with respect to such share of Series B Preferred Stock, as a result of holding such share of Series B Preferred Stock at the time of such transaction (including pursuant
to (x)&nbsp;prior to the Stockholder Approvals Date, <U>Section</U><U></U><U>&nbsp;IV</U> or (y)&nbsp;after the Stockholder Approvals Date, <U>Section V</U>), without having to convert such share of Series B Preferred Stock, as if they held the full
number of shares of Common Stock into which each such share of the Series B Preferred Stock held by them may then be converted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)
Notwithstanding anything to the contrary herein, an Adjustment Event shall not allow the Holder to acquire a higher percentage of any Class&nbsp;of Voting Securities of the Corporation than the Holder (together with its affiliates for purposes of
the BHC Act) beneficially owned immediately prior to such Adjustment Event. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;IX. Reports as to Adjustments. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever the number of shares of Common Stock into which the shares of the Series B Preferred Stock are convertible is adjusted as provided in
<U>Section</U><U></U><U>&nbsp;VIII</U>, the Corporation shall promptly, but in any event within ten days thereafter, compute such adjustment and furnish to the Holders a notice stating the number of shares of Common Stock into which each share of
the Series B Preferred Stock is convertible as a result of such adjustment, a brief statement of the facts requiring such adjustment and the computation thereof and when such adjustment will become effective. Amounts resulting from any calculation
hereunder will be rounded to the nearest 1/10,000th. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;X. Reservation of Stock. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Corporation shall, following the Charter Amendment Approval and the filing and acceptance of the Charter Amendment (as defined in the
Investment Agreements), reserve and keep available out of its authorized and unissued Common Stock and shares of Series C Preferred Stock, solely for issuance upon the conversion of shares of Series B Preferred Stock as provided in this Certificate
of Designations, free from any preemptive or other similar rights, such number of shares of Common Stock as shall from time to time be issuable upon the conversion of all the shares of Series B Preferred Stock then outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Following the approval of the applicable supplemental listing application, the Corporation hereby covenants and agrees that, for so long
as shares of the Common Stock are listed on the NYSE or any other national securities exchange or automated quotation system, the Corporation will, if permitted by the rules of such exchange or automated quotation system, list and keep listed that
number of shares of Common Stock issuable upon conversion of shares of all the Series B Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XI. Exclusion of
Other Rights. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of Series B Preferred Stock shall not have any voting powers except as expressly described herein, and,
except as may otherwise be required by Law, shall not have any preferences or relative, participating, optional or other special rights, other than those specifically set forth herein (as this Certificate of Designations may be amended from time to
time) and in the Charter. The shares of Series B Preferred Stock shall have no preemptive or subscription rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XII.
Severability of Provisions. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any voting powers, preferences or relative, participating, optional or other special rights of the
Series B Preferred Stock and qualifications, limitations and restrictions thereof set forth in this Certificate of Designations (as this Certificate of Designations may be amended from time to time) are invalid, unlawful or incapable of being
enforced by reason of any rule&nbsp;of Law, all other voting powers, preferences and relative, participating, optional and other special rights of Series B Preferred Stock and qualifications, limitations and restrictions thereof set forth in this
Certificate of Designations (as so amended) which can be given effect without the invalid, unlawful or unenforceable voting powers, preferences or relative, participating, optional or other special rights of Series B Preferred Stock and
qualifications, limitations and restrictions thereof shall, nevertheless, remain in full force and effect, and no voting powers, preferences or relative, participating, optional or other special rights of Series B Preferred Stock or qualifications,
limitations and restrictions thereof herein set forth shall be deemed dependent upon any other such voting powers, preferences or relative, participating, optional or other special rights of Series B Preferred Stock or qualifications, limitations
and restrictions thereof unless so expressed herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XIII. Cancellation of Series B Preferred Stock. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any shares of Series B Preferred Stock that have been duly converted in accordance with this Certificate of Designations, or reacquired by the
Corporation, shall be cancelled promptly thereafter and revert to authorized but unissued shares of Preferred Stock undesignated as to series. Such shares may be designated or redesignated and issued or reissued, as the case may be, as part of any
series of Preferred Stock. The Corporation may from time to time take such appropriate action as may be necessary to reduce the authorized number of shares of Series B Preferred Stock solely in accordance with the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XIV. Additional Authorized Shares. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything set forth in the Charter or this Certificate of Designations to the contrary, the Board or any authorized committee
of the Board, without the vote of the Holders, may increase or decrease the number of authorized shares of Series B Preferred Stock or other stock ranking junior or senior to, or on parity with, the Series B Preferred Stock as to dividends and the
distribution of assets upon any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XV. Determinations. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation shall have the sole right to make all calculations called for hereunder. Absent fraud or manifest error, such calculations
shall be final and binding on all Holders. The Corporation shall have the power to resolve any ambiguity and its action in so doing, as evidenced by a resolution of the Board, shall be final and conclusive unless clearly inconsistent with the intent
hereof. Amounts resulting from any calculation will be rounded, if necessary, to the nearest one <FONT STYLE="white-space:nowrap">ten-thousandth,</FONT> with five <FONT STYLE="white-space:nowrap">one-hundred</FONT> thousandths being rounded upwards.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XVI. No Redemption. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may not, at any time, redeem the outstanding shares of the Series B Preferred Stock, other than as otherwise expressly set
forth in <U>Section</U><U></U><U>&nbsp;VIII</U> with the prior approval of the Federal Reserve Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XVII. Maturity.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Series B Preferred Stock shall be perpetual, unless converted in accordance with this Certificate of Designations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XVIII. Repurchases. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the limitations imposed herein, the Corporation may purchase and sell shares of Series B Preferred Stock from time to time to such
extent, in such manner, and upon such terms as the Board or any duly authorized committee of the Board may determine; <U>provided</U> <U>that</U> any repurchase of shares of Series B Preferred Stock by the Corporation shall require prior approval of
the Federal Reserve Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XIX. No Sinking Fund. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of Series B Preferred Stock are not subject to the operation of a sinking fund. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XX. Notices. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All notices, demands or other communications to be given hereunder shall be in writing and shall be deemed to have been given (a)&nbsp;on the
date of delivery if delivered personally to the recipient, or if by email, upon delivery (<U>provided</U> that no auto-generated error or <FONT STYLE="white-space:nowrap">non-delivery</FONT> message is generated in response thereto), (b) on the
first Business Day following the date of dispatch if delivered utilizing a <FONT STYLE="white-space:nowrap">next-day</FONT> service by a recognized <FONT STYLE="white-space:nowrap">next-day</FONT> courier or (c)&nbsp;on the earlier of confirmed
receipt or the fifth business day following the date of mailing if delivered by registered or certified mail, return receipt requested, postage prepaid. All notices hereunder shall be delivered to (i)&nbsp;if to the Corporation, New York Community
Bancorp, Inc., 102 Duffy Avenue, Hicksville, New York 11801, Attention: Chief Executive Officer, Email: sandro.dinello@flagstar.com; with a copy to: General Counsel, Email: patrick.quinn@flagstar.com or (ii)&nbsp;if to any Holder or holder of Common
Stock, as the case may be, to such Holder or holder at the address listed in the stock record books of the Corporation, or, in each case, such other address or to the attention of such other Person as the recipient party has specified by prior
written notice to the sending party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XXI. Taxes. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Corporation and each Holder shall bear their own costs, fees and expenses in connection with any conversion contemplated by
<U>Section</U><U></U><U>&nbsp;III</U>, except that the Corporation shall pay any and all transfer taxes, stamp taxes or duties, documentary taxes, or other similar taxes imposed upon the issuance of shares of Common Stock on account of any
conversion contemplated by <U>Section</U><U></U><U>&nbsp;III</U>; <U>provided</U> that the Corporation shall not be required to pay any such tax to the extent such tax is payable because a Holder requests Common Stock to be registered in a name
other than such registered holder&#146;s name (including in connection with any Convertible Transfer) and no such Common Stock will be so registered unless and until the registered holder making such request has paid such taxes to the Corporation or
has established to the satisfaction of the Corporation that such taxes have been paid or are not payable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything
herein to the contrary, the Corporation and any applicable withholding agent shall be entitled to deduct and withhold from any consideration otherwise payable on or with respect to the Series B Preferred Stock (including upon conversion of any
Series B Preferred Stock) such amounts as it is required to deduct or withhold with respect to the making of such payment under the Internal Revenue Code of 1986, as amended (the &#147;<U>Code</U>&#148;), or any other applicable tax Law. If the
Holder is deemed for U.S. federal income tax purposes to have received a distribution with respect to the Series B Preferred Stock, the Corporation and any applicable withholding agent may satisfy any resulting applicable withholding obligations
(including with respect to backup withholding) required by applicable Tax Law imposed in connection with such deemed distribution by withholding from any other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
payments due with respect to the Series B Preferred Stock, including any payments upon conversion, repurchase or redemption of the Series B Preferred Stock. If any amounts are so deducted or
withheld and subsequently paid to the applicable Government Entity, such deducted or withheld amounts shall be treated for all purposes hereunder as having be paid to the person to which such amounts would have otherwise been payable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Corporation and each Holder each agree that there shall be no deemed distribution on the Series B Preferred Stock pursuant to
Section&nbsp;305(c) of the Code in respect of a difference between the &#147;issue price&#148; and the &#147;redemption price&#148; of the Series B Preferred Stock and except to the extent otherwise required by a &#147;determination&#148; within the
meaning of Section&nbsp;1313(a) of the Code, neither the Corporation nor Holder shall take any position inconsistent therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XXII. No Stock Certificates. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary contained in this Certificate of Designations, no shares of Series B Preferred Stock shall be issued
in physical, certificated form. All shares of Series B Preferred Stock shall be evidenced by book-entry on the record books maintained by the Corporation or its transfer agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XXIII. Transfers. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of Series B Preferred Stock are subject to the restrictions on transfer set forth in the Investment Agreement(s). Any purported
transfer in violation of such restrictions shall be null and void. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the Corporation has caused this Certificate of Designations to be
signed by the undersigned on this 11<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day of March, 2024. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>NEW YORK COMMUNITY BANCORP, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ R. Patrick Quinn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: R. Patrick Quinn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: General Counsel&nbsp;&amp; Corporate Secretary</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Certificate of Designations</I>] </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.3
<SEQUENCE>4
<FILENAME>d763888dex33.htm
<DESCRIPTION>EX-3.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT 3.3 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXECUTION VERSION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF DESIGNATIONS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SERIES C
NONCUMULATIVE CONVERTIBLE PREFERRED STOCK </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NEW YORK COMMUNITY BANCORP, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NEW YORK COMMUNITY BANCORP, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware (the
&#147;<U>Corporation</U>&#148;), in accordance with the provisions of Sections 103, 141 and 151 thereof, does hereby certify that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
accordance with the provisions of the Amended and Restated Certificate of Incorporation, as amended, and the Amended and Restated Bylaws of the Corporation and applicable law, the Board of Directors of the Corporation (the &#147;<U>Board</U>&#148;),
duly adopted the following resolution on March&nbsp;6, 2024, creating a series of Preferred Stock of the Corporation designated as &#147;Series C Noncumulative Convertible Preferred Stock&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">RESOLVED, that pursuant to the Delaware General Corporation Law (the &#147;<U>DGCL</U>&#148;), the Charter and the Amended and Restated Bylaws
of the Corporation, the Board hereby establishes a series of Preferred Stock, par value $0.01 per share, of the Corporation and fixes and determines the designation, powers, preferences, redemption rights, qualifications, privileges, limitations,
restrictions and special or relative rights thereof as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;I. Designation and Amount. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A series of Preferred Stock designated as the &#147;Series C Noncumulative Convertible Preferred Stock&#148; (&#147;<U>Series C Preferred
Stock</U>&#148;) is hereby established. The total number of authorized shares of Series C Preferred Stock shall be 523,369. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;II.</B> <B>Definitions</B><B>.</B> As used herein, the following terms shall have the following meanings, unless
the context otherwise requires: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Adjustment Event</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;VII(a)</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; means, with respect to any Person, any other Person that, directly or indirectly through one or more
intermediaries, controls, is controlled by, or is under common control with, such specified Person (as used in this definition, the term &#147;control&#148; means the possession, directly or indirectly, of the power to direct or cause the direction
of the management or policies of a Person, whether through ownership of voting securities, by contract or otherwise). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Applicable
Conversion Rate</U>&#148; means, for each share of Series C Preferred Stock, the number of shares of Common Stock equal to the product of (a)&nbsp;one thousand (1,000) <I>multiplied by</I> (b)&nbsp;the quotient of (i)&nbsp;the Base Price <I>divided
by</I> (ii)&nbsp;the then-applicable Conversion Price, subject to adjustment pursuant to <U>Section VII</U> for any applicable event occurring subsequent to the initial determination of the Applicable Conversion Rate. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Authorized Shares Limit</U>&#148; means, at any time of determination, the total
number of authorized shares of Common Stock under the Charter reduced by the number of shares of Common Stock that are issued and outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Base Price</U>&#148; means $2.00. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>BHC Act</U>&#148; means the Bank Holding Company Act of 1956 (as amended) and its implementing regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Board</U>&#148; means the Board of Directors of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means any day, other than a Saturday, Sunday or other day on which banking institutions in the city of New
York, New York are required or authorized by Law to be closed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Certificate of Designations</U>&#148; means this Certificate of
Designations of Series C Preferred Stock of the Corporation, dated March&nbsp;11, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Charter</U>&#148; means the Amended and
Restated Certificate of Incorporation of the Corporation, as amended, supplemented and/or restated from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Charter
Amendment Approval</U>&#148; means the approval of the proposal to amend the Charter in a manner to increase the total authorized number of shares of Common Stock to at least 1,700,000,000 by the affirmative vote of a majority of votes cast by the
holders of shares of Common Stock, at the meeting of the Corporation&#146;s stockholders at which a vote is taken with respect to such Charter amendment proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Charter Amendment Approval Date</U>&#148; means the day that is the second Business Day after the date on which Charter Amendment
Approval has been obtained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Class</U><U></U><U>&nbsp;of Voting Security</U>&#148; shall be interpreted in a manner consistent
with how &#147;class of voting shares&#148; is defined in 12 C.F.R. Section&nbsp;225.2(q)(3) or any successor provision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing</U>&#148; has the meaning set forth in the Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Date</U>&#148; means the date that any shares of Series C Preferred Stock are first issued. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Price</U>&#148; of the Common Stock (or other relevant capital stock or equity interest) on any date of determination means
the closing sale price or, if no closing sale price is reported, the last reported sale price of the shares of the Common Stock (or other relevant capital stock or equity interest) on the NYSE on such date. If the Common Stock (or other relevant
capital stock or equity interest) is not traded on the NYSE on any date of determination, the Closing Price of the Common Stock (or other relevant capital stock or equity interest) on such date of determination means the closing sale price as
reported in the composite transactions for the principal U.S. national or regional securities exchange on which the Common Stock (or other relevant capital stock or equity interest) is so listed or quoted, or, if no closing sale price is reported,
the last reported sale price on the principal U.S. national or regional securities </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
exchange on which the Common Stock (or other relevant capital stock or equity interest) is so listed or quoted, or if the Common Stock (or other relevant capital stock or equity interest) is not
so listed or quoted on a U.S. national or regional securities exchange, the last quoted bid price for the Common Stock (or other relevant capital stock or equity interest) in the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market as reported by OTC Markets Group Inc. or a similar organization, or, if that bid price is not available, the market price of the Common Stock (or
other relevant capital stock or equity interest) on that date as determined by a nationally recognized independent investment banking firm retained by the Corporation for this purpose. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Certificate of Designations, all references herein to the &#147;Closing Price&#148; and &#147;last reported sale
price&#148; of the Common Stock (or other relevant capital stock or equity interest) on the NYSE shall be such closing sale price and last reported sale price as reflected on the website of the NYSE (http://www.nyse.com) and as reported by Bloomberg
Professional service; <U>provided</U> that in the event that there is a discrepancy between the closing sale price or last reported sale price as reflected on the website of the NYSE and as reported by Bloomberg Professional service, the closing
sale price and last reported sale price on the website of the NYSE shall govern. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Common Stock</U>&#148; means the common stock,
$0.01 par value per share, of the Corporation authorized by the Corporation on or after the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Conversion
Date</U>&#148; means the date on which any shares of Series C Preferred Stock shall become convertible into any shares of Common Stock pursuant to <U>Section</U><U></U><U>&nbsp;III</U>; <U>provided</U>, <U>however</U>, that if a Conversion Date
would otherwise occur on or after an <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for an issuance, dividend or distribution that results in an adjustment of the Conversion Price pursuant to <U>Section</U><U></U><U>&nbsp;VII</U> and on or before
the Record Date for such issuance or distribution, such Conversion Date shall instead occur on the first calendar day after the Record Date for such issuance, dividend or distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Conversion Price</U>&#148; means, for each share of Series C Preferred Stock, the Base Price, as the same may be adjusted from time
to time in accordance with the terms of this Certificate of Designations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Convertible Transfer</U>&#148; means a transfer by the
Holder that is both (i)&nbsp;to a Person who is not an affiliate of the Holder for purposes of the BHC Act and (ii) (A)&nbsp;to the Corporation; (B)&nbsp;in a widespread public distribution; (C)&nbsp;in which no transferee (or group of associated
transferees) would receive 2% or more of the outstanding securities of any Class&nbsp;of Voting Securities of the Corporation; or (D)&nbsp;to a purchaser that would control more than 50% of every Class&nbsp;of Voting Securities of the Corporation
without any transfer from the Holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Corporation</U>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Current Market Price</U>&#148; means, on any date, the average of the daily Closing Price per share of the Common Stock or other
securities on each of the five consecutive Trading Days preceding the earlier of the day before the date of the issuance, dividend or distribution in question and the day before the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> with respect to the
issuance or distribution, giving rise to an adjustment to the Conversion Price pursuant to <U>Section</U><U></U><U>&nbsp;VII</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>DGCL</U>&#148; means the Delaware General Corporation Law, as amended from time to
time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Dividend Parity Stock</U>&#148; has the meaning specified in <U>Section IV(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Dividend Payment Date</U>&#148; means March&nbsp;17, June&nbsp;17, September&nbsp;17 and December&nbsp;17 of each year, commencing
June&nbsp;17, 2024; provided, however, that if any such date is not a Business Day, then such date shall nevertheless be a Dividend Payment Date but dividends on the Series C Preferred Stock, when, as and if declared, shall be paid on the next
succeeding Business Day (without adjustment in the amount of the dividend per share of Series C Preferred Stock). Each Dividend Payment Date &#147;relates&#148; to the Dividend Period most recently ending before such Dividend Payment Date, and vice
versa (with the words &#147;related&#148; and &#147;relating&#148; having correlative meanings). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Dividend Period</U>&#148; means
each period from and including a Dividend Payment Date (except that the initial Dividend Period shall commence on the Original Issue Date) and continuing to, but excluding, the next succeeding Dividend Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Dividend Rate</U>&#148; means 13%. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Dividend Record Date</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;IV(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Property</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;VII(h)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Ex-Date</FONT></U>&#148; means, when used with respect to any issuance, dividend or distribution
giving rise to an adjustment to the Conversion Price pursuant to <U>Section</U><U></U><U>&nbsp;VII</U>, the first date on which the applicable Common Stock or other securities trade without the right to receive the issuance, dividend or
distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Federal Reserve Board</U>&#148; means the Board of Governors of the Federal Reserve System. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Government Entity</U>&#148; means any (a)&nbsp;federal, state, local, municipal, foreign or other government; (b)&nbsp;governmental
entity of any nature (including any governmental agency, branch, department, official, committee or entity and any court or other tribunal), whether foreign or domestic; or (c)&nbsp;body exercising or entitled to exercise any administrative,
executive, judicial, legislative, police, regulatory, or taxing authority or power of any nature, whether foreign or domestic, including any arbitral tribunal and self-regulatory organizations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Holder</U>&#148; means the Person in whose name any shares of Series C Preferred Stock are registered, which may be treated by the
Corporation as the absolute owner of such shares of Series C Preferred Stock for the purpose of making payment and settling conversion and for all other purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR Act</U>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR Amount</U>&#148; means, with respect to any conversion of Series C Preferred
Stock hereunder held by a particular Holder, the sum of (a)&nbsp;the product of $2.73 and the aggregate number of shares of Common Stock purchased by the Holder at the Closing, <U>plus</U> (b)&nbsp;the product of $2.73 and the number of shares of
Common Stock being issued to upon any such conversion of Series C Preferred Stock hereunder held by such Holder <U>plus</U> (c)&nbsp;the product of $2.73 and the number of shares of Common Stock issued upon any prior conversion of Series C Preferred
Stock hereunder held by such Holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR Approvals</U>&#148; means, with respect to the shares of Series C Preferred Stock of
any Holder, the expiration or termination of any applicable waiting period (or extension thereof) under the HSR Act with respect to such Holder&#146;s acquisition or ownership of Common Stock upon conversion of such shares of Series C Preferred
Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR Approvals Date</U>&#148; means, with respect to the shares of Series C Preferred Stock of any Holder, the day that is
the fifth Business Day after the date on which such Holder shall have obtained the HSR Approvals. If a particular Holder&#146;s HSR Amount does not exceed the HSR Threshold (a &#147;<U><FONT STYLE="white-space:nowrap">Non-HSR</FONT>
Holder</U>&#148;), then such <FONT STYLE="white-space:nowrap">Non-HSR</FONT> Holder&#146;s HSR Approvals Date shall be determined by such <FONT STYLE="white-space:nowrap">Non-HSR</FONT> Holder in such <FONT STYLE="white-space:nowrap">Non-HSR</FONT>
Holder&#146;s sole discretion; provided, that such date shall not be later than the first HSR Approvals Date applicable to any holder with an HSR Amount that does exceed the HSR Threshold. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR Threshold</U>&#148; means $119.5&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Investment Agreements</U>&#148; means the investment agreements, by and between the Corporation and the investor parties thereto,
dated as of March&nbsp;7, 2024 (as amended, supplemented or restated from time to time). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Junior Stock</U>&#148; means the Common
Stock and any other class or series of stock of the Corporation that ranks junior to the Series C Preferred Stock either or both as to the payment of dividends and/or as to the distribution of assets on any liquidation, dissolution or winding up of
the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Law</U>&#148; means, with respect to any Person, any legal, regulatory and administrative laws, statutes,
rules, Orders and regulations applicable to such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liens</U>&#148; means any and all liens, charges, security interests,
options, claims, mortgages, pledges, proxies, voting trusts or agreements, obligations, understandings or arrangements, or other restrictions on title or transfer of any nature whatsoever. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liquidation Preference</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;VI(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>NYSE</U>&#148; means the New York Stock Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>NYSE Limit</U>&#148; means a number of shares of Common Stock equal to 19.9% of the shares of Common Stock outstanding immediately
prior to the execution of the Investment Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>NYSE Share Issuance Amount</U>&#148; means (a)&nbsp;the total number of
shares of Common Stock issued upon conversion of any shares of Series C Preferred Stock plus (b)&nbsp;the total number of shares of Common Stock issued at the Closing plus (c)&nbsp;the total number of shares of Common Stock issued upon conversion or
exchange of any shares of Series B Preferred Stock plus (d)&nbsp;the total number of shares of Common Stock issued upon conversion of any shares of Series D NVCE Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Order</U>&#148; means any applicable order, injunction, judgment, decree, ruling,
or writ of any Government Entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permanent Warrant</U>&#148; has the meaning set forth in the Investment Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means an individual, corporation, partnership, limited partnership, limited liability company, syndicate, person
(including a &#147;person&#148; as defined in Sections 13(d)(3) and 14(d) of the Exchange Act), trust, association or entity or government, political subdivision, agency or instrumentality of a government. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Preferred Stock</U>&#148; has the meaning set forth in the Charter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Record Date</U>&#148; means, with respect to any dividend, distribution or other transaction or event in which the holders of the
Common Stock have the right to receive any cash, securities or other property or in which the Common Stock is exchanged for or converted into any combination of cash, securities or other property, the date fixed for determination of holders of the
Common Stock entitled to receive such cash, securities or other property (whether such date is fixed by the Board or a duly authorized committee of the Board or by Law, contract or otherwise). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reorganization Event</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;VII(h)(ii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series A Preferred Stock</U>&#148; means the Corporation&#146;s
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Series A Noncumulative Perpetual Preferred Stock, par value $0.01 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series B Preferred Stock</U>&#148; means the Series B Noncumulative Convertible Preferred Stock, par value $0.01 per share, of the
Corporation, issued pursuant to the Investment Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series C Preferred Liquidation Amount</U>&#148; has the meaning
specified in <U>Section</U><U></U><U>&nbsp;VI(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series C Preferred Stock</U>&#148; has the meaning specified in
<U>Section</U><U></U><U>&nbsp;I</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series D NVCE Stock</U>&#148; means the Series D
<FONT STYLE="white-space:nowrap">Non-Voting</FONT> Common Equivalent Stock, par value $0.01 per share, of the Corporation, issuable upon conversion of a Permanent Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Share Issuance Approval</U>&#148; means the approval, by the affirmative vote of a majority of votes cast by holders of shares of
Common Stock at the meeting of the Corporation&#146;s stockholders at which a vote is taken with respect to such issuance, that is required under applicable NYSE rules as a result of the NYSE Share Issuance Amount exceeding the NYSE Limit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Share Issuance Approval Date</U>&#148; means the day that is the second Business Day after the date on which Share Issuance Approval
has been obtained. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Stockholder Approvals</U>&#148; means the Charter Amendment Approval and Share
Issuance Approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subject Series C Share</U>&#148; means a share of Series C Preferred Stock that is automatically converted
pursuant to <U>Section</U><U></U><U>&nbsp;III(a)</U>, <U>Section</U><U></U><U>&nbsp;III(b)</U>, <U>Section</U><U></U><U>&nbsp;III(c)</U> or <U>Section</U><U></U><U>&nbsp;III(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trading Day</U>&#148; means a day on which the shares of Common Stock: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) are not suspended from trading on any national or regional securities exchange or association or <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market at the close of business; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) have traded at least once on the national or regional securities exchange or association or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market that is the primary market for the trading of the Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;III. Conversion. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Conversion upon Convertible Transfer</U>. On the terms and in the manner set forth in this <U>Section</U><U></U><U>&nbsp;III</U>, upon
the consummation of any Convertible Transfer of shares of Series C Preferred Stock, each outstanding share of Series C Preferred Stock subject to such Convertible Transfer (each, a &#147;<U>Subject Series C Share</U>&#148;) shall automatically
convert into a number of shares of Common Stock equal to the Applicable Conversion Rate; <U>provided</U> that, if at that time of the Convertible Transfer, (A)&nbsp;the HSR Approvals and/or the Stockholder Approvals is required for the conversion of
the Subject Series C Shares into Common Stock and (B)&nbsp;the HSR Approvals or the Stockholder Approvals, as applicable, has not yet been obtained, then the maximum number of Subject Series C Shares that can convert into Common Stock without
receipt of the HSR Approvals or Stockholder Approvals, as applicable, shall so convert into Common Stock based on the Applicable Conversion Rate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Conversion on the HSR Approvals Date</U>. On the terms and in the manner set forth in this <U>Section</U><U></U><U>&nbsp;III</U>,
effective as of the close of business on the HSR Approvals Date with respect to outstanding shares of Series C Preferred Stock of a Holder, a number of shares of Series C Preferred Stock shall automatically convert into a number of shares of Common
Stock with such number being determined as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) in the event that the HSR Approvals Date occurs prior to both the Charter
Amendment Approval and Share Issuance Approval being obtained, the maximum number of shares of Common Stock that may be converted without (1)&nbsp;exceeding the Authorized Shares Limit or (2)&nbsp;the NYSE Share Issuance Amount exceeding the NYSE
Limit; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) in the event that the HSR Approvals Date occurs prior to the Charter Amendment Approval being obtained but after the Share
Issuance Approval has been obtained, the maximum number of shares of Common Stock that may be converted without exceeding the Authorized Shares Limit; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) in the event that the HSR Approvals Date occurs prior to the Share Issuance Approval being obtained but after the Charter Amendment
Approval has been obtained, the maximum number of shares of Common Stock that may be converted without exceeding the NYSE Share Issuance Amount exceeding the NYSE Limit. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Conversion on the Share Issuance Approval Date</U>. On the terms and in the manner
set forth in this <U>Section</U><U></U><U>&nbsp;III</U>, effective as of the close of business on the Share Issuance Approval Date with respect to outstanding shares of Series C Preferred Stock of a Holder, a number of shares of Series C Preferred
Stock shall automatically convert into a number of shares of Common Stock with such number being determined as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) in the event
that the Share Issuance Approval Date occurs prior to both the Charter Amendment Approval and HSR Approvals being obtained, the maximum number of shares of Common Stock that may be converted without (1)&nbsp;exceeding the Authorized Shares Limit or
(2)&nbsp;the HSR Amount exceeding the HSR Threshold; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) in the event that the Share Issuance Approval Date occurs prior to the Charter
Amendment Approval being obtained but after the HSR Approvals has been obtained, the maximum number of shares of Common Stock that may be converted without exceeding the Authorized Shares Limit; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) in the event that the Share Issuance Approval Date and the Charter Amendment Approval Date occur concurrently and prior to HSR Approvals
being obtained, the maximum number of shares of Common Stock that may be converted without the HSR Amount exceeding the HSR Limit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)
<U>Conversion on the Charter Amendment Approval Date</U>. On the terms and in the manner set forth in this <U>Section</U><U></U><U>&nbsp;III</U>, effective as of the close of business on the Charter Amendment Approval Date with respect to
outstanding shares of Series C Preferred Stock of a Holder, a number of shares of Series C Preferred Stock shall automatically convert into a number of shares of Common Stock with such number being determined as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) in the event that the Charter Amendment Approval Date occurs prior to both the Share Issuance Approval and HSR Approvals being obtained,
the maximum number of shares of Common Stock that may be converted without (1)&nbsp;the NYSE Share Issuance Amount exceeding the NYSE Limit or (2)&nbsp;the HSR Amount exceeding the HSR Limit; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) in the event that the Charter Amendment Approval Date occurs prior to the Share Issuance Approval being obtained but after the HSR
Approvals has been obtained, the maximum number of shares of Common Stock that may be converted without the NYSE Share Issuance Amount exceeding the NYSE Limit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The shares of Series C Preferred Stock shall not be convertible into any other class of capital stock of the Corporation, except in
accordance with this <U>Section</U><U></U><U>&nbsp;III</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Notwithstanding anything to the contrary contained in this Certificate of
Designations, prior to the receipt of the Stockholder Approvals, no Holder shall be permitted to convert more than 22% of the total number of shares of Series C Preferred Stock issued to such Holder at the Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) The shares of Common Stock issuable upon conversion of the Series C Preferred Stock
pursuant to <U>Section</U><U></U><U>&nbsp;III(b)</U>, <U>Section</U><U></U><U>&nbsp;III(c)</U> and <U>Section</U><U></U><U>&nbsp;III(d)</U> shall be allocated among the Holders on a <I>pro rata </I>basis of the aggregate dollar amount invested by
the Holders on the Closing Date; <U>provided</U> <U>that</U> such allocation shall be subject to any adjustment required to be made so as to not cause, in the event that HSR Approvals have not been obtained, any Holder&#146;s HSR Amount to exceed
the HSR Threshold. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Each Holder shall, promptly upon receipt of the HSR Approvals (if any) applicable to such Holder, provide written
notice to the Corporation thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) On the Conversion Date, the Corporation shall effect the conversion of the Subject Series C Shares
by delivering the shares of Common Stock so converted pursuant to <U>Section</U><U></U><U>&nbsp;III(a)</U>, <U>Section</U><U></U><U>&nbsp;III(b)</U>, <U>Section</U><U></U><U>&nbsp;III(c)</U> or <U>Section III(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) The Corporation and each Holder agree to, during the two Business Days prior to the Conversion Date, use commercially reasonable efforts
to calculate the number of shares of Common Stock issuable upon conversion of the Series C Preferred Stock pursuant to <U>Section</U><U></U><U>&nbsp;III(a)</U>, <U>Section</U><U></U><U>&nbsp;III(b)</U>, <U>Section</U><U></U><U>&nbsp;III(c)</U> and
<U>Section III(d) </U>in accordance with this <U>Section</U><U></U><U>&nbsp;III</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Prior to the close of business on any applicable
Conversion Date, the shares of Common Stock issuable upon conversion of any shares of Series C Preferred Stock pursuant to <U>Section</U><U></U><U>&nbsp;III</U> shall not be deemed outstanding for any purpose, and the Holders shall have no rights
with respect to the Common Stock (including voting rights, rights to respond to tender offers for the Common Stock and rights to receive any dividends or other distributions on the Common Stock) by virtue of holding shares of Series C Preferred
Stock, except as otherwise expressly set forth in this Certificate of Designations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Effective immediately prior to the close of
business on any applicable Conversion Date, the rights of the Holders with respect to the shares of the Series C Preferred Stock so converted shall cease and the Persons entitled to receive shares of Common Stock upon the conversion of such shares
of Series C Preferred Stock shall be treated for all purposes as having become the record and beneficial owners of such shares of Common Stock. In the event that the Holders shall not by written notice to the Corporation designate the name in which
shares of Common Stock and/or cash, securities or other property (including payments of cash in lieu of fractional shares) to be issued or paid upon conversion of shares of Series C Preferred Stock should be registered or paid or the manner in which
such shares should be delivered, the Corporation shall be entitled to register and deliver such shares, and make such payment, in the name of the Holders and in the manner shown on the records of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) No fractional shares of Common Stock shall be issued upon any conversion of shares of Series C Preferred Stock. If more than one share of
Series C Preferred Stock shall be surrendered for conversion at any one time by the same Holder, the number of full shares of Common Stock issuable upon conversion thereof shall be computed on the basis of the aggregate number of shares of Series C
Preferred Stock so surrendered. Instead of any fractional shares of Common Stock that would otherwise be issuable upon conversion of any Subject Series C Share, the Corporation shall pay an amount in cash (rounded to the nearest cent) equal to the
fractional share of Common Stock that otherwise would be issuable hereunder, <I>multiplied by</I> the Closing Price of the Common Stock determined as of the second Trading Day immediately preceding the applicable Conversion Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) All shares of Common Stock which may be issued upon conversion of the shares of Series C
Preferred Stock will, upon issuance by the Corporation, be duly authorized, validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> free and clear of all Liens (other than transfer restrictions imposed under applicable
securities Laws) and not issued in violation of any preemptive right or Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) Effective immediately prior to the Conversion Date,
dividends or distributions shall no longer be declared on any Subject Series C Shares and such shares shall cease to be outstanding, in each case, subject to the rights of a Holder to receive any declared and unpaid dividends or distributions on
such shares and any other payments to which they are otherwise entitled pursuant to <U>Section</U><U></U><U>&nbsp;IV</U> or <U>Section</U><U></U><U>&nbsp;VII</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;IV. Dividend Rights. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Holders shall be entitled to receive, when, as and if declared by the Board (or a duly authorized committee of the Board), on each
Dividend Payment Date, out of funds legally available therefor, <FONT STYLE="white-space:nowrap">non-cumulative</FONT> cash dividends on the Series C Preferred Liquidation Amount per share of Series C Preferred Stock at a rate per annum equal to the
Dividend Rate on each Dividend Payment Date for each Dividend Period. Such dividends shall be payable in arrears (as provided below in this <U>Section</U><U></U><U>&nbsp;IV(a)</U>), but only when, as and if declared by the Board (or a duly
authorized committee of the Board). Dividends on the Series C Preferred Stock shall not be cumulative; Holders shall not be entitled to receive any dividends not declared by the Board (or a duly authorized committee of the Board) and no interest, or
sum of money in lieu of interest, shall be payable in respect of any dividend not so declared. Dividends on the Series C Preferred Stock shall not be declared or set aside for payment if and to the extent such dividends would cause the Corporation
to fail to comply with the capital adequacy rules of the Federal Reserve Board (or, as and if applicable, the capital adequacy rules or regulations of any successor appropriate federal banking agency) applicable to the Corporation. Dividends that
are payable on the Series C Preferred Stock on any Dividend Payment Date will be payable to Holders as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th calendar day before such Dividend
Payment Date or such other record date fixed by the Board (or a duly authorized committee of the Board) that is not more than 60 nor less than 10 days prior to such Dividend Payment Date (each, a &#147;<U>Dividend Record Date</U>&#148;). Any such
day that is a Dividend Record Date shall be a Dividend Record Date whether or not such day is a Business Day. Dividends payable on the Series C Preferred Stock shall be computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year
consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months. The Corporation&#146;s determination of any dividend rate and its calculation of the amount of dividends for any Dividend Period will be maintained on file at the
Corporation&#146;s principal offices and will be available to any Holder upon request and will be final and binding in the absence of manifest error. Holders shall not be entitled to any dividends, whether payable in cash, securities or other
property, other than dividends (if any) declared and payable on the Series C Preferred Stock as specified in this <U>Section</U><U></U><U>&nbsp;IV</U> (subject to the other provisions of this Certificate of Designations); provided, that the
foregoing shall not limit or modify the rights of any Holder to receive any dividend or other distribution pursuant to <U>Section</U><U></U><U>&nbsp;VII</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) So long as any share of Series C Preferred Stock remains outstanding, no dividend shall
be declared or paid on the Common Stock or any other shares of Junior Stock (other than any dividend in connection with the implementation of a shareholders&#146; rights plan or the redemption or repurchase of any rights under any such plan), unless
full dividends for the last preceding Dividend Period on all outstanding shares of Series C Preferred Stock have been declared and paid (or declared and a sum sufficient for the payment thereof has been set aside). The Corporation and its
subsidiaries shall not purchase, redeem or otherwise acquire, directly or indirectly, for consideration any shares of Common Stock or other Junior Stock (other than (A)&nbsp;as a result of a reclassification of such Junior Stock for or into other
Junior Stock, (B)&nbsp;the exchange or conversion of one share of such Junior Stock for or into another share of such Junior Stock, (C)&nbsp;purchases, redemptions or other acquisitions of shares of Junior Stock in connection with any employment
contract, benefit plan or other similar arrangement with or for the benefit of employees, officers, directors or consultants or (D)&nbsp;the purchase of fractional interests in shares of Junior Stock pursuant to the conversion or exchange provisions
of such securities or the security being converted or exchanged) nor shall the Corporation pay or make available any monies for a sinking fund for the redemption of any shares of Common Stock or any other shares of Junior Stock during a Dividend
Period, unless the full dividends for the most recently completed Dividend Period on all outstanding shares of Series C Preferred Stock have been declared and paid (or declared and a sum sufficient for the payment thereof has been set aside). The
foregoing provision shall not restrict the ability of the Corporation or any affiliate of the Corporation to engage in any market-making transactions in Junior Stock in the ordinary course of business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) When dividends are not paid in full upon the shares of Series C Preferred Stock and other equity securities ranking on a parity, which,
for avoidance of doubt, includes the Series A Preferred Stock and the Series B Preferred Stock, with the Series C Preferred Stock as to payment of dividends (&#147;<U>Dividend Parity Stock</U>&#148;), all dividends declared and unpaid for payment on
a dividend payment date with respect to the Series C Preferred Stock and the Dividend Parity Stock shall be shared ratably by the Holders and holders of any Dividend Parity Stock, in proportion to the respective amounts of the declared and unpaid
dividends relating to the current dividend period. To the extent a dividend period with respect to any Dividend Parity Stock coincides with more than one Dividend Period with respect to the Series C Preferred Stock, for purposes of the immediately
preceding sentence the Board shall treat such dividend period as two or more consecutive dividend periods, none of which coincides with more than one Dividend Period with respect to the Series C Preferred Stock, or shall treat such dividend
period(s) with respect to any Dividend Parity Stock and Dividend Period(s) with respect to the Series C Preferred Stock for purposes of the immediately preceding sentence in any other manner that it deems to be fair and equitable in order to achieve
ratable payments of dividends on such Dividend Parity Stock and the Series C Preferred Stock. To the extent a Dividend Period with respect to the Series C Preferred Stock coincides with more than one dividend period with respect to any Dividend
Parity Stock, for purposes of the first sentence of this paragraph the Board shall treat such Dividend Period as two or more consecutive Dividend Periods, none of which coincides with more than one dividend period with respect to such Dividend
Parity Stock, or shall treat such Dividend Period(s) with respect to the Series C Preferred Stock and dividend period(s) with respect to any Dividend Parity Stock for purposes of the first sentence of this paragraph in any other manner that it deems
to be fair and equitable in order to achieve ratable payments of dividends on the Series C Preferred Stock and such Dividend Parity Stock. The term </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#147;<U>dividend period</U>&#148; as used in this paragraph means such dividend periods as are provided for in the terms of any Dividend Parity Stock and, in the case of shares of Series C
Preferred Stock, Dividend Periods applicable to shares of Series C Preferred Stock; and the term &#147;<U>dividend payment dates</U>&#148; as used in this paragraph means such dividend payment dates as are provided for in the terms of any Dividend
Parity Stock and, in the case of shares of Series C Preferred Stock, Dividend Payment Dates applicable to shares of Series C Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Subject to the foregoing, such dividends (payable in cash, securities or other property) as may be determined by the Board (or a duly
authorized committee of the Board) may be declared and paid on any securities, including Common Stock, any other Junior Stock and any Dividend Parity Stock, from time to time out of any funds legally available for such payment. In the event such
dividends are declared and paid, the Holders shall be entitled to receive the greater of the (i)&nbsp;dividends that would be due to the Holders on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis or (ii)&nbsp;dividends such Holder
receives on its shares of Series C Preferred Stock during the same period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding any provision in this Certificate of
Designations to the contrary, Holders shall not be entitled to receive any dividends or distributions on any shares of Series C Preferred Stock on or after the applicable Conversion Date in respect of such shares of Series C Preferred Stock that
have been converted as provided herein, except to the extent that any such dividends or distributions have been declared by the Board or any duly authorized committee of the Board and the Record Date for such dividend occurs prior to such applicable
Conversion Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;V. Voting. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding any stated or statutory voting rights, except as set forth in <U>Section</U><U></U><U>&nbsp;V(b)</U>, the Holders shall
not be entitled to vote (in their capacity as Holders) on any matter submitted to a vote of the stockholders of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) So
long as any shares of Series C Preferred Stock are outstanding, the Corporation shall not, without the written consent or affirmative vote, given in person or by proxy, at a meeting called for that purpose by holders of at least a majority of the
outstanding shares of Series C Preferred Stock, voting as a single and separate class, amend, alter or repeal (including by merger, consolidation or otherwise, and whether in a single transaction or a series of related transactions, other than a
Reorganization Event pursuant to which the Series C Preferred Stock is treated in accordance with <U>Section</U><U></U><U>&nbsp;VII(h)</U>) any provision of (i)&nbsp;this Certificate of Designations or (ii)&nbsp;the Charter, in either case, that
would alter, modify or change the preferences, rights, privileges or powers of the Series C Preferred Stock so as to, or in a manner that would, significantly and adversely affect the preferences, rights, privileges or powers of the Series C
Preferred Stock; <U>provided</U> that any such amendment or alteration to any provision of this Certificate of Designations or the Charter that alters, modifies or changes the preferences, rights, privileges or powers of a particular Holder so as
to, or in a manner that would, significantly and adversely affect the preferences, rights, privileges or powers of such Holder in a manner disproportionate from any other Holder shall require the prior written consent of such significantly and
adversely affected Holder; <U>provided</U><I>, </I><U>further</U>, that neither (x)&nbsp;any increase in the amount of the authorized or issued Series C Preferred Stock or any securities convertible into Series C Preferred Stock nor (y)&nbsp;the
creation and issuance, or an increase in the authorized or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
issued amount, of any series of Preferred Stock, or any securities convertible into Preferred Stock, ranking equal with and/or junior to the Series C Preferred Stock with respect to the payment
of dividends (whether such dividends are cumulative or <FONT STYLE="white-space:nowrap">non-cumulative)</FONT> and/or the distribution of assets upon the Corporation&#146;s liquidation, dissolution or winding up, in either case, will, in and of
itself, be deemed to significantly and adversely affect the preferences, rights, privileges or powers of the Series C Preferred Stock or any Holder and the Holders will have no right to vote their shares of Series C Preferred Stock or consent to
such action solely by reason of such an increase, creation or issuance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding the foregoing, the Corporation shall not,
without the written consent or affirmative vote, given in person or by proxy, at a meeting called for that purpose by the unanimous consent of the holders of the outstanding shares of Series C Preferred Stock, amend, alter or repeal (including by
merger, consolidation or otherwise, and whether in a single transaction or a series of related transactions, other than a Reorganization Event pursuant to which the Series C Preferred Stock is treated in accordance with
<U>Section</U><U></U><U>&nbsp;VII(h)</U>) the definitions of Applicable Conversion Rate, Base Price, Conversion Price, Dividend Rate or Series C Preferred Liquidation Amount under this Certificate of Designations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding the foregoing, the Holders shall not have any voting rights set out in <U>Section</U><U></U><U>&nbsp;V(b)</U> if, at or
prior to the effective time of the act with respect to which such vote would otherwise be required, all outstanding shares of Series C Preferred Stock shall have been converted into shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;VI. Rank; Liquidation. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) In the event of any liquidation, dissolution or winding up of the affairs of the Corporation, whether voluntary or involuntary, holders of
the Series C Preferred Stock shall be entitled to receive, out of the assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the Corporation, and after satisfaction of all liabilities
and obligations to creditors of the Corporation and subject to the rights of any securities ranking senior to the Series C Preferred Stock, before any distribution of such assets or proceeds is made to or set aside for the holders of Common Stock,
in full an amount per share equal to the Base Price multiplied by the Applicable Conversion Rate, together with an amount equal to all dividends (if any) that have been declared but not paid prior to the date of payment of such distribution (but
without any amount in respect of dividends that have not been declared prior to such payment date) (the &#147;<U>Series C Preferred Liquidation Amount</U>&#148;). The rights of the Series C Preferred Stock pursuant to this
<U>Section</U><U></U><U>&nbsp;VI(a)</U> shall rank <I>pari passu</I> with the rights of the Series A Preferred Stock and Series B Preferred Stock. Thereafter, the Series C Preferred Stock will participate with the Common Stock on an <FONT
STYLE="white-space:nowrap">as-converted</FONT> basis as if Series C Preferred Stock was converted immediately prior to such liquidation, dissolution or winding up. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If in any distribution described in <U>Section</U><U></U><U>&nbsp;VI(a)</U> above the assets of the Corporation or proceeds thereof are
not sufficient to pay the Liquidation Preferences (as defined below) in full to all holders of the Series C Preferred Stock and all holders of any stock of the Corporation ranking equally with the Series C Preferred Stock as to such distribution,
the amounts paid to the holders of the Series C Preferred Stock and to the holders of all such other stock shall be paid pro rata in accordance with the respective aggregate Liquidation Preferences </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the holders of the Series C Preferred Stock and the holders of all such other stock. In any such distribution, the &#147;<U>Liquidation Preference</U>&#148; of any holder of stock of the
Corporation shall mean the amount otherwise payable to such holder in such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an amount equal to any declared but unpaid dividends (and,
in the case of any holder of stock other than the Series C Preferred Stock and on which dividends accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not declared, as applicable). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) For purposes of this <U>Section</U><U></U><U>&nbsp;VI</U>, the sale, conveyance, exchange or transfer (for cash, shares of stock,
securities or other consideration) of all or substantially all of the property and assets of the Corporation shall not be deemed a voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Corporation, nor shall the
merger, consolidation or any other business combination transaction of the Corporation into or with any other corporation or Person or the merger, consolidation or any other business combination of any other corporation or Person into or with the
Corporation be deemed to be a voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;VII. Adjustments. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Conversion Price shall be subject to the adjustments described in this <U>Section</U><U></U><U>&nbsp;VII</U> (each such event set
forth in <U>clauses (b)</U>&nbsp;through <U>(h)</U>, an &#147;<U>Adjustment Event</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Stock Dividends and
Distributions</U>. If the Corporation pays dividends or other distributions on the Common Stock in shares of Common Stock, then the Conversion Price will be adjusted by multiplying the Conversion Price in effect at 5:00 p.m., New York City time on
the Trading Day immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such dividend or distribution by the following fraction: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">OS<SUB
STYLE="font-size:75%; vertical-align:bottom">0</SUB></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the number of shares of Common Stock outstanding immediately prior to <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such dividend or distribution.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the sum of (x)&nbsp;the number of shares of Common Stock outstanding immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such dividend or distribution, <I>plus</I> (y)&nbsp;the total number of shares of
Common Stock issued in such dividend or distribution.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The adjustment pursuant to this <U>clause (b)</U>&nbsp;shall become effective at 9:00 a.m., New York City time
on the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such dividend or distribution. For the purposes of this <U>clause (b)</U>, the number of shares of Common Stock at the time outstanding shall not include shares held in treasury by the
Corporation. If any dividend or distribution described in this <U>clause (b)</U>&nbsp;is declared but not so paid or made, the Conversion Price shall be readjusted, effective as of the date the Board publicly announces its decision not to make such
dividend or distribution, to such Conversion Price that would be in effect if such dividend or distribution had not been declared. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Subdivisions, Splits and Combinations of Common Stock</U>. If the Corporation
subdivides, splits or combines the shares of Common Stock, then the Conversion Price will be adjusted by multiplying the Conversion Price in effect at 5:00 p.m., New York City time on the Trading Day immediately prior to the effective date of such
share subdivision, split or combination by the following fraction: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0 </SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the number of shares of Common Stock outstanding immediately prior to the effective date of such share subdivision, split or combination.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">OS<SUP STYLE="font-size:75%; vertical-align:top">1 </SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the number of shares of Common Stock outstanding immediately after the opening of business on the effective date of such share subdivision, split or combination.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The adjustment pursuant to this clause (c)&nbsp;shall become effective at 9:00 a.m., New York City time on the
effective date of such subdivision, split or combination. For the purposes of this clause (c), the number of shares of Common Stock at the time outstanding shall not include shares held in treasury by the Corporation. If any subdivision, split or
combination described in this clause (c)&nbsp;is announced but the outstanding shares of Common Stock are not subdivided, split or combined, the Conversion Price shall be readjusted, effective as of the date the Board publicly announces its decision
not to subdivide, split or combine the outstanding shares of Common Stock, to such Conversion Price that would be in effect if such subdivision, split or combination had not been announced. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Debt or Asset Distributions</U>. If the Corporation distributes to all or substantially all holders of shares of Common Stock evidences
of indebtedness, shares of capital stock, securities, cash or other assets (excluding any dividend or distribution referred to in clause (b)&nbsp;above, any dividend or distribution paid exclusively in cash, any consideration payable in connection
with a tender or exchange offer made by the Corporation or any of its subsidiaries, and any dividend of shares of capital stock of any class or series, or similar equity interests, of or relating to a subsidiary or other business unit in the case of
certain <FONT STYLE="white-space:nowrap">spin-off</FONT> transactions as described below), then the Conversion Price will be adjusted by multiplying the Conversion Price in effect at 5:00 p.m., New York City time on the Trading Day immediately prior
to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution by the following fraction: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SP0&nbsp;&#150;&nbsp;FMV</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></P></TD>

<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the Current Market Price per share of Common Stock on such date.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">FMV</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the fair market value of the portion of the distribution applicable to one share of Common Stock on such date as reasonably determined by the Board; provided that, if &#147;FMV&#148; as set forth above is equal to or greater than
&#147;SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#148; as set forth above, in lieu of the foregoing adjustment, adequate provision shall be made so that each Holder shall receive on the date on which such distribution is made to
holders of Common Stock, for each share of Series C Preferred Stock, the amount of such distribution such Holder would have received had such holder owned a number of shares of Common Stock equal to the Applicable Conversion Rate on the <FONT
STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In a <FONT STYLE="white-space:nowrap">&#147;spin-off&#148;,</FONT> where the Corporation
makes a distribution to all holders of shares of Common Stock consisting of capital stock of any class or series, or similar equity interests of, or relating to, a subsidiary or other business unit, if a Holder did not participate in such
distribution with respect to such shares of Series C Preferred Stock as provided for in <U>Section</U><U></U><U>&nbsp;IV</U>, the Conversion Price with respect to such share held by such Holder will be adjusted on the 15<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP> Trading Day after the effective date of the distribution by multiplying such Conversion Price in effect immediately prior to such 15<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Trading
Day by the following fraction: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">MP<SUB
STYLE="font-size:75%; vertical-align:bottom">0</SUB></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">MP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>+&nbsp;MP<SUB
STYLE="font-size:75%; vertical-align:bottom">s</SUB></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">MP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the average of the Closing Prices of the Common Stock over the first 10 Trading Days commencing on and including the fifth Trading Day following the effective date of such distribution.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">MP<SUB STYLE="font-size:75%; vertical-align:bottom">s</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the average of the Closing Prices of the capital stock or equity interests representing the portion of the distribution applicable to one share of Common Stock over the first 10 Trading Days commencing on and including the fifth
Trading Day following the effective date of such distribution, or, if not traded on a national or regional securities exchange or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, the fair
market value of the capital stock or equity interests representing the portion of the distribution applicable to one share of Common Stock on such date as reasonably determined by the Board.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any adjustment pursuant to this <U>clause (d)</U><U></U>&nbsp;shall become effective immediately prior to 9:00
a.m., New York City time, on the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution. In the event that such distribution described in this <U>clause (d)</U>&nbsp;is not so paid or made, the Conversion Price shall be readjusted,
effective as of the date the Board publicly announces its decision not to pay or make such dividend or distribution, to the Conversion Price that would then be in effect if such dividend or distribution had not been declared. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Cash Distributions</U>. If the Corporation makes a distribution consisting exclusively of cash to all holders of Common Stock,
excluding any (i)&nbsp;regular quarterly cash dividend on the Common Stock not in excess of $0.05 per share, which per share amount shall be adjusted accordingly in the event that the Corporation subdivides, splits or combines the shares of Common
Stock, (ii)&nbsp;cash that is distributed in a Reorganization Event or as part of a <FONT STYLE="white-space:nowrap">&#147;spin-off&#148;</FONT> referred to in <U>clause (d)</U>&nbsp;above, (iii) dividend or distribution in connection with the
Corporation&#146;s liquidation, dissolution or <FONT STYLE="white-space:nowrap">winding-up,</FONT> and (iv)&nbsp;consideration payable in connection with a tender or exchange offer made by the Corporation or any of its subsidiaries, then in each
event, the Conversion Price in effect immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution will be multiplied by the following fraction: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&nbsp;&#150;&nbsp;DIV</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the Closing Price per share of Common Stock on the Trading Day immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Date.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">DIV</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the amount per share of Common Stock of the cash distribution, as determined pursuant to the introduction to this <U>clause (e)</U>.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that any distribution described in this <U>clause</U><U></U><U>&nbsp;(e)</U> is not so made, the
Conversion Price shall be readjusted, effective as of the date the Board publicly announces its decision not to pay such distribution, to the Conversion Price which would then be in effect if such distribution had not been declared. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if &#147;DIV&#148; as set forth above is equal to or greater than &#147;SP<SUB
STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#148; as set forth above, in lieu of the foregoing adjustment, adequate provision shall be made so that each Holder shall have the right to receive on the date on which the relevant cash dividend
or distribution is distributed to holders of Common Stock, for each share of Series C Preferred Stock, the amount of cash such Holder would have received had such holder owned a number of shares of Common Stock equal to the Applicable Conversion
Rate on the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Self-Tender Offers and Exchange Offers</U>. If
the Corporation or any of its subsidiaries successfully completes a tender or exchange offer for the Common Stock where the cash and the value of any other consideration included in the payment per share of the Common Stock exceeds the Closing Price
per share of the Common Stock on the Trading Day immediately succeeding the expiration of the tender or exchange offer, then the Conversion Price will be adjusted by multiplying the Conversion Price in effect at 5:00 p.m., New York City time prior
to the commencement of the offer by the following fraction: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&nbsp;x&nbsp;SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">AC&nbsp;+&nbsp;(SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&nbsp;x&nbsp;OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP>)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the Closing Price per share of Common Stock on the Trading Day immediately succeeding the commencement of the tender or exchange offer.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the number of shares of Common Stock outstanding immediately prior to the expiration of the tender or exchange offer, including any shares validly tendered and not withdrawn.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the number of shares of Common Stock outstanding immediately after the expiration of the tender or exchange offer (after giving effect to such tender offer or exchange offer).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">AC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the aggregate cash and fair market value of the other consideration payable in the tender or exchange offer, as reasonably determined by the Board.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any adjustment made pursuant to this clause (f)&nbsp;shall become effective immediately
prior to 9:00 a.m., New York City time, on the Trading Day immediately following the expiration of the tender or exchange offer. In the event that the Corporation or one of its subsidiaries is obligated to purchase shares of Common Stock pursuant to
any such tender offer or exchange offer, but the Corporation or such subsidiary is permanently prevented by applicable law from effecting any such purchases, or all such purchases are rescinded, then the Conversion Price shall be readjusted to be
such Conversion Price that would then be in effect if such tender offer or exchange offer had not been made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Rights Plans</U>. To
the extent that the Corporation has a rights plan in effect with respect to the Common Stock on any Conversion Date, upon conversion of any shares of the Series C Preferred Stock, the Holders will receive, in addition to the shares of Common Stock,
the rights under the rights plan, unless, prior to such Conversion Date, the rights have separated from the shares of Common Stock, in which case the Conversion Price will be adjusted at the time of separation as if the Corporation had made a
distribution to all holders of Common Stock as described in clause (d)&nbsp;above, subject to readjustment in the event of the expiration, termination or redemption of such rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Reorganization Events</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Upon the occurrence of a Reorganization Event prior to an applicable Conversion Date, each share of Series C Preferred Stock outstanding
immediately prior to such Reorganization Event shall, without the consent of any Holders, be entitled to receive, out of the assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the
Corporation, and after satisfaction of all liabilities and obligations to creditors of the Corporation and subject to the rights of any securities ranking senior to the Series C Preferred Stock, before any distribution of such assets or proceeds is
made to or set aside for the holders of Common Stock and any other Junior Stock, in full, the greater of the (1)&nbsp;amount per share equal to two times the Series C Preferred Liquidation Amount or (2)&nbsp;amount equal to the distribution amount
of such assets or proceeds of the Corporation as was receivable by a holder of the number of shares of Common Stock into which such share of Series C Preferred Stock was convertible immediately prior to such Reorganization Event (such payment, the
&#147;<U>Exchange Property</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) A &#147;<U>Reorganization Event</U>&#148; shall mean: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) any consolidation, merger, conversion or other similar business combination of the Corporation with or into another Person,
in each case, pursuant to which all or substantially all of the Common Stock outstanding will be converted into cash, securities, or other property of the Corporation or another Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) any sale, transfer, lease, or conveyance to another Person of all or substantially all of the property and assets of the
Corporation and its subsidiaries, taken as a whole, in each case pursuant to which all of the Common Stock outstanding will be converted into cash, securities, or other property of the Corporation or another Person; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) any reclassification of the Common Stock into securities other than the
Common Stock; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(4) any statutory exchange of all of the outstanding shares of Common Stock for securities of another
Person (other than in connection with a merger or acquisition). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) The provisions of this <U>Section</U><U></U><U>&nbsp;VII(h)</U>
shall similarly apply to successive Reorganization Events or any series of transactions that results in a Reorganization Event and the provisions of <U>Section</U><U></U><U>&nbsp;VII(h)</U> shall apply to any shares of capital stock of the
Corporation (or any successor) received by the holders of the Common Stock in any such Reorganization Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) The Corporation (or any
successor) shall, at least twenty days prior to the occurrence of any Reorganization Event, provide written notice to the Holders of the anticipated occurrence of such event and of the type and amount of the cash, securities or other property that
constitutes the Exchange Property; <U>provided</U>, that no such notice shall be required if the anticipated occurrence of any Reorganization Event is disclosed in any registration statement, prospectus, report, schedule or proxy statement filed
with or furnished by the Corporation to the U.S. Securities and Exchange Commission. Failure to deliver such notice shall not affect the operation of this <U>Section</U><U></U><U>&nbsp;VII</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) No adjustment to the Conversion Price shall be made with respect to a share of Series C Preferred Stock if the Holder thereof has
participated in the transaction that would otherwise give rise to an adjustment with respect to such share of Series C Preferred Stock, as a result of holding such share of Series C Preferred Stock at the time of such transaction (including pursuant
to <U>Section</U><U></U><U>&nbsp;IV</U>), without having to convert such share of Series C Preferred Stock, as if they held the full number of shares of Common Stock into which each such share of the Series C Preferred Stock held by them may then be
converted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Notwithstanding anything to the contrary herein, an Adjustment Event shall not allow the Holder to acquire a higher
percentage of any Class&nbsp;of Voting Securities of the Corporation than the Holder (together with its affiliates for purposes of the BHC Act) beneficially owned immediately prior to such Adjustment Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;VIII. Reports as to Adjustments. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever the number of shares of Common Stock into which the shares of the Series C Preferred Stock are convertible is adjusted as provided in
<U>Section</U><U></U><U>&nbsp;VII</U>, the Corporation shall promptly, but in any event within ten days thereafter, compute such adjustment and furnish to the Holders a notice stating the number of shares of Common Stock into which each share of the
Series C Preferred Stock is convertible as a result of such adjustment, a brief statement of the facts requiring such adjustment and the computation thereof and when such adjustment will become effective. Amounts resulting from any calculation
hereunder will be rounded to the nearest 1/10,000th. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;IX. Reservation of Stock. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Corporation shall, following the Charter Amendment Approval and the filing and acceptance of the Charter Amendment (as defined in the
Investment Agreements), reserve and keep available out of its authorized and unissued Common Stock, solely for issuance upon the conversion of shares of Series C Preferred Stock as provided in this Certificate of Designations, free from any
preemptive or other similar rights, such number of shares of Common Stock as shall from time to time be issuable upon the conversion of all the shares of Series C Preferred Stock then outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Following the approval of the applicable supplemental listing application, the Corporation hereby covenants and agrees that, for so long
as shares of the Common Stock are listed on the NYSE or any other national securities exchange or automated quotation system, the Corporation will, if permitted by the rules of such exchange or automated quotation system, list and keep listed that
number of shares of Common Stock issuable upon conversion of shares of all the Series C Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;X. Exclusion of
Other Rights. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of Series C Preferred Stock shall not have any voting powers except as expressly described herein, and,
except as may otherwise be required by Law, shall not have any preferences or relative, participating, optional or other special rights, other than those specifically set forth herein (as this Certificate of Designations may be amended from time to
time) and in the Charter. The shares of Series C Preferred Stock shall have no preemptive or subscription rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XI.
Severability of Provisions. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any voting powers, preferences or relative, participating, optional or other special rights of the
Series C Preferred Stock and qualifications, limitations and restrictions thereof set forth in this Certificate of Designations (as this Certificate of Designations may be amended from time to time) are invalid, unlawful or incapable of being
enforced by reason of any rule&nbsp;of Law, all other voting powers, preferences and relative, participating, optional and other special rights of Series C Preferred Stock and qualifications, limitations and restrictions thereof set forth in this
Certificate of Designations (as so amended) which can be given effect without the invalid, unlawful or unenforceable voting powers, preferences or relative, participating, optional or other special rights of Series C Preferred Stock and
qualifications, limitations and restrictions thereof shall, nevertheless, remain in full force and effect, and no voting powers, preferences or relative, participating, optional or other special rights of Series C Preferred Stock or qualifications,
limitations and restrictions thereof herein set forth shall be deemed dependent upon any other such voting powers, preferences or relative, participating, optional or other special rights of Series C Preferred Stock or qualifications, limitations
and restrictions thereof unless so expressed herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XII. Cancellation of Series C Preferred Stock. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any shares of Series C Preferred Stock that have been duly converted in accordance with this Certificate of Designations, or reacquired by the
Corporation, shall be cancelled promptly thereafter and revert to authorized but unissued shares of Preferred Stock undesignated as to series. Such shares may be designated or redesignated and issued or reissued, as the case may be, as part of any
series of Preferred Stock. The Corporation may from time to time take such appropriate action as may be necessary to reduce the authorized number of shares of Series C Preferred Stock solely in accordance with the foregoing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XIII. Additional Authorized Shares. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything set forth in the Charter or this Certificate of Designations to the contrary, the Board or any authorized committee
of the Board, without the vote of the Holders, may increase or decrease the number of authorized shares of Series C Preferred Stock or other stock ranking junior or senior to, or on parity with, the Series C Preferred Stock as to dividends and the
distribution of assets upon any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XIV. Determinations. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation shall have the sole right to make all calculations called for hereunder. Absent fraud or manifest error, such calculations
shall be final and binding on all Holders. The Corporation shall have the power to resolve any ambiguity and its action in so doing, as evidenced by a resolution of the Board, shall be final and conclusive unless clearly inconsistent with the intent
hereof. Amounts resulting from any calculation will be rounded, if necessary, to the nearest one <FONT STYLE="white-space:nowrap">ten-thousandth,</FONT> with five <FONT STYLE="white-space:nowrap">one-hundred</FONT> thousandths being rounded upwards.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XV. No Redemption. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may not, at any time, redeem the outstanding shares of the Series C Preferred Stock, other than as otherwise expressly set
forth in <U>Section</U><U></U><U>&nbsp;VII</U> with the prior approval of the Federal Reserve Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XVI. Maturity.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Series C Preferred Stock shall be perpetual, unless converted in accordance with this Certificate of Designations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XVII. Repurchases. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the limitations imposed herein, the Corporation may purchase and sell shares of Series C Preferred Stock from time to time to such
extent, in such manner, and upon such terms as the Board or any duly authorized committee of the Board may determine; <U>provided</U> <U>that</U> any repurchase of shares of Series C Preferred Stock by the Corporation shall require prior approval of
the Federal Reserve Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XVIII. No Sinking Fund. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of Series C Preferred Stock are not subject to the operation of a sinking fund. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XIX. Notices. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All notices, demands or other communications to be given hereunder shall be in writing and shall be deemed to have been given (a)&nbsp;on the
date of delivery if delivered personally to the recipient, or if by email, upon delivery (<U>provided</U> that no auto-generated error or <FONT STYLE="white-space:nowrap">non-delivery</FONT> message is generated in response thereto), (b) on the
first Business Day following the date of dispatch if delivered utilizing a <FONT STYLE="white-space:nowrap">next-day</FONT> service by a recognized <FONT STYLE="white-space:nowrap">next-day</FONT> courier or (c)&nbsp;on the earlier of confirmed
receipt or the fifth business day following the date of mailing if delivered by registered or certified mail, return receipt requested, postage prepaid. All notices hereunder shall be delivered to (i)&nbsp;if to the Corporation, New York Community
Bancorp, Inc., 102 Duffy Avenue, Hicksville, New York 11801, Attention: Chief Executive Officer, Email: sandro.dinello@flagstar.com; with a copy to: General Counsel, Email: patrick.quinn@flagstar.com or (ii)&nbsp;if to any Holder or holder of Common
Stock, as the case may be, to such Holder or holder at the address listed in the stock record books of the Corporation, or, in each case, such other address or to the attention of such other Person as the recipient party has specified by prior
written notice to the sending party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XX. Taxes. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Corporation and each Holder shall bear their own costs, fees and expenses in connection with any conversion contemplated by
<U>Section</U><U></U><U>&nbsp;III</U>, except that the Corporation shall pay any and all transfer taxes, stamp taxes or duties, documentary taxes, or other similar taxes imposed upon the issuance of shares of Common Stock on account of any
conversion contemplated by <U>Section</U><U></U><U>&nbsp;III</U>; <U>provided</U> that the Corporation shall not be required to pay any such tax to the extent such tax is payable because a Holder requests Common Stock to be registered in a name
other than such registered holder&#146;s name (including in connection with any Convertible Transfer) and no such Common Stock will be so registered unless and until the registered holder making such request has paid such taxes to the Corporation or
has established to the satisfaction of the Corporation that such taxes have been paid or are not payable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything
herein to the contrary, the Corporation and any applicable withholding agent shall be entitled to deduct and withhold from any consideration otherwise payable on or with respect to the Series C Preferred Stock (including upon conversion of any
Series C Preferred Stock) such amounts as it is required to deduct or withhold with respect to the making of such payment under the Internal Revenue Code of 1986, as amended (the &#147;<U>Code</U>&#148;), or any other applicable tax Law. If the
Holder is deemed for U.S. federal income tax purposes to have received a distribution with respect to the Series C Preferred Stock, the Corporation and any applicable withholding agent may satisfy any resulting applicable withholding obligations
(including with respect to backup withholding) required by applicable Tax Law imposed in connection with such deemed distribution by withholding from any other payments due with respect to the Series C Preferred Stock, including any payments upon
conversion, repurchase or redemption of the Series C Preferred Stock. If any amounts are so deducted or withheld and subsequently paid to the applicable Government Entity, such deducted or withheld amounts shall be treated for all purposes hereunder
as having be paid to the person to which such amounts would have otherwise been payable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Corporation and each Holder each agree that there shall be no deemed distribution on
the Series C Preferred Stock pursuant to Section&nbsp;305(c) of the Code in respect of a difference between the &#147;issue price&#148; and the &#147;redemption price&#148; of the Series C Preferred Stock and except to the extent otherwise required
by a &#147;determination&#148; within the meaning of Section&nbsp;1313(a) of the Code, neither the Corporation nor Holder shall take any position inconsistent therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XXI. No Stock Certificates. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary contained in this Certificate of Designations, no shares of Series C Preferred Stock shall be issued
in physical, certificated form. All shares of Series C Preferred Stock shall be evidenced by book-entry on the record books maintained by the Corporation or its transfer agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XXII. Transfers. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of Series C Preferred Stock are subject to the restrictions on transfer set forth in the Investment Agreements. Any purported
transfer in violation of such restrictions shall be null and void. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the Corporation has caused this Certificate of Designations to be
signed by the undersigned on this 11<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day of March, 2024. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>NEW YORK COMMUNITY BANCORP, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ R. Patrick Quinn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: R. Patrick Quinn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title: General Counsel&nbsp;&amp; Corporate Secretary</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Certificate of Designations</I>] </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.4
<SEQUENCE>5
<FILENAME>d763888dex34.htm
<DESCRIPTION>EX-3.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT 3.4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF DESIGNATIONS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SERIES D <FONT
STYLE="white-space:nowrap">NON-VOTING</FONT> COMMON EQUIVALENT STOCK </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NEW YORK COMMUNITY BANCORP, INC. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NEW YORK
COMMUNITY BANCORP, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware (the &#147;<U>Corporation</U>&#148;), in accordance with the provisions of Sections 103, 141 and 151 thereof, does hereby
certify that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the provisions of the Amended and Restated Certificate of Incorporation, as amended, and the Amended and
Restated Bylaws of the Corporation and applicable law, the Board of Directors of the Corporation (the &#147;<U>Board</U>&#148;), duly adopted the following resolution on March&nbsp;10, 2024, creating a series of Preferred Stock of the Corporation
designated as &#147;Series D <FONT STYLE="white-space:nowrap">Non-Voting</FONT> Common Equivalent Stock&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">RESOLVED, that pursuant to
the Delaware General Corporation Law (the &#147;<U>DGCL</U>&#148;), the Charter and the Amended and Restated Bylaws of the Corporation, the Board hereby establishes a series of Preferred Stock, par value $0.01 per share, of the Corporation and fixes
and determines the designation, powers, preferences, redemption rights, qualifications, privileges, limitations, restrictions and special or relative rights thereof as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;I. Designation and Amount. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A series of Preferred Stock designated as the &#147;Series D <FONT STYLE="white-space:nowrap">Non-Voting</FONT> Common Equivalent Stock&#148;
(&#147;<U>Series D NVCE Stock</U>&#148;) is hereby established. The total number of authorized shares of Series D NVCE Stock shall be 315,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;II.</B> <B>Definitions</B><B>.</B> As used herein, the following terms shall have the following meanings, unless
the context otherwise requires: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Adjustment Event</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;VII(a)</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; means, with respect to any Person, any other Person that, directly or indirectly through one or more
intermediaries, controls, is controlled by, or is under common control with, such specified Person (as used in this definition, the term &#147;control&#148; means the possession, directly or indirectly, of the power to direct or cause the direction
of the management or policies of a Person, whether through ownership of voting securities, by contract or otherwise). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Applicable
Conversion Rate</U>&#148; means, for each share of Series D NVCE Stock, the number of shares of Common Stock equal to the product of (a)&nbsp;one thousand (1,000) <I>multiplied by</I> (b)&nbsp;the quotient of (i)&nbsp;the Base Price <I>divided
by</I> (ii)&nbsp;the then-applicable Conversion Price, subject to adjustment pursuant to <U>Section VII</U> for any applicable event occurring subsequent to the initial determination of the Applicable Conversion Rate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Base Price</U>&#148; means $2.00. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>BHC Act</U>&#148; means the Bank Holding Company Act of 1956 (as amended) and its
implementing regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Board</U>&#148; means the Board of Directors of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means any day, other than a Saturday, Sunday or other day on which banking institutions in the city of New
York, New York are required or authorized by Law to be closed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Certificate of Designations</U>&#148; means this Certificate of
Designations of Series D NVCE Stock of the Corporation, dated March&nbsp;11, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Charter</U>&#148; means the Amended and
Restated Certificate of Incorporation of the Corporation, as amended, supplemented and/or restated from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Charter
Amendment Approval</U>&#148; means the approval of the proposal to amend the Charter in a manner to increase the total authorized number of shares of Common Stock to at least 1,700,000,000 by the affirmative vote of a majority of votes cast by the
holders of shares of Common Stock, at the meeting of the Corporation&#146;s stockholders at which a vote is taken with respect to such Charter amendment proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Class</U><U></U><U>&nbsp;of Voting Security</U>&#148; shall be interpreted in a manner consistent with how &#147;class of voting
shares&#148; is defined in 12 C.F.R. Section&nbsp;225.2(q)(3) or any successor provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Date</U>&#148; means the date
that any shares of Series D NVCE Stock are first issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Price</U>&#148; of the Common Stock (or other relevant capital
stock or equity interest) on any date of determination means the closing sale price or, if no closing sale price is reported, the last reported sale price of the shares of the Common Stock (or other relevant capital stock or equity interest) on the
NYSE on such date. If the Common Stock (or other relevant capital stock or equity interest) is not traded on the NYSE on any date of determination, the Closing Price of the Common Stock (or other relevant capital stock or equity interest) on such
date of determination means the closing sale price as reported in the composite transactions for the principal U.S. national or regional securities exchange on which the Common Stock (or other relevant capital stock or equity interest) is so listed
or quoted, or, if no closing sale price is reported, the last reported sale price on the principal U.S. national or regional securities exchange on which the Common Stock (or other relevant capital stock or equity interest) is so listed or quoted,
or if the Common Stock (or other relevant capital stock or equity interest) is not so listed or quoted on a U.S. national or regional securities exchange, the last quoted bid price for the Common Stock (or other relevant capital stock or equity
interest) in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market as reported by OTC Markets Group Inc. or a similar organization, or, if that bid price is not available, the market price of the
Common Stock (or other relevant capital stock or equity interest) on that date as determined by a nationally recognized independent investment banking firm retained by the Corporation for this purpose. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Certificate of Designations, all references herein to the &#147;Closing
Price&#148; and &#147;last reported sale price&#148; of the Common Stock (or other relevant capital stock or equity interest) on the NYSE shall be such closing sale price and last reported sale price as reflected on the website of the NYSE
(http://www.nyse.com) and as reported by Bloomberg Professional service; <U>provided</U> that in the event that there is a discrepancy between the closing sale price or last reported sale price as reflected on the website of the NYSE and as reported
by Bloomberg Professional service, the closing sale price and last reported sale price on the website of the NYSE shall govern. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Common Stock</U>&#148; means the common stock, $0.01 par value per share, of the Corporation authorized by the Corporation on or
after the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Conversion Date</U>&#148; means the date on which any shares of Series D NVCE Stock shall become
convertible into any shares of Common Stock pursuant to <U>Section</U><U></U><U>&nbsp;III(a)</U>; <U>provided</U>, <U>however</U>, that if a Conversion Date would otherwise occur on or after an <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for an
issuance, dividend or distribution that results in an adjustment of the Conversion Price pursuant to <U>Section</U><U></U><U>&nbsp;VII</U> and on or before the Record Date for such issuance, dividend or distribution, such Conversion Date shall
instead occur on the first calendar day after the Record Date for such issuance, dividend or distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Conversion
Price</U>&#148; means, for each share of Series D NVCE Stock, the Base Price, as the same may be adjusted from time to time in accordance with the terms of this Certificate of Designations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Convertible Transfer</U>&#148; means a transfer by the Holder that is both (i)&nbsp;to a Person who is not an affiliate of the Holder
for purposes of the BHC Act and (ii) (A)&nbsp;to the Corporation; (B)&nbsp;in a widespread public distribution; (C)&nbsp;in which no transferee (or group of associated transferees) would receive 2% or more of the outstanding securities of any
Class&nbsp;of Voting Securities of the Corporation; or (D)&nbsp;to a purchaser that would control more than 50% of every Class&nbsp;of Voting Securities of the Corporation without any transfer from the Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Corporation</U>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Current Market Price</U>&#148; means, on any date, the average of the daily Closing Price per share of the Common Stock or other
securities on each of the five consecutive Trading Days preceding the earlier of the day before the date of the issuance, dividend or distribution in question and the day before the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> with respect to the
issuance or distribution, giving rise to an adjustment to the Conversion Price pursuant to <U>Section</U><U></U><U>&nbsp;VII</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>DGCL</U>&#148; means the Delaware General Corporation Law, as amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Property</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;VII(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Ex-Date</FONT></U>&#148; means, when used with respect to any issuance, dividend or distribution
giving rise to an adjustment to the Conversion Price pursuant to <U>Section</U><U></U><U>&nbsp;VII</U>, the first date on which the applicable Common Stock or other securities trade without the right to receive the issuance, dividend or
distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Federal Reserve Board</U>&#148; means the Board of Governors of the Federal Reserve System. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Government Entity</U>&#148; means any (a)&nbsp;federal, state, local, municipal,
foreign or other government; (b)&nbsp;governmental entity of any nature (including any governmental agency, branch, department, official, committee or entity and any court or other tribunal), whether foreign or domestic; or (c)&nbsp;body exercising
or entitled to exercise any administrative, executive, judicial, legislative, police, regulatory, or taxing authority or power of any nature, whether foreign or domestic, including any arbitral tribunal and self-regulatory organizations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Holder</U>&#148; means the Person in whose name any shares of Series D NVCE Stock are registered, which may be treated by the
Corporation as the absolute owner of such shares of Series D NVCE Stock for the purpose of making payment and settling conversion and for all other purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR Act</U>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR Amount</U>&#148; means, with respect to any conversion of Series D NVCE Stock hereunder held by a particular Holder, the sum of
(a)&nbsp;the product of $2.73 and the aggregate number of shares of Common Stock purchased by the Holder at the Closing, <U>plus</U> (b)&nbsp;the product of $2.73 and the number of shares of Common Stock being issued to such Holder upon any such
conversion of Series C Preferred Stock held by such Holder <U>plus</U> (c)&nbsp;the product of $2.73 and the number of shares of Common Stock issued upon any prior conversion of Series C Preferred Stock held by such Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR Approvals</U>&#148; means, with respect to the shares of Series D NVCE Stock of any Holder, the expiration or termination of any
applicable waiting period (or extension thereof) under the HSR Act with respect to such Holder&#146;s acquisition or ownership of Common Stock upon conversion of such shares of Series D NVCE Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR Threshold</U>&#148; means $119.5&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Investment Agreements</U>&#148; means the investment agreements, by and between the Corporation and the investor parties thereto,
dated as of March 7, 2024 (as amended, supplemented or restated from time to time). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Law</U>&#148; means, with respect to any
Person, any legal, regulatory and administrative laws, statutes, rules, Orders and regulations applicable to such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liens</U>&#148; means any and all liens, charges, security interests, options, claims, mortgages, pledges, proxies, voting trusts or
agreements, obligations, understandings or arrangements, or other restrictions on title or transfer of any nature whatsoever. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>NVCE Dividend Amount</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;IV(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>NYSE</U>&#148; means the New York Stock Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>NYSE Limit</U>&#148; means a number of shares of Common Stock equal to 19.9% of the shares of Common Stock outstanding immediately
prior to the execution of the Investment Agreements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>NYSE Share Issuance Amount</U>&#148; means the total number of (a)&nbsp;shares of
Common Stock issued upon conversion of any shares of Series D NVCE Stock, <I>plus</I> (b)&nbsp;shares of Common Stock issued at the Closing, <I>plus</I> (c)&nbsp;shares of Common Stock issued upon conversion or exchange of any shares of Series B
Preferred Stock, <I>plus</I> (d)&nbsp;shares of Common Stock issued upon conversion of any shares of Series C Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Order</U>&#148; means any applicable order, injunction, judgment, decree, ruling, or writ of any Government Entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permanent Warrant</U>&#148; has the meaning set forth in the Investment Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means an individual, corporation, partnership, limited partnership, limited liability company, syndicate, person
(including a &#147;person&#148; as defined in Sections 13(d)(3) and 14(d) of the Exchange Act), trust, association or entity or government, political subdivision, agency or instrumentality of a government. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Preferred Stock</U>&#148; has the meaning set forth in the Charter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Record Date</U>&#148; means, with respect to any dividend, distribution or other transaction or event in which the holders of the
Common Stock have the right to receive any cash, securities or other property or in which the Common Stock is exchanged for or converted into any combination of cash, securities or other property, the date fixed for determination of holders of the
Common Stock entitled to receive such cash, securities or other property (whether such date is fixed by the Board or a duly authorized committee of the Board or by Law, contract or otherwise). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reorganization Event</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;VII(i)(ii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series B Preferred Stock</U>&#148; means the Series B Noncumulative Convertible Preferred Stock, par value $0.01 per share, of the
Corporation, issued pursuant to the Investment Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series C Preferred Stock</U>&#148; means the Series C Noncumulative
Convertible Preferred Stock, par value $0.01 per share, of the Corporation, issued pursuant to the Investment Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Series
D NVCE Stock</U>&#148; has the meaning specified in <U>Section</U><U></U><U>&nbsp;I</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Share Issuance Approval</U>&#148; means
the approval, by the affirmative vote of a majority of votes cast by holders of shares of Common Stock at the meeting of the Corporation&#146;s stockholders at which a vote is taken with respect to such issuance, that is required under applicable
NYSE rules as a result of the NYSE Share Issuance Amount exceeding the NYSE Limit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Stockholder Approvals</U>&#148; means the
Charter Amendment Approval and Share Issuance Approval. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subject Series D Share</U>&#148; means a share of Series D NVCE Stock that is
automatically converted pursuant to <U>Section</U><U></U><U>&nbsp;III(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trading Day</U>&#148; means a day on which the
shares of Common Stock: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) are not suspended from trading on any national or regional securities exchange or association
or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market at the close of business; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) have traded at least once on the national or regional securities exchange or association or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market that is the primary market for the trading of the Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;III. Conversion. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Conversion upon Convertible Transfer</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The shares of Series D NVCE Stock shall not be convertible into any other class of capital stock of the Corporation, except in accordance
with this <U>Section</U><U></U><U>&nbsp;III</U>. On the terms and in the manner set forth in this <U>Section</U><U></U><U>&nbsp;III</U>, upon the consummation of any Convertible Transfer of shares of Series D NVCE Stock, each outstanding share of
Series D NVCE Stock subject to such Convertible Transfer (each, a &#147;<U>Subject Series D Share</U>&#148;) shall automatically convert into a number of shares of Common Stock equal to the Applicable Conversion Rate; <U>provided</U> that, if at
that time of the Convertible Transfer, (A)&nbsp;the HSR Approvals and/or the Stockholder Approvals is required for the conversion of the Subject Series D Shares into Common Stock and (B)&nbsp;the HSR Approvals or the Stockholder Approvals, as
applicable, has not yet been obtained, then the maximum number of Subject Series D Shares that can convert into Common Stock without receipt of the HSR Approvals or Stockholder Approvals, as applicable, shall so convert into Common Stock based on
the Applicable Conversion Rate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) On the Conversion Date, the Corporation shall effect the conversion of the Subject Series D Shares
by delivering the shares of Common Stock so converted pursuant to <U>Section</U><U></U><U>&nbsp;III(a)(i)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The shares of Common
Stock issuable upon conversion of the Subject Series D Shares pursuant to <U>Section</U><U></U><U>&nbsp;III(a)(i)</U> shall be allocated among the applicable Holders in such Convertible Transfer on a <I>pro rata </I>basis of the aggregate dollar
amount invested by the Holders on the Closing Date; <U>provided</U> <U>that</U> such allocation shall be subject to any adjustment required to be made so as to not cause, in the event that HSR Approvals have not been obtained, any Holder&#146;s HSR
Amount to exceed the HSR Threshold. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Prior to the close of business on any applicable Conversion Date, the shares of Common Stock
issuable upon conversion of any shares of Series D NVCE Stock pursuant to <U>Section</U><U></U><U>&nbsp;III(a)(i)</U> shall not be deemed outstanding for any purpose, and the Holders shall have no rights with respect to the Common Stock (including
voting rights, rights to respond to tender offers for the Common Stock, and rights to receive any dividends or other distributions on the Common Stock) by virtue of holding shares of Series D NVCE Stock, except as otherwise expressly set forth in
this Certificate of Designations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Effective immediately prior to the close of business on any applicable Conversion Date,
the rights of the Holders with respect to the shares of the Series D NVCE Stock so converted shall cease and the Persons entitled to receive shares of Common Stock upon the conversion of such shares of Series D NVCE Stock shall be treated for all
purposes as having become the record and beneficial owners of such shares of Common Stock. In the event that the Holders shall not by written notice to the Corporation designate the name in which shares of Common Stock and/or cash, securities or
other property (including payments of cash in lieu of fractional shares) to be issued or paid upon conversion of shares of Series D NVCE Stock should be registered or paid or the manner in which such shares should be delivered, the Corporation shall
be entitled to register and deliver such shares, and make such payment, in the name of the Holders and in the manner shown on the records of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) No fractional shares of Common Stock shall be issued upon any conversion of shares of Series D NVCE Stock. If more than one share of
Series D NVCE Stock shall be surrendered for conversion at any one time by the same Holder, the number of full shares of Common Stock issuable upon conversion thereof shall be computed on the basis of the aggregate number of shares of Series D NVCE
Stock so surrendered. Instead of any fractional shares of Common Stock that would otherwise be issuable upon conversion of any Subject Series D Share, the Corporation shall pay an amount in cash (rounded to the nearest cent) equal to the fractional
share of Common Stock, that otherwise would be issuable hereunder, <I>multiplied by</I> the Closing Price of the Common Stock determined as of the second Trading Day immediately preceding the applicable Conversion Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) All shares of Common Stock which may be issued upon conversion of the shares of Series D NVCE Stock will, upon issuance by the
Corporation, be duly authorized, validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> free and clear of all Liens (other than transfer restrictions imposed under applicable securities Laws) and not issued in
violation of any preemptive right or Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Effective immediately prior to the Conversion Date, dividends or distributions shall no
longer be declared on any Subject Series D Shares and such shares shall cease to be outstanding, in each case, subject to the rights of a Holder to receive any declared and unpaid dividends or distributions on such shares and any other payments to
which they are otherwise entitled pursuant to <U>Section</U><U></U><U>&nbsp;IV</U> or <U>Section</U><U></U><U>&nbsp;VII</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;IV. Dividend Rights. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) From and after the Closing Date to (but excluding) the applicable Conversion Date, (i)&nbsp;the Holders shall be entitled to receive,
when, as and if declared by the Board or any duly authorized committee of the Board (but only out of assets legally available therefor under the DGCL) all cash dividends or distributions (including regular quarterly dividends or distributions)
declared and paid or made in respect of the shares of Common Stock, at the same time and on the same terms as holders of Common Stock, in an amount per share of Series D NVCE Stock equal to the product of (x)&nbsp;the Applicable Conversion Rate then
in effect and (y)&nbsp;any per share dividend or distribution, as applicable, declared and paid or made in respect of each share of Common Stock (the &#147;<U>NVCE Dividend Amount</U>&#148;), and (ii)&nbsp;the Board or any duly authorized committee
thereof may not declare and pay any cash dividend or make any cash </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
distribution in respect of Common Stock unless the Board or any duly authorized committee of the Board declares and pays to the Holders, at the same time and on the same terms as holders of
Common Stock, the NVCE Dividend Amount per share of Series D NVCE Stock. Notwithstanding any provision in this <U>Section</U><U></U><U>&nbsp;IV(a)</U>&nbsp;to the contrary, no Holder of a share of Series D NVCE Stock shall be entitled to receive any
dividend or distribution made with respect to the Common Stock where the Record Date for determination of holders of Common Stock entitled to receive such dividend or distribution occurs prior to the date of issuance of such share of Series D NVCE
Stock. The foregoing shall not limit or modify the rights of any Holder to receive any dividend or other distribution pursuant to <U>Section</U><U></U><U>&nbsp;VII</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each dividend or distribution declared and paid pursuant to <U>Section</U><U></U><U>&nbsp;IV(a)</U> will be payable to Holders of record
of shares of Series D NVCE Stock as they appear in the records of the Corporation at the close of business on the same day as the Record Date for the corresponding dividend or distribution to the holders of shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except as set forth in this Certificate of Designations, the Corporation shall have no obligation to pay, and the holders of shares of
Series D NVCE Stock shall have no right to receive, dividends or distributions at any time, including with respect to dividends or distributions with respect to Common Stock or any other class or series of authorized Preferred Stock. To the extent
the Corporation declares dividends or distributions on the Series D NVCE Stock and on any Common Stock but does not make full payment of such declared dividends or distributions, the Corporation will allocate the dividend payments on a <I>pro
rata</I> basis among the holders of the shares of Series D NVCE Stock and the holders of any Common Stock then outstanding. For purposes of calculating the allocation of partial dividend payments, the Corporation will allocate dividend payments on a
<I>pro rata</I> basis among the Holders and the holders of any Common Stock so that the amount of dividends or distributions paid per share on the shares of Series D NVCE Stock and such Common Stock shall in all cases bear to each other the same
ratio that payable dividends or distributions per share on the shares of the Series D NVCE Stock and such Common Stock (but without, in the case of any noncumulative Preferred Stock, accumulation of dividends or distributions for prior dividend
periods) bear to each other. The foregoing right shall not be cumulative and shall not in any way create any claim or right in favor of Holders in the event that dividends or distributions have not been declared or paid in respect of any prior
calendar quarter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) No interest or sum of money in lieu of interest will be payable in respect of any dividend payment or payments on
shares of Series D NVCE Stock that may be in arrears. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Holders shall not be entitled to any dividends or distributions, whether
payable in cash, securities or other property, other than dividends or distributions (if any) declared and payable on shares of Series D NVCE Stock as specified in this Certificate of Designations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Notwithstanding any provision in this Certificate of Designations to the contrary, Holders shall not be entitled to receive any dividends
or distributions on any shares of Series D NVCE Stock on or after the applicable Conversion Date in respect of such shares of Series D NVCE Stock that have been converted as provided herein, except to the extent that any such dividends or
distributions have been declared by the Board or any duly authorized committee of the Board and the Record Date for such dividend occurs prior to such applicable Conversion Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;V. Voting. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding any stated or statutory voting rights, except as set forth in <U>Section</U><U></U><U>&nbsp;V(b)</U>, the Holders shall
not be entitled to vote (in their capacity as Holders) on any matter submitted to a vote of the stockholders of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) So
long as any shares of Series D NVCE Stock are outstanding, the Corporation shall not, without the written consent or affirmative vote, given in person or by proxy, at a meeting called for that purpose by holders of at least a majority of the
outstanding shares of Series D NVCE Stock, voting as a single and separate class, amend, alter or repeal (including by merger, consolidation or otherwise, and whether in a single transaction or a series of related transactions, other than a
Reorganization Event pursuant to which the Series D NVCE Stock is treated in accordance with <U>Section</U><U></U><U>&nbsp;VII(i)</U>) any provision of (i)&nbsp;this Certificate of Designations or (ii)&nbsp;the Charter, in either case, that would
alter, modify or change the preferences, rights, privileges or powers of the Series D NVCE Stock so as to, or in a manner that would, significantly and adversely affect the preferences, rights, privileges or powers of the Series D NVCE Stock;
<U>provided</U><I>, </I>that any such amendment or alteration to any provision of this Certificate of Designations or the Charter that alters, modifies or changes the preferences, rights, privileges or powers of a particular Holder so as to, or in a
manner that would, significantly and adversely affect the preferences, rights, privileges or powers of such Holder in a manner disproportionate from any other Holder shall require the prior written consent of such significantly and adversely
affected Holder; <U>provided</U><I>, </I><U>further</U>, that neither (x)&nbsp;any increase in the amount of the authorized or issued Series D NVCE Stock or any securities convertible into Series D NVCE Stock nor (y)&nbsp;the creation and issuance,
or an increase in the authorized or issued amount, of any series of Preferred Stock, or any securities convertible into Preferred Stock, ranking equal with and/or junior to the Series D NVCE Stock with respect to the payment of dividends (whether
such dividends are cumulative or <FONT STYLE="white-space:nowrap">non-cumulative)</FONT> and/or the distribution of assets upon the Corporation&#146;s liquidation, dissolution or winding up, in either case, will, in and of itself, be deemed to
significantly and adversely affect the preferences, rights, privileges or powers of the Series D NVCE Stock or any Holder and the Holders will have no right to vote their shares of Series D NVCE Stock or consent to such action solely by reason of
such an increase, creation or issuance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding the foregoing, the Corporation shall not, without the written consent or
affirmative vote, given in person or by proxy, at a meeting called for that purpose by the unanimous consent of the holders of the outstanding shares of Series D NVCE Stock, amend, alter or repeal (including by merger, consolidation or otherwise,
and whether in a single transaction or a series of related transactions, other than a Reorganization Event pursuant to which the Series D NVCE Stock is treated in accordance with <U>Section</U><U></U><U>&nbsp;VII(i)</U>) the definitions of Base
Price, Conversion Price or Applicable Conversion Rate under this Certificate of Designations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding the foregoing, the Holders shall not have any voting rights set out in
<U>Section</U><U></U><U>&nbsp;V(b)</U> if, at or prior to the effective time of the act with respect to which such vote would otherwise be required, all outstanding shares of Series D NVCE Stock shall have been converted into shares of Common Stock.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;VI. Liquidation. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms hereof, the Series D NVCE Stock shall, consistent with the requirements of 12 C.F.R. Section&nbsp;217.20(b)(1) (or
any successor regulation) with respect to common equity tier 1 capital, rank equally with the Common Stock with respect to dividends or distributions (including regular quarterly dividends) declared by the Board and rights upon any liquidation,
dissolution, winding up or similar proceeding of the Corporation, as provided in the Charter; provided, that, in the event of any liquidation, dissolution or winding up of the affairs of the Corporation, holders of the Series D Preferred Stock shall
be entitled to receive, in preference to the holders of the Common Stock, an amount per share equal to $0.0001. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) For purposes of this
<U>Section</U><U></U><U>&nbsp;VI</U>, the sale, conveyance, exchange or transfer (for cash, shares of stock, securities or other consideration) of all or substantially all of the property and assets of the Corporation shall not be deemed a voluntary
or involuntary dissolution, liquidation or winding up of the affairs of the Corporation, nor shall the merger, consolidation or any other business combination transaction of the Corporation into or with any other corporation or Person or the merger,
consolidation or any other business combination of any other corporation or Person into or with the Corporation be deemed to be a voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;VII. Adjustments. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Conversion Price shall be subject to the adjustments described in this <U>Section</U><U></U><U>&nbsp;VII</U> (each such event set
forth in <U>Section</U><U></U><U>&nbsp;VII(b)</U> through <U>Section</U><U></U><U>&nbsp;VII(i)</U>, an &#147;<U>Adjustment Event</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Stock Dividends and Distributions</U>. If the Corporation pays dividends or other distributions on the Common Stock in shares of Common
Stock, then the Conversion Price will be adjusted by multiplying the Conversion Price in effect at 5:00 p.m., New York City time on the Trading Day immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such dividend or
distribution by the following fraction: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="30%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately prior to <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such dividend or distribution.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the sum of (x)&nbsp;the number of shares of Common Stock outstanding immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such dividend or distribution, plus (y)&nbsp;the total number of shares of Common
Stock issued in such dividend or distribution.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The adjustment pursuant to this <U>Section</U><U></U><U>&nbsp;VII(b)</U> shall become effective at 9:00 a.m.,
New York City time on the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such dividend or distribution. For the purposes of this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<U>Section</U><U></U><U>&nbsp;VII(b)</U>, the number of shares of Common Stock at the time outstanding shall not include shares held in treasury by the Corporation. If any dividend or
distribution described in this <U>Section</U><U></U><U>&nbsp;VII(b)</U> is declared but not so paid or made, the Conversion Price shall be readjusted, effective as of the date the Board publicly announces its decision not to make such dividend or
distribution, to such Conversion Price that would be in effect if such dividend or distribution had not been declared. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)
<U>Subdivisions, Splits and Combinations of Common Stock</U>. If the Corporation subdivides, splits or combines the shares of Common Stock, then the Conversion Price will be adjusted by multiplying the Conversion Price in effect at 5:00 p.m., New
York City time on the Trading Day immediately prior to the effective date of such share subdivision, split or combination by the following fraction: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="30%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately prior to the effective date of such share subdivision, split or combination.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately after the opening of business on the effective date of such share subdivision, split or combination.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The adjustment pursuant to this <U>Section</U><U></U><U>&nbsp;VII(c)</U> shall become effective at 9:00 a.m.,
New York City time on the effective date of such subdivision, split or combination. For the purposes of this <U>Section</U><U></U><U>&nbsp;VII(c)</U>, the number of shares of Common Stock at the time outstanding shall not include shares held in
treasury by the Corporation. If any subdivision, split or combination described in this <U>Section</U><U></U><U>&nbsp;VII(c)</U> is announced but the outstanding shares of Common Stock are not subdivided, split or combined, the Conversion Price
shall be readjusted, effective as of the date the Board publicly announces its decision not to subdivide, split or combine the outstanding shares of Common Stock, to such Conversion Price that would be in effect if such subdivision, split or
combination had not been announced. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Issuance of Stock Purchase Rights</U>. If the Corporation issues to all or substantially all
holders of the shares of Common Stock rights or warrants (other than rights or warrants issued pursuant to a dividend reinvestment plan or share purchase plan or other similar plans) entitling them, for a period of up to 45 days from the date of
issuance of such rights or warrants, to subscribe for or purchase the shares of Common Stock at less than the Current Market Price on the date immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such issuance, then the
Conversion Price will be adjusted by multiplying the Conversion Price in effect at 5:00 p.m., New York City time on the Trading Day immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such issuance by the following fraction:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&nbsp;+&nbsp;Y</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB> + X</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">X</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the total number of shares of Common Stock issuable pursuant to such rights or warrants.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Y</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock equal to the aggregate price payable to exercise such rights or warrants divided by the Current Market Price on the date immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Date</FONT>
for the issuance of such rights or warrants.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any adjustment pursuant to this <U>Section</U><U></U><U>&nbsp;VII(d)</U> shall become effective immediately
prior to 9:00 a.m., New York City time, on the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such issuance. For the purposes of this <U>Section</U><U></U><U>&nbsp;VII(d)</U>, the number of shares of Common Stock at the time outstanding shall
not include shares held in treasury by the Corporation. The Corporation shall not issue any such rights or warrants in respect of shares of the Common Stock held in treasury by the Corporation. In the event that such rights or warrants described in
this <U>Section</U><U></U><U>&nbsp;VII(d)</U> are not so issued, the Conversion Price shall be readjusted, effective as of the date the Board publicly announces its decision not to issue such rights or warrants, to the Conversion Price that would
then be in effect if such issuance had not been declared. To the extent that such rights or warrants are not exercised prior to their expiration or shares of Common Stock are otherwise not delivered pursuant to such rights or warrants upon the
exercise of such rights or warrants, the Conversion Price shall be readjusted to such Conversion Price that would then be in effect had the adjustment made upon the issuance of such rights or warrants been made on the basis of the delivery of only
the number of shares of Common Stock actually delivered. In determining the aggregate offering price payable for such shares of Common Stock, there shall be taken into account any consideration received for such rights or warrants and the value of
such consideration (if other than cash, to be reasonably determined by the Board). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Debt or Asset Distributions</U>. If the
Corporation distributes to all or substantially all holders of shares of Common Stock evidences of indebtedness, shares of capital stock, securities, cash or other assets (excluding any dividend or distribution referred to in
<U>Section</U><U></U><U>&nbsp;VII(b)</U>, any dividend or distribution paid exclusively in cash, any consideration payable in connection with a tender or exchange offer made by the Corporation or any of its subsidiaries, and any dividend of shares
of capital stock of any class or series, or similar equity interests, of or relating to a subsidiary or other business unit in the case of certain <FONT STYLE="white-space:nowrap">spin-off</FONT> transactions as described below), then the Conversion
Price will be adjusted by multiplying the Conversion Price in effect at 5:00 p.m., New York City time on the Trading Day immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution by the following fraction: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0&nbsp;</SUB>&#150;&nbsp;FMV</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Current Market Price per share of Common Stock on such date.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">FMV</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the fair market value of the portion of the distribution applicable to one share of Common Stock on such date as reasonably determined by the Board; <U>provided</U> that, if &#147;FMV&#148; as set forth above is equal to or greater
than &#147;SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#148; as set forth above, in lieu of the foregoing adjustment, adequate provision shall be made so that each Holder shall receive on the date on which such distribution is made
to holders of Common Stock, for each share of Series D NVCE Stock, the amount of such distribution such Holder would have received had such holder owned a number of shares of Common Stock equal to the Applicable Conversion Rate on the <FONT
STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In a <FONT STYLE="white-space:nowrap">&#147;spin-off&#148;,</FONT> where the Corporation makes a distribution
to all holders of shares of Common Stock consisting of capital stock of any class or series, or similar equity interests of, or relating to, a subsidiary or other business unit, if a Holder did not participate in such distribution with respect to
such shares of Series D NVCE Stock as provided for in <U>Section</U><U></U><U>&nbsp;IV</U>, the Conversion Price with respect to such share held by such Holder will be adjusted on the 15<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Trading
Day after the effective date of the distribution by multiplying such Conversion Price in effect immediately prior to such 15<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Trading Day by the following fraction: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">MP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">MP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&nbsp;+&nbsp;MP<SUB STYLE="font-size:75%; vertical-align:bottom">s</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">MP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Closing Prices of the Common Stock over the first 10 Trading Days commencing on and including the fifth Trading Day following the effective date of such distribution.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">MP<SUB STYLE="font-size:75%; vertical-align:bottom">s</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Closing Prices of the capital stock or equity interests representing the portion of the distribution applicable to one share of Common Stock over the first 10 Trading Days commencing on and including the fifth
Trading Day following the effective date of such distribution, or, if not traded on a national or regional securities exchange or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, the fair
market value of the capital stock or equity interests representing the portion of the distribution applicable to one share of Common Stock on such date as reasonably determined by the Board.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any adjustment pursuant to this <U>Section</U><U></U><U>&nbsp;VII(e)</U> shall become effective immediately
prior to 9:00 a.m., New York City time, on the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution. In the event that such distribution described in this <U>Section</U><U></U><U>&nbsp;VII(e)</U> is not so paid or made, the
Conversion Price shall be readjusted, effective as of the date the Board publicly announces its decision not to pay or make such dividend or distribution, to the Conversion Price that would then be in effect if such dividend or distribution had not
been declared. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Cash Distributions</U>. If the Corporation makes a distribution consisting exclusively of cash to all holders of
Common Stock, excluding any (i)&nbsp;cash dividend on the Common Stock to the extent a corresponding cash dividend is paid on the Series D NVCE Stock pursuant to <U>Section</U><U></U><U>&nbsp;IV(a)</U>, (ii) cash that is distributed in a
Reorganization Event or as part of a <FONT STYLE="white-space:nowrap">&#147;spin-off&#148;</FONT> referred to in <U>Section</U><U></U><U>&nbsp;VII(e)</U>, (iii) dividend or distribution in connection with the Corporation&#146;s liquidation,
dissolution or <FONT STYLE="white-space:nowrap">winding-up,</FONT> and (iv)&nbsp;consideration payable in connection with a tender or exchange offer made by the Corporation or any of its subsidiaries, then in each event, the Conversion Price in
effect immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution will be multiplied by the following fraction: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0&nbsp;</SUB>&#150;&nbsp;DIV</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Closing Price per share of Common Stock on the Trading Day immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Date.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">DIV</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the amount per share of Common Stock of the cash distribution, as determined pursuant to the introduction to this <U>Section&nbsp;VII(f)</U>.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that any distribution described in this <U>Section</U><U></U><U>&nbsp;VII(f)</U> is not so made,
the Conversion Price shall be readjusted, effective as of the date the Board publicly announces its decision not to pay such distribution, to the Conversion Price which would then be in effect if such distribution had not been declared. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if &#147;DIV&#148; as set forth above is equal to or greater than &#147;SP<SUB
STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#148; as set forth above, in lieu of the foregoing adjustment, adequate provision shall be made so that each Holder shall have the right to receive on the date on which the relevant cash dividend
or distribution is distributed to holders of Common Stock, for each share of Series D NVCE Stock, the amount of cash such Holder would have received had such holder owned a number of shares of Common Stock equal to the Applicable Conversion Rate on
the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Self-Tender Offers and Exchange Offers</U>. If the
Corporation or any of its subsidiaries successfully completes a tender or exchange offer for the Common Stock where the cash and the value of any other consideration included in the payment per share of the Common Stock exceeds the Closing Price per
share of the Common Stock on the Trading Day immediately succeeding the expiration of the tender or exchange offer, then the Conversion Price will be adjusted by multiplying the Conversion Price in effect at 5:00 p.m., New York City time prior to
the commencement of the offer by the following fraction: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB> x SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">AC&nbsp;+&nbsp;(SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&nbsp;x&nbsp;OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP>)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Closing Price per share of Common Stock on the Trading Day immediately succeeding the commencement of the tender or exchange offer.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately prior to the expiration of the tender or exchange offer, including any shares validly tendered and not withdrawn.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">OS<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately after the expiration of the tender or exchange offer (after giving effect to such tender offer or exchange offer).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">AC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the aggregate cash and fair market value of the other consideration payable in the tender or exchange offer, as reasonably determined by the Board.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any adjustment made pursuant to this <U>Section</U><U></U><U>&nbsp;VII(g)</U> shall become
effective immediately prior to 9:00 a.m., New York City time, on the Trading Day immediately following the expiration of the tender or exchange offer. In the event that the Corporation or one of its subsidiaries is obligated to purchase shares of
Common Stock pursuant to any such tender offer or exchange offer, but the Corporation or such subsidiary is permanently prevented by applicable law from effecting any such purchases, or all such purchases are rescinded, then the Conversion Price
shall be readjusted to be such Conversion Price that would then be in effect if such tender offer or exchange offer had not been made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Rights Plans</U>. To the extent that the Corporation has a rights plan in effect with respect to the Common Stock on any Conversion
Date, upon conversion of any shares of the Series D NVCE Stock, the Holders will receive, in addition to the shares of Common Stock, the rights under the rights plan, unless, prior to such Conversion Date, the rights have separated from the shares
of Common Stock, in which case the Conversion Price will be adjusted at the time of separation as if the Corporation had made a distribution to all holders of Common Stock as described in <U>Section</U><U></U><U>&nbsp;VII(e)</U>, subject to
readjustment in the event of the expiration, termination or redemption of such rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Reorganization Events</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Upon the occurrence of a Reorganization Event prior to an applicable Conversion Date, each share of Series D NVCE Stock outstanding
immediately prior to such Reorganization Event shall, without the consent of Holders, automatically convert into the types and amounts of securities, cash, and other property that is or was receivable in such Reorganization Event by a holder (other
than the counterparty to the Reorganization Event or an Affiliate of such other party) of the number of shares of Common Stock into which such share of Series D NVCE Stock was convertible immediately prior to such Reorganization Event in exchange
for such shares of Series D NVCE Stock (such securities, cash, and other property, the &#147;<U>Exchange Property</U>&#148;); <U>provided</U> <U>that</U>, to the extent receipt of any Exchange Property would be prohibited by Law or would require the
Holder to obtain any consent, authorization, approval, license or permit of any Governmental Entity to acquire or hold the Exchange Property, then the portion of the Series D NVCE Stock of such Holder that such Holder is prohibited by Law or
requires such action to acquire or hold shall instead either (A)&nbsp;convert into a substantially identical <FONT STYLE="white-space:nowrap">non-voting</FONT> security (with commensurate voting powers and conversion rights as the Series D NVCE
Stock hereunder) of the entity surviving such Reorganization Event or other entity in which holders of shares of Common Stock receive securities in connection with such Reorganization Event or (B)&nbsp;if proper provision is not made to give effect
to the foregoing <U>subclause (A)</U>, remain outstanding without any alterations to the terms thereof and be convertible into the Exchange Property. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) A &#147;<U>Reorganization Event</U>&#148; shall mean: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) any consolidation, merger, conversion or other similar business combination of the Corporation with or into another Person,
in each case, pursuant to which all or substantially all of the Common Stock outstanding will be converted into cash, securities, or other property of the Corporation or another Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) any sale, transfer, lease, or conveyance to another Person of all or substantially all of the property and assets of the
Corporation and its subsidiaries, taken as a whole, in each case pursuant to which all of the Common Stock outstanding will be converted into cash, securities, or other property of the Corporation or another Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) any reclassification of the Common Stock into securities other than the Common Stock; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(4) any statutory exchange of all of the outstanding shares of Common Stock for securities of another Person (other than in
connection with a merger or acquisition). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) In the event that holders of the shares of the Common Stock have the opportunity to elect
the form of consideration to be received in such Reorganization Event, the Corporation shall ensure that the Holders have the same opportunity to elect the form of consideration in accordance with the same procedures and pro ration mechanics that
apply to the election to be made by the holders of the Common Stock. The amount of Exchange Property receivable upon conversion of any Series D NVCE Stock shall be determined based upon the Conversion Price in effect on the date on which such
Reorganization Event is consummated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) The provisions of this <U>Section</U><U></U><U>&nbsp;VII(i)</U> shall similarly apply to
successive Reorganization Events or any series of transactions that results in a Reorganization Event and the provisions of <U>Section</U><U></U><U>&nbsp;VII(i)</U> shall apply to any shares of capital stock of the Corporation (or any successor)
received by the holders of the Common Stock in any such Reorganization Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) The Corporation (or any successor) shall, at least
twenty (20)&nbsp;days prior to the occurrence of any Reorganization Event, use reasonable best efforts to provide written notice to the Holders of the anticipated occurrence of such event and of the type and amount of the cash, securities or other
property that constitutes the Exchange Property; <U>provided</U>, that no such notice shall be required if the anticipated occurrence of any Reorganization Event is disclosed in any registration statement, prospectus, report, schedule or proxy
statement publicly filed with or furnished by the Corporation to the U.S. Securities and Exchange Commission. Failure to deliver such notice shall not affect the operation of this <U>Section</U><U></U><U>&nbsp;VII</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) The Corporation shall not enter into any agreement for a transaction constituting a Reorganization Event unless such agreement provides
for the conversion of the Series D NVCE Stock into the Exchange Property in a manner that is consistent with and gives effect to this <U>Section</U><U></U><U>&nbsp;VII(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) No adjustment to the Conversion Price shall be made with respect to a share of Series D NVCE Stock if the Holder thereof has participated
in the transaction that would otherwise give rise to an adjustment with respect to such share of Series D NVCE Stock, as a result of holding such share of Series D NVCE Stock at the time of such transaction (including pursuant to
<U>Section</U><U></U><U>&nbsp;IV</U>), without having to convert such share of Series D NVCE Stock, as if they held the full number of shares of Common Stock into which each such share of the Series D NVCE Stock held by them may then be converted.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Notwithstanding anything to the contrary herein, an Adjustment Event shall not allow the
Holder to acquire a higher percentage of any Class&nbsp;of Voting Securities of the Corporation than the Holder (together with its affiliates for purposes of the BHC Act) beneficially owned immediately prior to such Adjustment Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;VIII. Reports as to Adjustments. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever the number of shares of Common Stock into which the shares of the Series D NVCE Stock are convertible is adjusted as provided in
<U>Section</U><U></U><U>&nbsp;VII</U>, the Corporation shall promptly, but in any event within ten days thereafter, compute such adjustment and furnish to the Holders a notice stating the number of shares of Common Stock into which each share of the
Series D NVCE Stock is convertible as a result of such adjustment, a brief statement of the facts requiring such adjustment and the computation thereof and when such adjustment will become effective. Amounts resulting from any calculation hereunder
will be rounded to the nearest 1/10,000th. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;IX. Reservation of Stock. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Corporation shall, following the Charter Amendment Approval and the filing and acceptance of the Charter Amendment (as defined in the
Investment Agreements), reserve and keep available out of its authorized and unissued Common Stock, solely for issuance upon the conversion of shares of Series D NVCE Stock as provided in this Certificate of Designations, free from any preemptive or
other similar rights, such number of shares of Common Stock as shall from time to time be issuable upon the conversion of all the shares of Series D NVCE Stock then outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Following the approval of the applicable supplemental listing application with NYSE, the Corporation hereby covenants and agrees that, for
so long as shares of the Common Stock are listed on the NYSE or any other national securities exchange or automated quotation system, the Corporation will, if permitted by the rules of such exchange or automated quotation system, list and keep
listed that number of shares of Common Stock issuable upon conversion of shares of all the Series D NVCE Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;X.
Exclusion of Other Rights. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of Series D NVCE Stock shall not have any voting powers except as expressly described herein,
and, except as may otherwise be required by Law, shall not have any preferences or relative, participating, optional or other special rights, other than those specifically set forth herein (as this Certificate of Designations may be amended from
time to time) and in the Charter. The shares of Series D NVCE Stock shall have no preemptive or subscription rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XI. Severability of Provisions. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any voting powers, preferences or relative, participating, optional or other special rights of the Series D NVCE Stock and qualifications,
limitations and restrictions thereof set forth in this Certificate of Designations (as this Certificate of Designations may be amended from time to time) are invalid, unlawful or incapable of being enforced by reason of any rule&nbsp;of Law, all
other voting powers, preferences and relative, participating, optional and other special rights of Series D NVCE Stock and qualifications, limitations and restrictions thereof set forth in this Certificate of Designations (as so amended) which can
be given effect without the invalid, unlawful or unenforceable voting powers, preferences or relative, participating, optional or other special rights of Series D NVCE Stock and qualifications, limitations and restrictions thereof shall,
nevertheless, remain in full force and effect, and no voting powers, preferences or relative, participating, optional or other special rights of Series D NVCE Stock or qualifications, limitations and restrictions thereof herein set forth shall be
deemed dependent upon any other such voting powers, preferences or relative, participating, optional or other special rights of Series D NVCE Stock or qualifications, limitations and restrictions thereof unless so expressed herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XII. Cancellation of Series D NVCE Stock. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any shares of Series D NVCE Stock that have been duly converted in accordance with this Certificate of Designations, or reacquired by the
Corporation, shall be cancelled promptly thereafter and revert to authorized but unissued shares of Preferred Stock undesignated as to series. Such shares may be designated or redesignated and issued or reissued, as the case may be, as part of any
series of Preferred Stock. The Corporation may from time to time take such appropriate action as may be necessary to reduce the authorized number of shares of Series D NVCE Stock solely in accordance with the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XIII. Additional Authorized Shares. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything set forth in the Charter or this Certificate of Designations to the contrary, the Board or any authorized committee
of the Board, without the vote of the Holders, may increase or decrease the number of authorized shares of Series D NVCE Stock or other stock ranking junior or senior to, or on parity with, the Series D NVCE Stock as to dividends and the
distribution of assets upon any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XIV. Determinations. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation shall have the sole right to make all calculations called for hereunder. Absent fraud or manifest error, such calculations
shall be final and binding on all Holders. The Corporation shall have the power to resolve any ambiguity and its action in so doing, as evidenced by a resolution of the Board, shall be final and conclusive unless clearly inconsistent with the intent
hereof. Amounts resulting from any calculation will be rounded, if necessary, to the nearest one <FONT STYLE="white-space:nowrap">ten-thousandth,</FONT> with five <FONT STYLE="white-space:nowrap">one-hundred</FONT> thousandths being rounded upwards.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Series D NVCE Stock is intended to qualify as common equity tier 1 capital for purposes of 12 C.F.R. Section&nbsp;217.20(b)(1) (or
any successor regulation), and the terms of this Certificate of Designation shall be interpreted, construed and applied to achieve such regulatory capital treatment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XV. No Redemption. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may not, at any time, redeem the outstanding shares of the Series D NVCE Stock, other than as otherwise expressly set forth in
<U>Section</U><U></U><U>&nbsp;VII</U> with the prior approval of the Board to the extent otherwise required by law or regulation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XVI. Maturity. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Series D NVCE Stock shall be perpetual, unless converted in accordance with this Certificate of Designations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XVII. Repurchases. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the limitations imposed herein, the Corporation may purchase and sell shares of Series D NVCE Stock from time to time to such
extent, in such manner, and upon such terms as the Board or any duly authorized committee of the Board may determine; <U>provided</U> that any repurchase of shares of Series D NVCE Stock by the Corporation shall require prior approval of the Board
to the extent otherwise required by law or regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XVIII. No Sinking Fund. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of Series D NVCE Stock are not subject to the operation of a sinking fund. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XIX. Notices. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All notices, demands or other communications to be given hereunder shall be in writing and shall be deemed to have been given (a)&nbsp;on the
date of delivery if delivered personally to the recipient, or if by email, upon delivery (<U>provided</U> that no auto-generated error or <FONT STYLE="white-space:nowrap">non-delivery</FONT> message is generated in response thereto), (b) on the
first Business Day following the date of dispatch if delivered utilizing a <FONT STYLE="white-space:nowrap">next-day</FONT> service by a recognized <FONT STYLE="white-space:nowrap">next-day</FONT> courier or (c)&nbsp;on the earlier of confirmed
receipt or the fifth business day following the date of mailing if delivered by registered or certified mail, return receipt requested, postage prepaid. All notices hereunder shall be delivered to (i)&nbsp;if to the Corporation, New York Community
Bancorp, Inc., 102 Duffy Avenue, Hicksville, New York 11801, Attention: Chief Executive Officer, Email: sandro.dinello@flagstar.com; with a copy to: General Counsel, Email: patrick.quinn@flagstar.com or (ii)&nbsp;if to any Holder or holder of Common
Stock, as the case may be, to such Holder or holder at the address listed in the stock record books of the Corporation, or, in each case, such other address or to the attention of such other Person as the recipient party has specified by prior
written notice to the sending party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XX. Taxes. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Corporation and each Holder shall bear their own costs, fees and expenses in connection with any conversion contemplated by
<U>Section</U><U></U><U>&nbsp;III(a)(i)</U>, except that the Corporation shall pay any and all transfer taxes, stamp taxes or duties, documentary taxes, or other similar taxes in connection with, or arising by reason of, any issuance or delivery of
shares of Series D NVCE Stock or Common Stock or other securities issued on account of Series D NVCE Stock pursuant hereto, including in connection with any conversion contemplated by <U>Section</U><U></U><U>&nbsp;III(a)(i)</U>;
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<U>provided</U> that the Corporation shall not be required to pay any such tax that may be payable in connection with any conversion contemplated by <U>Section</U><U></U><U>&nbsp;III(a)(i)</U> to
the extent such tax is payable because a registered holder of Series D NVCE Stock requests Common Stock to be registered in a name other than such registered holder&#146;s name and no such Common Stock will be so registered unless and until the
registered holder making such request has paid such taxes to the Corporation or has established to the satisfaction of the Corporation that such taxes have been paid or are not payable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Corporation and each Holder agree that (i)&nbsp;it is intended that the Series D NVCE Stock not constitute &#147;preferred stock&#148;
within the meaning of Section&nbsp;305 of the Internal Revenue Code of 1986, as amended (the &#147;<U>Code</U>&#148;), and the Treasury Regulations promulgated thereunder and (ii)&nbsp;except to the extent otherwise required by a
&#147;determination&#148; within the meaning of Section&nbsp;1313(a) of the Code, neither the Corporation nor any Holder shall treat the Series D NVCE Stock as such for United States federal income tax or withholding tax purposes or otherwise take
any position inconsistent with such treatment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything herein to the contrary, the Corporation shall be entitled to
deduct and withhold from any consideration otherwise payable on or with respect to the Series D NVCE Stock such amounts as it is required to deduct or withhold with respect to the making of such payment under the Code, or any other applicable tax
Law. If any amounts are so deducted or withheld and subsequently paid to the applicable Government Entity, such deducted or withheld amounts shall be treated for all purposes hereunder as having been paid to the person to which such amounts would
have otherwise been payable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;XXI. No Stock Certificates. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary contained in this Certificate of Designations, no shares of Series D NVCE Stock shall be issued in
physical, certificated form. All shares of Series D NVCE Stock shall be evidenced by book-entry on the record books maintained by the Corporation or its transfer agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the Corporation has caused this Certificate of Designations to be
signed by the undersigned on this 11<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day of March, 2024. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>NEW YORK COMMUNITY BANCORP, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ R. Patrick Quinn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: R. Patrick Quinn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: General Counsel&nbsp;&amp; Corporate Secretary</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Certificate of Designations</I>] </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>6
<FILENAME>d763888dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>CONFIDENTIAL </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS SECURITY HAS BEEN
ACQUIRED FOR INVESTMENT AND WITHOUT A VIEW TO DISTRIBUTION AND HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#147;ACT&#148;), OR UNDER STATE SECURITIES LAWS. NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER
DISPOSITION OF THIS SECURITY OR ANY INTEREST OR PARTICIPATION THEREIN MAY BE MADE EXCEPT (A)&nbsp;PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR (B)&nbsp;PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE
SECURITIES LAWS AND, IN THE CASE OF CLAUSE (B), UNLESS THE COMPANY RECEIVES AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WARRANT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>to
purchase </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[&#149;]<SUP STYLE="font-size:75%; vertical-align:top">1</SUP> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Shares of </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Series D <FONT
STYLE="white-space:nowrap">Non-Voting</FONT> Common Equivalent Stock </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>of </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NEW YORK COMMUNITY BANCORP, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>a Delaware Corporation </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No. 01</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Issue Date: <U>March</U><U></U><U>&nbsp;11, 2024</U></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amount equal to a number of shares of NVCE Stock convertible into (x) the total number of shares of Common
Stock issued under the Investment Agreement (on an as converted basis without regard to any limitation on conversion or exchange), <I>multiplied</I> by (y) 60%. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Table of Contents </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DEFINITIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NUMBER OF SHARES; PERSONS ENTITLED TO EXERCISE WARRANT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EXERCISE OF WARRANT; TERM</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LIMITATION OF EXERCISE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">COVENANTS AND REPRESENTATIONS OF THE COMPANY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ISSUANCE OF SHARES; AUTHORIZATION; LISTING</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">COMPLIANCE WITH SECURITIES LAWS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NO FRACTIONAL SHARES OR SCRIP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NO RIGHTS AS STOCKHOLDERS; TRANSFER BOOKS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TRANSFER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">REGISTRY OF WARRANT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LOSS, THEFT, DESTRUCTION OR MUTILATION OF WARRANT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SATURDAYS, SUNDAYS, HOLIDAYS, ETC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RULE 144 INFORMATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.&#8194;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ADJUSTMENTS AND OTHER RIGHTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">16.&#8194;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BUSINESS COMBINATIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">17.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TRANSFER TAXES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">18.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WITHHOLDING</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">19.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MISCELLANEOUS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Index of Defined Terms </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">i</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Applicable Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Appraisal Procedure</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Business Combination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">business day</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Designations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible Transfer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current Market Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Ex-Date</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,&nbsp;4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expiration Time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair Market Value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issue Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Market Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Newly Issued Company Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice of Exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NVCE Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,&nbsp;1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">person</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share Recipient</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subject Record Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trading Day</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant Certificate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrantholder</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Definitions</U>. Unless the context otherwise requires, when used herein the following
terms shall have the meanings indicated. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>affiliate</I>&#148; of a specified person is any person that, directly or indirectly, controls, is controlled by, or is under common
control with, such specified person; <U>provided</U> that if the Warrantholder is controlled by a private equity sponsor or similar investment firm, &#147;affiliate&#148; shall not include any &#147;portfolio company&#148; (as such term is
customarily used in the private equity industry), or any investment fund or vehicle (other than any such fund or vehicle with a direct or indirect interest in any Purchaser, of or related to or affiliated with or managed by such sponsor or firm. For
purposes of this definition, &#147;control&#148; (including, with correlative meanings, the terms &#147;controlled by&#148; and &#147;under common control with&#148;) when used with respect to any person, means the possession, directly or
indirectly, of the power to cause the direction of management or policies of such person, whether through the ownership of voting securities, by contract or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Applicable Price</I>&#148; means the applicable Conversion Price (as defined in the Certificate of Designations), as may be adjusted
from time to time pursuant to the Certificate of Designations; <U>provided</U> that the Applicable Price shall also be adjusted as set forth in Section VII of the Certificate of Designations, without duplication, for the cumulative effect of all
events occurring on or after the issuance of this Warrant and prior to the date the Warrant has been exercised in full for which no adjustment was made to the Conversion Price under the Certificate of Designations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Appraisal Procedure</I>&#148; means a procedure whereby two independent appraisers, one chosen by the Company and one chosen by the
Warrantholder, shall mutually agree upon the determinations then the subject of appraisal. Each party shall deliver a notice to the other appointing its appraiser within fifteen (15)&nbsp;days after the Appraisal Procedure is invoked. If within
thirty (30)&nbsp;days after appointment of the two appraisers they are unable to mutually agree upon the amount in question, a third independent appraiser shall be chosen within ten (10)&nbsp;days thereafter by the mutual agreement of such first two
appraisers or, if such first two appraisers fail to agree upon the appointment of a third appraiser, such appointment shall be made by the American Arbitration Association, or any organization successor thereto, from a panel of arbitrators having
experience in the appraisal of the subject matter to be appraised. The decision of the third appraiser so appointed and chosen shall be given within thirty (30)&nbsp;days after the selection of such third appraiser. If three appraisers shall be
appointed and the determination of one appraiser is disparate from the middle determination by more than twice the amount by which the other determination is disparate from the middle determination, then the determination of such appraiser shall be
excluded, the remaining two determinations shall be averaged and such average shall be binding and conclusive on the Company and the Warrantholder; otherwise, the average of all three determinations shall be binding and conclusive on the Company and
the Warrantholder. The costs of conducting any Appraisal Procedure shall be borne by the Company; <U>provided</U> that, if the final determination of the appraisers is less than the fair market value determination of the Board of Directors, then
such costs shall be borne solely by the Warrantholder. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Business Combination</I>&#148; means, whether in a single transaction or series of
related transactions, a merger, division, consolidation, share exchange, reorganization, sale of all or substantially all of the Company&#146;s assets to another person or similar transaction (which may include a reclassification) involving the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>business day</I>&#148; means any day other than a Saturday, a Sunday or a day on which banks in New York, New York are
authorized by Law to be closed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Certificate of Designations</I>&#148; means the Certificate of Designations of the NVCE Stock,
filed with the Delaware Secretary of State on March&nbsp;11, 2024, effective as of March&nbsp;11, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Convertible
Transfer</I>&#148; shall have the meaning set forth in the Certificate of Designations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Current Market Price</I>&#148; means, on
any date, the average of the daily Market Price per share of the Common Stock or other securities on each of the five consecutive Trading Days preceding the earlier of the day before the date of the issuance, dividend or distribution in question and
the day before the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> with respect to the issuance or distribution, giving rise to an adjustment to the Exercise Price pursuant to <U>Section</U><U></U><U>&nbsp;15</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I><FONT STYLE="white-space:nowrap">Ex-Date</FONT></I>&#148; means, when used with respect to any issuance, dividend or distribution
giving rise to an adjustment to the Exercise Price pursuant to <U>Section</U><U></U><U>&nbsp;15</U>, the first date on which the applicable Common Stock or other securities trade without the right to receive the issuance, dividend or distribution.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Excluded Stock</I>&#148; means (i)&nbsp;shares of Common Stock issued by the Company as a stock dividend payable in shares of
Common Stock, or upon any subdivision or <FONT STYLE="white-space:nowrap">split-up</FONT> of the outstanding shares of Common Stock, in each case, which is subject to Section VII(b) of the Certificate of Designations, or upon conversion of
securities (but not the issuance of such securities convertible or exchangeable into Common Stock which will be subject to the provision of <U>Section</U><U></U><U>&nbsp;15(b)</U>), (ii) shares of Common Stock to be issued in good faith to
directors, officers, employees, consultants or other agents of the Company or its Subsidiaries pursuant to options, restricted stock units, other equity-based awards or other compensatory arrangements approved by the Board of Directors in the
ordinary course of providing equity compensation awards, (iii)&nbsp;any shares of Common Stock issued upon conversion of the NVCE Stock, (iv)&nbsp;any shares issued upon the conversion of the Shares issued under this Warrant, (v)&nbsp;any other
securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date hereof;<U>&nbsp;provided</U>&nbsp;that, in the case of this <U>clause (v)</U>, such securities have not been amended subsequent
to the issuance of this Warrant to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities or to extend the term of such securities, and (vi)&nbsp;any shares of capital stock
issued or sold to the Warrantholder or any of its affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Exercise Price</I>&#148; means $2,500.00; <U>provided</U>, that
the foregoing shall be subject to adjustment as expressly set forth herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Fair Market Value</I>&#148; means, with respect to any security or other property,
the fair market value of such security or other property as determined by the Board of Directors, acting in good faith in reliance on advice received by the Board of Directors from a nationally recognized independent investment banking firm retained
by the Company for the purpose of determining the fair market value of shares of the NVCE Stock and certified in a resolution to the Warrantholder. If the Warrantholder does not accept the Board of Director&#146;s calculation of fair market value
and, thereafter, the Warrantholder and the Company are unable to agree on fair market value, then the Appraisal Procedure shall be used to determine fair market value. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Group</I>&#148; means a group as contemplated by Section&nbsp;13(d)(3) of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Investment Agreement</I>&#148; means the Investment Agreement, dated as of March&nbsp;7, 2024, as it may be amended from time to
time, by and between the Company and [<I>Purchaser</I>]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Issue Date</I>&#148; means the date first set forth above opposite the
heading Issue Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Market Price</I>&#148; means, with respect to (1)&nbsp;the NVCE Stock, on any given day, (a)&nbsp;the last
sale price, regular way, or, in case no such sale takes place on such day, the average of the closing bid and asked prices, regular way, of the shares of the NVCE Stock on the principal exchange or market on which the NVCE Stock is so listed or
quoted, (b)&nbsp;if the NVCE Stock is not so publicly traded, the product of (i)&nbsp;the number of shares of Common Stock issuable upon conversion of the NVCE Stock <I>multiplied by</I> (ii)&nbsp;the last sale price, regular way, or, in case no
such sale takes place on such day, the average of the closing bid and asked prices, regular way, of the shares of the Common Stock on the principal exchange or market on which the Common Stock is so listed or quoted or (c)&nbsp;if neither the
foregoing <U>clause (a)</U>&nbsp;nor <U>clause (b)</U>&nbsp;applies, the Fair Market Value of a share of the NVCE Stock and (2)&nbsp;the Common Stock, on any given day, (a)&nbsp;the last sale price, regular way, or, in case no such sale takes place
on such day, the average of the closing bid and asked prices, regular way, of the shares of the Common Stock on the principal exchange or market on which the Common Stock is so listed or quoted or (b)&nbsp;if the foregoing <U>clause
(a)</U>&nbsp;does not apply, the Fair Market Value of a share of the Common Stock. &#147;Market Price&#148; shall be determined without reference to after-hours or extended-hours trading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>&#147;NVCE Stock</I>&#148; means a series of preferred stock, par value $0.01 per share, of the Company designated as Series D <FONT
STYLE="white-space:nowrap">Non-Voting</FONT> Common Equivalent Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Notice of Exercise</I>&#148; means a duly completed and
executed Notice of Exercise, the form of which is annexed hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>person</I>&#148; means any individual, corporation (including <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit),</FONT></FONT> general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, Governmental Entity or other entity of any
kind or nature. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Standard Settlement Period</I>&#148; means the standard settlement period, expressed in a number of trading
days, on the Company&#146;s primary trading market with respect to the Common Stock as in effect on the date of delivery of a Notice of Exercise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Trading Day</I>&#148; means a day on which the shares of Common Stock: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) are not suspended from trading on any national or regional securities exchange or association or <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market at the close of business; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) have traded at least once on the
national or regional securities exchange or association or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market that is the primary market for the trading of the Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Transfer</I>&#148; means to sell, transfer, make any short sale of, loan, grant any option for the purchase of or interest in or
otherwise dispose of this Warrant or any rights hereunder; provided, however, that a pledge or other encumbrance of this Warrant or any rights hereunder that creates a mere security interest in this Warrant or any rights hereunder shall not
constitute a Transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Warrant</I>&#148; means this Warrant issued pursuant to the Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Warrant Certificate</I>&#148; means this certificate evidencing this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Warrantholder</I>&#148; means the person who shall from time to time own this Warrant, including any transferee thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Number of Shares</U><U>; Persons Entitled to Exercise Warrant</U>. On the terms and subject to the conditions, requirements and
procedures set forth herein, New York Community Bancorp, Inc., a Delaware corporation (the &#147;<I>Company</I>&#148;), hereby certifies that, unless this Warrant has been earlier redeemed, surrendered, cancelled or exercised in full, for value
received, this Warrant is exercisable in whole at any time or in part from time to time, for, in the aggregate, [&#149;]<SUP STYLE="font-size:75%; vertical-align:top">2</SUP> duly authorized, validly issued, fully-paid and nonassessable shares of
NVCE Stock (&#147;<I>Shares</I>&#148;), as such number may be adjusted in accordance with the terms of this Warrant, free and clear of all Liens (other than transfer restrictions imposed under applicable securities Laws), by the Warrantholder. The
number of Shares and the Exercise Price are subject to adjustment as provided herein and in the Certificate of Designations, and all references to &#147;Shares&#148; and &#147;Exercise Price&#148; herein shall be deemed to include any such
adjustment or series of adjustments. If this Warrant is transferred in a Convertible Transfer to any person for whom the underlying NVCE Stock would automatically convert into Common Stock pursuant to Section III(a) of the Certificate of
Designations if transferred directly, then, notwithstanding anything to the contrary in this Warrant, this Warrant shall be exercisable by such person in whole at any time or in part from time to time for the number of shares of Common Stock into
which the Shares would be convertible pursuant to the Certificate of Designations at the time of exercise, and the remaining terms of this Warrant shall apply to such exercise<I> mutatis mutandis</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Exercise of Warrant; Term</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) On the terms and subject to the conditions, requirements and procedures set forth herein, on and after September&nbsp;10, 2024, and prior
to 5:00 p.m. (New York City time) on the seven (7)&nbsp;year anniversary of the Issue Date (the &#147;<I>Expiration Time</I>&#148;) this Warrant may be exercised by the Warrantholder, in whole or in part, from time to time, at any time after 9:00
a.m., New York City time, on the Issue Date by (x)&nbsp;the delivery by the Warrantholder to the Company of a Notice of Exercise and (y)&nbsp;if applicable, payment by the Warrantholder to the Company of the Exercise Price for the Shares specified
in such Notice of Exercise pursuant to <U>Section</U><U></U><U>&nbsp;3(b)</U>. </P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amount equal to a number of shares of NVCE Stock convertible into (x)&nbsp;the total number of shares of Common
Stock issued under the Investment Agreement (on an as converted basis without regard to any limitation on conversion), <I>multiplied by</I> (y) 60%. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Payment of the Exercise Price for the Shares in any exercise pursuant to
<U>Section</U><U></U><U>&nbsp;3(a)</U> shall be effected by the Company withholding, from the Shares that would otherwise be delivered to the Warrantholder upon such exercise, an amount of Shares equal in value to the aggregate Exercise Price in
respect of the Shares as to which this Warrant is so exercised, based on the Market Price on the business day immediately prior to the date on which this Warrant is exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If the Warrantholder exercises a portion (but not all) of this Warrant pursuant to <U>Section</U><U></U><U>&nbsp;3(a)</U>, the
Warrantholder will, at the option of the Warrantholder, be entitled to receive from the Company, within a reasonable time, and in any event not exceeding three (3)&nbsp;business days after notice thereof to the Company, a new Warrant Certificate in
substantially identical form to this Warrant Certificate, but for the purchase of that number of Shares that remain issuable pursuant to this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) If the Warrantholder does not elect to receive a new Warrant Certificate in accordance with <U>Section</U><U></U><U>&nbsp;3(c)</U>, then,
notwithstanding anything herein to the contrary, the Warrantholder shall not be required to physically surrender this Warrant to the Company until this Warrant has been exercised in full, in which case, the Warrantholder shall surrender this Warrant
to the Company for cancellation within three (3)&nbsp;business days after the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in the issuance of a portion of the total number of Shares
issuable hereunder shall have the effect of lowering the outstanding number of Shares issuable hereunder in an amount equal to the applicable number of Shares issued upon such partial exercises hereof. The Warrantholder and the Company shall
maintain records showing the number of Shares issued upon partial exercises hereof and the date of such issuances. The Company shall inform the Warrantholder if a Notice of Exercise has not been duly completed within two (2)&nbsp;business days of
receipt of such notice, but shall not refuse or object to the issuance of the Shares upon receipt of, and pursuant to, a duly completed Notice of Exercise. <B>The Warrantholder, by acceptance of this Warrant, acknowledges and agrees that, by reason
of the provisions of this </B><B><U>Section</U></B><B><U></U></B><B><U>&nbsp;3</U></B><B>, following the exercise of a portion of this Warrant, the number of Shares issuable hereunder at any given time may be less than the amount stated on the face
hereof.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding any other provision hereof, if an exercise of any portion of this Warrant is to be made in connection
with a public offering or a sale of the Company (pursuant to a merger, sale of stock, or otherwise), such exercise may, at the election of the Warrantholder (as set forth in the applicable Notice of Exercise), be conditioned upon the consummation of
such transaction, in which case, such exercise shall not be deemed to be effective until immediately prior to the consummation of such transaction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) At the Expiration Time, this Warrant shall terminate and the Warrantholder shall have no
right to acquire any shares pursuant hereto, other than settlement of any exercise pursuant to <U>Section</U><U></U><U>&nbsp;3(a)</U> that properly occurred prior to the Expiration Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Limitation of Exercise</U>. The Warrantholder shall have no right to exercise this Warrant, and the Company shall have no obligation to
effect any exercise of this Warrant, to the extent that after giving effect to any exercise of this Warrant, such exercise would or would reasonably be expected to (a)&nbsp;cause the Warrantholder, its affiliates or any of their partners or
principals to (i) &#147;control&#148; the Company or be required to become a bank holding company, in each case, pursuant to the BHC Act, its implementing regulations or the terms of any commitment made to the Federal Reserve by the Warrantholder or
its affiliates; or (ii)&nbsp;serve as a source of financial strength to the Company pursuant to the BHC Act; or (b)&nbsp;require the Warrantholder, its affiliates or any of their partners or principals to have made any advance filing with, obtained
any approval, authorization consent, permit or license of, or provided notice to, any Governmental Entity under Law (which such filing has not been made, or approval, authorization, consent, permit or license has not been obtained or such notice has
not been duly provided), including the expiration of any waiting periods associated therewith (including any extensions thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.
<U>Covenants and Representations of the Company</U>. The Company hereby represents, covenants and agrees, as applicable: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except and to
the extent as waived or consented to by the Warrantholder, the Company shall not by any action, including amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or intentionally seek to avoid the observance or performance of any of the terms of this Warrant, but shall at all times in good faith assist in the carrying out of all such terms and in the taking
of all such actions as may be necessary or appropriate to protect the rights of the Warrantholder as set forth in this Warrant against impairment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Company shall (i)&nbsp;not increase the par value of any Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii)&nbsp;issue duly authorized, validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> Shares upon the proper exercise of this Warrant, and (iii)&nbsp;use reasonable best efforts to
(x)&nbsp;obtain all such authorizations, exemptions or consents required of the Company from any Governmental Entity as may be necessary to enable the Company to perform its express obligations under this Warrant and (y)&nbsp;take all necessary
actions so that the Shares may be issued without violation of Law or any requirement of any securities exchange on which the Shares or the Common Stock are listed or traded. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Before taking any action which would result in an adjustment in the number of Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, and take all such corporate action, as may be necessary in order that the Company may validly and legally issue fully paid and <FONT
STYLE="white-space:nowrap">non-assessable</FONT> Shares at the Exercise Price as so adjusted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Company shall solely for the purpose of providing for the exercise of this Warrant
(A)&nbsp;reserve that number of shares of NVCE Stock sufficient for issuance upon exercise of this Warrant and (B)&nbsp;promptly (and in no event later than five (5)&nbsp;business days following the Issue Date) take all action necessary to reserve
up to 315,000,000 shares of Common Stock for issuance upon conversion of shares of NVCE Stock and promptly following the Company&#146;s receipt of the Requisite Stockholder Vote and the filing and acceptance of the Charter Amendment with the
Delaware Secretary of State, reserve Common Stock sufficient for issuance of shares of Common Stock upon conversion of such shares of NVCE Stock in full without regard to any limitation on such conversion in accordance with their terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Issuance of Shares; Authorization</U><U>; Listing</U>. In the event of any exercise of this Warrant in accordance with and on the terms
and subject to the conditions hereof, any Shares issued pursuant to such exercise, if applicable, shall be issued in such name(s) as the Warrantholder may designate and shall be delivered by the Company to such named person(s) within the earlier of
(i)&nbsp;two (2) business days after the date on which this Warrant has been duly exercised in accordance with the terms hereof and (ii)&nbsp;the number of business days comprising the Standard Settlement Period after the date on which this Warrant
has been duly exercised in accordance with the terms hereof. Any such delivery shall be made via book-entry transfer crediting the account of the Warrantholder through the Company&#146;s transfer agent and registrar for the NVCE Stock. The Company
hereby represents and warrants that any Shares issued upon the exercise of this Warrant in accordance with <U>Section</U><U></U><U>&nbsp;3</U> shall, subject to the Requisite Stockholder Vote and the filing and acceptance of the Charter Amendment
with the Delaware Secretary of State, be duly authorized, validly issued, fully-paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> issued without violation of any preemptive or similar rights of any stockholder of the Company, and free
and clear of all Liens (other than transfer restrictions imposed under Law or Liens created by the Warrantholder occurring prior to, or contemporaneously with, such exercise). The Company agrees that the Shares so issued shall be deemed to have been
issued if this Warrant is exercised pursuant to <U>Section</U><U></U><U>&nbsp;2</U> (the person to whom such Shares shall be deemed to have been so issued in accordance with <U>Section</U><U></U><U>&nbsp;2</U>, the &#147;<I>Share
Recipient</I>&#148;)<I></I>&nbsp;as of the close of business on the date on which the Notice of Exercise is delivered to the Company in accordance with the terms hereof (it being agreed that payment of the Exercise Price by net settlement pursuant
to <U>Section</U><U></U><U>&nbsp;3(b)</U> shall be deemed to occur by delivery to the Company of the Notice of Exercise), notwithstanding that the stock transfer books of the Company may then be closed or certificates representing such Shares may
not be actually delivered on such date. The Company shall, at its sole expense, use reasonable best efforts to (a)&nbsp;procure the listing of (x)&nbsp;this Warrant and (y)&nbsp;the Shares and other securities issuable upon exercise of this Warrant
(solely to the extent they are shares of Common Stock), in each case, subject to issuance or notice of issuance on all stock exchanges on which the Common Stock is then listed or traded, and (b)&nbsp;maintain the listing of this Warrant and/or such
Shares and other securities issuable upon exercise of this Warrant or issuable upon the conversion of the shares of NVCE Stock into which this Warrant is exercisable (solely to the extent they are shares of Common Stock) after issuance. The Company
will use reasonable best efforts to ensure that the Shares may be issued without violation of any applicable law or regulation or of any requirement of any securities exchange on which the Shares are listed or traded. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Compliance with Securities Laws</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Warrantholder, by acceptance hereof, acknowledges that the offer and sale of this Warrant and any Shares to be issued upon exercise
hereof have not been registered under the Securities Act or under any U.S. state security Law and are being acquired pursuant to an exemption from registration under the Securities Act solely for the Warrantholder&#146;s own account, and not as a
nominee for any other party, and for investment with no present intention to distribute this Warrant (or any Shares issuable upon exercise hereof) to any person in violation of the Securities Act or any U.S. state securities Law, and that the
Warrantholder will not offer, sell or otherwise dispose of this Warrant or any Shares to be issued upon exercise hereof except pursuant to an effective registration statement, or an exemption from registration, under the Securities Act and any U.S.
state securities Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as provided in <U>Section</U><U></U><U>&nbsp;7(c)</U>, this Warrant and any Shares issued upon exercise
hereof shall be stamped or imprinted with a legend in substantially the form (which, in the case of the Shares, shall be in the form of an appropriate book entry notation) set forth in Section&nbsp;4.2 of the Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Company shall promptly cause such legend to be removed from any certificate or other instrument for this Warrant or the Shares and the
Company shall deliver all necessary documents to the transfer agent in connection therewith without charge as to this Warrant or any Shares upon request of (x)&nbsp;the Warrantholder, upon receipt by the Company of an opinion of counsel reasonably
satisfactory to the Company to the effect that such legend is no longer required under the Securities Act and applicable state laws or (y)&nbsp;the Warrantholder at a time when the offer and sale of this Warrant or the Shares have been registered
under the Securities Act (unless subject to any transfer restrictions under Rule 144 for affiliates) or may otherwise be transferred pursuant to any applicable rules thereunder, including eligibility to be transferred if Rule 144 under the
Securities Act is available for the sale of this Warrant or the Shares without volume and manner of sale restrictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Company
and the Warrantholder acknowledge that the Shares issuable upon exercise of this Warrant, including the Common Stock issuable upon conversion of the Shares, shall be entitled to the benefits of the Registration Rights Agreement, as the same may be
amended, amended and restated or supplemented from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>No Fractional Shares or Scrip</U>. No fractional Shares or scrip
representing fractional Shares shall be issued upon any exercise of this Warrant. In lieu of any fractional Share to which the Share Recipient would otherwise be entitled, the Share Recipient shall be entitled to receive a cash payment equal to the
Market Price on the last business day preceding the date of exercise less the portion of the Exercise Price attributable to such fractional share; <U>provided</U> that, if the making of a cash payment in lieu of the issuance of a fractional share is
prohibited by Law or contract, the number of shares issued by the Company upon exercise of this Warrant shall be rounded to the nearest whole share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>No Rights as Stockholders; Transfer Books</U>. This Warrant does not entitle the Warrantholder to any rights of a holder of NVCE Stock
prior to the date of exercise hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective immediately prior to the close of business on such date of exercise, the Share Recipient shall
have any rights as a holder of NVCE Stock. The Company will at no time close its transfer books against Transfer of this Warrant in any manner which interferes with the timely exercise of this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Transfer</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
Subject to compliance with Law and <U>Section</U><U></U><U>&nbsp;10(b)</U>, without obtaining the consent of the Company to assign or transfer this Warrant, this Warrant and all rights hereunder are transferable, in whole or in part, upon the books
of the Company by the registered holder hereof in person or by duly authorized attorney, or by means of electronic transmission, and a new warrant shall be made and delivered by the Company, of the same tenor and date as this Warrant but registered
in the name of the transferee, upon surrender of this Warrant, duly endorsed, to the office or agency of the Company described in <U>Section</U><U></U><U>&nbsp;2</U>, and delivery of the form of assignment annexed hereto, duly completed and
executed. All expenses (other than stock transfer taxes) and other charges payable in connection with the preparation, execution and delivery of the new warrants certificate pursuant to this <U>Section</U><U></U><U>&nbsp;10</U> shall be paid by the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything herein or in the Investment Agreement to the contrary (but subject to <U>Sections 10(c)</U> and
<U>(d)</U>), from the Issue Date and until September&nbsp;10, 2024: (i) the Warrantholder shall not (and shall cause any of its affiliates who own or hold Newly Issued Company Securities not to), directly or indirectly, sell, transfer, or otherwise
dispose of any shares of Common Stock or Preferred Stock or the Permanent Warrant, in each case, issued pursuant to the Investment Agreement (collectively, &#147;<I>Newly Issued Company Securities</I>&#148;); <U>provided</U> that the foregoing shall
not prohibit any Warrantholder (or any of its affiliates) from selling, transferring or otherwise disposing of any Newly Issued Company Securities solely (A)&nbsp;to any of its affiliates, so long as such affiliate (x)&nbsp;does not at such time
have in place any short sale, loan, hypothecation, pledge, offer, grant or sale of, any option or other contract for the sale of, or agreement to engage in any of the foregoing transactions with respect to, any shares of Common Stock or Preferred
Stock or the Permanent Warrant and (y)&nbsp;agrees to be bound by the terms of this <U>Section</U><U></U><U>&nbsp;10</U>, (B) pursuant to, and as expressly required by, a legally binding contract to which such Warrantholder or its affiliates was a
party on or prior to March&nbsp;9, 2024, as demonstrated by the books and records of the Warrantholder that will be provided to the Company reasonably prior to any action being taken in reliance on the exception in this <U>subclause (B)</U>
(excluding any amendments, supplements, restatements, waivers or other modification thereto that occur on or after March&nbsp;10, 2024), or (C)&nbsp;pursuant to the exercise of existing contractual rights (such as put options) established on or
prior to March&nbsp;9, 2024, as demonstrated by the books and records of the Warrantholder that will be provided to the Company reasonably prior to any action being taken in reliance on the exception in this <U>subclause (C)</U> (excluding any
amendments, supplements, restatements, waivers or other modification thereto that occur on or after March&nbsp;10, 2024); and (ii)&nbsp;the Warrantholder shall not (and shall cause (x)&nbsp;its controlled affiliates and (y)&nbsp;any entity that
controls Warrantholder&nbsp;or is under common control with Warrantholder (except as for set forth on <B>Annex A,</B> so long as any entity listed in <B>Annex A</B> will not, directly or indirectly, enter into, or agree to, any transaction in this
<U>clause (ii)</U>&nbsp;with respect to, on the account of, or for the benefit of the Newly Issued Company Securities or for the purpose of hedging to any extent the Newly Issued Company Securities) not
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to), directly or indirectly, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the sale of, or agree to engage in any of the foregoing
transactions with respect to, any shares of Common Stock or Preferred Stock or the Permanent Warrant. In the event of a violation of the immediately preceding sentence by any Warrantholder, this Warrant (or portion thereof held by such
Warrantholder) shall immediately and automatically (without any further action by the Company, such Warrantholder or any other person) terminate (without any further issuance of any securities hereunder) and such Warrantholder shall have no further
right to exercise all or any portion of this Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) In the event that the Company waives, amends or terminates the restrictions in
<U>Section</U><U></U><U>&nbsp;10(b)</U> for any person who received (i)&nbsp;shares of Common Stock or Preferred Stock or (ii)&nbsp;a Permanent Warrant, in each case, issued pursuant to any Other Investment Agreement, then such waiver, amendment or
termination shall automatically (without any further action by the Company or any Warrantholder) also apply to the Warrantholder in respect of this Warrant on a pro rata basis relative to the waiver for such other person. The Company shall use
reasonable best efforts to provide a written notice to the Warrantholder (at least 3 business days before the effectiveness of any such waiver, amendment or termination) that describes (to the extent permitted by Law) such waiver, amendment or
termination in reasonable detail and the basis upon which it is expected to apply relative to the Warrantholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding
anything in <U>Section</U><U></U><U>&nbsp;10(b)</U> to the contrary, if the Warrantholder is, or is affiliated with, a multi-manager investment vehicle, the Warrantholder and its affiliates may make any short sale of, loan, hypothecate, pledge,
offer, grant or sell any option or other contract for the purchase of, or agree to engage in any of the foregoing transactions with respect to, any shares of Common Stock or Preferred Stock or the Permanent Warrant (including any Newly Issued
Company Securities) prior to September&nbsp;10, 2024, so long as the decision to take such action is not made by (a)&nbsp;the portfolio managers who made the investment decision to purchase the Newly Issued Company Securities held by the Holder (or
any of its affiliates) (the &#147;<U>Investment Decision</U>&#148;), (b) any person who was involved in the Investment Decision or (c)&nbsp;any other person who is acting at the direction or instruction of the persons covered by <U>clause
(a)</U>&nbsp;and <U>(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Registry of Warrant</U>. The Company shall maintain a registry in which, subject to such reasonable
regulations as it may prescribe, it shall register Warrant Certificates (showing the name and address of the Warrantholder as the registered holder of this Warrant) and exchanges and transfers thereof. This Warrant may be surrendered for exchange or
exercise, in accordance with its terms, and the Company shall be entitled to rely in all respects upon such registry, and the Company shall not be affected by any notice to the contrary, except any Transfer of the Warrant effected in accordance with
the provisions of this Warrant, including <U>Section</U><U></U><U>&nbsp;10</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Loss, Theft, Destruction or Mutilation of
Warrant</U>. Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of the Warrant Certificate and, in the case of loss, theft or destruction, on delivery of an indemnity agreement
reasonably satisfactory in form and substance to the Company or, in the case of any such mutilation, upon surrender and cancellation of the Warrant Certificate, the Company shall execute and deliver, in lieu of such lost, stolen, destroyed or
mutilated Warrant Certificate, a new Warrant Certificate of like tenor and representing the right to purchase the same aggregate number of Shares issuable pursuant to such lost, stolen, destroyed or mutilated Warrant Certificate, less the number of
Shares previously issued upon any exercise of this Warrant pursuant to <U>Section</U><U></U><U>&nbsp;3</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of
any action or the expiration of any right required or granted herein shall not be a business day, then such action may be taken or such right may be exercised on the next succeeding day that is a business day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Rule 144 Information</U>. The Company covenants that it will use reasonable best efforts to timely file all reports and other documents
that may be required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations promulgated by the U.S. Securities and Exchange Commission (the &#147;<I>SEC</I>&#148;) thereunder (or, if the Company is not required
to file such reports under the Securities Act or the Exchange Act, it will, upon the request of any Warrantholder, make publicly available such information as may be necessary to permit sales pursuant to Rule 144), and it will use reasonable best
efforts to take such further action as any Warrantholder may reasonably request, all to the extent required from time to time to enable such holder to sell the Warrants without registration under the Securities Act within the limitation of the
exemptions provided by (i)&nbsp;Rule 144 or Regulation&nbsp;S under the Securities Act, as such rules may be amended from time to time, or (ii)&nbsp;any successor rule or regulation hereafter adopted by the SEC. Upon the written request of any
Warrantholder, the Company will deliver to such Warrantholder a written statement that it has complied with such requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.
<U>Adjustments and Other Rights</U>. The Exercise Price and the number of Shares issuable upon exercise of this Warrant shall be subject to adjustment from time to time as follows; <U>provided</U> that if more than one section or subsection of this
<U>Section</U><U></U><U>&nbsp;15</U> is applicable to a single event, the section or subsection shall be applied that produces the largest adjustment and no single event shall cause an adjustment under more than one section or subsection of this
<U>Section</U><U></U><U>&nbsp;15</U> so as to result in duplication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Stock Splits, Subdivisions, Reclassifications or
Combinations</U>. If the Company shall (i)&nbsp;declare, order, and pay or make a dividend or make a distribution on its NVCE Stock payable in shares of NVCE Stock (which shall not include any shares of NVCE Stock issued by the Company upon exercise
of this Warrant), (ii)&nbsp;split, subdivide or reclassify the outstanding shares of NVCE Stock into a greater number of shares or (iii)&nbsp;combine or reclassify the outstanding shares of NVCE Stock into a smaller number of shares, in each case,
then the number of Shares issuable upon exercise of this Warrant at the time of the record date for such dividend or distribution or the effective date of such split, subdivision, combination or reclassification shall be proportionately adjusted so
that the Warrantholder immediately after such record date or effective date, as applicable, upon exercise of this Warrant, shall be entitled to purchase the number of shares of NVCE Stock which such holder would have been entitled to receive in
respect of the Shares after such date had this Warrant been exercised in full immediately prior to such record date or effective date, as applicable. In such event, the Exercise Price in effect at the time of the record date for such dividend or
distribution or the effective date of such split, subdivision, combination or reclassification shall be adjusted to the number obtained by dividing (x)&nbsp;the product of (1)&nbsp;the number of Shares issuable upon the exercise of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
this Warrant before such adjustment determined pursuant to the immediately preceding sentence, <I>multiplied by</I> (2)&nbsp;the Exercise Price in effect immediately prior to the record or
effective date, as applicable, with respect to the dividend, distribution, split, subdivision, reclassification or combination giving rise to this adjustment by (y)&nbsp;the new number of Shares issuable upon exercise of this Warrant in full
determined pursuant to the immediately preceding sentence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Common Stock Issued at Less than the Applicable Price</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) If the Company issues or sells, or agrees to issue or sell, any Common Stock or other securities that are convertible into or exchangeable
or exercisable for (or are otherwise linked to) Common Stock (in each case, other than Excluded Stock) for consideration per share less than the Applicable Price, then the Exercise Price in effect immediately prior to each such issuance or sale will
immediately (except as provided below) be reduced to the price determined by multiplying the Exercise Price in effect immediately prior to such issuance or sale by a fraction, (x)&nbsp;the numerator of which shall be (1)&nbsp;the number of shares of
Common Stock outstanding immediately prior to such issuance or sale, <I>plus</I> (2)&nbsp;the number of shares of Common Stock which the aggregate consideration received by the Company for the total number of such additional shares of Common Stock
so issued or sold would purchase at the Applicable Price absent the adjustments contemplated by this <U>clause (b)(i)</U>, and (y)&nbsp;the denominator of which shall be the number of shares of Common Stock outstanding immediately after such
issuance or sale. In such event, the number of shares of NVCE Stock issuable upon the exercise of this Warrant shall be increased to the number obtained by dividing (x)&nbsp;the product of (1)&nbsp;the number of Shares issuable upon the exercise of
this Warrant before such adjustment and (2)&nbsp;the Exercise Price in effect immediately prior to the issuance or sale giving rise to this adjustment, by (y)&nbsp;the new Exercise Price determined in accordance with the immediately preceding
sentence. For the avoidance of doubt, no increase in the Exercise Price or reduction in the number of Shares issuable upon exercise of this Warrant shall be made pursuant to this <U>subclause (i)</U>&nbsp;of this
<U>Section</U><U></U><U>&nbsp;15(b)</U>, other than as would be contemplated by <U>Section</U><U></U><U>&nbsp;15(b)(ii)(3)(D)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii)
For the purposes of any adjustment of the Exercise Price and the number of Shares issuable upon the exercise of this Warrant pursuant to this <U>Section</U><U></U><U>&nbsp;15(b)</U>, the following provisions shall be applicable: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the case of the issuance or sale of equity or equity-linked securities for cash, the amount of the
consideration received by the Company shall be deemed to be the amount of the cash paid therefor before deducting therefrom any discounts, commissions or placement fees allowed, paid or incurred by the Company for any underwriter, placement agent or
otherwise in connection with the issuance and sale thereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the case of the issuance or sale of equity or equity-linked securities (otherwise than upon the conversion
of securities of the Company) for a consideration in whole or in part other than cash, including securities acquired in exchange therefor (other than securities by their terms so exchangeable), the consideration other than cash shall be deemed to be
the Fair Market Value, before deducting therefrom any discounts, commissions or placement fees allowed, paid or incurred by the Company for any underwriter, placement agent or otherwise in connection with the issuance and sale thereof.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the case of the issuance of (x)&nbsp;options, warrants or other rights to purchase or acquire equity or
equity-linked securities (whether or not at the time exercisable) or (y)&nbsp;securities by their terms convertible into or exchangeable for equity or equity-linked securities (whether or not at the time so convertible or exchangeable) or options,
warrants or rights to purchase such convertible or exchangeable securities (whether or not at the time exercisable): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The aggregate maximum number of shares of securities deliverable upon exercise of such options, warrants or
other rights to purchase or acquire equity or equity-linked securities shall be deemed to have been issued at the time such options, warrants or rights are issued and for a consideration equal to the consideration (determined in the manner provided
in <U>Section</U><U></U><U>&nbsp;15(b)(i)</U> and <U>(ii)</U>), if any, received by the Company upon the issuance or sale of such options, warrants or rights, <I>plus</I> the minimum purchase price provided in such options, warrants or rights for
the equity or equity-linked securities covered thereby. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The aggregate maximum number of shares of equity or equity-linked securities deliverable upon conversion of or
in exchange for any such convertible or exchangeable securities, or upon the exercise of options, warrants or other rights to purchase or acquire such convertible or exchangeable securities and the subsequent conversion or exchange thereof, shall be
deemed to have been issued at the time such securities were issued or such options, warrants or rights were issued and for a consideration equal to the consideration, if any, received by the Company for any such securities and related options,
warrants or rights (excluding any cash received on account of accrued interest or accrued dividends), <I>plus</I> the additional consideration (in each case, determined in the manner provided in <U>Section</U><U></U><U>&nbsp;15(b)(i)</U> and
<U>(ii)</U>), if any, to be received by the Company upon the conversion or exchange of such securities, or upon the exercise of any related options, warrants or rights to purchase or acquire such convertible or exchangeable securities and the
subsequent conversion or exchange thereof. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On any change in the number of shares of equity or equity-linked securities deliverable upon exercise of any
such options, warrants or rights or conversion or exchange of such convertible or exchangeable securities or any change in the consideration to be received by the Company upon such exercise, conversion or exchange, but excluding changes resulting
from the anti-dilution provisions thereof (to the extent comparable to (or less favorable than) the anti-dilution provisions contained herein), the Exercise Price and the number of Shares issuable upon exercise of this Warrant as then in effect
shall forthwith be readjusted to such Exercise Price and number of Shares as would have been obtained had an adjustment been made upon the issuance or sale of such options, warrants or rights not exercised prior to such change, or of such
convertible or exchangeable securities not converted or exchanged prior to such change, upon the basis of such change. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Upon the expiration of any options, warrants or rights to purchase equity or equity-linked securities, in each
case, which shall not have been exercised and for which any adjustment was made pursuant to this <U>Section</U><U></U><U>&nbsp;15(b)</U> upon the issuance or sale thereof, the Exercise Price and the number of Shares issuable upon exercise of this
Warrant as then in effect hereunder shall, upon such expiration, be recomputed to such Exercise Price and number of Shares as would have been obtained had an adjustment been made upon the issuance or sale of such options, warrants or rights on the
basis of the issuance of only the number of shares of Common Stock actually issued upon the exercise of such options, warrants or rights. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(E)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Exercise Price and the number of Shares issuable upon exercise of this Warrant shall have been adjusted
upon the issuance or sale of any such options, warrants, rights or convertible or exchangeable securities, no further adjustment of the Exercise Price or the number of Shares issuable upon the exercise of this Warrant shall be made for the actual
issuance of NVCE Stock upon the exercise, conversion or exchange hereof. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Issuance of Stock Purchase Rights</U>. If the Company issues to all or substantially
all holders of the shares of Common Stock rights or warrants (other than rights or warrants issued pursuant to a dividend reinvestment plan or share purchase plan or other similar plans) entitling them, for a period of up to 45 days from the date of
issuance of such rights or warrants, to subscribe for or purchase the shares of Common Stock at less than the Market Price on the date immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such issuance, then the Exercise
Price will be adjusted by multiplying the Exercise Price in effect at 5:00 p.m., New York City time on the Trading Day immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such issuance by the following fraction: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&nbsp;+&nbsp;Y</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB> + X</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Where, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB> = the number of shares of Common Stock outstanding immediately prior to the <FONT
STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">X = the total number of shares of Common Stock issuable pursuant to such
rights or warrants. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Y = the number of shares of Common Stock equal to the aggregate price payable to exercise such rights or warrants
divided by the Market Price on the date immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for the issuance of such rights or warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any adjustment pursuant to this <U>Section</U><U></U><U>&nbsp;15(c)</U> shall become effective immediately prior to 9:00 a.m., New York City time, on the <FONT
STYLE="white-space:nowrap">Ex-Date</FONT> for such issuance. For the purposes of this <U>Section</U><U></U><U>&nbsp;15(c)</U>, the number of shares of Common Stock at the time outstanding shall not include shares held in treasury by the Company. The
Company shall not issue any such rights or warrants in respect of shares of the Common Stock held in treasury by the Company. In the event that such rights or warrants described in this <U>Section</U><U></U><U>&nbsp;15(c)</U> are not so issued, the
Exercise Price shall be readjusted, effective as of the date the Board of Directors publicly announces its decision not to issue such rights or warrants, to the Exercise Price that would then be in effect if such issuance had not been declared. To
the extent that such rights or warrants are not exercised prior to their expiration or shares of Common Stock are otherwise not delivered pursuant to such rights or warrants upon the exercise of such rights or warrants, the Exercise Price shall be
readjusted to such Exercise Price that would then be in effect had the adjustment made upon the issuance of such rights or warrants been made on the basis of the delivery of only the number of shares of Common Stock actually delivered. In
determining the aggregate offering price payable for such shares of Common Stock, there shall be taken into account any consideration received for such rights or warrants and the value of such consideration (if other than cash, to be reasonably
determined by the Board of Directors). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Debt or Asset Distributions</U>. If the Company distributes to all or substantially all
holders of shares of Common Stock evidences of indebtedness, shares of capital stock, securities, cash or other assets (excluding any dividend or distribution referred to in <U>Section</U><U></U><U>&nbsp;15(a)</U>, any rights or warrants referred to
in <U>Section</U><U></U><U>&nbsp;15(c)</U>, any dividend or distribution paid exclusively in cash, any consideration payable in connection with a tender or exchange offer made by the Company or any of its Subsidiaries, and any dividend of shares of
capital stock of any class or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
series, or similar equity interests, of or relating to a Subsidiary or other business unit in the case of certain <FONT STYLE="white-space:nowrap">spin-off</FONT> transactions as described
below), then the Exercise Price will be adjusted by multiplying the Exercise Price in effect at 5:00 p.m., New York City time on the Trading Day immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution by the
following fraction: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0&nbsp;</SUB>&#150;&#8201;FMV</P></TD>

<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB> = the Current Market Price per share of Common Stock on such date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">FMV = the fair market value of the portion of the distribution applicable to one share of Common Stock on such date as reasonably determined by
the Board of Directors; <U>provided</U> that, if &#147;FMV&#148; as set forth above is equal to or greater than &#147;SP0&#148; as set forth above, in lieu of the foregoing adjustment, adequate provision shall be made so that each holder of shares
of Common Stock shall receive on the date on which such distribution is made to holders of Common Stock, for each share of Common Stock issuable upon exercise of this Warrant, the amount of such distribution such Warrantholder would have received
had such Warrantholder owned a number of shares of Common Stock issuable (assuming payment of the Exercise Price in Shares) pursuant to this Warrant on the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In a <FONT STYLE="white-space:nowrap">&#147;spin-off,&#148;</FONT> where the Company makes a distribution to all holders of shares of Common Stock consisting
of capital stock of any class or series, or similar equity interests of, or relating to, a Subsidiary or other business unit, the Exercise Price with respect to such Warrantholder will be adjusted on the 15th Trading Day after the effective date of
the distribution by multiplying such Exercise Price in effect immediately prior to such 15th Trading Day by the following fraction: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">MP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">MP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#8201;+&nbsp;MP<SUB STYLE="font-size:75%; vertical-align:bottom">s</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">MP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB> = the average of the Market Prices of the Common Stock over the first 10 Trading
Days commencing on and including the fifth Trading Day following the effective date of such distribution. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">MP<SUB
STYLE="font-size:75%; vertical-align:bottom">s</SUB> = the average of the Market Prices of the capital stock or equity interests representing the portion of the distribution applicable to one share of Common Stock over the first 10 Trading Days
commencing on and including the fifth Trading Day following the effective date of such distribution, or, if not traded on a national or regional securities exchange or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, the fair market value of the capital stock or equity interests representing the portion of the distribution applicable to one share of Common
Stock on such date as reasonably determined by the Board of Directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any adjustment pursuant to this <U>Section</U><U></U><U>&nbsp;15(d)</U> shall become effective immediately
prior to 9:00 a.m., New York City time, on the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution. In the event that such distribution described in this <U>Section</U><U></U><U>&nbsp;15(d)</U> is not so paid or made, the Exercise
Price shall be readjusted, effective as of the date the Board of Directors publicly announces its decision not to pay or make such dividend or distribution, to the Exercise Price that would then be in effect if such dividend or distribution had not
been declared. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Cash Distributions</U>. If the Company makes a distribution consisting exclusively of cash to all holders of Common
Stock, excluding (i)&nbsp;any cash that is distributed in a Business Combination or as part of a <FONT STYLE="white-space:nowrap">&#147;spin-off&#148;</FONT> referred to in <U>Section</U><U></U><U>&nbsp;15(d)</U>, (ii) any dividend or distribution
in connection with the Company&#146;s liquidation, dissolution or <FONT STYLE="white-space:nowrap">winding-up,</FONT> and (iii)&nbsp;any consideration payable in connection with a tender or exchange offer made by the Company or any of its
Subsidiaries, then in each event, the Exercise Price in effect immediately prior to the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution will be multiplied by the following fraction: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0&nbsp;</SUB>&#150;&#8201;DIV</P></TD>

<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB> = the Market Price per share of Common Stock on the Trading Day immediately
preceding the <FONT STYLE="white-space:nowrap">Ex-Date.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">DIV = the amount per share of Common Stock of the cash distribution, as
determined pursuant to the introduction to this <U>Section&nbsp;15(e)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that any distribution described in this
<U>Section</U><U></U><U>&nbsp;15(e)</U> is not so made, the Exercise Price shall be readjusted, effective as of the date the Board of Directors publicly announces its decision not to pay such distribution, to the Exercise Price which would then be
in effect if such distribution had not been declared. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if &#147;DIV&#148; as set forth above is equal to or greater than
&#147;SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#148; as set forth above, in lieu of the foregoing adjustment, adequate provision shall be made so that each Warrantholder shall have the right to receive on the date on which the
relevant cash dividend or distribution is distributed to holders of Common Stock, for each share of Common Stock issuable upon exercise of this Warrant, the amount of cash such Warrantholder would have received had such Warrantholder owned a number
of shares of Common Stock issuable (assuming payment of the Exercise Price in Shares) pursuant to this Warrant on the <FONT STYLE="white-space:nowrap">Ex-Date</FONT> for such distribution. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Self-Tender Offers and Exchange Offers</U>. If the Company or any of its Subsidiaries
successfully completes a tender or exchange offer for the Common Stock where the cash and the value of any other consideration included in the payment per share of the Common Stock exceeds the Market Price per share of the Common Stock on the
Trading Day immediately succeeding the expiration of the tender or exchange offer, then the Exercise Price will be adjusted by multiplying the Exercise Price in effect at 5:00 p.m., New York City time prior to the commencement of the offer by the
following fraction: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&nbsp;x&nbsp;SP<SUB
STYLE="font-size:75%; vertical-align:bottom">0</SUB></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">AC&nbsp;+&nbsp;(SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&nbsp;x&nbsp;OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP>)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB> = the Market Price per share of Common Stock on the Trading Day immediately
succeeding the commencement of the tender or exchange offer. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB> = the number of
shares of Common Stock outstanding immediately prior to the expiration of the tender or exchange offer, including any shares validly tendered and not withdrawn. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">OS<SUP STYLE="font-size:75%; vertical-align:top">1</SUP> = the number of shares of Common Stock outstanding immediately after the expiration of
the tender or exchange offer (after giving effect to such tender offer or exchange offer). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">AC = the aggregate cash and fair market value
of the other consideration payable in the tender or exchange offer, as reasonably determined by the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any adjustment made pursuant to
this <U>Section</U><U></U><U>&nbsp;15(f)</U> shall become effective immediately prior to 9:00 a.m., New York City time, on the Trading Day immediately following the expiration of the tender or exchange offer. In the event that the Company or one of
its Subsidiaries is obligated to purchase shares of Common Stock pursuant to any such tender offer or exchange offer, but the Company or such Subsidiary is permanently prevented by applicable Law from effecting any such purchases, or all such
purchases are rescinded, then the Exercise Price shall be readjusted to be such Exercise Price that would then be in effect if such tender offer or exchange offer had not been made. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Rights Plans</U>. To the extent that the Company has a rights plan in effect with
respect to the Common Stock on any exercise date, upon issuance of any Common Stock, the Warrantholders will receive, in addition to the shares of Common Stock, the rights under the rights plan, unless, prior to such exercise date, the rights have
separated from the shares of Common Stock, in which case the Exercise Price will be adjusted at the time of separation as if the Company had made a distribution to all holders of Common Stock as described in <U>Section</U><U></U><U>&nbsp;15(d)</U>,
subject to readjustment in the event of the expiration, termination or redemption of such rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Rounding of Calculations;
Minimum Adjustments</U>. All calculations under this <U>Section</U><U></U><U>&nbsp;15</U> shall be made to the nearest <FONT STYLE="white-space:nowrap">one-hundredth</FONT> (1/100th)&nbsp;of a cent or to the nearest
<FONT STYLE="white-space:nowrap">one-hundredth</FONT> (1/100th)&nbsp;of a share, as the case may be. No adjustment in the Exercise Price or the number of Shares into which this Warrant is exercisable shall be made if the amount of such adjustment
would be less than $0.01 or <FONT STYLE="white-space:nowrap">one-hundredth</FONT> (1/100th)&nbsp;of a share of NVCE Stock, but any such amount shall be carried forward and an adjustment with respect thereto shall be made at the time of and together
with any subsequent adjustment which, together with such amount and any other amount or amounts so carried forward, shall aggregate $0.01 or <FONT STYLE="white-space:nowrap">one-hundredth</FONT> (1/100th) of a share of NVCE Stock or more. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Timing of Issuance of Additional NVCE Stock Upon Certain Adjustments</U>. In any case in which (i)&nbsp;the provisions of this
<U>Section</U><U></U><U>&nbsp;15</U> shall require that an adjustment shall become effective immediately after a record date (the &#147;<I>Subject Record Date</I>&#148;) for an event, and (ii)&nbsp;the Warrantholder exercises this Warrant after the
Subject Record Date and before the consummation of such event, the Company may defer until the consummation of such event, (A)&nbsp;issuing to the Warrantholder or Share Recipient (as applicable) the additional shares of NVCE Stock issuable upon
such exercise by reason of the adjustment required by such event and (B)&nbsp;paying to such Warrantholder or Share Recipient (as applicable) any amount of cash in lieu of a fractional share of NVCE Stock; provided, however, that the Company upon
request shall deliver to such Warrantholder or Share Recipient a due bill or other appropriate instrument evidencing such Warrantholder&#146;s or Share Recipient&#146;s right to receive such additional shares, and such cash, upon the occurrence of
the event requiring such adjustment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <U>Statement Regarding Adjustments</U>. Whenever the Exercise Price or the number of Shares into
which this Warrant is exercisable shall be adjusted as provided in <U>Section</U><U></U><U>&nbsp;15</U>, the Company shall cause a statement setting forth in reasonable detail such adjustment and the facts upon which it is based and certifying the
calculation thereof to be delivered the Warrantholder as promptly as practicable after the event giving rise to such adjustment at the address appearing in the Warrant registry. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <U>Notice of Adjustment Event</U>. In the event that the Company shall propose to take any action of the type described in this
<U>Section</U><U></U><U>&nbsp;15</U> (but only if the action of the type described in this <U>Section</U><U></U><U>&nbsp;15</U> would result in an adjustment in the Exercise Price or the number of Shares into which this Warrant is exercisable or a
change in the type of securities or property to be delivered upon exercise of this Warrant), the Company shall provide written notice to the Warrantholder, which notice shall specify the record date, if any, with respect to any such action and the
approximate date on which such action is to take place. Such notice shall also set forth the facts with respect thereto as shall be reasonably necessary (provided that in no event shall such notice contain any information that, at the time such
notice is delivered, the Company reasonably believes to be material, <FONT STYLE="white-space:nowrap">non-public</FONT> information) to indicate the effect on the Exercise Price and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the number, kind or class of shares or other securities or property which shall be deliverable upon exercise of this Warrant. In the case of any action that would require the fixing of a record
date, such notice shall be given at least 10 days prior to the date so fixed, and in case of all other action, such notice shall be given at least 15 days prior to the taking of such proposed action. Failure to give such notice, or any defect
therein, shall not affect the legality or validity of any such action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <U>Adjustment Rules</U>. Any adjustments pursuant to this
<U>Section</U><U></U><U>&nbsp;15</U> shall be made successively whenever an event referred to herein shall occur. If an adjustment in Exercise Price made hereunder would reduce the Exercise Price to an amount below par value of the NVCE Stock, then
such adjustment in Exercise Price made hereunder shall reduce the Exercise Price to the par value of the NVCE Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <U>Prohibited
Actions</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company agrees that it will not take any action which would entitle the Warrantholder to an adjustment of the
Exercise Price if the total number of shares of NVCE Stock issuable after such action upon exercise of this Warrant, together with all shares of NVCE Stock then outstanding and all shares of NVCE Stock then issuable upon the exercise of all
outstanding options, warrants, conversion and other rights, would exceed the total number of shares of NVCE Stock then authorized by the Company Certificate of Incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Notwithstanding anything herein to the contrary, no adjustment to the Exercise Price or the number of Shares shall be permitted to the
extent that such adjustment would cause the Warrantholder (together with its affiliates or any other party with which the Warrantholder may be aggregated for purposes of the BHC Act, Change in Bank Control Act or any successor or similar law) to own
or be deemed to control (A) 10% or more of any class of voting securities of the Company (unless such holder has obtained approval to own more than 10%, and in such case, the applicable limit shall be 24.9% or such lower number contained in any
approval) or <FONT STYLE="white-space:nowrap">(B)&nbsp;one-third</FONT> or more of the Company&#146;s &#147;total equity,&#148; in each case as interpreted and calculated in accordance the BHC Act, the Change in Bank Control Act, and their
implementing regulations, including 12 CFR 225.34. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Business Combinations</U>. In case of any Business Combination, the
Warrantholder&#146;s right to receive Shares upon exercise of this Warrant shall be converted, effective upon the occurrence of such Business Combination, into the right to acquire the number of shares of stock or other securities or property
(including cash) that a holder of the number of Shares immediately prior to such Business Combination would have been entitled to receive upon consummation of such Business Combination (without taking into account any limitations or restrictions on
the exercisability of this Warrant). In determining the kind and amount of stock, securities or the property (including cash) receivable upon the occurrence of such Business Combination, if the holders of Common Stock have the right to elect the
kind or amount of consideration receivable upon consummation of such Business Combination, then the Warrantholder shall have the right at the same time to make the same election with respect to the number of shares of stock or other securities or
property which the Warrantholder would have been entitled to receive upon exercise of this Warrant by providing a written notice of such election to the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>Transfer Taxes</U>. The Company shall bear and pay any and all transfer taxes, stamp
taxes or duties, documentary taxes, or other similar taxes in connection with, or arising by reason of, any issuance or delivery of this Warrant or any shares of NVCE Stock issuable upon exercise of this Warrant; <U>provided</U> that the Company
shall not be required to pay any such tax that may be payable in connection with any exercise of this Warrant to the extent such tax is payable because the registered holder of this Warrant requests NVCE Stock to be registered in a name other than
such registered holder&#146;s name and no such NVCE Stock will be so registered unless and until the registered holder making such request has paid such taxes to the Company or has established to the satisfaction of the Company that such taxes have
been paid or are not payable. The Company and the Warrantholder shall reasonably cooperate to avoid or minimize the imposition of transfer taxes, stamp taxes or duties, documentary taxes, or other similar taxes on the transactions described in the
first sentence of this <U>Section</U><U></U><U>&nbsp;17</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>Withholding</U>. Notwithstanding any other provision of this Warrant,
the Company and any applicable withholding agent shall be entitled to deduct and withhold from any amounts otherwise payable to the Warrantholder such amounts as are required to be deducted or withheld with respect to this Warrant under the Code or
any other applicable Tax Law. If the Warrantholder is deemed for U.S. federal income Tax purposes to have received a distribution with respect to this Warrant, the Company or any applicable withholding agent may satisfy any resulting applicable
withholding obligations (including backup withholding) required by applicable Law imposed in connection with such deemed distribution by withholding from any other payments due to, or amounts of, the Warrantholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>Miscellaneous</U>. The provisions of Article VI of the Investment Agreement are hereby incorporated by reference into this Warrant,
<I>mutatis mutandis</I>, as if they were restated in full, with each reference to &#147;this Agreement&#148; in such sections of the Investment Agreement being deemed a reference to this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the Company has caused this Warrant to be duly executed by a duly
authorized officer as of the Issue Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>NEW YORK COMMUNITY BANCORP, INC.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Address:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Attest:</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Warrant</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Acknowledged and Agreed:</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>[PURCHASER]</B></P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Warrant</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Form of Notice of Exercise] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Date: ______________ </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">TO:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">[__________] </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NEW YORK COMMUNITY BANCORP, INC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RE: Election to Subscribe for
and Purchase Series D <FONT STYLE="white-space:nowrap">Non-Voting</FONT> Common Equivalent Stock </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned, pursuant to the provisions set forth in
the attached Warrant, hereby exercises the Warrant for the number of shares of the Series D <FONT STYLE="white-space:nowrap">Non-Voting</FONT> Common Equivalent Stock (the &#147;<I>NVCE Stock</I>&#148;) set forth below and directs the Company to
issue such shares of NVCE Stock to the Share Recipient set forth below. The undersigned, in accordance with <U>Section</U><U></U><U>&nbsp;3(b)</U> of the Warrant, hereby agrees to pay the aggregate Exercise Price for such shares (as such price may
be adjusted in accordance with <U>Section</U><U></U><U>&nbsp;15</U> of the Warrant) of NVCE Stock pursuant to the net settlement provisions of <U>Section</U><U></U><U>&nbsp;3(b)</U> of the Warrant. A new warrant evidencing the remaining shares of
NVCE Stock covered by such Warrant, but not yet subscribed for and purchased, if any, should be issued in the name set forth below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a condition to the
exercise of the Warrant hereby, the undersigned certifies that is in compliance with (and at all times has been in compliance with) <U>Section</U><U></U><U>&nbsp;10(b)</U> of the Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of Shares of NVCE Stock Exercised: _______________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share Recipient(s): _______________ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of Shares of NVCE
Stock to be Delivered After Application of Net Settlement Provisions of <U>Section</U><U></U><U>&nbsp;3(b)</U>: _______________ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name and Address of
Person to be </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Issued New Warrant: ________________________________ </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holder:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Form of Notice of Exercise</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Form of Assignment to be Executed if Warrantholder </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Desires to Transfer Warrants Evidenced Hereby] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR VALUE RECEIVED __________________________________________________________ hereby sells, assigns and transfers unto </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000">(Please print name) identifying</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000">(Please insert social security or other number)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>(City, including zip code)</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the right to purchase ________ shares of Series D <FONT STYLE="white-space:nowrap">Non-Voting</FONT> Common Equivalent Stock
pursuant to the Warrant represented by the within Warrant Certificate and does hereby irrevocably constitute and appoint _______________ as attorney to transfer said Warrant Certificate with full power of substitution in the premises. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Signature</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">(Signature must conform in all respects to name of holder as specified on the face of the Warrant Certificate and must bear a signature guarantee by a bank, trust company or member broker of the New York, Midwest or Pacific Stock
Exchange)</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature Guaranteed</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Form of Assignment</I>] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>7
<FILENAME>d763888dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT 10.1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXECUTION VERSION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTMENT AGREEMENT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">by and
between </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">NEW YORK COMMUNITY BANCORP, INC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">LIBERTY STRATEGIC CAPITAL
(CEN) HOLDINGS, LLC </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of March&nbsp;7, 2024 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(and as amended as of March&nbsp;11, 2024) </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE&nbsp;I</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">PURCHASE; CLOSING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE&nbsp;II</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">REPRESENTATIONS AND WARRANTIES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Adverse Effect</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Representations and Warranties of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Representations and Warranties of Purchaser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE&nbsp;III</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">COVENANTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Filings; Other Actions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Information Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidentiality</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public Announcement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period Conduct</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Material Change</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE&nbsp;IV</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ADDITIONAL AGREEMENTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governance Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Materially Burdensome Condition</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reservation for Issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange Listing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Designations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State Securities Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Opportunities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Recourse</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transaction Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE&nbsp;V</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">TERMINATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE&nbsp;VI</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">MISCELLANEOUS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Extension; Waiver</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notices</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interpretation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Counterparts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entire Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governing Law; Jurisdiction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Waiver of Jury Trial</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assignment; Third-Party Beneficiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Specific Performance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidential Supervisory Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Delivery by Electronic Transmission</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>LIST OF EXHIBITS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;A:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Designations (Series B)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;B:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Designations (Series C)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit C:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Registration Rights Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit D:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CEO Terms</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit E:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Executive</FONT> Chairman Terms</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit F:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permanent Warrant Terms</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit G:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholder Vote Warrant Terms</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEX OF DEFINED TERMS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accredited Investors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">As-Converted</FONT> Basis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BHC Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Board <FONT STYLE="white-space:nowrap">Non-Objections</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Board of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Board Representative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">business day</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Designations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chosen Courts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Claim Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Code</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Bank</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Bylaws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Certificate of Incorporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Disclosure Schedule</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Equity Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Fundamental Rep</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Opportunity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company PSU Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Regulatory Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Reports</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Restricted Stock Award</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company RSU Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Share Issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Stock Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidential Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidentiality Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Data Breach</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">De Minimis Claim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Delaware Secretary of State</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Direct Claim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director Rights Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enforceability Exceptions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ERISA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ERISA Affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">extent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Federal Reserve</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fraud</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GAAP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Entity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSR Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnified Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnifying Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Information Rights Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Institutional Accredited Investor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment Amount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">knowledge</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legacy Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Liens</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Losses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">made available</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Adverse Effect</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Materially Burdensome Condition</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Multiemployer Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Multiple Employer Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Party</FONT> Affiliates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Voting</FONT> Common Equivalent Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NYSE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Order</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ordinary course</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ordinary course of business</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other Permanent Warrant</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pandemic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pandemic Measures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permanent Warrant</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">person</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Personal Data</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchaser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchaser Fundamental Rep</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Registration Rights Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Representatives</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Response Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Securities Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SRO</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Return</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Party Claim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Threshold Amount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">transactions contemplated by this Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">transactions contemplated hereby</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Voting Regulatory Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">v </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>INVESTMENT AGREEMENT,</B> dated as of March&nbsp;7, 2024 and as amended on March 11, 2024
(this &#147;<U>Agreement</U>&#148;), by and between New York Community Bancorp, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), and Liberty Strategic Capital (CEN) Holdings, LLC, a Delaware limited liability company
(&#147;<U>Purchaser</U>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. <U>The Investment</U>. The Company desires to sell and issue to Purchaser, and Purchaser desires to purchase from the Company, as an
investment in the Company, (i)&nbsp;shares of (a)&nbsp;common stock, par value $0.01 per share, of the Company (the &#147;<U>Common Stock</U>&#148;), (b)&nbsp;a series of preferred stock, par value $0.01 per share, of the Company designated as
Series B Noncumulative Convertible Preferred Stock (the &#147;<U>Series B Preferred Stock</U>&#148;), having the terms set forth in the Certificate of Designations of the Series B Preferred Stock, in the form attached hereto as
<U>Exhibit</U><U></U><U>&nbsp;A</U> (the &#147;<U>Certificate of Designations (Series B)</U>&#148;), and (c)&nbsp;a series of preferred stock, par value $0.01 per share, of the Company designated as Series C Noncumulative Convertible Preferred Stock
(the &#147;<U>Series C Preferred Stock</U>&#148; and together with the Series B Preferred Stock, the &#147;<U>Preferred Stock</U>&#148;), having the terms set forth in the Certificate of Designations of the Series C Preferred Stock, in the form
attached hereto as <U>Exhibit</U><U></U><U>&nbsp;B</U> (the &#147;<U>Certificate of Designations (Series&nbsp;C)</U>&#148; and together with the Certificate of Designations (Series B), the &#147;<U>Certificate of Designations</U>&#148;), and, in the
case of <U>clauses (b)</U>&nbsp;and <U>(c)</U>, which shall be made a part of the Company&#146;s Amended and Restated Certificate of Incorporation (as amended, restated, supplemented or otherwise modified from time to time, the &#147;<U>Company
Certificate of Incorporation</U>&#148;), by the filing of the Certificate of Designations with the Secretary of State of the State of Delaware (the &#147;<U>Delaware Secretary of State</U>&#148;) and (ii)&nbsp;warrants on the terms and conditions
set forth on <U>Exhibit F</U> (the &#147;<U>Permanent Warrant</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. <U>The Other Investment Agreements</U>. Substantially
concurrently with the execution and delivery hereof, the Company is entering into other contracts or agreements with certain other purchasers providing for the issuance of (i)&nbsp;shares of Common Stock and/or Preferred Stock and (ii)&nbsp;warrants
on the terms and conditions set forth therein (each, an &#147;<U>Other Permanent Warrant</U>&#148;), in each case and in the same ratio of Common Stock to Preferred Stock, with proceeds to the Company in an amount, together with the Investment
Amount, equal to not less than $1,050,000,000 and entered into in furtherance of the transactions contemplated hereby or thereby (each, an &#147;<U>Other Investment Agreement</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. <U>The Securities</U>. The term &#147;<U>Securities</U>&#148; refers collectively to the (a)&nbsp;(i) shares of Common Stock and Preferred
Stock and (ii)&nbsp;Permanent Warrant, in each case, issuable pursuant hereto, (b)&nbsp;shares of Common Stock to be issued upon the conversion of the Preferred Stock issuable pursuant hereto (such conversions, the &#147;<U>Conversions</U>&#148;),
(c) shares of <FONT STYLE="white-space:nowrap">non-voting,</FONT> common equivalent preferred stock to be issued upon exercise of the Permanent Warrant and (d)&nbsp;shares of Common Stock to be issued upon the conversion of the <FONT
STYLE="white-space:nowrap">non-voting,</FONT> common equivalent preferred stock to be issued upon the exercise of the Permanent Warrant. When purchased, the shares of Common Stock, Series B Preferred Stock and Series C Preferred Stock purchased
hereunder will be evidenced by book-entry notation. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">D. <U>Registration Rights Agreement</U>. At the Closing, the Company and Purchaser will
enter into a Registration Rights Agreement attached hereto as <U>Exhibit C</U> (the &#147;<U>Registration Rights Agreement</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">E.
<U>Governance</U>. Concurrently with the entry into this Agreement, the Company and Company Bank shall have (i)&nbsp;taken such actions as are reasonably necessary to provide for (A)&nbsp;Joseph M. Otting to replace Alessandro P. DiNello as
President and Chief Executive Officer of the Company and Company Bank effective April&nbsp;1, 2024, on the terms set forth in <U>Exhibit D</U>; and (B)&nbsp;Sandro DiNello to become <FONT STYLE="white-space:nowrap">Non-Executive</FONT> Chairman of
the Company and Company Bank effective April&nbsp;1, 2024, on the terms set forth in <U>Exhibit E</U>; and (ii)&nbsp;received any approval, consent, nonobjection, or waiver thereof, required of any Governmental Entity in connection with the
appointments and compensation arrangements set forth in <U>clause (i)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE,</B> in consideration of the premises, and
of the representations, warranties, covenants and agreements set forth herein, the parties agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;I </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>PURCHASE; CLOSING </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1 <U>Purchase</U>. On the terms and subject to the conditions set forth herein, at the Closing, Purchaser shall purchase from
the Company, and the Company shall sell and issue to Purchaser, the number of duly authorized, validly issued, fully-paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of (a)&nbsp;Common Stock, free and clear of all Liens (as
defined below) (other than transfer restrictions imposed under applicable securities Laws), set forth in <U>Section</U><U></U><U>&nbsp;1.2(c)(i)(1)(A)</U>, (b) Series B Preferred Stock, free and clear of all Liens (other than transfer restrictions
imposed under the Certificate of Designations (Series B) or applicable securities Laws), set forth in <U>Section</U><U></U><U>&nbsp;1.2(c)(i)(1)(B)</U> and (c)&nbsp;Series C Preferred Stock, free and clear of all Liens (other than transfer
restrictions imposed under the Certificate of Designations (Series C) or applicable securities Laws), set forth in <U>Section</U><U></U><U>&nbsp;1.2(c)(i)(1)(C)</U> (collectively, the &#147;<U>Company Share Issuance</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2 <U>Closing</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Time and Date of Closing</U>. Subject to the satisfaction or, to the extent permitted by Law, written waiver (by the party entitled to
grant such waiver) of the conditions set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)</U> (other than those conditions that by their nature are to be satisfied at the Closing, but subject to satisfaction or, to the extent permitted by Law, written
waiver of those conditions by the party entitled to grant such waiver), the closing of the Company Share Issuance (the &#147;<U>Closing</U>&#148;) shall take place (i)&nbsp;three (3) business days following the execution and delivery of this
Agreement, remotely by the electronic exchange of counterpart signature pages to the documents and agreements contemplated hereby to be executed and delivered at the Closing (the &#147;<U>Expected Closing Date</U>&#148;), or (ii)&nbsp;such other
date, time and/or location as may be mutually agreed in writing by the Company and Purchaser; <U>provided</U> that, if the conditions set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)</U> have not been so satisfied or, to the extent permitted by
Law, waived on or prior to the date that is three (3)&nbsp;business days following the execution and delivery of this Agreement, then the Closing shall take place on the first business day on which such conditions have been so satisfied or waived;
<U>provided</U>, <U>further</U>, <U>however</U>, that in no event shall the Closing take place later </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
than the fifth (5<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) business day after the Expected Closing Date. The date on which the Closing occurs is referred to as the &#147;<U>Closing
Date.</U>&#148; Unless otherwise agreed by the Company and Purchaser, in the event (A)&nbsp;the Closing does not occur within five (5)&nbsp;business days after the Expected Closing Date and (B)&nbsp;Purchaser delivered the Investment Amount to the
Company pursuant to <U>Section</U><U></U><U>&nbsp;1.2(c)(ii)(1)</U>, the Company shall, as promptly as reasonably practicable (but not later than one business day thereafter), return such Investment Amount to Purchaser by wire transfer of United
States dollars in immediately available funds to the account specified by Purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Closing Conditions</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The obligation of Purchaser, on the one hand, and the Company, on the other hand, to effect the Closing is subject to the
satisfaction or, to the extent permitted by Law, written waiver by Purchaser and the Company prior to the Closing of the following conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) no injunction, order, judgment, writ, directive, enforcement action, decree, or regulatory restriction of any Governmental
Entity (each, an &#147;<U>Order</U>&#148;) or other legal restraint or prohibition preventing the consummation of the Company Share Issuance. No applicable Law shall have been enacted, entered, promulgated or enforced (which remains in effect) by
any Governmental Entity that prohibits or makes illegal consummation of the Company Share Issuance or any of the other transactions contemplated by this Agreement or that prohibits, restrains or enjoins Purchaser or its affiliates from owning any
Securities or voting any voting Securities in accordance with the terms thereof; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) the Company shall have filed the
requisite Supplemental Listing Application in respect of the Common Stock (A)&nbsp;issued hereunder and (B)&nbsp;to be issued upon the conversion of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock, in each case,
in accordance with rules of the New York Stock Exchange (the &#147;<U>NYSE</U>&#148;), and no further action shall be required to authorize such additional shares for listing, subject to official notice of issuance; provided if such Supplemental
Listing Application is not approved as a result of the number of authorized shares of Common Stock being insufficient, then (I)&nbsp;the Company shall immediately <FONT STYLE="white-space:nowrap">re-file</FONT> covering just the authorized amount
and (II)&nbsp;promptly following the approval and adoption of the Charter Amendment in accordance with <U>Section</U><U></U><U>&nbsp;3.1(c)</U>, the Company shall file a Supplemental Listing Application in respect of the Common Stock not covered by
the initial approval; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) the purchase and sale of shares of Common Stock, Series B Preferred Stock and/or Series C
Preferred Stock (with proceeds to the Company in an amount, which together with the Investment Amount, is greater than or equal to $600,000,000) shall have been consummated, or will be consummated substantially concurrently with the Closing, in all
material respects in accordance with the terms and conditions of such Other Investment Agreement(s); and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(4) each of the Certificate of Designations shall have been filed with and
accepted by the Delaware Secretary of State and be in full force and effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The obligation of Purchaser to effect
the Closing is also subject to the satisfaction or, to the extent permitted by Law, written waiver by Purchaser prior to the Closing of each of the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) the representations and warranties of the Company contained in (A)<U>&nbsp;Section</U><U></U><U>&nbsp;2.2(b)(i)</U>,
<U>Section</U><U></U><U>&nbsp;2.2(c)(iii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(g)</U>, <U>Section</U><U></U><U>&nbsp;2.2(h)</U>,<U> Section</U><U></U><U>&nbsp;2.2(r)</U> and <U>Section</U><U></U><U>&nbsp;2.2(v)</U> shall be true and correct (other
than, in the case of <U>Section</U><U></U><U>&nbsp;2.2(b)(i)</U>, such failures to be true and correct as are de minimis) in all respects as of the date hereof and as of the Closing as though made at and as of the Closing (except to the extent such
representations and warranties are expressly made as of another date, in which case as of such date); (B) <U>Section</U><U></U><U>&nbsp;2.2(a)(i)</U>-<U>(iii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(b)(ii)</U> and
<U>Section</U><U></U><U>&nbsp;2.2(c)(i)</U> (in each case, read without giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations and warranties) shall be true and correct in all material
respects as of the date hereof and as of the Closing as though made at and as of the Closing (except to the extent such representations and warranties are expressly made as of another date, in which case as of such date); and (C)&nbsp;all other
representations and warranties of the Company set forth in <U>Section</U><U></U><U>&nbsp;2.2</U> (in each case, read without giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations or
warranties) shall be true and correct in all respects as of the date hereof and as of the Closing as though made at and as of the Closing (except to the extent such representations and warranties are expressly made as of another date, in which case
as of such date); provided that, for purposes of this subclause (C), such representations and warranties shall be deemed to be true and correct unless the failure(s) of such representations and warranties to be so true and correct, either
individually or in the aggregate, and without giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations or warranties, has had or would reasonably be expected to have a Material Adverse Effect;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) the Company shall have performed and complied with, in all material respects, all obligations, covenants and
agreements required to be performed or complied with by it at or prior to the Closing hereunder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) since the date
hereof, no Material Adverse Effect shall have occurred and no circumstance, event, change, occurrence, development or effect shall have occurred that, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect;
and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(4) Purchaser shall have received a certificate, dated as of the Closing Date, signed on behalf of the Company by the
Chief Executive Officer or Chief Financial Officer of the Company certifying to the effect that the conditions set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)(ii)(1)</U>, <U>Section</U><U></U><U>&nbsp;1.2(b)(ii)(2)</U> and
<U>Section</U><U></U><U>&nbsp;1.2(b)(ii)(3)</U> have been satisfied. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The obligation of the Company to effect the Closing is subject to the
satisfaction or, to the extent permitted by Law, written waiver by the Company prior to the Closing of the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) the representations and warranties of Purchaser contained herein (without giving effect to any &#147;material&#148; or
&#147;materiality&#148; qualifications contained in such representations and warranties) shall be true and correct as of the date hereof and as of the Closing as though made at and as of the Closing (except to the extent such representations and
warranties are expressly made as of another date, in which case as of such date), except to the extent the failure(s) of such representations or warranties to be true and correct, either individually or in the aggregate, and without giving effect to
any &#147;material&#148; or &#147;materiality&#148; qualifications contained in such representations and warranties, would not prevent or materially impair or delay the ability of Purchaser to consummate the Closing; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) Purchaser shall have performed and complied with, in all material respects, all covenants and agreements required to be
performed or complied with by it at or prior to the Closing hereunder; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) the Company shall have received a
certificate, dated as of the Closing Date, signed on behalf of Purchaser by an authorized signatory of Purchaser certifying to the effect that the conditions set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)(iii)(1)</U> and
<U>Section</U><U></U><U>&nbsp;1.2(b)(iii)(2)</U> have been satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Closing Deliveries</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) At the Closing, the Company will deliver to Purchaser: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) confirmation of book-entry notation in the name of Purchaser shares of Common Stock and Preferred Stock, free and clear of
all Liens (other than transfer restrictions imposed under the Certificate of Designations (as applicable) or applicable securities Laws) as follows: a number of shares of (A)&nbsp;Common Stock equal to 34,940,000, (B) Series B Preferred Stock equal
to 143,355, and (C)&nbsp;Series C Preferred Stock equal to 46,705. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) a counterpart signature page, to the Permanent
Warrant on the terms and condition set forth on <U>Exhibit F</U>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) a counterpart signature page, duly executed by the
Company, to the Registration Rights Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(4) a legal opinion in customary form from counsel to the Company covering
due authorization and issuance; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(5) evidence that delivery of the investment amounts payable to the Company pursuant
to the Other Investment Agreements by the other purchasers party thereto shall occur substantially concurrently with the Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) At the Closing, Purchaser will deliver to the Company: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) by wire transfer of immediately available funds to an account designated by the Company in writing, an aggregate purchase
price of $450,000,000 (the &#147;<U>Investment Amount</U>&#148;); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) a properly completed and executed Internal Revenue
Service (&#147;<U>IRS</U>&#148;) Form <FONT STYLE="white-space:nowrap">W-9</FONT> for Purchaser; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) a counterpart
signature page, duly executed by Purchaser, to the Registration Rights Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;II </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REPRESENTATIONS AND WARRANTIES </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1 <U>Material Adverse Effect</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) As used herein, the term &#147;<U>Material Adverse Effect</U>&#148; means any effect, change, event, circumstance, condition, occurrence
or development that, either individually or in the aggregate, has had or would reasonably be expected to have a material adverse effect on the business, properties, assets, liabilities, results of operations or financial condition of the Company and
its Subsidiaries taken as a whole (provided, that Material Adverse Effect shall not be deemed to include the impact or effects of any (A)&nbsp;changes, after the date hereof, in U.S. generally accepted accounting principles (&#147;<U>GAAP</U>&#148;)
or applicable regulatory accounting requirements, (B)&nbsp;changes, after the date hereof, in Laws (including any Pandemic Measures) of general applicability to companies in the industries in which the Company and its Subsidiaries operate, or
interpretations thereof by courts or other Governmental Entities, (C)&nbsp;changes, after the date hereof, in global, national or regional political conditions (including the outbreak of war or acts of terrorism) or in economic or market (including
equity, credit and debt markets, as well as changes in interest rates) conditions affecting the financial services industry generally and not specifically relating to the Company or its Subsidiaries (including any such changes arising out of the
Pandemic or any Pandemic Measures), (D)&nbsp;changes, after the date hereof, resulting from hurricanes, earthquakes, tornados, floods or other natural disasters or from any outbreak of any disease or other public health event (including the
Pandemic), (E)&nbsp;public disclosure of the execution of this Agreement or any Other Investment Agreement, public disclosure or consummation of the transactions contemplated hereby or thereby (including any effect on a party&#146;s relationships
with its customers) (it being understood and agreed that the foregoing shall not apply for purposes of the representations and warranties in <U>Section</U><U></U><U>&nbsp;2.2(c)(ii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(d)</U> or
<U>Section</U><U></U><U>&nbsp;2.2(k)(vi)</U>) or actions expressly required by this Agreement or that are taken with the prior written consent of Purchaser in contemplation of the transactions contemplated by this Agreement or any Other Investment
Agreement, (F)&nbsp;decline in the trading price of the Company&#146;s securities or the failure, in and of itself, to meet earnings projections or internal financial forecasts (it being understood that the underlying causes of such decline or
failure may be taken into account in determining whether a Material Adverse Effect has occurred or is reasonably expected to occur, except to the extent otherwise excluded by this proviso), (G) any stockholder litigation arising out of, related to,
or in connection with this Agreement or any Other Investment Agreement or the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Investment that is brought or threatened against the Company or the Board of Directors from and following the date of this Agreement and prior to the Closing (&#147;<U>Stockholder
Litigation</U>&#148;) (it being understood and agreed that the foregoing shall not apply for purposes of the representations and warranties in <U>Section</U><U></U><U>&nbsp;2.2(c)(ii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(d)</U> or
<U>Section</U><U></U><U>&nbsp;2.2(k)(vi)</U>), or (H)&nbsp;expenses incurred by the Company in negotiating, documenting, effecting and consummating the transactions contemplated by this Agreement or any Other Investment Agreement; except, with
respect to the foregoing subclauses&nbsp;(A), (B), (C) or (D), to the extent that the effects of such change are disproportionately adverse to the business, properties, assets, liabilities, results of operations or financial condition of the Company
and its Subsidiaries, taken as a whole, as compared to other companies in the industry in which the Company and its Subsidiaries operate). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) As used herein: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) &#147;<U>Pandemic</U>&#148; means any outbreaks, epidemics or pandemics, or any variants, evolutions or mutations thereof,
and the governmental and other responses thereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) &#147;<U>Pandemic Measures</U>&#148; means any quarantine,
&#147;shelter in place,&#148; &#147;stay at home,&#148; workforce reduction, social distancing, shutdown, closure, sequester or other Laws or policies or recommendations promulgated by any Governmental Entity, including the Centers for Disease
Control and Prevention and the World Health Organization, in each case, in connection with or in response to any Pandemic; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) &#147;<U>Subsidiary</U>&#148; when used with respect to any person, means any subsidiary of such person within the
meaning ascribed to such term in either <FONT STYLE="white-space:nowrap">Rule&nbsp;1-02</FONT> of <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-X</FONT> promulgated by the Securities and Exchange Commission (the &#147;<U>SEC</U>&#148;) or the
BHC Act; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) &#147;<U>Governmental Entity</U>&#148; means any court, administrative agency or commission or other
governmental authority or instrumentality or SRO of competent jurisdiction; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) &#147;<U>Law</U>&#148; means any law,
statute, code, ordinance, rule, regulation, requirement, policy or guideline of any Governmental Entity or stock exchange or Order. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2 <U>Representations and Warranties of the Company</U>. Except as disclosed in (i)&nbsp;the disclosure schedule delivered by
the Company to Purchaser concurrently herewith (the &#147;<U>Company Disclosure Schedule</U>&#148;); <U>provided</U> that (A)&nbsp;no such item is required to be set forth as an exception to a representation or warranty if its absence would not
result in the related representation or warranty being deemed untrue or incorrect, (B)&nbsp;the mere inclusion of an item in the Company Disclosure Schedule as an exception to a representation or warranty shall not be deemed an admission by the
Company that such item represents a material exception or fact, effect, change, event, circumstance, condition, occurrence or development or that such item would or would reasonably be expected to result in a Material Adverse Effect, and
(C)&nbsp;any disclosures made with respect to a section of this <U>Section</U><U></U><U>&nbsp;2.2</U> shall be deemed to qualify any other section of this <U>Section</U><U></U><U>&nbsp;2.2</U> (1)&nbsp;specifically referenced or cross-referenced or
(2)&nbsp;if it is reasonably apparent on its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
face (notwithstanding the absence of a specific cross-reference) from a reading of the disclosure that such disclosure applies to such other section or (ii)&nbsp;any Company Reports publicly
filed or furnished by the Company after January&nbsp;1, 2023 (but disregarding risk factor disclosures contained under the heading &#147;Risk Factors,&#148; or disclosures of risks set forth in any &#147;forward-looking statements&#148; disclaimer
or any other statements that are similarly nonspecific or cautionary, predictive or forward-looking in nature), the Company hereby represents and warrants to Purchaser as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Corporate Organization</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware
and is a bank holding company duly registered under the Bank Holding Company Act of 1956 (&#147;<U>BHC Act</U>&#148;). The Company has the corporate power and authority to own or lease all of its properties and assets and to carry on its business as
it is now being conducted. The Company is duly licensed or qualified to do business and in good standing in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or
leased by it makes such licensing, qualification or standing necessary, except where the failure to be so licensed or qualified or to be in good standing would not, either individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect. True, correct and complete copies of the Company Certificate of Incorporation and the Company Bylaws (as defined below) as in effect as of the entry into this Agreement have been made available to Purchaser. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Except as would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect,
each Subsidiary of the Company (a &#147;<U>Company Subsidiary</U>&#148;) (A)&nbsp;is duly organized and validly existing under the laws of its jurisdiction of organization, (B)&nbsp;is duly licensed or qualified to do business and, where such
concept is recognized under Law, in good standing in all jurisdictions where its ownership or leasing of property or the conduct of its business requires it to be so licensed or qualified or in good standing, and (C)&nbsp;has all requisite corporate
power and authority to own or lease its properties and assets and to carry on its business as now conducted. There are no restrictions on the ability of any Company Subsidiary to pay dividends or distributions except, in the case of a Company
Subsidiary that is a regulated entity, for restrictions on dividends or distributions generally applicable to all similarly regulated entities. Other than Flagstar Bank, National Association, a national banking association and a wholly-owned
Subsidiary of the Company (&#147;<U>Company Bank</U>&#148;), and those Subsidiaries set forth in <U>Section</U><U></U><U>&nbsp;2.2(a)(ii)</U> of the Company Disclosure Schedule, there are no Company Subsidiaries that would constitute
&#147;significant subsidiaries&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> of the SEC as of the entry into this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The deposit accounts of Company Bank are insured by the FDIC through the Deposit Insurance Fund (as defined in
Section&nbsp;3(y) of the Federal Deposit Insurance Act of 1950) to the fullest extent permitted by Law, all premiums and assessments required to be paid in connection therewith have been paid when due, and no proceedings for the termination of such
insurance are pending or threatened. Company Bank is a member in good standing of the Federal Home Loan Bank of New York and owns the requisite amount of stock therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Capitalization</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The authorized capital stock of the Company consists of 900,000,000 shares of Common Stock and 5,000,000 shares of
preferred stock, par value of $0.01 (the &#147;<U>Company Preferred Stock</U>&#148;). As of March&nbsp;1, 2024, there were 744,099,232 shares of Common Stock issued and outstanding, including 5,828,669 shares of Common Stock granted in respect of
outstanding Common Stock subject to vesting, repurchase or other lapse restriction (each, a &#147;<U>Company Restricted Stock Award</U>&#148;), and (in addition to the foregoing) (A)&nbsp;22,809,071 shares of Common Stock held in treasury, (B)
1,712,824 shares of Common Stock (assuming performance goals are satisfied at the maximum level) reserved for issuance upon the settlement of outstanding performance-based restricted stock unit awards in respect of shares of Common Stock granted
under the Company Stock Plans (&#147;<U>Company PSU Awards</U>&#148;), (C) 7,201,022 shares of Common Stock reserved for issuance upon the settlement of outstanding restricted stock unit awards in respect of shares of Common Stock granted under the
Company Stock Plans (&#147;<U>Company RSU Awards</U>&#148; and, together with the Company Restricted Stock Awards and Company PSU Awards, the &#147;<U>Company Equity Awards</U>&#148;), (D) 16,170,583 shares of Common Stock reserved for issuance
pursuant to future grants under the Company Stock Plans and (E)&nbsp;515,000&nbsp;shares of the Company Preferred Stock issued and outstanding. As of March&nbsp;1, 2024, there were 10,244,408 shares of Common Stock reserved for issuance upon the
exercise of the warrants under the Bifurcated Option Note Unit Securities of New York Community Capital Trust V and 20,600,000 Depositary Shares (each representing a 1/40th interest in a share of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Series A Noncumulative Perpetual Preferred Stock of the Company) outstanding. As of the entry into this Agreement, except as set forth in the immediately preceding sentences, as
contemplated hereby, as contemplated by any Other Investment Agreement and for changes since March&nbsp;1, 2024 resulting from the exercise, vesting or settlement of any Company Equity Awards described in the immediately preceding sentence, there
are no other shares of capital stock or other equity or voting securities of the Company issued, reserved for issuance or outstanding. All of the issued and outstanding shares of Common Stock have been duly authorized and validly issued and are
fully paid, nonassessable and free of preemptive rights, with no personal liability attaching to the ownership thereof. There are no bonds, debentures, notes or other indebtedness that have the right to vote on any matters on which stockholders of
the Company may vote. As of the entry into this Agreement, other than (1)&nbsp;the Company Equity Awards issued prior to the entry into this Agreement as described in this <U>Section</U><U></U><U>&nbsp;2.2(b)(i)</U> or (2)&nbsp;as set forth in this
Agreement or any Other Investment Agreement, there are no (x)&nbsp;outstanding subscriptions, options, warrants, stock appreciation rights, phantom units, scrip, rights to subscribe to, preemptive rights, anti-dilutive rights, rights of first
refusal or similar rights, puts, calls, commitments or agreements of any character relating to, or securities or rights convertible or exchangeable into or exercisable for, or valued by reference to, shares of capital stock or other equity or voting
securities of or ownership interest in the Company, or (y)&nbsp;contracts, commitments, understandings or arrangements by which the Company may become bound to issue additional shares of its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
capital stock or other equity or voting securities of or ownership interests in the Company, or that otherwise obligate the Company to issue, transfer, sell, purchase, redeem or otherwise
acquire, any of the foregoing. Other than this Agreement and any Other Investment Agreement, there are no voting trusts, shareholder agreements, proxies or other similar agreements in effect to which the Company or any of its Subsidiaries is a party
or is bound with respect to the voting or transfer of Common Stock or other equity interests of the Company. As used herein, &#147;<U>Company Stock Plans</U>&#148; means the New York Community Bancorp, Inc. 2020 Omnibus Incentive Plan, the Flagstar
Bancorp, Inc. 2016 Stock Award and Incentive Plan and the New York Community Bancorp, Inc. 2012 Stock Incentive Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Company owns, directly or indirectly, all of the issued and outstanding shares of capital stock or other equity
ownership interests of each Company Subsidiary, free and clear of any liens, claims, title defects, mortgages, pledges, charges, encumbrances and security interests whatsoever (&#147;<U>Liens</U>&#148;), and all of such shares or equity ownership
interests are duly authorized and validly issued and are fully paid, nonassessable (except, with respect to bank Subsidiaries, as provided under 12 U.S.C. &#167;&nbsp;55 or any comparable provision of applicable state Law) and free of preemptive
rights, with no personal liability attaching to the ownership thereof. No Company Subsidiary has or is bound by any outstanding subscriptions, options, warrants, calls, rights, commitments or agreements of any character calling for the purchase or
issuance of any shares of capital stock or any other equity security of such Subsidiary or any securities representing the right to purchase or otherwise receive any shares of capital stock or any other equity security of such Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Authority; No Violation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company has full corporate power and authority to execute and deliver this Agreement, to perform its obligations
hereunder and to consummate the Closing. The execution and delivery of this Agreement, the performance by the Company of its obligations hereunder and the consummation of the Closing (including the Investment) have been declared advisable and duly
and validly approved by the board of directors of the Company (the &#147;<U>Board of Directors</U>&#148;). As of or prior to the entry into this Agreement, the Board of Directors has determined that (A)&nbsp;the Company Share Issuance and the
Conversions (collectively, the &#147;<U>Investment</U>&#148;), on the terms and subject to the conditions set forth herein, is in the best interests of the Company and its stockholders and (B)&nbsp;the issuance of the shares of Common Stock and/or
Preferred Stock, in each case, pursuant to the Other Investment Agreements and the other transactions contemplated thereby, on the terms and subject to the conditions set forth therein, in each case, are in the best interests of the Company and its
stockholders and has adopted a resolution to the foregoing effect. No corporate proceedings on the part of the Company or any of its Subsidiaries are necessary to approve this Agreement or for the Company to perform its obligations hereunder or
consummate the Closing. This Agreement has been duly and validly executed and delivered by the Company and (assuming due authorization, execution and delivery by Purchaser) constitutes a valid and binding obligation of the Company, enforceable
against the Company in accordance with its terms (except in all cases as such enforceability may be limited by bankruptcy, insolvency, fraudulent transfer, moratorium, reorganization or similar Laws of general applicability relating to or affecting
the rights of creditors generally and the availability of equitable remedies (the &#147;<U>Enforceability Exceptions</U>&#148;)). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) None of the execution and delivery of this Agreement by the Company,
the performance by the Company of its obligations hereunder, the consummation by the Company of the Investment, or compliance by the Company with any of the terms or provisions hereof, will (A)&nbsp;violate any provision of the Company Certificate
of Incorporation or the Amended and Restated Bylaws of the Company (as amended, restated, supplemented or otherwise modified from time to time, the &#147;<U>Company Bylaws</U>&#148;) or (B)&nbsp;assuming that the consents and approvals referred to
in <U>Section</U><U></U><U>&nbsp;2.2(d)</U> are duly obtained, (x)&nbsp;violate any Law applicable to the Company, any of its Subsidiaries or any of their respective properties or assets or (y)&nbsp;violate, conflict with, result in a breach of any
provision of or the loss of any benefit under, constitute a default (or an event which, with notice or lapse of time, or both, would constitute a default) under, result in the termination of or a right of termination or cancellation under,
accelerate the performance required by, or result in the creation of any Lien upon any of the respective properties or assets of the Company or any of its Subsidiaries under, any of the terms, conditions or provisions of any note, bond, mortgage,
indenture, deed of trust, license, lease, agreement or other instrument or obligation to which the Company or any of its Subsidiaries is a party, or by which they or any of their respective properties or assets may be bound, except (in the case of
<U>clauses</U><U></U><U>&nbsp;(B)(x)</U> and <U>(B)(y)</U> above) for such violations, conflicts, breaches, defaults, terminations, cancellations, accelerations or creations which would not, either individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The shares of Common Stock to be issued (x)&nbsp;hereunder have been
and (y)&nbsp;subject to the Requisite Stockholder Vote and the filing of the Charter Amendment with the Delaware Secretary of State, upon the conversion of Preferred Stock pursuant to the Certificate of Designations will be, in each case, validly
authorized and, when issued, will be validly issued, fully paid and nonassessable and free and clear of all Liens, and no current or past stockholder of the Company will have any preemptive right or similar rights in respect thereof. The shares of
Preferred Stock to be issued hereunder have been validly authorized and, when issued, will be validly issued, fully paid and nonassessable and free and clear of all Liens, and no current or past stockholder of the Company will have any preemptive
right or similar rights in respect of any such issuance or exercise. Neither the Common Stock nor the Preferred Stock will be issued in violation of any applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <U>Consents and Approvals</U>. Except for (i)&nbsp;the approvals set forth on <U>Section</U><U></U><U>&nbsp;2.2(d)</U> of the Company
Disclosure Schedule, (ii)&nbsp;the Board <FONT STYLE="white-space:nowrap">Non-Objections,</FONT> (iii)&nbsp;the filing of the requisite Supplemental Listing Application and any other required applications, filings and notices, as applicable, with
the NYSE, and the approval of the listing of the shares of Common Stock (A)&nbsp;issued hereunder and (B)&nbsp;to be issued upon the Conversions, (iv)&nbsp;the filing of any registration statement with the SEC in accordance with the terms and
subject to the conditions of the Registration Rights Agreement, (v)&nbsp;filings required under, and compliance with other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable requirements of, the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Hart-Scott-Rodino</FONT></FONT> Antitrust Improvements Act of 1976 and the rules and regulations
promulgated thereunder (the &#147;<U>HSR</U><U></U><U>&nbsp;Act</U>&#148;) with respect to the Conversions, (vi)&nbsp;the Requisite Stockholder Vote, (vii)&nbsp;the filing of the Certificate of Designations and the Charter Amendment with the
Delaware Secretary of State and (viii)&nbsp;such filings and approvals as are required to be made or obtained under the securities or &#147;Blue Sky&#148; laws of various states in connection with the Investment, no consents or approvals of or
filings or registrations with any Governmental Entity are necessary in connection with (A)&nbsp;the execution and delivery by the Company of this Agreement or (B)&nbsp;the Investment and the other transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) <U>Reports</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) As of the entry into this Agreement, the Company and each of its Subsidiaries have timely filed (or furnished) all
reports, registrations and statements, together with any amendments required to be made with respect thereto, that they were required to file (or furnish, as applicable) since January&nbsp;1, 2023 with the following Governmental Entities:
(A)&nbsp;any state regulatory authority, (B)&nbsp;the SEC, (C)&nbsp;the Board of Governors of the Federal Reserve System or Federal Reserve Bank of New York (together, the &#147;<U>Federal Reserve</U>&#148;), (D)&nbsp;the Office of the Comptroller
of the Currency, (E)&nbsp;any foreign regulatory authority and (F)&nbsp;any self-regulatory organization (an &#147;<U>SRO</U>&#148;), including any report, form, correspondence, registration or statement required to be filed (or furnished, as
applicable) pursuant to the laws, rules or regulations of the U.S., any state, any foreign entity, or any Governmental Entity, and have paid all fees and assessments due and payable in connection therewith, except where the failure to file (or
furnish, as applicable) such report, registration or statement or to pay such fees and assessments would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Subject to
<U>Section</U><U></U><U>&nbsp;6.13</U>, except for normal examinations conducted by a Governmental Entity in the ordinary course of business of the Company and its Subsidiaries, (x)&nbsp;no Governmental Entity has initiated or has pending any
proceeding or, to the Company&#146;s knowledge, investigation into the business or operations of the Company or any of its Subsidiaries since January&nbsp;1, 2023, which remains unresolved, (y)&nbsp;there is no unresolved violation, criticism, or
exception by any Governmental Entity with respect to any report or statement relating to any examinations or inspections of the Company or any of its Subsidiaries, and (z)&nbsp;there has been no formal or informal inquiries by, or disagreements or
disputes with, any Governmental Entity with respect to the business, operations, policies or procedures of the Company or any of its Subsidiaries since January&nbsp;1, 2023; in each case, which would reasonably be expected to have, either
individually or in the aggregate, a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) An accurate copy of each final registration statement,
prospectus, report, schedule and definitive proxy statement filed with or furnished by the Company to the SEC since January&nbsp;1, 2023 pursuant to the Securities Act of 1933 (the &#147;<U>Securities Act</U>&#148;), or the Exchange Act (the
&#147;<U>Company Reports</U>&#148;) is publicly available. No such Company Report, as of the date thereof (and, in the case of registration statements and proxy statements, on the dates of effectiveness and the dates of the relevant meetings,
respectively), contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary in order to make the statements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
therein, in light of the circumstances in which they were made, not misleading, except that information filed or furnished as of a later date (but before the entry into this Agreement) shall be
deemed to modify information as of an earlier date. As of their respective dates, all Company Reports filed under the Securities Act and the Exchange Act complied in all material respects with the published rules and regulations of the SEC with
respect thereto. As of the entry into this Agreement, (A)&nbsp;no executive officer of the Company has failed in any respect to make the certifications required of him or her under Section&nbsp;302 or 906 of the Sarbanes-Oxley Act and (B)&nbsp;there
are no outstanding comments from or unresolved issues raised by the SEC with respect to any of the Company Reports. There are no deposits of the Company Bank that are required by Law or contract to be withdrawn or that the Company Bank can no longer
hold given the Company Bank&#146;s deposit rating as of the date hereof, other than any waivers granted by a government-sponsored enterprise as of the date hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) To the knowledge of the Company, as of the date hereof, the Company is not aware of any facts that cause the Company to
reasonably believe that the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023 (A) will not be filed with the SEC on or before March&nbsp;15, 2024, (B) will, except as has
already been disclosed in the Company Reports, contain any additional material weaknesses in the design or operation of internal control over financial reporting (as defined in Rule <FONT STYLE="white-space:nowrap">13a-15(f)</FONT> of the Exchange
Act) and (C)&nbsp;will contain any material changes to the financial statements as compared to the consolidated statements of condition and consolidated statements of (loss) income of the Company included in its Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> filed on February&nbsp;29, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) <U>Financial Statements</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The financial statements of the Company and its Subsidiaries included (or incorporated by reference) in the Company
Reports (including the related notes, where applicable) (A)&nbsp;have been prepared from, and are in accordance with, the books and records of the Company and its Subsidiaries, (B)&nbsp;fairly present in all material respects the consolidated
results of operations, cash flows, changes in stockholders&#146; equity and consolidated financial position of the Company and its Subsidiaries for the respective fiscal periods or as of the respective dates therein set forth (subject in the case of
unaudited statements to <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments normal in nature and amount), (C)&nbsp;complied, as of their respective dates of filing with the SEC, in all material respects with applicable accounting
requirements and with the published rules and regulations of the SEC with respect thereto, (D)&nbsp;have been prepared in accordance with GAAP consistently applied during the periods involved, except, in each case, as indicated in such statements or
in the notes thereto and (E)&nbsp;to the knowledge of the Company, are not expected to be revised, resubmitted or restated in any way. The books and records of the Company and its Subsidiaries have been, since January&nbsp;1, 2023, and are being,
maintained in all material respects in accordance with GAAP and any other applicable legal and accounting requirements. Since January&nbsp;1, 2023 and prior to the entry into this Agreement, no independent public accounting firm of the Company has
resigned (or informed the Company that it intends to resign) or been dismissed as independent public accountants of the Company as a result of, or in connection with, any disagreements with the Company on a matter of accounting principles or
practices, financial statement disclosure or auditing scope or procedure. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Except as would not, either individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect, neither the Company nor any of its Subsidiaries has any liability required by GAAP to be reflected on a consolidated balance sheet of the Company (whether absolute, accrued, contingent or
otherwise and whether due or to become due), except for (A)&nbsp;those liabilities that are reflected or reserved against on the consolidated balance sheet of the Company included in its Quarterly Report on
<FONT STYLE="white-space:nowrap">Form&nbsp;10-Q</FONT> for the fiscal quarter ended September&nbsp;30, 2023 (including any notes thereto), (B) liabilities incurred in the ordinary course of business consistent with past practice since
September&nbsp;30, 2023, (C) fees and expenses payable to any financial advisor, counsel or other professional in connection with this Agreement or each Other Investment Agreement and the transactions contemplated hereby or thereby and
(D)&nbsp;obligations under this Agreement or any Other Investment Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The records, systems, controls, data
and information of the Company and its Subsidiaries are recorded, stored, maintained and operated under means (including any electronic, mechanical or photographic process, whether computerized or not) that are under the exclusive ownership and
direct control of the Company or its Subsidiaries or accountants (including all means of access thereto and therefrom), except for any <FONT STYLE="white-space:nowrap">non-exclusive</FONT> ownership and
<FONT STYLE="white-space:nowrap">non-direct</FONT> control that would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company&nbsp;has (x)&nbsp;implemented and maintains disclosure controls
and procedures (as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15(e)</FONT> of the Exchange Act) to ensure that material information relating to the Company, including its Subsidiaries, is made known to the chief executive officer and
the chief financial officer of the Company by others within those entities as appropriate to allow timely decisions regarding required disclosures and to make the certifications required by the Exchange Act and Sections&nbsp;302 and 906 of the
Sarbanes-Oxley Act, and (y)&nbsp;disclosed, based on its most recent evaluation prior to the entry into this Agreement, to the Company&#146;s outside auditors and the audit committee of the Board of Directors any (A)&nbsp;significant deficiencies
and material weaknesses in the design or operation of internal control over financial reporting (as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15(f)</FONT> of the Exchange Act) that would reasonably be expected to adversely affect the
Company&#146;s ability to record, process, summarize and report financial information, and (B)&nbsp;fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#146;s internal controls over
financial reporting. To the knowledge of the Company, there is no reason to believe that the Company&#146;s outside auditors and its chief executive officer and chief financial officer will not be able to give the certifications and attestations
required pursuant to the rules and regulations adopted pursuant to Section&nbsp;404 of the Sarbanes-Oxley Act, without qualification, when next due. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Since January&nbsp;1, 2023, (A)&nbsp;neither the Company nor any of
its Subsidiaries, nor, to the knowledge of the Company, any director, officer, auditor, accountant or representative of the Company or any of its Subsidiaries, has received or otherwise had or obtained knowledge of any material complaint,
allegation, assertion or claim, whether written or oral regarding the accounting or auditing practices, procedures, methodologies or methods (including with respect to loan loss reserves, write-downs, charge-offs and accruals) of the Company or any
of its Subsidiaries or their respective internal accounting controls, including any material complaint, allegation, assertion or claim that the Company or any of its Subsidiaries has engaged in questionable accounting or auditing practices, and
(B)&nbsp;no attorney representing the Company or any of its Subsidiaries, whether or not employed by the Company or any of its Subsidiaries, has reported evidence of a material violation of securities Laws, breach of fiduciary duty or similar
violation by the Company or any of its Subsidiaries or any of their respective officers, directors, employees or agents to the Board of Directors or any committee thereof, or to the knowledge of the Company, to any director or officer of the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) <U>Broker</U><U>&#146;</U><U>s Fees</U>. Other than Jefferies Group LLC (the &#147;<U>Placement
Agents/Arrangers</U>&#148;), neither the Company nor any of its affiliates nor any other person acting on its behalf (other than its officers acting in such capacity) has dealt with any broker, finder, commission agent, placement agent or arranger
in connection with the sale of the Securities and the transactions contemplated by this Agreement, and the Company is not under any obligation to pay any broker&#146;s fee or commission in connection with such transactions other than to the
Placement Agents/Arrangers. Neither the Company nor any of its affiliates nor any other person acting on its behalf (other than its officers acting in such capacity) has solicited offers for, or offered or sold, the Securities other than through the
Placement Agents/Arrangers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) <U>Absence of Certain Changes or Events</U>. Since January&nbsp;1, 2023 through the entry into this
Agreement, there has not been any effect, change, event, circumstance, condition, occurrence or development that has had or would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <U>Legal Proceedings</U>. As of the entry into this Agreement, subject to <U>Section</U><U></U><U>&nbsp;6.13</U>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) neither the Company nor any of its Subsidiaries is a party to any, and there are no pending or threatened in writing or,
to the Company&#146;s knowledge, otherwise threatened, legal, administrative, arbitral or other proceedings, claims, audit, examination, actions or governmental or regulatory investigations by or before any Governmental Entity of any nature against
the Company or any of its Subsidiaries or any of their current or former directors or executive officers (A)&nbsp;that would, individually or in the aggregate, reasonably be expected to result in a material restriction on, or material liability
being imposed against, the Company or any of its Subsidiaries or any of their respective businesses, (B)&nbsp;that would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect or (C)&nbsp;challenging the validity
or propriety of the transactions contemplated by this Agreement or the Other Investment Agreements; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) there is no
Order imposed upon the Company, any of its Subsidiaries or any of their current or former directors or executive officers (in each of their capacities as such) or the assets of the Company or any of its Subsidiaries that would reasonably be expected
to be material to the Company and its Subsidiaries taken as a whole. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) <U>Taxes and Tax Returns</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Each of the Company and its Subsidiaries has duly and timely filed (including all valid applicable extensions) all
material Tax Returns in all jurisdictions in which Tax Returns are required to be filed by it, and all such Tax Returns are true, correct, and complete in all material respects. Neither the Company nor any of its Subsidiaries is the beneficiary of
any extension of time within which to file any material Tax Return (other than extensions to file Tax Returns obtained in the ordinary course of business). All material Taxes of the Company and its Subsidiaries (whether or not shown on any Tax
Returns) that are due have been fully and timely paid. Each of the Company and its Subsidiaries has withheld and paid all material Taxes required to have been withheld and paid in connection with amounts paid or owing to any employee, creditor,
shareholder, independent contractor or other third party. Neither the Company nor any of its Subsidiaries has granted any extension or waiver of the limitation period applicable to any material Tax that remains in effect. The federal income Tax
Returns of the Company and its Subsidiaries for all years to and including 2022 have been examined by the Internal Revenue Service or are Tax Returns with respect to which the applicable period for assessment under applicable Law, after giving
effect to extensions or waivers, has expired. Neither the Company nor any of its Subsidiaries has received written notice of assessment or proposed assessment in connection with any material amount of Taxes, and there are no threatened in writing or
pending disputes, claims, audits, examinations or other proceedings regarding any material Tax of the Company and its Subsidiaries or the assets of the Company and its Subsidiaries. Neither the Company nor any of its Subsidiaries is a party to or is
bound by any Tax sharing, allocation or indemnification agreement or arrangement (other than such an agreement or arrangement exclusively between or among the Company and its Subsidiaries). Neither the Company nor any of its Subsidiaries&nbsp;(A)
has been a member of an affiliated group filing a consolidated federal income Tax Return (other than a group the common parent of which was the Company) or (B)&nbsp;has any material liability for the Taxes of any person (other than the Company or
any of its Subsidiaries) under Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any similar provision of any Law), as a transferee or successor, by contract or otherwise. Neither the Company nor any of its
Subsidiaries has been, within the past two (2)&nbsp;years, a &#147;distributing corporation&#148; or a &#147;controlled corporation&#148; (within the meaning of Section&nbsp;355(a)(1)(A) of the Internal Revenue Code of 1986 (the
&#147;<U>Code</U>&#148;)) in a distribution of stock intending to qualify for <FONT STYLE="white-space:nowrap">tax-free</FONT> treatment under Section&nbsp;355 of the Code. Neither the Company nor any of its Subsidiaries has participated in a
&#147;listed transaction&#148; within the meaning of Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.6011-4(b).</FONT> At no time during the past five (5)&nbsp;years has the Company been a U.S. real property holding corporation
within the meaning of Section&nbsp;897(c)(2) of the Code. The Company is classified as a Subchapter C corporation for U.S. federal tax purposes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) As used herein, (A) &#147;<U>Tax</U>&#148; or &#147;<U>Taxes</U>&#148; means all federal, state, local, and foreign
income, excise, gross receipts, ad valorem, profits, gains, property, capital, sales, transfer, use, license, payroll, employment, social security, severance, unemployment, unclaimed property, withholding, duties, excise, windfall profits,
intangibles, franchise, backup withholding, value added, alternative or <FONT STYLE="white-space:nowrap">add-on</FONT> minimum, estimated and other taxes, charges, levies or like assessments together with all penalties and additions to tax and
interest thereon; and (B) &#147;<U>Tax Return</U>&#148; means any return, declaration, report, claim for refund, or information return or statement relating to Taxes, including any schedule or attachment thereto, and including any amendment thereof,
supplied or required to be supplied to a Governmental Entity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k) <U>Employees and Employee Benefit Plans</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) As used herein, &#147;<U>Company Benefit Plans</U>&#148; means all employee benefit plans (as defined in Section&nbsp;3(3)
of the Employee Retirement Income Security Act of 1974 (&#147;<U>ERISA</U>&#148;)), whether or not subject to ERISA, and all stock option, stock purchase, restricted stock, stock-based, incentive, deferred compensation, retiree medical or life
insurance, supplemental retirement, severance, welfare or other benefit plans, programs or arrangements, retention, bonus, employment, change in control, termination or severance plans, programs, policies, practices, agreements or arrangements
(whether or not funded and whether or not in writing) that are maintained, contributed to or sponsored or maintained by, or required to be contributed to, the Company or any of its Subsidiaries for the benefit of any current or former employee,
officer or director of the Company or any of its Subsidiaries, excluding, in each case, any &#147;multiemployer plan&#148; within the meaning of Section&nbsp;4001(a)(3) of ERISA (a &#147;<U>Multiemployer Plan</U>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Each Company Benefit Plan has been established, operated and administered in all material respects in accordance with its
terms and the requirements of all applicable Laws, including ERISA and the Code. Each Company Benefit Plan that is intended to be qualified under Section&nbsp;401(a) of the Code has received a favorable determination letter from the IRS and, to the
Company&#146;s knowledge, nothing has occurred, whether by action or failure to act, that could reasonably be expected to adversely affect the qualified status of such Company Benefit Plan under Section&nbsp;401(a) of the Code. Neither the Company
nor any Company Subsidiary has engaged in a transaction that could subject the Company or any of its Subsidiaries to a material tax or material penalty pursuant to Section&nbsp;4975 or 4976 of the Code or Section&nbsp;502 of ERISA. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) No Company Benefit Plan is subject to Title IV or Section&nbsp;302 of ERISA or Section&nbsp;412 or 4971 of the Code nor
has the Company or any of its Subsidiaries or ERISA Affiliates, at any time during the last six years, contributed to or been obligated to contribute to an employee benefit plan subject to Title IV or Section&nbsp;302 of ERISA. None of the Company,
its Subsidiaries nor any ERISA Affiliate (as defined below) has, at any time during the last six years, contributed to or been obligated to contribute to any Multiemployer Plan or a plan that has two or more contributing sponsors at least two of
whom are not under common control, within the meaning of Section&nbsp;4063 of ERISA (a &#147;<U>Multiple Employer Plan</U>&#148;), and none of the Company and its Subsidiaries nor any ERISA Affiliate has incurred any liability to a Multiemployer
Plan or Multiple Employer Plan as a result of a complete or partial withdrawal (as those terms are defined in Part 1 of Subtitle E of Title IV of ERISA) from a Multiemployer Plan or Multiple Employer Plan. As used herein, &#147;<U>ERISA
Affiliate</U>&#148; means, with respect to any entity, trade or business, any other entity, trade or business that is, or was at the relevant time, a member of a group described in Section&nbsp;414(b), (c), (m) or (o)&nbsp;of the Code or
Section&nbsp;4001(b)(1) of ERISA that includes or included the first entity, trade or business, or that is, or was at the relevant time, a member of the same &#147;controlled group&#148; as the first entity, trade or business pursuant to
Section&nbsp;4001(a)(14) of ERISA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Neither the Company, nor any of its Subsidiaries, sponsors or has any
obligation with respect to any employee benefit plan that provides for any post-employment or post-retirement health or medical or life insurance benefits for retired, former or current employees or beneficiaries or dependents thereof, except as
required by Section&nbsp;4980B of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) All contributions required to be made to any Company Benefit Plan by Law
or any plan document, and all premiums due or payable with respect to insurance policies funding any Company Benefit Plan, for any period through the entry into this Agreement, have been timely made or paid in full or, to the extent not required to
be made or paid on or before the entry into this Agreement, have been fully reflected on the books and records of the Company, except as, either individually or in the aggregate, would not reasonably be expected to result in any material liability
to the Company and its Subsidiaries, taken as a whole. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) Other than as provided herein or the Other Investment
Agreements, none of the execution and delivery of this Agreement or the Other Investment Agreements, the transactions contemplated by this Agreement, the Other Investment Agreements or the Investment will (either alone or in conjunction with any
other event) (A)&nbsp;entitle any employee, officer, director or individual independent contractor of the Company or any of its Subsidiaries to any payment or benefit, (B)&nbsp;result in, accelerate, cause the vesting, exercisability, funding,
payment or delivery of, or increase in the amount or value of, any payment, right or other benefit to any employee, officer, director or independent contractor of the Company or any of its Subsidiaries, (C)&nbsp;accelerate the timing of or cause the
Company or any of its Subsidiaries to transfer or set aside any assets to fund any material benefits under any Company Benefit Plan, (D)&nbsp;result in any limitation on the right of the Company or any of its Subsidiaries to amend, merge, terminate
or receive a reversion of assets from any Company Benefit Plan or related trust, or (E)&nbsp;result in any &#147;excess parachute payment&#148; within the meaning of Section&nbsp;280G of the Code. No Company Benefit Plan provides for the <FONT
STYLE="white-space:nowrap">gross-up</FONT> or reimbursement of Taxes under Section&nbsp;4999 or 409A of the Code, or otherwise. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) The Company and its Subsidiaries are in compliance in all material respects with, and since January&nbsp;1, 2023 have
complied in all material respects with, all Laws regarding employment and employment practices, terms and conditions of employment, compensation and benefits, wages and hours, paid sick leave, classification of employees as exempt or nonexempt and
workers as employees or independent contractors, equitable pay practices, privacy rights, labor disputes, employment discrimination, sexual or racial harassment or discrimination, workers&#146; compensation, unemployment insurance, disability rights
or benefits, retaliation, immigration, family and medical leave, occupational safety and health, plant closings and layoffs and other laws in respect of any reduction in force (including notice, information and consultation requirements). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(l) <U>Compliance with Applicable Law and Privacy Obligations</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company and each of its Subsidiaries hold, and have at all times since January&nbsp;1, 2023, held, all licenses,
franchises, permits and authorizations necessary for the lawful conduct of their respective businesses and ownership of their respective properties, rights and assets under and pursuant to each (and have paid all fees and assessments due and payable
in connection therewith), except where neither the cost of failure to hold nor the cost of obtaining and holding such license, franchise, permit or authorization (nor the failure to pay any fees or assessments) would, either individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect, and, to the knowledge of the Company, no suspension or cancellation of any such necessary license, franchise, permit or authorization is threatened. Except as would not, either
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, the Company and its Subsidiaries have complied with any Law applicable to the Company or any of its Subsidiaries, including all laws relating to the privacy
and security of data or information that constitutes &#147;personal data,&#148; &#147;personally identifiable information,&#148; &#147;nonpublic personal information,&#148; &#147;personal information&#148; or a similar term (&#147;<U>Personal
Data</U>&#148;), the USA PATRIOT Act, the Bank Secrecy Act, the Equal Credit Opportunity Act and Regulation&nbsp;B, the Fair Housing Act, the Community Reinvestment Act, the Fair Credit Reporting Act, the Truth in Lending Act and Regulation&nbsp;Z,
the Home Mortgage Disclosure Act, the Fair Debt Collection Practices Act, the Electronic Fund Transfer Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, any regulations promulgated by the Consumer Financial Protection Bureau, the
Interagency Policy Statement on Retail Sales of Nondeposit Investment Products, the SAFE Mortgage Licensing Act of 2008, the Real Estate Settlement Procedures Act and Regulation&nbsp;X, and any other Laws relating to bank secrecy, discriminatory
lending, financing or leasing practices, consumer protection, money laundering prevention, foreign assets control, U.S. sanctions laws and regulations, Sections&nbsp;23A and 23B of the Federal Reserve Act, the Sarbanes-Oxley Act, and all agency
requirements relating to the origination, sale and servicing of mortgage and consumer loans. Company Bank has a Community Reinvestment Act rating of &#147;satisfactory&#148; or better. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Except as would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect,
none of the Company, any of its Subsidiaries or, to the Company&#146;s knowledge, any director, officer, employee, agent or other person acting on behalf of the Company or any of its Subsidiaries has, directly or indirectly, (A)&nbsp;used any funds
of the Company or its Subsidiaries for unlawful contributions, unlawful gifts, unlawful entertainment or other expenses relating to political activity, (B)&nbsp;made any unlawful payment to foreign or domestic governmental officials or employees or
to foreign or domestic political parties or campaigns from funds of the Company or its Subsidiaries, (C)&nbsp;violated any provision that would result in the violation of the Foreign Corrupt Practices Act of 1977 or any similar Law,
(D)&nbsp;established or maintained any unlawful fund of monies or other assets of the Company or its Subsidiaries, (E)&nbsp;made any fraudulent entry on the books or records of the Company or its Subsidiaries or (F)&nbsp;made any unlawful bribe,
unlawful rebate, unlawful payoff, unlawful influence payment, unlawful kickback or other unlawful payment to any person, private or public, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
regardless of form, whether in money, property or services, to obtain favorable treatment in securing business to obtain special concessions for the Company or its Subsidiaries, to pay for
favorable treatment for business secured or to pay for special concessions already obtained for the Company or its Subsidiaries, or is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S.
Department of the Treasury. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The Company maintains a written information privacy and security program that maintains
reasonable measures to protect the privacy, confidentiality, integrity and security of all Personal Data against any (A)&nbsp;loss or misuse of Personal Data, (B)&nbsp;unauthorized or unlawful operations performed upon Personal Data or (C)&nbsp;any
other act or omission that compromises the security or confidentiality of Personal Data (clauses&nbsp;(A) through (C), a &#147;<U>Data Breach</U>&#148;). The Company has not experienced any Data Breach that, either individually or in the aggregate,
would reasonably be expected to have a Material Adverse Effect. To the knowledge of the Company, there are no data security or other technological vulnerabilities with respect to the Company&#146;s information technology systems or networks that,
either individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. Since January&nbsp;1, 2023, except as would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect, the Company and its Subsidiaries are and have been compliant with their written data privacy and security policies and all contractual commitments of the Company and its Subsidiaries concerning privacy, data protection, data security and the
collection, storage, use and other processing of Personal Data. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Except as would not, either individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect: (A)&nbsp;the Company and each of its Subsidiaries have properly administered all accounts for which it acts as a fiduciary, including accounts for which it serves as a trustee,
agent, custodian, personal representative, guardian, conservator or investment advisor, in accordance with the terms of the governing documents and applicable state, federal and foreign law; and (B)&nbsp;none of the Company, any of its Subsidiaries,
or any of its or its Subsidiaries&#146; directors, officers or employees, has committed any breach of trust or fiduciary duty with respect to any such fiduciary account, and the accountings for each such fiduciary account are true, correct and
complete and accurately reflect the assets and results of such fiduciary account. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(m) <U>Agreements with Governmental Entities</U>.
Subject to <U>Section</U><U></U><U>&nbsp;6.13</U>, as of the entry into this Agreement, neither the Company nor any of its Subsidiaries is subject to any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cease-and-desist</FONT></FONT> Order, or is a party to any written agreement, consent agreement or memorandum of understanding with, or is a party to any commitment letter or similar
undertaking to, or has been ordered to pay any material civil money penalty by, or has been since January&nbsp;1, 2023, a recipient of any supervisory letter from, or since January&nbsp;1, 2023, has adopted any board resolutions at the direction of,
any Governmental Entity, in each case, that (i)&nbsp;currently restricts in any material respect or would reasonably be expected to restrict in any material respect the conduct of its business or (ii)&nbsp;in any material manner relates to its
capital adequacy, its ability to pay dividends, its credit or risk management policies, its management or its business (each, whether or not set forth in the Company Disclosure Schedule, a &#147;<U>Company Regulatory Agreement</U>&#148;), nor has
the Company or any of its Subsidiaries been advised in writing or, to the knowledge of the Company, threatened verbally, since January&nbsp;1, 2023 through the date hereof, by any Governmental Entity that it is considering issuing, initiating,
ordering or requesting any such Company Regulatory Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(n) <U>Investment Securities and Commodities</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Each of the Company and its Subsidiaries has good title in all material respects to all securities and commodities owned
by it (except those sold under repurchase agreements) which are material to the Company and its Subsidiaries on a consolidated basis, free and clear of any Liens, except for such failures to have good title as are set forth in the financial
statements included in the Company Reports as of the entry into this Agreement or to the extent such securities or commodities are pledged in the ordinary course of business to secure obligations of the Company or its Subsidiaries. Such securities
and commodities are valued on the books of the Company in accordance with GAAP in all material respects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Company
and its Subsidiaries and their respective businesses employ investment, securities, commodities, risk management and other policies, practices and procedures that the Company believes are prudent and reasonable in the context of such businesses, and
the Company and its Subsidiaries have, since January&nbsp;1, 2023, been in compliance with such policies, practices and procedures in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(o) <U>Loan Portfolio</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Except as would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect,
each written or oral loan, loan agreement, note or borrowing arrangement (including leases, credit enhancements, commitments, guarantees and interest-bearing assets) (collectively, &#147;<U>Loans</U>&#148;) of the Company and its Subsidiaries
(A)&nbsp;is evidenced by notes, agreements or other evidences of indebtedness that are true, genuine and what they purport to be, (B)&nbsp;has been secured by valid Liens, as applicable, and (C)&nbsp;is the legal, valid and binding obligation of the
obligor named therein, enforceable in accordance with its terms, subject to the Enforceability Exceptions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Except as
would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, each outstanding Loan of the Company or any of its Subsidiaries (including Loans held for resale to investors) was solicited and
originated, and is and has been administered and, where applicable, serviced, and the relevant Loan files are being maintained, in all material respects in accordance with the relevant notes or other credit or security documents, the written
underwriting standards of the Company and its Subsidiaries (and, in the case of Loans held for resale to investors, the underwriting standards, if any, of the applicable investors) and with all applicable federal, state and local laws, regulations
and rules. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) There are no outstanding Loans made by the Company or any of its
Subsidiaries to any &#147;executive officer&#148; or other &#147;insider&#148; (as each such term is defined in Regulation O promulgated by the Federal Reserve) of the Company or its Subsidiaries, other than Loans that are subject to and that were
made and continue to be in compliance with Regulation O or that are exempt therefrom. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) To the knowledge of the
Company, the allowance for credit losses reflected in the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on February&nbsp;29, 2024 was calculated in accordance with GAAP and applicable regulatory guidance.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(p) <U>Related Party Transactions</U>. There are no transactions or series of related transactions, agreements, arrangements or
understandings, nor are there any currently proposed transactions, agreements, arrangements or understandings or series of related transactions, agreements, arrangements or understandings between the Company or any of its Subsidiaries, on the one
hand, and any current or former director or &#147;executive officer&#148; (as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;3b-7</FONT> under the Exchange Act) of the Company or any of its Subsidiaries or any person who beneficially owns (as
defined in <FONT STYLE="white-space:nowrap">Rules&nbsp;13d-3</FONT> and <FONT STYLE="white-space:nowrap">13d-5</FONT> of the Exchange Act) 5% or more of the outstanding Common Stock (or any of such person&#146;s immediate family members or
affiliates) (other than Subsidiaries of the Company) on the other hand, of the type required to be reported in any Company Report pursuant to Item&nbsp;404 of <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-K</FONT> promulgated under the Exchange
Act that have not been so reported on a timely basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(q) <U>Offering of Securities</U>. Neither the Company, nor any of its
Subsidiaries, nor any person acting on its or their behalf has (i)&nbsp;directly or indirectly, taken any action (including any offering of any securities of the Company under circumstances which would require the integration of such offering with
the offering of any of the Securities to be issued pursuant hereto under the Securities Act and the rules and regulations of the SEC promulgated thereunder) that might subject the Investment to the registration requirements of the Securities Act or
(ii)&nbsp;offered the Securities or any similar securities for sale to, or solicited any offer to buy any of the same from, or otherwise approached or negotiated in respect thereof with, any person, other than Purchaser, the counterparty to each
Other Investment Agreement and not more than thirty-five (35)&nbsp;other Institutional Accredited Investors and fifteen (15)&nbsp;other Accredited Investors that are directors or executive officers of the Company, each of which has been offered the
Securities at a private sale for investment. As used herein, (x) &#147;<U>Institutional Accredited Investor</U>&#148; means an institutional accredited investor as defined in Rule 501(a)(1), (2), (3) or (7)&nbsp;under the Securities Act and (y)
&#147;<U>Accredited Investors</U>&#148; means an accredited investor as defined in Rule 501(a)(4) under the Securities Act. None of the Company nor any of its Subsidiaries has offered the Securities or any similar securities during the six
(6)&nbsp;months prior to the entry into this Agreement to anyone, other than Purchaser, the counterparty to each Other Investment Agreement and not more than thirty-five (35)&nbsp;other Institutional Accredited Investors and fifteen (15)&nbsp;other
Accredited Investors. The Company has no intention to offer the Securities or any similar security during the six (6)&nbsp;months from the entry into this Agreement, except as contemplated by this Agreement or each Other Investment Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(r) <U>Other Investments</U>. The per share purchase price of the shares of Common Stock
and/or Preferred Stock purchased under each Other Investment Agreement is not less than the per share purchase price of the shares of Common Stock, Series B Preferred Stock or Series C Preferred Stock issued pursuant to the Investment. Except as
expressly set forth in the Other Investment Agreements executed as of the date of this Agreement and that has been delivered to Purchaser concurrently with the execution of this Agreement, each Other Investment Agreement does not include provisions
that are more favorable to the purchaser party thereto compared to the rights, benefits and obligations of Purchaser under this Agreement (it being understood that each Other Investment Agreement may differ with respect to (i)&nbsp;such other
purchaser&#146;s governance rights with respect to the Company and (ii)&nbsp;any provision necessary or advisable to consummate the transactions contemplated thereby arising out of or related to the identity of the other purchaser. Except as set
forth in the preceding sentence with the respect to the provisions of any Other Investment Agreement, neither the Company nor any of its Subsidiaries has entered into any (or modified any existing) contract, agreement, arrangement or understanding
with any purchaser party to the Other Investment Agreements (or any affiliate thereof) that has the effect of establishing rights or otherwise benefiting such other purchaser in a manner more favorable to such purchaser than the rights, benefits and
obligations of Purchaser in this Agreement. Each Other Permanent Warrant (A)&nbsp;includes or will include (as applicable) the same exercise price and (B)&nbsp;does not or will not (as applicable) include provisions that are more favorable in any
material respect to the holder thereof compared to the rights, benefits and obligations of Purchaser under the Permanent Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(s)
<U>General Solicitation</U>. Neither the Company, nor any Company Subsidiary nor any of their respective affiliates, nor any person acting on its or their behalf, has offered or sold the Securities by any form of general solicitation or general
advertising, including, but not limited to, the following: (i)&nbsp;any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media or broadcast over television or radio; (ii)&nbsp;any website posting
or widely distributed <FONT STYLE="white-space:nowrap">e-mail;</FONT> or (iii)&nbsp;any seminar or meeting whose attendees have been invited by any general solicitation or general advertising. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(t) <U>Board Reconstitution</U>. The Board Reconstitution has been duly and validly approved by the Board of Directors and no other corporate
proceedings on the part of the Company are necessary to approve each Board Reconstitution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(u) <U>Borrowings</U>. There are no
restrictions (including, without limitation, on amounts, maturities, collateral or rates of interest) on the ability of the Company or Company Bank to borrow under any federal loan program or discount window other than those generally applicable to
banking organizations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) <U>Receivership</U>. No Governmental Entity shall have been appointed as receiver or conservator for Company
Bank. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(w) <U>No Other Representations or Warranties</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Except for the representations and warranties made by the Company in this <U>Section</U><U></U><U>&nbsp;2.2</U>, neither
the Company, any of its Subsidiaries, any of their respective Representatives, nor any other person makes, has made or has been authorized to make any express or implied representation or warranty with respect to the Company, any of its Subsidiaries
or their respective businesses, operations, assets, liabilities, conditions (financial or otherwise) or prospects, and the Company hereby disclaims any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
such other representations or warranties. In particular, without limiting the foregoing disclaimer, neither the Company, any of its Subsidiaries, any of their respective Representatives, nor any
other person makes, has made or has been authorized to make any representation or warranty to Purchaser or any of its affiliates or its or their respective Representatives with respect to (A)&nbsp;any financial projection, forecast, estimate, budget
or prospective information relating to the Company or any of its Subsidiaries or their respective businesses, operations, assets, liabilities, conditions (financial or otherwise) or prospects or (B)&nbsp;except for the representations and warranties
made by the Company in this <U>Section</U><U></U><U>&nbsp;2.2</U>, any oral or written information presented to Purchaser or any of its affiliates or its or their respective Representatives in the course of (x)&nbsp;their due diligence investigation
of the Company or its Subsidiaries, (y)&nbsp;the negotiation of this Agreement or (z)&nbsp;the transactions contemplated hereby. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Company acknowledges and agrees that neither Purchaser, its Representatives, nor any other person has made, is making
or has been authorized to make any express or implied representation or warranty other than those expressly set forth in in <U>Section</U><U></U><U>&nbsp;2.3</U>, and in entering into this Agreement, the Company is relying exclusively on its own
independent investigation and the representations and warranties expressly set forth in <U>Section</U><U></U><U>&nbsp;2.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3 <U>Representations and Warranties of Purchaser</U>. Purchaser hereby represents and warrants to the Company that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Corporate Organization</U>. Purchaser is duly organized, validly existing and in good standing under the laws of the jurisdiction of
its organization. Purchaser has the corporate, partnership or limited liability company power and authority to own or lease all of its properties and assets and to carry on its business as it is now being conducted. Purchaser is duly licensed or
qualified to do business and, where such concept is recognized under Law, in good standing in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes
such licensing, qualification or standing necessary, except where the failure to be so licensed or qualified or to be in good standing would not, either individually or in the aggregate, reasonably be expected to materially and adversely affect
Purchaser&#146;s ability to perform its obligations under this Agreement or consummate the transactions contemplated hereby on a timely basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Authority; No Violation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Purchaser has full corporate, partnership or limited liability company power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and, subject to other actions described in this <U>Section</U><U></U><U>&nbsp;2.3(b)</U> and <U>Section</U><U></U><U>&nbsp;2.3(c)</U>, to consummate the Closing. No other corporate proceedings on the
part of Purchaser or any of Purchaser&#146;s partners or equityholders are necessary to approve or adopt this Agreement, for Purchaser to perform its obligations hereunder or to consummate the transactions contemplated hereby. This Agreement has
been duly and validly executed and delivered by Purchaser and (assuming due authorization, execution and delivery by the Company) constitutes a valid and binding obligation of Purchaser, enforceable against Purchaser in accordance with its terms
(except in all cases as such enforceability may be limited by the Enforceability Exceptions). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Neither the execution and delivery of this Agreement by Purchaser, the
performance by Purchaser of its obligations hereunder nor consummation by Purchaser of the transactions contemplated hereby, including the Investment, nor compliance by Purchaser with any of the terms or provisions hereof, will (A)&nbsp;violate any
provision of Purchaser&#146;s certificate or articles of incorporation or bylaws (or other comparable charter or organizational documents) or (B)&nbsp;assuming that the consents and approvals referred to in <U>Section</U><U></U><U>&nbsp;2.3(c)</U>
are duly obtained, (x)&nbsp;violate any Law applicable to Purchaser or any of its properties or assets or (y)&nbsp;violate, conflict with, result in a breach of any provision of or the loss of any benefit under, constitute a default (or an event
which, with notice or lapse of time, or both, would constitute a default) under, result in the termination of or a right of termination or cancellation under, accelerate the performance required by, or result in the creation of any Lien upon any of
the properties or assets of Purchaser under, any of the terms, conditions or provisions of any note, bond, mortgage, indenture, deed of trust, license, lease, agreement or other instrument or obligation to which Purchaser is a party, or by which
Purchaser or any of its properties or assets may be bound, except (in the case of <U>clauses</U><U></U><U>&nbsp;(B)(x)</U> and <U>(B)(y)</U> above) for such violations, conflicts, breaches, defaults, terminations, cancellations, accelerations or
creations which would not, either individually or in the aggregate, reasonably be expected to materially and adversely affect Purchaser&#146;s ability to consummate the Investment and the other transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Consents and Approvals</U>. Except for (i)&nbsp;the approvals set forth on <U>Section</U><U></U><U>&nbsp;2.2(d)</U> of the Company
Disclosure Schedule, (ii)&nbsp;the Board <FONT STYLE="white-space:nowrap">Non-Objections,</FONT> (iii)&nbsp;the filing of the requisite Supplemental Listing Application and any other required applications, filings and notices, as applicable, with
the NYSE, and the approval of the listing of the shares of Common Stock and shares of Common Stock (A)&nbsp;issued hereunder and (B)&nbsp;to be issued upon the Conversions, (iv)&nbsp;the filing of any registration statement with the SEC in
accordance with the terms and subject to the conditions of the Registration Rights Agreement, (v)&nbsp;filings required under, and compliance with other applicable requirements of, the HSR Act with respect to the Conversions, (vi)&nbsp;the Requisite
Stockholder Vote, (vii)&nbsp;the filing of the Certificate of Designations and the Charter Amendment with the Delaware Secretary of State and (viii)&nbsp;such filings and approvals as are required to be made or obtained under the securities or
&#147;Blue Sky&#148; laws of various states in connection with the Investment, no consents or approvals of or filings or registrations with any Governmental Entity are necessary in connection with (A)&nbsp;the execution and delivery by Purchaser of
this Agreement or (B)&nbsp;the Investment and the other transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <U>Sufficiency of Funds</U>. Purchaser has
available cash on hand or other sources of immediately available funds sufficient to enable it to perform all of its payment obligations hereunder and consummate the transactions contemplated by this Agreement, including the Investment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) <U>Purchase for Investment</U>. Purchaser represents that it is an Institutional
Accredited Investor acting for its own account (and not for the account of others) or as a fiduciary or agent for others (which others are also Institutional Accredited Investors). Purchaser represents that it is purchasing the Securities for its
own account or for one or more separate accounts maintained by it for the benefit of one or more other Institutional Accredited Investors and not with a view to the distribution thereof in violation of the securities Laws; <U>provided</U> that the
disposition of Purchaser&#146;s property shall at all times be within Purchaser&#146;s control. Purchaser understands that the Securities have not been registered under the Securities Act and may be resold only if registered pursuant to the
provisions of the Securities Act or if an exemption from registration is available, except under circumstances where neither such registration nor such an exemption is required by Law, and that the Company is not required to register the Securities.
Purchaser further represents and warrants that Purchaser (i)&nbsp;will not sell, transfer or otherwise dispose of the Securities or any interest therein except in a registered transaction or in a transaction exempt from or not subject to the
registration requirements of the Securities Act and (ii)&nbsp;was given the opportunity to ask questions and receive answers concerning the terms and conditions of the offering and to obtain any additional information which the Company possesses or
can acquire without unreasonable effort or expense. Purchaser acknowledges that the Securities will bear a restrictive legend substantially in the form set forth in <U>Section</U><U></U><U>&nbsp;4.2(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) <U>No &#147;Bad Actor&#148; Disqualification Events</U>. If Purchaser is a person enumerated in Rule 506(d)(1), neither Purchaser nor, to
Purchaser&#146;s knowledge, its affiliates, nor any of their respective officers, directors, employees, agents, partners or members, is subject to any &#147;bad actor&#148; disqualifying event described in Rule&nbsp;506(d)(1)(i)-(viii) of the
Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) <U>Information</U>. Purchaser (i)&nbsp;is not being provided with disclosures that would be required if the offer
and sale of the Securities were registered under the Securities Act, nor is Purchaser being provided with any offering circular or prospectus prepared in connection with the offer and sale of the Securities; (ii)&nbsp;has had the opportunity to ask
questions of and receive answers from the Company directly; (iii)&nbsp;has been provided a reasonable opportunity to undertake and has undertaken its own examination of the Company and its Subsidiaries and the terms of the Securities to the extent
Purchaser deems necessary to make its decision to invest in the Securities and (iv)&nbsp;has availed itself of publicly available financial and other information concerning the Company and its Subsidiaries to the extent Purchaser deems necessary to
make its decision to purchase the Securities. Purchaser has sought such accounting, legal and tax advice as it has considered necessary or advisable to make an informed investment decision with respect to its acquisition of the Securities. The
purchase of Securities by Purchaser has not been solicited by or through anyone other than the Company or the Placement Agents/Arrangers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) <U>Ability to Bear Economic Risk of Investment</U>. Purchaser recognizes that an investment in the Securities involves substantial risk.
Purchaser has the ability to bear the economic risk of the prospective investment in the Securities, including the ability to hold the Securities indefinitely, and further including the ability to bear a complete loss of all of Purchaser&#146;s
investment in the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <U>Ownership</U>. Except as disclosed to the Company, as of the entry into this Agreement, neither
Purchaser nor any of its affiliates (other than any affiliate with respect to which Purchaser is not the party exercising control over investment decisions) are the owners of record or the Beneficial Owners (as such term is defined under Rule <FONT
STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act) of shares of Common Stock or securities convertible into or exchangeable for Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) <U>Bank Regulatory Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Purchaser is not aware of any facts or circumstances that would reasonably be expected to cause Purchaser to be deemed to
be &#147;acting in concert&#148; (as that term is defined in Regulation Y) with any other person in connection with the transactions contemplated by this Agreement or the Other Investment Agreements. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Neither Purchaser nor any of its affiliates for purposes of the BHC Act is a bank holding company or &#147;controls&#148;
a &#147;bank&#148; (as such terms are defined under the BHC Act or its implementing regulations). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Purchaser is not
aware of any facts or circumstances that, upon consummation of the transactions contemplated herein, would reasonably be expected to cause Purchaser or any of its affiliates to be presumed to &#147;control&#148; the Company or Company Bank for
purposes of the BHC Act or Regulation Y. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k) <U>Information Supplied</U>. The information supplied or to be supplied by Purchaser in
writing specifically for inclusion or incorporation by reference in any documents filed or to be filed with the SEC or any other Governmental Entity in connection with the transactions contemplated by this Agreement or the Other Investment
Agreements will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not
misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(l) <U>Brokers and Finders</U>. Neither Purchaser nor its affiliates, any of its or their respective officers, directors,
employees or agents has employed any broker or finder or incurred any liability for any financial advisory fees, brokerage fees, commissions or finder&#146;s fees, in each case, for which the Company would be liable (other than as set forth in
<U>Section</U><U></U><U>&nbsp;4.12</U>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(m) <U>No Other Representations or Warranties</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Except for the representations and warranties expressly made by Purchaser in this <U>Section</U><U></U><U>&nbsp;2.3</U>,
neither Purchaser, its Representatives, nor any other person makes, has made or has been authorized to make any express or implied representation or warranty with respect to Purchaser or its businesses, operations, conduct, assets, liabilities,
conditions (financial or otherwise) or prospects, and Purchaser hereby disclaims any such other representations or warranties. In particular, without limiting the foregoing disclaimer, neither Purchaser, its Representatives, nor any other person
makes, has made or has been authorized to make any representation or warranty to the Company or any of its Subsidiaries or its or their respective Representatives with respect to (A)&nbsp;any financial projection, forecast, estimate, budget or
prospective information relating to Purchaser or its businesses, operations, conduct, assets, liabilities, conditions (financial or otherwise) or prospects or (B)&nbsp;except for the representations and warranties expressly made by Purchaser in this
<U>Section</U><U></U><U>&nbsp;2.3</U>, any oral, electronic, written or other information presented or made available to the Company or any of its Subsidiaries or its or their respective Representatives in the course of (x)&nbsp;their due diligence
investigation of Purchaser or its affiliates, (y)&nbsp;the negotiation of this Agreement or (z)&nbsp;the transactions contemplated hereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Purchaser acknowledges and agrees that neither the Company, any of its
Subsidiaries, any of their respective Representative, nor any other person has made, is making or has been authorized to make any express or implied representation or warranty other than those expressly set forth in
<U>Section</U><U></U><U>&nbsp;2.2</U>, and in entering into this Agreement, Purchaser is relying exclusively on its own independent investigation and the representations and warranties expressly set forth in <U>Section</U><U></U><U>&nbsp;2.2</U>.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;III </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>COVENANTS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1 <U>Filings; Other Actions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Purchaser, on the one hand, and the Company, on the other hand, will (and will cause their respective affiliates to) cooperate and
consult with the other party and use reasonable best efforts to (i)&nbsp;promptly prepare and file (as applicable) all permits, consents, approvals, confirmations (whether in writing or orally) and authorizations of all third parties and
Governmental Entities which are necessary or advisable to consummate the transactions contemplated hereby, including making an appropriate filing of a Notification and Report Form pursuant to the HSR Act with respect to the Conversions, and
(ii)&nbsp;respond as promptly as practicable to any request for information from (including supplying any additional information or documentary material that may be requested by) any Governmental Entity relating to the foregoing, in each case, so as
to enable the parties hereto to consummate the transactions contemplated by this Agreement, including the Investment, as promptly as reasonably practicable following the entry into this Agreement. Purchaser and the Company shall use their respective
commercially reasonable efforts to obtain clearance pursuant to the HSR Act with respect to the Conversions (such clearance, &#147;<U>HSR Clearance</U>&#148;), as promptly as reasonably practicable following the entry into this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) To the extent permitted by Law, each party hereto agrees to keep the other party reasonably apprised of the status of matters referred to
in this <U>Section</U><U></U><U>&nbsp;3.1(b)</U>. Purchaser and the Company shall promptly correct or supplement any information provided by it or on its behalf for use in any filing made with, or written materials submitted to, any third party or
any Governmental Entity in connection with the transactions to which it will be party as contemplated hereby, if and to the extent (A)&nbsp;that information previously provided by it or on its behalf shall have become false or misleading in any
material respect or (B)&nbsp;necessary or advisable to ensure that such document would not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they are made, not misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) The Company shall as promptly as reasonably practicable, duly call, give notice of,
establish a record date for, convene and hold a stockholders&#146; meeting (whether annual or special) (the &#147;<U>Stockholders</U><U>&#146;</U><U> Meeting</U>&#148;), for the purpose of, among other matters, obtaining the requisite approval
(i)&nbsp;of the Company&#146;s stockholders to adopt an amendment to the Company Certificate of Incorporation to (A)&nbsp;increase the number of authorized shares of Common Stock therein to at least 1,700,000,000 and (B)&nbsp;amend Article Fourth,
Section C, Clauses 1 and 4 of the Company Certificate of Incorporation in a manner to exempt Purchaser and its affiliates (but not any other stockholder of the Company) from the application of Article Fourth, Section C, Clauses 1 and 4 of the
Company Certificate of Incorporation (each, a &#147;<U>Charter Amendment</U>&#148;), (ii) to the extent required, under the applicable rules of the NYSE (the &#147;<U>Exchange Approval</U>&#148;) for issuances of shares of Common Stock in excess of
19.9% of the total voting power of the Company&#146;s securities immediately preceding the entry into this Agreement ((i) and (ii), collectively, the &#147;<U>Requisite Stockholder Vote</U>&#148;) and (iii)&nbsp;of a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-3</FONT></FONT> reverse stock split of the Company&#146;s Common Stock. To the extent reasonably practicable, the Company will file the preliminary proxy for any such meeting no
later than April&nbsp;2, 2024. The Company shall promptly respond to any comments received from the SEC on the proxy statement and will use reasonable best effort to have the Stockholders&#146; Meeting no later than May&nbsp;17, 2024. The Company
shall (A)&nbsp;through its Board of Directors recommend to its stockholders the approval and adoption of the Charter Amendment, the Exchange Approval and the reverse stock split referenced in clause (iii)&nbsp;above (the &#147;<U>Company
Recommendations</U>&#148;), (B) include such Company Recommendations in the proxy statement delivered to its stockholders in connection with the Requisite Stockholder Vote and (C)&nbsp;use its reasonable best efforts to obtain the Requisite
Stockholder Vote and the requisite stockholder approval of the reverse stock split referenced in clause (iii)&nbsp;above. Purchaser shall vote all shares of Common Stock held by Purchaser as of the record date for such meeting in favor of the
approval and adoption of the Charter Amendment and the Exchange Approval. Neither the Board of Directors nor any committee thereof shall withdraw, qualify or modify, or propose publicly to withdraw, qualify or modify, in a manner adverse to
Purchaser, the Company Recommendations or take any action, or make any public statement, filing or release inconsistent with the Company Recommendations. The Company shall adjourn or postpone the Stockholders&#146; Meeting, if, as of the time for
which such meeting is originally scheduled there are insufficient shares of Common Stock represented (either in person or by proxy) to constitute a quorum necessary to conduct the business of such meeting. The Company shall also adjourn or postpone
the Stockholders&#146; Meeting, if on the date of the Stockholders&#146; Meeting the Company has not received proxies representing a sufficient number of shares of Common Stock necessary to obtain the Requisite Stockholder Vote and, following such
adjournment or postponement, the Company shall solicit proxies representing a sufficient number of shares of Common Stock necessary to obtain the Requisite Stockholder Vote. Following the first of either such adjournment or postponement, if
requested by Purchaser, the Company shall retain a proxy solicitor reasonably acceptable to, and on terms reasonably acceptable to, Purchaser in connection with obtaining the Requisite Stockholder Vote and the requisite approval of the reverse stock
split referenced in clause (iii)&nbsp;above. After obtaining the Requisite Stockholder Vote, the Company shall as promptly as reasonably practical, file the Charter Amendment with the Delaware Secretary of State, as required by applicable Law, and
provide Purchaser a certificate from the Delaware Secretary of State evidencing that the Charter Amendment is in full force and effect within five (5)&nbsp;business days after the date of the Stockholders&#146; Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) To the extent permitted by applicable Law, the parties shall promptly advise each other upon receiving any communication from any
Governmental Entity whose consent, waiver, approval or authorization is required for consummation of the transactions contemplated by this Agreement that causes such party to believe that there is a reasonable likelihood that any such required
approval, consent or authorization will not be obtained or that the receipt of such approval, consent or authorization will be materially delayed or conditioned. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) Each party shall execute and deliver after the Closing, such further certificates,
agreements, instruments and other documents and take such other actions as the other party may reasonably request, in each case, to consummate, implement or evidence the Investment, the Charter Amendment or any exchange contemplated by
<U>Section</U><U></U><U>&nbsp;3.1(f)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Following the Closing, and after the HSR Clearance, upon the written request delivered by Purchaser to the Company or by
the Company to Purchaser, Purchaser and the Company shall cooperate in good faith with each other and use their respective reasonable best efforts to provide for Purchaser (but not any other stockholder of the Company), as promptly as practicable,
to exchange all or a portion of Purchaser&#146;s shares of Series B Preferred Stock for (A)&nbsp;in the event that the Requisite Stockholder Vote has been obtained, of Common Stock or, (B)&nbsp;in the event that the Requisite Stockholder Vote has
not been obtained, shares of Series C Preferred Stock; <U>provided</U> that any such exchange, and the Company&#146;s obligations to effect such exchange under this <U>Section</U><U></U><U>&nbsp;3.1(f)(i)</U> shall be subject to receipt of any
required permit, authorization, consent, Order or approval from any Governmental Entity in connection with any such exchange. Prior to the receipt of the Requisite Stockholder Vote, Purchaser agrees that it shall not (i)&nbsp;convert or exchange any
shares of Series B Preferred Stock into any shares of Common Stock or (ii)&nbsp;convert more than 6,751 shares of Series C Preferred Stock into any shares of Common Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Notwithstanding the foregoing, if, as a result of, or pursuant to, the provisions of
<U>Section</U><U></U><U>&nbsp;3.1(f)(i)</U>, Purchaser will acquire, or be deemed by the Federal Reserve or any other banking regulator having jurisdiction over the Company or Company Bank to be acquiring, ten percent (10%) or more of a class of
voting securities of the Company, then, notwithstanding <U>Section</U><U></U><U>&nbsp;4.3</U> or anything herein to the contrary, each of Purchaser and the Company, shall use (and cause its affiliates to use) its and their reasonable best efforts to
obtain any additional approval, consent or <FONT STYLE="white-space:nowrap">non-objection</FONT> of the Federal Reserve or any other Governmental Entity (including pursuant to the Change in Bank Control Act of 1978) required in connection with the
acquisition or control of 10% or more of a class of voting securities of the Company (the &#147;<U>Voting Regulatory Approvals</U>&#148;), including by furnishing to the Federal Reserve or other applicable Governmental Entity such information as is
usual and customary in connection with such applications by similarly situated investors or issuers, as applicable, but subject to the limitations set forth in <U>Section</U><U></U><U>&nbsp;4.3</U>; <U>provided</U>, however, that this
<U>Section</U><U></U><U>&nbsp;3.1(f)(ii)</U> shall not require Purchaser or the Company to take any action, or commit to take or refrain from taking any action, or accept or agree to any condition or restriction, in connection with obtaining the
Voting Regulatory Approvals that would or would be reasonably be expected to be a Materially Burdensome Condition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) The Company and Purchaser shall use reasonable best efforts to agree upon the Permanent
Warrant, which shall contain the terms and conditions described on <U>Exhibit F</U> and other customary terms and conditions as may be reasonably required to give full effect to such terms and conditions prior to the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) If the Requisite Stockholder Vote is not obtained by the date that is the one hundred and eightieth (180<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP>) day after the Closing Date, the Company shall promptly thereafter issue to Purchaser warrants on the terms described on <U>Exhibit G</U> and, in such circumstance, the Company and Purchaser shall
use reasonable best efforts to, as promptly as reasonably practicable, agree upon a form of warrant on the terms described on <U>Exhibit G</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2 <U>Information Rights</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Following the Closing, so long as Purchaser, together with its affiliates, continues to beneficially own in the aggregate at least the
lesser of (i) 2.5% of the outstanding shares of Common Stock (on an <FONT STYLE="white-space:nowrap">As-Converted</FONT> Basis) and (ii) 25% of the Common Stock (on an <FONT STYLE="white-space:nowrap">As-Converted</FONT> Basis) that Purchaser
beneficially owns immediately following the Closing (the &#147;<U>Information Rights Period</U>&#148;), solely for Permitted Purposes, at Purchaser&#146;s sole cost and expense, the Company shall, and shall cause each of its Subsidiaries to, afford
Purchaser and its officers, employees, accountants, counsel and other Representatives reasonable access upon prior written notice and during normal business hours and in such manner as not to interfere unreasonably with the conduct of the business
of the Company and its Subsidiaries to the (A)&nbsp;officers, employees, properties, offices and other facilities of the Company and its Subsidiaries, and (B)&nbsp;contracts, licenses, books and records and other documents relating to the business
of the Company and its Subsidiaries. As used herein, &#147;<U><FONT STYLE="white-space:nowrap">As-Converted</FONT> Basis</U>&#148; means, at any time, the applicable number of shares of Common Stock issued and outstanding, counting as shares of
Common Stock issued and outstanding, without duplication, all shares of Common Stock (A)&nbsp;issued and outstanding, (B)&nbsp;into which shares of Preferred Stock issued and outstanding are convertible and (C)&nbsp;into which shares of preferred
stock of the Company that are issued and outstanding are convertible or exchangeable, as adjusted from time to time for any reorganization, recapitalization, reclassification, stock dividend, stock split, reverse stock split or other like changes in
the Company&#146;s capitalization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing, neither the Company nor its Subsidiaries shall be obligated to
provide such access, materials or information to the extent the Company determines, in its reasonable judgment, that doing so would reasonably be expected to (i)&nbsp;violate or prejudice the rights of its clients, depositors or customers,
(ii)&nbsp;result in the disclosure of trade secrets or competitively sensitive information in a manner detrimental to the Company or any of its Subsidiaries, (iii)&nbsp;violate any Law or agreement or obligation of confidentiality owing to a third
party (including any Governmental Entity), (iv) jeopardize the protection of an attorney-client privilege, attorney work product protection or other legal privilege or (v)&nbsp;be adverse to the interests of the Company or any of its Subsidiaries in
any pending or threatened claim, action, suit, litigation, investigation, examination or proceeding asserted by Purchaser; <U>provided</U>, <U>however</U>, that the Company shall use reasonable best efforts to make other arrangements (including
using reasonable best efforts to redact information or make substitute disclosure arrangements) that would enable disclosure to Purchaser to occur without, in the case of the (A)&nbsp;foregoing <U>clause (i)</U>, violating or prejudicing such right;
(B)&nbsp;foregoing <U>clause (ii)</U>, disclosing such trade secrets or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
competitively sensitive information in a manner detrimental to the Company or any of its Subsidiaries; (C)&nbsp;foregoing <U>clause (iii)</U>, violating such Law or agreement or obligation;
(D)&nbsp;foregoing <U>clause (iv)</U>, jeopardizing such privilege; and (E)&nbsp;foregoing <U>clause (v)</U>, such adverse consequences. The foregoing shall not limit the right of any Board Representative or the Board Observer to participate in any
meeting of the Board of Directors or receive any information that is otherwise made available to the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3
<U>Confidentiality</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Each of Purchaser and the Company shall (and shall cause its affiliates and its and its affiliates&#146;
respective officers, directors, employees, agents, advisors and representatives (collectively, &#147;<U>Representatives</U>&#148;) to) hold all information furnished by or on behalf of the other party or its affiliates or their respective
Representatives in confidence to the extent required by, and in accordance with, the provisions of the <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement, dated February&nbsp;1, 2024, by and between Liberty 77 Capital, L.P. and the
Company (the &#147;<U>Confidentiality Agreement</U>&#148;). Notwithstanding the foregoing, the provisions of <U>Section</U><U></U><U>&nbsp;3.3(b)</U> will supersede any conflicting provision in the Confidentiality Agreement (but <FONT
STYLE="white-space:nowrap">non-conflicting</FONT> provisions will otherwise continue in full force and effect in accordance with their respective terms). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) In addition to Purchaser&#146;s obligations under the Confidentiality Agreement, from the Closing until two (2)&nbsp;years after the last
date of the Director Rights Period, Purchaser shall (and shall cause its affiliates and its and its affiliates&#146; respective Representatives to)&nbsp;(i) keep confidential any information (including oral, written, electronic or other information)
concerning the Company or its affiliates that has been, will be or may be furnished to Purchaser, its affiliates or their respective Representatives by or on behalf of the Company (or its affiliates) or any of its or their respective Representatives
pursuant hereto or in connection with Purchaser&#146;s (or its affiliates&#146;) investment or potential investment in the Company (collectively, the &#147;<U>Confidential Information</U>&#148;) and (ii)&nbsp;use Confidential Information solely for
noncompetitive purposes; <U>provided</U> that notwithstanding the foregoing or anything to the contrary herein or in the Confidentiality Agreement, Purchaser (and its affiliates and its and its affiliates&#146; respective Representatives) shall be
free to use (x)&nbsp;for any purpose any information in intangible form, retained in the unaided memory of such persons, relating to or resulting from access to Confidential Information and (y)&nbsp;any generalized learnings from evaluating,
monitoring and administering Purchaser&#146;s (or its affiliates&#146;) investment in the Company, which do not constitute tangible Confidential Information furnished by or on behalf of the Company (or its affiliates) or any of its or their
respective Representatives, for purposes of evaluating or modifying their business strategies); <U>provided</U> that the Confidential Information shall not include information that (A)&nbsp;was or becomes generally available to the public, other
than as a result of a disclosure by Purchaser, its affiliates or their respective Representatives in violation of this <U>Section</U><U></U><U>&nbsp;3.3(b)</U>, the Confidentiality Agreement, (B)&nbsp;was or becomes available to Purchaser, its
affiliates or their respective Representatives on a <FONT STYLE="white-space:nowrap">non-confidential</FONT> basis from a source (other than the Company, its affiliates or any of their respective Representatives), so long as such source was not, to
Purchaser&#146;s, its affiliates&#146; or their respective Representatives&#146; (as applicable) knowledge, subject to any obligation to the Company or its Subsidiaries to keep such information confidential, (C)&nbsp;at the time of disclosure is
already in the possession of Purchaser, its affiliates or their respective Representatives, so long as such information is not, to Purchaser&#146;s, its affiliates&#146; or their respective </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Representatives&#146; (as applicable) knowledge, subject to any obligation to the Company or its Subsidiaries to keep such information confidential, or (D)&nbsp;was independently developed by
Purchaser, its affiliates or its or their respective Representatives without reference to, incorporation of, reliance on or other use of any Confidential Information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Each of the Company and Purchaser agree, on behalf of themselves, their affiliates and its and their respective Representatives, that
Confidential Information may be disclosed by Purchaser and its affiliates solely (i)&nbsp;to Purchaser&#146;s affiliates and its and their respective Representatives to the extent required for the purposes of evaluating, monitoring, administering or
taking any other action with respect to Purchaser&#146;s (or its affiliates&#146;) investment in the Company (including pursuing any sale or disposition of all or part of its investment in the Company), complying with Purchaser&#146;s (or its
affiliates&#146;) legal, regulatory, tax or other compliance obligations, or ensuring compliance with the terms of, enforcing, defending or understanding any right or obligation in respect of this Agreement, the Company Certificate of Incorporation,
the Certificate of Designations, the Company Bylaws or any other agreement or instrument relating to the Company (each, a &#147;<U>Permitted Purpose</U>&#148;); <U>provided</U> that Purchaser direct such persons (or, in the case of its controlled
affiliates, cause such persons) to treat the Confidential Information in a confidential manner and in accordance with the terms herein, (ii)&nbsp;to any transferees; <U>provided</U>, that such transferee has entered into a confidentiality agreement
pursuant to which such transferee agrees to treat the Confidential Information in a confidential manner and in accordance with the terms herein and pursuant to which Purchaser or one of its affiliates agrees to be responsible for any breach by such
transferee in accordance with the terms of the confidentiality agreement, and (iii)&nbsp;in the event that Purchaser, any of its affiliates or any of its or their respective Representatives are required by Law or requested or required by any
Governmental Entity (including by deposition, interrogatory, request for documents, subpoena, civil investigative demand or similar process) to disclose any Confidential Information, in each case, so long as Purchaser, its affiliates and its and
their respective Representatives (as applicable), to the extent reasonably practicable and permitted by Law, (A)&nbsp;promptly provide notice thereof to the Company, (B)&nbsp;reasonably cooperate with the Company (at the Company&#146;s sole expense)
to resist or narrow such request or requirement, including in seeking a protective order or other appropriate remedy, prior to any such disclosure and (C)&nbsp;limit such disclosure to that which is then so required or requested and use reasonable
efforts to obtain assurances that confidential treatment will be accorded to such disclosed Confidential Information; <U>provided</U>, that, for the avoidance of doubt, the foregoing clauses (A), (B) and (C)&nbsp;shall not apply to disclosure
requests or requirements of a Governmental Entity which are not specifically targeted at this Agreement, the parties hereto or the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4 <U>Public Announcement</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The initial press release with respect to the transactions contemplated hereby shall be a joint press release that has been agreed upon
by Purchaser and the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Thereafter, (i)&nbsp;the Company shall not (and shall cause its affiliates and its and their
respective Representatives not to) make any public release, statement or announcement in respect of this Agreement or the proposed or actual investment in the Company by Purchaser contemplated hereunder and (ii)&nbsp;Purchaser shall not (and shall
cause its affiliates and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
its and their respective Representatives not to) make any public release, statement or announcement in respect of this Agreement, the proposed or actual investment in the Company by Purchaser
contemplated hereunder or the transactions contemplated hereby, in each case, except (A)&nbsp;as required by Law, in which case, to the extent permitted by Law and practicable under the circumstances, the party required to make such release,
statement or announcement shall consult with the other party about, and allow the other party reasonable time to comment on (and shall consider such comments in good faith), such release, statement or announcement in advance of such issuance,
(B)&nbsp;communications by the Company to its stockholders and employees that are reasonably necessary or advisable in connection with the Investment, or the issuance of Common Stock and/or Preferred Stock pursuant to any Other Investment Agreement,
(C)&nbsp;with the prior written consent of the other party (which consent shall not be unreasonably withheld, conditioned or delayed), or (D)&nbsp;for such releases, statements or announcements that are consistent with other such releases,
statements or announcements made on or after the entry into this Agreement in compliance with this <U>Section</U><U></U><U>&nbsp;3.4</U>. Notwithstanding anything in the foregoing, Purchaser and each of its affiliates may provide customary
disclosure of the status and subject matter of this Agreement and transactions contemplated hereby to their respective limited partners and investors, subject to customary confidentiality undertakings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5 <U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period Conduct</U>. Prior to the earlier of the Closing or the
termination of this Agreement pursuant to <U>Article V</U>, except (i)&nbsp;as may be required by Law applicable to the Company or any of its Subsidiaries, (ii)&nbsp;with the prior written consent of Purchaser (such consent not to be unreasonably
withheld, conditioned or delayed) or (iii)&nbsp;as may be expressly contemplated or required by this Agreement (including as set forth in the Company Disclosure Schedule), the Company shall use commercially reasonable efforts to carry on its
business in the ordinary course of business in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6 <U>Material Contracts</U>. Between the date hereof
and the Closing, the Company and its Subsidiaries will not enter into or amend any contract that would be a material contract under SEC rules or would require disclosure on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> without the consent of
Purchaser, not to be unreasonably withheld. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7 <U>No Material Change</U>. Between the date hereof and the Closing, the
Company shall promptly notify Purchaser in writing of (i)&nbsp;any action, arbitration, audit, hearing, investigation, litigation, suit, subpoena or summons issued, commenced, brought, conducted or heard by or before, or otherwise involving, any
Governmental Entity or arbitrator pending or, to the knowledge of the Company threatened against the Company or any of its Subsidiaries that (A)&nbsp;questions or would reasonably be expected to question the validity of this Agreement or the other
agreements contemplated hereby or thereby or any actions taken or to be taken by the Company, or its Subsidiaries with respect hereto or thereto, or (B)&nbsp;seeks to enjoin or otherwise restrain the transactions contemplated hereby or thereby or
(ii)&nbsp;any fact, change, event or circumstance known to it that has had or would reasonably be likely to have a Material Adverse Effect or which it believes would or would be reasonably likely to cause or constitute a material breach of any of
its representations, warranties or covenants contained herein or that reasonably could be expected to give rise, individually or in the aggregate, to the failure of a condition in <U>Article II</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;IV </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ADDITIONAL AGREEMENTS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1 <U>Governance Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The Company shall, as promptly as reasonably practicable, reconstitute the Board of Directors so that (i)&nbsp;the number of directors
that will comprise the Board of Directors shall be ten (10)&nbsp;and (ii) of such members of the Board of Directors, six (6)&nbsp;shall be members of the Board of Directors as of immediately prior to the Closing (the &#147;<U>Legacy
Directors</U>&#148;), one (1)&nbsp;shall be a designee of the Investor (who shall be Steven T. Mnuchin, who shall also be appointed as lead independent director), two (2)&nbsp;shall be designees or serve at the recommendation of the Other Investors
and one (1)&nbsp;shall be Joseph Otting; provided that the Board Reconstitution and the appointment of any new director to the Board of Directors shall be subject, in each case, to any applicable requirement to obtain prior approval, consent or <FONT
STYLE="white-space:nowrap">non-objection</FONT> of any Governmental Entity and the expiration of any applicable notice period under Law (the &#147;<U>Board <FONT STYLE="white-space:nowrap">Non-Objections</FONT></U>&#148;). Thereafter, the Company
shall ensure that one Legacy Director shall resign following the Company&#146;s filing of its Current Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023 and the number of directors that will
comprise the Board of Directors shall be reduced to nine (9). In furtherance thereof, as promptly as reasonably practicable, and in any event by the Closing, the Company will deliver to Purchaser resignation letters from Directors sufficient to
complete the Board Reconstitution subject either to Closing or the Board <FONT STYLE="white-space:nowrap">Non-Objections.</FONT> As of the Closing and for so long as Purchaser holds at least 2.5% of the outstanding shares of Common Stock (on an <FONT
STYLE="white-space:nowrap">As-Converted</FONT> Basis), Purchaser shall have the right to designate one representative in <FONT STYLE="white-space:nowrap">non-voting</FONT> observer capacity to the Board of Directors (the &#147;<U>Board
Observer</U>&#148;). The Board Observer shall have the right to attend all meetings (including meetings held by telephone or other electronic means) of the Board of Directors and each committee and subcommittee thereof and any Company advisory board
(including any committee, subcommittee, and/or advisory board created after the date hereof), and, in this respect, the Company shall invite the Board Observer and shall give the Board Observer copies of all notices, minutes, consents, and other
materials that it provides to its directors, committee, subcommittee and Company advisory board members at the same time and in the same manner as provided to such directors, committee, subcommittee and Company advisory board members.
Notwithstanding the foregoing, the Company shall have the right to exclude the Board Observer from all or any portion of any meeting and to withhold any notices, minutes, consents and other materials from the Board Observer if the Company reasonably
determines that such attendance or access would jeopardize the protection of an attorney-client privilege, attorney work product protection or other legal privilege, <U>provided</U>, however, that the Company shall use reasonable best efforts to
make other arrangements that would enable disclosure to the Board Observer to occur without jeopardizing such protection or privilege. The Board Observer shall be required to enter into a customary confidentiality agreement with the Company prior to
attending any meeting of the Board of Directors or receiving any notices, minutes, consents or other materials. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Promptly following the Closing, the Company shall procure the resignation of one Legacy
Director (whose term of office expires in 2024) in addition to the resignation contemplated by <U>Section</U><U></U><U>&nbsp;4.1(a)</U> and, thereafter subject to the receipt of the applicable Board
<FONT STYLE="white-space:nowrap">Non-Objections,</FONT> the Company shall, as promptly as reasonably practicable, cause one person nominated by the Purchaser to be appointed to the Board of Directors. As a result, Purchaser will have the right,
subject to the receipt of applicable Board <FONT STYLE="white-space:nowrap">Non-Objections,</FONT> to appoint two (2)&nbsp;persons to the Board of Directors (each, a &#147;<U>Board Representative</U>&#148;). Steven T. Mnuchin shall be appointed to
the Board of Directors in that certain class of directors with a term of office expiring at the 2026 annual meeting of the Company&#146;s stockholders. For the avoidance of doubt, following receipt of applicable Board
<FONT STYLE="white-space:nowrap">Non-Objections,</FONT> if at any time during the Director Rights Period (as defined below) Purchasers choose to have only one Board Representative on the Board of Directors, Purchasers shall nevertheless maintain the
right to appoint a second Board Representative during the Director Rights Period. If and when Purchasers notify the Company in writing (with email being sufficient) that they have determined to so appoint a second Board Representative during the
Director Rights Period, the Company shall take all such actions as may be necessary to appoint such second Board Representative to the Board of Directors, including increasing the size of the Board of Directors as needed to accommodate such
appointment. Each such Board Representative must satisfy any applicable corporate governance or regulatory requirements under SEC rules and regulations, the rules of the NYSE or similar authority, or any federal or state banking Laws and comply with
the Company&#146;s policies and procedures applicable to all directors or committee members, as applicable. No individual shall be eligible to be a Board Representative if he or she has been involved in any of the events enumerated under Item 2(d)
of Schedule 13D under the Exchange Act or Item 401(f) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act or is subject to any Order that is then in effect and prohibits service as a director of any U.S. public company
or a bank holding company. Following the effectiveness of the appointment of any Board Representative, the Company shall use reasonable best efforts to take all such reasonable actions so that a Board Representative is appointed to each standing
committee of the Board of Directors, subject to satisfying any applicable corporate governance, regulatory requirements or the rules of the NYSE. The Company agrees that at all times during the Directors Rights Period, each committee of the Board of
Directors will have at least three (3)&nbsp;members other than a Board Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Following the Closing, so long as Purchaser,
together with its affiliates, continues to beneficially own in the aggregate at least the lesser of (i) 2.5% of the outstanding shares of Common Stock (on an <FONT STYLE="white-space:nowrap">As-Converted</FONT> Basis) and (ii) 25% of the Common
Stock (on an <FONT STYLE="white-space:nowrap">As-Converted</FONT> Basis) that Purchaser beneficially owns immediately following the Closing (the &#147;<U>Director Rights Period</U>&#148;) (A) the Company shall (I)&nbsp;include each Board
Representative in the Company&#146;s slate of director nominees and recommend to its stockholders that its stockholders vote in favor of electing such Board Representative to the Board of Directors at the Company&#146;s annual meeting of
stockholders at which such Board Representative&#146;s term expires and (II)&nbsp;at the annual meeting of the Company&#146;s stockholders for the year in which such Board Representative&#146;s term expires, use reasonable best efforts to have such
Board Representative elected as a director of the Company, including that the Company shall solicit proxies for each such person to the same extent as it does for any other nominee of the Board of Directors to the Board of Directors and
(B)&nbsp;upon the death, resignation, retirement, disqualification or removal from office of a Board Representative prior to the end of such Board Representative&#146;s term, (I)&nbsp;Purchaser shall have the power to designate each Board
Representative&#146;s replacement and (II)&nbsp;the Board of Directors shall fill the vacancy resulting therefrom with Purchaser&#146;s designated replacement Board Representative as promptly as practicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) Immediately following the Director Rights Period, Purchaser will have no further rights
under <U>Section</U><U></U><U>&nbsp;4.1(a)</U> through <U>Section</U><U></U><U>&nbsp;4.1(c)</U> and, at the written request of the Board of Directors, shall cause each Board Representative to resign from the Board of Directors as promptly as
reasonably practicable thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) The Board Representatives shall (i)&nbsp;be entitled to the same compensation, expense
reimbursement, exculpation and indemnification from the Company as the other independent directors serving on the Board of Directors (and, with respect to indemnification, the Company&#146;s obligations shall apply prior to any other indemnification
to which a Board Representative may be entitled) and (ii)&nbsp;receive the same coverage under D&amp;O insurance policies maintained by the Company as the other directors serving on the Board of Directors for the duration of the Director Rights
Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) Subject to the Board <FONT STYLE="white-space:nowrap">Non-Objections,</FONT> the Board Representatives shall also be elected
to the board of directors of Company Bank, which shall be reconstituted consistent with the Board Reconstitution. Any Board Representative shall serve on the Company Bank board of directors for so long as they sit on the Board of Directors. In
addition, the Board Representatives will have the same committee rights with respect to any committees of the board of directors of Company Bank, and all other rights they are provided as Board Representatives, including those provided in this
<U>Section</U><U></U><U>&nbsp;4.1</U>, shall also apply to their service on the Company Bank board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) The Company shall
notify the Board Representatives of all (i)&nbsp;regular and special meetings of the Board of Directors and (ii)&nbsp;regular and special meetings of any committee of the Board of Directors of which a Board Representative is a member. The Company
shall provide the Board Representatives with copies of all notices, minutes, consents and other materials provided to all other members of both the Board of Directors and the board of directors of Company Bank concurrently as such materials are
provided to the other members (the &#147;<U>Board Materials</U>&#148;). Other than confidential supervisory information, as described in <U>Section</U><U></U><U>&nbsp;6.13</U>, each Board Representative shall have the right to share all <FONT
STYLE="white-space:nowrap">non-privileged</FONT> Board Materials with Purchaser for Permitted Purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) Notwithstanding anything
herein to the contrary, no Board Representative shall be entitled to participate in, or be entitled to receive the notice or materials referred to in the foregoing <U>Section</U><U></U><U>&nbsp;4.1(g)</U> with respect to, any meeting of the Board of
Directors or any committee thereof (or any portion thereof) with respect to which he or she is reasonably likely to have a conflict of interest (as reasonably determined in good faith by the other members of the Board of Directors (or such
committee) in their sole discretion) with respect to the subject matter of such meeting or any portion of such meeting, including any matter related to the discussion, evaluation or vote upon a matter in which Purchaser (or any of its affiliates)
has a business or financial interest (other than solely by reason of its interest as a stockholder of the Company); <U>provided</U>, <U>however</U>, that the Company shall use commercially reasonable efforts to make other arrangements (including
segmenting portions of meetings, redacting information or making substitute disclosure arrangements) that would enable participation in such meetings by, and disclosure of information and materials to, such Board Representative without such Board
Representative learning information about the matter(s) giving rise to such conflict of interest. The Company shall not treat the Board Representatives differently with respect to conflicts of interest relative to how the Company treats other
members of the Board of Directors with respect to conflicts of interest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2 <U>Legend</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Purchaser agrees that all certificates or other instruments representing the Securities issued pursuant hereto will bear a legend
substantially to the following effect: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) THIS SECURITY HAS BEEN ACQUIRED FOR INVESTMENT AND WITHOUT A VIEW TO
DISTRIBUTION AND HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE &#147;ACT&#148;), OR UNDER STATE SECURITIES LAWS. NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THIS SECURITY OR ANY INTEREST OR
PARTICIPATION THEREIN MAY BE MADE EXCEPT (A)&nbsp;PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR (B)&nbsp;PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS AND, IN THE CASE OF CLAUSE (B),
UNLESS THE COMPANY RECEIVES AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Any transferee of any Securities or any interest therein, by its acceptance thereof, shall be deemed to have made the representations set
forth in <U>Section</U><U></U><U>&nbsp;2.3</U> of this Agreement. The Company shall not be required to register the transfer of any Securities to any person unless the Company receives from the proposed transferee a written instrument in form and
substance reasonably satisfactory to the Company in which such transferee makes the representations and warranties set forth in <U>Section</U><U></U><U>&nbsp;2.3</U> and, if the Company so reasonably requests, an opinion of counsel in form and
substance reasonably satisfactory to the Company to the effect that registration under the Securities Act is not required in connection with such transfer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) The Company shall promptly cause the legend to be removed from any certificate for any Securities held by Purchaser or any of its
affiliates and the Company shall deliver all necessary documents to the transfer agent in connection therewith without charge as to any Securities (i)&nbsp;upon request of Purchaser, upon receipt by the Company of an opinion of counsel reasonably
satisfactory to the Company to the effect that such legend is no longer required under the Securities Act and applicable state Laws or (ii)&nbsp;when such Securities shall have been registered under the Securities Act or may otherwise be transferred
pursuant to any applicable rules thereunder, including eligibility to be transferred if Rule 144 under the Securities Act is available for the sale of the Securities without volume and manner of sale restrictions and the Company shall use reasonable
best efforts to deliver all necessary documents to the transfer agent in connection therewith without charge as to any Securities, including the delivery of an opinion of counsel that such legend is no longer required under the Securities Act and
applicable state Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3 <U>No Materially Burdensome Condition</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding anything to the contrary herein, Purchaser shall not be required to take any action, or commit to take or refrain from
taking any action, or accept or agree to any condition or restriction, in each case, that would reasonably be expected to cause Purchaser, its affiliates or any of their partners or principals to (i) &#147;control&#148; the Company or be required to
become a bank holding company, in each case, pursuant to the BHC Act; (ii)&nbsp;serve as a source of financial strength to the Company pursuant to the BHC Act or (iii)&nbsp;enter into any capital or liquidity maintenance agreement or any similar
agreement with any Governmental Entity, provide capital support to the Company or any of its Subsidiaries or otherwise commit to or contribute any additional capital to, provide other funds to, or make any other investment in, the Company or any of
its Subsidiaries (each of <U>clauses (i)</U>&nbsp;through <U>(iii)</U>, a &#147;<U>Materially Burdensome Condition</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) In
the event either party believes that the imposition of a Materially Burdensome Condition is reasonably likely to occur, it shall promptly notify the other party and both parties shall cooperate in good faith to consider, to the extent commercially
reasonable, such modifications or arrangements as may be necessary or advisable to avoid imposition of the Materially Burdensome Condition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4 <U>Reservation for Issuance</U>. As promptly as practicable following the Closing, but no later than five (5)&nbsp;business
days, the Company shall take all action to reserve up to 800,000,000 shares of Common Stock for issuance upon conversion of (i)&nbsp;Preferred Stock issuable pursuant to this Agreement and
<FONT STYLE="white-space:nowrap">(ii)&nbsp;non-voting,</FONT> common equivalent preferred stock for which the Permanent Warrant may be exercised, in each case, (w)&nbsp;in accordance with the terms of this Agreement, the Certificate of Designations
and the Permanent Warrant (as applicable) and (x)&nbsp;excluding any adjustments applicable thereto. Promptly following the Company&#146;s receipt of the Requisite Stockholder Vote and the filing of the Charter Amendment with the Delaware Secretary
of State, the Company shall reserve that number of additional shares of Common Stock sufficient for issuance of shares of (A)&nbsp;Common Stock upon the conversion of the Preferred Stock and
<FONT STYLE="white-space:nowrap">(B)&nbsp;non-voting,</FONT> common equivalent preferred stock for which the Permanent Warrant may be exercised, in each case, (y)&nbsp;in accordance with the terms of this Agreement, the Certificate of Designations
and the Permanent Warrant (as applicable) and (z)&nbsp;excluding any adjustments applicable thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5 <U>Indemnity</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Following the Closing, the Company shall indemnify, defend and hold harmless Purchaser and its affiliates, to the fullest extent
permitted by Law, from and against any and all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs, losses, liabilities, damages, payments, fees, expenses (including reasonable attorneys&#146; fees and
disbursements) and amounts paid in settlement (collectively, &#147;<U>Losses</U>&#148;; <U>provided</U>, <U>however</U>, that &#147;Losses&#148; do not include, (x)&nbsp;except to the extent awarded in a Third Party Claim, punitive, exemplary,
consequential or special damages or (y)&nbsp;lost profits, opportunity costs or damages based upon a multiple of earnings, revenues or similar financial measure (even if under Law such lost profits, opportunity costs or damages based upon a multiple
of earnings, revenues or similar financial measure would be considered reasonably foreseeable or not special damages) if such Loss directly results from (i)&nbsp;any inaccuracy in or breach of any of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company&#146;s representations or warranties in <U>Section</U><U></U><U>&nbsp;2.2</U> or (ii)&nbsp;the Company&#146;s breach of any agreements or covenants made by the Company herein (except,
in the case of this clause (ii), as set forth in <U>Section</U><U></U><U>&nbsp;4.5(a)</U> of the Company Disclosure Schedule). Notwithstanding the foregoing, the Company shall have no obligation under this
<U>Section</U><U></U><U>&nbsp;4.5(a)</U>&nbsp;(A) following the expiration of the applicable survival period set forth in <U>Section</U><U></U><U>&nbsp;4.5(n)</U> or (B)&nbsp;in respect of any claim, action, suit, litigation, dispute or proceeding
threatened or commenced against the Company and/or any Company Subsidiary and/or any of their respective directors, officers or employees (including if Purchaser or any of its affiliates or its or their respective directors, officers, employees,
shareholders or controlling persons are or are threatened to be made party thereto)&nbsp;(x) in connection with any Stockholder Litigation or actions expressly required by, or taken with the prior written consent of Purchaser pursuant to, this
Agreement or (y)&nbsp;that seeks to enjoin, restrain or prohibit the transactions contemplated by this Agreement or the Other Investment Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Following the Closing, Purchaser shall indemnify, defend and hold harmless each of the Company and its Subsidiaries, to the fullest
extent permitted by Law, from and against any and all Losses actually incurred by the Company or any of its Subsidiaries if such Loss directly results from (i)&nbsp;any inaccuracy in or breach of any of Purchaser&#146;s representations or warranties
in <U>Section</U><U></U><U>&nbsp;2.3</U> or (ii)&nbsp;Purchaser&#146;s breach of any agreements or covenants made by Purchaser herein. Notwithstanding the foregoing, Purchaser shall have no obligation under this
<U>Section</U><U></U><U>&nbsp;4.5(b)</U> following the expiration of the applicable survival period set forth in <U>Section</U><U></U><U>&nbsp;4.5(n)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) A party that may desire to seek indemnification hereunder (each, an &#147;<U>Indemnified Party</U>&#148;) shall give written notice to
the party indemnifying it (the &#147;<U>Indemnifying Party</U>&#148;) of any claim that does not result from a third party with respect to which it seeks indemnification (a &#147;<U>Direct Claim</U>&#148;) promptly (and, in any event, not later than
fifteen (15)&nbsp;business days) after the first discovery by such Indemnified Party of any fact, event, circumstance, development or matters giving rise to such claim. Such notice (a &#147;<U>Claim Notice</U>&#148;) shall (i)&nbsp;describe such
Direct Claim in reasonable detail (including the facts underlying each particular claim and an identification of all the particular sections of therein pursuant to which indemnification is and will be being sought); (ii) attach copies of any written
evidence or demand upon which such Direct Claim is based (to the extent that such written evidence or demand is not reasonably available at such time, the Indemnified Party shall so indicate and promptly provide such evidence when it becomes
available); and (iii)&nbsp;set forth the estimated amount (broken down by each individual claim) for which the Indemnifying Party may be liable, to the extent then known. The Indemnifying Party shall have thirty (30)&nbsp;days after its receipt of
such notice to respond in writing to the Direct Claim (a &#147;<U>Response Notice</U>&#148;). If the Indemnifying Party does not deliver a Response Notice within such thirty <FONT STYLE="white-space:nowrap">(30)-day</FONT> period, the Indemnifying
Party shall be deemed to have agreed to such claim and the Indemnifying Party&#146;s obligation to indemnify, compensate or reimburse the Indemnified Party for the full amount of all Losses resulting therefrom. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) In case any such action, suit, claim or proceeding is threatened or commenced against an Indemnified Party by any person who is not a
party to this Agreement or an affiliate of any party to this Agreement, with respect to which the Indemnifying Party is or may be obligated to provide indemnification under <U>Section</U><U></U><U>&nbsp;4.5(a)</U> or
<U>Section</U><U></U><U>&nbsp;4.5(b)</U> (as applicable) (a &#147;<U>Third Party Claim</U>&#148;), the Indemnified Party shall, as promptly as reasonably practicable, cause a Claim Notice regarding any Third Party Claim of which it has knowledge
that is covered by this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<U>Section</U><U></U><U>&nbsp;4.5</U> to be delivered to the Indemnifying Party. The Claim Notice shall (i)&nbsp;describe such Third Party Claim in reasonable detail (including the identity of
the applicable third party, the facts underlying each particular claim and an identification of all the particular sections of therein pursuant to which indemnification is and will be being sought); (ii) attach copies of any written evidence or
demand upon which such Third Party Claim is based (to the extent that such written evidence or demand is not reasonably available at such time, the Indemnified Party shall so indicate and promptly provide such evidence when it becomes available);
and (iii)&nbsp;set forth the estimated amount (broken down by each individual claim) for which the Indemnifying Party may be liable, to the extent then known. The Indemnifying Party shall have the right but not the obligation to assume control of
the defense of any Third Party Claim by, no later than the thirtieth (30<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) day after its receipt of such Claim Notice, notifying the Indemnified Party that, subject to the other provisions of
this <U>Section</U><U></U><U>&nbsp;4.5</U>, the Indemnifying Party has elected to conduct and control the defense, negotiation or settlement of the applicable Third Party Claim and any action, suit, claim or proceeding resulting therefrom with
counsel reasonably acceptable to the Indemnified Party and at the Indemnifying Party&#146;s sole cost and expense. If the Indemnifying Party elects to assume the defense of a Third Party Claim, the Indemnified Party will have the right, but not the
obligation, to participate in any such defense and to employ separate counsel of its choosing at its own expense; <U>provided</U> that if the Indemnified Party is advised by outside counsel that an actual conflict of interest (other than one of a
monetary nature) would make it inappropriate for the same counsel to represent both the Indemnifying Party and the Indemnified Party with respect to the Third Party Claim, then the Indemnifying Party shall pay the reasonable, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> and documented fees, costs and expenses of counsel employed by the Indemnified Party; <U>provided</U>, <U>further</U>, that the Indemnifying Party shall only be
liable for the legal fees and expenses for one law firm for all Indemnified Parties (taken together with respect to any single action or group of related actions) in connection with any Third Party Claim (plus one local counsel in each applicable
jurisdiction). If the Indemnifying Party does not assume the defense of the Third Party Claim within the thirty <FONT STYLE="white-space:nowrap">(30)-day</FONT> period referenced in this <U>Section</U><U></U><U>&nbsp;4.5</U>, (x) the Indemnified
Party may defend against the Third Party Claim and (y)&nbsp;the Indemnifying Party will have the right, but not the obligation, to participate in any such defense and to employ separate counsel of its choosing at its own expense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding anything in this <U>Section</U><U></U><U>&nbsp;4.5</U> to the contrary, (i)&nbsp;the Indemnified Party shall not, without
the prior written consent of the Indemnifying Party, (x)&nbsp;consent to the entry of any Order, (y)&nbsp;settle or compromise or (z)&nbsp;enter into any settlement or similar agreement with respect to, any Third Party Claim, unless such Order or
proposed settlement or compromise or agreement (A)&nbsp;involves an unconditional release of the Indemnifying Party in respect of such Third Party Claim and (B)&nbsp;does not contain any admission or finding of wrongdoing on behalf of the
Indemnifying Party and (ii)&nbsp;the Indemnifying Party shall not, without the prior written consent of the Indemnified Party, (x)&nbsp;consent to the entry of any Order, (y)&nbsp;settle or compromise or (z)&nbsp;enter into any settlement or similar
agreement with respect to, any Third Party Claim, unless the Order or proposed settlement or compromise or agreement (A)&nbsp;involves only the payment of money damages against which the Indemnified Party is indemnified in full by the Indemnifying
Party, (B)&nbsp;does not impose an injunction or other equitable relief upon the Indemnified Party, (C)&nbsp;involves an unconditional release of the Indemnified Party in respect of such Third Party Claim and (D)&nbsp;does not involve a finding or
admission of any violation of Law or other wrongdoing by the Indemnified Party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) The failure by an Indemnified Party to timely or properly provide, pursuant to
<U>Section</U><U></U><U>&nbsp;4.5(c)</U> or <U>Section</U><U></U><U>&nbsp;4.5(d)</U>, any Claim Notice to the Indemnifying Party shall not relieve the Indemnifying Party of its obligations hereunder, except to the extent, and only to the extent
that, the Indemnifying Party is actually and directly prejudiced by such failure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) For purposes of the indemnity contained in
<U>Section</U><U></U><U>&nbsp;4.5(a)(i)</U> and <U>Section</U><U></U><U>&nbsp;4.5(b)(i)</U>, all qualifications and limitations set forth in such representations and warranties as to &#147;materiality,&#148; &#147;Material Adverse Effect&#148; and
words of similar import (other than <U>Section</U><U></U><U>&nbsp;2.2(f)(i)(B)</U>, <U>Section</U><U></U><U>&nbsp;2.2(f)(iii)(A)</U> and <U>Section</U><U></U><U>&nbsp;2.2(k)(iv)</U>), shall be disregarded in determining whether there shall have been
any inaccuracy in or breach of any representations and warranties in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) Except in the case of any inaccuracy or breach
of any Company Fundamental Reps, the Company shall not be required to indemnify the Indemnified Parties pursuant to <U>Section</U><U></U><U>&nbsp;4.5(a)(i)</U>, (i)&nbsp;with respect to any individual claim (or group of related claims) for
indemnification if the amount of Losses with respect to such individual claim (or group of related claims) is less than $100,000 (any individual claim (or group of related claims) involving Losses less than such amount being referred to as a
&#147;<U>De Minimis Claim</U>&#148;) and (ii)&nbsp;unless and until the aggregate amount of all Losses incurred with respect to all claims (other than De Minimis Claims) pursuant to <U>Section</U><U></U><U>&nbsp;4.5(a)(i)</U> exceeds an amount equal
to 1.5% of the Investment Amount (such amount, the &#147;<U>Threshold Amount</U>&#148;), in which event the Company shall be responsible for only the amount of such Losses in excess of the Threshold Amount, but subject to the last sentence of this
<U>Section</U><U></U><U>&nbsp;4.5(h)</U>. Except in the case of any inaccuracy or breach of any Purchaser Fundamental Reps, Purchaser shall not be required to indemnify the Indemnified Parties pursuant to <U>Section</U><U></U><U>&nbsp;4.5(b)(i)</U>,
(1)&nbsp;with respect to any De Minimis Claim and (2)&nbsp;unless and until the aggregate amount of all Losses incurred with respect to all claims (other than De Minimis Claims) pursuant to <U>Section</U><U></U><U>&nbsp;4.5(b)(i)</U> exceeds the
Threshold Amount, in which event Purchaser shall be responsible for only the amount of such Losses in excess of the Threshold Amount, but subject to the last sentence of this <U>Section</U><U></U><U>&nbsp;4.5(h)</U>. Except in the case of any
inaccuracy or breach of any Company Fundamental Reps or Purchaser Fundamental Reps, the cumulative indemnification obligation of (x)&nbsp;the Company under <U>Section</U><U></U><U>&nbsp;4.5(a)</U> shall in no event exceed 10% of the Investment
Amount and (y)&nbsp;Purchaser under <U>Section</U><U></U><U>&nbsp;4.5(b)</U> shall in no event exceed 10% of the Investment Amount. In the case of any inaccuracy or breach of any Company Fundamental Reps or Purchaser Fundamental Reps, the cumulative
indemnification obligation of (x)&nbsp;the Company under <U>Section</U><U></U><U>&nbsp;4.5(a)</U> shall in no event exceed the Investment Amount and (y)&nbsp;Purchaser under <U>Section</U><U></U><U>&nbsp;4.5(b)</U> shall in no event exceed the
Investment Amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Any claim for indemnification pursuant to <U>Section</U><U></U><U>&nbsp;4.5</U> can only be brought on or prior
to the eighteen (18)&nbsp;month anniversary of the Closing Date; <U>provided</U>, that (i)&nbsp;a claim for indemnification pursuant to <U>Section</U><U></U><U>&nbsp;4.5(a)(i)</U> in respect of an inaccuracy of any of the representations of the
Company set forth in <U>Section</U><U></U><U>&nbsp;2.2(a)(i)</U>, <U>Section</U><U></U><U>&nbsp;2.2(b)(i)</U>, <U>Section</U><U></U><U>&nbsp;2.2(b)(ii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(c)(i)</U>,
<U>Section</U><U></U><U>&nbsp;2.2(c)(ii)(A)</U>, <U>Section</U><U></U><U>&nbsp;2.2(c)(iii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(g)</U> and <U>Section</U><U></U><U>&nbsp;2.2(v)</U> (each, a &#147;<U>Company Fundamental Rep</U>&#148;) or pursuant to
<U>Section</U><U></U><U>&nbsp;4.5(b)(i)</U> in respect of any of the representations of Purchaser set forth in <U>Section</U><U></U><U>&nbsp;2.3(a)</U>, <U>Section</U><U></U><U>&nbsp;2.3(b)(ii)</U> and <U>Section</U><U></U><U>&nbsp;2.3(l)</U> (each,
a &#147;<U>Purchaser Fundamental Rep</U>&#148;), in each case, can be brought on or prior to the third (3<SUP STYLE="font-size:75%; vertical-align:top">rd</SUP>) anniversary of the Closing Date and (ii)&nbsp;if a compliant notice of a valid claim
for indemnification </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
pursuant to <U>Section</U><U></U><U>&nbsp;4.5(a)</U> or <U>Section</U><U></U><U>&nbsp;4.5(b)</U> is duly provided prior to the end of the applicable foregoing survival period with respect
thereto, then the obligation to indemnify, defend and hold harmless in respect of such inaccuracy or breach shall survive as to such claim until such claim has been finally resolved. Except for a claim of Fraud, the indemnity provided for in this
<U>Section</U><U></U><U>&nbsp;4.5</U> shall be the sole and exclusive monetary remedy of Indemnified Parties after the Closing for any inaccuracy in or breach of any representation or warranty or any breach of any covenant or agreement contained in
this Agreement to be performed at or prior to the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) Where one and the same set of facts, circumstances or events qualifies
under more than one provision entitling an Indemnified Party to a claim or remedy hereunder, such Indemnified Party shall not be entitled to duplicative recovery of Losses arising out of such facts, circumstances or events. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k) Each Indemnified Party shall use commercially reasonable efforts to mitigate any Loss upon and after obtaining knowledge of any event,
set of facts, circumstance or occurrence that would reasonably be expected to give rise to any Loss that would reasonably be expected to give rise to an indemnity obligation pursuant to this <U>Section</U><U></U><U>&nbsp;4.5</U>. In the event that
an Indemnified Party shall fail to use commercially reasonable efforts to mitigate any such Loss, then notwithstanding anything contained herein to the contrary, the Indemnifying Party shall not be required to indemnify any Indemnified Party for
that portion of any Losses that would reasonably be expected to have been avoided if all Indemnified Parties had made such efforts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(l)
If an Indemnified Party has or may have a right to recover any Loss against or from any third party (including any insurance company in its capacity as an insurer), such Indemnified Party shall use commercially reasonable efforts to seek recovery
against and from such third party and if the Indemnified Party recovers any such amount from such third party after the Indemnifying Party makes any payment pursuant to this <U>Section</U><U></U><U>&nbsp;4.5</U> in respect of such Loss, then the
Indemnified Party shall promptly remit to the Indemnifying Party the lesser of the amount previously paid by the Indemnifying Party to the Indemnified Party in respect of such Loss and the amount the Indemnified Party received from such third party
in respect of such Loss (net of all reasonable costs of collection). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(m) Any indemnification payments pursuant to this
<U>Section</U><U></U><U>&nbsp;4.5</U> shall be treated as an adjustment to the Investment Amount for the Securities for U.S. federal income and applicable state and local Tax purposes, except to the extent otherwise required by a
&#147;determination&#148; within the meaning of Section&nbsp;1313(a) of the Code (or any similar provision of state or local Law). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(n)
Each of the representations and warranties set forth herein shall survive the Closing under this Agreement for a period of eighteen (18)&nbsp;months following the Closing Date and, thereafter, except in the case of Fraud, shall expire and have no
force and effect, including in respect of this <U>Section</U><U></U><U>&nbsp;4.5</U>; <U>provided</U>, however, that the Company Fundamental Reps and the Purchaser Fundamental Reps shall survive the Closing under this agreement for a period of <FONT
STYLE="white-space:nowrap">thirty-six</FONT> (36)&nbsp;months following the Closing Date, in each case, subject to <U>Section</U><U></U><U>&nbsp;4.5(i)</U>. Except as otherwise provided herein, all covenants and agreements contained herein, other
than those which by their terms are to be performed in whole or in part after the Closing Date (which shall survive in accordance with their terms), shall survive the closing under this Agreement for a period of twelve (12)&nbsp;months following the
Closing Date (or until final resolution of any claim or action arising from the breach of such covenant if notice of such breach was provided prior to the end of such period). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6 <U>Exchange Listing</U>. Prior to and, if necessary, following the Closing,
the Company shall use reasonable best efforts to cause (a)&nbsp;the shares of Common Stock (i)&nbsp;issued hereunder and (ii)&nbsp;to be issued upon the Conversions, (b)&nbsp;the Permanent Warrants and (c)&nbsp;the warrants on the terms described on
<U>Exhibit G</U>, in each case, to be approved for listing on the NYSE, subject to official notice of issuance and upon receipt of the Requisite Stockholder Vote (if applicable). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7 <U>Certificate of Designations</U>. In connection with the Closing, the Company shall file each of the Certificate of
Designations with the Delaware Secretary of State. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8 <U>State Securities Laws</U>. The Company shall use commercially
reasonable efforts to obtain all necessary permits and qualifications, if any, or secure an exemption therefrom, required by any state or country pursuant to Laws prior to the offer and sale by Purchaser of Common Stock and/or the Preferred Stock.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.9 <U>Company Opportunities</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Except as expressly provided in this Agreement, Purchaser and any related investment funds, each Board Representative, and any of their
respective affiliates, have the right to, and shall have no duty (contractual or otherwise) not to (i)&nbsp;invest in, carry on and conduct, whether directly, or as a partner in any partnership, or as a joint venturer in any joint venture, or as an
officer, director, stockholder, equityholder or investor in any person, or as a participant in any syndicate, pool, trust or association, any business of any kind, nature or description, whether or not such business is competitive with or in the
same or similar lines of business as the Company or any of its Subsidiaries, (ii)&nbsp;do business with any client, customer, vendor or lessor of any of the Company or its affiliates or (iii)&nbsp;make investments in any kind of property in which
the Company may make investments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) In the event that Purchaser or any related investment funds, the Board Representatives or any of
their respective affiliates, acquires knowledge of a potential transaction or matter that may be a corporate opportunity for the Company or any of its Subsidiaries, none of Purchaser or any related investment funds, each Board Representative or any
of their respective affiliates, shall have any duty (contractual or otherwise) to communicate or present such corporate opportunity to the Company or to refrain from pursuing or acquiring such corporate opportunity for its own benefit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) None of Purchaser, any related investment fund, each Board Representative or any of their respective affiliates shall be liable to the
Company or any of its Subsidiaries or stockholders of the Company for breach of any duty (contractual or otherwise) by reason of the fact that Purchaser or any related investment fund thereof, each Board Representative or any of their respective
affiliates pursues or acquires such opportunity for itself, directs such opportunity to another person, or does not present such opportunity to the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding <U>Section</U><U></U><U>&nbsp;4.9(a)</U>-<U>(c)</U>, if each Board
Representative is presented with any potential transaction or corporate opportunity solely and expressly in his or her capacity as a member of the Board of Directors and that is specifically identified as a potential transaction or corporate
opportunity for the Company or its Subsidiaries (a &#147;<U>Company Opportunity</U>&#148;), then each Board Representative shall be required to first present such Company Opportunity to the Company prior to each Board Representative&#146;s pursuit
of, or investment in, such Company Opportunity. The Company shall not treat the Board Representatives differently with respect to Corporate Opportunities relative to how the Company treats other members of the Board of Directors with respect to
Corporate Opportunities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10 <U>No Recourse</U>. This Agreement may only be enforced against, and any actions, suits,
proceedings, claims, demands, disputes, cross claims, counterclaims or causes of action (whether in contract or tort or otherwise) that may be based upon, arise out of or relate to this Agreement or any Other Investment Agreement or the transactions
contemplated hereby or thereby, or the negotiation, execution or performance of this Agreement or any Other Investment Agreement or the transactions contemplated hereby or thereby, may be made only against the entities that are expressly identified
as the party or parties to such agreement(s). No person who is not a party hereto, including any past, present or future direct or indirect equityholder, director, officer, employee, incorporator, member, manager, partner, affiliate, agent,
attorney, financing source, assignee or representative of any party hereto or its affiliates or any former, current or future direct or indirect equityholder, director, officer, employee, incorporator, agent, attorney, representative, partner,
member, manager, affiliate, agent, assignee or representative of any of the foregoing (&#147;<U><FONT STYLE="white-space:nowrap">Non-Party</FONT> Affiliates</U>&#148;), shall have any liability (whether in contract or in tort, in law or in equity,
or based upon any theory that seeks to impose liability of an entity party against its owners or affiliates) to any other party hereto (or its affiliates) for any obligations or liabilities arising under, in connection with or related to this
Agreement or the transactions contemplated hereby, or for any claim based on, in respect of, or by reason of this Agreement or the transactions contemplated hereby, or the negotiation, execution or performance of this Agreement or the transactions
contemplated hereby, and each party hereto irrevocably and unconditionally waives and releases all such liabilities, claims and obligations against any such <FONT STYLE="white-space:nowrap">Non-Party</FONT> Affiliates. Notwithstanding the foregoing,
nothing in this <U>Section</U><U></U><U>&nbsp;4.10</U> shall (or is meant to) limit in any manner the rights and obligations of Liberty 77 Capital, L.P. under the Confidentiality Agreement, to the extent expressly provided therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.11 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The Company shall pay any and all transfer Taxes, stamp Taxes or duties, documentary Taxes, or other similar Taxes imposed upon the
issuance of shares of Common Stock or Preferred Stock pursuant to this Agreement or the issuance of shares of Common Stock on account of the conversion of Preferred Stock pursuant to the Certificate of Designations; <U>provided</U> that the Company
shall not be required to pay any such Tax that may be payable in connection with any issuance of Common Stock pursuant to a conversion of Preferred Stock to the extent such Tax is payable because a registered holder of Preferred Stock requests
Common Stock to be registered in a name other than such registered holder&#146;s name (including in connection with any Convertible Transfer (as defined in the Certificate of Designations)) and, no such Common Stock will be so registered unless and
until the registered holder making such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
request has paid such taxes to the Company or has established to the satisfaction of the Company that such taxes have been paid or are not payable. The Company and Purchaser shall reasonably
cooperate to avoid or minimize the imposition of transfer Taxes, stamp Taxes or duties, documentary Taxes, or other similar Taxes described in the first sentence of this <U>Section</U><U></U><U>&nbsp;4.11</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything herein or in the Certificate of Designations to the contrary, the Company and any applicable withholding agent
shall be entitled to deduct and withhold from any consideration otherwise payable on or with respect to the Common Stock or Preferred Stock (including upon conversion of any Preferred Stock) such amounts as it is required to deduct or withhold with
respect to the making of such payment under the Code or any other applicable Tax Law. If the holder of Preferred Stock is deemed for U.S. federal income tax purposes to have received a distribution with respect to the Preferred Stock, the Company or
an applicable withholding agent may satisfy any resulting applicable withholding obligations (including with respect to backup withholding) imposed in connection with such deemed distribution by withholding from any other payments due with respect
to the Preferred Stock or Common Stock, including any payments upon conversion, repurchase or redemption of the Preferred Stock or Common Stock to the extent required by applicable Tax Law. If any amounts are so deducted or withheld and subsequently
paid to the applicable Governmental Entity, such deducted or withheld amounts shall be treated for all purposes of this Agreement and the Certificate of Designations as having been paid to the person to which such amounts would have otherwise been
payable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Following the Closing, if the Company becomes aware that an event or other occurrence has occurred that, if the Preferred
Stock were treated as &#147;preferred stock&#148; for purposes of Section&nbsp;305 of the Code, would cause a deemed distribution, with respect to the Preferred Stock, pursuant to Section&nbsp;305(c) of the Code, the Company shall use commercially
reasonable efforts to notify Purchaser of such event or occurrence and shall consult with Purchaser in good faith regarding the treatment of such event or occurrence. The Company and Purchaser agree that there shall be no deemed distribution on the
Preferred Stock pursuant to Section&nbsp;305(c) of the Code in respect of a difference between the &#147;issue price&#148; and the &#147;redemption price&#148; of the Preferred Stock and except to the extent otherwise required by a
&#147;determination&#148; within the meaning of Section&nbsp;1313(a) of the Code, neither the Company nor Purchaser shall take any position inconsistent therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) Following the Closing, Purchaser shall provide the Company with a proposed allocation of the Investment Amount among the shares of Common
Stock and Preferred Stock delivered at the Closing and the Permanent Warrant for U.S. tax purposes. The Company may propose reasonable comments to the proposed allocation within fifteen (15)&nbsp;days of receiving the proposed allocation, and
Purchaser shall consider such comments in good faith. Thereafter, Purchaser shall provide the Company with a final allocation for U.S. tax purposes and such final allocation shall be binding on Purchaser and the Company for all U.S. tax purposes. In
the event that the Company issues additional warrants to Purchaser pursuant to <U>Section</U><U></U><U>&nbsp;3.1(h)</U> of this Agreement, Purchaser shall provide a proposed adjusted allocation to the Company, which may propose reasonable comments
to the proposed adjusted allocation within fifteen (15)&nbsp;days of receiving the proposed adjusted allocation, and Purchaser shall consider such comments in good faith. Thereafter, Purchaser shall provide the Company with a final adjusted
allocation for U.S. tax purposes and such final adjusted allocation shall be binding on Purchaser and the Company for all U.S. tax purposes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.12 <U>Transaction Expenses</U>. Promptly following the Closing, the Company
shall reimburse Purchaser for Purchaser&#146;s reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred in connection with the evaluation, negotiation and
implementation of the Investment and the other transactions contemplated by this Agreement; <U>provided</U> that the Company&#146;s obligations for expense reimbursement pursuant to this <U>Section</U><U></U><U>&nbsp;4.12</U> shall be limited to a
cap of $900,000. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;V </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TERMINATION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1 <U>Termination</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) This Agreement may be terminated prior to the Closing: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) by mutual written agreement of the Company and Purchaser; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) by the Company or Purchaser, upon written notice to the other party, in the event that the Closing does not occur on or
before the tenth (10<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) business day following date hereof (such date, the &#147;<U>Termination Date</U>&#148;); <U>provided</U>, <U>however</U>, that the right to terminate this Agreement
pursuant to this <U>Section</U><U></U><U>&nbsp;5.1(a)(ii)</U> shall not be available to any party whose failure to fulfill any obligation under this Agreement shall have been the cause of, or shall have resulted in, the failure of the Closing to
occur on or prior to such date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) by the Company (<U>provided</U> that the Company is not then in material breach of
any representation, warranty, covenant or other agreement contained herein that is a condition to Purchaser&#146;s obligation to effect the Closing), if there shall have been a breach of any of the covenants or agreements or any of the
representations or warranties set forth herein on the part of Purchaser, which breach, either individually or in the aggregate with all other breaches by Purchaser, would constitute, if occurring or continuing as of the Closing, the failure of a
condition set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)(iii)</U>, and which is not cured prior to the Termination Date following written notice to Purchaser, or by its nature or timing cannot be cured during such period (or such fewer days as
remain prior to the Termination Date); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) by Purchaser (<U>provided</U> that Purchaser is not then in material
breach of any representation, warranty, covenant or other agreement contained herein that is a condition to the Company&#146;s obligation to effect the Closing), if there shall have been a breach of any of the covenants or agreements contained
herein or any of the representations or warranties set forth herein on the part of the Company, which breach, either individually or in the aggregate with all such other breaches by the Company, would constitute, if occurring or continuing as of the
Closing, the failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)(ii)</U>, and which is not cured prior to the Termination Date following written notice to Purchaser, or by its nature or timing cannot be cured during such period
(or such fewer days as remain prior to the Termination Date). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Following the Closing, <U>Section</U><U></U><U>&nbsp;3.1(c)</U>,
<U>Section</U><U></U><U>&nbsp;4.1</U>, <U>Section</U><U></U><U>&nbsp;4.2</U>, <U>Section</U><U></U><U>&nbsp;4.4</U> and <U>Section</U><U></U><U>&nbsp;4.9</U> shall automatically terminate on the date that Purchaser (together with its affiliates)
ceases to own any shares of capital stock of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2 <U>Effect of Termination</U>. In the event of any termination
of this Agreement as provided in <U>Section</U><U></U><U>&nbsp;5.1</U>, this Agreement (other than <U>Section</U><U></U><U>&nbsp;3.3(a)</U>, <U>Section</U><U></U><U>&nbsp;3.4</U>, this <U>Section</U><U></U><U>&nbsp;5.2</U> and <U>Article VI</U>,
which shall remain in full force and effect) shall forthwith become wholly void and of no further force and effect, and none of the Company, Purchaser, any of their respective affiliates or any of the officers, directors, members or partners of any
of them shall have any liability of any nature whatsoever hereunder, or in connection with the transactions contemplated hereby; <U>provided</U> that nothing herein shall relieve any party hereto from any liability for Fraud or willful and
intentional breach of any covenant or agreement expressly set forth herein. &#147;Fraud&#148; means an intentional misrepresentation with respect to a representation or warranty set forth in <U>Section</U><U></U><U>&nbsp;2.2</U> or
<U>Section</U><U></U><U>&nbsp;2.3</U>, which such intentional misrepresentation was (i)&nbsp;inaccurate on the date hereof, and (ii)&nbsp;made with (A)&nbsp;the specific intent of deceiving and inducing the other party to enter into this Agreement
and upon which the other party actually relied to its detriment, and (B)&nbsp;actual knowledge (without any duty of investigation or inquiry) of the inaccuracy of such intentional misrepresentation; <U>provided</U> that &#147;Fraud&#148; shall not
include any claim (including equitable fraud, promissory fraud and unfair dealings fraud) based on constructive knowledge, recklessness, negligent misrepresentation or a similar theory. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;VI </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MISCELLANEOUS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1 <U>Amendment</U>. This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or
otherwise, except by a written instrument signed on behalf of each of the parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2 <U>Extension; Waiver</U>. Each party
may, to the extent permitted by Law, (a)&nbsp;extend the time for the performance of any of the obligations or other acts of the Company, in the case of Purchaser, or Purchaser, in the case of the Company, (b)&nbsp;waive any inaccuracies in the
representations and warranties contained herein or in any document delivered pursuant hereto on the part of the Company, in the case of Purchaser, or Purchaser, in the case of the Company, and (c)&nbsp;waive compliance with any of the agreements or
satisfaction of any conditions for its benefit contained herein. Any agreement on the part of a party to any such extension or waiver shall be valid only if set forth in a written instrument signed on behalf of such party, but such extension or
waiver or failure to insist on strict compliance with an obligation, covenant, agreement or condition shall not operate as a waiver of, or estoppel with respect to, any subsequent or other failure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3 <U>Expenses</U>. Except as otherwise expressly set forth herein, including in <U>Section</U><U></U><U>&nbsp;4.12</U>, all
costs, fees and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such cost, fee or expense. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4 <U>Notices</U>. All notices and other communications hereunder shall be in
writing and shall be deemed duly given on (a)&nbsp;the date of delivery if delivered personally, or if by email, upon delivery (<U>provided</U> that no auto-generated error or <FONT STYLE="white-space:nowrap">non-delivery</FONT> or similar message
is generated in response thereto), (b)&nbsp;the first (1st) business day following the date of dispatch if delivered utilizing a <FONT STYLE="white-space:nowrap">next-day</FONT> service by a recognized
<FONT STYLE="white-space:nowrap">next-day</FONT> courier or (c)&nbsp;the earlier of confirmation of receipt or the fifth (5th) business day following the date of mailing if delivered by registered or certified mail, return receipt requested, postage
prepaid. All notices hereunder shall be delivered to the addresses set forth below, or pursuant to such other instructions as may be designated in writing by the party to receive such notice: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to the Company, to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">NEW YORK COMMUNITY BANCORP, INC. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">102 Duffy Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Hicksville,
New York 11801 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: &#8195;&#8195;R. Patrick Quinn </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Senior Executive Vice President, General Counsel and Corporate Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: &#8195;&#8195;&#8194;Patrick.Quinn@flagstar.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">With a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">One Manhattan West </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">New York,
NY 10001 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: Sven Mickisch; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Christopher M. Barlow; </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Matthew
Nemeroff </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: Sven.Mickisch@skadden.com; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Christopher.Barlow@skadden.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Matthew.Nemeroff@skadden.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">and </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to Purchaser, to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Liberty Strategic Capital (CEN) Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">c/o Liberty 77 Capital L.P. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">2099 Pennsylvania Avenue NW </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20006 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: [Reserved.] </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email:
[Reserved.] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">With a copy (which shall not constitute notice) to </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Sullivan&nbsp;&amp; Cromwell LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">125 Broad Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">New York, NY
10004 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: H. Rodgin Cohen </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Mark J. Menting </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Jared M.
Fishman </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: cohenhr@sullcrom.com; mentingm@sullcrom.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">FishmanJ@sullcrom.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5 <U>Interpretation</U>. The parties have participated jointly in negotiating and drafting this Agreement. In the event that an
ambiguity or a question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of
any provision hereof. When a reference is made in this Agreement to Articles, Sections, Exhibits or Schedules, such reference shall be to an Article or Section of or Exhibit or Schedule to this Agreement, unless otherwise indicated. The table of
contents and headings contained herein are for reference purposes only and shall not affect in any way the meaning or interpretation hereof. Whenever the words &#147;include,&#148; &#147;includes&#148; or &#147;including&#148; are used herein, they
shall be deemed to be followed by the words &#147;without limitation.&#148; The word &#147;or&#148; shall not be exclusive. References to &#147;the date hereof&#148; mean the date of this Agreement. Notwithstanding anything herein to the contrary,
neither Purchaser nor any of its affiliates and neither the Company nor any of its Subsidiaries shall be required to take any action that is prohibited by Law or any Governmental Entity. As used herein, the &#147;<U>knowledge</U>&#148; of Purchaser
means the actual knowledge of any of the officers of Purchaser, and the &#147;knowledge&#148; of the Company means the actual knowledge of any of the officers of the Company listed on <U>Section</U><U></U><U>&nbsp;6.5</U> of the Company Disclosure
Schedule. As used herein, (a)&nbsp;&#147;<U>business day</U>&#148; means any day other than a Saturday, a Sunday or a day on which banks in New York, New York are authorized by Law to be closed, (b)&nbsp;&#147;<U>person</U>&#148; means any
individual, corporation (including <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit),</FONT></FONT> general or limited partnership, limited liability company, joint venture, estate, trust, association, organization,
Governmental Entity or other entity of any kind or nature, (c)&nbsp;an &#147;affiliate&#148; of a specified person is any person that, directly or indirectly, controls, is controlled by, or is under common control with, such specified person;
<U>provided</U> that &#147;affiliate&#148; shall not include any &#147;portfolio company&#148; (as such term is customarily used in the private equity industry) of any investment fund affiliated with or managed by such person or any investment fund
or vehicle (other than any such fund or vehicle with a direct or indirect interest in such person) of or related to or affiliated with such person, (d)&nbsp;&#147;<U>party</U>&#148; means a party to this Agreement, unless the context clearly
suggests otherwise, (e)&nbsp;&#147;<U>made available</U>&#148; means any document or other information provided by one party to the other party, including any document or other information that was (i)&nbsp;included in the virtual data room of a
party at least one (1)&nbsp;business day prior to the date hereof or (ii)&nbsp;filed by a party with the SEC since January&nbsp;1, 2023 and publicly available on EDGAR at least one (1)&nbsp;business day prior to the date hereof, (f)&nbsp;the
&#147;<U>transactions contemplated hereby</U>&#148; and &#147;<U>transactions contemplated by this Agreement</U>&#148; shall include the purchase and sale of Securities contemplated by <U>Section</U><U></U><U>&nbsp;1.1</U>,
(g)&nbsp;&#147;<U>ordinary course</U>&#148; and &#147;<U>ordinary course of business</U>&#148; with respect to either party, means conduct consistent with past practice and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the normal <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> customs, practices and procedures of such party, taking into account any changes to such
practices as may have occurred in response to any Pandemic, including compliance with Pandemic Measures, (h) &#147;<U>U.S.</U>&#148; means the United States of America and (i) &#147;<U>extent</U>&#148; in the phrase &#147;to the extent&#148; means
the degree to which a subject or other thing extends and such phrase shall not mean simply &#147;if&#148;. Any reference herein to any statute, includes all amendments thereto and all rules and regulations promulgated thereunder. The Company
Disclosure Schedule, as well as all other schedules and all exhibits hereto, shall be deemed part of this Agreement and included in any reference to this Agreement. All references to &#147;dollars&#148; or &#147;$&#148; herein are to U.S. dollars.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6 <U>Counterparts</U>. This Agreement may be executed in counterparts, all of which shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each of the parties and delivered to the other party, it being understood that all parties need not sign the same counterpart. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7 <U>Entire Agreement</U>. This Agreement (including the documents and the instruments referred to herein), together with the
Registration Rights Agreement and Confidentiality Agreement, constitute the entire agreement among the parties and supersede all prior agreements and understandings, written, oral or otherwise, among the parties with respect to the subject matter
hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.8 <U>Governing Law; Jurisdiction</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) This Agreement shall be governed by, construed and enforced in accordance with the laws of the State of Delaware, without regard to any
applicable conflicts of law principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Each party agrees that it will bring any action, suit, litigation, dispute or proceeding in
respect of any claim arising out of or related to this Agreement or the transactions contemplated hereby exclusively in the Delaware Court of Chancery and any state appellate court therefrom within the State of Delaware, or, if the Delaware Court of
Chancery declines to accept jurisdiction over a particular matter, any federal or state court of competent jurisdiction located in the State of Delaware (the &#147;<U>Chosen Courts</U>&#148;), and, solely in connection with claims arising under this
Agreement or the transactions that are the subject of this Agreement, (i)&nbsp;irrevocably submits to the exclusive jurisdiction of the Chosen Courts, (ii)&nbsp;waives any objection (A)&nbsp;to laying venue in any such action, suit, litigation,
dispute or proceeding in the Chosen Courts and (B)&nbsp;that the Chosen Courts are an inconvenient forum or do not have jurisdiction over any party and (iii)&nbsp;agrees that service of process upon such party in any such action, suit, litigation,
dispute or proceeding will be effective if notice is given in accordance with <U>Section</U><U></U><U>&nbsp;6.4</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.9
<U>Waiver of Jury Trial</U>. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE HEREUNDER IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND, THEREFORE, EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE
EXTENT PERMITTED BY LAW AT THE TIME OF INSTITUTION OF THE APPLICABLE LITIGATION, ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY ACTION, SUIT, LITIGATION, DISPUTE OR PROCEEDING, DIRECTLY OR
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
INDIRECTLY, ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE
OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY SUCH ACTION, SUIT, LITIGATION, DISPUTE OR PROCEEDING, SEEK TO ENFORCE THE FOREGOING WAIVER, (B)&nbsp;IT UNDERSTANDS AND HAS CONSIDERED THE
IMPLICATIONS OF THIS WAIVER, (C)&nbsp;IT MAKES THIS WAIVER VOLUNTARILY, AND (D)&nbsp;IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <U>SECTION</U><U></U><U>&nbsp;6.9</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10 <U>Assignment; Third-Party Beneficiaries</U>. Neither this Agreement nor any of the rights, interests or obligations
hereunder shall be assigned by any of the parties (whether by operation of law or otherwise) without the prior written consent of Purchaser, in the case of the Company, or the Company, in the case of Purchaser. Any purported assignment in
contravention hereof shall be null and void. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns, other than as expressly set
forth herein (including <U>Section</U><U></U><U>&nbsp;4.9</U> and <U>Section</U><U></U><U>&nbsp;4.10</U>). Except as set forth in the foregoing sentence or otherwise expressly set forth herein (including <U>Section</U><U></U><U>&nbsp;4.10</U>), this
Agreement (including the documents and instruments referred to herein) is not otherwise intended to, and does not, confer upon any person other than the parties, any rights or remedies hereunder, including the right to rely upon the representations
and warranties set forth herein; <U>provided</U>, however, that the Placement Agents/Arrangers shall be a third party beneficiary of this Agreement solely with respect to <U>Section</U><U></U><U>&nbsp;2.2</U> and
<U>Section</U><U></U><U>&nbsp;2.3</U>, and may rely upon the representations and warranties contained therein. The representations and warranties herein are the product of negotiations among the parties and are for the sole benefit of the parties.
Any inaccuracies in such representations and warranties are subject to waiver by the parties in accordance herewith without notice or liability to any other person. In some instances, the representations and warranties herein may represent an
allocation among the parties of risks associated with particular matters regardless of the knowledge of any of the parties. Consequently, persons other than the parties may not rely upon the representations and warranties herein as characterizations
of actual facts, events, developments or circumstances as of the date hereof or as of any other date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.11 <U>Specific
Performance</U>. The parties agree that irreparable damage would occur if any provision hereof were not performed in accordance with its specific terms or otherwise breached. Accordingly, the parties shall be entitled to specific performance of the
terms hereof, including an injunction or injunctions to prevent breaches or threatened breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof (including the parties&#146; obligation to consummate the
Investment), in addition to any other remedy to which they are entitled at Law or in equity. Each party further waives any (a)&nbsp;defense in any action, suit, litigation, dispute or proceeding for specific performance that a remedy at Law would be
adequate and (b)&nbsp;requirement under any Law to post security or a bond as a prerequisite to obtaining equitable relief. A party&#146;s pursuit of an injunction, specific performance or other equitable remedies at any time shall not be deemed an
election of remedies or waiver of the right to pursue any other right or remedy to which such party may be entitled. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.12 <U>Severability</U>. Whenever possible, each provision or portion of any
provision of this Agreement shall be interpreted in such manner as to be effective and valid under Law, but if any provision or portion of any provision hereof is held to be invalid, illegal or unenforceable in any respect under any Law in any
jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision or portion of any provision in such jurisdiction, and this Agreement shall be reformed, construed and enforced in such jurisdiction such that the
invalid, illegal or unenforceable provision or portion thereof shall be interpreted to be only so broad as is enforceable. Further, if any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be
invalid, illegal, void or unenforceable, the parties hereto shall use their best efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or
restriction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.13 <U>Confidential Supervisory Information</U>. Notwithstanding any other provision herein, no disclosure,
representation or warranty shall be made (or other action taken) pursuant hereto that would involve the disclosure of confidential supervisory information (including confidential supervisory information as defined or identified in 12 C.F.R.
&#167;&nbsp;4.32(b), 12&nbsp;C.F.R. &#167; 261.2(b) and 12 C.F.R. &#167;&nbsp;309.5(g)(8)) of a Governmental Entity by any party to the extent prohibited by Law; <U>provided</U> that, to the extent legally permissible, appropriate substitute
disclosures or actions shall be made or taken under circumstances in which the limitations of this <U>Section</U><U></U><U>&nbsp;6.13</U> apply in order that those limitations do not have the effect of misleading any party hereto, which substitute
actions may include diligence calls and communications by Purchaser (or its counsel) with the Company, its counsel, or its regulators. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.14 <U>Delivery by Electronic Transmission</U>. This Agreement and any signed agreement or instrument entered into in connection
herewith, and any amendments or waivers hereto or thereto, to the extent signed and delivered by email delivery of a &#147;.pdf&#148; format data file or other electronic means, shall be treated in all manner and respects as an original agreement or
instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No party or to any such agreement or instrument shall raise the use of email delivery of a
&#147;.pdf&#148; format data file or other electronic means to deliver a signature hereto or any amendment hereto or the fact that any signature or agreement or instrument was transmitted or communicated through the use of email delivery of a
&#147;.pdf&#148; format data file or other electronic means as a defense to the formation of a contract and each party forever waives any such defense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature page follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF,</B> this Agreement has been duly executed and delivered by the duly
authorized officers of the parties as of the date first herein above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">NEW YORK COMMUNITY BANCORP, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ R. Patrick Quinn</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: R. Patrick Quinn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: General Counsel &amp; Corporate Secretary</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Investment Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">LIBERTY STRATEGIC CAPITAL (CEN) HOLDINGS, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jesse Burwell</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Jesse Burwell</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Treasurer, Chief Financial Officer, Senior Managing Director and Chief Compliance Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Investment Agreement</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit G </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Stockholder Vote Warrant Terms </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Term</U>: 10
year warrants </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Strike price</U>: $2.00 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Settlement</U>: Cash </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Warrant coverage</U>: If Requisite
Stockholder Vote is not obtained by the date that is the 180th day after the Closing Date, Purchaser will receive cash settled warrants with warrant coverage of 160% with a strike price set at the deal price. The warrant becomes exercisable 60 days
after issuance if the Requisite Stockholder Vote is not obtained by such date. If the Requisite Stockholder Vote is obtained prior to such date, the warrant will be cancelled in full. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, warrant coverage will increase by 20% every 60 days thereafter if the Requisite Stockholder Vote is not obtained; provided that the maximum
warrant coverage shall not exceed 220%. The additional 20% will not be exercisable and will cancelled if the Requisite Stockholder Vote is obtained in the 60 days after issuance. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Example Calculations </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="18%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Days after Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Warrant&nbsp;Issued<BR>(total&nbsp;warrant)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Warrant&nbsp;Exercisable</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Warrants&nbsp;subject&nbsp;to<BR>cancelation</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">180</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">160%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">160</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">240</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20%(180%)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">160</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">300</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20%(200%)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">180</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">360</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20%(220%)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">420</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0 (220%)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">220</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Transfer Restrictions</U>: Not subject to any transfer restrictions other than applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Registration &amp; Listing</U>: The Company will use reasonable efforts to register and if possible, list, the warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Documentation</U>: If the Requisite Stockholder Vote is not obtained by the date that is the 180<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day
after the Closing Date, the Company and Purchaser shall use reasonable best efforts to, as promptly as reasonably practicable, agree upon a form of warrant agreement and preferred certificate of designation; terms to be consistent with other warrant
and other preferred in an agreed upon deal, except as noted; terms to ensure that neither warrant nor underlying stock are &#147;voting securities&#148; for bank regulatory purposes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>8
<FILENAME>d763888dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT 10.2 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXECUTION FORM </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTMENT
AGREEMENT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">by and between </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">NEW YORK COMMUNITY BANCORP, INC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[HUDSON BAY PURCHASERS] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of March&nbsp;7, 2024 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(and as amended as of March 11, 2024) </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">ARTICLE&nbsp;I</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">PURCHASE; CLOSING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Purchase</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">ARTICLE&nbsp;II</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">REPRESENTATIONS AND WARRANTIES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Material Adverse Effect</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Representations and Warranties of the Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Representations and Warranties of Purchaser</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">ARTICLE&nbsp;III</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">COVENANTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Filings; Other Actions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Public Announcement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Material Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period Conduct</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Material Change</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">ARTICLE&nbsp;IV</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">ADDITIONAL AGREEMENTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>[Reserved]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Legend</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Materially Burdensome Condition</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Reservation for Issuance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Indemnity</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Exchange Listing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certificate of Designations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>State Securities Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Company Opportunities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Recourse</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE&nbsp;V</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">MISCELLANEOUS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Amendment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Extension; Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Entire Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governing Law; Jurisdiction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Waiver of Jury Trial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Assignment; Third-Party Beneficiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Specific Performance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Confidential Supervisory Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Delivery by Electronic Transmission</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LIST OF EXHIBITS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit A:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Certificate of Designations (Series B)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit B:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Certificate of Designations (Series C)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit C:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Permanent Warrant Terms</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit D:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Registration Rights Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit E:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Stockholder Vote Warrant Terms</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEX OF DEFINED TERMS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accredited Investors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BHC Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Board of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">business day</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Designations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Designations (Series B)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Designations (Series C)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charter Amendment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chosen Courts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Claim Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Code</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Bank</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Bylaws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Certificate of Incorporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Disclosure Schedule</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Equity Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Fundamental Rep</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company PSU Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Recommendations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Regulatory Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Reports</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Restricted Stock Award</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company RSU Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Share Issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Stock Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Data Breach</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">De Minimis Claim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Delaware Secretary of State</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Direct Claim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enforceability Exceptions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ERISA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ERISA Affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange Approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">extent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Federal Reserve</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fraud</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GAAP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Entity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSR&nbsp;Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSR Clearance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnified Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnifying Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Institutional Accredited Investor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment Amount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IRS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">knowledge</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Liens</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Losses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">made available</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Adverse Effect</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Materially Burdensome Condition</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Multiemployer Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Multiple Employer Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Party</FONT> Affiliates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NYSE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Order</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ordinary course</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ordinary course of business</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other Investment Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other Permanent Warrant</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pandemic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pandemic Measures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permanent Warrant</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">person</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Personal Data</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Placement Agents/Arrangers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Press Release</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchaser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchaser Fundamental Rep</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Registration Rights Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Representatives</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Requisite Stockholder Vote</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Response Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Securities Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SRO</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholder Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; Meeting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Return</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Party Claim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Threshold Amount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">transactions contemplated by this Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">transactions contemplated hereby</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Voting Regulatory Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">v </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>INVESTMENT AGREEMENT,</B> dated as of March&nbsp;7, 2024 and as amended on March 11, 2024
(this &#147;<U>Agreement</U>&#148;), by and between New York Community Bancorp, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), and [Hudson Bay Purchasers] (&#147;<U>Purchaser</U>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. <U>The
Investment</U>. The Company desires to sell and issue to Purchaser, and Purchaser desires to purchase from the Company, as an investment in the Company, (i)&nbsp;shares of (a)&nbsp;common stock, par value $0.01 per share, of the Company (the
&#147;<U>Common Stock</U>&#148;), (b) a series of preferred stock, par value $0.01 per share, of the Company designated as Series B Noncumulative Convertible Preferred Stock (the &#147;<U>Series B Preferred Stock</U>&#148;), having the terms set
forth in the Certificate of Designations of the Series B Preferred Stock, in the form attached hereto as <U>Exhibit</U><U></U><U>&nbsp;A</U> (the &#147;<U>Certificate of Designations (Series B)</U>&#148;) and (c)&nbsp;a series of preferred stock,
par value $0.01 per share, of the Company designated as Series C Noncumulative Convertible Preferred Stock (the &#147;<U>Series C Preferred Stock</U>&#148; and together with the Series B Preferred Stock, the &#147;<U>Preferred Stock</U>&#148;),
having the terms set forth in the Certificate of Designations of the Series C Preferred Stock, in the form attached hereto as <U>Exhibit</U><U></U><U>&nbsp;B</U> (the &#147;<U>Certificate of Designations (Series&nbsp;C)</U>&#148; and together with
the Certificate of Designations (Series B), the &#147;<U>Certificate of Designations</U>&#148;), which shall be made a part of the Company&#146;s Amended and Restated Certificate of Incorporation (as amended, restated, supplemented or otherwise
modified from time to time, the &#147;<U>Company Certificate of Incorporation</U>&#148;) by the filing of the Certificate of Designations (Series C) with the Secretary of State of the State of Delaware (the &#147;<U>Delaware Secretary of
State</U>&#148;) and (ii)&nbsp;warrants on the terms and conditions set forth on <U>Exhibit C</U> (the &#147;<U>Permanent Warrant</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. <U>The Other Investment Agreements</U>. Substantially concurrently with the execution and delivery hereof, the Company is entering into
other contracts or agreements with certain other purchasers providing for the issuance of (i)&nbsp;shares of Common Stock, (ii)&nbsp;shares of Preferred Stock and/or (iii)&nbsp;warrants on the terms and conditions set forth therein (each, an
&#147;<U>Other Permanent Warrant</U>&#148;), in each case, with proceeds to the Company in an amount, together with the Investment Amount, equal to not less than $1,050,000,000.00 and entered into in furtherance of the transactions contemplated
hereby or thereby (each, an &#147;<U>Other Investment Agreement</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. <U>The Securities</U>. The term
&#147;<U>Securities</U>&#148; refers collectively to the (a)&nbsp;(i) shares of Common Stock and Preferred Stock and (ii)&nbsp;Permanent Warrant, in each case, issuable pursuant hereto,&nbsp;(b) shares of Common Stock to be issued upon the
conversion of the Preferred Stock issuable pursuant hereto (such conversions, the &#147;<U>Conversions</U>&#148;), (c) shares of <FONT STYLE="white-space:nowrap">non-voting,</FONT> common equivalent preferred stock to be issued upon the exercise of
the Permanent Warrant and (d)&nbsp;shares of Common Stock to be issued upon the conversion of the <FONT STYLE="white-space:nowrap">non-voting,</FONT> common equivalent preferred stock to be issued upon the exercise of the Permanent Warrant. When
purchased, the shares of Common Stock and Preferred Stock purchased hereunder will be evidenced by book-entry notation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">D.
<U>Registration Rights Agreement</U>. At the Closing, the Company and Purchaser will enter into a Registration Rights Agreement attached hereto as <U>Exhibit </U><U>D</U> (the &#147;<U>Registration Rights Agreement</U>&#148;). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE,</B> in consideration of the premises, and of the representations,
warranties, covenants and agreements set forth herein, the parties agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;I </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>PURCHASE; CLOSING </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1 <U>Purchase</U>. On the terms and subject to the conditions set forth herein, at the Closing, Purchaser shall purchase from
the Company, and the Company shall sell and issue to Purchaser, the number of duly authorized, validly issued, fully-paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of (a)&nbsp;Common Stock, free and clear of all Liens (as
defined below) (other than transfer restrictions imposed under applicable securities Laws), set forth in <U>Section</U><U></U><U>&nbsp;1.2(c)(</U><U>i</U><U>)(1)(A)</U>, (b) Series B Preferred Stock, free and clear of all Liens (other than transfer
restrictions imposed under the Certificate of Designations (Series B) or applicable securities Laws), set forth in <U>Section</U><U></U><U>&nbsp;1.2(c)(</U><U>i</U><U>)(1)(B)</U>, and (c)&nbsp;Series C Preferred Stock, free and clear of all Liens
(as defined below) (other than transfer restrictions imposed under the Certificate of Designations (Series C) or applicable securities Laws), set forth in <U>Section</U><U></U><U>&nbsp;1.2(c)(</U><U>i</U><U>)(1)(C)</U> (the &#147;<U>Company Share
Issuance</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2 <U>Closing</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Time and Date of Closing</U>. Subject to the satisfaction or, to the extent permitted by Law, written waiver (by the party entitled to
grant such waiver) of the conditions set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)</U> (other than those conditions that by their nature are to be satisfied at the Closing, but subject to satisfaction or, to the extent permitted by Law, written
waiver of those conditions by the party entitled to grant such waiver), the closing of the Company Share Issuance (the &#147;<U>Closing</U>&#148;) shall take place (i)&nbsp;three (3) business days following the execution and delivery of this
Agreement, remotely by the electronic exchange of counterpart signature pages to the documents and agreements contemplated hereby to be executed and delivered at the Closing (the &#147;<U>Expected Closing Date</U>&#148;), or (ii)&nbsp;such other
date, time and/or location as may be mutually agreed in writing by the Company and Purchaser; <U>provided</U> that, if the conditions set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)</U> have not been so satisfied or, to the extent permitted by
Law, waived on or prior to the date that is three (3)&nbsp;business days following the execution and delivery of this Agreement, then the Closing shall take place on the first business day on which such conditions have been so satisfied or waived;
<U>provided</U>, <U>further</U>, <U>however</U>, that in no event shall the Closing take place later than the fifth (5<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) business day after the Expected Closing Date. The date on which the
Closing occurs is referred to as the &#147;<U>Closing Date.</U>&#148; Unless otherwise agreed by the Company and Purchaser, in the event (A)&nbsp;the Closing does not occur within five (5)&nbsp;business days after the Expected Closing Date and
(B)&nbsp;Purchaser delivered the Investment Amount to the Company pursuant to <U>Section</U><U></U><U>&nbsp;1.2(c)(ii)(1)</U>, the Company shall, as promptly as reasonably practicable (but not later than one business day thereafter), return such
Investment Amount to Purchaser by wire transfer of United States dollars in immediately available funds to the account specified by Purchaser. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Closing Conditions</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The obligation of Purchaser, on the one hand, and the Company, on the other hand, to effect the Closing is subject to the
satisfaction or, to the extent permitted by Law, written waiver by Purchaser and the Company prior to the Closing of the following conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) no injunction, order, judgment, writ, directive, enforcement action, decree, or regulatory restriction of any Governmental
Entity (each, an &#147;<U>Order</U>&#148;) or other legal restraint or prohibition preventing the consummation of the Company Share Issuance. No applicable Law shall have been enacted, entered, promulgated or enforced (which remains in effect) by
any Governmental Entity that prohibits or makes illegal consummation of the Company Share Issuance or any of the other transactions contemplated by this Agreement or that prohibits, restrains or enjoins Purchaser or its affiliates from owning any
Securities or voting any voting Securities in accordance with the terms thereof; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) the Company shall have filed the
requisite Supplemental Listing Application in respect of the Common Stock issued hereunder and the Common Stock to be issued upon the conversion of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock, in each case, in
accordance with rules of the New York Stock Exchange (the &#147;<U>NYSE</U>&#148;), and no further action shall be required to authorize such additional shares for listing, subject to official notice of issuance; provided if such Supplemental
Listing Application is not approved as a result of the number of authorized shares of Common Stock being insufficient, then (A)&nbsp;the Company shall immediately <FONT STYLE="white-space:nowrap">re-file</FONT> covering just the authorized amount
and (B)&nbsp;promptly following the approval and adoption of the Charter Amendment in accordance with <U>Section</U><U></U><U>&nbsp;3.1(c)</U>, the Company shall file a Supplemental Listing Application in respect of the Common Stock not covered by
the initial approval; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) the purchase and sale of shares of Common Stock and/or Preferred Stock (with proceeds to the
Company in an amount, which together with the Investment Amount, is greater than or equal to $600,000,000) shall have been consummated, or will be consummated substantially concurrently with the Closing, in all material respects in accordance with
the terms and conditions of such Other Investment Agreement(s); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(4) the Certificate of Designations shall have been
filed with and accepted by the Delaware Secretary of State and be in full force and effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The obligation of Purchaser to effect the Closing is also subject to
the satisfaction or, to the extent permitted by Law, written waiver by Purchaser prior to the Closing of each of the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) the representations and warranties of the Company contained in
(A)<U>&nbsp;Section</U><U></U><U>&nbsp;2.2(b)(</U><U>i</U><U>)</U>, <U>Section</U><U></U><U>&nbsp;2.2(c)(iii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(g)</U>, <U>Section</U><U></U><U>&nbsp;2.2(h)</U>, <U>Section</U><U></U><U>&nbsp;2.2(r)</U> and
<U>Section</U><U></U><U>&nbsp;2.2(u)</U> shall be true and correct (other than, in the case of <U>Section</U><U></U><U>&nbsp;2.2(b)(</U><U>i</U><U>)</U>, such failures to be true and correct as are de minimis) in all respects as of the date hereof
and as of the Closing as though made at and as of the Closing (except to the extent such representations and warranties are expressly made as of another date, in which case as of such date); (B)
<U>Section</U><U></U><U>&nbsp;2.2(a)(</U><U>i</U><U>)</U>-<U>(iii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(b)(ii)</U> and <U>Section</U><U></U><U>&nbsp;2.2(c)(</U><U>i</U><U>)</U> (in each case, read without giving effect to any qualification as to
materiality or Material Adverse Effect set forth in such representations and warranties) shall be true and correct in all material respects as of the date hereof and as of the Closing as though made at and as of the Closing (except to the extent
such representations and warranties are expressly made as of another date, in which case as of such date); and (C)&nbsp;all other representations and warranties of the Company set forth in <U>Section</U><U></U><U>&nbsp;2.2</U> (in each case, read
without giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations or warranties) shall be true and correct in all respects as of the date hereof and as of the Closing as though made at and as
of the Closing (except to the extent such representations and warranties are expressly made as of another date, in which case as of such date); provided that, for purposes of this subclause (C), such representations and warranties shall be deemed to
be true and correct unless the failure(s) of such representations and warranties to be so true and correct, either individually or in the aggregate, and without giving effect to any qualification as to materiality or Material Adverse Effect set
forth in such representations or warranties, has had or would reasonably be expected to have a Material Adverse Effect; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) the Company shall have performed and complied with, in all material respects, all obligations, covenants and agreements
required to be performed or complied with by it at or prior to the Closing hereunder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) since the date hereof, no
Material Adverse Effect shall have occurred and no circumstance, event, change, occurrence, development or effect shall have occurred that, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(4) Purchaser shall have received a certificate, dated as of the Closing Date, signed on behalf of the Company by the Chief
Executive Officer or Chief Financial Officer of the Company certifying to the effect that the conditions set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)(ii)(1)</U>, <U>Section</U><U></U><U>&nbsp;1.2(b)(ii)(2)</U> and
<U>Section</U><U></U><U>&nbsp;1.2(b)(ii)(3)</U> have been satisfied. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The obligation of the Company to effect the
Closing is subject to the satisfaction or, to the extent permitted by Law, written waiver by the Company prior to the Closing of the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) the representations and warranties of Purchaser contained herein (without giving effect to any &#147;material&#148; or
&#147;materiality&#148; qualifications contained in such representations and warranties) shall be true and correct as of the date hereof and as of the Closing as though made at and as of the Closing (except to the extent such representations and
warranties are expressly made as of another date, in which case as of such date), except to the extent the failure(s) of such representations or warranties to be true and correct, either individually or in the aggregate, and without giving effect to
any &#147;material&#148; or &#147;materiality&#148; qualifications contained in such representations and warranties, would not prevent or materially impair or delay the ability of Purchaser to consummate the Closing; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) Purchaser shall have performed and complied with, in all material
respects, all covenants and agreements required to be performed or complied with by it at or prior to the Closing hereunder; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) the Company shall have received a certificate, dated as of the Closing Date, signed on behalf of Purchaser by an
authorized signatory of Purchaser certifying to the effect that the conditions set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)(iii)(1)</U> and <U>Section</U><U></U><U>&nbsp;1.2(b)(iii)(2)</U> have been satisfied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Closing Deliveries</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) At the Closing, the Company will deliver to Purchaser: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) confirmation of book-entry notation in the name of Purchaser shares of Common Stock and Preferred Stock, free and clear of
all Liens (other than transfer restrictions imposed under the Certificate of Designations (as applicable) or applicable securities Laws) as follows: (A) [23,161,647]<SUP STYLE="font-size:75%; vertical-align:top">1</SUP> shares of Common Stock,
(B)&nbsp;Series B Preferred Stock equal to [36,850]<SUP STYLE="font-size:75%; vertical-align:top">2</SUP> and (C)&nbsp;Series C Preferred Stock equal to [64,988];<SUP STYLE="font-size:75%; vertical-align:top">3</SUP> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) a counterpart signature page, to the Permanent Warrant on the terms and condition set forth on <U>Exhibit C</U>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) a counterpart signature page, duly executed by the Company, to the Registration Rights Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(4) evidence that delivery of the investment amounts payable to the Company pursuant to the Other Investment Agreements by the
other purchasers party thereto shall occur substantially concurrently with the Closing; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(5) a legal opinion in
customary form from counsel to the Company covering due authorization and issuance of the Common Stock and Preferred Stock and the Common Stock issuable upon conversion of the Preferred Stock. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Aggregate shares of Common Stock of Hudson Bay Purchasers. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Aggregate shares of Series B Preferred Stock of Hudson Bay Purchasers. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">3</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Aggregate shares of Series C Preferred Stock of Hudson Bay Purchasers. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) At the Closing, Purchaser will deliver to the Company: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) by wire transfer of immediately available funds to an account designated by the Company in writing, an aggregate purchase
price of [$250,000,000.00]<SUP STYLE="font-size:75%; vertical-align:top">4</SUP> (the &#147;<U>Investment Amount</U>&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) a properly completed and executed Internal Revenue Service (&#147;<U>IRS</U>&#148;) Form
<FONT STYLE="white-space:nowrap">W-9</FONT> for Purchaser; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) a counterpart signature page, duly executed by
Purchaser, to the Registration Rights Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;II </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REPRESENTATIONS AND WARRANTIES </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1 <U>Material Adverse Effect</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) As used herein, the term &#147;<U>Material Adverse Effect</U>&#148; means any effect, change, event, circumstance, condition, occurrence
or development that, either individually or in the aggregate, has had or would reasonably be expected to have a material adverse effect on the business, properties, assets, liabilities, results of operations or financial condition of the Company and
its Subsidiaries taken as a whole (provided, that Material Adverse Effect shall not be deemed to include the impact or effects of any (A)&nbsp;changes, after the date hereof, in U.S. generally accepted accounting principles (&#147;<U>GAAP</U>&#148;)
or applicable regulatory accounting requirements, (B)&nbsp;changes, after the date hereof, in Laws (including any Pandemic Measures) of general applicability to companies in the industries in which the Company and its Subsidiaries operate, or
interpretations thereof by courts or other Governmental Entities, (C)&nbsp;changes, after the date hereof, in global, national or regional political conditions (including the outbreak of war or acts of terrorism) or in economic or market (including
equity, credit and debt markets, as well as changes in interest rates) conditions affecting the financial services industry generally and not specifically relating to the Company or its Subsidiaries (including any such changes arising out of the
Pandemic or any Pandemic Measures), (D)&nbsp;changes, after the date hereof, resulting from hurricanes, earthquakes, tornados, floods or other natural disasters or from any outbreak of any disease or other public health event (including the
Pandemic), (E)&nbsp;public disclosure of the execution of this Agreement or any Other Investment Agreement, public disclosure or consummation of the transactions contemplated hereby or thereby (including any effect on a party&#146;s relationships
with its customers) (it being understood and agreed that the foregoing shall not apply for purposes of the representations and warranties in <U>Section</U><U></U><U>&nbsp;2.2(c)(ii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(d)</U> or
<U>Section</U><U></U><U>&nbsp;2.2(k)(vi)</U>) or actions expressly required by this Agreement or that are taken with the prior written consent of Purchaser in contemplation of the transactions contemplated by this Agreement or any Other Investment
Agreement, (F)&nbsp;decline in the trading price of the Company&#146;s securities or the failure, in and of itself, to meet earnings projections or internal financial forecasts (it being understood that the underlying causes of such decline or
failure may be taken into account in determining whether a Material Adverse Effect has occurred or is reasonably expected to occur, </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">4</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Aggregate Investment Amount of Hudson Bay Purchasers.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
except to the extent otherwise excluded by this proviso), (G) any stockholder litigation arising out of, related to, or in connection with this Agreement or any Other Investment Agreement or the
Investment that is brought or threatened against the Company or the Board of Directors from and following the date of this Agreement and prior to the Closing (&#147;Stockholder Litigation&#148;) (it being understood and agreed that the foregoing
shall not apply for purposes of the representations and warranties in <U>Section</U><U></U><U>&nbsp;2.2(c)(ii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(d)</U> or <U>Section</U><U></U><U>&nbsp;2.2(k)(vi)</U>), or (H)&nbsp;expenses incurred by the
Company in negotiating, documenting, effecting and consummating the transactions contemplated by this Agreement or any Other Investment Agreement; except, with respect to the foregoing subclauses&nbsp;(A), (B), (C) or (D), to the extent that the
effects of such change are disproportionately adverse to the business, properties, assets, liabilities, results of operations or financial condition of the Company and its Subsidiaries, taken as a whole, as compared to other companies in the
industry in which the Company and its Subsidiaries operate). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) As used herein: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) &#147;<U>Pandemic</U>&#148; means any outbreaks, epidemics or pandemics, or any variants, evolutions or mutations thereof,
and the governmental and other responses thereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) &#147;<U>Pandemic Measures</U>&#148; means any quarantine,
&#147;shelter in place,&#148; &#147;stay at home,&#148; workforce reduction, social distancing, shutdown, closure, sequester or other Laws or policies or recommendations promulgated by any Governmental Entity, including the Centers for Disease
Control and Prevention and the World Health Organization, in each case, in connection with or in response to any Pandemic; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) &#147;<U>Subsidiary</U>&#148; when used with respect to any person, means any subsidiary of such person within the
meaning ascribed to such term in either <FONT STYLE="white-space:nowrap">Rule&nbsp;1-02</FONT> of <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-X</FONT> promulgated by the Securities and Exchange Commission (the &#147;<U>SEC</U>&#148;) or the
BHC Act; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) &#147;<U>Governmental Entity</U>&#148; means any court, administrative agency or commission or other
governmental authority or instrumentality or SRO of competent jurisdiction; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) &#147;<U>Law</U>&#148; means any law,
statute, code, ordinance, rule, regulation, requirement, policy or guideline of any Governmental Entity or stock exchange or Order. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2 <U>Representations and Warranties of the Company</U>. Except as disclosed in (i)&nbsp;the disclosure schedule delivered by
the Company to Purchaser concurrently herewith (the &#147;<U>Company Disclosure Schedule</U>&#148;); <U>provided</U> that (A)&nbsp;no such item is required to be set forth as an exception to a representation or warranty if its absence would not
result in the related representation or warranty being deemed untrue or incorrect, (B)&nbsp;the mere inclusion of an item in the Company Disclosure Schedule as an exception to a representation or warranty shall not be deemed an admission by the
Company that such item represents a material exception or fact, effect, change, event, circumstance, condition, occurrence or development or that such item would or would reasonably be expected to result in a Material Adverse Effect, and
(C)&nbsp;any disclosures made </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with respect to a section of this <U>Section</U><U></U><U>&nbsp;2.2</U> shall be deemed to qualify any other section of this <U>Section</U><U></U><U>&nbsp;2.2</U> (1)&nbsp;specifically referenced
or cross-referenced or (2)&nbsp;if it is reasonably apparent on its face (notwithstanding the absence of a specific cross-reference) from a reading of the disclosure that such disclosure applies to such other section or (ii)&nbsp;any Company Reports
publicly filed or furnished by the Company after January&nbsp;1, 2023 (but disregarding risk factor disclosures contained under the heading &#147;Risk Factors,&#148; or disclosures of risks set forth in any &#147;forward-looking statements&#148;
disclaimer or any other statements that are similarly nonspecific or cautionary, predictive or forward-looking in nature), the Company hereby represents and warrants to Purchaser as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Corporate Organization</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware
and is a bank holding company duly registered under the Bank Holding Company Act of 1956 (&#147;<U>BHC Act</U>&#148;). The Company has the corporate power and authority to own or lease all of its properties and assets and to carry on its business as
it is now being conducted. The Company is duly licensed or qualified to do business and in good standing in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or
leased by it makes such licensing, qualification or standing necessary, except where the failure to be so licensed or qualified or to be in good standing would not, either individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect. True, correct and complete copies of the Company Certificate of Incorporation and the Company Bylaws (as defined below) as in effect as of the entry into this Agreement have been made available to Purchaser. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Except as would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect,
each Subsidiary of the Company (a &#147;<U>Company Subsidiary</U>&#148;) (A)&nbsp;is duly organized and validly existing under the laws of its jurisdiction of organization, (B)&nbsp;is duly licensed or qualified to do business and, where such
concept is recognized under Law, in good standing in all jurisdictions where its ownership or leasing of property or the conduct of its business requires it to be so licensed or qualified or in good standing, and (C)&nbsp;has all requisite corporate
power and authority to own or lease its properties and assets and to carry on its business as now conducted. There are no restrictions on the ability of any Company Subsidiary to pay dividends or distributions except, in the case of a Company
Subsidiary that is a regulated entity, for restrictions on dividends or distributions generally applicable to all similarly regulated entities. Other than Flagstar Bank, National Association, a national banking association and a wholly-owned
Subsidiary of the Company (&#147;<U>Company Bank</U>&#148;), and those Subsidiaries set forth in <U>Section</U><U></U><U>&nbsp;2.2(a)(ii)</U> of the Company Disclosure Schedule, there are no Company Subsidiaries that would constitute
&#147;significant subsidiaries&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> of the SEC as of the entry into this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The deposit accounts of Company Bank are insured by the FDIC through the Deposit Insurance Fund (as defined in
Section&nbsp;3(y) of the Federal Deposit Insurance Act of 1950) to the fullest extent permitted by Law, all premiums and assessments required to be paid in connection therewith have been paid when due, and no proceedings for the termination of such
insurance are pending or threatened. Company Bank is a member in good standing of the Federal Home Loan Bank of New York and owns the requisite amount of stock therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Capitalization</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The authorized capital stock of the Company consists of 900,000,000 shares of Common Stock and 5,000,000 shares of
preferred stock, par value of $0.01 (the &#147;<U>Company Preferred Stock</U>&#148;). As of March&nbsp;1, 2024, there were 744,099,232 shares of Common Stock issued and outstanding, including 5,828,669 shares of Common Stock granted in respect of
outstanding Common Stock subject to vesting, repurchase or other lapse restriction (each, a &#147;<U>Company Restricted Stock Award</U>&#148;), and (in addition to the foregoing) (A)&nbsp;22,809,071 shares of Common Stock held in treasury, (B)
1,712,824 shares of Common Stock (assuming performance goals are satisfied at the maximum level) reserved for issuance upon the settlement of outstanding performance-based restricted stock unit awards in respect of shares of Common Stock granted
under the Company Stock Plans (&#147;<U>Company PSU Awards</U>&#148;), (C) 7,201,022 shares of Common Stock reserved for issuance upon the settlement of outstanding restricted stock unit awards in respect of shares of Common Stock granted under the
Company Stock Plans (&#147;<U>Company RSU Awards</U>&#148; and, together with the Company Restricted Stock Awards and Company PSU Awards, the &#147;<U>Company Equity Awards</U>&#148;), (D) 16,170,583 shares of Common Stock reserved for issuance
pursuant to future grants under the Company Stock Plans and (E)&nbsp;515,000&nbsp;shares of the Company Preferred Stock issued and outstanding. As of March&nbsp;1, 2024, there were 10,244,408 shares of Common Stock reserved for issuance upon the
exercise of the warrants under the Bifurcated Option Note Unit Securities of New York Community Capital Trust V and 20,600,000 Depositary Shares (each representing a 1/40th interest in a share of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Series A Noncumulative Perpetual Preferred Stock of the Company) outstanding. As of the entry into this Agreement, except as set forth in the immediately preceding sentences, as
contemplated hereby, as contemplated by any Other Investment Agreement and for changes since March&nbsp;1, 2024 resulting from the exercise, vesting or settlement of any Company Equity Awards described in the immediately preceding sentence, there
are no other shares of capital stock or other equity or voting securities of the Company issued, reserved for issuance or outstanding. All of the issued and outstanding shares of Common Stock have been duly authorized and validly issued and are
fully paid, nonassessable and free of preemptive rights, with no personal liability attaching to the ownership thereof. There are no bonds, debentures, notes or other indebtedness that have the right to vote on any matters on which stockholders of
the Company may vote. As of the entry into this Agreement, other than (1)&nbsp;the Company Equity Awards issued prior to the entry into this Agreement as described in this <U>Section</U><U></U><U>&nbsp;2.2(b)(</U><U>i</U><U>)</U> or (2)&nbsp;as set
forth in this Agreement or any Other Investment Agreement, there are no (x)&nbsp;outstanding subscriptions, options, warrants, stock appreciation rights, phantom units, scrip, rights to subscribe to, preemptive rights, anti-dilutive rights, rights
of first refusal or similar rights, puts, calls, commitments or agreements of any character relating to, or securities or rights convertible or exchangeable into or exercisable for, or valued by reference to, shares of capital stock or other equity
or voting securities of or ownership interest in the Company, or (y)&nbsp;contracts, commitments, understandings or arrangements by which the Company may become bound to issue additional shares of its
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
capital stock or other equity or voting securities of or ownership interests in the Company, or that otherwise obligate the Company to issue, transfer, sell, purchase, redeem or otherwise
acquire, any of the foregoing. Other than this Agreement and any Other Investment Agreement, there are no voting trusts, shareholder agreements, proxies or other similar agreements in effect to which the Company or any of its Subsidiaries is a party
or is bound with respect to the voting or transfer of Common Stock or other equity interests of the Company. As used herein, &#147;Company Stock Plans&#148; means the New York Community Bancorp, Inc. 2020 Omnibus Incentive Plan, the Flagstar
Bancorp, Inc. 2016 Stock Award and Incentive Plan and the New York Community Bancorp, Inc. 2012 Stock Incentive Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Company owns, directly or indirectly, all of the issued and outstanding shares of capital stock or other equity
ownership interests of each Company Subsidiary, free and clear of any liens, claims, title defects, mortgages, pledges, charges, encumbrances and security interests whatsoever (&#147;<U>Liens</U>&#148;), and all of such shares or equity ownership
interests are duly authorized and validly issued and are fully paid, nonassessable (except, with respect to bank Subsidiaries, as provided under 12 U.S.C. &#167;&nbsp;55 or any comparable provision of applicable state Law) and free of preemptive
rights, with no personal liability attaching to the ownership thereof. No Company Subsidiary has or is bound by any outstanding subscriptions, options, warrants, calls, rights, commitments or agreements of any character calling for the purchase or
issuance of any shares of capital stock or any other equity security of such Subsidiary or any securities representing the right to purchase or otherwise receive any shares of capital stock or any other equity security of such Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Authority; No Violation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company has full corporate power and authority to execute and deliver this Agreement, to perform its obligations
hereunder and to consummate the Closing. The execution and delivery of this Agreement, the performance by the Company of its obligations hereunder and the consummation of the Closing (including the Investment) have been declared advisable and duly
and validly approved by the board of directors of the Company (the &#147;<U>Board of Directors</U>&#148;). As of or prior to the entry into this Agreement, the Board of Directors has determined that (A)&nbsp;the Company Share Issuance and the
Conversions (collectively, the &#147;<U>Investment</U>&#148;), on the terms and subject to the conditions set forth herein, is in the best interests of the Company and its stockholders and (B)&nbsp;the issuance of the shares of Common Stock and/or
Preferred Stock, in each case, pursuant to the Other Investment Agreements and the other transactions contemplated thereby, on the terms and subject to the conditions set forth therein, in each case, are in the best interests of the Company and its
stockholders and has adopted a resolution to the foregoing effect. No other corporate proceedings on the part of the Company or any of its Subsidiaries are necessary to approve this Agreement or for the Company to perform its obligations hereunder
or consummate the Closing. This Agreement has been duly and validly executed and delivered by the Company and (assuming due authorization, execution and delivery by Purchaser) constitutes a valid and binding obligation of the Company, enforceable
against the Company in accordance with its terms (except in all cases as such enforceability may be limited by bankruptcy, insolvency, fraudulent transfer, moratorium, reorganization or similar Laws of general applicability relating to or affecting
the rights of creditors generally and the availability of equitable remedies (the &#147;<U>Enforceability Exceptions</U>&#148;)). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) None of the execution and delivery of this Agreement by the Company,
the performance by the Company of its obligations hereunder, the consummation by the Company of the Investment, or compliance by the Company with any of the terms or provisions hereof, will (A)&nbsp;violate any provision of the Company Certificate
of Incorporation or the Amended and Restated Bylaws of the Company (as amended, restated, supplemented or otherwise modified from time to time, the &#147;<U>Company Bylaws</U>&#148;) or (B)&nbsp;assuming that the consents and approvals referred to
in <U>Section</U><U></U><U>&nbsp;2.2(d)</U> are duly obtained, (x)&nbsp;violate any Law applicable to the Company, any of its Subsidiaries or any of their respective properties or assets or (y)&nbsp;violate, conflict with, result in a breach of any
provision of or the loss of any benefit under, constitute a default (or an event which, with notice or lapse of time, or both, would constitute a default) under, result in the termination of or a right of termination or cancellation under,
accelerate the performance required by, or result in the creation of any Lien upon any of the respective properties or assets of the Company or any of its Subsidiaries under, any of the terms, conditions or provisions of any note, bond, mortgage,
indenture, deed of trust, license, lease, agreement or other instrument or obligation to which the Company or any of its Subsidiaries is a party, or by which they or any of their respective properties or assets may be bound, except (in the case of
<U>clauses</U><U></U><U>&nbsp;(B)(x)</U> and <U>(B)(y)</U> above) for such violations, conflicts, breaches, defaults, terminations, cancellations, accelerations or creations which would not, either individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The shares of Common Stock to be issued (x)&nbsp;hereunder and
(y)&nbsp;subject to the Requisite Stockholder Vote and the filing of the Charter Amendment with the Delaware Secretary of State, upon the Conversions will be, in each case, validly authorized and, when issued, will be validly issued, fully paid and
nonassessable and free and clear of all Liens, and no current or past stockholder of the Company will have any preemptive right or similar rights in respect thereof. The shares of Preferred Stock to be issued hereunder have been validly authorized
and, when issued, will be validly issued, fully paid and nonassessable and free and clear of all Liens, and no current or past stockholder of the Company will have any preemptive right or similar rights in respect of any such issuance or exercise.
Neither the Common Stock nor the Preferred Stock will be issued in violation of any applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <U>Consents and Approvals</U>.
Except for (i)&nbsp;the approvals set forth on <U>Section</U><U></U><U>&nbsp;2.2(d)</U> of the Company Disclosure Schedule, (ii) [Reserved], (iii) the filing of the requisite Supplemental Listing Application and any other required applications,
filings and notices, as applicable, with the NYSE, and the approval of the listing of the shares of Common Stock to be issued (A)&nbsp;hereunder and (B)&nbsp;upon the Conversions, (iv)&nbsp;the filing of any registration statement with the SEC in
accordance with the terms and subject to the conditions of the Registration Rights Agreement, (v)&nbsp;filings required under, and compliance with other applicable requirements of, the Hart&#151;Scott&#151;Rodino Antitrust Improvements Act of 1976
and the rules and regulations promulgated thereunder (the &#147;<U>HSR&nbsp;Act</U>&#148;) with respect to the Conversions, (vi)&nbsp;the Requisite Stockholder Vote, (vii)&nbsp;the filing of the Certificate of Designations and the Charter Amendment
with the Delaware </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Secretary of State and (viii)&nbsp;such filings and approvals as are required to be made or obtained under the securities or &#147;Blue Sky&#148; laws of various states in connection with the
Investment, no consents or approvals of or filings or registrations with any Governmental Entity are necessary in connection with (A)&nbsp;the execution and delivery by the Company of this Agreement or (B)&nbsp;the Investment and the other
transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) <U>Reports</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) As of the entry into this Agreement, the Company and each of its Subsidiaries have timely filed (or furnished) all
reports, registrations and statements, together with any amendments required to be made with respect thereto, that they were required to file (or furnish, as applicable) since January&nbsp;1, 2023 with the following Governmental Entities:
(A)&nbsp;any state regulatory authority, (B)&nbsp;the SEC, (C)&nbsp;the Board of Governors of the Federal Reserve System or Federal Reserve Bank of New York (together, the &#147;<U>Federal Reserve</U>&#148;), (D)&nbsp;the Office of the Comptroller
of the Currency, (E)&nbsp;any foreign regulatory authority and (F)&nbsp;any self-regulatory organization (an &#147;<U>SRO</U>&#148;), including any report, form, correspondence, registration or statement required to be filed (or furnished, as
applicable) pursuant to the laws, rules or regulations of the U.S., any state, any foreign entity, or any Governmental Entity, and have paid all fees and assessments due and payable in connection therewith, except where the failure to file (or
furnish, as applicable) such report, registration or statement or to pay such fees and assessments would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Subject to
<U>Section</U><U></U><U>&nbsp;5.13</U>, except for normal examinations conducted by a Governmental Entity in the ordinary course of business of the Company and its Subsidiaries, (x)&nbsp;no Governmental Entity has initiated or has pending any
proceeding or, to the Company&#146;s knowledge, investigation into the business or operations of the Company or any of its Subsidiaries since January&nbsp;1, 2023, which remains unresolved, (y)&nbsp;there is no unresolved violation, criticism, or
exception by any Governmental Entity with respect to any report or statement relating to any examinations or inspections of the Company or any of its Subsidiaries, and (z)&nbsp;there has been no formal or informal inquiries by, or disagreements or
disputes with, any Governmental Entity with respect to the business, operations, policies or procedures of the Company or any of its Subsidiaries since January&nbsp;1, 2023; in each case, which would reasonably be expected to have, either
individually or in the aggregate, a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) An accurate copy of each final registration statement,
prospectus, report, schedule and definitive proxy statement filed with or furnished by the Company to the SEC since January 1, 2023 pursuant to the Securities Act of 1933 (the &#147;<U>Securities Act</U>&#148;), or the Exchange Act (the
&#147;<U>Company Reports</U>&#148;) is publicly available. No such Company Report, as of the date thereof (and, in the case of registration statements and proxy statements, on the dates of effectiveness and the dates of the relevant meetings,
respectively), contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances in which they were made, not
misleading, except that information filed or furnished as of a later date (but before the entry into this Agreement) shall be deemed to modify information as of an earlier date. As of their respective dates, all Company Reports filed under the
Securities Act and the Exchange Act complied in all </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
material respects with the published rules and regulations of the SEC with respect thereto. As of the entry into this Agreement, (A)&nbsp;no executive officer of the Company has failed in any
respect to make the certifications required of him or her under Section&nbsp;302 or 906 of the Sarbanes-Oxley Act and (B)&nbsp;there are no outstanding comments from or unresolved issues raised by the SEC with respect to any of the Company Reports.
There are no deposits of the Company Bank that are required by Law or contract to be withdrawn or that the Company Bank can no longer hold given the Company Bank&#146;s deposit rating as of the date hereof, other than any waivers granted by a
government-sponsored enterprise as of the date hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) To the knowledge of the Company, as of the date hereof, the
Company is not aware of any facts that cause the Company to reasonably believe that the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023 (A) will not be filed with the SEC on
or before March&nbsp;15, 2024, (B) will, except as has already been disclosed in the Company Reports, contain any additional material weaknesses in the design or operation of internal control over financial reporting (as defined in Rule <FONT
STYLE="white-space:nowrap">13a-15(f)</FONT> of the Exchange Act) and (C)&nbsp;will contain any material changes to the financial statements as compared to the consolidated statements of condition and consolidated statements of (loss) income of the
Company included in its Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on February&nbsp;29, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f)
<U>Financial Statements</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The financial statements of the Company and its Subsidiaries included (or incorporated
by reference) in the Company Reports (including the related notes, where applicable) (A)&nbsp;have been prepared from, and are in accordance with, the books and records of the Company and its Subsidiaries, (B)&nbsp;fairly present in all material
respects the consolidated results of operations, cash flows, changes in stockholders&#146; equity and consolidated financial position of the Company and its Subsidiaries for the respective fiscal periods or as of the respective dates therein set
forth (subject in the case of unaudited statements to <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments normal in nature and amount), (C)&nbsp;complied, as of their respective dates of filing with the SEC, in all material respects
with applicable accounting requirements and with the published rules and regulations of the SEC with respect thereto, (D)&nbsp;have been prepared in accordance with GAAP consistently applied during the periods involved, except, in each case, as
indicated in such statements or in the notes thereto and (E)&nbsp;to the knowledge of the Company, are not expected to be revised, resubmitted or restated in any way. The books and records of the Company and its Subsidiaries have been, since
January&nbsp;1, 2023, and are being, maintained in all material respects in accordance with GAAP and any other applicable legal and accounting requirements. Since January&nbsp;1, 2023 and prior to the entry into this Agreement, no independent public
accounting firm of the Company has resigned (or informed the Company that it intends to resign) or been dismissed as independent public accountants of the Company as a result of, or in connection with, any disagreements with the Company on a matter
of accounting principles or practices, financial statement disclosure or auditing scope or procedure. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Except as would not, either individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect, neither the Company nor any of its Subsidiaries has any liability required by GAAP to be reflected on a consolidated balance sheet of the Company (whether absolute, accrued, contingent or
otherwise and whether due or to become due), except for (A)&nbsp;those liabilities that are reflected or reserved against on the consolidated balance sheet of the Company included in its Quarterly Report on
<FONT STYLE="white-space:nowrap">Form&nbsp;10-Q</FONT> for the fiscal quarter ended September&nbsp;30, 2023 (including any notes thereto), (B) liabilities incurred in the ordinary course of business consistent with past practice since
September&nbsp;30, 2023, (C) fees and expenses payable to any financial advisor, counsel or other professional in connection with this Agreement or each Other Investment Agreement and the transactions contemplated hereby or thereby and
(D)&nbsp;obligations under this Agreement or any Other Investment Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The records, systems, controls, data
and information of the Company and its Subsidiaries are recorded, stored, maintained and operated under means (including any electronic, mechanical or photographic process, whether computerized or not) that are under the exclusive ownership and
direct control of the Company or its Subsidiaries or accountants (including all means of access thereto and therefrom), except for any <FONT STYLE="white-space:nowrap">non-exclusive</FONT> ownership and
<FONT STYLE="white-space:nowrap">non-direct</FONT> control that would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company&nbsp;has (x)&nbsp;implemented and maintains disclosure controls
and procedures (as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15(e)</FONT> of the Exchange Act) to ensure that material information relating to the Company, including its Subsidiaries, is made known to the chief executive officer and
the chief financial officer of the Company by others within those entities as appropriate to allow timely decisions regarding required disclosures and to make the certifications required by the Exchange Act and Sections&nbsp;302 and 906 of the
Sarbanes-Oxley Act, and (y)&nbsp;disclosed, based on its most recent evaluation prior to the entry into this Agreement, to the Company&#146;s outside auditors and the audit committee of the Board of Directors any (A)&nbsp;significant deficiencies
and material weaknesses in the design or operation of internal control over financial reporting (as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15(f)</FONT> of the Exchange Act) that would reasonably be expected to adversely affect the
Company&#146;s ability to record, process, summarize and report financial information, and (B)&nbsp;fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#146;s internal controls over
financial reporting. To the knowledge of the Company, there is no reason to believe that the Company&#146;s outside auditors and its chief executive officer and chief financial officer will not be able to give the certifications and attestations
required pursuant to the rules and regulations adopted pursuant to Section&nbsp;404 of the Sarbanes-Oxley Act, without qualification, when next due. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Since January&nbsp;1, 2023, (A)&nbsp;neither the Company nor any of its Subsidiaries, nor, to the knowledge of the
Company, any director, officer, auditor, accountant or representative of the Company or any of its Subsidiaries, has received or otherwise had or obtained knowledge of any material complaint, allegation, assertion or claim, whether written or oral
regarding the accounting or auditing practices, procedures, methodologies or methods (including with respect to loan loss reserves, write-downs, charge-offs and accruals) of the Company or any of its Subsidiaries or their respective internal
accounting controls, including any material complaint, allegation, assertion or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
claim that the Company or any of its Subsidiaries has engaged in questionable accounting or auditing practices, and (B)&nbsp;no attorney representing the Company or any of its Subsidiaries,
whether or not employed by the Company or any of its Subsidiaries, has reported evidence of a material violation of securities Laws, breach of fiduciary duty or similar violation by the Company or any of its Subsidiaries or any of their respective
officers, directors, employees or agents to the Board of Directors or any committee thereof, or to the knowledge of the Company, to any director or officer of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) <U>Broker</U><U>&#146;</U><U>s Fees</U>. Other than Jefferies Group LLC (the &#147;<U>Placement Agents/Arrangers</U>&#148;), neither the
Company nor any of its affiliates nor any other person acting on its behalf (other than its officers acting in such capacity) has dealt with any broker, finder, commission agent, placement agent or arranger in connection with the sale of the
Securities and the transactions contemplated by this Agreement, and the Company is not under any obligation to pay any broker&#146;s fee or commission in connection with such transactions other than to the Placement Agents/Arrangers. Neither the
Company nor any of its affiliates nor any other person acting on its behalf (other than its officers acting in such capacity) has solicited offers for, or offered or sold, the Securities other than through the Placement Agents/Arrangers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) <U>Absence of Certain Changes or Events</U>. Since January&nbsp;1, 2023 through the entry into this Agreement, there has not been any
effect, change, event, circumstance, condition, occurrence or development that has had or would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <U>Legal Proceedings</U>. As of the entry into this Agreement, subject to <U>Section</U><U></U><U>&nbsp;5.13</U>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) neither the Company nor any of its Subsidiaries is a party to any, and there are no pending or threatened in writing or,
to the Company&#146;s knowledge, otherwise threatened, legal, administrative, arbitral or other proceedings, claims, audit, examination, actions or governmental or regulatory investigations by or before any Governmental Entity of any nature against
the Company or any of its Subsidiaries or any of their current or former directors or executive officers (A)&nbsp;that would, individually or in the aggregate, reasonably be expected to result in a material restriction on, or material liability
being imposed against, the Company or any of its Subsidiaries or any of their respective businesses, (B)&nbsp;that would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect or (C)&nbsp;challenging the validity
or propriety of the transactions contemplated by this Agreement or the Other Investment Agreements; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) there is no
Order imposed upon the Company, any of its Subsidiaries or any of their current or former directors or executive officers (in each of their capacities as such) or the assets of the Company or any of its Subsidiaries that would reasonably be expected
to be material to the Company and its Subsidiaries taken as a whole. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) <U>Taxes and Tax Returns</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Each of the Company and its Subsidiaries has duly and timely filed (including all valid applicable extensions) all
material Tax Returns in all jurisdictions in which Tax Returns are required to be filed by it, and all such Tax Returns are true, correct, and complete in all material respects. Neither the Company nor any of its Subsidiaries is the beneficiary of
any extension of time within which to file any material Tax Return (other than extensions to file Tax Returns obtained in the ordinary course of business). All material Taxes of the Company and its Subsidiaries (whether or not shown on any Tax
Returns) that are due have been fully and timely paid. Each of the Company and its Subsidiaries has withheld and paid all material Taxes required to have been withheld and paid in connection with amounts paid or owing to any employee, creditor,
shareholder, independent contractor or other third party. Neither the Company nor any of its Subsidiaries has granted any extension or waiver of the limitation period applicable to any material Tax that remains in effect. The federal income Tax
Returns of the Company and its Subsidiaries for all years to and including 2022 have been examined by the Internal Revenue Service or are Tax Returns with respect to which the applicable period for assessment under applicable Law, after giving
effect to extensions or waivers, has expired. Neither the Company nor any of its Subsidiaries has received written notice of assessment or proposed assessment in connection with any material amount of Taxes, and there are no threatened in writing or
pending disputes, claims, audits, examinations or other proceedings regarding any material Tax of the Company and its Subsidiaries or the assets of the Company and its Subsidiaries. Neither the Company nor any of its Subsidiaries is a party to or is
bound by any Tax sharing, allocation or indemnification agreement or arrangement (other than such an agreement or arrangement exclusively between or among the Company and its Subsidiaries). Neither the Company nor any of its Subsidiaries&nbsp;(A)
has been a member of an affiliated group filing a consolidated federal income Tax Return (other than a group the common parent of which was the Company) or (B)&nbsp;has any material liability for the Taxes of any person (other than the Company or
any of its Subsidiaries) under Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any similar provision of any Law), as a transferee or successor, by contract or otherwise. Neither the Company nor any of its
Subsidiaries has been, within the past two (2)&nbsp;years, a &#147;distributing corporation&#148; or a &#147;controlled corporation&#148; (within the meaning of Section&nbsp;355(a)(1)(A) of the Internal Revenue Code of 1986 (the
&#147;<U>Code</U>&#148;)) in a distribution of stock intending to qualify for <FONT STYLE="white-space:nowrap">tax-free</FONT> treatment under Section&nbsp;355 of the Code. Neither the Company nor any of its Subsidiaries has participated in a
&#147;listed transaction&#148; within the meaning of Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.6011-4(b).</FONT> At no time during the past five (5)&nbsp;years has the Company been a U.S. real property holding corporation
within the meaning of Section&nbsp;897(c)(2) of the Code. The Company is classified as a Subchapter C corporation for U.S. federal tax purposes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) As used herein, (A) &#147;<U>Tax</U>&#148; or &#147;<U>Taxes</U>&#148; means all federal, state, local, and foreign
income, excise, gross receipts, ad valorem, profits, gains, property, capital, sales, transfer, use, license, payroll, employment, social security, severance, unemployment, unclaimed property, withholding, duties, excise, windfall profits,
intangibles, franchise, backup withholding, value added, alternative or <FONT STYLE="white-space:nowrap">add-on</FONT> minimum, estimated and other taxes, charges, levies or like assessments together with all penalties and additions to tax and
interest thereon; and (B) &#147;<U>Tax Return</U>&#148; means any return, declaration, report, claim for refund, or information return or statement relating to Taxes, including any schedule or attachment thereto, and including any amendment thereof,
supplied or required to be supplied to a Governmental Entity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k) <U>Employees and Employee Benefit Plans</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) As used herein, &#147;<U>Company Benefit Plans</U>&#148; means all employee benefit plans (as defined in Section&nbsp;3(3)
of the Employee Retirement Income Security Act of 1974 (&#147;<U>ERISA</U>&#148;)), whether or not subject to ERISA, and all stock option, stock purchase, restricted stock, stock-based, incentive, deferred compensation, retiree medical or life
insurance, supplemental retirement, severance, welfare or other benefit plans, programs or arrangements, retention, bonus, employment, change in control, termination or severance plans, programs, policies, practices, agreements or arrangements
(whether or not funded and whether or not in writing) that are maintained, contributed to or sponsored or maintained by, or required to be contributed to, the Company or any of its Subsidiaries for the benefit of any current or former employee,
officer or director of the Company or any of its Subsidiaries, excluding, in each case, any &#147;multiemployer plan&#148; within the meaning of Section&nbsp;4001(a)(3) of ERISA (a &#147;<U>Multiemployer Plan</U>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Each Company Benefit Plan has been established, operated and administered in all material respects in accordance with its
terms and the requirements of all applicable Laws, including ERISA and the Code. Each Company Benefit Plan that is intended to be qualified under Section&nbsp;401(a) of the Code has received a favorable determination letter from the IRS and, to the
Company&#146;s knowledge, nothing has occurred, whether by action or failure to act, that could reasonably be expected to adversely affect the qualified status of such Company Benefit Plan under Section&nbsp;401(a) of the Code. Neither the Company
nor any Company Subsidiary has engaged in a transaction that could subject the Company or any of its Subsidiaries to a material tax or material penalty pursuant to Section&nbsp;4975 or 4976 of the Code or Section&nbsp;502 of ERISA. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) No Company Benefit Plan is subject to Title IV or Section&nbsp;302 of ERISA or Section&nbsp;412 or 4971 of the Code nor
has the Company or any of its Subsidiaries or ERISA Affiliates, at any time during the last six years, contributed to or been obligated to contribute to an employee benefit plan subject to Title IV or Section&nbsp;302 of ERISA. None of the Company,
its Subsidiaries nor any ERISA Affiliate (as defined below) has, at any time during the last six years, contributed to or been obligated to contribute to any Multiemployer Plan or a plan that has two or more contributing sponsors at least two of
whom are not under common control, within the meaning of Section&nbsp;4063 of ERISA (a &#147;<U>Multiple Employer Plan</U>&#148;), and none of the Company and its Subsidiaries nor any ERISA Affiliate has incurred any liability to a Multiemployer
Plan or Multiple Employer Plan as a result of a complete or partial withdrawal (as those terms are defined in Part 1 of Subtitle E of Title IV of ERISA) from a Multiemployer Plan or Multiple Employer Plan. As used herein, &#147;<U>ERISA
Affiliate</U>&#148; means, with respect to any entity, trade or business, any other entity, trade or business that is, or was at the relevant time, a member of a group described in Section&nbsp;414(b), (c), (m) or (o)&nbsp;of the Code or
Section&nbsp;4001(b)(1) of ERISA that includes or included the first entity, trade or business, or that is, or was at the relevant time, a member of the same &#147;controlled group&#148; as the first entity, trade or business pursuant to
Section&nbsp;4001(a)(14) of ERISA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Neither the Company, nor any of its Subsidiaries, sponsors or has any
obligation with respect to any employee benefit plan that provides for any post-employment or post-retirement health or medical or life insurance benefits for retired, former or current employees or beneficiaries or dependents thereof, except as
required by Section&nbsp;4980B of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) All contributions required to be made to any Company Benefit Plan by Law
or any plan document, and all premiums due or payable with respect to insurance policies funding any Company Benefit Plan, for any period through the entry into this Agreement, have been timely made or paid in full or, to the extent not required to
be made or paid on or before the entry into this Agreement, have been fully reflected on the books and records of the Company, except as, either individually or in the aggregate, would not reasonably be expected to result in any material liability
to the Company and its Subsidiaries, taken as a whole. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) Other than as provided herein or the Other Investment
Agreements, none of the execution and delivery of this Agreement or the Other Investment Agreements, the transactions contemplated by this Agreement, the Other Investment Agreements or the Investment will (either alone or in conjunction with any
other event) (A)&nbsp;entitle any employee, officer, director or individual independent contractor of the Company or any of its Subsidiaries to any payment or benefit, (B)&nbsp;result in, accelerate, cause the vesting, exercisability, funding,
payment or delivery of, or increase in the amount or value of, any payment, right or other benefit to any employee, officer, director or independent contractor of the Company or any of its Subsidiaries, (C)&nbsp;accelerate the timing of or cause the
Company or any of its Subsidiaries to transfer or set aside any assets to fund any material benefits under any Company Benefit Plan, (D)&nbsp;result in any limitation on the right of the Company or any of its Subsidiaries to amend, merge, terminate
or receive a reversion of assets from any Company Benefit Plan or related trust, or (E)&nbsp;result in any &#147;excess parachute payment&#148; within the meaning of Section&nbsp;280G of the Code. No Company Benefit Plan provides for the <FONT
STYLE="white-space:nowrap">gross-up</FONT> or reimbursement of Taxes under Section&nbsp;4999 or 409A of the Code, or otherwise. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) The Company and its Subsidiaries are in compliance in all material respects with, and since January&nbsp;1, 2023 have
complied in all material respects with, all Laws regarding employment and employment practices, terms and conditions of employment, compensation and benefits, wages and hours, paid sick leave, classification of employees as exempt or nonexempt and
workers as employees or independent contractors, equitable pay practices, privacy rights, labor disputes, employment discrimination, sexual or racial harassment or discrimination, workers&#146; compensation, unemployment insurance, disability rights
or benefits, retaliation, immigration, family and medical leave, occupational safety and health, plant closings and layoffs and other laws in respect of any reduction in force (including notice, information and consultation requirements). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(l) <U>Compliance with Applicable Law and Privacy Obligations</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company and each of its Subsidiaries hold, and have at all times since January&nbsp;1, 2023, held, all licenses,
franchises, permits and authorizations necessary for the lawful conduct of their respective businesses and ownership of their respective properties, rights and assets under and pursuant to each (and have paid all fees and assessments due and payable
in connection therewith), except where neither the cost of failure to hold nor the cost of obtaining and holding such license, franchise, permit or authorization (nor the failure to pay any fees or assessments) would, either individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect, and, to the knowledge of the Company, no suspension or cancellation of any such necessary license, franchise, permit or authorization is threatened. Except as would not, either
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, the Company and its Subsidiaries have complied with any Law applicable to the Company or any of its Subsidiaries, including all laws relating to the privacy
and security of data or information that constitutes &#147;personal data,&#148; &#147;personally identifiable information,&#148; &#147;nonpublic personal information,&#148; &#147;personal information&#148; or a similar term (&#147;<U>Personal
Data</U>&#148;), the USA PATRIOT Act, the Bank Secrecy Act, the Equal Credit Opportunity Act and Regulation&nbsp;B, the Fair Housing Act, the Community Reinvestment Act, the Fair Credit Reporting Act, the Truth in Lending Act and Regulation&nbsp;Z,
the Home Mortgage Disclosure Act, the Fair Debt Collection Practices Act, the Electronic Fund Transfer Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, any regulations promulgated by the Consumer Financial Protection Bureau, the
Interagency Policy Statement on Retail Sales of Nondeposit Investment Products, the SAFE Mortgage Licensing Act of 2008, the Real Estate Settlement Procedures Act and Regulation&nbsp;X, and any other Laws relating to bank secrecy, discriminatory
lending, financing or leasing practices, consumer protection, money laundering prevention, foreign assets control, U.S. sanctions laws and regulations, Sections&nbsp;23A and 23B of the Federal Reserve Act, the Sarbanes-Oxley Act, and all agency
requirements relating to the origination, sale and servicing of mortgage and consumer loans. Company Bank has a Community Reinvestment Act rating of &#147;satisfactory&#148; or better. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Except as would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect,
none of the Company, any of its Subsidiaries or, to the Company&#146;s knowledge, any director, officer, employee, agent or other person acting on behalf of the Company or any of its Subsidiaries has, directly or indirectly, (A)&nbsp;used any funds
of the Company or its Subsidiaries for unlawful contributions, unlawful gifts, unlawful entertainment or other expenses relating to political activity, (B)&nbsp;made any unlawful payment to foreign or domestic governmental officials or employees or
to foreign or domestic political parties or campaigns from funds of the Company or its Subsidiaries, (C)&nbsp;violated any provision that would result in the violation of the Foreign Corrupt Practices Act of 1977 or any similar Law,
(D)&nbsp;established or maintained any unlawful fund of monies or other assets of the Company or its Subsidiaries, (E)&nbsp;made any fraudulent entry on the books or records of the Company or its Subsidiaries or (F)&nbsp;made any unlawful bribe,
unlawful rebate, unlawful payoff, unlawful influence payment, unlawful kickback or other unlawful payment to any person, private or public, regardless of form, whether in money, property or services, to obtain favorable treatment in securing
business to obtain special concessions for the Company or its Subsidiaries, to pay for favorable treatment for business secured or to pay for special concessions already obtained for the Company or its Subsidiaries, or is currently subject to any
U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The Company maintains a written information privacy and security
program that maintains reasonable measures to protect the privacy, confidentiality, integrity and security of all Personal Data against any (A)&nbsp;loss or misuse of Personal Data, (B)&nbsp;unauthorized or unlawful operations performed upon
Personal Data or (C)&nbsp;any other act or omission that compromises the security or confidentiality of Personal Data (clauses&nbsp;(A) through (C), a &#147;<U>Data Breach</U>&#148;). The Company has not experienced any Data Breach that, either
individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. To the knowledge of the Company, there are no data security or other technological vulnerabilities with respect to the Company&#146;s information
technology systems or networks that, either individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. Since January&nbsp;1, 2023, except as would not, either individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect, the Company and its Subsidiaries are and have been compliant with their written data privacy and security policies and all contractual commitments of the Company and its Subsidiaries concerning privacy,
data protection, data security and the collection, storage, use and other processing of Personal Data. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Except as
would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect: (A)&nbsp;the Company and each of its Subsidiaries have properly administered all accounts for which it acts as a fiduciary, including
accounts for which it serves as a trustee, agent, custodian, personal representative, guardian, conservator or investment advisor, in accordance with the terms of the governing documents and applicable state, federal and foreign law; and
(B)&nbsp;none of the Company, any of its Subsidiaries, or any of its or its Subsidiaries&#146; directors, officers or employees, has committed any breach of trust or fiduciary duty with respect to any such fiduciary account, and the accountings for
each such fiduciary account are true, correct and complete and accurately reflect the assets and results of such fiduciary account. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(m)
<U>Agreements with Governmental Entities</U>. Subject to <U>Section</U><U></U><U>&nbsp;5.13</U>, as of the entry into this Agreement, neither the Company nor any of its Subsidiaries is subject to any <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">cease-and-desist</FONT></FONT> Order, or is a party to any written agreement, consent agreement or memorandum of understanding with, or is a party to any commitment letter or similar undertaking to, or has been ordered to
pay any material civil money penalty by, or has been since January&nbsp;1, 2023, a recipient of any supervisory letter from, or since January&nbsp;1, 2023, has adopted any board resolutions at the direction of, any Governmental Entity, in each case,
that (i)&nbsp;currently restricts in any material respect or would reasonably be expected to restrict in any material respect the conduct of its business or (ii)&nbsp;in any material manner relates to its capital adequacy, its ability to pay
dividends, its credit or risk management policies, its management or its business (each, whether or not set forth in the Company Disclosure Schedule, a &#147;<U>Company Regulatory Agreement</U>&#148;), nor has the Company or any of its Subsidiaries
been advised in writing or, to the knowledge of the Company, threatened verbally, since January&nbsp;1, 2023 through the date hereof, by any Governmental Entity that it is considering issuing, initiating, ordering or requesting any such Company
Regulatory Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(n) <U>Investment Securities and Commodities</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Each of the Company and its Subsidiaries has good title in all material respects to all securities and commodities owned
by it (except those sold under repurchase agreements) which are material to the Company and its Subsidiaries on a consolidated basis, free and clear of any Liens, except for such failures to have good title as are set forth in the financial
statements included in the Company Reports as of the entry into this Agreement or to the extent such securities or commodities are pledged in the ordinary course of business to secure obligations of the Company or its Subsidiaries. Such securities
and commodities are valued on the books of the Company in accordance with GAAP in all material respects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Company
and its Subsidiaries and their respective businesses employ investment, securities, commodities, risk management and other policies, practices and procedures that the Company believes are prudent and reasonable in the context of such businesses, and
the Company and its Subsidiaries have, since January&nbsp;1, 2023, been in compliance with such policies, practices and procedures in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(o) <U>Loan Portfolio</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Except as would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect,
each written or oral loan, loan agreement, note or borrowing arrangement (including leases, credit enhancements, commitments, guarantees and interest-bearing assets) (collectively, &#147;<U>Loans</U>&#148;) of the Company and its Subsidiaries
(A)&nbsp;is evidenced by notes, agreements or other evidences of indebtedness that are true, genuine and what they purport to be, (B)&nbsp;has been secured by valid Liens, as applicable, and (C)&nbsp;is the legal, valid and binding obligation of the
obligor named therein, enforceable in accordance with its terms, subject to the Enforceability Exceptions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Except as
would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, each outstanding Loan of the Company or any of its Subsidiaries (including Loans held for resale to investors) was solicited and
originated, and is and has been administered and, where applicable, serviced, and the relevant Loan files are being maintained, in all material respects in accordance with the relevant notes or other credit or security documents, the written
underwriting standards of the Company and its Subsidiaries (and, in the case of Loans held for resale to investors, the underwriting standards, if any, of the applicable investors) and with all applicable federal, state and local laws, regulations
and rules. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) There are no outstanding Loans made by the Company or any of its Subsidiaries to any &#147;executive
officer&#148; or other &#147;insider&#148; (as each such term is defined in Regulation O promulgated by the Federal Reserve) of the Company or its Subsidiaries, other than Loans that are subject to and that were made and continue to be in compliance
with Regulation O or that are exempt therefrom. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) To the knowledge of the Company, the allowance for credit losses
reflected in the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on February&nbsp;29, 2024 was calculated in accordance with GAAP and applicable regulatory guidance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(p) <U>Related Party Transactions</U>. There are no transactions or series of related
transactions, agreements, arrangements or understandings, nor are there any currently proposed transactions, agreements, arrangements or understandings or series of related transactions, agreements, arrangements or understandings between the Company
or any of its Subsidiaries, on the one hand, and any current or former director or &#147;executive officer&#148; (as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;3b-7</FONT> under the Exchange Act) of the Company or any of its Subsidiaries
or any person who beneficially owns (as defined in <FONT STYLE="white-space:nowrap">Rules&nbsp;13d-3</FONT> and <FONT STYLE="white-space:nowrap">13d-5</FONT> of the Exchange Act) 5% or more of the outstanding Common Stock (or any of such
person&#146;s immediate family members or affiliates) (other than Subsidiaries of the Company) on the other hand, of the type required to be reported in any Company Report pursuant to Item&nbsp;404 of
<FONT STYLE="white-space:nowrap">Regulation&nbsp;S-K</FONT> promulgated under the Exchange Act that have not been so reported on a timely basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(q) <U>Offering of Securities</U>. Neither the Company, nor any of its Subsidiaries, nor any person acting on its or their behalf has
(i)&nbsp;directly or indirectly, taken any action (including any offering of any securities of the Company under circumstances which would require the integration of such offering with the offering of any of the Securities to be issued pursuant
hereto under the Securities Act and the rules and regulations of the SEC promulgated thereunder) that might subject the Investment to the registration requirements of the Securities Act or (ii)&nbsp;offered the Securities or any similar securities
for sale to, or solicited any offer to buy any of the same from, or otherwise approached or negotiated in respect thereof with, any person, other than Purchaser, the counterparty to each Other Investment Agreement and not more than thirty-five
(35)&nbsp;other Institutional Accredited Investors and fifteen (15)&nbsp;other Accredited Investors that are directors or executive officers of the Company, each of which has been offered the Securities at a private sale for investment. As used
herein, (x) &#147;<U>Institutional Accredited Investor</U>&#148; means an institutional accredited investor as defined in Rule 501(a)(1), (2), (3) or (7)&nbsp;under the Securities Act and (y) &#147;<U>Accredited Investors</U>&#148; means an
accredited investor as defined in Rule 501(a)(4) under the Securities Act. None of the Company nor any of its Subsidiaries has offered the Securities or any similar securities during the six (6)&nbsp;months prior to the entry into this Agreement to
anyone, other than Purchaser, the counterparty to each Other Investment Agreement and not more than thirty-five (35)&nbsp;other Institutional Accredited Investors and fifteen (15)&nbsp;other Accredited Investors. The Company has no intention to
offer the Securities or any similar security during the six (6)&nbsp;months from the entry into this Agreement, except as contemplated by this Agreement or each Other Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(r) <U>Other Investments</U>. The per share purchase price of the shares of Common Stock and/or Preferred Stock purchased under each Other
Investment Agreement is not less than the per share purchase price of the shares of Common Stock and Preferred Stock issued pursuant to the Investment. Except as expressly set forth in the Other Investment Agreements executed as of the date of this
Agreement and that has been delivered to Purchaser concurrently with the execution of this Agreement, each Other Investment Agreement does not include provisions that are more favorable to the purchaser party thereto compared to the rights, benefits
and obligations of Purchaser under this Agreement (it being understood that each Other Investment Agreement may differ with respect to (i)&nbsp;such other purchaser&#146;s governance rights with respect to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company, (ii)&nbsp;any provision necessary or advisable to consummate the transactions contemplated thereby arising out of or related to the identity of the other purchaser, including
regulatory requirements related to manner of settlement for regulated funds or advisers, (iii)&nbsp;any rights with respect to confidentiality obligations, information rights and public announcements and (iv)&nbsp;the Common Stock issuable at the
Closing pursuant to the Other Investment Agreement entered into with Liberty Strategic Capital (CEN) Holdings, LLC). Except as set forth in the preceding sentence with the respect to the provisions of any Other Investment Agreement, neither the
Company nor any of its Subsidiaries has entered into any (or modified any existing) contract, agreement, arrangement or understanding with any purchaser party to the Other Investment Agreements (or any affiliate thereof) that has the effect of
establishing rights or otherwise benefiting such other purchaser in a manner more favorable to such purchaser than the rights, benefits and obligations of Purchaser in this Agreement. Each Other Permanent Warrant (A)&nbsp;includes or will include
(as applicable) the same exercise price and (B)&nbsp;does not or will not (as applicable) include provisions that are more favorable in any material respect to the holder thereof compared to the rights, benefits and obligations of Purchaser under
the Permanent Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(s) <U>General Solicitation</U>. Neither the Company, nor any Company Subsidiary nor any of their respective
affiliates, nor any person acting on its or their behalf, has offered or sold the Securities by any form of general solicitation or general advertising, including, but not limited to, the following: (i)&nbsp;any advertisement, article, notice or
other communication published in any newspaper, magazine, or similar media or broadcast over television or radio; (ii)&nbsp;any website posting or widely distributed <FONT STYLE="white-space:nowrap">e-mail;</FONT> or (iii)&nbsp;any seminar or
meeting whose attendees have been invited by any general solicitation or general advertising. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(t) <U>Borrowings</U>. There are no
restrictions (including, without limitation, on amounts, maturities, collateral or rates of interest) on the ability of the Company or Company Bank to borrow under any federal loan program or discount window other than those generally applicable to
banking organizations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(u) <U>Receivership</U>. No Governmental Entity shall have been appointed as receiver or conservator for Company
Bank. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) <U>No Other Representations or Warranties</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Except for the representations and warranties made by the Company in this <U>Section</U><U></U><U>&nbsp;2.2</U>, neither
the Company, any of its Subsidiaries, any of their respective Representatives, nor any other person makes, has made or has been authorized to make any express or implied representation or warranty with respect to the Company, any of its Subsidiaries
or their respective businesses, operations, assets, liabilities, conditions (financial or otherwise) or prospects, and the Company hereby disclaims any such other representations or warranties. In particular, without limiting the foregoing
disclaimer, neither the Company, any of its Subsidiaries, any of their respective Representatives, nor any other person makes, has made or has been authorized to make any representation or warranty to Purchaser or any of its affiliates or its or
their respective Representatives with respect to (A)&nbsp;any financial projection, forecast, estimate, budget or prospective information relating to the Company or any of its Subsidiaries or their respective businesses, operations, assets,
liabilities, conditions (financial or otherwise) or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
prospects or (B)&nbsp;except for the representations and warranties made by the Company in this <U>Section</U><U></U><U>&nbsp;2.2</U>, any oral or written information presented to Purchaser or
any of its affiliates or its or their respective Representatives in the course of (x)&nbsp;their due diligence investigation of the Company or its Subsidiaries, (y)&nbsp;the negotiation of this Agreement or (z)&nbsp;the transactions contemplated
hereby. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Company acknowledges and agrees that neither Purchaser, its Representatives, nor any other person has
made, is making or has been authorized to make any express or implied representation or warranty other than those expressly set forth in in <U>Section</U><U></U><U>&nbsp;2.3</U>, and in entering into this Agreement, the Company is relying
exclusively on its own independent investigation and the representations and warranties expressly set forth in <U>Section</U><U></U><U>&nbsp;2.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3 <U>Representations and Warranties of Purchaser</U>. Purchaser hereby represents and warrants to the Company that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Corporate Organization</U>. Purchaser is duly organized, validly existing and in good standing under the laws of the jurisdiction of
its organization. Purchaser has the corporate, partnership or limited liability company power and authority to own or lease all of its properties and assets and to carry on its business as it is now being conducted. Purchaser is duly licensed or
qualified to do business and, where such concept is recognized under Law, in good standing in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes
such licensing, qualification or standing necessary, except where the failure to be so licensed or qualified or to be in good standing would not, either individually or in the aggregate, reasonably be expected to materially and adversely affect
Purchaser&#146;s ability to perform its obligations under this Agreement or consummate the transactions contemplated hereby on a timely basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Authority; No Violation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Purchaser has full corporate, partnership or limited liability company power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and, subject to other actions described in this <U>Section</U><U></U><U>&nbsp;2.3(b)</U> and <U>Section</U><U></U><U>&nbsp;2.3(c)</U>, to consummate the Closing. The execution and delivery of this
Agreement, the performance by Purchaser of its obligations hereunder and the consummation of the Closing (including the Investment) have been duly and validly approved by Purchaser&#146;s board of directors or other equivalent governing body, as
applicable. No other corporate proceedings on the part of Purchaser or any of Purchaser&#146;s partners or equityholders are necessary to approve or adopt this Agreement, for Purchaser to perform its obligations hereunder or to consummate the
transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by Purchaser and (assuming due authorization, execution and delivery by the Company) constitutes a valid and binding obligation of Purchaser,
enforceable against Purchaser in accordance with its terms (except in all cases as such enforceability may be limited by the Enforceability Exceptions). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Neither the execution and delivery of this Agreement by Purchaser, the
performance by Purchaser of its obligations hereunder nor consummation by Purchaser of the transactions contemplated hereby, including the Investment, nor compliance by Purchaser with any of the terms or provisions hereof, will (A)&nbsp;violate any
provision of Purchaser&#146;s certificate or articles of incorporation or bylaws (or other comparable charter or organizational documents) or (B)&nbsp;assuming that the consents and approvals referred to in <U>Section</U><U></U><U>&nbsp;2.3(c)</U>
are duly obtained, (x)&nbsp;violate any Law applicable to Purchaser or any of its properties or assets or (y)&nbsp;violate, conflict with, result in a breach of any provision of or the loss of any benefit under, constitute a default (or an event
which, with notice or lapse of time, or both, would constitute a default) under, result in the termination of or a right of termination or cancellation under, accelerate the performance required by, or result in the creation of any Lien upon any of
the properties or assets of Purchaser under, any of the terms, conditions or provisions of any note, bond, mortgage, indenture, deed of trust, license, lease, agreement or other instrument or obligation to which Purchaser is a party, or by which
Purchaser or any of its properties or assets may be bound, except (in the case of <U>clauses</U><U></U><U>&nbsp;(B)(x)</U> and <U>(B)(y)</U> above) for such violations, conflicts, breaches, defaults, terminations, cancellations, accelerations or
creations which would not, either individually or in the aggregate, reasonably be expected to materially and adversely affect Purchaser&#146;s ability to consummate the Investment and the other transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Consents and Approvals</U>. Except for (i)&nbsp;the approvals set forth on <U>Section</U><U></U><U>&nbsp;2.2(d)</U> of the Company
Disclosure Schedule, (ii) [Reserved], (iii) the filing of the requisite Supplemental Listing Application and any other required applications, filings and notices, as applicable, with the NYSE, and the approval of the listing of the shares of Common
Stock and shares of Common Stock (A)&nbsp;issued hereunder and (B)&nbsp;to be issued upon the Conversions, (iv)&nbsp;the filing of any registration statement with the SEC in accordance with the terms and subject to the conditions of the Registration
Rights Agreement, (v)&nbsp;filings required under, and compliance with other applicable requirements of, the HSR Act with respect to the Conversions, (vi)&nbsp;the Requisite Stockholder Vote, (vii)&nbsp;the filing of the Certificate of Designations
and the Charter Amendment with the Delaware Secretary of State and (viii)&nbsp;such filings and approvals as are required to be made or obtained under the securities or &#147;Blue Sky&#148; laws of various states in connection with the Investment,
no consents or approvals of or filings or registrations with any Governmental Entity are necessary in connection with (A)&nbsp;the execution and delivery by Purchaser of this Agreement or (B)&nbsp;the Investment and the other transactions
contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <U>Sufficiency of Funds</U>. Purchaser has available cash on hand or other sources of immediately available
funds sufficient to enable it to perform all of its payment obligations hereunder and consummate the transactions contemplated by this Agreement, including the Investment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) <U>Purchase for Investment</U>. Purchaser represents that it is an Institutional Accredited Investor acting for its own account (and not
for the account of others) or as a fiduciary or agent for others (which others are also Institutional Accredited Investors). Purchaser represents that it is purchasing the Securities for its own account or for one or more separate accounts
maintained by it for the benefit of one or more other Institutional Accredited Investors and not with a view to the distribution thereof in violation of the securities Laws; <U>provided</U> that the disposition of Purchaser&#146;s property shall at
all times be within Purchaser&#146;s control. Purchaser understands that the Securities have not been registered under the Securities </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Act and may be resold only if registered pursuant to the provisions of the Securities Act or if an exemption from registration is available, except under circumstances where neither such
registration nor such an exemption is required by Law, and that the Company is not required to register the Securities. Purchaser further represents and warrants that Purchaser (i)&nbsp;will not sell, transfer or otherwise dispose of the Securities
or any interest therein except in a registered transaction or in a transaction exempt from or not subject to the registration requirements of the Securities Act and (ii)&nbsp;was given the opportunity to ask questions and receive answers concerning
the terms and conditions of the offering and to obtain any additional information which the Company possesses or can acquire without unreasonable effort or expense. Purchaser acknowledges that the Securities will bear a restrictive legend
substantially in the form set forth in <U>Section</U><U></U><U>&nbsp;4.2(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) <U>No &#147;Bad Actor&#148; Disqualification
Events</U>. If Purchaser is a person enumerated in Rule 506(d)(1), neither Purchaser nor, to Purchaser&#146;s knowledge, its affiliates, nor any of their respective officers, directors, employees, agents, partners or members, is subject to any
&#147;bad actor&#148; disqualifying event described in Rule&nbsp;506(d)(1)(i)-(viii) of the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) <U>Information</U>.
Purchaser (i)&nbsp;is not being provided with disclosures that would be required if the offer and sale of the Securities were registered under the Securities Act, nor is Purchaser being provided with any offering circular or prospectus prepared in
connection with the offer and sale of the Securities; (ii)&nbsp;has had the opportunity to ask questions of and receive answers from the Company directly; (iii)&nbsp;has been provided a reasonable opportunity to undertake and has undertaken its own
examination of the Company and its Subsidiaries and the terms of the Securities to the extent Purchaser deems necessary to make its decision to invest in the Securities and (iv)&nbsp;has availed itself of publicly available financial and other
information concerning the Company and its Subsidiaries to the extent Purchaser deems necessary to make its decision to purchase the Securities. Purchaser has sought such accounting, legal and tax advice as it has considered necessary or advisable
to make an informed investment decision with respect to its acquisition of the Securities. The purchase of Securities by Purchaser has not been solicited by or through anyone other than the Company or the Placement Agents/Arrangers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) <U>Ability to Bear Economic Risk of Investment</U>. Purchaser recognizes that an investment in the Securities involves substantial risk.
Purchaser has the ability to bear the economic risk of the prospective investment in the Securities, including the ability to hold the Securities indefinitely, and further including the ability to bear a complete loss of all of Purchaser&#146;s
investment in the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <U>Ownership</U>. Except as disclosed to the Company, as of the entry into this Agreement, neither
Purchaser nor any of its affiliates (other than any affiliate with respect to which Purchaser is not the party exercising control over investment decisions) are the owners of record or the Beneficial Owners (as such term is defined under Rule <FONT
STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act) of shares of Common Stock or securities convertible into or exchangeable for Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) <U>Bank Regulatory Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Purchaser is not aware of any facts or circumstances that would reasonably be expected to cause Purchaser to be deemed to
be &#147;acting in concert&#148; (as that term is defined in Regulation Y) with any other person in connection with the transactions contemplated by this Agreement or the Other Investment Agreements. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Neither Purchaser nor any of its affiliates for purposes of the BHC Act is a bank holding company or &#147;controls&#148;
a &#147;bank&#148; (as such terms are defined under the BHC Act or its implementing regulations). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Purchaser is not
aware of any facts or circumstances that, upon consummation of the transactions contemplated herein, would reasonably be expected to cause Purchaser or any of its affiliates to be presumed to &#147;control&#148; the Company or Company Bank for
purposes of the BHC Act or Regulation Y. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k) <U>Information Supplied</U>. The information supplied or to be supplied by Purchaser in
writing specifically for inclusion or incorporation by reference in any documents filed or to be filed with the SEC or any other Governmental Entity in connection with the transactions contemplated by this Agreement or the Other Investment
Agreements will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not
misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(l) <U>Brokers and Finders</U>. Neither Purchaser nor its affiliates, any of its or their respective officers, directors,
employees or agents has employed any broker or finder or incurred any liability for any financial advisory fees, brokerage fees, commissions or finder&#146;s fees, in each case, for which the Company would be liable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(m) <U>No Other Representations or Warranties</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Except for the representations and warranties expressly made by Purchaser in this <U>Section</U><U></U><U>&nbsp;2.3</U>,
neither Purchaser, its Representatives, nor any other person makes, has made or has been authorized to make any express or implied representation or warranty with respect to Purchaser or its businesses, operations, conduct, assets, liabilities,
conditions (financial or otherwise) or prospects, and Purchaser hereby disclaims any such other representations or warranties. In particular, without limiting the foregoing disclaimer, neither Purchaser, its Representatives, nor any other person
makes, has made or has been authorized to make any representation or warranty to the Company or any of its Subsidiaries or its or their respective Representatives with respect to (A)&nbsp;any financial projection, forecast, estimate, budget or
prospective information relating to Purchaser or its businesses, operations, conduct, assets, liabilities, conditions (financial or otherwise) or prospects or (B)&nbsp;except for the representations and warranties expressly made by Purchaser in this
<U>Section</U><U></U><U>&nbsp;2.3</U>, any oral, electronic, written or other information presented or made available to the Company or any of its Subsidiaries or its or their respective Representatives in the course of (x)&nbsp;their due diligence
investigation of Purchaser or its affiliates, (y)&nbsp;the negotiation of this Agreement or (z)&nbsp;the transactions contemplated hereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Purchaser acknowledges and agrees that neither the Company, any of its
Subsidiaries, any of their respective Representative, nor any other person has made, is making or has been authorized to make any express or implied representation or warranty other than those expressly set forth in
<U>Section</U><U></U><U>&nbsp;2.2</U>, and in entering into this Agreement, Purchaser is relying exclusively on its own independent investigation and the representations and warranties expressly set forth in <U>Section</U><U></U><U>&nbsp;2.2</U>.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;III </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>COVENANTS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1 <U>Filings; Other Actions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Purchaser, on the one hand, and the Company, on the other hand, will (and will cause their respective affiliates to) cooperate and
consult with the other party and use reasonable best efforts to (i)&nbsp;promptly prepare and file (as applicable) all permits, consents, approvals, confirmations (whether in writing or orally) and authorizations of all third parties and
Governmental Entities which are necessary or advisable to consummate the transactions contemplated hereby, including making an appropriate filing of a Notification and Report Form pursuant to the HSR Act with respect to the Conversions, and
(ii)&nbsp;respond as promptly as practicable to any request for information from (including supplying any additional information or documentary material that may be requested by) any Governmental Entity relating to the foregoing, in each case, so as
to enable the parties hereto to consummate the transactions contemplated by this Agreement, including the Investment, as promptly as reasonably practicable following the entry into this Agreement. Purchaser and the Company shall use their respective
commercially reasonable efforts to obtain clearance pursuant to the HSR Act with respect to the Conversions (such clearance, &#147;<U>HSR Clearance</U>&#148;), as promptly as reasonably practicable following the entry into this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) To the extent permitted by Law, Purchaser and the Company will (i)&nbsp;have the right to review in advance all the information to the
extent relating to such other party, and any of its respective affiliates and its and their respective directors, officers, partners and shareholders, which appears in any filing made with, or written materials submitted to, any Governmental Entity
(and to the extent practicable, each will consult with the other party relating to the exchange of such information) and (ii)&nbsp;consult with the other in advance of any substantive meeting or conference with any Governmental Entity that is
reasonably likely to relate to or affect Purchaser or its investment in the Company in connection with the transactions contemplated by this Agreement. In exercising the foregoing right, each party agrees to act reasonably and as promptly as
reasonably practicable. To the extent permitted by Law, each party hereto agrees to keep the other party reasonably apprised of the status of matters referred to in this <U>Section</U><U></U><U>&nbsp;3.1(b)</U>. Purchaser and the Company shall
promptly correct or supplement any information provided by it or on its behalf for use in any filing made with, or written materials submitted to, any third party or any Governmental Entity in connection with the transactions to which it will be
party as contemplated hereby, if and to the extent (A)&nbsp;that information previously provided by it or on its behalf shall have become false or misleading in any material respect or (B)&nbsp;necessary or advisable to ensure that such document
would not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
therein, in light of the circumstances under which they are made, not misleading. Materials furnished pursuant to this <U>Section</U><U></U><U>&nbsp;3.1(b)</U> may be redacted (1)&nbsp;to remove
references concerning the valuation of the Company and the transactions contemplated hereby, including the Investment, or other confidential information, (2)&nbsp;as necessary to comply with contractual arrangements and (3)&nbsp;as necessary to
address reasonable privilege concerns, and the parties may reasonably designate any competitively sensitive or any confidential business material provided to the other under this <U>Section</U><U></U><U>&nbsp;3.1(b)</U> as &#147;counsel only&#148;
or, as appropriate, as &#147;outside counsel only&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) The Company shall as promptly as reasonably practicable, duly call, give
notice of, establish a record date for, convene and hold a stockholders&#146; meeting (whether annual or special) (the &#147;<U>Stockholders&#146; Meeting</U>&#148;), for the purpose of, among other matters, obtaining the requisite approval
(i)&nbsp;of the Company&#146;s stockholders to adopt an amendment to the Company Certificate of Incorporation to (A)&nbsp;increase the number of authorized shares of Common Stock therein to at least 1,700,000,000 and (B)&nbsp;amend Article Fourth,
Section C, Clauses 1 and 4 of the Company Certificate of Incorporation in a manner to exempt Purchaser and its affiliates from the application of Article Fourth, Section C, Clauses 1 and 4 of the Company Certificate of Incorporation (each, a
&#147;<U>Charter Amendment</U>&#148;), (ii) to the extent required, under the applicable rules of the NYSE (the &#147;<U>Exchange Approval</U>&#148;) for issuances of shares of Common Stock in excess of 19.9% of the total voting power of the
Company&#146;s securities immediately preceding the entry into this Agreement ((i) and (ii)&nbsp;collectively, the &#147;<U>Requisite Stockholder Vote</U>&#148;) and (iii)&nbsp;of a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-3</FONT></FONT> reverse stock split of the Company&#146;s Common Stock. To the extent reasonably practicable, the Company will file the preliminary proxy for any such meeting no
later than April&nbsp;2, 2024. The Company shall promptly respond to any comments received from the SEC on the proxy statement and will use reasonable best effort to have the Stockholders&#146; Meeting no later than May&nbsp;17, 2024. The Company
shall (A)&nbsp;through its Board of Directors recommend to its stockholders the approval and adoption of the Charter Amendment, and the Exchange Approval and the reverse stock split referenced in clause (iii)&nbsp;above (the &#147;<U>Company
Recommendations</U>&#148;), (B) include such Company Recommendations in the proxy statement delivered to its stockholders in connection with the Requisite Stockholder Vote and (C)&nbsp;use its reasonable best efforts to obtain the Requisite
Stockholder Vote. Neither the Board of Directors nor any committee thereof shall withdraw, qualify or modify, or propose publicly to withdraw, qualify or modify, in a manner adverse to Purchaser, the Company Recommendations or take any action, or
make any public statement, filing or release inconsistent with the Company Recommendations. The Company shall adjourn or postpone the Stockholders&#146; Meeting, if, as of the time for which such meeting is originally scheduled there are
insufficient shares of Common Stock represented (either in person or by proxy) to constitute a quorum necessary to conduct the business of such meeting. The Company shall also adjourn or postpone the Stockholders&#146; Meeting, if on the date of the
Stockholders&#146; Meeting the Company has not received proxies representing a sufficient number of shares of Common Stock necessary to obtain the Requisite Stockholder Vote and, following such adjournment or postponement, the Company shall solicit
proxies representing a sufficient number of shares of Common Stock necessary to obtain the Requisite Stockholder Vote. Following the first of either such adjournment or postponement, if requested by Purchaser, the Company shall retain a proxy
solicitor reasonably acceptable to, and on terms reasonably acceptable to, Purchaser in connection with obtaining the Requisite Stockholder Vote. After obtaining the Requisite Stockholder Vote, the Company shall as promptly as reasonably practical,
file the Charter Amendment with the Delaware Secretary of State, as required by applicable Law, and provide Purchaser a certificate from the Delaware Secretary of State evidencing that the Charter Amendment is in full force and effect within five
(5)&nbsp;business days after the date of the Stockholders&#146; Meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) To the extent permitted by applicable Law, the parties shall promptly advise each other
upon receiving any communication from any Governmental Entity whose consent, waiver, approval or authorization is required for consummation of the transactions contemplated by this Agreement that causes such party to believe that there is a
reasonable likelihood that any such required approval, consent or authorization will not be obtained or that the receipt of such approval, consent or authorization will be materially delayed or conditioned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) Each party shall execute and deliver after the Closing, such further certificates, agreements, instruments and other documents and take
such other actions as the other party may reasonably request, in each case, to consummate, implement or evidence the Investment or the Charter Amendment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)
Following the Closing, and after the HSR Clearance, upon the written request delivered by Purchaser to the Company or by the Company to Purchaser, Purchaser and the Company shall cooperate in good faith with each other and use their respective
reasonable best efforts to provide for Purchaser, as promptly as practicable, to exchange all or a portion of Purchaser&#146;s shares of Series B Preferred Stock for (A)&nbsp;in the event that the Requisite Stockholder Vote has been obtained, shares
of Common Stock or (B)&nbsp;in the event that the Requisite Stockholder Vote has not been obtained, shares of Series C Preferred Stock; <U>provided</U> that any such exchange, and the Company&#146;s obligations to effect such exchange under this
<U>Section</U><U></U><U>&nbsp;3.1(f)(</U><U>i</U><U>)</U> shall be subject to receipt of any required permit, authorization, consent, Order or approval from any Governmental Entity in connection with any such exchange. The Purchaser agrees that it
shall not convert or exchange, as applicable, any shares of Series B Preferred Stock or Series C Preferred Stock into any shares of Common Stock prior to the receipt of the Requisite Stockholder Vote. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Notwithstanding the foregoing, if, as a result of, or pursuant to, the provisions of
<U>Section</U><U></U><U>&nbsp;3.1(f)(</U><U>i</U><U>)</U>, Purchaser will acquire, or be deemed by the Federal Reserve or any other banking regulator having jurisdiction over the Company or Company Bank to be acquiring, ten percent (10%) or more of
a class of voting securities of the Company, then, notwithstanding <U>Section</U><U></U><U>&nbsp;4.3</U> or anything herein to the contrary, each of Purchaser and the Company, shall use (and cause its affiliates to use) its and their reasonable best
efforts to obtain any additional approval, consent or <FONT STYLE="white-space:nowrap">non-objection</FONT> of the Federal Reserve or any other Governmental Entity (including pursuant to the Change in Bank Control Act of 1978) required in connection
with the acquisition or control of 10% or more of a class of voting securities of the Company (the &#147;<U>Voting Regulatory Approvals</U>&#148;), including by furnishing to the Federal Reserve or other applicable Governmental Entity such
information as is usual and customary in connection with such applications by similarly situated investors or issuers, as applicable, but subject to the limitations set forth in <U>Section</U><U></U><U>&nbsp;4.3</U>; <U>provided</U>, however, that
this <U>Section</U><U></U><U>&nbsp;3.1(f)(ii)</U> shall not require Purchaser or the Company to take any action, or commit to take or refrain from taking any action, or accept or agree to any condition or restriction, in connection with obtaining
the Voting Regulatory Approvals that would or would be reasonably be expected to be a Materially Burdensome Condition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) The Company and Purchaser shall use reasonable best efforts to agree upon the Permanent
Warrant, which shall contain the terms and conditions described on <U>Exhibit C</U> and other customary terms and conditions as may be reasonably required to give full effect to such terms and conditions prior to the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) If the Requisite Stockholder Vote is not obtained by the date that is the one hundred and eightieth (180<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP>) day after the Closing Date, the Company shall promptly thereafter issue to Purchaser warrants on the terms described on <U>Exhibit E</U> and, in such circumstance, the Company and Purchaser shall
use reasonable best efforts to, as promptly as reasonably practicable, agree upon a form of warrant on the terms described on <U>Exhibit&nbsp;E</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2 <U>Public Announcement</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The Company shall (i)&nbsp;by no later than 9:30 A.M., New York City time, on the first
(1<SUP STYLE="font-size:75%; vertical-align:top">st</SUP>) business day following the date hereof, issue a press release, public announcement and/or marketing materials (collectively, the &#147;<U>Press Release</U>&#148;) disclosing the material
terms of the transactions contemplated hereby and any material <FONT STYLE="white-space:nowrap">non-public</FONT> information provided to Purchaser in connection with the transactions contemplated hereby and (ii)&nbsp;as promptly as reasonably
practicable following the entry into this Agreement, file a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> with the SEC in accordance with applicable Law. From and after the issuance of the Press Release, Purchaser shall not be
in possession of any material, <FONT STYLE="white-space:nowrap">non-public</FONT> information received from the Company or any of its officers, directors, employees or agents (including the Placement Agents/Arrangers). In addition, notwithstanding
the foregoing, the Company shall not publicly disclose the name of Purchaser, any affiliate of Purchaser or investment adviser to Purchaser, or include the name of Purchaser, any affiliate of Purchaser or investment adviser of Purchaser without the
prior written consent of Purchaser (A)&nbsp;in the Press Release, (B)&nbsp;in any other press release, public announcement or marketing materials, or (C)&nbsp;in any filing with the SEC, any regulatory agency or the NYSE, except (I)&nbsp;as required
by Law, in which case, to the extent permitted by Law and practicable under the circumstances, the Company shall consult with Purchaser about, and allow Purchaser reasonable time to comment on (and shall consider such comments in good faith), such
release, statement or announcement in advance of such issuance, (II)&nbsp;in connection with any registration statement contemplated by the Registration Rights Agreement (which shall be subject to review and comment of Purchaser pursuant to the
terms of the Registration Rights Agreement), (III) with the prior written consent of Purchaser (which consent shall not be unreasonably withheld, conditioned or delayed) or (IV)&nbsp;for such releases, statements or announcements that are consistent
with other such releases, statements or announcements made on or after the entry into this Agreement in compliance with this <U>Section</U><U></U><U>&nbsp;3.2</U>. Following the issuance of the Press Release or the filing of such Form <FONT
STYLE="white-space:nowrap">8-K,</FONT> the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective
Representatives (including the Placement Agents/Arrangers) on the one hand, and Purchaser or any of its Representatives, on the other hand, shall terminate and be of no further force or effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Purchaser shall not (and shall cause its affiliates and its and their respective
Representatives not to) make any public release, statement or announcement in respect of this Agreement, the proposed or actual investment in the Company by Purchaser contemplated hereunder or the transactions contemplated hereby, in each case,
except (i)&nbsp;as required by Law, in which case, to the extent permitted by Law and practicable under the circumstances, Purchaser shall consult with the Company about, and allow the Company reasonable time to comment on (and shall consider such
comments in good faith), such release, statement or announcement in advance of such issuance, (ii)&nbsp;with the prior written consent of the Company (which consent shall not be unreasonably withheld, conditioned or delayed), or (iii)&nbsp;for such
releases, statements or announcements that are consistent with other such releases, statements or announcements made on or after the entry into this Agreement in compliance with this <U>Section</U><U></U><U>&nbsp;3.2</U>. Notwithstanding anything in
the foregoing, Purchaser and each of its affiliates may provide customary disclosure of the status and subject matter of this Agreement and transactions contemplated hereby to their respective limited partners and investors, subject to customary
confidentiality undertakings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3 <U>Material Contracts</U>. Between the date hereof and the Closing, the Company and its
Subsidiaries will not enter into or amend any contract that would be a material contract under SEC rules or would require disclosure on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> without the consent of Purchaser, not to be unreasonably
withheld. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4 <U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period Conduct</U>. Prior to the earlier of the Closing
or the termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;4.12</U>, except (i)&nbsp;as may be required by Law applicable to the Company or any of its Subsidiaries, (ii)&nbsp;with the prior written consent of Purchaser (such
consent not to be unreasonably withheld, conditioned or delayed) or (iii)&nbsp;as may be expressly contemplated or required by this Agreement (including as set forth in the Company Disclosure Schedule), the Company shall use commercially reasonable
efforts to carry on its business in the ordinary course of business in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5 <U>No Material Change</U>.
Between the date hereof and the Closing, the Company shall promptly notify Purchaser in writing of (i)&nbsp;any action, arbitration, audit, hearing, investigation, litigation, suit, subpoena or summons issued, commenced, brought, conducted or heard
by or before, or otherwise involving, any Governmental Entity or arbitrator pending or, to the knowledge of the Company threatened against the Company or any of its Subsidiaries that (A)&nbsp;questions or would reasonably be expected to question the
validity of this Agreement or the other agreements contemplated hereby or thereby or any actions taken or to be taken by the Company, or its Subsidiaries with respect hereto or thereto, or (B)&nbsp;seeks to enjoin or otherwise restrain the
transactions contemplated hereby or thereby or (ii)&nbsp;any fact, change, event or circumstance known to it that has had or would reasonably be likely to have a Material Adverse Effect or which it believes would or would be reasonably likely to
cause or constitute a material breach of any of its representations, warranties or covenants contained herein or that reasonably could be expected to give rise, individually or in the aggregate, to the failure of a condition in <U>Article II</U>.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;IV </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ADDITIONAL AGREEMENTS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1 <U>[Reserved]</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2 <U>Legend</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Purchaser agrees that all certificates or other instruments representing the Securities issued pursuant hereto will bear a legend
substantially to the following effect: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) THIS SECURITY HAS BEEN ACQUIRED FOR INVESTMENT AND WITHOUT A VIEW TO
DISTRIBUTION AND HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE &#147;ACT&#148;), OR UNDER STATE SECURITIES LAWS. NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THIS SECURITY OR ANY INTEREST OR
PARTICIPATION THEREIN MAY BE MADE EXCEPT (A)&nbsp;PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR (B)&nbsp;PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS AND, IN THE CASE OF CLAUSE (B),
UNLESS THE COMPANY RECEIVES AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Any transferee of any Securities or any interest therein (other than a transferee who receives such securities in a transaction pursuant
to an effective registration statement under the Securities Act or in a transaction exempt from registration pursuant to Rule 144), by its acceptance thereof, shall be deemed to have made the representations set forth in
<U>Section</U><U></U><U>&nbsp;2.3</U> of this Agreement. The Company shall not be required to register the transfer of any Securities to any person unless the Company receives from the proposed transferee a written instrument in form and substance
reasonably satisfactory to the Company in which such transferee makes the representations and warranties set forth in <U>Section</U><U></U><U>&nbsp;2.3</U> and, if the Company so reasonably requests, an opinion of counsel in form and substance
reasonably satisfactory to the Company to the effect that registration under the Securities Act is not required in connection with such transfer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) The Company shall promptly cause the legend to be removed from any certificate for any Securities held by Purchaser or any of its
affiliates and the Company shall deliver all necessary documents to the transfer agent in connection therewith without charge as to any Securities (i)&nbsp;upon request of Purchaser, upon receipt by the Company of an opinion of counsel reasonably
satisfactory to the Company to the effect that such legend is no longer required under the Securities Act and applicable state Laws or (ii)&nbsp;when such Securities shall have been registered under the Securities Act or may otherwise be transferred
pursuant to any applicable rules thereunder, including eligibility to be transferred if Rule 144 under the Securities Act is available for the sale of the Securities without volume and manner of sale restrictions and the Company shall use reasonable
best efforts to deliver all necessary documents to the transfer agent in connection therewith without charge as to any Securities, including the delivery of an opinion of counsel that such legend is no longer required under the Securities Act and
applicable state Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3 <U>No Materially Burdensome Condition</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding anything to the contrary herein, Purchaser shall not be required to take any action, or commit to take or refrain from
taking any action, or accept or agree to any condition or restriction, in each case, that would reasonably be expected to cause Purchaser, its affiliates or any of their partners or principals to (i) &#147;control&#148; the Company or be required to
become a bank holding company, in each case, pursuant to the BHC Act; (ii)&nbsp;serve as a source of financial strength to the Company pursuant to the BHC Act or (iii)&nbsp;enter into any capital or liquidity maintenance agreement or any similar
agreement with any Governmental Entity, provide capital support to the Company or any of its Subsidiaries or otherwise commit to or contribute any additional capital to, provide other funds to, or make any other investment in, the Company or any of
its Subsidiaries (each of <U>clauses (</U><U>i</U><U>)</U>&nbsp;through <U>(iii)</U>, a &#147;<U>Materially Burdensome Condition</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) In the event either party believes that the imposition of a Materially Burdensome Condition is reasonably likely to occur, it shall
promptly notify the other party and both parties shall cooperate in good faith to consider, to the extent commercially reasonable, such modifications or arrangements as may be necessary or advisable to avoid imposition of the Materially Burdensome
Condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4 <U>Reservation for Issuance</U>. As promptly as practicable following the Closing, but no later than five
(5)&nbsp;business days, the Company shall take all action to reserve up to 800,000,000 shares of Common Stock for issuance upon conversion of shares of (i)&nbsp;Preferred Stock issuable pursuant to this Agreement and
<FONT STYLE="white-space:nowrap">(ii)&nbsp;non-voting,</FONT> common equivalent preferred stock for which the Permanent Warrant may be exercised, in each case, (w)&nbsp;in accordance with the terms of this Agreement, the Certificate of Designations
and the Permanent Warrant (as applicable) and (x)&nbsp;excluding any adjustments applicable thereto. Promptly following the Company&#146;s receipt of the Requisite Stockholder Vote and the filing of the Charter Amendment with the Delaware Secretary
of State, the Company shall reserve that number of additional shares of Common Stock sufficient for issuance of shares of (A)&nbsp;Common Stock upon the Conversions and <FONT STYLE="white-space:nowrap">(B)&nbsp;non-voting,</FONT> common equivalent
preferred stock for which the Permanent Warrant may be exercised, in each case, (y)&nbsp;in accordance with the terms of this Agreement, the Certificate of Designations and the Permanent Warrant (as applicable) and (z)&nbsp;excluding any adjustments
applicable thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5 <U>Indemnity</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Following the Closing, the Company shall indemnify, defend and hold harmless Purchaser and its affiliates, to the fullest extent
permitted by Law, from and against any and all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs, losses, liabilities, damages, payments, fees, expenses (including reasonable attorneys&#146; fees and
disbursements) and amounts paid in settlement (collectively, &#147;<U>Losses</U>&#148;; <U>provided</U>, <U>however</U>, that &#147;Losses&#148; do not include, (x)&nbsp;except to the extent awarded in a Third Party Claim, punitive, exemplary,
consequential or special damages or (y)&nbsp;lost profits, opportunity costs or damages based upon a multiple of earnings, revenues or similar financial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
measure (even if under Law such lost profits, opportunity costs or damages based upon a multiple of earnings, revenues or similar financial measure would be considered reasonably foreseeable or
not special damages) if such Loss directly results from (i)&nbsp;any inaccuracy in or breach of any of the Company&#146;s representations or warranties in <U>Section</U><U></U><U>&nbsp;2.2</U> or (ii)&nbsp;the Company&#146;s breach of any agreements
or covenants made by the Company herein (except, in the case of this clause (ii), as set forth in <U>Section</U><U></U><U>&nbsp;4.5(a)</U> of the Company Disclosure Schedule). Notwithstanding the foregoing, the Company shall have no obligation under
this <U>Section</U><U></U><U>&nbsp;4.5(a)</U>&nbsp;(A) following the expiration of the applicable survival period set forth in <U>Section</U><U></U><U>&nbsp;4.5(o)</U> or (B)&nbsp;in respect of any claim, action, suit, litigation, dispute or
proceeding threatened or commenced against the Company and/or any Company Subsidiary and/or any of their respective directors, officers or employees (including if Purchaser or any of its affiliates or its or their respective directors, officers,
employees, shareholders or controlling persons are or are threatened to be made party thereto)&nbsp;(x) in connection with any Stockholder Litigation or actions expressly required by, or taken with the prior written consent of Purchaser pursuant to,
this Agreement or (y)&nbsp;that seeks to enjoin, restrain or prohibit the transactions contemplated by this Agreement or the Other Investment Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Following the Closing, Purchaser shall indemnify, defend and hold harmless each of the Company and its Subsidiaries, to the fullest
extent permitted by Law, from and against any and all Losses actually incurred by the Company or any of its Subsidiaries if such Loss directly results from (i)&nbsp;any inaccuracy in or breach of any of Purchaser&#146;s representations or warranties
in <U>Section</U><U></U><U>&nbsp;2.3</U> or (ii)&nbsp;Purchaser&#146;s breach of any agreements or covenants made by Purchaser herein. Notwithstanding the foregoing, Purchaser shall have no obligation under this
<U>Section</U><U></U><U>&nbsp;4.5(b)</U> following the expiration of the applicable survival period set forth in <U>Section</U><U></U><U>&nbsp;4.5(o)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) A party that may desire to seek indemnification hereunder (each, an &#147;<U>Indemnified Party</U>&#148;) shall give written notice to
the party indemnifying it (the &#147;<U>Indemnifying Party</U>&#148;) of any claim that does not result from a third party with respect to which it seeks indemnification (a &#147;<U>Direct Claim</U>&#148;) promptly (and, in any event, not later than
fifteen (15)&nbsp;business days) after the first discovery by such Indemnified Party of any fact, event, circumstance, development or matters giving rise to such claim. Such notice (a &#147;<U>Claim Notice</U>&#148;) shall (i)&nbsp;describe such
Direct Claim in reasonable detail (including the facts underlying each particular claim and an identification of all the particular sections of therein pursuant to which indemnification is and will be being sought); (ii) attach copies of any written
evidence or demand upon which such Direct Claim is based (to the extent that such written evidence or demand is not reasonably available at such time, the Indemnified Party shall so indicate and promptly provide such evidence when it becomes
available); and (iii)&nbsp;set forth the estimated amount (broken down by each individual claim) for which the Indemnifying Party may be liable, to the extent then known. The Indemnifying Party shall have thirty (30)&nbsp;days after its receipt of
such notice to respond in writing to the Direct Claim (a &#147;<U>Response Notice</U>&#148;). If the Indemnifying Party does not deliver a Response Notice within such thirty <FONT STYLE="white-space:nowrap">(30)-day</FONT> period, the Indemnifying
Party shall be deemed to have agreed to such claim and the Indemnifying Party&#146;s obligation to indemnify, compensate or reimburse the Indemnified Party for the full amount of all Losses resulting therefrom. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) In case any such action, suit, claim or proceeding is threatened or commenced against an Indemnified Party by any person who is not a
party to this Agreement or an affiliate of any party to this Agreement, with respect to which the Indemnifying Party is or may be obligated to provide indemnification under <U>Section</U><U></U><U>&nbsp;4.5(a)</U> or
<U>Section</U><U></U><U>&nbsp;4.5(b)</U> (as applicable) (a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#147;<U>Third Party Claim</U>&#148;), the Indemnified Party shall, as promptly as reasonably practicable, cause a Claim Notice regarding any Third Party Claim of which it has knowledge that is
covered by this <U>Section</U><U></U><U>&nbsp;4.5</U> to be delivered to the Indemnifying Party. The Claim Notice shall (i)&nbsp;describe such Third Party Claim in reasonable detail (including the identity of the applicable third party, the facts
underlying each particular claim and an identification of all the particular sections of therein pursuant to which indemnification is and will be being sought); (ii) attach copies of any written evidence or demand upon which such Third Party Claim
is based (to the extent that such written evidence or demand is not reasonably available at such time, the Indemnified Party shall so indicate and promptly provide such evidence when it becomes available); and (iii)&nbsp;set forth the estimated
amount (broken down by each individual claim) for which the Indemnifying Party may be liable, to the extent then known. The Indemnifying Party shall have the right but not the obligation to assume control of the defense of any Third Party Claim by,
no later than the thirtieth (30<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) day after its receipt of such Claim Notice, notifying the Indemnified Party that, subject to the other provisions of this <U>Section</U><U></U><U>&nbsp;4.5</U>,
the Indemnifying Party has elected to conduct and control the defense, negotiation or settlement of the applicable Third Party Claim and any action, suit, claim or proceeding resulting therefrom with counsel reasonably acceptable to the Indemnified
Party and at the Indemnifying Party&#146;s sole cost and expense. If the Indemnifying Party elects to assume the defense of a Third Party Claim, the Indemnified Party will have the right, but not the obligation, to participate in any such defense
and to employ separate counsel of its choosing at its own expense; <U>provided</U> that if the Indemnified Party is advised by outside counsel that an actual conflict of interest (other than one of a monetary nature) would make it inappropriate for
the same counsel to represent both the Indemnifying Party and the Indemnified Party with respect to the Third Party Claim, then the Indemnifying Party shall pay the reasonable,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> and documented fees, costs and expenses of counsel employed by the Indemnified Party; <U>provided</U>, <U>further</U>, that the Indemnifying Party shall
only be liable for the legal fees and expenses for one law firm for all Indemnified Parties (taken together with respect to any single action or group of related actions) in connection with any Third Party Claim (plus one local counsel in each
applicable jurisdiction). If the Indemnifying Party does not assume the defense of the Third Party Claim within the thirty <FONT STYLE="white-space:nowrap">(30)-day</FONT> period referenced in this <U>Section</U><U></U><U>&nbsp;4.5</U>, (x) the
Indemnified Party may defend against the Third Party Claim and (y)&nbsp;the Indemnifying Party will have the right, but not the obligation, to participate in any such defense and to employ separate counsel of its choosing at its own expense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding anything in this <U>Section</U><U></U><U>&nbsp;4.5</U> to the contrary, (i)&nbsp;the Indemnified Party shall not, without
the prior written consent of the Indemnifying Party, (x)&nbsp;consent to the entry of any Order, (y)&nbsp;settle or compromise or (z)&nbsp;enter into any settlement or similar agreement with respect to, any Third Party Claim, unless such Order or
proposed settlement or compromise or agreement (A)&nbsp;involves an unconditional release of the Indemnifying Party in respect of such Third Party Claim and (B)&nbsp;does not contain any admission or finding of wrongdoing on behalf of the
Indemnifying Party and (ii)&nbsp;the Indemnifying Party shall not, without the prior written consent of the Indemnified Party, (x)&nbsp;consent to the entry of any Order, (y)&nbsp;settle or compromise or (z)&nbsp;enter into any settlement or similar
agreement with respect to, any Third Party Claim, unless the Order or proposed settlement or compromise or agreement (A)&nbsp;involves only the payment of money damages against which the Indemnified Party is indemnified in full by the Indemnifying
Party, (B)&nbsp;does not impose an injunction or other equitable relief upon the Indemnified Party, (C)&nbsp;involves an unconditional release of the Indemnified Party in respect of such Third Party Claim and (D)&nbsp;does not involve a finding or
admission of any violation of Law or other wrongdoing by the Indemnified Party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) The failure by an Indemnified Party to timely or properly provide, pursuant to
<U>Section</U><U></U><U>&nbsp;4.5(c)</U> or <U>Section</U><U></U><U>&nbsp;4.5(d)</U>, any Claim Notice to the Indemnifying Party shall not relieve the Indemnifying Party of its obligations hereunder, except to the extent, and only to the extent
that, the Indemnifying Party is actually and directly prejudiced by such failure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) For purposes of the indemnity contained in
<U>Section</U><U></U><U>&nbsp;4.5(a)(</U><U>i</U><U>)</U> and <U>Section</U><U></U><U>&nbsp;4.5(b)(</U><U>i</U><U>)</U>, all qualifications and limitations set forth in such representations and warranties as to &#147;materiality,&#148;
&#147;<U>Material Adverse Effect</U>&#148; and words of similar import (other than <U>Section</U><U></U><U>&nbsp;2.2(f)(</U><U>i</U><U>)(B)</U>, <U>Section</U><U></U><U>&nbsp;2.2(f)(iii)(A)</U> and <U>Section</U><U></U><U>&nbsp;2.2(k)(iv)</U>),
shall be disregarded in determining whether there shall have been any inaccuracy in or breach of any representations and warranties in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) Except in the case of any inaccuracy or breach of any Company Fundamental Reps, the Company shall not be required to indemnify the
Indemnified Parties pursuant to <U>Section</U><U></U><U>&nbsp;4.5(a)(</U><U>i</U><U>)</U>, (i)&nbsp;with respect to any individual claim (or group of related claims) for indemnification if the amount of Losses with respect to such individual claim
(or group of related claims) is less than $100,000 (any individual claim (or group of related claims) involving Losses less than such amount being referred to as a &#147;<U>De Minimis Claim</U>&#148;) and (ii)&nbsp;unless and until the aggregate
amount of all Losses incurred with respect to all claims (other than De Minimis Claims) pursuant to <U>Section</U><U></U><U>&nbsp;4.5(a)(</U><U>i</U><U>)</U> exceeds an amount equal to 1.5% of the Investment Amount (such amount, the
&#147;<U>Threshold Amount</U>&#148;), in which event the Company shall be responsible for only the amount of such Losses in excess of the Threshold Amount, but subject to the last sentence of this <U>Section</U><U></U><U>&nbsp;4.5(h)</U>. Except in
the case of any inaccuracy or breach of any Purchaser Fundamental Reps, Purchaser shall not be required to indemnify the Indemnified Parties pursuant to <U>Section</U><U></U><U>&nbsp;4.5(b)(</U><U>i</U><U>)</U>, (1)&nbsp;with respect to any De
Minimis Claim and (2)&nbsp;unless and until the aggregate amount of all Losses incurred with respect to all claims (other than De Minimis Claims) pursuant to <U>Section</U><U></U><U>&nbsp;4.5(b)(</U><U>i</U><U>)</U> exceeds the Threshold Amount, in
which event Purchaser shall be responsible for only the amount of such Losses in excess of the Threshold Amount, but subject to the last sentence of this <U>Section</U><U></U><U>&nbsp;4.5(h)</U>. Except in the case of any inaccuracy or breach of any
Company Fundamental Reps or Purchaser Fundamental Reps, the cumulative indemnification obligation of (x)&nbsp;the Company under <U>Section</U><U></U><U>&nbsp;4.5(a)</U> shall in no event exceed 10% of the Investment Amount and (y)&nbsp;Purchaser
under <U>Section</U><U></U><U>&nbsp;4.5(b)</U> shall in no event exceed 10% of the Investment Amount. In the case of any inaccuracy or breach of any Company Fundamental Reps or Purchaser Fundamental Reps, the cumulative indemnification obligation of
(x)&nbsp;the Company under <U>Section</U><U></U><U>&nbsp;4.5(a)</U> shall in no event exceed the Investment Amount and (y)&nbsp;Purchaser under <U>Section</U><U></U><U>&nbsp;4.5(b)</U> shall in no event exceed the Investment Amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Any claim for indemnification pursuant to <U>Section</U><U></U><U>&nbsp;4.5</U> can only be brought on or prior to the eighteen
(18)&nbsp;month anniversary of the Closing Date; <U>provided</U>, that (i)&nbsp;a claim for indemnification pursuant to <U>Section</U><U></U><U>&nbsp;4.5(a)(</U><U>i</U><U>)</U> in respect of an inaccuracy of any of the representations of the
Company set forth in <U>Section</U><U></U><U>&nbsp;2.2(a)(</U><U>i</U><U>)</U>, <U>Section</U><U></U><U>&nbsp;2.2(b)(</U><U>i</U><U>)</U>, <U>Section</U><U></U><U>&nbsp;2.2(b)(ii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(c)(</U><U>i</U><U>)</U>,
<U>Section</U><U></U><U>&nbsp;2.2(c)(ii)(A)</U>, <U>Section</U><U></U><U>&nbsp;2.2(c)(iii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(g)</U> and <U>Section</U><U></U><U>&nbsp;2.2(u)</U> (each, a &#147;Company Fundamental Rep&#148;) or pursuant to
<U>Section</U><U></U><U>&nbsp;4.5(b)(</U><U>i</U><U>)</U> in respect of any of the representations of Purchaser set forth in <U>Section</U><U></U><U>&nbsp;2.3(a)</U>, <U>Section</U><U></U><U>&nbsp;2.3(b)(ii)</U> and
<U>Section</U><U></U><U>&nbsp;2.3(l)</U> (each, a &#147;Purchaser Fundamental Rep&#148;), in each case, can be brought on or prior to the third (3<SUP STYLE="font-size:75%; vertical-align:top">rd</SUP>) anniversary of the Closing Date and
(ii)&nbsp;if a compliant notice of a valid claim for indemnification pursuant to <U>Section</U><U></U><U>&nbsp;4.5(a)</U> or <U>Section</U><U></U><U>&nbsp;4.5(b)</U> is duly provided prior to the end of the applicable foregoing survival period with
respect thereto, then the obligation to indemnify, defend and hold harmless in respect of such inaccuracy or breach shall survive as to such claim until such claim has been finally resolved. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) Except for a claim of Fraud, the indemnity provided for in this
<U>Section</U><U></U><U>&nbsp;4.5</U> shall be the sole and exclusive monetary remedy of Indemnified Parties after the Closing for any inaccuracy in or breach of any representation or warranty or any breach of any covenant or agreement contained in
this Agreement to be performed at or prior to the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k) Where one and the same set of facts, circumstances or events qualifies
under more than one provision entitling an Indemnified Party to a claim or remedy hereunder, such Indemnified Party shall not be entitled to duplicative recovery of Losses arising out of such facts, circumstances or events. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(l) Each Indemnified Party shall use commercially reasonable efforts to mitigate any Loss upon and after obtaining knowledge of any event,
set of facts, circumstance or occurrence that would reasonably be expected to give rise to any Loss that would reasonably be expected to give rise to an indemnity obligation pursuant to this <U>Section</U><U></U><U>&nbsp;4.5</U>. In the event that
an Indemnified Party shall fail to use commercially reasonable efforts to mitigate any such Loss, then notwithstanding anything contained herein to the contrary, the Indemnifying Party shall not be required to indemnify any Indemnified Party for
that portion of any Losses that would reasonably be expected to have been avoided if all Indemnified Parties had made such efforts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(m)
If an Indemnified Party has or may have a right to recover any Loss against or from any third party (including any insurance company in its capacity as an insurer), such Indemnified Party shall use commercially reasonable efforts to seek recovery
against and from such third party and if the Indemnified Party recovers any such amount from such third party after the Indemnifying Party makes any payment pursuant to this <U>Section</U><U></U><U>&nbsp;4.5</U> in respect of such Loss, then the
Indemnified Party shall promptly remit to the Indemnifying Party the lesser of the amount previously paid by the Indemnifying Party to the Indemnified Party in respect of such Loss and the amount the Indemnified Party received from such third party
in respect of such Loss (net of all reasonable costs of collection). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(n) Any indemnification payments pursuant to this
<U>Section</U><U></U><U>&nbsp;4.5</U> shall be treated as an adjustment to the Investment Amount for the Securities for U.S. federal income and applicable state and local Tax purposes, except to the extent otherwise required by a
&#147;determination&#148; within the meaning of Section&nbsp;1313(a) of the Code (or any similar provision of state or local Law). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(o)
Each of the representations and warranties set forth herein shall survive the Closing under this Agreement for a period of eighteen (18)&nbsp;months following the Closing Date and, thereafter, except in the case of Fraud, shall expire and have no
force and effect, including in respect of this <U>Section</U><U></U><U>&nbsp;4.5</U>; <U>provided</U>, however, that the Company Fundamental Reps and the Purchaser Fundamental Reps shall survive the Closing under this agreement for a period of <FONT
STYLE="white-space:nowrap">thirty-six</FONT> (36)&nbsp;months following the Closing Date, in each case, subject to <U>Section</U><U></U><U>&nbsp;4.5(</U><U>i</U><U>)</U>. Except as otherwise provided herein, all covenants and agreements contained
herein, other than those which by their terms are to be performed in whole or in part after the Closing Date (which shall survive in accordance with their terms), shall survive the closing under this Agreement for a period of twelve (12)&nbsp;months
following the Closing Date (or until final resolution of any claim or action arising from the breach of such covenant if notice of such breach was provided prior to the end of such period). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6 <U>Exchange Listing</U>. Prior to and, if necessary, following the Closing,
the Company shall use reasonable best efforts to cause (a)&nbsp;the shares of Common Stock (i)&nbsp;issued hereunder and (ii)&nbsp;to be issued upon the Conversions, (b)&nbsp;the Permanent Warrants and (c)&nbsp;the warrants on the terms described on
<U>Exhibit E</U>, in each case, to be approved for listing on the NYSE, subject to official notice of issuance and upon receipt of the Requisite Stockholder Vote (if applicable). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7 <U>Certificate of Designations</U>. In connection with the Closing, the Company shall file the Certificate of Designations
with the Delaware Secretary of State. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8 <U>State Securities Laws</U>. The Company shall use commercially reasonable
efforts to obtain all necessary permits and qualifications, if any, or secure an exemption therefrom, required by any state or country pursuant to Laws prior to the offer and sale by Purchaser of Common Stock and/or the Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.9 <U>Company Opportunities</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Except as expressly provided in this Agreement, Purchaser and any related investment funds, and any of their respective affiliates, have
the right to, and shall have no duty (contractual or otherwise) not to (i)&nbsp;invest in, carry on and conduct, whether directly, or as a partner in any partnership, or as a joint venturer in any joint venture, or as an officer, director,
stockholder, equityholder or investor in any person, or as a participant in any syndicate, pool, trust or association, any business of any kind, nature or description, whether or not such business is competitive with or in the same or similar lines
of business as the Company or any of its Subsidiaries, (ii)&nbsp;do business with any client, customer, vendor or lessor of any of the Company or its affiliates or (iii)&nbsp;make investments in any kind of property in which the Company may make
investments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) In the event that Purchaser or any related investment funds or any of their respective affiliates, acquires knowledge
of a potential transaction or matter that may be a corporate opportunity for the Company or any of its Subsidiaries, none of Purchaser or any related investment funds or any of their respective affiliates, shall have any duty (contractual or
otherwise) to communicate or present such corporate opportunity to the Company or to refrain from pursuing or acquiring such corporate opportunity for its own benefit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) None of Purchaser, any related investment fund or any of their respective affiliates shall be liable to the Company or any of its
Subsidiaries or stockholders of the Company for breach of any duty (contractual or otherwise) by reason of the fact that Purchaser or any related investment fund thereof or any of their respective affiliates pursues or acquires such opportunity for
itself, directs such opportunity to another person, or does not present such opportunity to the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10 <U>No Recourse</U>. This Agreement may only be enforced against, and any
actions, suits, proceedings, claims, demands, disputes, cross claims, counterclaims or causes of action (whether in contract or tort or otherwise) that may be based upon, arise out of or relate to this Agreement or any Other Investment Agreement or
the transactions contemplated hereby or thereby, or the negotiation, execution or performance of this Agreement or any Other Investment Agreement or the transactions contemplated hereby or thereby, may be made only against the entities that are
expressly identified as the party or parties to such agreement(s). No person who is not a party hereto, including any past, present or future direct or indirect equityholder, director, officer, employee, incorporator, member, manager, partner,
affiliate, agent, attorney, financing source, assignee or representative of any party hereto or its affiliates or any former, current or future direct or indirect equityholder, director, officer, employee, incorporator, agent, attorney,
representative, partner, member, manager, affiliate, agent, assignee or representative of any of the foregoing (&#147;<U><FONT STYLE="white-space:nowrap">Non-Party</FONT> Affiliates</U>&#148;), shall have any liability (whether in contract or in
tort, in law or in equity, or based upon any theory that seeks to impose liability of an entity party against its owners or affiliates) to any other party hereto (or its affiliates) for any obligations or liabilities arising under, in connection
with or related to this Agreement or the transactions contemplated hereby, or for any claim based on, in respect of, or by reason of this Agreement or the transactions contemplated hereby, or the negotiation, execution or performance of this
Agreement or the transactions contemplated hereby, and each party hereto irrevocably and unconditionally waives and releases all such liabilities, claims and obligations against any such <FONT STYLE="white-space:nowrap">Non-Party</FONT> Affiliates.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.11 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The Company shall pay any and all transfer Taxes, stamp Taxes or duties, documentary Taxes, or other similar Taxes imposed upon the
issuance of shares of Common Stock and Preferred Stock pursuant to this Agreement or the issuance of shares of Common Stock on account of the conversion of Preferred Stock pursuant to the Certificate of Designations; <U>provided</U> that the Company
shall not be required to pay any such Tax that may be payable in connection with any issuance of Common Stock pursuant to a conversion of Preferred Stock to the extent such Tax is payable because a registered holder of Preferred Stock requests
Common Stock to be registered in a name other than such registered holder&#146;s name and, no such Common Stock will be so registered unless and until the registered holder making such request has paid such taxes to the Company or has established to
the satisfaction of the Company that such taxes have been paid or are not payable. The Company and Purchaser shall reasonably cooperate to avoid or minimize the imposition of transfer Taxes, stamp Taxes or duties, documentary Taxes, or other similar
Taxes described in the first sentence of this <U>Section</U><U></U><U>&nbsp;4.11</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything herein or in the
Certificate of Designations to the contrary, the Company and any applicable withholding agent shall be entitled to deduct and withhold from any consideration otherwise payable on or with respect to the Common Stock or Preferred Stock (including upon
conversion of any Preferred Stock) such amounts as it is required to deduct or withhold with respect to the making of such payment under the Code or any other applicable Tax Law. If the holder of Preferred Stock is deemed for U.S. federal income tax
purposes to have received a distribution with respect to the Preferred Stock, the Company or an applicable withholding agent may satisfy any resulting applicable withholding obligations (including with respect to backup withholding) imposed in
connection with such deemed distribution by withholding from any other payments due with respect to the Common </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Stock or Preferred Stock, including any payments upon conversion, repurchase or redemption of the Common Stock or Preferred Stock to the extent required by applicable Tax Law. If any amounts are
so deducted or withheld and subsequently paid to the applicable Governmental Entity, such deducted or withheld amounts shall be treated for all purposes of this Agreement and the Certificate of Designations as having been paid to the person to which
such amounts would have otherwise been payable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Following the Closing, if the Company becomes aware that an event or other
occurrence has occurred that, if the Preferred Stock were treated as &#147;preferred stock&#148; for purposes of Section&nbsp;305 of the Code, would cause a deemed distribution, with respect to the Preferred Stock, pursuant to Section&nbsp;305(c) of
the Code, the Company shall use commercially reasonable efforts to notify Purchaser of such event or occurrence and shall consult with Purchaser in good faith regarding the treatment of such event or occurrence. The Company and Purchaser agree that
there shall be no deemed distribution on the Preferred Stock pursuant to Section&nbsp;305(c) of the Code in respect of a difference between the &#147;issue price&#148; and the &#147;redemption price&#148; of the Preferred Stock and except to the
extent otherwise required by a &#147;determination&#148; within the meaning of Section&nbsp;1313(a) of the Code, neither the Company nor Purchaser shall take any position inconsistent therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) Following the Closing, Purchaser shall provide the Company with a proposed allocation of the Investment Amount among the shares of Series
C Preferred Stock delivered at the Closing and the Permanent Warrant for U.S. tax purposes.&nbsp;The Company may propose reasonable comments to the proposed allocation within fifteen (15)&nbsp;days of receiving the proposed allocation, and Purchaser
shall consider such comments in good faith. Thereafter, Purchaser shall provide the Company with a final allocation for U.S. tax purposes and such final allocation shall be binding on Purchaser and the Company for all U.S. tax purposes. In the event
that the Company issues additional warrants to Purchaser pursuant to <U>Section</U><U></U><U>&nbsp;3.1(h)</U> of this Agreement, Purchaser shall provide a proposed adjusted allocation to the Company, which may propose reasonable comments to the
proposed adjusted allocation within fifteen (15)&nbsp;days of receiving the proposed adjusted allocation, and Purchaser shall consider such comments in good faith. Thereafter, Purchaser shall provide the Company with a final adjusted allocation for
U.S. tax purposes and such final adjusted allocation shall be binding on Purchaser and the Company for all U.S. tax purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.12 <U>Termination</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) This Agreement may be terminated prior to the Closing: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) by mutual written agreement of the Company and Purchaser; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) by the Company or Purchaser, upon written notice to the other party, in the event that the Closing does not occur on or
before the tenth (10<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) business day following date hereof (such date, the &#147;<U>Termination Date</U>&#148;); <U>provided</U>, <U>however</U>, that the right to terminate this Agreement
pursuant to this <U>Section</U><U></U><U>&nbsp;4.12(a)(ii)</U> shall not be available to any party whose failure to fulfill any obligation under this Agreement shall have been the cause of, or shall have resulted in, the failure of the Closing to
occur on or prior to such date; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) by the Company (<U>provided</U> that the Company is not then in
material breach of any representation, warranty, covenant or other agreement contained herein that is a condition to Purchaser&#146;s obligation to effect the Closing), if there shall have been a breach of any of the covenants or agreements or any
of the representations or warranties set forth herein on the part of Purchaser, which breach, either individually or in the aggregate with all other breaches by Purchaser, would constitute, if occurring or continuing as of the Closing, the failure
of a condition set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)(iii)</U>, and which is not cured prior to the Termination Date following written notice to Purchaser, or by its nature or timing cannot be cured during such period (or such fewer days
as remain prior to the Termination Date); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) by Purchaser (<U>provided</U> that Purchaser is not then in material
breach of any representation, warranty, covenant or other agreement contained herein that is a condition to the Company&#146;s obligation to effect the Closing), if there shall have been a breach of any of the covenants or agreements contained
herein or any of the representations or warranties set forth herein on the part of the Company, which breach, either individually or in the aggregate with all such other breaches by the Company, would constitute, if occurring or continuing as of the
Closing, the failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)(ii)</U>, and which is not cured prior to the Termination Date following written notice to Purchaser, or by its nature or timing cannot be cured during such period
(or such fewer days as remain prior to the Termination Date). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Following the Closing, <U>Section</U><U></U><U>&nbsp;4.2</U>,
<U>Section</U><U></U><U>&nbsp;4.4</U> and <U>Section</U><U></U><U>&nbsp;4.9</U> shall automatically terminate on the date that Purchaser (together with its affiliates) ceases to own any shares of capital stock of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) In the event of any termination of this Agreement as provided in <U>Section</U><U></U><U>&nbsp;4.12</U>, this Agreement (other than
<U>Section</U><U></U><U>&nbsp;3.2</U>, this <U>Section</U><U></U><U>&nbsp;4.12(c)</U> and <U>Article V</U>, which shall remain in full force and effect) shall forthwith become wholly void and of no further force and effect, and none of the Company,
Purchaser, any of their respective affiliates or any of the officers, directors, members or partners of any of them shall have any liability of any nature whatsoever hereunder, or in connection with the transactions contemplated hereby;
<U>provided</U> that nothing herein shall relieve any party hereto from any liability for Fraud or willful and intentional breach of any covenant or agreement expressly set forth herein. &#147;<U>Fraud</U>&#148; means an intentional
misrepresentation with respect to a representation or warranty set forth in <U>Section</U><U></U><U>&nbsp;2.2</U> or <U>Section</U><U></U><U>&nbsp;2.3</U>, which such intentional misrepresentation was (i)&nbsp;inaccurate on the date hereof, and
(ii)&nbsp;made with (A)&nbsp;the specific intent of deceiving and inducing the other party to enter into this Agreement and upon which the other party actually relied to its detriment, and (B)&nbsp;actual knowledge (without any duty of investigation
or inquiry) of the inaccuracy of such intentional misrepresentation; <U>provided</U> that &#147;Fraud&#148; shall not include any claim (including equitable fraud, promissory fraud and unfair dealings fraud) based on constructive knowledge,
recklessness, negligent misrepresentation or a similar theory. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;V </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MISCELLANEOUS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1 <U>Amendment</U>. This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or
otherwise, except by a written instrument signed on behalf of each of the parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2 <U>Extension; Waiver</U>. Each party
may, to the extent permitted by Law, (a)&nbsp;extend the time for the performance of any of the obligations or other acts of the Company, in the case of Purchaser, or Purchaser, in the case of the Company, (b)&nbsp;waive any inaccuracies in the
representations and warranties contained herein or in any document delivered pursuant hereto on the part of the Company, in the case of Purchaser, or Purchaser, in the case of the Company, and (c)&nbsp;waive compliance with any of the agreements or
satisfaction of any conditions for its benefit contained herein. Any agreement on the part of a party to any such extension or waiver shall be valid only if set forth in a written instrument signed on behalf of such party, but such extension or
waiver or failure to insist on strict compliance with an obligation, covenant, agreement or condition shall not operate as a waiver of, or estoppel with respect to, any subsequent or other failure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3 <U>Expenses</U>. Except as otherwise expressly set forth herein, all costs, fees and expenses incurred in connection with
this Agreement and the transactions contemplated hereby shall be paid by the party incurring such cost, fee or expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4
<U>Notices</U>. All notices and other communications hereunder shall be in writing and shall be deemed duly given on (a)&nbsp;the date of delivery if delivered personally, or if by email, upon delivery (<U>provided</U> that no auto-generated error
or <FONT STYLE="white-space:nowrap">non-delivery</FONT> or similar message is generated in response thereto), (b)&nbsp;the first (1st) business day following the date of dispatch if delivered utilizing a
<FONT STYLE="white-space:nowrap">next-day</FONT> service by a recognized <FONT STYLE="white-space:nowrap">next-day</FONT> courier or (c)&nbsp;the earlier of confirmation of receipt or the fifth (5th) business day following the date of mailing if
delivered by registered or certified mail, return receipt requested, postage prepaid. All notices hereunder shall be delivered to the addresses set forth below, or pursuant to such other instructions as may be designated in writing by the party to
receive such notice: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to the Company, to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">New York Community Bancorp, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">102 Duffy Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Hicksville,
New York 11801 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: R. Patrick Quinn, Senior Executive Vice President, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">General Counsel and Corporate Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: Patrick.Quinn@flagstar.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">With a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">One Manhattan West </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">New York,
NY 10001 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: Sven Mickisch; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Christopher M. Barlow; </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Matthew
Nemeroff </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: Sven.Mickisch@skadden.com; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Christopher.Barlow@skadden.com; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Matthew.Nemeroff@skadden.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">and </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to Purchaser, to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">[Hudson Bay Purchasers] </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">c/o
Hudson Bay Capital Management LP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">28 Havemeyer Place, 2nd Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Greenwich, CT 06830 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention:
Legal Notices </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: [Reserved.] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">With a copy (which shall not constitute notice) to </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Schulte Roth&nbsp;&amp; Zabel LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">919 Third Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">New York, New
York 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: Eleazer Klein </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: eleazer.klein@srz.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5 <U>Interpretation</U>. The parties have participated jointly in negotiating and drafting this Agreement. In the event that an
ambiguity or a question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of
any provision hereof. When a reference is made in this Agreement to Articles, Sections, Exhibits or Schedules, such reference shall be to an Article or Section of or Exhibit or Schedule to this Agreement, unless otherwise indicated. The table of
contents and headings contained herein are for reference purposes only and shall not affect in any way the meaning or interpretation hereof. Whenever the words &#147;include,&#148; &#147;includes&#148; or &#147;including&#148; are used herein, they
shall be deemed to be followed by the words &#147;without limitation.&#148; The word &#147;or&#148; shall not be exclusive. References to &#147;the date hereof&#148; mean the date of this Agreement. Notwithstanding anything herein to the contrary,
neither Purchaser nor any of its affiliates and neither the Company nor any of its Subsidiaries shall be required to take any action that is prohibited by Law or any Governmental Entity. As used herein, the &#147;<U>knowledge</U>&#148; of Purchaser
means the actual knowledge of any of the officers of Purchaser, and the &#147;knowledge&#148; of the Company means the actual knowledge of any of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the officers of the Company listed on <U>Section</U><U></U><U>&nbsp;5.5</U> of the Company Disclosure Schedule. As used herein, (a)&nbsp;&#147;<U>business day</U>&#148; means any day other than a
Saturday, a Sunday or a day on which banks in New York, New York are authorized by Law to be closed, (b)&nbsp;&#147;person&#148; means any individual, corporation (including
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit),</FONT></FONT> general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, Governmental Entity or other entity
of any kind or nature, (c)&nbsp;an &#147;<U>affiliate</U>&#148; of a specified person is any person that directly or indirectly, controls, is controlled by, or is under common control with, such specified person; <U>provided</U> that
&#147;affiliate&#148; shall not include any &#147;portfolio company&#148; (as such term is customarily used in the private equity industry) of any investment fund affiliated with or managed by such person or any investment fund or vehicle (other
than any such fund or vehicle with a direct or indirect interest in such person) of or related to or affiliated with such person, (d)&nbsp;&#147;<U>party</U>&#148; means a party to this Agreement, unless the context clearly suggests otherwise,
(e)&nbsp;&#147;<U>made available</U>&#148; means any document or other information provided by one party to the other party, including any document or other information that was (i)&nbsp;included in the virtual data room of a party at least one
(1)&nbsp;business day prior to the date hereof or (ii)&nbsp;filed by a party with the SEC since January&nbsp;1, 2023 and publicly available on EDGAR at least one (1)&nbsp;business day prior to the date hereof, (f)&nbsp;the &#147;<U>transactions
contemplated hereby</U>&#148; and &#147;<U>transactions contemplated by this Agreement</U>&#148; shall include the purchase and sale of Securities contemplated by <U>Section</U><U></U><U>&nbsp;1.1</U>, (g)&nbsp;&#147;<U>ordinary course</U>&#148; and
&#147;<U>ordinary course of business</U>&#148; with respect to either party, means conduct consistent with past practice and the normal <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> customs, practices and
procedures of such party, taking into account any changes to such practices as may have occurred in response to any Pandemic, including compliance with Pandemic Measures, (h) &#147;<U>U.S.</U>&#148; means the United States of America, (i)
&#147;extent&#148; in the phrase &#147;to the extent&#148; means the degree to which a subject or other thing extends and such phrase shall not mean simply &#147;if&#148; and (j) &#147;<U>Representatives</U>&#148; means each party and its and its
affiliates&#146; respective officers, directors, employees, agents, advisors and representatives Any reference herein to any statute, includes all amendments thereto and all rules and regulations promulgated thereunder. The Company Disclosure
Schedule, as well as all other schedules and all exhibits hereto, shall be deemed part of this Agreement and included in any reference to this Agreement. All references to &#147;dollars&#148; or &#147;$&#148; herein are to U.S. dollars. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6 <U>Counterparts</U>. This Agreement may be executed in counterparts, all of which shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each of the parties and delivered to the other party, it being understood that all parties need not sign the same counterpart. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7 <U>Entire Agreement</U>. This Agreement (including the documents and the instruments referred to herein), together with the
Registration Rights Agreement, constitute the entire agreement among the parties and supersede all prior agreements and understandings, written, oral or otherwise, among the parties with respect to the subject matter hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8 <U>Governing Law; Jurisdiction</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) This Agreement shall be governed by, construed and enforced in accordance with the laws of the State of Delaware, without regard to any
applicable conflicts of law principles. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Each party agrees that it will bring any action, suit, litigation, dispute or
proceeding in respect of any claim arising out of or related to this Agreement or the transactions contemplated hereby exclusively in the Delaware Court of Chancery and any state appellate court therefrom within the State of Delaware, or, if the
Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any federal or state court of competent jurisdiction located in the State of Delaware (the &#147;<U>Chosen Courts</U>&#148;), and, solely in connection with claims
arising under this Agreement or the transactions that are the subject of this Agreement, (i)&nbsp;irrevocably submits to the exclusive jurisdiction of the Chosen Courts, (ii)&nbsp;waives any objection (A)&nbsp;to laying venue in any such action,
suit, litigation, dispute or proceeding in the Chosen Courts and (B)&nbsp;that the Chosen Courts are an inconvenient forum or do not have jurisdiction over any party and (iii)&nbsp;agrees that service of process upon such party in any such action,
suit, litigation, dispute or proceeding will be effective if notice is given in accordance with <U>Section</U><U></U><U>&nbsp;5.4</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9 <U>Waiver of Jury Trial</U>. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE HEREUNDER IS LIKELY TO
INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND, THEREFORE, EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE EXTENT PERMITTED BY LAW AT THE TIME OF INSTITUTION OF THE APPLICABLE LITIGATION, ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY
JURY IN RESPECT OF ANY ACTION, SUIT, LITIGATION, DISPUTE OR PROCEEDING, DIRECTLY OR INDIRECTLY, ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A)&nbsp;NO
REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY SUCH ACTION, SUIT, LITIGATION, DISPUTE OR PROCEEDING, SEEK TO ENFORCE THE FOREGOING WAIVER,
(B)&nbsp;IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C)&nbsp;IT MAKES THIS WAIVER VOLUNTARILY, AND (D)&nbsp;IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN
THIS <U>SECTION</U><U></U><U>&nbsp;5.9</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10 <U>Assignment; Third-Party Beneficiaries</U>. Neither this Agreement nor
any of the rights, interests or obligations hereunder shall be assigned by any of the parties (whether by operation of law or otherwise) without the prior written consent of Purchaser, in the case of the Company, or the Company, in the case of
Purchaser. Any purported assignment in contravention hereof shall be null and void. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and
assigns, other than as expressly set forth herein (including <U>Section</U><U></U><U>&nbsp;4.9</U> and <U>Section</U><U></U><U>&nbsp;4.10</U>). Except as set forth in the foregoing sentence or otherwise expressly set forth herein (including
<U>Section</U><U></U><U>&nbsp;4.10</U>), this Agreement (including the documents and instruments referred to herein) is not otherwise intended to, and does not, confer upon any person other than the parties, any rights or remedies hereunder,
including the right to rely upon the representations and warranties set forth herein; <U>provided</U>, however, that the Placement Agents/Arrangers shall be a third party beneficiary of this Agreement solely with respect to
<U>Section</U><U></U><U>&nbsp;2.2</U> and <U>Section</U><U></U><U>&nbsp;2.3</U>, and may rely upon the representations and warranties contained therein. The representations and warranties herein are the product of negotiations among the parties and
are for the sole benefit of the parties. Any inaccuracies in such representations and warranties are subject to waiver by the parties in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
accordance herewith without notice or liability to any other person. In some instances, the representations and warranties herein may represent an allocation among the parties of risks associated
with particular matters regardless of the knowledge of any of the parties. Consequently, persons other than the parties may not rely upon the representations and warranties herein as characterizations of actual facts, events, developments or
circumstances as of the date hereof or as of any other date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11 <U>Specific Performance</U>. The parties agree that
irreparable damage would occur if any provision hereof were not performed in accordance with its specific terms or otherwise breached. Accordingly, the parties shall be entitled to specific performance of the terms hereof, including an injunction or
injunctions to prevent breaches or threatened breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof (including the parties&#146; obligation to consummate the Investment), in addition to any other
remedy to which they are entitled at Law or in equity. Each party further waives any (a)&nbsp;defense in any action, suit, litigation, dispute or proceeding for specific performance that a remedy at Law would be adequate and (b)&nbsp;requirement
under any Law to post security or a bond as a prerequisite to obtaining equitable relief. A party&#146;s pursuit of an injunction, specific performance or other equitable remedies at any time shall not be deemed an election of remedies or waiver of
the right to pursue any other right or remedy to which such party may be entitled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12 <U>Severability</U>. Whenever
possible, each provision or portion of any provision of this Agreement shall be interpreted in such manner as to be effective and valid under Law, but if any provision or portion of any provision hereof is held to be invalid, illegal or
unenforceable in any respect under any Law in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision or portion of any provision in such jurisdiction, and this Agreement shall be reformed, construed
and enforced in such jurisdiction such that the invalid, illegal or unenforceable provision or portion thereof shall be interpreted to be only so broad as is enforceable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13 <U>Confidential Supervisory Information</U>. Notwithstanding any other provision herein, no disclosure, representation or
warranty shall be made (or other action taken) pursuant hereto that would involve the disclosure of confidential supervisory information (including confidential supervisory information as defined or identified in 12 C.F.R. &#167;&nbsp;4.32(b),
12&nbsp;C.F.R. &#167; 261.2(b) and 12 C.F.R. &#167;&nbsp;309.5(g)(8)) of a Governmental Entity by any party to the extent prohibited by Law; <U>provided</U> that, to the extent legally permissible, appropriate substitute disclosures or actions shall
be made or taken under circumstances in which the limitations of this <U>Section</U><U></U><U>&nbsp;5.13</U> apply in order that those limitations do not have the effect of misleading any party hereto, which substitute actions may include diligence
calls and communications by Purchaser (or its counsel) with the Company, its counsel, or its regulators. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14 <U>Delivery by
Electronic Transmission</U>. This Agreement and any signed agreement or instrument entered into in connection herewith, and any amendments or waivers hereto or thereto, to the extent signed and delivered by email delivery of a &#147;.pdf&#148;
format data file or other electronic means, shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered
in person. No party or to any such agreement or instrument shall raise the use of email delivery of a &#147;.pdf&#148; format data file or other electronic </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
means to deliver a signature hereto or any amendment hereto or the fact that any signature or agreement or instrument was transmitted or communicated through the use of email delivery of a
&#147;.pdf&#148; format data file or other electronic means as a defense to the formation of a contract and each party forever waives any such defense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature page follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF,</B> this Agreement has been duly executed and delivered by the duly
authorized officers of the parties as of the date first herein above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">NEW YORK COMMUNITY BANCORP, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Investment Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">[HUDSON BAY PURCHASERS]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Investment Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit E </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Stockholder Vote Warrant Terms </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Term</U>: 10
year warrants </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Strike price</U>: $2.00 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Settlement</U>:
Cash </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Warrant coverage</U>: If Requisite Stockholder Vote is not obtained by the date that is the 180th day after the Closing Date, Purchaser will
receive cash settled warrants with warrant coverage of 160% with a strike price set at the deal price. The warrant becomes exercisable 60 days after issuance if the Requisite Stockholder Vote is not obtained by such date. If the Requisite
Stockholder Vote is obtained prior to such date, the warrant will be cancelled in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, warrant coverage will increase by 20% every 60 days
thereafter if the Requisite Stockholder Vote is not obtained; provided that the maximum warrant coverage shall not exceed 220%. The additional 20% will not be exercisable and will cancelled if the Requisite Stockholder Vote is obtained in the 60
days after issuance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Example Calculations </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Days after Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Warrant Issued<br>(total warrant)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Warrant&nbsp;Exercisable</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Warrants&nbsp;subject&nbsp;to<BR>cancelation</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">180</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">160%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">160</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">240</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20% (180%)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">160</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">300</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20% (200%)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">180</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">360</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20% (220%)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">420</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0 (220%)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">220</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Underlying Stock</U>: Exercisable for cumulative <FONT STYLE="white-space:nowrap">non-voting</FONT> preferred stock with a
13.00% dividend rate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Transfer Restrictions</U>: Not subject to any transfer restrictions other than applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Registration</U><U></U><U>&nbsp;&amp; Listing</U>: The Company will use reasonable efforts to register and if possible, list, the warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Documentation</U>: If the Requisite Stockholder Vote is not obtained by the date that is the 180<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day
after the Closing Date, the Company and Purchaser shall use reasonable best efforts to, as promptly as reasonably practicable, agree upon a form of warrant agreement and preferred certificate of designation; terms to be consistent with other warrant
and other preferred in an agreed upon deal, except as noted; terms to ensure that neither warrant nor underlying stock are &#147;voting securities&#148; for bank regulatory purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Investment Agreement</I>] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>9
<FILENAME>d763888dex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT 10.3 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXECUTION VERSION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTMENT
AGREEMENT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">by and between </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">NEW YORK COMMUNITY BANCORP, INC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">RCP EAGLE HOLDINGS LP, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">solely in a limited
capacity, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REVERENCE CAPITAL PARTNERS OPPORTUNITIES FUND V (PE FUND III), L.P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REVERENCE CAPITAL PARTNERS OPPORTUNITIES FUND <FONT STYLE="white-space:nowrap">V-A</FONT> (PE FUND III), L.P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REVERENCE CAPITAL PARTNERS OPPORTUNITIES FUND V (AI) (PE FUND III), L.P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REVERENCE CAPITAL PARTNERS OPPORTUNITIES FUND V (FOO) (PE FUND III), L.P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of March&nbsp;7, 2024 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(and as amended as of March 11, 2024) </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">ARTICLE&nbsp;I</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">PURCHASE; CLOSING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Purchase</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">ARTICLE&nbsp;II</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">REPRESENTATIONS AND WARRANTIES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Material Adverse Effect</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Representations and Warranties of the Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Representations and Warranties of Purchaser</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">ARTICLE&nbsp;III</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">COVENANTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Filings; Other Actions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Information Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Confidentiality</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Public Announcement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period Conduct</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Material Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Material Change</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">ARTICLE&nbsp;IV</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">ADDITIONAL AGREEMENTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governance Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Legend</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Materially Burdensome Condition</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Reservation for Issuance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Indemnity</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Exchange Listing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certificate of Designations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>State Securities Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Company Opportunities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Recourse</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">ARTICLE&nbsp;V</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">MISCELLANEOUS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Amendment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Extension; Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Entire Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governing Law; Jurisdiction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Waiver of Jury Trial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Assignment; Third-Party Beneficiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Specific Performance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Confidential Supervisory Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Delivery by Electronic Transmission</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Guaranty</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LIST OF EXHIBITS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;A:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Designations (Series B)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit B:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Designations (Series C)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit C:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permanent Warrant Terms</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit D:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Registration Rights Agreement</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit E:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholder Vote Warrant Terms</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEX OF DEFINED TERMS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accredited Investors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">As-Converted</FONT> Basis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BHC Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Board of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Board Representative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">business day</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Designations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charter Amendment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chosen Courts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Claim Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Code</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Bank</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Bylaws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Certificate of Incorporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Disclosure Schedule</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Equity Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Fundamental Rep</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Opportunity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company PSU Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Recommendations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Regulatory Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Reports</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Restricted Stock Award</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company RSU Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Share Issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Stock Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidential Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidentiality Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Data Breach</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">De Minimis Claim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Delaware Secretary of State</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Direct Claim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director Rights Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enforceability Exceptions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ERISA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ERISA Affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange Approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">extent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Federal Reserve</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fraud</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GAAP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Entity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSR Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnified Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnifying Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Information Rights Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Institutional Accredited Investor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment Amount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IRS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">knowledge</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Liens</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Losses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">made available</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Adverse Effect</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Materially Burdensome Condition</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Multiemployer Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Multiple Employer Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Party</FONT> Affiliates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Voting</FONT> Common Equivalent Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NYSE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Order</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ordinary course</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ordinary course of business</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other Investment Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pandemic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pandemic Measures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permanent Warrant</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">person</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Personal Data</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Placement Agents/Arrangers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchaser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchaser Fundamental Rep</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Registration Rights Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Representatives</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Requisite Stockholder Vote</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Response Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Securities Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SRO</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholder Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; Meeting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Return</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Party Claim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Threshold Amount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">transactions contemplated by this Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">transactions contemplated hereby</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Voting Regulatory Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">v </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>INVESTMENT AGREEMENT,</B> dated as of March&nbsp;7, 2024 and as amended on March 11, 2024
(this &#147;<U>Agreement</U>&#148;), by and between NEW YORK COMMUNITY BANCORP, INC., a Delaware corporation (the &#147;<U>Company</U>&#148;), and RCP EAGLE HOLDINGS LP, a Delaware limited partnership (&#147;<U>Purchaser</U>&#148;), and solely for
<U>Section</U><U></U><U>&nbsp;2.3(e)</U>, <U>Section</U><U></U><U>&nbsp;5.15</U> and the other sections in <U>ARTICLE</U><U></U><U>&nbsp;V</U>, REVERENCE CAPITAL PARTNERS OPPORTUNITIES FUND V (PE FUND III), L.P., a Delaware limited partnership,
REVERENCE CAPITAL PARTNERS OPPORTUNITIES FUND <FONT STYLE="white-space:nowrap">V-A</FONT> (PE FUND III), L.P., a Delaware limited partnership, REVERENCE CAPITAL PARTNERS OPPORTUNITIES FUND V (AI) (PE FUND III), a Delaware limited partnership, L.P.
and REVERENCE CAPITAL PARTNERS OPPORTUNITIES FUND V (FOO) (PE FUND III), L.P., a Delaware limited partnership (collectively, the &#147;<U>Parent Funds</U>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. <U>The
Investment</U>. The Company desires to sell and issue to Purchaser, and Purchaser desires to purchase from the Company, as an investment in the Company, (i)&nbsp;shares of (a)&nbsp;common stock, par value $0.01 per share, of the Company (the
&#147;<U>Common Stock</U>&#148;), (b) a series of preferred stock, par value $0.01 per share, of the Company designated as Series B Noncumulative Convertible Preferred Stock (the &#147;<U>Series B Preferred Stock</U>&#148;), having the terms set
forth in the Certificate of Designations of the Series B Preferred Stock, in the form attached hereto as <U>Exhibit</U><U></U><U>&nbsp;A</U> (the &#147;<U>Certificate of Designations</U> <U>(Series B)</U>&#148;) and (c)&nbsp;a series of preferred
stock, par value $0.01 per share, of the Company designated as Series C Noncumulative Convertible Preferred Stock (the &#147;<U>Series C Preferred Stock</U>&#148; and together with the Series B Preferred Stock, the &#147;<U>Preferred
Stock</U>&#148;), having the terms set forth in the Certificate of Designations of the Series C Preferred Stock, in the form attached hereto as <U>Exhibit</U><U></U><U>&nbsp;B</U> (the &#147;<U>Certificate of Designations</U>
<U>(Series&nbsp;C)</U>&#148; and together with the Certificate of Designations (Series B), the &#147;<U>Certificate of Designations</U>&#148;), which shall be made a part of the Company&#146;s Amended and Restated Certificate of Incorporation (as
amended, restated, supplemented or otherwise modified from time to time, the &#147;<U>Company Certificate of Incorporation</U>&#148;) by the filing of the Certificate of Designations (Series C) with the Secretary of State of the State of Delaware
(the &#147;<U>Delaware Secretary of State</U>&#148;) and (ii)&nbsp;warrants on the terms and conditions set forth on <U>Exhibit C</U> (the &#147;<U>Permanent Warrant</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. <U>The Other Investment Agreements</U>. Substantially concurrently with the execution and delivery hereof, the Company is entering into
other contracts or agreements with certain other purchasers providing for the issuance of (i)&nbsp;shares of Common Stock, (ii)&nbsp;shares of Preferred Stock and/or (ii)&nbsp;warrants on the terms and conditions set forth therein (each, an
&#147;<U>Other Permanent Warrant</U>&#148;), in each case, with proceeds to the Company in an amount, together with the Investment Amount, equal to not less than $1,050,000,000.00 and entered into in furtherance of the transactions contemplated
hereby or thereby (each, an &#147;<U>Other Investment Agreement</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. <U>The Securities</U>. The term
&#147;<U>Securities</U>&#148; refers collectively to the (a)&nbsp;(i) shares of Common Stock and Preferred Stock and (ii)&nbsp;Permanent Warrant, in each case, issuable pursuant hereto,&nbsp;(b) shares of Common Stock to be issued upon the
conversion of the Preferred Stock issuable pursuant hereto (such conversions, the &#147;<U>Conversions</U>&#148;), (c) shares of <FONT STYLE="white-space:nowrap">non-voting,</FONT> common equivalent preferred stock to be issued upon the exercise of
the Permanent Warrant and (d)&nbsp;shares of Common Stock to be issued upon the conversion of the <FONT STYLE="white-space:nowrap">non-voting,</FONT> common equivalent preferred stock to be issued upon the exercise of the Permanent Warrant. When
purchased, the shares of Common Stock and Preferred Stock purchased hereunder will be evidenced by book-entry notation. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">D. <U>Registration Rights Agreement</U>. At the Closing, the Company and Purchaser will
enter into a Registration Rights Agreement attached hereto as <U>Exhibit </U><U>D</U> (the &#147;<U>Registration Rights Agreement</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">E. <U>Parent Funds</U>. As an inducement to the Company&#146;s willingness to enter into this Agreement, the Parent Funds desires, on behalf
of Purchaser, the collective wholly-owned subsidiary of the Parent Funds, to enter into this Agreement for purposes of (i)&nbsp;making the representations and warranties in <U>Section</U><U></U><U>&nbsp;2.3(e)</U>, (ii) guaranteeing certain
obligations of Purchaser hereunder pursuant to <U>Section</U><U></U><U>&nbsp;5.15</U> and (iii)&nbsp;the other sections in <U>ARTICLE</U><U></U><U>&nbsp;V</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE,</B> in consideration of the premises, and of the representations, warranties, covenants and agreements set forth herein,
the parties agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;I </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>PURCHASE; CLOSING </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1 <U>Purchase</U>. On the terms and subject to the conditions set forth herein, at the Closing, Purchaser shall purchase from
the Company, and the Company shall sell and issue to Purchaser, the number of duly authorized, validly issued, fully-paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of (a)&nbsp;Common Stock, free and clear of all Liens (as
defined below) (other than transfer restrictions imposed under applicable securities Laws), set forth in <U>Section</U><U></U><U>&nbsp;1.2(c)(i)(1)(A),</U> (b) Series B Preferred Stock, free and clear of all Liens (other than transfer restrictions
imposed under the Certificate of Designations (Series B) or applicable securities Laws), set forth in <U>Section</U><U></U><U>&nbsp;1.2(c)(i)(1)(B)</U>, and (c)&nbsp;Series C Preferred Stock, free and clear of all Liens (as defined below) (other
than transfer restrictions imposed under the Certificate of Designations (Series C) or applicable securities Laws), set forth in <U>Section</U><U></U><U>&nbsp;1.2(c)(i)(1)</U>(C) (the &#147;<U>Company Share Issuance</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2 <U>Closing</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Time and Date of Closing</U>. Subject to the satisfaction or, to the extent permitted by Law, written waiver (by the party entitled to
grant such waiver) of the conditions set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)</U> (other than those conditions that by their nature are to be satisfied at the Closing, but subject to satisfaction or, to the extent permitted by Law, written
waiver of those conditions by the party entitled to grant such waiver), the closing of the Company Share Issuance (the &#147;Closing&#148;) shall take place (i)&nbsp;three (3) business days following the execution and delivery of this Agreement,
remotely by the electronic exchange of counterpart signature pages to the documents and agreements contemplated hereby to be executed and delivered at the Closing (the &#147;<U>Expected Closing Date</U>&#148;), or (ii)&nbsp;such other date, time
and/or location as may be mutually agreed in writing by the Company and Purchaser; <U>provided</U> that, if the conditions set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)</U> have not been so satisfied or, to the extent permitted by Law, waived on
or prior to the date that is three (3)&nbsp;business days following the execution and delivery of this Agreement, then the Closing shall take place on the first business day on which such conditions have been so
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
satisfied or waived; <U>provided</U>, <U>further</U>, <U>however</U>, that in no event shall the Closing take place later than the fifth (5<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>)
business day after the Expected Closing Date. The date on which the Closing occurs is referred to as the &#147;<U>Closing Date</U>.&#148; Unless otherwise agreed by the Company and Purchaser, in the event (A)&nbsp;the Closing does not occur within
five (5)&nbsp;business days after the Expected Closing Date and (B)&nbsp;Purchaser delivered the Investment Amount to the Company pursuant to <U>Section</U><U></U><U>&nbsp;1.2(c)(ii)(1)</U>, the Company shall, as promptly as reasonably practicable
(but not later than one business day thereafter), return such Investment Amount to Purchaser by wire transfer of United States dollars in immediately available funds to the account specified by Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Closing Conditions</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The obligation of Purchaser, on the one hand, and the Company, on the other hand, to effect the Closing is subject to the
satisfaction or, to the extent permitted by Law, written waiver by Purchaser and the Company prior to the Closing of the following conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) no injunction, order, judgment, writ, directive, enforcement action, decree, or regulatory restriction of any Governmental
Entity (each, an &#147;Order&#148;) or other legal restraint or prohibition preventing the consummation of the Company Share Issuance. No applicable Law shall have been enacted, entered, promulgated or enforced (which remains in effect) by any
Governmental Entity that prohibits or makes illegal consummation of the Company Share Issuance or any of the other transactions contemplated by this Agreement or that prohibits, restrains or enjoins Purchaser or its affiliates from owning any
Securities or voting any voting Securities in accordance with the terms thereof; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) the Company shall have filed the
requisite Supplemental Listing Application in respect of the Common Stock issued hereunder and the Common Stock to be issued upon the conversion of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock, in each case, in
accordance with rules of the New York Stock Exchange (the &#147;<U>NYSE</U>&#148;), and no further action shall be required to authorize such additional shares for listing, subject to official notice of issuance; <U>provided</U> if such Supplemental
Listing Application is not approved as a result of the number of authorized shares of Common Stock being insufficient, then (A)&nbsp;the Company shall immediately <FONT STYLE="white-space:nowrap">re-file</FONT> covering just the authorized amount
and (B)&nbsp;promptly following the approval and adoption of the Charter Amendment in accordance with <U>Section</U><U></U><U>&nbsp;3.1(c)</U>, the Company shall file a Supplemental Listing Application in respect of the Common Stock not covered by
the initial approval; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) the purchase and sale of shares of Common Stock and/or Preferred Stock (with proceeds to the
Company in an amount, which together with the Investment Amount, is greater than or equal to $600,000,000) shall have been consummated, or will be consummated substantially concurrently with the Closing, in all material respects in accordance with
the terms and conditions of such Other Investment Agreement(s); and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(4) the Certificate of Designations shall have been filed with and accepted
by the Delaware Secretary of State and be in full force and effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The obligation of Purchaser to effect the
Closing is also subject to the satisfaction or, to the extent permitted by Law, written waiver by Purchaser prior to the Closing of each of the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) the representations and warranties of the Company contained in (A) <U>Section&nbsp;2.2(b)(i)</U>,
<U>Section</U><U></U><U>&nbsp;2.2(c)(iii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(g)</U>, <U>Section</U><U></U><U>&nbsp;2.2(h)</U>, <U>Section</U><U></U><U>&nbsp;2.2(r)</U> and <U>Section</U><U></U><U>&nbsp;2.2(u)</U> shall be true and correct (other
than, in the case of <U>Section</U><U></U><U>&nbsp;2.2(b)(i)</U>, such failures to be true and correct as are de minimis) in all respects as of the date hereof and as of the Closing as though made at and as of the Closing (except to the extent such
representations and warranties are expressly made as of another date, in which case as of such date); (B) <U>Section</U><U></U><U>&nbsp;2.2(a)(i)</U>-<U>(iii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(b)(ii)</U> and
<U>Section</U><U></U><U>&nbsp;2.2(c)(i)</U> (in each case, read without giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations and warranties) shall be true and correct in all material
respects as of the date hereof and as of the Closing as though made at and as of the Closing (except to the extent such representations and warranties are expressly made as of another date, in which case as of such date); and (C)&nbsp;all other
representations and warranties of the Company set forth in <U>Section</U><U></U><U>&nbsp;2.2</U> (in each case, read without giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations or
warranties) shall be true and correct in all respects as of the date hereof and as of the Closing as though made at and as of the Closing (except to the extent such representations and warranties are expressly made as of another date, in which case
as of such date); provided that, for purposes of this subclause (C), such representations and warranties shall be deemed to be true and correct unless the failure(s) of such representations and warranties to be so true and correct, either
individually or in the aggregate, and without giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations or warranties, has had or would reasonably be expected to have a Material Adverse Effect;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) the Company shall have performed and complied with, in all material respects, all obligations, covenants and
agreements required to be performed or complied with by it at or prior to the Closing hereunder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) since the date
hereof, no Material Adverse Effect shall have occurred and no circumstance, event, change, occurrence, development or effect shall have occurred that, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect;
and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(4) Purchaser shall have received a certificate, dated as of the Closing Date, signed on behalf of the Company by the
Chief Executive Officer or Chief Financial Officer of the Company certifying to the effect that the conditions set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)(ii)(1)</U>, <U>Section</U><U></U><U>&nbsp;1.2(b)(ii)(2)</U> and
<U>Section</U><U></U><U>&nbsp;1.2(b)(ii)(3)</U> have been satisfied. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The obligation of the Company to effect the Closing is subject to the
satisfaction or, to the extent permitted by Law, written waiver by the Company prior to the Closing of the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) the representations and warranties of Purchaser contained herein (without giving effect to any &#147;material&#148; or
&#147;materiality&#148; qualifications contained in such representations and warranties) shall be true and correct as of the date hereof and as of the Closing as though made at and as of the Closing (except to the extent such representations and
warranties are expressly made as of another date, in which case as of such date), except to the extent the failure(s) of such representations or warranties to be true and correct, either individually or in the aggregate, and without giving effect to
any &#147;material&#148; or &#147;materiality&#148; qualifications contained in such representations and warranties, would not prevent or materially impair or delay the ability of Purchaser to consummate the Closing; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) Purchaser shall have performed and complied with, in all material respects, all covenants and agreements required to be
performed or complied with by it at or prior to the Closing hereunder; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) the Company shall have received a
certificate, dated as of the Closing Date, signed on behalf of Purchaser by an authorized signatory of Purchaser certifying to the effect that the conditions set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)(iii)(1)</U> and
<U>Section</U><U></U><U>&nbsp;1.2(b)(iii)(2)</U> have been satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Closing Deliveries</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) At the Closing, the Company will deliver to Purchaser: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) confirmation of book-entry notation in the name of Purchaser shares of Common Stock and Preferred Stock, free and clear of
all Liens (other than transfer restrictions imposed under the Certificate of Designations (as applicable) or applicable securities Laws) as follows: (A) 18,529,318 shares of Common Stock, (B)&nbsp;Series B Preferred Stock equal to 11,857 and
(B)&nbsp;Series C Preferred Stock equal to 69,614. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) a counterpart signature page, to the Permanent Warrant on the
terms and condition set forth on <U>Exhibit C</U>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) a counterpart signature page, duly executed by the Company, to the
Registration Rights Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(4) evidence that delivery of the investment amounts payable to the Company pursuant to
the Other Investment Agreements by the other purchasers party thereto shall occur substantially concurrently with the Closing; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(5) a legal opinion in customary form from counsel to the Company covering due authorization and issuance of the Common Stock
and Preferred Stock and the Common Stock issuable upon conversion of the Preferred Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) At the Closing, Purchaser will deliver to the Company: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) by wire transfer of immediately available funds to an account designated by the Company in writing, an aggregate purchase
price of $200,000,000.00 (the &#147;<U>Investment Amount</U>&#148;); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) a properly completed and executed Internal
Revenue Service (&#147;IRS&#148;) Form <FONT STYLE="white-space:nowrap">W-9</FONT> for Purchaser; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) a counterpart
signature page, duly executed by Purchaser, to the Registration Rights Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;II </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REPRESENTATIONS AND WARRANTIES </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1 <U>Material Adverse Effect</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) As used herein, the term &#147;<U>Material Adverse Effect</U>&#148; means any effect, change, event, circumstance, condition, occurrence
or development that, either individually or in the aggregate, has had or would reasonably be expected to have a material adverse effect on the business, properties, assets, liabilities, results of operations or financial condition of the Company and
its Subsidiaries taken as a whole (provided, that Material Adverse Effect shall not be deemed to include the impact or effects of any (A)&nbsp;changes, after the date hereof, in U.S. generally accepted accounting principles (&#147;<U>GAAP</U>&#148;)
or applicable regulatory accounting requirements, (B)&nbsp;changes, after the date hereof, in Laws (including any Pandemic Measures) of general applicability to companies in the industries in which the Company and its Subsidiaries operate, or
interpretations thereof by courts or other Governmental Entities, (C)&nbsp;changes, after the date hereof, in global, national or regional political conditions (including the outbreak of war or acts of terrorism) or in economic or market (including
equity, credit and debt markets, as well as changes in interest rates) conditions affecting the financial services industry generally and not specifically relating to the Company or its Subsidiaries (including any such changes arising out of the
Pandemic or any Pandemic Measures), (D)&nbsp;changes, after the date hereof, resulting from hurricanes, earthquakes, tornados, floods or other natural disasters or from any outbreak of any disease or other public health event (including the
Pandemic), (E)&nbsp;public disclosure of the execution of this Agreement or any Other Investment Agreement, public disclosure or consummation of the transactions contemplated hereby or thereby (including any effect on a party&#146;s relationships
with its customers) (it being understood and agreed that the foregoing shall not apply for purposes of the representations and warranties in <U>Section</U><U></U><U>&nbsp;2.2(c)(ii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(d)</U> or
<U>Section</U><U></U><U>&nbsp;2.2(k)(vi)</U>) or actions expressly required by this Agreement or that are taken with the prior written consent of Purchaser in contemplation of the transactions contemplated by this Agreement or any Other Investment
Agreement, (F)&nbsp;decline in the trading price of the Company&#146;s securities or the failure, in and of itself, to meet earnings projections or internal financial forecasts (it being understood that the underlying causes of such decline or
failure may be taken into account in determining whether a Material Adverse Effect has occurred or is reasonably expected to occur, except to the extent otherwise excluded by this proviso), (G) any stockholder litigation arising out of, related to,
or in connection with this Agreement or any Other Investment Agreement or the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Investment that is brought or threatened against the Company or the Board of Directors from and following the date of this Agreement and prior to the Closing (&#147;<U>Stockholder
Litigation</U>&#148;) (it being understood and agreed that the foregoing shall not apply for purposes of the representations and warranties in <U>Section</U><U></U><U>&nbsp;2.2(c)(ii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(d)</U> or
<U>Section</U><U></U><U>&nbsp;2.2(k)(vi)</U>), or (H)&nbsp;expenses incurred by the Company in negotiating, documenting, effecting and consummating the transactions contemplated by this Agreement or any Other Investment Agreement; except, with
respect to the foregoing subclauses&nbsp;(A), (B), (C) or (D), to the extent that the effects of such change are disproportionately adverse to the business, properties, assets, liabilities, results of operations or financial condition of the Company
and its Subsidiaries, taken as a whole, as compared to other companies in the industry in which the Company and its Subsidiaries operate). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) As used herein: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) &#147;<U>Pandemic</U>&#148; means any outbreaks, epidemics or pandemics, or any variants, evolutions or mutations thereof,
and the governmental and other responses thereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) &#147;<U>Pandemic Measures</U>&#148; means any quarantine,
&#147;shelter in place,&#148; &#147;stay at home,&#148; workforce reduction, social distancing, shutdown, closure, sequester or other Laws or policies or recommendations promulgated by any Governmental Entity, including the Centers for Disease
Control and Prevention and the World Health Organization, in each case, in connection with or in response to any Pandemic; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) &#147;<U>Subsidiary</U>&#148; when used with respect to any person, means any subsidiary of such person within the
meaning ascribed to such term in either <FONT STYLE="white-space:nowrap">Rule&nbsp;1-02</FONT> of <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-X</FONT> promulgated by the Securities and Exchange Commission (the &#147;SEC&#148;) or the BHC Act;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) &#147;<U>Governmental Entity</U>&#148; means any court, administrative agency or commission or other governmental
authority or instrumentality or SRO of competent jurisdiction; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) &#147;<U>Law</U>&#148; means any law, statute,
code, ordinance, rule, regulation, requirement, policy or guideline of any Governmental Entity or stock exchange or Order. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2 <U>Representations and Warranties of the Company</U>. Except as disclosed in (i)&nbsp;the disclosure schedule delivered by
the Company to Purchaser concurrently herewith (the &#147;<U>Company Disclosure Schedule</U>&#148;); <U>provided</U> that (A)&nbsp;no such item is required to be set forth as an exception to a representation or warranty if its absence would not
result in the related representation or warranty being deemed untrue or incorrect, (B)&nbsp;the mere inclusion of an item in the Company Disclosure Schedule as an exception to a representation or warranty shall not be deemed an admission by the
Company that such item represents a material exception or fact, effect, change, event, circumstance, condition, occurrence or development or that such item would or would reasonably be expected to result in a Material Adverse Effect, and
(C)&nbsp;any disclosures made with respect to a section of this <U>Section</U><U></U><U>&nbsp;2.2</U> shall be deemed to qualify any other section of this <U>Section</U><U></U><U>&nbsp;2.2</U> (1)&nbsp;specifically referenced or cross-referenced or
(2)&nbsp;if it is reasonably apparent on its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
face (notwithstanding the absence of a specific cross-reference) from a reading of the disclosure that such disclosure applies to such other section or (ii)&nbsp;any Company Reports publicly
filed or furnished by the Company after January&nbsp;1, 2023 (but disregarding risk factor disclosures contained under the heading &#147;Risk Factors,&#148; or disclosures of risks set forth in any &#147;forward-looking statements&#148; disclaimer
or any other statements that are similarly nonspecific or cautionary, predictive or forward-looking in nature), the Company hereby represents and warrants to Purchaser as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Corporate Organization</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware
and is a bank holding company duly registered under the Bank Holding Company Act of 1956 (&#147;<U>BHC Act</U>&#148;). The Company has the corporate power and authority to own or lease all of its properties and assets and to carry on its business as
it is now being conducted. The Company is duly licensed or qualified to do business and in good standing in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or
leased by it makes such licensing, qualification or standing necessary, except where the failure to be so licensed or qualified or to be in good standing would not, either individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect. True, correct and complete copies of the Company Certificate of Incorporation and the Company Bylaws (as defined below) as in effect as of the entry into this Agreement have been made available to Purchaser. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Except as would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect,
each Subsidiary of the Company (a &#147;<U>Company Subsidiary</U>&#148;) (A)&nbsp;is duly organized and validly existing under the laws of its jurisdiction of organization, (B)&nbsp;is duly licensed or qualified to do business and, where such
concept is recognized under Law, in good standing in all jurisdictions where its ownership or leasing of property or the conduct of its business requires it to be so licensed or qualified or in good standing, and (C)&nbsp;has all requisite corporate
power and authority to own or lease its properties and assets and to carry on its business as now conducted. There are no restrictions on the ability of any Company Subsidiary to pay dividends or distributions except, in the case of a Company
Subsidiary that is a regulated entity, for restrictions on dividends or distributions generally applicable to all similarly regulated entities. Other than Flagstar Bank, National Association, a national banking association and a wholly-owned
Subsidiary of the Company (&#147;<U>Company Bank</U>&#148;), and those Subsidiaries set forth in <U>Section</U><U></U><U>&nbsp;2.2(a)(ii)</U> of the Company Disclosure Schedule, there are no Company Subsidiaries that would constitute
&#147;significant subsidiaries&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> of the SEC as of the entry into this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The deposit accounts of Company Bank are insured by the FDIC through the Deposit Insurance Fund (as defined in
Section&nbsp;3(y) of the Federal Deposit Insurance Act of 1950) to the fullest extent permitted by Law, all premiums and assessments required to be paid in connection therewith have been paid when due, and no proceedings for the termination of such
insurance are pending or threatened. Company Bank is a member in good standing of the Federal Home Loan Bank of New York and owns the requisite amount of stock therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Capitalization</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The authorized capital stock of the Company consists of 900,000,000 shares of Common Stock and 5,000,000 shares of
preferred stock, par value of $0.01 (the &#147;<U>Company Preferred Stock</U>&#148;). As of March&nbsp;1, 2024, there were 744,099,232 shares of Common Stock issued and outstanding, including 5,828,669 shares of Common Stock granted in respect of
outstanding Common Stock subject to vesting, repurchase or other lapse restriction (each, a &#147;<U>Company Restricted Stock Award</U>&#148;), and (in addition to the foregoing) (A)&nbsp;22,809,071 shares of Common Stock held in treasury, (B)
1,712,824 shares of Common Stock (assuming performance goals are satisfied at the maximum level) reserved for issuance upon the settlement of outstanding performance-based restricted stock unit awards in respect of shares of Common Stock granted
under the Company Stock Plans (&#147;<U>Company PSU Awards</U>&#148;), (C) 7,201,022 shares of Common Stock reserved for issuance upon the settlement of outstanding restricted stock unit awards in respect of shares of Common Stock granted under the
Company Stock Plans (&#147;<U>Company RSU Awards</U>&#148; and, together with the Company Restricted Stock Awards and Company PSU Awards, the &#147;<U>Company Equity Awards</U>&#148;), (D) 16,170,583 shares of Common Stock reserved for issuance
pursuant to future grants under the Company Stock Plans and (E)&nbsp;515,000&nbsp;shares of the Company Preferred Stock issued and outstanding. As of March&nbsp;1, 2024, there were 10,244,408 shares of Common Stock reserved for issuance upon the
exercise of the warrants under the Bifurcated Option Note Unit Securities of New York Community Capital Trust V and 20,600,000 Depositary Shares (each representing a 1/40th interest in a share of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Series A Noncumulative Perpetual Preferred Stock of the Company) outstanding. As of the entry into this Agreement, except as set forth in the immediately preceding sentences, as
contemplated hereby, as contemplated by any Other Investment Agreement and for changes since March&nbsp;1, 2024 resulting from the exercise, vesting or settlement of any Company Equity Awards described in the immediately preceding sentence, there
are no other shares of capital stock or other equity or voting securities of the Company issued, reserved for issuance or outstanding. All of the issued and outstanding shares of Common Stock have been duly authorized and validly issued and are
fully paid, nonassessable and free of preemptive rights, with no personal liability attaching to the ownership thereof. There are no bonds, debentures, notes or other indebtedness that have the right to vote on any matters on which stockholders of
the Company may vote. As of the entry into this Agreement, other than (1)&nbsp;the Company Equity Awards issued prior to the entry into this Agreement as described in this <U>Section</U><U></U><U>&nbsp;2.2(b)(i)</U> or (2)&nbsp;as set forth in this
Agreement or any Other Investment Agreement, there are no (x)&nbsp;outstanding subscriptions, options, warrants, stock appreciation rights, phantom units, scrip, rights to subscribe to, preemptive rights, anti-dilutive rights, rights of first
refusal or similar rights, puts, calls, commitments or agreements of any character relating to, or securities or rights convertible or exchangeable into or exercisable for, or valued by reference to, shares of capital stock or other equity or voting
securities of or ownership interest in the Company, or (y)&nbsp;contracts, commitments, understandings or arrangements by which the Company may become bound to issue additional shares of its capital stock or other equity or voting securities of or
ownership interests in the Company, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
or that otherwise obligate the Company to issue, transfer, sell, purchase, redeem or otherwise acquire, any of the foregoing. Other than this Agreement and any Other Investment Agreement, there
are no voting trusts, shareholder agreements, proxies or other similar agreements in effect to which the Company or any of its Subsidiaries is a party or is bound with respect to the voting or transfer of Common Stock or other equity interests of
the Company. As used herein, &#147;<U>Company Stock Plans</U>&#148; means the New York Community Bancorp, Inc. 2020 Omnibus Incentive Plan, the Flagstar Bancorp, Inc. 2016 Stock Award and Incentive Plan and the New York Community Bancorp, Inc. 2012
Stock Incentive Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Company owns, directly or indirectly, all of the issued and outstanding shares of capital
stock or other equity ownership interests of each Company Subsidiary, free and clear of any liens, claims, title defects, mortgages, pledges, charges, encumbrances and security interests whatsoever (&#147;<U>Liens</U>&#148;), and all of such shares
or equity ownership interests are duly authorized and validly issued and are fully paid, nonassessable (except, with respect to bank Subsidiaries, as provided under 12 U.S.C. &#167;&nbsp;55 or any comparable provision of applicable state Law) and
free of preemptive rights, with no personal liability attaching to the ownership thereof. No Company Subsidiary has or is bound by any outstanding subscriptions, options, warrants, calls, rights, commitments or agreements of any character calling
for the purchase or issuance of any shares of capital stock or any other equity security of such Subsidiary or any securities representing the right to purchase or otherwise receive any shares of capital stock or any other equity security of such
Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Authority; No Violation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company has full corporate power and authority to execute and deliver this Agreement, to perform its obligations
hereunder and to consummate the Closing. The execution and delivery of this Agreement, the performance by the Company of its obligations hereunder and the consummation of the Closing (including the Investment) have been declared advisable and duly
and validly approved by the board of directors of the Company (the &#147;<U>Board of Directors</U>&#148;). As of or prior to the entry into this Agreement, the Board of Directors has determined that (A)&nbsp;the Company Share Issuance and the
Conversions (collectively, the &#147;<U>Investment</U>&#148;), on the terms and subject to the conditions set forth herein, is in the best interests of the Company and its stockholders and (B)&nbsp;the issuance of the shares of Common Stock and/or
Preferred Stock, in each case, pursuant to the Other Investment Agreements and the other transactions contemplated thereby, on the terms and subject to the conditions set forth therein, in each case, are in the best interests of the Company and its
stockholders and has adopted a resolution to the foregoing effect. No other corporate proceedings on the part of the Company or any of its Subsidiaries are necessary to approve this Agreement or for the Company to perform its obligations hereunder
or consummate the Closing. This Agreement has been duly and validly executed and delivered by the Company and (assuming due authorization, execution and delivery by Purchaser) constitutes a valid and binding obligation of the Company, enforceable
against the Company in accordance with its terms (except in all cases as such enforceability may be limited by bankruptcy, insolvency, fraudulent transfer, moratorium, reorganization or similar Laws of general applicability relating to or affecting
the rights of creditors generally and the availability of equitable remedies (the &#147;<U>Enforceability Exceptions</U>&#148;)). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) None of the execution and delivery of this Agreement by the Company,
the performance by the Company of its obligations hereunder, the consummation by the Company of the Investment, or compliance by the Company with any of the terms or provisions hereof, will (A)&nbsp;violate any provision of the Company Certificate
of Incorporation or the Amended and Restated Bylaws of the Company (as amended, restated, supplemented or otherwise modified from time to time, the &#147;<U>Company Bylaws</U>&#148;) or (B)&nbsp;assuming that the consents and approvals referred to
in <U>Section</U><U></U><U>&nbsp;2.2(d)</U> are duly obtained, (x)&nbsp;violate any Law applicable to the Company, any of its Subsidiaries or any of their respective properties or assets or (y)&nbsp;violate, conflict with, result in a breach of any
provision of or the loss of any benefit under, constitute a default (or an event which, with notice or lapse of time, or both, would constitute a default) under, result in the termination of or a right of termination or cancellation under,
accelerate the performance required by, or result in the creation of any Lien upon any of the respective properties or assets of the Company or any of its Subsidiaries under, any of the terms, conditions or provisions of any note, bond, mortgage,
indenture, deed of trust, license, lease, agreement or other instrument or obligation to which the Company or any of its Subsidiaries is a party, or by which they or any of their respective properties or assets may be bound, except (in the case of
<U>clauses</U><U></U><U>&nbsp;(B)(x)</U> and <U>(B)(y)</U> above) for such violations, conflicts, breaches, defaults, terminations, cancellations, accelerations or creations which would not, either individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The shares of Common Stock to be issued (x)&nbsp;hereunder and
(y)&nbsp;subject to the Requisite Stockholder Vote and the filing of the Charter Amendment with the Delaware Secretary of State, upon the Conversions will be, in each case, validly authorized and, when issued, will be validly issued, fully paid and
nonassessable and free and clear of all Liens, and no current or past stockholder of the Company will have any preemptive right or similar rights in respect thereof. The shares of Preferred Stock to be issued hereunder have been validly authorized
and, when issued, will be validly issued, fully paid and nonassessable and free and clear of all Liens, and no current or past stockholder of the Company will have any preemptive right or similar rights in respect of any such issuance or exercise.
Neither the Common Stock nor the Preferred Stock will be issued in violation of any applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <U>Consents and Approvals</U>.
Except for (i)&nbsp;the approvals set forth on <U>Section</U><U></U><U>&nbsp;2.2(d)</U> of the Company Disclosure Schedule, (ii)&nbsp;the Board <FONT STYLE="white-space:nowrap">Non-Objections,</FONT> (iii)&nbsp;the filing of the requisite
Supplemental Listing Application and any other required applications, filings and notices, as applicable, with the NYSE, and the approval of the listing of the shares of Common Stock to be issued (A)&nbsp;hereunder and (B)&nbsp;upon the Conversions,
(iv)&nbsp;the filing of any registration statement with the SEC in accordance with the terms and subject to the conditions of the Registration Rights Agreement, (v)&nbsp;filings required under, and compliance with other applicable requirements of,
the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Hart-Scott-Rodino</FONT></FONT> Antitrust Improvements Act of 1976 and the rules and regulations promulgated thereunder (the &#147;<U>HSR</U><U></U><U>&nbsp;Act</U>&#148;) with
respect to the Conversions, (vi)&nbsp;the Requisite Stockholder Vote, (vii)&nbsp;the filing of the Certificate of Designations and the Charter Amendment with the Delaware Secretary of State and (viii)&nbsp;such filings and approvals as are
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
required to be made or obtained under the securities or &#147;Blue Sky&#148; laws of various states in connection with the Investment, no consents or approvals of or filings or registrations with
any Governmental Entity are necessary in connection with (A)&nbsp;the execution and delivery by the Company of this Agreement or (B)&nbsp;the Investment and the other transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) <U>Reports</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) As of the entry into this Agreement, the Company and each of its Subsidiaries have timely filed (or furnished) all
reports, registrations and statements, together with any amendments required to be made with respect thereto, that they were required to file (or furnish, as applicable) since January&nbsp;1, 2023 with the following Governmental Entities:
(A)&nbsp;any state regulatory authority, (B)&nbsp;the SEC, (C)&nbsp;the Board of Governors of the Federal Reserve System or Federal Reserve Bank of New York (together, the &#147;<U>Federal Reserve</U>&#148;), (D)&nbsp;the Office of the Comptroller
of the Currency, (E)&nbsp;any foreign regulatory authority and (F)&nbsp;any self-regulatory organization (an &#147;<U>SRO</U>&#148;), including any report, form, correspondence, registration or statement required to be filed (or furnished, as
applicable) pursuant to the laws, rules or regulations of the U.S., any state, any foreign entity, or any Governmental Entity, and have paid all fees and assessments due and payable in connection therewith, except where the failure to file (or
furnish, as applicable) such report, registration or statement or to pay such fees and assessments would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Subject to
<U>Section</U><U></U><U>&nbsp;5.13</U>, except for normal examinations conducted by a Governmental Entity in the ordinary course of business of the Company and its Subsidiaries, (x)&nbsp;no Governmental Entity has initiated or has pending any
proceeding or, to the Company&#146;s knowledge, investigation into the business or operations of the Company or any of its Subsidiaries since January&nbsp;1, 2023, which remains unresolved, (y)&nbsp;there is no unresolved violation, criticism, or
exception by any Governmental Entity with respect to any report or statement relating to any examinations or inspections of the Company or any of its Subsidiaries, and (z)&nbsp;there has been no formal or informal inquiries by, or disagreements or
disputes with, any Governmental Entity with respect to the business, operations, policies or procedures of the Company or any of its Subsidiaries since January&nbsp;1, 2023; in each case, which would reasonably be expected to have, either
individually or in the aggregate, a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) An accurate copy of each final registration statement,
prospectus, report, schedule and definitive proxy statement filed with or furnished by the Company to the SEC since January&nbsp;1, 2023 pursuant to the Securities Act of 1933 (the &#147;Securities Act&#148;), or the Exchange Act (the
&#147;<U>Company Reports</U>&#148;) is publicly available. No such Company Report, as of the date thereof (and, in the case of registration statements and proxy statements, on the dates of effectiveness and the dates of the relevant meetings,
respectively), contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances in which they were made, not
misleading, except that information filed or furnished as of a later date (but before the entry into this Agreement) shall be deemed to modify information as of an earlier date. As of their respective dates, all Company Reports filed under the
Securities Act and the Exchange Act complied in all material respects with the published rules and regulations of the SEC with respect thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
As of the entry into this Agreement, (A)&nbsp;no executive officer of the Company has failed in any respect to make the certifications required of him or her under Section&nbsp;302 or 906 of the
Sarbanes-Oxley Act and (B)&nbsp;there are no outstanding comments from or unresolved issues raised by the SEC with respect to any of the Company Reports. There are no deposits of the Company Bank that are required by Law or contract to be withdrawn
or that the Company Bank can no longer hold given the Company Bank&#146;s deposit rating as of the date hereof, other than any waivers granted by a government-sponsored enterprise as of the date hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) To the knowledge of the Company, as of the date hereof, the Company is not aware of any facts that cause the Company to
reasonably believe that the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023 (A) will not be filed with the SEC on or before March&nbsp;15, 2024, (B) will, except as has
already been disclosed in the Company Reports, contain any additional material weaknesses in the design or operation of internal control over financial reporting (as defined in Rule <FONT STYLE="white-space:nowrap">13a-15(f)</FONT> of the Exchange
Act) and (C)&nbsp;will contain any material changes to the financial statements as compared to the consolidated statements of condition and consolidated statements of (loss) income of the Company included in its Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> filed on February&nbsp;29, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) <U>Financial Statements</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The financial statements of the Company and its Subsidiaries included (or incorporated by reference) in the Company
Reports (including the related notes, where applicable) (A)&nbsp;have been prepared from, and are in accordance with, the books and records of the Company and its Subsidiaries, (B)&nbsp;fairly present in all material respects the consolidated
results of operations, cash flows, changes in stockholders&#146; equity and consolidated financial position of the Company and its Subsidiaries for the respective fiscal periods or as of the respective dates therein set forth (subject in the case of
unaudited statements to <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments normal in nature and amount), (C)&nbsp;complied, as of their respective dates of filing with the SEC, in all material respects with applicable accounting
requirements and with the published rules and regulations of the SEC with respect thereto, (D)&nbsp;have been prepared in accordance with GAAP consistently applied during the periods involved, except, in each case, as indicated in such statements or
in the notes thereto and (E)&nbsp;to the knowledge of the Company, are not expected to be revised, resubmitted or restated in any way. The books and records of the Company and its Subsidiaries have been, since January&nbsp;1, 2023, and are being,
maintained in all material respects in accordance with GAAP and any other applicable legal and accounting requirements. Since January&nbsp;1, 2023 and prior to the entry into this Agreement, no independent public accounting firm of the Company has
resigned (or informed the Company that it intends to resign) or been dismissed as independent public accountants of the Company as a result of, or in connection with, any disagreements with the Company on a matter of accounting principles or
practices, financial statement disclosure or auditing scope or procedure. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Except as would not, either individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect, neither the Company nor any of its Subsidiaries has any liability required by GAAP to be reflected on a consolidated balance sheet of the Company (whether absolute, accrued, contingent or
otherwise and whether due or to become due), except for (A)&nbsp;those liabilities that are reflected or reserved against on the consolidated balance sheet of the Company included in its Quarterly Report on
<FONT STYLE="white-space:nowrap">Form&nbsp;10-Q</FONT> for the fiscal quarter ended September&nbsp;30, 2023 (including any notes thereto), (B) liabilities incurred in the ordinary course of business consistent with past practice since
September&nbsp;30, 2023, (C) fees and expenses payable to any financial advisor, counsel or other professional in connection with this Agreement or each Other Investment Agreement and the transactions contemplated hereby or thereby and
(D)&nbsp;obligations under this Agreement or any Other Investment Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The records, systems, controls, data
and information of the Company and its Subsidiaries are recorded, stored, maintained and operated under means (including any electronic, mechanical or photographic process, whether computerized or not) that are under the exclusive ownership and
direct control of the Company or its Subsidiaries or accountants (including all means of access thereto and therefrom), except for any <FONT STYLE="white-space:nowrap">non-exclusive</FONT> ownership and
<FONT STYLE="white-space:nowrap">non-direct</FONT> control that would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company&nbsp;has (x)&nbsp;implemented and maintains disclosure controls
and procedures (as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15(e)</FONT> of the Exchange Act) to ensure that material information relating to the Company, including its Subsidiaries, is made known to the chief executive officer and
the chief financial officer of the Company by others within those entities as appropriate to allow timely decisions regarding required disclosures and to make the certifications required by the Exchange Act and Sections&nbsp;302 and 906 of the
Sarbanes-Oxley Act, and (y)&nbsp;disclosed, based on its most recent evaluation prior to the entry into this Agreement, to the Company&#146;s outside auditors and the audit committee of the Board of Directors any (A)&nbsp;significant deficiencies
and material weaknesses in the design or operation of internal control over financial reporting (as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15(f)</FONT> of the Exchange Act) that would reasonably be expected to adversely affect the
Company&#146;s ability to record, process, summarize and report financial information, and (B)&nbsp;fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#146;s internal controls over
financial reporting. To the knowledge of the Company, there is no reason to believe that the Company&#146;s outside auditors and its chief executive officer and chief financial officer will not be able to give the certifications and attestations
required pursuant to the rules and regulations adopted pursuant to Section&nbsp;404 of the Sarbanes-Oxley Act, without qualification, when next due. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Since January&nbsp;1, 2023, (A)&nbsp;neither the Company nor any of its Subsidiaries, nor, to the knowledge of the
Company, any director, officer, auditor, accountant or representative of the Company or any of its Subsidiaries, has received or otherwise had or obtained knowledge of any material complaint, allegation, assertion or claim, whether written or oral
regarding the accounting or auditing practices, procedures, methodologies or methods (including with respect to loan loss reserves, write-downs, charge-offs and accruals) of the Company or any of its Subsidiaries or their respective internal
accounting controls, including any material complaint, allegation, assertion or claim that the Company or any of its Subsidiaries has engaged in questionable accounting or auditing practices, and (B)&nbsp;no attorney representing the Company or any
of its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Subsidiaries, whether or not employed by the Company or any of its Subsidiaries, has reported evidence of a material violation of securities Laws, breach of fiduciary duty or similar violation by
the Company or any of its Subsidiaries or any of their respective officers, directors, employees or agents to the Board of Directors or any committee thereof, or to the knowledge of the Company, to any director or officer of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) <U>Broker</U><U>&#146;</U><U>s Fees</U>. Other than Jefferies Group LLC (the &#147;<U>Placement Agents/Arrangers</U>&#148;), neither the
Company nor any of its affiliates nor any other person acting on its behalf (other than its officers acting in such capacity) has dealt with any broker, finder, commission agent, placement agent or arranger in connection with the sale of the
Securities and the transactions contemplated by this Agreement, and the Company is not under any obligation to pay any broker&#146;s fee or commission in connection with such transactions other than to the Placement Agents/Arrangers. Neither the
Company nor any of its affiliates nor any other person acting on its behalf (other than its officers acting in such capacity) has solicited offers for, or offered or sold, the Securities other than through the Placement Agents/Arrangers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) <U>Absence of Certain Changes or Events</U>. Since January&nbsp;1, 2023 through the entry into this Agreement, there has not been any
effect, change, event, circumstance, condition, occurrence or development that has had or would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <U>Legal Proceedings</U>. As of the entry into this Agreement, subject to <U>Section</U><U></U><U>&nbsp;5.13</U>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) neither the Company nor any of its Subsidiaries is a party to any, and there are no pending or threatened in writing or,
to the Company&#146;s knowledge, otherwise threatened, legal, administrative, arbitral or other proceedings, claims, audit, examination, actions or governmental or regulatory investigations by or before any Governmental Entity of any nature against
the Company or any of its Subsidiaries or any of their current or former directors or executive officers (A)&nbsp;that would, individually or in the aggregate, reasonably be expected to result in a material restriction on, or material liability
being imposed against, the Company or any of its Subsidiaries or any of their respective businesses, (B)&nbsp;that would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect or (C)&nbsp;challenging the validity
or propriety of the transactions contemplated by this Agreement or the Other Investment Agreements; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) there is no
Order imposed upon the Company, any of its Subsidiaries or any of their current or former directors or executive officers (in each of their capacities as such) or the assets of the Company or any of its Subsidiaries that would reasonably be expected
to be material to the Company and its Subsidiaries taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) <U>Taxes and Tax Returns</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Each of the Company and its Subsidiaries has duly and timely filed (including all valid applicable extensions) all
material Tax Returns in all jurisdictions in which Tax Returns are required to be filed by it, and all such Tax Returns are true, correct, and complete in all material respects. Neither the Company nor any of its
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Subsidiaries is the beneficiary of any extension of time within which to file any material Tax Return (other than extensions to file Tax Returns obtained in the ordinary course of business). All
material Taxes of the Company and its Subsidiaries (whether or not shown on any Tax Returns) that are due have been fully and timely paid. Each of the Company and its Subsidiaries has withheld and paid all material Taxes required to have been
withheld and paid in connection with amounts paid or owing to any employee, creditor, shareholder, independent contractor or other third party. Neither the Company nor any of its Subsidiaries has granted any extension or waiver of the limitation
period applicable to any material Tax that remains in effect. The federal income Tax Returns of the Company and its Subsidiaries for all years to and including 2022 have been examined by the Internal Revenue Service or are Tax Returns with respect
to which the applicable period for assessment under applicable Law, after giving effect to extensions or waivers, has expired. Neither the Company nor any of its Subsidiaries has received written notice of assessment or proposed assessment in
connection with any material amount of Taxes, and there are no threatened in writing or pending disputes, claims, audits, examinations or other proceedings regarding any material Tax of the Company and its Subsidiaries or the assets of the Company
and its Subsidiaries. Neither the Company nor any of its Subsidiaries is a party to or is bound by any Tax sharing, allocation or indemnification agreement or arrangement (other than such an agreement or arrangement exclusively between or among the
Company and its Subsidiaries). Neither the Company nor any of its Subsidiaries&nbsp;(A) has been a member of an affiliated group filing a consolidated federal income Tax Return (other than a group the common parent of which was the Company) or
(B)&nbsp;has any material liability for the Taxes of any person (other than the Company or any of its Subsidiaries) under Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any similar provision of any Law), as a
transferee or successor, by contract or otherwise. Neither the Company nor any of its Subsidiaries has been, within the past two (2)&nbsp;years, a &#147;distributing corporation&#148; or a &#147;controlled corporation&#148; (within the meaning of
Section&nbsp;355(a)(1)(A) of the Internal Revenue Code of 1986 (the &#147;<U>Code</U>&#148;)) in a distribution of stock intending to qualify for <FONT STYLE="white-space:nowrap">tax-free</FONT> treatment under Section&nbsp;355 of the Code. Neither
the Company nor any of its Subsidiaries has participated in a &#147;listed transaction&#148; within the meaning of Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.6011-4(b).</FONT> At no time during the past five (5)&nbsp;years
has the Company been a U.S. real property holding corporation within the meaning of Section&nbsp;897(c)(2) of the Code. The Company is classified as a Subchapter C corporation for U.S. federal tax purposes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) As used herein, (A) &#147;<U>Tax</U>&#148; or &#147;<U>Taxes</U>&#148; means all federal, state, local, and foreign
income, excise, gross receipts, ad valorem, profits, gains, property, capital, sales, transfer, use, license, payroll, employment, social security, severance, unemployment, unclaimed property, withholding, duties, excise, windfall profits,
intangibles, franchise, backup withholding, value added, alternative or <FONT STYLE="white-space:nowrap">add-on</FONT> minimum, estimated and other taxes, charges, levies or like assessments together with all penalties and additions to tax and
interest thereon; and (B) &#147;<U>Tax Return</U>&#148; means any return, declaration, report, claim for refund, or information return or statement relating to Taxes, including any schedule or attachment thereto, and including any amendment thereof,
supplied or required to be supplied to a Governmental Entity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k) <U>Employees and Employee Benefit Plans</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) As used herein, &#147;<U>Company Benefit Plans</U>&#148; means all employee benefit plans (as defined in Section&nbsp;3(3)
of the Employee Retirement Income Security Act of 1974 (&#147;<U>ERISA</U>&#148;)), whether or not subject to ERISA, and all stock option, stock purchase, restricted stock, stock-based, incentive, deferred compensation, retiree medical or life
insurance, supplemental retirement, severance, welfare or other benefit plans, programs or arrangements, retention, bonus, employment, change in control, termination or severance plans, programs, policies, practices, agreements or arrangements
(whether or not funded and whether or not in writing) that are maintained, contributed to or sponsored or maintained by, or required to be contributed to, the Company or any of its Subsidiaries for the benefit of any current or former employee,
officer or director of the Company or any of its Subsidiaries, excluding, in each case, any &#147;multiemployer plan&#148; within the meaning of Section&nbsp;4001(a)(3) of ERISA (a &#147;<U>Multiemployer Plan</U>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Each Company Benefit Plan has been established, operated and administered in all material respects in accordance with its
terms and the requirements of all applicable Laws, including ERISA and the Code. Each Company Benefit Plan that is intended to be qualified under Section&nbsp;401(a) of the Code has received a favorable determination letter from the IRS and, to the
Company&#146;s knowledge, nothing has occurred, whether by action or failure to act, that could reasonably be expected to adversely affect the qualified status of such Company Benefit Plan under Section&nbsp;401(a) of the Code. Neither the Company
nor any Company Subsidiary has engaged in a transaction that could subject the Company or any of its Subsidiaries to a material tax or material penalty pursuant to Section&nbsp;4975 or 4976 of the Code or Section&nbsp;502 of ERISA. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) No Company Benefit Plan is subject to Title IV or Section&nbsp;302 of ERISA or Section&nbsp;412 or 4971 of the Code nor
has the Company or any of its Subsidiaries or ERISA Affiliates, at any time during the last six years, contributed to or been obligated to contribute to an employee benefit plan subject to Title IV or Section&nbsp;302 of ERISA. None of the Company,
its Subsidiaries nor any ERISA Affiliate (as defined below) has, at any time during the last six years, contributed to or been obligated to contribute to any Multiemployer Plan or a plan that has two or more contributing sponsors at least two of
whom are not under common control, within the meaning of Section&nbsp;4063 of ERISA (a &#147;<U>Multiple Employer Plan</U>&#148;), and none of the Company and its Subsidiaries nor any ERISA Affiliate has incurred any liability to a Multiemployer
Plan or Multiple Employer Plan as a result of a complete or partial withdrawal (as those terms are defined in Part 1 of Subtitle E of Title IV of ERISA) from a Multiemployer Plan or Multiple Employer Plan. As used herein, &#147;<U>ERISA
Affiliate</U>&#148; means, with respect to any entity, trade or business, any other entity, trade or business that is, or was at the relevant time, a member of a group described in Section&nbsp;414(b), (c), (m) or (o)&nbsp;of the Code or
Section&nbsp;4001(b)(1) of ERISA that includes or included the first entity, trade or business, or that is, or was at the relevant time, a member of the same &#147;controlled group&#148; as the first entity, trade or business pursuant to
Section&nbsp;4001(a)(14) of ERISA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Neither the Company, nor any of its Subsidiaries, sponsors or has any
obligation with respect to any employee benefit plan that provides for any post- employment or post-retirement health or medical or life insurance benefits for retired, former or current employees or beneficiaries or dependents thereof, except as
required by Section&nbsp;4980B of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) All contributions required to be made to any Company Benefit Plan by Law
or any plan document, and all premiums due or payable with respect to insurance policies funding any Company Benefit Plan, for any period through the entry into this Agreement, have been timely made or paid in full or, to the extent not required to
be made or paid on or before the entry into this Agreement, have been fully reflected on the books and records of the Company, except as, either individually or in the aggregate, would not reasonably be expected to result in any material liability
to the Company and its Subsidiaries, taken as a whole. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) Other than as provided herein or the Other Investment
Agreements, none of the execution and delivery of this Agreement or the Other Investment Agreements, the transactions contemplated by this Agreement, the Other Investment Agreements or the Investment will (either alone or in conjunction with any
other event) (A)&nbsp;entitle any employee, officer, director or individual independent contractor of the Company or any of its Subsidiaries to any payment or benefit, (B)&nbsp;result in, accelerate, cause the vesting, exercisability, funding,
payment or delivery of, or increase in the amount or value of, any payment, right or other benefit to any employee, officer, director or independent contractor of the Company or any of its Subsidiaries, (C)&nbsp;accelerate the timing of or cause the
Company or any of its Subsidiaries to transfer or set aside any assets to fund any material benefits under any Company Benefit Plan, (D)&nbsp;result in any limitation on the right of the Company or any of its Subsidiaries to amend, merge, terminate
or receive a reversion of assets from any Company Benefit Plan or related trust, or (E)&nbsp;result in any &#147;excess parachute payment&#148; within the meaning of Section&nbsp;280G of the Code. No Company Benefit Plan provides for the <FONT
STYLE="white-space:nowrap">gross-up</FONT> or reimbursement of Taxes under Section&nbsp;4999 or 409A of the Code, or otherwise. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) The Company and its Subsidiaries are in compliance in all material respects with, and since January&nbsp;1, 2023 have
complied in all material respects with, all Laws regarding employment and employment practices, terms and conditions of employment, compensation and benefits, wages and hours, paid sick leave, classification of employees as exempt or nonexempt and
workers as employees or independent contractors, equitable pay practices, privacy rights, labor disputes, employment discrimination, sexual or racial harassment or discrimination, workers&#146; compensation, unemployment insurance, disability rights
or benefits, retaliation, immigration, family and medical leave, occupational safety and health, plant closings and layoffs and other laws in respect of any reduction in force (including notice, information and consultation requirements). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(l) <U>Compliance with Applicable Law and Privacy Obligations</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company and each of its Subsidiaries hold, and have at all times since January&nbsp;1, 2023, held, all licenses,
franchises, permits and authorizations necessary for the lawful conduct of their respective businesses and ownership of their respective properties, rights and assets under and pursuant to each (and have paid all fees and assessments due and payable
in connection therewith), except where neither the cost of failure to hold nor the cost of obtaining and holding such license, franchise, permit or authorization (nor the failure to pay any fees or assessments) would, either individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect, and, to the knowledge of the Company, no suspension or cancellation of any such necessary license, franchise, permit or authorization is threatened. Except as would not, either
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, the Company and its Subsidiaries have complied with any Law applicable to the Company or any of its Subsidiaries, including all laws relating to the privacy
and security of data or information that constitutes &#147;personal data,&#148; &#147;personally identifiable information,&#148; &#147;nonpublic personal information,&#148; &#147;personal information&#148; or a similar term (&#147;<U>Personal
Data</U>&#148;), the USA PATRIOT Act, the Bank Secrecy Act, the Equal Credit Opportunity Act and Regulation&nbsp;B, the Fair Housing Act, the Community Reinvestment Act, the Fair Credit Reporting Act, the Truth in Lending Act and Regulation&nbsp;Z,
the Home Mortgage Disclosure Act, the Fair Debt Collection Practices Act, the Electronic Fund Transfer Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, any regulations promulgated by the Consumer Financial Protection Bureau, the
Interagency Policy Statement on Retail Sales of Nondeposit Investment Products, the SAFE Mortgage Licensing Act of 2008, the Real Estate Settlement Procedures Act and Regulation&nbsp;X, and any other Laws relating to bank secrecy, discriminatory
lending, financing or leasing practices, consumer protection, money laundering prevention, foreign assets control, U.S. sanctions laws and regulations, Sections&nbsp;23A and 23B of the Federal Reserve Act, the Sarbanes-Oxley Act, and all agency
requirements relating to the origination, sale and servicing of mortgage and consumer loans. Company Bank has a Community Reinvestment Act rating of &#147;satisfactory&#148; or better. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Except as would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect,
none of the Company, any of its Subsidiaries or, to the Company&#146;s knowledge, any director, officer, employee, agent or other person acting on behalf of the Company or any of its Subsidiaries has, directly or indirectly, (A)&nbsp;used any funds
of the Company or its Subsidiaries for unlawful contributions, unlawful gifts, unlawful entertainment or other expenses relating to political activity, (B)&nbsp;made any unlawful payment to foreign or domestic governmental officials or employees or
to foreign or domestic political parties or campaigns from funds of the Company or its Subsidiaries, (C)&nbsp;violated any provision that would result in the violation of the Foreign Corrupt Practices Act of 1977 or any similar Law,
(D)&nbsp;established or maintained any unlawful fund of monies or other assets of the Company or its Subsidiaries, (E)&nbsp;made any fraudulent entry on the books or records of the Company or its Subsidiaries or (F)&nbsp;made any unlawful bribe,
unlawful rebate, unlawful payoff, unlawful influence payment, unlawful kickback or other unlawful payment to any person, private or public, regardless of form, whether in money, property or services, to obtain favorable treatment in securing
business to obtain special concessions for the Company or its Subsidiaries, to pay for favorable treatment for business secured or to pay for special concessions already obtained for the Company or its Subsidiaries, or is currently subject to any
U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The Company maintains a written information privacy and security
program that maintains reasonable measures to protect the privacy, confidentiality, integrity and security of all Personal Data against any (A)&nbsp;loss or misuse of Personal Data, (B)&nbsp;unauthorized or unlawful operations performed upon
Personal Data or (C)&nbsp;any other act or omission that compromises the security or confidentiality of Personal Data (clauses&nbsp;(A) through (C), a &#147;<U>Data Breach</U>&#148;). The Company has not experienced any Data Breach that, either
individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. To the knowledge of the Company, there are no data security or other technological vulnerabilities with respect to the Company&#146;s information
technology systems or networks that, either individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. Since January&nbsp;1, 2023, except as would not, either individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect, the Company and its Subsidiaries are and have been compliant with their written data privacy and security policies and all contractual commitments of the Company and its Subsidiaries concerning privacy,
data protection, data security and the collection, storage, use and other processing of Personal Data. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Except as
would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect: (A)&nbsp;the Company and each of its Subsidiaries have properly administered all accounts for which it acts as a fiduciary, including
accounts for which it serves as a trustee, agent, custodian, personal representative, guardian, conservator or investment advisor, in accordance with the terms of the governing documents and applicable state, federal and foreign law; and
(B)&nbsp;none of the Company, any of its Subsidiaries, or any of its or its Subsidiaries&#146; directors, officers or employees, has committed any breach of trust or fiduciary duty with respect to any such fiduciary account, and the accountings for
each such fiduciary account are true, correct and complete and accurately reflect the assets and results of such fiduciary account. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(m)
<U>Agreements with Governmental Entities</U>. Subject to <U>Section</U><U></U><U>&nbsp;5.13</U>, as of the entry into this Agreement, neither the Company nor any of its Subsidiaries is subject to any <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">cease-and-desist</FONT></FONT> Order, or is a party to any written agreement, consent agreement or memorandum of understanding with, or is a party to any commitment letter or similar undertaking to, or has been ordered to
pay any material civil money penalty by, or has been since January&nbsp;1, 2023, a recipient of any supervisory letter from, or since January&nbsp;1, 2023, has adopted any board resolutions at the direction of, any Governmental Entity, in each case,
that (i)&nbsp;currently restricts in any material respect or would reasonably be expected to restrict in any material respect the conduct of its business or (ii)&nbsp;in any material manner relates to its capital adequacy, its ability to pay
dividends, its credit or risk management policies, its management or its business (each, whether or not set forth in the Company Disclosure Schedule, a &#147;<U>Company Regulatory Agreement</U>&#148;), nor has the Company or any of its Subsidiaries
been advised in writing or, to the knowledge of the Company, threatened verbally, since January&nbsp;1, 2023 through the date hereof, by any Governmental Entity that it is considering issuing, initiating, ordering or requesting any such Company
Regulatory Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(n) <U>Investment Securities and Commodities</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Each of the Company and its Subsidiaries has good title in all material respects to all securities and commodities owned
by it (except those sold under repurchase agreements) which are material to the Company and its Subsidiaries on a consolidated basis, free and clear of any Liens, except for such failures to have good title as are set forth in the financial
statements included in the Company Reports as of the entry into this Agreement or to the extent such securities or commodities are pledged in the ordinary course of business to secure obligations of the Company or its Subsidiaries. Such securities
and commodities are valued on the books of the Company in accordance with GAAP in all material respects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Company
and its Subsidiaries and their respective businesses employ investment, securities, commodities, risk management and other policies, practices and procedures that the Company believes are prudent and reasonable in the context of such businesses, and
the Company and its Subsidiaries have, since January&nbsp;1, 2023, been in compliance with such policies, practices and procedures in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(o) <U>Loan Portfolio</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Except as would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect,
each written or oral loan, loan agreement, note or borrowing arrangement (including leases, credit enhancements, commitments, guarantees and interest-bearing assets) (collectively, &#147;<U>Loans</U>&#148;) of the Company and its Subsidiaries
(A)&nbsp;is evidenced by notes, agreements or other evidences of indebtedness that are true, genuine and what they purport to be, (B)&nbsp;has been secured by valid Liens, as applicable, and (C)&nbsp;is the legal, valid and binding obligation of the
obligor named therein, enforceable in accordance with its terms, subject to the Enforceability Exceptions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Except as
would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, each outstanding Loan of the Company or any of its Subsidiaries (including Loans held for resale to investors) was solicited and
originated, and is and has been administered and, where applicable, serviced, and the relevant Loan files are being maintained, in all material respects in accordance with the relevant notes or other credit or security documents, the written
underwriting standards of the Company and its Subsidiaries (and, in the case of Loans held for resale to investors, the underwriting standards, if any, of the applicable investors) and with all applicable federal, state and local laws, regulations
and rules. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) There are no outstanding Loans made by the Company or any of its Subsidiaries to any &#147;executive
officer&#148; or other &#147;insider&#148; (as each such term is defined in Regulation O promulgated by the Federal Reserve) of the Company or its Subsidiaries, other than Loans that are subject to and that were made and continue to be in compliance
with Regulation O or that are exempt therefrom. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) To the knowledge of the Company, the allowance for credit losses
reflected in the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on February&nbsp;29, 2024 was calculated in accordance with GAAP and applicable regulatory guidance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(p) <U>Related Party Transactions</U>. There are no transactions or series of related transactions, agreements, arrangements or
understandings, nor are there any currently proposed transactions, agreements, arrangements or understandings or series of related transactions, agreements, arrangements or understandings between the Company or any of its Subsidiaries, on the one
hand, and any current or former director or &#147;executive officer&#148; (as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;3b-7</FONT> under the Exchange Act) of the Company or any of its Subsidiaries or any person who beneficially owns (as
defined in <FONT STYLE="white-space:nowrap">Rules&nbsp;13d-3</FONT> and <FONT STYLE="white-space:nowrap">13d-5</FONT> of the Exchange Act) 5% or more of the outstanding Common Stock (or any of such person&#146;s immediate family members or
affiliates) (other than Subsidiaries of the Company) on the other hand, of the type required to be reported in any Company Report pursuant to Item&nbsp;404 of <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-K</FONT> promulgated under the Exchange
Act that have not been so reported on a timely basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(q) <U>Offering of Securities</U>. Neither the Company, nor any of its
Subsidiaries, nor any person acting on its or their behalf has (i)&nbsp;directly or indirectly, taken any action (including any offering of any securities of the Company under circumstances which would require the integration of such offering with
the offering of any of the Securities to be issued pursuant hereto under the Securities Act and the rules and regulations of the SEC promulgated thereunder) that might subject the Investment to the registration requirements of the Securities Act or
(ii)&nbsp;offered the Securities or any similar securities for sale to, or solicited any offer to buy any of the same from, or otherwise approached or negotiated in respect thereof with, any person, other than Purchaser, the counterparty to each
Other Investment Agreement and not more than thirty-five (35)&nbsp;other Institutional Accredited Investors and fifteen (15)&nbsp;other Accredited Investors that are directors or executive officers of the Company, each of which has been offered the
Securities at a private sale for investment. As used herein, (x) &#147;<U>Institutional Accredited Investor</U>&#148; means an institutional accredited investor as defined in Rule 501(a)(1), (2), (3), (7) or (8)&nbsp;under the Securities Act and (y)
&#147;<U>Accredited Investors</U>&#148; means an accredited investor as defined in Rule 501(a)(4) under the Securities Act. None of the Company nor any of its Subsidiaries has offered the Securities or any similar securities during the six
(6)&nbsp;months prior to the entry into this Agreement to anyone, other than Purchaser, the counterparty to each Other Investment Agreement and not more than thirty-five (35)&nbsp;other Institutional Accredited Investors and fifteen (15)&nbsp;other
Accredited Investors. The Company has no intention to offer the Securities or any similar security during the six (6)&nbsp;months from the entry into this Agreement, except as contemplated by this Agreement or each Other Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(r) <U>Other Investments</U>. The per share purchase price of the shares of Common Stock and/or Preferred Stock purchased under each Other
Investment Agreement is not less than the per share purchase price of the shares of Common Stock and Preferred Stock issued pursuant to the Investment. Except as expressly set forth in the Other Investment Agreements executed as of the date of this
Agreement and that has been delivered to Purchaser concurrently with the execution of this Agreement, each Other Investment Agreement does not include provisions that are more favorable to the purchaser party thereto compared to the rights, benefits
and obligations of Purchaser under this Agreement (it being understood that each Other Investment Agreement may differ with respect to (i)&nbsp;such other purchaser&#146;s governance rights with respect to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company, (ii)&nbsp;any provision necessary or advisable to consummate the transactions contemplated thereby arising out of or related to the identity of the other purchaser, including
regulatory requirements related to manner of settlement for regulated funds or advisers, (iii)&nbsp;any rights with respect to confidentiality obligations, information rights and public announcements and (iv)&nbsp;the Common Stock issuable at the
Closing pursuant to the Other Investment Agreement entered into with Liberty Strategic Capital (CEN) Holdings, LLC). Except as set forth in the preceding sentence with the respect to the provisions of any Other Investment Agreement, neither the
Company nor any of its Subsidiaries has entered into any (or modified any existing) contract, agreement, arrangement or understanding with any purchaser party to the Other Investment Agreements (or any affiliate thereof) that has the effect of
establishing rights or otherwise benefiting such other purchaser in a manner more favorable to such purchaser than the rights, benefits and obligations of Purchaser in this Agreement. Each Other Permanent Warrant (A)&nbsp;includes or will include
(as applicable) the same exercise price and (B)&nbsp;does not or will not (as applicable) include provisions that are more favorable in any material respect to the holder thereof compared to the rights, benefits and obligations of Purchaser under
the Permanent Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(s) <U>General Solicitation</U>. Neither the Company, nor any Company Subsidiary nor any of their respective
affiliates, nor any person acting on its or their behalf, has offered or sold the Securities by any form of general solicitation or general advertising, including, but not limited to, the following: (i)&nbsp;any advertisement, article, notice or
other communication published in any newspaper, magazine, or similar media or broadcast over television or radio; (ii)&nbsp;any website posting or widely distributed <FONT STYLE="white-space:nowrap">e-mail;</FONT> or (iii)&nbsp;any seminar or
meeting whose attendees have been invited by any general solicitation or general advertising. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(t) <U>Borrowings</U>. There are no
restrictions (including, without limitation, on amounts, maturities, collateral or rates of interest) on the ability of the Company or Company Bank to borrow under any federal loan program or discount window other than those generally applicable to
banking organizations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(u) <U>Receivership</U>. No Governmental Entity shall have been appointed as receiver or conservator for Company
Bank. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) <U>No Other Representations or Warranties</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Except for the representations and warranties made by the Company in this <U>Section</U><U></U><U>&nbsp;2.2</U>, neither
the Company, any of its Subsidiaries, any of their respective Representatives, nor any other person makes, has made or has been authorized to make any express or implied representation or warranty with respect to the Company, any of its Subsidiaries
or their respective businesses, operations, assets, liabilities, conditions (financial or otherwise) or prospects, and the Company hereby disclaims any such other representations or warranties. In particular, without limiting the foregoing
disclaimer, neither the Company, any of its Subsidiaries, any of their respective Representatives, nor any other person makes, has made or has been authorized to make any representation or warranty to Purchaser or any of its affiliates or its or
their respective Representatives with respect to (A)&nbsp;any financial projection, forecast, estimate, budget or prospective information relating to the Company or any of its Subsidiaries or their respective businesses, operations, assets,
liabilities, conditions (financial or otherwise) or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
prospects or (B)&nbsp;except for the representations and warranties made by the Company in this <U>Section</U><U></U><U>&nbsp;2.2</U>, any oral or written information presented to Purchaser or
any of its affiliates or its or their respective Representatives in the course of (x)&nbsp;their due diligence investigation of the Company or its Subsidiaries, (y)&nbsp;the negotiation of this Agreement or (z)&nbsp;the transactions contemplated
hereby. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Company acknowledges and agrees that neither Purchaser, its Representatives, nor any other person has
made, is making or has been authorized to make any express or implied representation or warranty other than those expressly set forth in in <U>Section</U><U></U><U>&nbsp;2.3</U>, and in entering into this Agreement, the Company is relying
exclusively on its own independent investigation and the representations and warranties expressly set forth in <U>Section</U><U></U><U>&nbsp;2.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3 <U>Representations and Warranties of Purchaser</U>. Purchaser hereby represents and warrants to the Company, and solely for
purposes of <U>Section</U><U></U><U>&nbsp;2.3(e)</U>, the Parent Funds hereby represents and warrants to the Company, that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)
<U>Corporate Organization</U>. Purchaser is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization. Purchaser has the corporate, partnership or limited liability company power and authority to
own or lease all of its properties and assets and to carry on its business as it is now being conducted. Purchaser is duly licensed or qualified to do business and, where such concept is recognized under Law, in good standing in each jurisdiction in
which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing, qualification or standing necessary, except where the failure to be so licensed or qualified or to
be in good standing would not, either individually or in the aggregate, reasonably be expected to materially and adversely affect Purchaser&#146;s ability to perform its obligations under this Agreement or consummate the transactions contemplated
hereby on a timely basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Authority; No Violation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Purchaser has full corporate, partnership or limited liability company power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and, subject to other actions described in this <U>Section</U><U></U><U>&nbsp;2.3(b)</U> and <U>Section</U><U></U><U>&nbsp;2.3(c)</U>, to consummate the Closing. The execution and delivery of this
Agreement, the performance by Purchaser of its obligations hereunder and the consummation of the Closing (including the Investment) have been duly and validly approved by Purchaser&#146;s board of directors or other equivalent governing body, as
applicable. No other corporate proceedings on the part of Purchaser or any of Purchaser&#146;s partners or equityholders are necessary to approve or adopt this Agreement, for Purchaser to perform its obligations hereunder or to consummate the
transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by Purchaser and (assuming due authorization, execution and delivery by the Company) constitutes a valid and binding obligation of Purchaser,
enforceable against Purchaser in accordance with its terms (except in all cases as such enforceability may be limited by the Enforceability Exceptions). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Neither the execution and delivery of this Agreement by Purchaser, the
performance by Purchaser of its obligations hereunder nor consummation by Purchaser of the transactions contemplated hereby, including the Investment, nor compliance by Purchaser with any of the terms or provisions hereof, will (A)&nbsp;violate any
provision of Purchaser&#146;s certificate or articles of incorporation or bylaws (or other comparable charter or organizational documents) or (B)&nbsp;assuming that the consents and approvals referred to in <U>Section</U><U></U><U>&nbsp;2.3(c)</U>
are duly obtained, (x)&nbsp;violate any Law applicable to Purchaser or any of its properties or assets or (y)&nbsp;violate, conflict with, result in a breach of any provision of or the loss of any benefit under, constitute a default (or an event
which, with notice or lapse of time, or both, would constitute a default) under, result in the termination of or a right of termination or cancellation under, accelerate the performance required by, or result in the creation of any Lien upon any of
the properties or assets of Purchaser under, any of the terms, conditions or provisions of any note, bond, mortgage, indenture, deed of trust, license, lease, agreement or other instrument or obligation to which Purchaser is a party, or by which
Purchaser or any of its properties or assets may be bound, except (in the case of <U>clauses</U><U></U><U>&nbsp;(B)(x)</U> and <U>(B)(y)</U> above) for such violations, conflicts, breaches, defaults, terminations, cancellations, accelerations or
creations which would not, either individually or in the aggregate, reasonably be expected to materially and adversely affect Purchaser&#146;s ability to consummate the Investment and the other transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Consents and Approvals</U>. Except for (i)&nbsp;the approvals set forth on <U>Section</U><U></U><U>&nbsp;2.2(d)</U> of the Company
Disclosure Schedule, (ii)&nbsp;the Board <FONT STYLE="white-space:nowrap">Non-Objections,</FONT> (iii)&nbsp;the filing of the requisite Supplemental Listing Application and any other required applications, filings and notices, as applicable, with
the NYSE, and the approval of the listing of the shares of Common Stock and shares of Common Stock (A)&nbsp;issued hereunder and (B)&nbsp;to be issued upon the Conversions, (iv)&nbsp;the filing of any registration statement with the SEC in
accordance with the terms and subject to the conditions of the Registration Rights Agreement, (v)&nbsp;filings required under, and compliance with other applicable requirements of, the HSR Act with respect to the Conversions, (vi)&nbsp;the Requisite
Stockholder Vote, (vii)&nbsp;the filing of the Certificate of Designations and the Charter Amendment with the Delaware Secretary of State and (viii)&nbsp;such filings and approvals as are required to be made or obtained under the securities or
&#147;Blue Sky&#148; laws of various states in connection with the Investment, no consents or approvals of or filings or registrations with any Governmental Entity are necessary in connection with (A)&nbsp;the execution and delivery by Purchaser of
this Agreement or (B)&nbsp;the Investment and the other transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <U>Sufficiency of Funds</U>. Purchaser has
available cash on hand or other sources of immediately available funds sufficient to enable it to perform all of its payment obligations hereunder and consummate the transactions contemplated by this Agreement, including the Investment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) <U>Parent Funds</U>. The Parent Funds collectively own all of the equity interests in Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) <U>Purchase for Investment</U>. Purchaser represents that it is an Institutional Accredited Investor acting for its own account (and not
for the account of others) or as a fiduciary or agent for others (which others are also Institutional Accredited Investors). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Purchaser represents that it is purchasing the Securities for its own account or for one or more separate accounts maintained by it for the benefit of one or more other Institutional Accredited
Investors and not with a view to the distribution thereof in violation of the securities Laws; <U>provided</U> that the disposition of Purchaser&#146;s property shall at all times be within Purchaser&#146;s control. Purchaser understands that the
Securities have not been registered under the Securities Act and may be resold only if registered pursuant to the provisions of the Securities Act or if an exemption from registration is available, except under circumstances where neither such
registration nor such an exemption is required by Law, and that the Company is not required to register the Securities. Purchaser further represents and warrants that Purchaser (i)&nbsp;will not sell, transfer or otherwise dispose of the Securities
or any interest therein except in a registered transaction or in a transaction exempt from or not subject to the registration requirements of the Securities Act and (ii)&nbsp;was given the opportunity to ask questions and receive answers concerning
the terms and conditions of the offering and to obtain any additional information which the Company possesses or can acquire without unreasonable effort or expense. Purchaser acknowledges that the Securities will bear a restrictive legend
substantially in the form set forth in <U>Section</U><U></U><U>&nbsp;4.2(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) <U>No </U><U>&#147;</U><U>Bad
Actor</U><U>&#148;</U><U> Disqualification Events</U>. If Purchaser is a person enumerated in Rule 506(d)(1), neither Purchaser nor, to Purchaser&#146;s knowledge, its affiliates, nor any of their respective officers, directors, employees, agents,
partners or members, is subject to any &#147;bad actor&#148; disqualifying event described in Rule&nbsp;506(d)(1)(i)-(viii) of the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) <U>Information</U>. Purchaser (i)&nbsp;is not being provided with disclosures that would be required if the offer and sale of the
Securities were registered under the Securities Act, nor is Purchaser being provided with any offering circular or prospectus prepared in connection with the offer and sale of the Securities; (ii)&nbsp;has had the opportunity to ask questions of and
receive answers from the Company directly; (iii)&nbsp;has been provided a reasonable opportunity to undertake and has undertaken its own examination of the Company and its Subsidiaries and the terms of the Securities to the extent Purchaser deems
necessary to make its decision to invest in the Securities and (iv)&nbsp;has availed itself of publicly available financial and other information concerning the Company and its Subsidiaries to the extent Purchaser deems necessary to make its
decision to purchase the Securities. Purchaser has sought such accounting, legal and tax advice as it has considered necessary or advisable to make an informed investment decision with respect to its acquisition of the Securities. The purchase of
Securities by Purchaser has not been solicited by or through anyone other than the Company or the Placement Agents/Arrangers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)
<U>Ability to Bear Economic Risk of Investment</U>. Purchaser recognizes that an investment in the Securities involves substantial risk. Purchaser has the ability to bear the economic risk of the prospective investment in the Securities, including
the ability to hold the Securities indefinitely, and further including the ability to bear a complete loss of all of Purchaser&#146;s investment in the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) <U>Ownership</U>. Except as disclosed to the Company, as of the entry into this Agreement, neither Purchaser nor any of its affiliates
(other than any affiliate with respect to which Purchaser is not the party exercising control over investment decisions) are the owners of record or the Beneficial Owners (as such term is defined under Rule
<FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act) of shares of Common Stock or securities convertible into or exchangeable for Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k) <U>Bank Regulatory Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Purchaser is not aware of any facts or circumstances that would reasonably be expected to cause Purchaser to be deemed to
be &#147;acting in concert&#148; (as that term is defined in Regulation Y) with any other person in connection with the transactions contemplated by this Agreement or the Other Investment Agreements. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Neither Purchaser nor any of its affiliates for purposes of the BHC Act is a bank holding company or &#147;controls&#148;
a &#147;bank&#148; (as such terms are defined under the BHC Act or its implementing regulations). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) Purchaser is not
aware of any facts or circumstances that, upon consummation of the transactions contemplated herein, would reasonably be expected to cause Purchaser or any of its affiliates to be presumed to &#147;control&#148; the Company or Company Bank for
purposes of the BHC Act or Regulation Y. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(l) <U>Information Supplied</U>. The information supplied or to be supplied by Purchaser in
writing specifically for inclusion or incorporation by reference in any documents filed or to be filed with the SEC or any other Governmental Entity in connection with the transactions contemplated by this Agreement or the Other Investment
Agreements will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not
misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(m) <U>Brokers and Finders</U>. Neither Purchaser nor its affiliates, any of its or their respective officers, directors,
employees or agents has employed any broker or finder or incurred any liability for any financial advisory fees, brokerage fees, commissions or finder&#146;s fees, in each case, for which the Company would be liable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(n) <U>No Other Representations or Warranties</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Except for the representations and warranties expressly made by Purchaser in this <U>Section</U><U></U><U>&nbsp;2.3</U>,
neither Purchaser, its Representatives, nor any other person makes, has made or has been authorized to make any express or implied representation or warranty with respect to Purchaser or its businesses, operations, conduct, assets, liabilities,
conditions (financial or otherwise) or prospects, and Purchaser hereby disclaims any such other representations or warranties. In particular, without limiting the foregoing disclaimer, neither Purchaser, its Representatives, nor any other person
makes, has made or has been authorized to make any representation or warranty to the Company or any of its Subsidiaries or its or their respective Representatives with respect to (A)&nbsp;any financial projection, forecast, estimate, budget or
prospective information relating to Purchaser or its businesses, operations, conduct, assets, liabilities, conditions (financial or otherwise) or prospects or (B)&nbsp;except for the representations and warranties expressly made by Purchaser in this
<U>Section</U><U></U><U>&nbsp;2.3</U>, any oral, electronic, written or other information presented or made available to the Company or any of its Subsidiaries or its or their respective Representatives in the course of (x)&nbsp;their due diligence
investigation of Purchaser or its affiliates, (y)&nbsp;the negotiation of this Agreement or (z)&nbsp;the transactions contemplated hereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Purchaser acknowledges and agrees that neither the Company, any of its
Subsidiaries, any of their respective Representative, nor any other person has made, is making or has been authorized to make any express or implied representation or warranty other than those expressly set forth in
<U>Section</U><U></U><U>&nbsp;2.2</U>, and in entering into this Agreement, Purchaser is relying exclusively on its own independent investigation and the representations and warranties expressly set forth in <U>Section</U><U></U><U>&nbsp;2.2</U>.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;III </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>COVENANTS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1 <U>Filings; Other Actions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Purchaser, on the one hand, and the Company, on the other hand, will (and will cause their respective affiliates to) cooperate and
consult with the other party and use reasonable best efforts to (i)&nbsp;promptly prepare and file (as applicable) all permits, consents, approvals, confirmations (whether in writing or orally) and authorizations of all third parties and
Governmental Entities which are necessary or advisable to consummate the transactions contemplated hereby, including making an appropriate filing of a Notification and Report Form pursuant to the HSR Act with respect to the Conversions, and
(ii)&nbsp;respond as promptly as practicable to any request for information from (including supplying any additional information or documentary material that may be requested by) any Governmental Entity relating to the foregoing, in each case, so as
to enable the parties hereto to consummate the transactions contemplated by this Agreement, including the Investment, as promptly as reasonably practicable following the entry into this Agreement. Purchaser and the Company shall use their respective
commercially reasonable efforts to obtain clearance pursuant to the HSR Act with respect to the Conversions (such clearance, &#147;<U>HSR Clearance</U>&#148;), as promptly as reasonably practicable following the entry into this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) To the extent permitted by Law, Purchaser and the Company will (i)&nbsp;have the right to review in advance all the information to the
extent relating to such other party, and any of its respective affiliates and its and their respective directors, officers, partners and shareholders, which appears in any filing made with, or written materials submitted to, any Governmental Entity
(and to the extent practicable, each will consult with the other party relating to the exchange of such information) and (ii)&nbsp;consult with the other in advance of any substantive meeting or conference with any Governmental Entity that is
reasonably likely to relate to or affect Purchaser or its investment in the Company in connection with the transactions contemplated by this Agreement. In exercising the foregoing right, each party agrees to act reasonably and as promptly as
reasonably practicable. To the extent permitted by Law, each party hereto agrees to keep the other party reasonably apprised of the status of matters referred to in this <U>Section</U><U></U><U>&nbsp;3.1(b)</U>. Purchaser and the Company shall
promptly correct or supplement any information provided by it or on its behalf for use in any filing made with, or written materials submitted to, any third party or any Governmental Entity in connection with the transactions to which it will be
party as contemplated hereby, if and to the extent (A)&nbsp;that information previously provided by it or on its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
behalf shall have become false or misleading in any material respect or (B)&nbsp;necessary or advisable to ensure that such document would not contain any untrue statement of a material fact or
omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading. Materials furnished pursuant to this
<U>Section</U><U></U><U>&nbsp;3.1(b)</U> may be redacted (1)&nbsp;to remove references concerning the valuation of the Company and the transactions contemplated hereby, including the Investment, or other Confidential Information, (2)&nbsp;as
necessary to comply with contractual arrangements and (3)&nbsp;as necessary to address reasonable privilege concerns, and the parties may reasonably designate any competitively sensitive or any confidential business material provided to the other
under this <U>Section</U><U></U><U>&nbsp;3.1(b)</U> as &#147;counsel only&#148; or, as appropriate, as &#147;outside counsel only&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) The Company shall as promptly as reasonably practicable, duly call, give notice of, establish a record date for, convene and hold a
stockholders&#146; meeting (whether annual or special) (the &#147;<U>Stockholders&#146; Meeting</U>&#148;), for the purpose of, among other matters, obtaining the requisite approval (i)&nbsp;of the Company&#146;s stockholders to adopt an amendment
to the Company Certificate of Incorporation to (A)&nbsp;increase the number of authorized shares of Common Stock therein to at least 1,700,000,000 and (B)&nbsp;amend Article Fourth, Section C, Clauses 1 and 4 of the Company Certificate of
Incorporation in a manner to exempt Purchaser and its affiliates from the application of Article Fourth, Section C, Clauses 1 and 4 of the Company Certificate of Incorporation (each, a &#147;<U>Charter Amendment</U>&#148;), (ii) to the extent
required, under the applicable rules of the NYSE (the &#147;<U>Exchange Approval</U>&#148;) for issuances of shares of Common Stock in excess of 19.9% of the total voting power of the Company&#146;s securities immediately preceding the entry into
this Agreement ((i) and (ii)&nbsp;collectively, the &#147;<U>Requisite Stockholder Vote</U>&#148;) and (iii)&nbsp;of a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-3</FONT></FONT> reverse stock split of the Company&#146;s
Common Stock. To the extent reasonably practicable, the Company will file the preliminary proxy for any such meeting no later than April&nbsp;2, 2024. The Company shall promptly respond to any comments received from the SEC on the proxy statement
and will use reasonable best effort to have the Stockholders&#146; Meeting no later than May&nbsp;17, 2024. The Company shall (A)&nbsp;through its Board of Directors recommend to its stockholders the approval and adoption of the Charter Amendment,
the Exchange Approval and the reverse stock split referenced in clause (iii)&nbsp;above (the &#147;<U>Company Recommendations</U>&#148;), (B) include such Company Recommendations in the proxy statement delivered to its stockholders in connection
with the Requisite Stockholder Vote and (C)&nbsp;use its reasonable best efforts to obtain the Requisite Stockholder Vote. Neither the Board of Directors nor any committee thereof shall withdraw, qualify or modify, or propose publicly to withdraw,
qualify or modify, in a manner adverse to Purchaser, the Company Recommendations or take any action, or make any public statement, filing or release inconsistent with the Company Recommendations. The Company shall adjourn or postpone the
Stockholders&#146; Meeting, if, as of the time for which such meeting is originally scheduled there are insufficient shares of Common Stock represented (either in person or by proxy) to constitute a quorum necessary to conduct the business of such
meeting. The Company shall also adjourn or postpone the Stockholders&#146; Meeting, if on the date of the Stockholders&#146; Meeting the Company has not received proxies representing a sufficient number of shares of Common Stock necessary to obtain
the Requisite Stockholder Vote and, following such adjournment or postponement, the Company shall solicit proxies representing a sufficient number of shares of Common Stock necessary to obtain the Requisite Stockholder Vote. Following the first of
either such adjournment or postponement, if requested by Purchaser, the Company shall retain a proxy solicitor reasonably acceptable to, and on terms reasonably acceptable to, Purchaser in connection with obtaining the Requisite Stockholder Vote.
After obtaining the Requisite Stockholder Vote, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company shall as promptly as reasonably practical, file the Charter Amendment with the Delaware Secretary of State, as required by applicable Law, and provide Purchaser a certificate from the
Delaware Secretary of State evidencing that the Charter Amendment is in full force and effect within five (5)&nbsp;business days after the date of the Stockholders&#146; Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) To the extent permitted by applicable Law, the parties shall promptly advise each other upon receiving any communication from any
Governmental Entity whose consent, waiver, approval or authorization is required for consummation of the transactions contemplated by this Agreement that causes such party to believe that there is a reasonable likelihood that any such required
approval, consent or authorization will not be obtained or that the receipt of such approval, consent or authorization will be materially delayed or conditioned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) Each party shall execute and deliver after the Closing, such further certificates, agreements, instruments and other documents and take
such other actions as the other party may reasonably request, in each case, to consummate, implement or evidence the Investment or the Charter Amendment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)
Following the Closing, and after the HSR Clearance, upon the written request delivered by Purchaser to the Company or by the Company to Purchaser, Purchaser and the Company shall cooperate in good faith with each other and use their respective
reasonable best efforts to provide for Purchaser, as promptly as practicable, to exchange all or a portion of Purchaser&#146;s shares of Series B Preferred Stock for (A)&nbsp;in the event that the Requisite Stockholder Vote has been obtained, shares
of Common Stock or (B)&nbsp;in the event that the Requisite Stockholder Vote has not been obtained, shares of Series C Preferred Stock; <U>provided</U> that any such exchange, and the Company&#146;s obligations to effect such exchange under this
<U>Section</U><U></U><U>&nbsp;3.1(f)(i)</U> shall be subject to receipt of any required permit, authorization, consent, Order or approval from any Governmental Entity in connection with any such exchange. The Purchaser agrees that it shall not
convert or exchange, as applicable, any shares of Series B Preferred Stock or Series C Preferred Stock into any shares of Common Stock prior to the receipt of the Requisite Stockholder Vote. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Notwithstanding the foregoing, if, as a result of, or pursuant to, the provisions of
<U>Section</U><U></U><U>&nbsp;3.1(f)(i)</U>, Purchaser will acquire, or be deemed by the Federal Reserve or any other banking regulator having jurisdiction over the Company or Company Bank to be acquiring, ten percent (10%) or more of a class of
voting securities of the Company, then, notwithstanding <U>Section</U><U></U><U>&nbsp;4.3</U> or anything herein to the contrary, each of Purchaser and the Company, shall use (and cause its affiliates to use) its and their reasonable best efforts to
obtain any additional approval, consent or <FONT STYLE="white-space:nowrap">non-objection</FONT> of the Federal Reserve or any other Governmental Entity (including pursuant to the Change in Bank Control Act of 1978) required in connection with the
acquisition or control of 10% or more of a class of voting securities of the Company (the &#147;<U>Voting Regulatory Approvals</U>&#148;), including by furnishing to the Federal Reserve or other applicable Governmental Entity such information as is
usual and customary in connection with such applications by similarly situated investors or issuers, as applicable, but subject to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
limitations set forth in <U>Section</U><U></U><U>&nbsp;4.3</U>; <U>provided</U>, however, that this <U>Section</U><U></U><U>&nbsp;3.1(f)(ii)</U> shall not require Purchaser or the Company to take
any action, or commit to take or refrain from taking any action, or accept or agree to any condition or restriction, in connection with obtaining the Voting Regulatory Approvals that would or would be reasonably be expected to be a Materially
Burdensome Condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) The Company and Purchaser shall use reasonable best efforts to agree upon the Permanent Warrant, which shall
contain the terms and conditions described on <U>Exhibit C</U> and other customary terms and conditions as may be reasonably required to give full effect to such terms and conditions prior to the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) If the Requisite Stockholder Vote is not obtained by the date that is the one hundred and eightieth (180<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP>) day after the Closing Date, the Company shall promptly thereafter issue to Purchaser warrants on the terms described on <U>Exhibit E</U> and, in such circumstance, the Company and Purchaser shall
use reasonable best efforts to, as promptly as reasonably practicable, agree upon a form of warrant on the terms described on <U>Exhibit&nbsp;E</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2 <U>Information Rights</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Following the Closing, so long as Purchaser, together with its affiliates, continues to beneficially own (A)&nbsp;in the aggregate at
least the lesser of (i) 2.5% of the outstanding shares of Common Stock (on an <FONT STYLE="white-space:nowrap">As-Converted</FONT> Basis) and (ii) 25% of the Common Stock (on an <FONT STYLE="white-space:nowrap">As-Converted</FONT> Basis) that
Purchaser beneficially owns immediately following the Closing or (B)&nbsp;any shares of Preferred Stock (the &#147;<U>Information Rights Period</U>&#148;), solely for Permitted Purposes, at Purchaser&#146;s sole cost and expense, the Company shall,
and shall cause each of its Subsidiaries to, afford Purchaser and its officers, employees, accountants, counsel and other Representatives reasonable access upon prior written notice and during normal business hours and in such manner as not to
interfere unreasonably with the conduct of the business of the Company and its Subsidiaries to the (x)&nbsp;officers, employees, properties, offices and other facilities of the Company and its Subsidiaries, and (y)&nbsp;contracts, licenses, books
and records and other documents relating to the business of the Company and its Subsidiaries. As used herein, &#147;<U><FONT STYLE="white-space:nowrap">As-Converted</FONT> Basis</U>&#148; means, at any time, the applicable number of shares of Common
Stock issued and outstanding, counting as shares of Common Stock issued and outstanding, without duplication, all shares of Common Stock (I)&nbsp;issued and outstanding, (II)&nbsp;into which shares of Preferred Stock issued and outstanding are
convertible and (III)&nbsp;into which shares of preferred stock of the Company that are issued and outstanding are convertible or exchangeable, as adjusted from time to time for any reorganization, recapitalization, reclassification, stock dividend,
stock split, reverse stock split or other like changes in the Company&#146;s capitalization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing, neither
the Company nor its Subsidiaries shall be obligated to provide such access, materials or information to the extent the Company determines, in its reasonable judgment, that doing so would reasonably be expected to (i)&nbsp;violate or prejudice the
rights of its clients, depositors or customers, (ii)&nbsp;result in the disclosure of trade secrets or competitively sensitive information in a manner detrimental to the Company or any of its Subsidiaries, (iii)&nbsp;violate any Law or agreement or
obligation of confidentiality owing to a third party (including any Governmental Entity), (iv) jeopardize the protection of an attorney-client privilege, attorney work product protection or other legal privilege or (v)&nbsp;be adverse to the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
interests of the Company or any of its Subsidiaries in any pending or threatened claim, action, suit, litigation, investigation, examination or proceeding asserted by Purchaser; <U>provided</U>,
<U>however</U>, that the Company shall use reasonable best efforts to make other arrangements (including using reasonable best efforts to redact information or make substitute disclosure arrangements) that would enable disclosure to Purchaser to
occur without, in the case of the (A)&nbsp;foregoing <U>clause (i)</U>, violating or prejudicing such right; (B)&nbsp;foregoing <U>clause (ii)</U>, disclosing such trade secrets or competitively sensitive information in a manner detrimental to the
Company or any of its Subsidiaries; (C)&nbsp;foregoing <U>clause (iii)</U>, violating such Law or agreement or obligation; (D)&nbsp;foregoing <U>clause (iv)</U>, jeopardizing such privilege; and (E)&nbsp;foregoing <U>clause (v)</U>, such adverse
consequences. The foregoing shall not limit the right of the Board Representative to participate in any meeting of the Board of Directors or receive any information that is otherwise made available to the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3 <U>Confidentiality</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Each of Purchaser and the Company shall (and shall cause its affiliates and its and its affiliates&#146; respective officers, directors,
employees, agents, advisors and representatives (collectively, &#147;<U>Representatives</U>&#148;) to) hold all information furnished by or on behalf of the other party or its affiliates or their respective Representatives in confidence to the
extent required by, and in accordance with, the provisions of the <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement, dated March&nbsp;3, 2024, by and between Reverence Capital Partners, L.P. and the Company (the
&#147;<U>Confidentiality Agreement</U>&#148;). Notwithstanding the foregoing, the provisions of <U>Section</U><U></U><U>&nbsp;3.3(b)</U> will supersede any conflicting provision in the Confidentiality Agreement (but
<FONT STYLE="white-space:nowrap">non-conflicting</FONT> provisions will otherwise continue in full force and effect in accordance with their respective terms). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) In addition to Purchaser&#146;s obligations under the Confidentiality Agreement, from the Closing until two (2)&nbsp;years after the last
date of the Director Rights Period, Purchaser shall (and shall cause its affiliates and its and its affiliates&#146; respective Representatives to)&nbsp;(i) keep confidential any information (including oral, written, electronic or other information)
concerning the Company or its affiliates that has been, will be or may be furnished to Purchaser, its affiliates or their respective Representatives by or on behalf of the Company (or its affiliates) or any of its or their respective Representatives
pursuant hereto or in connection with Purchaser&#146;s (or its affiliates&#146;) investment or potential investment in the Company (collectively, the &#147;<U>Confidential Information</U>&#148;) and (ii)&nbsp;use Confidential Information solely for
a Permitted Purpose; <U>provided</U> that notwithstanding the foregoing or anything to the contrary herein or in the Confidentiality Agreement, Purchaser (and its affiliates and its and its affiliates&#146; respective Representatives) shall be free
to use (x)&nbsp;for any purpose any information in intangible form, retained in the unaided memory of such persons, relating to or resulting from access to Confidential Information and (y)&nbsp;any generalized learnings from evaluating, monitoring
and administering Purchaser&#146;s (or its affiliates&#146;) investment in the Company, which do not constitute tangible Confidential Information furnished by or on behalf of the Company (or its affiliates) or any of its or their respective
Representatives, for purposes of evaluating or modifying their business strategies); <U>provided</U> that the Confidential Information shall not include information that (A)&nbsp;was or becomes generally available to the public, other than as a
result of a disclosure by Purchaser, its affiliates or their respective Representatives in violation of this <U>Section</U><U></U><U>&nbsp;3.3(b)</U>, the Confidentiality Agreement, (B)&nbsp;was or becomes available to Purchaser, its affiliates or
their respective Representatives on a <FONT STYLE="white-space:nowrap">non-confidential</FONT> basis from a source (other than the Company, its affiliates </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or any of their respective Representatives), so long as such source was not, to Purchaser&#146;s, its affiliates&#146; or their respective Representatives&#146; (as applicable) knowledge, subject
to any obligation to the Company or its Subsidiaries to keep such information confidential, (C)&nbsp;at the time of disclosure is already in the possession of Purchaser, its affiliates or their respective Representatives, so long as such information
is not, to Purchaser&#146;s, its affiliates&#146; or their respective Representatives&#146; (as applicable) knowledge, subject to any obligation to the Company or its Subsidiaries to keep such information confidential, or (D)&nbsp;was independently
developed by Purchaser, its affiliates or its or their respective Representatives without reference to, incorporation of, reliance on or other use of any Confidential Information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Each of the Company and Purchaser agree, on behalf of themselves, their affiliates and its and their respective Representatives, that
Confidential Information may be disclosed by Purchaser and its affiliates solely (i)&nbsp;to Purchaser&#146;s affiliates and its and their respective Representatives to the extent required for the purposes of evaluating, monitoring, administering or
taking any other action with respect to Purchaser&#146;s (or its affiliates&#146;) investment in the Company (including pursuing any sale or disposition of all or part of its investment in the Company), complying with Purchaser&#146;s (or its
affiliates&#146;) legal, regulatory, tax or other compliance obligations, or ensuring compliance with the terms of, enforcing, defending or understanding any right or obligation in respect of this Agreement, the Company Certificate of Incorporation,
the Certificate of Designations, the Company Bylaws or any other agreement or instrument relating to the Company (each, a &#147;<U>Permitted Purpose</U>&#148;); <U>provided</U> that Purchaser direct such persons (or, in the case of its controlled
affiliates, cause such persons) to treat the Confidential Information in a confidential manner and in accordance with the terms herein, (ii)&nbsp;to any transferees; <U>provided</U>, that such transferee has entered into a confidentiality agreement
pursuant to which such transferee agrees to treat the Confidential Information in a confidential manner and in accordance with the terms herein and pursuant to which Purchaser or one of its affiliates agrees to be responsible for any breach by such
transferee in accordance with the terms of the confidentiality agreement, and (iii)&nbsp;in the event that Purchaser, any of its affiliates or any of its or their respective Representatives are required by Law or requested or required by any
Governmental Entity (including by deposition, interrogatory, request for documents, subpoena, civil investigative demand or similar process) to disclose any Confidential Information, in each case, so long as Purchaser, its affiliates and its and
their respective Representatives (as applicable), to the extent reasonably practicable and permitted by Law, (A)&nbsp;promptly provide notice thereof to the Company, (B)&nbsp;reasonably cooperate with the Company (at the Company&#146;s sole expense)
to resist or narrow such request or requirement, including in seeking a protective order or other appropriate remedy, prior to any such disclosure and (C)&nbsp;limit such disclosure to that which is then so required or requested and use reasonable
efforts to obtain assurances that confidential treatment will be accorded to such disclosed Confidential Information; <U>provided</U>, that, for the avoidance of doubt, the foregoing clauses (A), (B) and (C)&nbsp;shall not apply to disclosure
requests or requirements of a Governmental Entity which are not specifically targeted at this Agreement, the parties hereto or the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4 <U>Public Announcement</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The initial press release with respect to the transactions contemplated hereby shall be issued by the Company; <U>provided</U> that the
Company shall (i)&nbsp;not issue such press release without prior consultation with and written approval of Purchaser and (ii)&nbsp;give Purchaser the right to review and comment on such press release and (B)&nbsp;consider any such comments in good
faith, in each case, in advance of such issuance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Thereafter, (i)&nbsp;the Company shall not (and shall cause its affiliates and its and
their respective Representatives not to) make any public release, statement or announcement in respect of this Agreement or the proposed or actual investment in the Company by Purchaser contemplated hereunder and (ii)&nbsp;Purchaser shall not (and
shall cause its affiliates and its and their respective Representatives not to) make any public release, statement or announcement in respect of this Agreement, the proposed or actual investment in the Company by Purchaser contemplated hereunder or
the transactions contemplated hereby, in each case, except (A)&nbsp;as required by Law, in which case, to the extent permitted by Law and practicable under the circumstances, the party required to make such release, statement or announcement shall
consult with the other party about, and allow the other party reasonable time to comment on (and shall consider such comments in good faith), such release, statement or announcement in advance of such issuance, (B)&nbsp;communications by the Company
to its stockholders and employees that are reasonably necessary or advisable in connection with the Investment, or the issuance of Common Stock and/or Preferred Stock pursuant to any Other Investment Agreement, (C)&nbsp;with the prior written
consent of the other party (which consent shall not be unreasonably withheld, conditioned or delayed), or (D)&nbsp;for such releases, statements or announcements that are consistent with other such releases, statements or announcements made on or
after the entry into this Agreement in compliance with this <U>Section</U><U></U><U>&nbsp;3.4</U>. Notwithstanding anything in the foregoing, Purchaser and each of its affiliates may provide customary disclosure of the status and subject matter of
this Agreement and transactions contemplated hereby to their respective limited partners and investors, subject to customary confidentiality undertakings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5 <U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period Conduct</U>. Prior to the earlier of the Closing or the
termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;4.12</U>, except (i)&nbsp;as may be required by Law applicable to the Company or any of its Subsidiaries, (ii)&nbsp;with the prior written consent of Purchaser (such consent not
to be unreasonably withheld, conditioned or delayed) or (iii)&nbsp;as may be expressly contemplated or required by this Agreement (including as set forth in the Company Disclosure Schedule), the Company shall use commercially reasonable efforts to
carry on its business in the ordinary course of business in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6 <U>Material Contracts</U>. Between
the date hereof and the Closing, the Company and its Subsidiaries will not enter into or amend any contract that would be a material contract under SEC rules or would require disclosure on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> without
the consent of Purchaser, not to be unreasonably withheld. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7 <U>Material Change</U>. Between the date hereof and the
Closing, the Company shall promptly notify Purchaser in writing of (i)&nbsp;any action, arbitration, audit, hearing, investigation, litigation, suit, subpoena or summons issued, commenced, brought, conducted or heard by or before, or otherwise
involving, any Governmental Entity or arbitrator pending or, to the knowledge of the Company threatened against the Company or any of its Subsidiaries that (A)&nbsp;questions or would reasonably be expected to question the validity of this Agreement
or the other agreements contemplated hereby or thereby or any actions taken or to be taken by the Company, or its Subsidiaries with respect hereto or thereto, or (B)&nbsp;seeks to enjoin or otherwise restrain the transactions contemplated hereby or
thereby or (ii)&nbsp;any fact, change, event or circumstance known </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to it that has had or would reasonably be likely to have a Material Adverse Effect or which it believes would or would be reasonably likely to cause or constitute a material breach of any of its
representations, warranties or covenants contained herein or that reasonably could be expected to give rise, individually or in the aggregate, to the failure of a condition in <U>ARTICLE</U><U></U><U>&nbsp;II</U>. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;IV </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ADDITIONAL AGREEMENTS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1 <U>Governance Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Subject to the receipt of any applicable requirement to obtain prior approval, consent or nonobjection of any Governmental Entity (the
&#147;<U>Board <FONT STYLE="white-space:nowrap">Non-Objections</FONT></U>&#148;), the Company shall, as promptly as reasonably practicable, cause one (1)&nbsp;person nominated by Purchaser (the &#147;<U>Board Representative</U>&#148;) to be
appointed to the Board of Directors; <U>provided</U> that the Board Representative must satisfy the Company&#146;s customary onboarding process and any applicable corporate governance or regulatory requirements under SEC rules and regulations, the
rules of the NYSE or similar authority, or any federal or state banking Laws and comply with the Company&#146;s policies and procedures applicable to all directors or committee members, as applicable. No individual shall be eligible to be the Board
Representative if he or she has been involved in any of the events enumerated under Item 2(d) of Schedule 13D under the Exchange Act or Item 401(f) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act or is subject to
any Order that is then in effect and prohibits service as a director of any U.S. public company or a bank holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Following
the Closing, so long as Purchaser, together with its affiliates, continues to beneficially own in the aggregate at least the lesser of (i) 2.5% of the outstanding shares of Common Stock (on an <FONT STYLE="white-space:nowrap">As-Converted</FONT>
Basis) and (ii) 25% of the Common Stock (on an <FONT STYLE="white-space:nowrap">As-Converted</FONT> Basis) that Purchaser beneficially owns immediately following the Closing (the &#147;<U>Director Rights Period</U>&#148;), (A) the Company shall
(I)&nbsp;include the Board Representative in the Company&#146;s slate of director nominees and recommend to its stockholders that its stockholders vote in favor of electing the Board Representative to the Board of Directors at the Company&#146;s
annual meeting of stockholders at which the Board Representative&#146;s term expires and (II)&nbsp;at the annual meeting of the Company&#146;s stockholders for the year in which the Board Representative&#146;s term expires, use reasonable best
efforts to have the Board Representative elected as a director of the Company, including that the Company shall solicit proxies for each such person to the same extent as it does for any other nominee of the Board of Directors to the Board of
Directors and (B)&nbsp;upon the death, resignation, retirement, disqualification or removal from office of the Board Representative prior to the end of the Board Representative&#146;s term, (I)&nbsp;Purchaser shall have the power to designate the
Board Representative&#146;s replacement and (II)&nbsp;the Board of Directors shall fill the vacancy resulting therefrom with Purchaser&#146;s designated replacement Board Representative as promptly as practicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Immediately following the Director Rights Period, Purchaser will have no further rights under <U>Section</U><U></U><U>&nbsp;4.1(a)</U>
through <U>Section</U><U></U><U>&nbsp;4.1(b)</U> and, at the written request of the Board of Directors, shall cause the Board Representative to resign from the Board of Directors as promptly as reasonably practicable thereafter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) The Board Representative shall be entitled to the same compensation, expense
reimbursement, exculpation and indemnification from the Company as the other independent directors serving on the Board of Directors (and, with respect to indemnification, the Company&#146;s obligations shall apply prior to any other indemnification
to which the Board Representative may be entitled) and (ii)&nbsp;receive the same coverage under D&amp;O insurance policies maintained by the Company as the other directors serving on the Board of Directors for the duration of the Director Rights
Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) Subject to the Board <FONT STYLE="white-space:nowrap">Non-Objections,</FONT> the Board Representative shall also be elected
to the board of directors of Company Bank. The Board Representative shall serve on the Company Bank board of directors for so long as they sit on the Board of Directors. In addition, all other rights the Board Representative is provided in his or
her capacity as such, including those provided in this <U>Section</U><U></U><U>&nbsp;4.1</U>, shall also apply to his or her service on the Company Bank board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) The Company shall notify the Board Representative of all (i)&nbsp;regular and special meetings of the Board of Directors. The Company
shall provide the Board Representative with copies of all notices, minutes, consents and other materials provided to all other members of both the Board of Directors and the board of directors of Company Bank concurrently as such materials are
provided to the other members (the &#147;<U>Board Materials</U>&#148;). Other than confidential supervisory information, as described in <U>Section</U><U></U><U>&nbsp;5.13</U>, the Board Representative shall have the right to share all <FONT
STYLE="white-space:nowrap">non-privileged</FONT> Board Materials with Purchaser for Permitted Purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) Notwithstanding anything
herein to the contrary, no Board Representative shall be entitled to participate in, or be entitled to receive the notice or materials referred to in the foregoing <U>Section</U><U></U><U>&nbsp;4.1(f)</U> with respect to, any meeting of the Board of
Directors (or any portion thereof) with respect to which he or she is reasonably likely to have a conflict of interest (as reasonably determined in good faith by the other members of the Board of Directors in their sole discretion) with respect to
the subject matter of such meeting or any portion of such meeting, including any matter related to the discussion, evaluation or vote upon a matter in which Purchaser (or any of its affiliates) has a business or financial interest (other than solely
by reason of its interest as a stockholder of the Company); <U>provided</U>, <U>however</U>, that the Company shall use commercially reasonable efforts to make other arrangements (including segmenting portions of meetings, redacting information or
making substitute disclosure arrangements) that would enable participation in such meetings by, and disclosure of information and materials to, the Board Representative without the Board Representative learning information about the matter(s) giving
rise to such conflict of interest. The Company shall not treat the Board Representative differently with respect to conflicts of interest relative to how the Company treats other members of the Board of Directors with respect to conflicts of
interest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2 <U>Legend</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Purchaser agrees that all certificates or other instruments representing the Securities issued pursuant hereto will bear a legend
substantially to the following effect: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) THIS SECURITY HAS BEEN ACQUIRED FOR INVESTMENT AND WITHOUT A VIEW TO
DISTRIBUTION AND HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE &#147;ACT&#148;), OR UNDER STATE SECURITIES LAWS. NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THIS SECURITY OR ANY INTEREST OR
PARTICIPATION THEREIN MAY BE MADE EXCEPT (A)&nbsp;PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR (B)&nbsp;PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS AND, IN THE CASE OF CLAUSE (B),
UNLESS THE COMPANY RECEIVES AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Any transferee of any Securities or any interest therein (other than a transferee who receives such securities in a transaction pursuant
to an effective registration statement under the Securities Act or in a transaction exempt from registration pursuant to Rule 144), by its acceptance thereof, shall be deemed to have made the representations set forth in
<U>Section</U><U></U><U>&nbsp;2.3</U> of this Agreement. The Company shall not be required to register the transfer of any Securities to any person unless the Company receives from the proposed transferee a written instrument in form and substance
reasonably satisfactory to the Company in which such transferee makes the representations and warranties set forth in <U>Section</U><U></U><U>&nbsp;2.3</U> and, if the Company so reasonably requests, an opinion of counsel in form and substance
reasonably satisfactory to the Company to the effect that registration under the Securities Act is not required in connection with such transfer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) The Company shall promptly cause the legend to be removed from any certificate for any Securities held by Purchaser or any of its
affiliates and the Company shall deliver all necessary documents to the transfer agent in connection therewith without charge as to any Securities (i)&nbsp;upon request of Purchaser, upon receipt by the Company of an opinion of counsel reasonably
satisfactory to the Company to the effect that such legend is no longer required under the Securities Act and applicable state Laws or (ii)&nbsp;when such Securities shall have been registered under the Securities Act or may otherwise be transferred
pursuant to any applicable rules thereunder, including eligibility to be transferred if Rule 144 under the Securities Act is available for the sale of the Securities without volume and manner of sale restrictions and the Company shall use reasonable
best efforts to deliver all necessary documents to the transfer agent in connection therewith without charge as to any Securities, including the delivery of an opinion of counsel that such legend is no longer required under the Securities Act and
applicable state Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3 <U>No Materially Burdensome Condition</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding anything to the contrary herein, Purchaser shall not be required to take any action, or commit to take or refrain from
taking any action, or accept or agree to any condition or restriction, in each case, that would reasonably be expected to cause Purchaser, its affiliates or any of their partners or principals to (i) &#147;control&#148; the Company or be required to
become a bank holding company, in each case, pursuant to the BHC Act; (ii)&nbsp;serve as a source of financial strength to the Company pursuant to the BHC Act or (iii)&nbsp;enter into any capital or liquidity maintenance agreement or any similar
agreement with any Governmental Entity, provide capital support to the Company or any of its Subsidiaries or otherwise commit to or contribute any additional capital to, provide other funds to, or make any other investment in, the Company or any of
its Subsidiaries (each of <U>clauses (i)</U>&nbsp;through <U>(iii)</U>, a &#147;<U>Materially Burdensome Condition</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) In
the event either party believes that the imposition of a Materially Burdensome Condition is reasonably likely to occur, it shall promptly notify the other party and both parties shall cooperate in good faith to consider, to the extent commercially
reasonable, such modifications or arrangements as may be necessary or advisable to avoid imposition of the Materially Burdensome Condition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4 <U>Reservation for Issuance</U>. As promptly as practicable following the Closing, but no later than five (5)&nbsp;business
days, the Company shall take all action to reserve up to 800,000,000 shares of Common Stock for issuance upon conversion of shares of (i)&nbsp;Preferred Stock issuable pursuant to this Agreement and
<FONT STYLE="white-space:nowrap">(ii)&nbsp;non-voting,</FONT> common equivalent preferred stock for which the Permanent Warrant may be exercised, in each case, (w)&nbsp;in accordance with the terms of this Agreement, the Certificate of Designations
and the Permanent Warrant (as applicable) and (x)&nbsp;excluding any adjustments applicable thereto. Promptly following the Company&#146;s receipt of the Requisite Stockholder Vote and the filing of the Charter Amendment with the Delaware Secretary
of State, the Company shall reserve that number of additional shares of Common Stock sufficient for issuance of shares of (A)&nbsp;Common Stock upon the Conversions and <FONT STYLE="white-space:nowrap">(B)&nbsp;non-voting,</FONT> common equivalent
preferred stock for which the Permanent Warrant may be exercised, in each case, (y)&nbsp;in accordance with the terms of this Agreement, the Certificate of Designations and the Permanent Warrant (as applicable) and (z)&nbsp;excluding any adjustments
applicable thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5 <U>Indemnity</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Following the Closing, the Company shall indemnify, defend and hold harmless Purchaser and its affiliates, to the fullest extent
permitted by Law, from and against any and all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs, losses, liabilities, damages, payments, fees, expenses (including reasonable attorneys&#146; fees and
disbursements) and amounts paid in settlement (collectively, &#147;<U>Losses</U>&#148;; <U>provided</U>, <U>however</U>, that &#147;Losses&#148; do not include, (x)&nbsp;except to the extent awarded in a Third Party Claim, punitive, exemplary,
consequential or special damages or (y)&nbsp;lost profits, opportunity costs or damages based upon a multiple of earnings, revenues or similar financial measure (even if under Law such lost profits, opportunity costs or damages based upon a multiple
of earnings, revenues or similar financial measure would be considered reasonably foreseeable or not special damages) if such Loss directly results from (i)&nbsp;any inaccuracy in or breach of any of the Company&#146;s representations or warranties
in <U>Section</U><U></U><U>&nbsp;2.2</U> or (ii)&nbsp;the Company&#146;s breach of any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
agreements or covenants made by the Company herein (except, in the case of this clause (ii), as set forth in <U>Section</U><U></U><U>&nbsp;4.5(a)</U> of the Company Disclosure Schedule).
Notwithstanding the foregoing, the Company shall have no obligation under this <U>Section</U><U></U><U>&nbsp;4.5(a)</U>&nbsp;(A) following the expiration of the applicable survival period set forth in <U>Section</U><U></U><U>&nbsp;4.5(o)</U> or
(B)&nbsp;in respect of any claim, action, suit, litigation, dispute or proceeding threatened or commenced against the Company and/or any Company Subsidiary and/or any of their respective directors, officers or employees (including if Purchaser or
any of its affiliates or its or their respective directors, officers, employees, shareholders or controlling persons are or are threatened to be made party thereto)&nbsp;(x) in connection with any Stockholder Litigation or actions expressly required
by, or taken with the prior written consent of Purchaser pursuant to, this Agreement or (y)&nbsp;that seeks to enjoin, restrain or prohibit the transactions contemplated by this Agreement or the Other Investment Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Following the Closing, Purchaser shall indemnify, defend and hold harmless each of the Company and its Subsidiaries, to the fullest
extent permitted by Law, from and against any and all Losses actually incurred by the Company or any of its Subsidiaries if such Loss directly results from (i)&nbsp;any inaccuracy in or breach of any of Purchaser&#146;s representations or warranties
in <U>Section</U><U></U><U>&nbsp;2.3</U> or (ii)&nbsp;Purchaser&#146;s breach of any agreements or covenants made by Purchaser herein. Notwithstanding the foregoing, Purchaser shall have no obligation under this
<U>Section</U><U></U><U>&nbsp;4.5(b)</U> following the expiration of the applicable survival period set forth in <U>Section</U><U></U><U>&nbsp;4.5(o)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) A party that may desire to seek indemnification hereunder (each, an &#147;<U>Indemnified Party</U>&#148;) shall give written notice to
the party indemnifying it (the &#147;<U>Indemnifying Party</U>&#148;) of any claim that does not result from a third party with respect to which it seeks indemnification (a &#147;<U>Direct Claim</U>&#148;) promptly (and, in any event, not later than
fifteen (15)&nbsp;business days) after the first discovery by such Indemnified Party of any fact, event, circumstance, development or matters giving rise to such claim. Such notice (a &#147;<U>Claim Notice</U>&#148;) shall (i)&nbsp;describe such
Direct Claim in reasonable detail (including the facts underlying each particular claim and an identification of all the particular sections of therein pursuant to which indemnification is and will be being sought); (ii) attach copies of any written
evidence or demand upon which such Direct Claim is based (to the extent that such written evidence or demand is not reasonably available at such time, the Indemnified Party shall so indicate and promptly provide such evidence when it becomes
available); and (iii)&nbsp;set forth the estimated amount (broken down by each individual claim) for which the Indemnifying Party may be liable, to the extent then known. The Indemnifying Party shall have thirty (30)&nbsp;days after its receipt of
such notice to respond in writing to the Direct Claim (a &#147;<U>Response Notice</U>&#148;). If the Indemnifying Party does not deliver a Response Notice within such thirty <FONT STYLE="white-space:nowrap">(30)-day</FONT> period, the Indemnifying
Party shall be deemed to have agreed to such claim and the Indemnifying Party&#146;s obligation to indemnify, compensate or reimburse the Indemnified Party for the full amount of all Losses resulting therefrom. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) In case any such action, suit, claim or proceeding is threatened or commenced against an Indemnified Party by any person who is not a
party to this Agreement or an affiliate of any party to this Agreement, with respect to which the Indemnifying Party is or may be obligated to provide indemnification under <U>Section</U><U></U><U>&nbsp;4.5(a)</U> or
<U>Section</U><U></U><U>&nbsp;4.5(b)</U> (as applicable) (a &#147;<U>Third Party Claim</U>&#148;), the Indemnified Party shall, as promptly as reasonably practicable, cause a Claim Notice regarding any Third Party Claim of which it has knowledge
that is covered by this <U>Section</U><U></U><U>&nbsp;4.5</U> to be delivered to the Indemnifying Party. The Claim Notice shall (i)&nbsp;describe such Third Party Claim in reasonable detail (including the identity of the applicable third party, the
facts </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
underlying each particular claim and an identification of all the particular sections of therein pursuant to which indemnification is and will be being sought); (ii) attach copies of any written
evidence or demand upon which such Third Party Claim is based (to the extent that such written evidence or demand is not reasonably available at such time, the Indemnified Party shall so indicate and promptly provide such evidence when it becomes
available); and (iii)&nbsp;set forth the estimated amount (broken down by each individual claim) for which the Indemnifying Party may be liable, to the extent then known. The Indemnifying Party shall have the right but not the obligation to assume
control of the defense of any Third Party Claim by, no later than the thirtieth (30<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) day after its receipt of such Claim Notice, notifying the Indemnified Party that, subject to the other
provisions of this <U>Section</U><U></U><U>&nbsp;4.5</U>, the Indemnifying Party has elected to conduct and control the defense, negotiation or settlement of the applicable Third Party Claim and any action, suit, claim or proceeding resulting
therefrom with counsel reasonably acceptable to the Indemnified Party and at the Indemnifying Party&#146;s sole cost and expense. If the Indemnifying Party elects to assume the defense of a Third Party Claim, the Indemnified Party will have the
right, but not the obligation, to participate in any such defense and to employ separate counsel of its choosing at its own expense; <U>provided</U> that if the Indemnified Party is advised by outside counsel that an actual conflict of interest
(other than one of a monetary nature) would make it inappropriate for the same counsel to represent both the Indemnifying Party and the Indemnified Party with respect to the Third Party Claim, then the Indemnifying Party shall pay the reasonable, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> and documented fees, costs and expenses of counsel employed by the Indemnified Party; <U>provided</U>, <U>further</U>, that the Indemnifying Party shall only be
liable for the legal fees and expenses for one law firm for all Indemnified Parties (taken together with respect to any single action or group of related actions) in connection with any Third Party Claim (plus one local counsel in each applicable
jurisdiction). If the Indemnifying Party does not assume the defense of the Third Party Claim within the thirty <FONT STYLE="white-space:nowrap">(30)-day</FONT> period referenced in this <U>Section</U><U></U><U>&nbsp;4.5</U>, (x) the Indemnified
Party may defend against the Third Party Claim and (y)&nbsp;the Indemnifying Party will have the right, but not the obligation, to participate in any such defense and to employ separate counsel of its choosing at its own expense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding anything in this <U>Section</U><U></U><U>&nbsp;4.5</U> to the contrary, (i)&nbsp;the Indemnified Party shall not, without
the prior written consent of the Indemnifying Party, (x)&nbsp;consent to the entry of any Order, (y)&nbsp;settle or compromise or (z)&nbsp;enter into any settlement or similar agreement with respect to, any Third Party Claim, unless such Order or
proposed settlement or compromise or agreement (A)&nbsp;involves an unconditional release of the Indemnifying Party in respect of such Third Party Claim and (B)&nbsp;does not contain any admission or finding of wrongdoing on behalf of the
Indemnifying Party and (ii)&nbsp;the Indemnifying Party shall not, without the prior written consent of the Indemnified Party, (x)&nbsp;consent to the entry of any Order, (y)&nbsp;settle or compromise or (z)&nbsp;enter into any settlement or similar
agreement with respect to, any Third Party Claim, unless the Order or proposed settlement or compromise or agreement (A)&nbsp;involves only the payment of money damages against which the Indemnified Party is indemnified in full by the Indemnifying
Party, (B)&nbsp;does not impose an injunction or other equitable relief upon the Indemnified Party, (C)&nbsp;involves an unconditional release of the Indemnified Party in respect of such Third Party Claim and (D)&nbsp;does not involve a finding or
admission of any violation of Law or other wrongdoing by the Indemnified Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) The failure by an Indemnified Party to timely or
properly provide, pursuant to <U>Section</U><U></U><U>&nbsp;4.5(c)</U> or <U>Section</U><U></U><U>&nbsp;4.5(d)</U>, any Claim Notice to the Indemnifying Party shall not relieve the Indemnifying Party of its obligations hereunder, except to the
extent, and only to the extent that, the Indemnifying Party is actually and directly prejudiced by such failure. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) For purposes of the indemnity contained in <U>Section</U><U></U><U>&nbsp;4.5(a)(i)</U>
and <U>Section</U><U></U><U>&nbsp;4.5(b)(i)</U>, all qualifications and limitations set forth in such representations and warranties as to &#147;materiality,&#148; &#147;<U>Material Adverse Effect</U>&#148; and words of similar import (other than
<U>Section</U><U></U><U>&nbsp;2.2(f)(i)(B)</U>, <U>Section</U><U></U><U>&nbsp;2.2(f)(iii)(A)</U> and <U>Section</U><U></U><U>&nbsp;2.2(k)(iv)</U>), shall be disregarded in determining whether there shall have been any inaccuracy in or breach of any
representations and warranties in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) Except in the case of any inaccuracy or breach of any Company Fundamental Reps,
the Company shall not be required to indemnify the Indemnified Parties pursuant to <U>Section</U><U></U><U>&nbsp;4.5(a)(i)</U>, (i)&nbsp;with respect to any individual claim (or group of related claims) for indemnification if the amount of Losses
with respect to such individual claim (or group of related claims) is less than $100,000 (any individual claim (or group of related claims) involving Losses less than such amount being referred to as a &#147;<U>De Minimis Claim</U>&#148;) and
(ii)&nbsp;unless and until the aggregate amount of all Losses incurred with respect to all claims (other than De Minimis Claims) pursuant to <U>Section</U><U></U><U>&nbsp;4.5(a)(i)</U> exceeds an amount equal to 1.5% of the Investment Amount (such
amount, the &#147;<U>Threshold Amount</U>&#148;), in which event the Company shall be responsible for only the amount of such Losses in excess of the Threshold Amount, but subject to the last sentence of this
<U>Section</U><U></U><U>&nbsp;4.5(h)</U>. Except in the case of any inaccuracy or breach of any Purchaser Fundamental Reps, Purchaser shall not be required to indemnify the Indemnified Parties pursuant to <U>Section</U><U></U><U>&nbsp;4.5(b)(i)</U>,
(1)&nbsp;with respect to any De Minimis Claim and (2)&nbsp;unless and until the aggregate amount of all Losses incurred with respect to all claims (other than De Minimis Claims) pursuant to <U>Section</U><U></U><U>&nbsp;4.5(b)(i)</U> exceeds the
Threshold Amount, in which event Purchaser shall be responsible for only the amount of such Losses in excess of the Threshold Amount, but subject to the last sentence of this <U>Section</U><U></U><U>&nbsp;4.5(h)</U>. Except in the case of any
inaccuracy or breach of any Company Fundamental Reps or Purchaser Fundamental Reps, the cumulative indemnification obligation of (x)&nbsp;the Company under <U>Section</U><U></U><U>&nbsp;4.5(a)</U> shall in no event exceed 10% of the Investment
Amount and (y)&nbsp;Purchaser under <U>Section</U><U></U><U>&nbsp;4.5(b)</U> shall in no event exceed 10% of the Investment Amount. In the case of any inaccuracy or breach of any Company Fundamental Reps or Purchaser Fundamental Reps, the cumulative
indemnification obligation of (x)&nbsp;the Company under <U>Section</U><U></U><U>&nbsp;4.5(a)</U> shall in no event exceed the Investment Amount and (y)&nbsp;Purchaser under <U>Section</U><U></U><U>&nbsp;4.5(b)</U> shall in no event exceed the
Investment Amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Any claim for indemnification pursuant to <U>Section</U><U></U><U>&nbsp;4.5</U> can only be brought on or prior
to the eighteen (18)&nbsp;month anniversary of the Closing Date; <U>provided</U>, that (i)&nbsp;a claim for indemnification pursuant to <U>Section</U><U></U><U>&nbsp;4.5(a)(i)</U> in respect of an inaccuracy of any of the representations of the
Company set forth in <U>Section</U><U></U><U>&nbsp;2.2(a)(i)</U>, <U>Section</U><U></U><U>&nbsp;2.2(b)(i)</U>, <U>Section</U><U></U><U>&nbsp;2.2(b)(ii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(c)(i)</U>,
<U>Section</U><U></U><U>&nbsp;2.2(c)(ii)(A)</U>, <U>Section</U><U></U><U>&nbsp;2.2(c)(iii)</U>, <U>Section</U><U></U><U>&nbsp;2.2(g)</U> and <U>Section</U><U></U><U>&nbsp;2.2(u)</U> (each, a &#147;<U>Company Fundamental Rep</U>&#148;) or pursuant to
<U>Section</U><U></U><U>&nbsp;4.5(b)(i)</U> in respect of any of the representations of Purchaser set forth in <U>Section</U><U></U><U>&nbsp;2.3(a)</U>, <U>Section</U><U></U><U>&nbsp;2.3(b)(ii)</U> and <U>Section</U><U></U><U>&nbsp;2.3(m)</U> (each,
a &#147;<U>Purchaser Fundamental Rep</U>&#148;), in each case, can be brought on or prior to the third (3<SUP STYLE="font-size:75%; vertical-align:top">rd</SUP>) anniversary of the Closing Date and (ii)&nbsp;if a compliant notice of a valid claim
for indemnification pursuant to <U>Section</U><U></U><U>&nbsp;4.5(a)</U> or <U>Section</U><U></U><U>&nbsp;4.5(b)</U> is duly provided prior to the end of the applicable foregoing survival period with respect thereto, then the obligation to
indemnify, defend and hold harmless in respect of such inaccuracy or breach shall survive as to such claim until such claim has been finally resolved. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) Except for a claim of Fraud, the indemnity provided for in this
<U>Section</U><U></U><U>&nbsp;4.5</U> shall be the sole and exclusive monetary remedy of Indemnified Parties after the Closing for any inaccuracy in or breach of any representation or warranty or any breach of any covenant or agreement contained in
this Agreement to be performed at or prior to the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k) Where one and the same set of facts, circumstances or events qualifies
under more than one provision entitling an Indemnified Party to a claim or remedy hereunder, such Indemnified Party shall not be entitled to duplicative recovery of Losses arising out of such facts, circumstances or events. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(l) Each Indemnified Party shall use commercially reasonable efforts to mitigate any Loss upon and after obtaining knowledge of any event,
set of facts, circumstance or occurrence that would reasonably be expected to give rise to any Loss that would reasonably be expected to give rise to an indemnity obligation pursuant to this <U>Section</U><U></U><U>&nbsp;4.5</U>. In the event that
an Indemnified Party shall fail to use commercially reasonable efforts to mitigate any such Loss, then notwithstanding anything contained herein to the contrary, the Indemnifying Party shall not be required to indemnify any Indemnified Party for
that portion of any Losses that would reasonably be expected to have been avoided if all Indemnified Parties had made such efforts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(m)
If an Indemnified Party has or may have a right to recover any Loss against or from any third party (including any insurance company in its capacity as an insurer), such Indemnified Party shall use commercially reasonable efforts to seek recovery
against and from such third party and if the Indemnified Party recovers any such amount from such third party after the Indemnifying Party makes any payment pursuant to this <U>Section</U><U></U><U>&nbsp;4.5</U> in respect of such Loss, then the
Indemnified Party shall promptly remit to the Indemnifying Party the lesser of the amount previously paid by the Indemnifying Party to the Indemnified Party in respect of such Loss and the amount the Indemnified Party received from such third party
in respect of such Loss (net of all reasonable costs of collection). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(n) Any indemnification payments pursuant to this
<U>Section</U><U></U><U>&nbsp;4.5</U> shall be treated as an adjustment to the Investment Amount for the Securities for U.S. federal income and applicable state and local Tax purposes, except to the extent otherwise required by a
&#147;determination&#148; within the meaning of Section&nbsp;1313(a) of the Code (or any similar provision of state or local Law). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(o)
Each of the representations and warranties set forth herein shall survive the Closing under this Agreement for a period of eighteen (18)&nbsp;months following the Closing Date and, thereafter, except in the case of Fraud, shall expire and have no
force and effect, including in respect of this <U>Section</U><U></U><U>&nbsp;4.5</U>; <U>provided</U>, however, that the Company Fundamental Reps and the Purchaser Fundamental Reps shall survive the Closing under this agreement for a period of <FONT
STYLE="white-space:nowrap">thirty-six</FONT> (36)&nbsp;months following the Closing Date, in each case, subject to <U>Section</U><U></U><U>&nbsp;4.5(</U><I><U>i</U></I><U>)(ii)</U>. Except as otherwise provided herein, all covenants and agreements
contained herein, other than those which by their terms are to be performed in whole or in part after the Closing Date (which shall survive in accordance with their terms), shall survive the closing under this Agreement for a period of twelve
(12)&nbsp;months following the Closing Date (or until final resolution of any claim or action arising from the breach of such covenant if notice of such breach was provided prior to the end of such period). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6 <U>Exchange Listing</U>. Prior to and, if necessary, following the Closing,
the Company shall use reasonable best efforts to cause (a)&nbsp;the shares of Common Stock (i)&nbsp;issued hereunder and (ii)&nbsp;to be issued upon the Conversions, (b)&nbsp;the Permanent Warrants and (c)&nbsp;the warrants on the terms described on
<U>Exhibit E</U>, in each case, to be approved for listing on the NYSE, subject to official notice of issuance and upon receipt of the Requisite Stockholder Vote (if applicable). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7 <U>Certificate of Designations</U>. In connection with the Closing, the Company shall file the Certificate of Designations
with the Delaware Secretary of State. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8 <U>State Securities Laws</U>. The Company shall use commercially reasonable
efforts to obtain all necessary permits and qualifications, if any, or secure an exemption therefrom, required by any state or country pursuant to Laws prior to the offer and sale by Purchaser of Common Stock and/or the Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.9 <U>Company Opportunities</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Except as expressly provided in this Agreement, Purchaser and any related investment funds, the Board Representative, and any of their
respective affiliates, have the right to, and shall have no duty (contractual or otherwise) not to (i)&nbsp;invest in, carry on and conduct, whether directly, or as a partner in any partnership, or as a joint venturer in any joint venture, or as an
officer, director, stockholder, equityholder or investor in any person, or as a participant in any syndicate, pool, trust or association, any business of any kind, nature or description, whether or not such business is competitive with or in the
same or similar lines of business as the Company or any of its Subsidiaries, (ii)&nbsp;do business with any client, customer, vendor or lessor of any of the Company or its affiliates or (iii)&nbsp;make investments in any kind of property in which
the Company may make investments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) In the event that Purchaser or any related investment funds, the Board Representative or any of
their respective affiliates, acquires knowledge of a potential transaction or matter that may be a corporate opportunity for the Company or any of its Subsidiaries, none of Purchaser or any related investment funds, the Board Representative or any
of their respective affiliates, shall have any duty (contractual or otherwise) to communicate or present such corporate opportunity to the Company or to refrain from pursuing or acquiring such corporate opportunity for its own benefit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) None of Purchaser, any related investment fund, the Board Representative or any of their respective affiliates shall be liable to the
Company or any of its Subsidiaries or stockholders of the Company for breach of any duty (contractual or otherwise) by reason of the fact that Purchaser or any related investment fund thereof, the Board Representative or any of their respective
affiliates pursues or acquires such opportunity for itself, directs such opportunity to another person, or does not present such opportunity to the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding
<U>Section</U><U></U><U>&nbsp;4.9(a)</U>-<U>Section</U><U></U><U>&nbsp;4.9(c)</U>, if the Board Representative is presented with any potential transaction or corporate opportunity solely and expressly in his or her capacity as a member of the Board
of Directors and that is specifically identified as a potential transaction or corporate opportunity for the Company or its Subsidiaries (a &#147;<U>Company Opportunity</U>&#148;), then the Board Representative shall be required to first present
such Company Opportunity to the Company prior to the Board Representative&#146;s pursuit of, or investment in, such Company Opportunity. The Company shall not treat the Board Representative differently with respect to Corporate Opportunities
relative to how the Company treats other members of the Board of Directors with respect to Corporate Opportunities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10
<U>No Recourse</U>. This Agreement may only be enforced against, and any actions, suits, proceedings, claims, demands, disputes, cross claims, counterclaims or causes of action (whether in contract or tort or otherwise) that may be based upon, arise
out of or relate to this Agreement or any Other Investment Agreement or the transactions contemplated hereby or thereby, or the negotiation, execution or performance of this Agreement or any Other Investment Agreement or the transactions
contemplated hereby or thereby, may be made only against the entities that are expressly identified as the party or parties to such agreement(s). No person who is not a party hereto, including any past, present or future direct or indirect
equityholder, director, officer, employee, incorporator, member, manager, partner, affiliate, agent, attorney, financing source, assignee or representative of any party hereto or its affiliates or any former, current or future direct or indirect
equityholder, director, officer, employee, incorporator, agent, attorney, representative, partner, member, manager, affiliate, agent, assignee or representative of any of the foregoing (&#147;<U><FONT STYLE="white-space:nowrap">Non-Party</FONT>
Affiliates</U>&#148;), shall have any liability (whether in contract or in tort, in law or in equity, or based upon any theory that seeks to impose liability of an entity party against its owners or affiliates) to any other party hereto (or its
affiliates) for any obligations or liabilities arising under, in connection with or related to this Agreement or the transactions contemplated hereby, or for any claim based on, in respect of, or by reason of this Agreement or the transactions
contemplated hereby, or the negotiation, execution or performance of this Agreement or the transactions contemplated hereby, and each party hereto irrevocably and unconditionally waives and releases all such liabilities, claims and obligations
against any such <FONT STYLE="white-space:nowrap">Non-Party</FONT> Affiliates. Notwithstanding the foregoing, nothing in this <U>Section</U><U></U><U>&nbsp;4.10</U> shall (or is meant to) limit in any manner the rights and obligations of Reverence
Capital Partners, L.P. under the Confidentiality Agreement, to the extent expressly provided therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.11 <U>Tax
Matters</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The Company shall pay any and all transfer Taxes, stamp Taxes or duties, documentary Taxes, or other similar Taxes
imposed upon the issuance of shares of Common Stock and Preferred Stock pursuant to this Agreement or the issuance of shares of Common Stock on account of the conversion of Preferred Stock pursuant to the Certificate of Designations; <U>provided</U>
that the Company shall not be required to pay any such Tax that may be payable in connection with any issuance of Common Stock pursuant to a conversion of Preferred Stock to the extent such Tax is payable because a registered holder of Preferred
Stock requests Common Stock to be registered in a name other than such registered holder&#146;s name and, no such Common Stock will be so registered unless and until the registered holder making such request has paid such taxes to the Company or has
established to the satisfaction of the Company that such taxes have been paid or are not payable. The Company and Purchaser shall reasonably cooperate to avoid or minimize the imposition of transfer Taxes, stamp Taxes or duties, documentary Taxes,
or other similar Taxes described in the first sentence of this <U>Section</U><U></U><U>&nbsp;4.11</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything herein or in the Certificate of Designations to the contrary,
the Company and any applicable withholding agent shall be entitled to deduct and withhold from any consideration otherwise payable on or with respect to the Common Stock or Preferred Stock (including upon conversion of any Preferred Stock) such
amounts as it is required to deduct or withhold with respect to the making of such payment under the Code or any other applicable Tax Law. If the holder of Preferred Stock is deemed for U.S. federal income tax purposes to have received a
distribution with respect to the Preferred Stock, the Company or an applicable withholding agent may satisfy any resulting applicable withholding obligations (including with respect to backup withholding) imposed in connection with such deemed
distribution by withholding from any other payments due with respect to the Common Stock or Preferred Stock, including any payments upon conversion, repurchase or redemption of the Common Stock or Preferred Stock to the extent required by applicable
Tax Law. If any amounts are so deducted or withheld and subsequently paid to the applicable Governmental Entity, such deducted or withheld amounts shall be treated for all purposes of this Agreement and the Certificate of Designations as having been
paid to the person to which such amounts would have otherwise been payable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Following the Closing, if the Company becomes aware that
an event or other occurrence has occurred that, if the Preferred Stock were treated as &#147;preferred stock&#148; for purposes of Section&nbsp;305 of the Code, would cause a deemed distribution, with respect to the Preferred Stock, pursuant to
Section&nbsp;305(c) of the Code, the Company shall use commercially reasonable efforts to notify Purchaser of such event or occurrence and shall consult with Purchaser in good faith regarding the treatment of such event or occurrence. The Company
and Purchaser agree that there shall be no deemed distribution on the Preferred Stock pursuant to Section&nbsp;305(c) of the Code in respect of a difference between the &#147;issue price&#148; and the &#147;redemption price&#148; of the Preferred
Stock and except to the extent otherwise required by a &#147;determination&#148; within the meaning of Section&nbsp;1313(a) of the Code, neither the Company nor Purchaser shall take any position inconsistent therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) Following the Closing, Purchaser shall provide the Company with a proposed allocation of the Investment Amount among the shares of Series
C Preferred Stock delivered at the Closing and the Permanent Warrant for U.S. tax purposes.&nbsp;The Company may propose reasonable comments to the proposed allocation within fifteen (15)&nbsp;days of receiving the proposed allocation, and Purchaser
shall consider such comments in good faith. Thereafter, Purchaser shall provide the Company with a final allocation for U.S. tax purposes and such final allocation shall be binding on Purchaser and the Company for all U.S. tax purposes. In the event
that the Company issues additional warrants to Purchaser pursuant to <U>Section</U><U></U><U>&nbsp;3.1(h)</U> of this Agreement, Purchaser shall provide a proposed adjusted allocation to the Company, which may propose reasonable comments to the
proposed adjusted allocation within fifteen (15)&nbsp;days of receiving the proposed adjusted allocation, and Purchaser shall consider such comments in good faith. Thereafter, Purchaser shall provide the Company with a final adjusted allocation for
U.S. tax purposes and such final adjusted allocation shall be binding on Purchaser and the Company for all U.S. tax purposes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.12 <U>Termination</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) This Agreement may be terminated prior to the Closing: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) by mutual written agreement of the Company and Purchaser; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) by the Company or Purchaser, upon written notice to the other party, in the event that the Closing does not occur on or
before the tenth (10<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) business day following date hereof (such date, the &#147;Termination Date&#148;); <U>provided</U>, <U>however</U>, that the right to terminate this Agreement pursuant to
this <U>Section</U><U></U><U>&nbsp;4.12(a)(ii)</U> shall not be available to any party whose failure to fulfill any obligation under this Agreement shall have been the cause of, or shall have resulted in, the failure of the Closing to occur on or
prior to such date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) by the Company (<U>provided</U> that the Company is not then in material breach of any
representation, warranty, covenant or other agreement contained herein that is a condition to Purchaser&#146;s obligation to effect the Closing), if there shall have been a breach of any of the covenants or agreements or any of the representations
or warranties set forth herein on the part of Purchaser, which breach, either individually or in the aggregate with all other breaches by Purchaser, would constitute, if occurring or continuing as of the Closing, the failure of a condition set forth
in <U>Section</U><U></U><U>&nbsp;1.2(b)(iii)</U>, and which is not cured prior to the Termination Date following written notice to Purchaser, or by its nature or timing cannot be cured during such period (or such fewer days as remain prior to the
Termination Date); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) by Purchaser (<U>provided</U> that Purchaser is not then in material breach of any
representation, warranty, covenant or other agreement contained herein that is a condition to the Company&#146;s obligation to effect the Closing), if there shall have been a breach of any of the covenants or agreements contained herein or any of
the representations or warranties set forth herein on the part of the Company, which breach, either individually or in the aggregate with all such other breaches by the Company, would constitute, if occurring or continuing as of the Closing, the
failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;1.2(b)(ii)</U>, and which is not cured prior to the Termination Date following written notice to Purchaser, or by its nature or timing cannot be cured during such period (or such
fewer days as remain prior to the Termination Date). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Following the Closing, <U>Section</U><U></U><U>&nbsp;4.1</U>,
<U>Section</U><U></U><U>&nbsp;4.2</U>, <U>Section</U><U></U><U>&nbsp;4.4</U> and <U>Section</U><U></U><U>&nbsp;4.9</U> shall automatically terminate on the date that Purchaser (together with its affiliates) ceases to own any shares of capital stock
of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) In the event of any termination of this Agreement as provided in <U>Section</U><U></U><U>&nbsp;4.12</U>, this
Agreement (other than <U>Section</U><U></U><U>&nbsp;3.3(a)</U>, <U>Section</U><U></U><U>&nbsp;3.4</U>, this <U>Section</U><U></U><U>&nbsp;4.12(c)</U> and <U>ARTICLE</U><U></U><U>&nbsp;V</U>, which shall remain in full force and effect) shall
forthwith become wholly void and of no further force and effect, and none of the Company, Purchaser, any of their respective affiliates or any of the officers, directors, members or partners of any of them shall have any liability of any nature
whatsoever hereunder, or in connection with the transactions contemplated hereby; <U>provided</U> that nothing herein shall relieve any party hereto from any liability for Fraud or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
willful and intentional breach of any covenant or agreement expressly set forth herein. &#147;Fraud&#148; means an intentional misrepresentation with respect to a representation or warranty set
forth in <U>Section</U><U></U><U>&nbsp;2.2</U> or <U>Section</U><U></U><U>&nbsp;2.3</U>, which such intentional misrepresentation was (i)&nbsp;inaccurate on the date hereof, and (ii)&nbsp;made with (A)&nbsp;the specific intent of deceiving and
inducing the other party to enter into this Agreement and upon which the other party actually relied to its detriment, and (B)&nbsp;actual knowledge (without any duty of investigation or inquiry) of the inaccuracy of such intentional
misrepresentation; <U>provided</U> that &#147;Fraud&#148; shall not include any claim (including equitable fraud, promissory fraud and unfair dealings fraud) based on constructive knowledge, recklessness, negligent misrepresentation or a similar
theory. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;V </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MISCELLANEOUS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1 <U>Amendment</U>. This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or
otherwise, except by a written instrument signed on behalf of each of the parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2 <U>Extension; Waiver</U>. Each party
may, to the extent permitted by Law, (a)&nbsp;extend the time for the performance of any of the obligations or other acts of the Company, in the case of Purchaser, or Purchaser, in the case of the Company, (b)&nbsp;waive any inaccuracies in the
representations and warranties contained herein or in any document delivered pursuant hereto on the part of the Company, in the case of Purchaser, or Purchaser, in the case of the Company, and (c)&nbsp;waive compliance with any of the agreements or
satisfaction of any conditions for its benefit contained herein. Any agreement on the part of a party to any such extension or waiver shall be valid only if set forth in a written instrument signed on behalf of such party, but such extension or
waiver or failure to insist on strict compliance with an obligation, covenant, agreement or condition shall not operate as a waiver of, or estoppel with respect to, any subsequent or other failure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3 <U>Expenses</U>. Except as otherwise expressly set forth herein, all costs, fees and expenses incurred in connection with
this Agreement and the transactions contemplated hereby shall be paid by the party incurring such cost, fee or expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4
<U>Notices</U>. All notices and other communications hereunder shall be in writing and shall be deemed duly given on (a)&nbsp;the date of delivery if delivered personally, or if by email, upon delivery (<U>provided</U> that no auto-generated error
or <FONT STYLE="white-space:nowrap">non-delivery</FONT> or similar message is generated in response thereto), (b)&nbsp;the first (1st) business day following the date of dispatch if delivered utilizing a
<FONT STYLE="white-space:nowrap">next-day</FONT> service by a recognized <FONT STYLE="white-space:nowrap">next-day</FONT> courier or (c)&nbsp;the earlier of confirmation of receipt or the fifth (5th) business day following the date of mailing if
delivered by registered or certified mail, return receipt requested, postage prepaid. All notices hereunder shall be delivered to the addresses set forth below, or pursuant to such other instructions as may be designated in writing by the party to
receive such notice: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to the Company, to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">New York Community Bancorp, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">102 Duffy Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Hicksville,
New York 11801 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: R. Patrick Quinn, Senior Executive Vice President, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">General Counsel and Corporate Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: Patrick.Quinn@flagstar.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">With a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">One Manhattan West </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">New York,
NY 10001 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: Sven Mickisch; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Christopher M. Barlow; </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Matthew
Nemeroff </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: Sven.Mickisch@skadden.com; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Christopher.Barlow@skadden.com; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Matthew.Nemeroff@skadden.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">and </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to Purchaser, to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">c/o Reverence Capital Partners, L.P. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">590 Madison Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">New York,
New York 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: [Reserved.] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: [Reserved.] </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">With a copy
(which shall not constitute notice) to </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Kirkland&nbsp;&amp; Ellis LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">300 North LaSalle </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Chicago,
Illinois 60654 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: Mark A. Fennell, P.C.; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Kevin W. Mausert, P.C. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email:
mark.fennell@kirkland.com; </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">kevin.mausert@kirkland.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5 <U>Interpretation</U>. The parties have participated jointly in negotiating and drafting this Agreement. In the event that an
ambiguity or a question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of
any provision hereof. When a reference is made in this Agreement to Articles, Sections, Exhibits or Schedules, such reference shall be to an Article or Section of or Exhibit or Schedule to this Agreement, unless otherwise indicated. The table of
contents and headings contained herein are for reference purposes only and shall not affect in any way the meaning or interpretation hereof. Whenever the words &#147;include,&#148; &#147;includes&#148; or &#147;including&#148; are used herein, they
shall be deemed to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be followed by the words &#147;without limitation.&#148; The word &#147;or&#148; shall not be exclusive. References to &#147;the date hereof&#148; mean the date of this Agreement. Notwithstanding
anything herein to the contrary, neither Purchaser nor any of its affiliates and neither the Company nor any of its Subsidiaries shall be required to take any action that is prohibited by Law or any Governmental Entity. As used herein, the
&#147;knowledge&#148; of Purchaser means the actual knowledge of any of the officers of Purchaser, and the &#147;<U>knowledge</U>&#148; of the Company means the actual knowledge of any of the officers of the Company listed on
<U>Section</U><U></U><U>&nbsp;5.5</U> of the Company Disclosure Schedule. As used herein, (a)&nbsp;&#147;<U>business day</U>&#148; means any day other than a Saturday, a Sunday or a day on which banks in New York, New York are authorized by Law to
be closed, (b)&nbsp;&#147;<U>person</U>&#148; means any individual, corporation (including <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit),</FONT></FONT> general or limited partnership, limited liability company,
joint venture, estate, trust, association, organization, Governmental Entity or other entity of any kind or nature, (c)&nbsp;an &#147;<U>affiliate</U>&#148; of a specified person is any person that directly or indirectly, controls, is controlled by,
or is under common control with, such specified person; <U>provided</U> that &#147;affiliate&#148; shall not include any &#147;portfolio company&#148; (as such term is customarily used in the private equity industry) of any investment fund
affiliated with or managed by such person or any investment fund or vehicle (other than any such fund or vehicle with a direct or indirect interest in such person) of or related to or affiliated with such person, (d)&nbsp;&#147;<U>party</U>&#148;
means a party to this Agreement, unless the context clearly suggests otherwise, (e)&nbsp;&#147;<U>made available</U>&#148; means any document or other information provided by one party to the other party, including any document or other information
that was (i)&nbsp;included in the virtual data room of a party at least one (1)&nbsp;business day prior to the date hereof or (ii)&nbsp;filed by a party with the SEC since January&nbsp;1, 2023 and publicly available on EDGAR at least one
(1)&nbsp;business day prior to the date hereof, (f)&nbsp;the &#147;transactions contemplated hereby&#148; and &#147;<U>transactions contemplated by this Agreement</U>&#148; shall include the purchase and sale of Securities contemplated by
<U>Section</U><U></U><U>&nbsp;1.1</U>, (g)&nbsp;&#147;<U>ordinary course</U>&#148; and &#147;<U>ordinary course of business</U>&#148; with respect to either party, means conduct consistent with past practice and the normal <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> customs, practices and procedures of such party, taking into account any changes to such practices as may have occurred in response to any Pandemic, including
compliance with Pandemic Measures, (h) &#147;<U>U.S</U>.&#148; means the United States of America and (i) &#147;<U>extent</U>&#148; in the phrase &#147;to the extent&#148; means the degree to which a subject or other thing extends and such phrase
shall not mean simply &#147;if&#148;. Any reference herein to any statute, includes all amendments thereto and all rules and regulations promulgated thereunder. The Company Disclosure Schedule, as well as all other schedules and all exhibits hereto,
shall be deemed part of this Agreement and included in any reference to this Agreement. All references to &#147;dollars&#148; or &#147;$&#148; herein are to U.S. dollars. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6 <U>Counterparts</U>. This Agreement may be executed in counterparts, all of which shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each of the parties and delivered to the other party, it being understood that all parties need not sign the same counterpart. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7 <U>Entire Agreement</U>. This Agreement (including the documents and the instruments referred to herein), together with the
Registration Rights Agreement and Confidentiality Agreement, constitute the entire agreement among the parties and supersede all prior agreements and understandings, written, oral or otherwise, among the parties with respect to the subject matter
hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8 <U>Governing Law; Jurisdiction</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) This Agreement shall be governed by, construed and enforced in accordance with the laws of the State of Delaware, without regard to any
applicable conflicts of law principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Each party agrees that it will bring any action, suit, litigation, dispute or proceeding in
respect of any claim arising out of or related to this Agreement or the transactions contemplated hereby exclusively in the Delaware Court of Chancery and any state appellate court therefrom within the State of Delaware, or, if the Delaware Court of
Chancery declines to accept jurisdiction over a particular matter, any federal or state court of competent jurisdiction located in the State of Delaware (the &#147;<U>Chosen Courts</U>&#148;), and, solely in connection with claims arising under this
Agreement or the transactions that are the subject of this Agreement, (i)&nbsp;irrevocably submits to the exclusive jurisdiction of the Chosen Courts, (ii)&nbsp;waives any objection (A)&nbsp;to laying venue in any such action, suit, litigation,
dispute or proceeding in the Chosen Courts and (B)&nbsp;that the Chosen Courts are an inconvenient forum or do not have jurisdiction over any party and (iii)&nbsp;agrees that service of process upon such party in any such action, suit, litigation,
dispute or proceeding will be effective if notice is given in accordance with <U>Section</U><U></U><U>&nbsp;5.4</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9
<U>Waiver of Jury Trial</U>. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE HEREUNDER IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND, THEREFORE, EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE
EXTENT PERMITTED BY LAW AT THE TIME OF INSTITUTION OF THE APPLICABLE LITIGATION, ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY ACTION, SUIT, LITIGATION, DISPUTE OR PROCEEDING, DIRECTLY OR INDIRECTLY, ARISING OUT OF OR RELATING
TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE
EVENT OF ANY SUCH ACTION, SUIT, LITIGATION, DISPUTE OR PROCEEDING, SEEK TO ENFORCE THE FOREGOING WAIVER, (B)&nbsp;IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C)&nbsp;IT MAKES THIS WAIVER VOLUNTARILY, AND (D)&nbsp;IT HAS BEEN
INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <U>SECTION</U><U></U><U>&nbsp;5.9</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10 <U>Assignment; Third-Party Beneficiaries</U>. Neither this Agreement nor any of the rights, interests or obligations
hereunder shall be assigned by any of the parties (whether by operation of law or otherwise) without the prior written consent of Purchaser, in the case of the Company, or the Company, in the case of Purchaser. Any purported assignment in
contravention hereof shall be null and void. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns, other than as expressly set
forth herein (including <U>Section</U><U></U><U>&nbsp;4.9</U> and <U>Section</U><U></U><U>&nbsp;4.10</U>). Except as set forth in the foregoing sentence or otherwise expressly set forth herein (including <U>Section</U><U></U><U>&nbsp;4.10</U>), this
Agreement (including the documents and instruments referred to herein) is not otherwise intended to, and does not, confer upon any person other than the parties, any rights or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
remedies hereunder, including the right to rely upon the representations and warranties set forth herein; <U>provided</U>, however, that the Placement Agents/Arrangers shall be a third party
beneficiary of this Agreement solely with respect to <U>Section</U><U></U><U>&nbsp;2.2</U> and <U>Section</U><U></U><U>&nbsp;2.3</U>, and may rely upon the representations and warranties contained therein. The representations and warranties herein
are the product of negotiations among the parties and are for the sole benefit of the parties. Any inaccuracies in such representations and warranties are subject to waiver by the parties in accordance herewith without notice or liability to any
other person. In some instances, the representations and warranties herein may represent an allocation among the parties of risks associated with particular matters regardless of the knowledge of any of the parties. Consequently, persons other than
the parties may not rely upon the representations and warranties herein as characterizations of actual facts, events, developments or circumstances as of the date hereof or as of any other date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11 <U>Specific Performance</U>. The parties agree that irreparable damage would occur if any provision hereof were not
performed in accordance with its specific terms or otherwise breached. Accordingly, the parties shall be entitled to specific performance of the terms hereof, including an injunction or injunctions to prevent breaches or threatened breaches of this
Agreement or to enforce specifically the performance of the terms and provisions hereof (including the parties&#146; obligation to consummate the Investment), in addition to any other remedy to which they are entitled at Law or in equity. Each party
further waives any (a)&nbsp;defense in any action, suit, litigation, dispute or proceeding for specific performance that a remedy at Law would be adequate and (b)&nbsp;requirement under any Law to post security or a bond as a prerequisite to
obtaining equitable relief. A party&#146;s pursuit of an injunction, specific performance or other equitable remedies at any time shall not be deemed an election of remedies or waiver of the right to pursue any other right or remedy to which such
party may be entitled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12 <U>Severability</U>. Whenever possible, each provision or portion of any provision of this
Agreement shall be interpreted in such manner as to be effective and valid under Law, but if any provision or portion of any provision hereof is held to be invalid, illegal or unenforceable in any respect under any Law in any jurisdiction, such
invalidity, illegality or unenforceability shall not affect any other provision or portion of any provision in such jurisdiction, and this Agreement shall be reformed, construed and enforced in such jurisdiction such that the invalid, illegal or
unenforceable provision or portion thereof shall be interpreted to be only so broad as is enforceable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13 <U>Confidential
Supervisory Information</U>. Notwithstanding any other provision herein, no disclosure, representation or warranty shall be made (or other action taken) pursuant hereto that would involve the disclosure of confidential supervisory information
(including confidential supervisory information as defined or identified in 12 C.F.R. &#167;&nbsp;4.32(b), 12&nbsp;C.F.R. &#167; 261.2(b) and 12 C.F.R. &#167;&nbsp;309.5(g)(8)) of a Governmental Entity by any party to the extent prohibited by Law;
<U>provided</U> that, to the extent legally permissible, appropriate substitute disclosures or actions shall be made or taken under circumstances in which the limitations of this <U>Section</U><U></U><U>&nbsp;5.13</U> apply in order that those
limitations do not have the effect of misleading any party hereto, which substitute actions may include diligence calls and communications by Purchaser (or its counsel) with the Company, its counsel, or its regulators. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14 <U>Delivery by Electronic Transmission</U>. This Agreement and any signed
agreement or instrument entered into in connection herewith, and any amendments or waivers hereto or thereto, to the extent signed and delivered by email delivery of a &#147;.pdf&#148; format data file or other electronic means, shall be treated in
all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No party or to any such agreement or instrument shall
raise the use of email delivery of a &#147;.pdf&#148; format data file or other electronic means to deliver a signature hereto or any amendment hereto or the fact that any signature or agreement or instrument was transmitted or communicated through
the use of email delivery of a &#147;.pdf&#148; format data file or other electronic means as a defense to the formation of a contract and each party forever waives any such defense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15 <U>Guaranty</U>. The Parent Funds, severally in accordance with their Pro Rata Percentages and not jointly, hereby
irrevocably guarantee to Purchaser, the Company and their respective successors and assigns the prompt payment and performance of all of Purchaser&#146;s obligations pursuant to this Agreement, including Purchaser&#146;s delivery of the Investment
Amount at the Closing pursuant to <U>Section</U><U></U><U>&nbsp;1.2(c)(ii)(1)</U>. The obligations under this <U>Section</U><U></U><U>&nbsp;5.15</U> shall terminate upon the consummation of the Closing. &#147;<U>Pro Rata Percentages</U>&#148; shall
mean 74.10% in the case of Reverence Capital Partners Opportunities Fund V (PE Fund III), L.P., 22.83% in the case of Reverence Capital Partners Opportunities Fund <FONT STYLE="white-space:nowrap">V-A</FONT> (PE Fund II), L.P., 0.20% in the case of
Reverence Capital Partners Fund V (AI) (PE Fund III), L.P. and 2.87% in the case of Revenue Capital Partners Opportunities Fund V (FOO) (PE Fund III), L.P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature page follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF,</B> this Agreement has been duly executed and delivered by the duly
authorized officers of the parties as of the date first herein above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">NEW YORK COMMUNITY BANCORP, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ R. Patrick Quinn</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: R. Patrick Quinn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: General Counsel &amp; Corporate Secretary</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Investment Agreement</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">RCP EAGLE HOLDINGS LP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: RCP Eagle Holdings GP LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Its: General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Milton R. Berlinski</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Milton R. Berlinski</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Member</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Investment Agreement</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Solely for the purposes of (a)<U>&nbsp;Section</U><U></U><U>&nbsp;2.3</U>, as if a Purchaser hereunder,
(b)<U>&nbsp;Section</U><U></U><U>&nbsp;5.15</U>, as guarantor, and (c)&nbsp;the other sections in <U>ARTICLE</U><U></U><U>&nbsp;V</U>: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">REVERENCE CAPITAL PARTNERS</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">OPPORTUNITIES FUND V (PE FUND III), L.P.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Reverence Capital Partners</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Opportunities Fund V (PE FUND III) GP, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Reverence Capital Partners</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Opportunities Fund V (PE Fund III) GP, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Milton R. Berlinski</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name: Milton R. Berlinski</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: Managing Member</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">REVERENCE CAPITAL PARTNERS</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">OPPORTUNITIES FUND <FONT STYLE="white-space:nowrap">V-A</FONT> (PE FUND III), L.P.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Reverence Capital Partners</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Opportunities Fund V (PE FUND III) GP, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Reverence Capital Partners</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Opportunities Fund V (PE Fund III) GP, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP> <P STYLE="margin-bottom:1pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Milton R. Berlinski</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name: Milton R. Berlinski</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: Managing Member</TD></TR></TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Investment Agreement</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
<DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">REVERENCE CAPITAL PARTNERS</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">OPPORTUNITIES FUND V (AI) (PE FUND III), L.P.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Reverence Capital Partners</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Opportunities Fund V (PE FUND III) GP, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Reverence Capital Partners</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Opportunities Fund V (PE Fund III) GP, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP> <P STYLE="margin-bottom:1pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Milton R. Berlinski</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name: Milton R. Berlinski</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: Managing Member</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">REVERENCE CAPITAL PARTNERS</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">OPPORTUNITIES FUND V (FOO) (PE FUND III), L.P.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Reverence Capital Partners</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Opportunities Fund V (PE FUND III) GP, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Reverence Capital Partners</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Opportunities Fund V (PE Fund III) GP, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Milton R. Berlinski</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name: Milton R. Berlinski</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: Managing Member</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Investment Agreement</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit E </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Stockholder Vote Warrant Terms </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Term</U>: 10
year warrants </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Strike price</U>: $2.00 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Settlement</U>: Cash </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Warrant coverage</U>: If Requisite
Stockholder Vote is not obtained by the date that is the 180th day after the Closing Date, Purchaser will receive cash settled warrants with warrant coverage of 160% with a strike price set at the deal price. The warrant becomes exercisable 60 days
after issuance if the Requisite Stockholder Vote is not obtained by such date. If the Requisite Stockholder Vote is obtained prior to such date, the warrant will be cancelled in full. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, warrant coverage will increase by 20% every 60 days thereafter if the Requisite Stockholder Vote is not obtained; provided that the maximum
warrant coverage shall not exceed 220%. The additional 20% will not be exercisable and will cancelled if the Requisite Stockholder Vote is obtained in the 60 days after issuance. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Example Calculations </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="21%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Days after Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Warrant Issued<br>(total warrant)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Warrant Exercisable</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Warrants subject to<BR>cancelation</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">180</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">160%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">160</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">240</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20% (180%</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">160</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">300</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20% (200%</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">180</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">360</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20% (220%</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">420</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0 (220%</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">220</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Underlying Stock</U>: Exercisable for cumulative <FONT STYLE="white-space:nowrap">non-voting</FONT> preferred stock with a
13.00% dividend rate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Transfer Restrictions</U>: Not subject to any transfer restrictions other than applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Registration</U><U></U><U>&nbsp;&amp; Listing</U>: The Company will use reasonable efforts to register and if possible, list, the warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Documentation</U>: If the Requisite Stockholder Vote is not obtained by the date that is the 180<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day
after the Closing Date, the Company and Purchaser shall use reasonable best efforts to, as promptly as reasonably practicable, agree upon a form of warrant agreement and preferred certificate of designation; terms to be consistent with other warrant
and other preferred in an agreed upon deal, except as noted; terms to ensure that neither warrant nor underlying stock are &#147;voting securities&#148; for bank regulatory purposes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Investment Agreement</I>] </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>10
<FILENAME>d763888dex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT 10.4 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXECUTION VERSION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION RIGHTS AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">by and among </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York Community
Bancorp, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">the
Purchasers party hereto </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of March&nbsp;11, 2024 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Table of Contents </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>Page</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Definitions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Registration Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(a)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shelf Registration Statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(b)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Right to Request Shelf Take-Down</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(c)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[reserved]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(d)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Limitations on Shelf Take-Downs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(e)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Piggyback Registration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(f)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selection of Underwriters; Right to Participate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(g)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Priority of Securities Offered Pursuant to Underwritten Shelf Take-Downs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(h)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Priority of Securities Offered Pursuant to Piggyback Registration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(i)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Postponement; Suspensions; Blackout Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(j)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supplements and Amendments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(k)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsequent Holder Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Registration Procedures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(a)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Filing and Other Procedures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(b)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conditions to Registration Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(a)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification by the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(b)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification by the Shareholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(c)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notices of Claims, etc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(d)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contribution</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(e)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Exclusivity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Covenants Relating to Rule&nbsp;144</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination; Survival</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(a)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governing Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(b)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Waiver of Jury Trial</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(c)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entire Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(d)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendments and Waivers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(e)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Successors and Assigns</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(f)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(g)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Counterparts, Execution</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(h)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(i)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notices</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(j)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Specific Performance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(k)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interpretation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(l)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Limitations on Subsequent Registration Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">(m)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Further Assurances</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION RIGHTS AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS <B>REGISTRATION RIGHTS AGREEMENT</B>, dated as of March&nbsp;11, 2024 (this &#147;<B>Agreement</B>&#148;), is by and among New York
Community Bancorp, Inc., a Delaware corporation (the &#147;<B>Company</B>&#148;), and the undersigned parties listed as &#147;Purchaser&#148; on the signature pages hereto (each, a &#147;<B>Purchaser</B>&#148; and, collectively, the
&#147;<B>Purchasers</B>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>,<B> </B>on the date hereof, the Company issued to the Purchasers (a)&nbsp;an aggregate of 76,630,965 shares of common stock,
par value $0.01 per share, of the Company (the &#147;<B>Common Stock</B>&#148;), (b) an aggregate of 448,369 shares of Convertible Preferred Stock (as defined below), convertible into shares of Common Stock in accordance with the terms set forth in
the Certificate of Designations, issued pursuant to those certain Investment Agreements and (c)&nbsp;an aggregate of 315,000,000 Permanent Warrants (as defined in the Investment Agreements), each dated as of March&nbsp;7, 2024, between the Company
and each Purchaser (the &#147;<B>Investment Agreements</B>&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Company and the Purchasers are entering into
this Agreement in order to grant certain registration rights described herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, in consideration of the premises
and of the mutual covenants and obligations hereinafter set forth, and for other good and valuable considerations, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1. <U>Definitions</U>. As used herein, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Affiliate</B>&#148; means, with respect to any Person, any Person directly or indirectly controlling, controlled by or under common
control with, such other Person. For purposes of this definition, &#147;control&#148; (including, with correlative meanings, the terms &#147;controlled by&#148; and &#147;under common control with&#148;) when used with respect to any Person, means
the possession, directly or indirectly, of the power to cause the direction of management or policies of such Person, whether through the ownership of voting securities by contract or otherwise, <U>provided</U> that &#147;Affiliate&#148; shall not
include any portfolio company of any investment fund affiliated with or managed by such Person. For purposes of this Agreement, the Company and its subsidiaries, on the one hand, and any Shareholder, on the other, shall not be considered Affiliates.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Agreement</B>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Anchor Shareholder</B>&#148; means Liberty Strategic Capital (CEN) Holdings, LLC and its Affiliates who own Registrable Securities.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">As-Converted</FONT> Basis</B>&#148; means, at any time, the applicable number of shares of
Common Stock issued and outstanding, counting as shares of Common Stock issued and outstanding, without duplication, all shares of Common Stock (A)&nbsp;issued and outstanding, (B)&nbsp;into which shares of Convertible Preferred Stock issued and
outstanding are convertible, (C)&nbsp;into which shares of Convertible Preferred Stock issuable upon exercise of Warrants are convertible and (D)&nbsp;into which Warrants issued and outstanding are exercisable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Block Trade</B>&#148; means a registered securities offering in which an
underwriter agrees to purchase Registrable Securities at an agreed price or pricing formula without a prior public marketing process (also may be commonly referred to as an overnight transaction). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Board of Directors</B>&#148; means the board of directors of the Company, including, unless the context otherwise requires, any duly
authorized committee thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Day</B>&#148; means any day, other than a Saturday, Sunday or other day on which banking
institutions in the city of New York, New York are required or authorized by Law to be closed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Certificate of
Designations</B>&#148; means, collectively, the Certificate of Designations (Series B) and Certificate of Designations (Series C). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Certificate of Designations (Series B)</B>&#148; means the Certificate of Designations of the Series B Preferred Stock, filed with
the Secretary of State of the State of Delaware and effective on March&nbsp;11, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Certificate of Designations (Series
C)</B>&#148; means the Certificate of Designations of the Series C Preferred Stock, filed with the Secretary of State of the State of Delaware and effective on March&nbsp;11, 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Certificate of Designations (Series D)</B>&#148; means the Certificate of Designations of the Series D Preferred Stock, filed with
the Secretary of State of the State of Delaware and effective on March&nbsp;11, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Closing</B>&#148; means the closing of the
purchase and sale and issuance of (a)&nbsp;shares of Common Stock and (b)&nbsp;shares of Convertible Preferred Stock and (c)&nbsp;Permanent Warrants in each case, pursuant to the Investment Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Common Stock</B>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company</B>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Convertible Preferred Stock</B>&#148; means, collectively, the Series B Preferred Stock, Series C Preferred Stock and the Series D
Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>End of Suspension Notice</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(i)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Act</B>&#148; means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and regulations
promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Entity</B>&#148; means any court, administrative agency, commission, regulatory agency or
other federal, state, local or foreign governmental authority or instrumentality or any applicable self-regulatory organization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Agreements</B>&#148; has the meaning set forth in the Recitals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Law</B>&#148; means any applicable law, statute, code, ordinance, rule, regulation,
requirement, policy or order of any Governmental Entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Minimum Amount</B>&#148; means $25&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Other Shareholder</B>&#148; means RCP Eagle Holdings LP and its Affiliates who own Registrable Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Reg Rights Holders</B>&#148; means (a)&nbsp;the Anchor Shareholder, (b)&nbsp;each Purchaser and its respective Affiliates
and (c)&nbsp;any Person to whom Registrable Securities representing at least 2% of the then-outstanding shares of Common Stock (on an <FONT STYLE="white-space:nowrap">As-Converted</FONT> Basis) are transferred in accordance with
<U>Section</U><U></U><U>&nbsp;7(e)</U>, other than in a transaction that results in such securities ceasing to be Registrable Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Person</B>&#148; means an individual, a corporation, a partnership, an association, a limited liability company, a Governmental
Entity, a trust or other entity or organization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Piggyback Registration</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(e)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Piggyback Shareholder</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(e)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Preferred Stock Registration Event</B>&#148; means the date that is the one hundred and
twentieth (120<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) day after the date of issuance of the Convertible Preferred Stock, if the Requisite Stockholder Vote is not obtained by the Company on or prior to such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Prospectus</B>&#148; means the prospectus included in any Registration Statement (including a prospectus that discloses information
previously omitted from a prospectus filed as part of an effective Registration Statement in reliance upon Rule&nbsp;430A under the Securities Act), as amended or supplemented by any prospectus supplement or any issuer free writing prospectus (as
defined in Rule&nbsp;433 under the Securities Act), with respect to the terms of the offering of any portion of the Registrable Securities covered by such Registration Statement, and all other amendments and supplements to the Prospectus, including
post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Public Offering</B>&#148; means a public offering and sale of equity securities for cash pursuant to an effective Registration
Statement under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registrable Securities</B>&#148; means any (a)&nbsp;shares of Common Stock issued pursuant
to any Investment Agreement, (b)&nbsp;following the occurrence of a Preferred Stock Registration Event, shares of Convertible Preferred Stock (including Convertible Preferred Stock issuable upon exercise of Warrants), (c) the Permanent Warrants (as
defined in the Investment Agreements), (d) following the issuance of the Stockholder Vote Warrants (as defined in the Investment Agreements), the Stockholder Vote Warrants and (e)&nbsp;shares of Common Stock issued or issuable upon conversion of
shares of Convertible Preferred Stock and exercise of Warrants, including, in each case, any securities acquired as a result of any reclassification, recapitalization, stock split or combination, exchange or readjustment of such shares of Common
Stock or Convertible Preferred Stock or the Warrants, or any stock dividend or stock distribution in respect of such share of Common Stock or Convertible Preferred Stock or the Warrants; <U>provided</U> that such securities shall
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
cease to be Registrable Securities on the earliest to occur of (A)&nbsp;a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act
and such securities shall have been disposed of in accordance with such Registration Statement; (B)&nbsp;such securities shall have been sold in accordance with Rule&nbsp;144 and the restrictive legend shall have been removed; (C)&nbsp;such
securities shall have been transferred in a transaction in which the transferor&#146;s rights under this Agreement are not assigned to the transferee of the securities in accordance with the terms hereof; (D)&nbsp;such securities shall have been
otherwise transferred, new certificates or book entries credits for such securities not bearing a legend restricting further transfer shall have been delivered by the Company and subsequent public distribution of such securities shall not require
registration under the Securities Act; (E)&nbsp;such securities have ceased to be outstanding; or (F)&nbsp;with respect to the Shareholders other than the Anchor Shareholder, the date on which Rule 144 (or other similar exemption under the
Securities Act then in force) is available for the sale of such shares of Common Stock without regard to volume limitations or manner of sale requirements of Rule 144. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registration Expenses</B>&#148; means all expenses incurred in effecting any registration or any offering and sale pursuant hereto or
otherwise incident to the performance of or compliance with this Agreement, whether or not any Registrable Securities are sold under a Registration Statement in connection therewith, including registration, qualification, listing and filing fees
(including all SEC, stock exchange and Financial Industry Regulatory Authority, Inc. (&#147;<B>FINRA</B>&#148;) filing fees, as applicable), word processing, printing and copying expenses, messenger, telephone and delivery expenses, all transfer
agent and registrar fees and expenses, fees and disbursements of all law firms of the Company and all accountants and other persons retained by the Company (including the expenses of any opinions, audits/reviews or comfort letters and updates
thereof required by or incident to such performance), any reasonable fees and disbursements of underwriters customarily paid by issuers or sellers of securities, all fees and expenses of any special experts or other persons retained by the Company
in connection with any registration, all expenses related to the &#147;road show&#148; for any underwritten offering, including all travel, meals and lodging, and any blue sky (including reasonable fees and disbursements of counsel to any
underwriter incurred in connection with blue sky qualifications of the Registrable Securities as may be set forth in any underwriting agreement) and other securities Laws fees and expenses, as well as all internal fees and expenses of the Company
(including all salaries and expenses of its officers and employees performing legal or accounting duties) and any other fees and disbursements customarily paid by the issuers of securities. Notwithstanding anything herein to the contrary,
Registration Expenses shall not include Selling Expenses. In addition, in connection with any registration or underwritten offering pursuant hereto, the Company shall pay or reimburse the Shareholders for the reasonable and documented fees and
expenses of one (1)&nbsp;nationally recognized law firm, chosen by the holders of a majority of the Registrable Securities included in such registration or underwritten offering (or, in the case of a Block Trade, the Shareholder that initiated such
Block Trade), as their counsel, including, for the avoidance of doubt, in connection with any Underwritten Shelf Take-Down or Piggyback Registration and filing of a Shelf Registration Statement; <U>provided</U> that the Company shall not be
responsible for any such fees and expenses that exceed $150,000 for the first Underwritten Shelf Take-Down and $100,000 for any subsequent Underwritten Shelf Take-Down, in each case, pursuant hereto. Nothing in this definition shall impact any
agreement on expenses solely between the Company and any underwriter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registration Statement</B>&#148; means any registration statement (including any
Shelf Registration Statement) of the Company under the Securities Act which permits the Public Offering of any of the Registrable Securities pursuant to the provisions hereof, including the Prospectus, amendments and supplements to such registration
statement, including post-effective amendments, all exhibits and all material incorporated by reference or deemed to be incorporated by reference in such registration statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Requisite Stockholder Vote</B>&#148; has the meaning of such term in the Investment Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rule</B><B></B><B>&nbsp;144</B>&#148; means Rule&nbsp;144 under the Securities Act, as such rule may be amended from time to time, or
any similar rule or regulation hereafter adopted by the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>SEC</B>&#148; means the U.S. Securities and Exchange Commission.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Securities Act</B>&#148; means the Securities Act of 1933, as amended, or any successor statute, and the rules and regulations
promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Selling Expenses</B>&#148; means all underwriting discounts and selling commissions associated with
effecting any sales of Registrable Securities under any Registration Statement by the Shareholders and all stock transfer taxes applicable to the sale or transfer by the Shareholders of Registrable Securities to the underwriter(s) pursuant hereto.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series B Preferred Stock</B>&#148; means the preferred stock, par value $0.01 per share, of the Company designated as Series B
Noncumulative Convertible Preferred Stock, having the terms set forth in that certain Certificate of Designations (Series B). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series C Preferred Stock</B>&#148; means the preferred stock, par value $0.01 per share, of the Company designated as Series C
Noncumulative Convertible Preferred Stock, having the terms set forth in that certain Certificate of Designations (Series C). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series D Preferred Stock</B>&#148; means the preferred stock, par value $0.01 per share, of the Company designated as Series D <FONT
STYLE="white-space:nowrap">Non-Voting</FONT> Common Equivalent Stock, having the terms set forth in that certain Certificate of Designations (Series D). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Shareholders</B>&#148; means the Permitted Reg Rights Holders that hold Registrable Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Shelf Period</B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Shelf Registration Statement</B>&#148; shall mean the Form <FONT STYLE="white-space:nowrap">S-1</FONT> Shelf or the Form <FONT
STYLE="white-space:nowrap">S-3</FONT> Shelf. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Shelf Take-Down</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Special Registration</B>&#148; means the registration (a)&nbsp;in connection with any
employee stock option or other benefit plan, (b)&nbsp;for an exchange offer, as part of a merger, consolidation or similar transaction or for an offering of securities solely to the Company&#146;s existing stockholders, (c)&nbsp;for an offering
solely of debt that is convertible into equity securities of the Company, or (d)&nbsp;for a dividend reinvestment plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Suspension</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(i)(i)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Suspension Notice</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(i)(i)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Underwritten Shelf Take-Down</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Underwritten Shelf Take-Down Notice</B>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Warrants</B>&#148; means the Permanent Warrant (as defined in the Investment Agreements)
and the Stockholder Vote Warrants (as defined in the Investment Agreements). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2. <U>Registration Rights</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Shelf Registration Statement</U>. The Company will use its reasonable best efforts to promptly file with the SEC, no later than
forty-five (45)&nbsp;days following the date of this Agreement, a shelf registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (or successor form) (the &#147;<B>Form <FONT STYLE="white-space:nowrap">S-1</FONT>
Shelf</B>&#148;) covering the resale of all the Registrable Securities (determined as of two (2)&nbsp;business days prior to such submission or filing) on a delayed or continuous basis and shall use its commercially reasonable efforts to have such
Form <FONT STYLE="white-space:nowrap">S-1</FONT> Shelf declared effective as soon as reasonably practicable after the filing thereof, but no later than the earlier of (i) 75 days following the date of this Agreement if the Company is notified by the
SEC that the Shelf Registration Statement will not be &#147;reviewed&#148; (or 120 days following the date of this Agreement if the Company is notified by the SEC that the Shelf Registration Statement will be &#147;reviewed&#148;) and (ii)&nbsp;the
tenth (10th) business day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that the Shelf Registration Statement will not be &#147;reviewed&#148; or will not be subject to further review. The Company
shall promptly provide any SEC comments received to Shareholders named in such Registration Statement and will promptly respond to any such SEC comments. Following the filing of the Form <FONT STYLE="white-space:nowrap">S-1</FONT> Shelf, the Company
shall use its commercially reasonable efforts to convert the Form <FONT STYLE="white-space:nowrap">S-1</FONT> Shelf into a shelf registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> (or successor form) (the &#147;<B>Form <FONT
STYLE="white-space:nowrap">S-3</FONT> Shelf</B>&#148;), if the Company is then eligible to use a Form <FONT STYLE="white-space:nowrap">S-3</FONT> Shelf. Such Shelf Registration Statement shall provide for the resale of the Registrable Securities
included therein pursuant to any method or combination of methods legally available to, and requested by, any Shareholder named therein. The Shelf Registration Statement may also cover any other securities of the Company and other holders of the
Company&#146;s securities; <U>provided</U> that, for the avoidance of doubt, such other holders shall not be entitled to the rights of &#147;Shareholders&#148; hereunder. The Company shall maintain the continuous effectiveness of the Shelf
Registration Statement for the maximum period permitted by SEC rules, subject to any Suspension that may occur as described in <U>Section</U><U></U><U>&nbsp;2(i)</U>, and shall promptly prepare and file with the SEC such amendments, including
post-effective amendments, and supplements as may be necessary to keep a Shelf Registration Statement effective until such time as there are no longer any Registrable Securities outstanding (such period during which a Shelf Registration Statement is
effective, the &#147;<B>Shelf Period</B>&#148;). The Company shall use its reasonable best efforts to promptly replace any Shelf Registration Statement at or before expiration, if applicable, with a successor effective Shelf Registration Statement
until such time as there are no longer any Registrable Securities outstanding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Right to Request Shelf Take-Down</U>. At any time and from time to time during the
Shelf Period, the Anchor Shareholder and the Other Shareholder may, by written notice to the Company, request an offering pursuant to the Shelf Registration Statement of all or part of the Registrable Securities held by such Shareholder (a
&#147;<B>Shelf Take-Down</B>&#148;). The Anchor Shareholder or the Other Shareholder may, after any Shelf Registration Statement becomes effective, deliver a written notice to the Company (the &#147;<B>Underwritten Shelf Take-Down Notice</B>&#148;)
specifying that a Shelf Take-Down is intended to be conducted through an underwritten offering (including by means of a Block Trade) (such underwritten offering, an &#147;<B>Underwritten Shelf Take-Down</B>&#148;), which notice shall specify the
number and type of Registrable Securities intended to be included in such Underwritten Shelf Take-Down and the intended method(s) of distribution thereof; <U>provided</U> that the Anchor Shareholder and the Other Shareholder may not, without the
Company&#146;s prior written consent, request an Underwritten Shelf Take-Down the reasonably anticipated aggregate gross proceeds of which shall be less than the Minimum Amount, unless the number of Registrable Securities to be sold in such offering
represents all of such Shareholder&#146;s remaining Registrable Securities. The Company and the Anchor Shareholder or the Other Shareholder participating in an Underwritten Shelf Take-Down will enter into an underwriting agreement (including a
customary <FONT STYLE="white-space:nowrap">lock-up,</FONT> not to exceed ninety (90)&nbsp;days, if requested by the managing underwriter(s) in customary form with the managing underwriter(s) selected for such offering). The Company may include in
any Underwritten Shelf Take-Down (other than a Block Trade) pursuant to this <U>Section</U><U></U><U>&nbsp;2(b)</U> any additional securities of the same class without the prior written consent of the Anchor Shareholder or the Other Shareholder.
Notwithstanding anything to the contrary herein, (A)&nbsp;if the Anchor Shareholder or the Other Shareholder wishes to engage in (i)&nbsp;a Shelf Take-Down in the form of a Block Trade, (1)&nbsp;such Shareholder shall notify the Company of the Block
Trade not less than three (3)&nbsp;Business Days prior to the day such Block Trade is to commence, (2)&nbsp;Persons other than the Anchor Shareholder and the Other Shareholder shall not be entitled to make a demand for, receive notice of, or elect
to participate in, such Block Trade and (3)&nbsp;such Shareholder shall not be required to notify any other Person (except the Anchor Shareholder or Other Shareholder, as applicable) of such Block Trade or permit any other Person to participate in
such Block Trade, or (ii)&nbsp;a Shelf Take-Down that is not an Underwritten Shelf Take-Down, (1)&nbsp;such Shelf Take-Down may be made for less than the Minimum Amount, (2)&nbsp;Persons other than the Anchor Shareholder or the Other Shareholder
shall not be entitled to make a demand for, receive notice of, or elect to participate in, such Shelf Take-Down and (3)&nbsp;such Shareholder shall not be required to notify any other Person of such Shelf Take-Down or permit any other Person to
participate in such Shelf Take-Down, and (B)&nbsp;any Shareholder not included in a Block Trade shall not be subject to any underwriter <FONT STYLE="white-space:nowrap">lock-up</FONT> or be required to enter into or sign any <FONT
STYLE="white-space:nowrap">lock-up</FONT> in connection with such Block Trade. Notwithstanding anything to the contrary contained herein, the Company will not be in breach of this Agreement if an underwriter will not agree to the <FONT
STYLE="white-space:nowrap">lock-up</FONT> terms required by this <U>Section</U><U></U><U>&nbsp;2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>[reserved]</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Limitations on Shelf Take-Downs</U>. During the Shelf Period, the Anchor Shareholder and Other Shareholder shall each be entitled to
request a maximum of four (4)&nbsp;Underwritten Shelf Take-Downs (including Block Trades) pursuant to <U>Section</U><U></U><U>&nbsp;2(b)</U>; <U>provided</U> that the Company shall not be obligated to effect any Underwritten Shelf Take-Down
(including a Block Trade) within ninety (90)&nbsp;days after the pricing date of a previous Underwritten Shelf Take-Down, in each case, that is a marketed underwritten deal (for the avoidance of doubt, excluding a Block Trade). Any Underwritten
Shelf Take-Down (including a Block Trade) must be for at least the Minimum Amount, unless the number of Registrable Securities to be sold in such offering </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
represents all of the remaining Registrable Securities of the initiating Shareholder. Notwithstanding anything to the contrary herein, Shareholders shall be entitled to an unlimited number of
Shelf Take-Downs that are not Underwritten Shelf-Take Downs and such Shelf Take-Downs may be made for less than the Minimum Amount (for the avoidance of doubt, in the case of such <FONT STYLE="white-space:nowrap">non-underwritten</FONT> Shelf-Take
Downs, the Company shall not be required to perform the obligations applicable to underwritten offerings as set forth in <U>Section</U><U></U><U>&nbsp;3</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Piggyback Registration</U>. If the Company proposes or is required to file a registration statement under the Securities Act with
respect to an offering of Common Stock or similar equity securities of the Company, or the Company proposes a shelf take-down (other than (i)&nbsp;a Block Trade, (ii)&nbsp;an
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">at-the-market</FONT></FONT> offering or (iii)&nbsp;a Shelf Take-Down by a Shareholder that is not an Underwritten Shelf Take-Down), whether for its own account or for the account of
one or more securityholders of the Company, on a form and in a manner that would permit registration of the Registrable Securities, other than any Special Registration, the Company shall give written notice as promptly as practicable, but not later
than ten (10)&nbsp;days prior to the anticipated date of filing of such Registration Statement, or in the case of a shelf take-down, no later than five (5)&nbsp;days prior to the anticipated shelf take-down, to the Shareholders of its intention to
effect such registration or shelf take-down and, in the case of each Shareholder, shall include in such registration or shelf take-down all of such Shareholder&#146;s Registrable Securities (subject to <U>Section</U><U></U><U>&nbsp;2(h)</U>) with
respect to which the Company has received a written request from such Shareholder for inclusion therein within three (3)&nbsp;days after the Company&#146;s notice is given to such Shareholder (a &#147;<B>Piggyback Registration</B>&#148; and any such
requesting Shareholder that has not withdrawn its Registrable Securities from such Piggyback Registration, a &#147;<B>Piggyback Shareholder</B>&#148; with respect to such Piggyback Registration). In the event that a Shareholder makes such written
request, such Shareholder may withdraw its Registrable Securities from such Piggyback Registration by giving written notice to the Company and the managing underwriter(s), if any, at any time at least two (2)&nbsp;Business Days prior to the
effective date of the Registration Statement relating to such Piggyback Registration or the date of the launch of the shelf take-down. The Company may postpone (provided that Piggyback Shareholders are given the option to withdraw their Registrable
Securities from such postponed Piggyback Registration), terminate or withdraw any Piggyback Registration under this <U>Section</U><U></U><U>&nbsp;2(e)</U>, whether or not any Shareholder has elected to include Registrable Securities in such
registration. No Piggyback Registration shall count as an Underwritten Shelf Take-Down to which the Shareholders are entitled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)
<U>Selection </U><U>of Underwriters; Right to Participate</U>. The Anchor Shareholder or the Other Shareholder (if the Anchor Shareholder is not participating in such Underwritten Shelf Take-Down or participating in an amount less than the Minimum
Amount) or, in the case of a Block Trade, the Shareholder that initiated such Block Trade, shall have the right to select the managing underwriter(s) to administer an Underwritten Shelf Take-Down; <U>provided</U> that (i)&nbsp;such managing
underwriter(s) are reasonably acceptable to the Company and (ii)&nbsp;in the event that the Other Shareholder initiated such Underwritten Shelf Take-Down and the Anchor Shareholder is participating in an amount greater than the Minimum Amount, the
managing underwriter(s) will be jointly selected by the Anchor Shareholder and the Other Shareholder, in each case, acting reasonably. If a Piggyback Registration under <U>Section</U><U></U><U>&nbsp;2(e)</U> hereof is proposed to be underwritten,
the Company shall so advise the Shareholders as a part of the written notice given pursuant to <U>Section</U><U></U><U>&nbsp;2(e)</U> hereof. In such event, the managing underwriter(s) to administer the offering shall be chosen solely by the
Company. A Shareholder may participate in a registration or offering </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
hereunder only if such Shareholder agrees to sell such Registrable Securities on the basis provided in any underwriting agreement with the underwriter(s) and completes and executes all customary
questionnaires, powers of attorney, indemnities, underwriting agreements, <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements and other documents reasonably requested by the Company or the managing underwriter(s) under the terms of such
underwriting arrangements customary for selling Shareholders to enter into in secondary underwritten public offerings; <U>provided</U> that the Shareholders shall only be required to make representations and warranties to the Company or the
underwriters that are customary for such offerings under the circumstances (in no event, however, will the Shareholders be required to represent to the accuracy of the Company&#146;s disclosure, other than information specifically related to such
Shareholder&#146;s ownership position (including the lack of liens on such shares), the number of Registrable Securities proposed to be sold by such Shareholder and the name and address of such Shareholder). Notwithstanding anything to the contrary
herein, any underwriting agreement shall contain such representations and warranties by, and the other agreements on the part of, the Company to and for the benefit of the Shareholders as are customarily made by issuers to selling Shareholders in
secondary underwritten public offerings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Priority of Securities Offered Pursuant to Underwritten Shelf Take-Downs</U>. If the
managing underwriter(s) of an offering pursuant to an Underwritten Shelf Take-Down shall advise the Company and the Shareholders in writing that, in its good faith opinion, the total number or dollar amount of shares of Common Stock requested to be
included in such Underwritten Shelf Take-Down exceeds the number or dollar amount that can be sold in such offering without having an adverse effect on such offering, including the price at which such shares can be sold, then the Company shall
include in such Underwritten Shelf Take-Down the maximum number of shares that such underwriter advises can be so sold without having such adverse effect, allocated (i)&nbsp;first, to Registrable Securities requested by the Shareholders to be
included in such Underwritten Shelf Take-Down, pro rata among all such Shareholders on the basis of the number of Registrable Securities held by such Shareholders, (ii)&nbsp;second, if the maximum number of shares that such underwriter advises can
be so sold without having such adverse effect is not reached under the foregoing <U>subclause</U><U></U><U>&nbsp;(i)</U>, to any securities requested to be included therein by the Company and (iii)&nbsp;third, if the maximum number of shares that
such underwriter advises can be so sold without having such adverse effect is not reached under the foregoing <U>subclauses</U><U></U><U>&nbsp;(i)</U> and <U>(ii)</U>, to any securities requested to be included therein by any other Persons,
allocated among such Persons on a pro rata basis or in such other manner as they may agree. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Priority of Securities Offered
Pursuant to Piggyback Registration</U>. If the managing underwriter(s) of a registration of shares of Common Stock giving rise to a right to Piggyback Registration shall advise the Company and the Piggyback Shareholders with respect to such
Piggyback Registration in writing that, in its good faith opinion, the total number or dollar amount of shares of Common Stock proposed to be sold in such offering and Registrable Securities requested by such Piggyback Shareholders to be included
therein, in the aggregate, exceeds the number or dollar amount that can be sold in such offering without having an adverse effect on such offering, including the price at which such shares can be sold, then the Company shall include in such
registration the maximum number of shares that such underwriter advises can be so sold without having such adverse effect, allocated, if the Piggyback Registration is initiated as an underwritten: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) primary offering for the account of the Company: (x)&nbsp;first, to shares of Common
Stock to be included by the Company, (y)&nbsp;second, if the maximum number of shares that such underwriter advises can be so sold without having such adverse effect is not reached under the foregoing <U>subclause</U><U></U><U>&nbsp;(x)</U>, among
the Registrable Securities requested to be included therein by the Shareholders and securities requested to be included therein by other securityholders with applicable registration rights under a Permitted Agreement, pro rata among such Persons on
the basis of the number of shares requested to be included therein by each of them, and (z)&nbsp;third, if the maximum number of shares that such underwriter advises can be so sold without having such adverse effect is not reached under the
foregoing <U>subclauses</U><U></U><U>&nbsp;(x)</U> and <U>(y)</U>, among the securities requested to be included therein by other securityholders, pro rata among such Persons on the basis of the number of shares requested to be included therein by
each of them or in such other manner as they may agree; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) offering for the account of holder(s) of the Company&#146;s securities
other than the Company: (w)&nbsp;first, among the securities requested to be included therein by such holder who initiated the Piggyback Registration, (x)&nbsp;second, if the maximum number of shares that such underwriter advises can be so sold
without having such adverse effect is not reached under the foregoing <U>subclause</U><U></U><U>&nbsp;(w)</U>, among the Registrable Securities requested to be included therein by the Shareholders and securities requested to be included therein by
other securityholders with applicable registration rights under a Permitted Agreement, pro rata among such Persons on the basis of the number of shares requested to be included therein by each of them, (y)&nbsp;third, if the maximum number of shares
that such underwriter advises can be so sold without having such adverse effect is not reached under the foregoing <U>subclauses</U><U></U><U>&nbsp;(w)</U> and <U>(x)</U>, to any securities requested to be included therein by the Company and
(z)&nbsp;fourth, if the maximum number of shares that such underwriter advises can be so sold without having such adverse effect is not reached under the foregoing <U>subclauses</U><U></U><U>&nbsp;(w)</U>, <U>(x)</U> and <U>(y)</U>, to any
securities requested to be included therein by any other Persons, allocated among such Persons on a pro rata basis or in such other manner as they may agree. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Postponement; Suspensions; Blackout Period</U><U>. </U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company may postpone the filing or the effectiveness of a Shelf Registration Statement or the commencement of a Shelf Take-Down (or
suspend the continued use of a Shelf Registration Statement), including requiring the Shareholders to suspend any offerings of Registrable Securities pursuant hereto (a &#147;<B>Suspension</B>&#148;), (A) if the Shelf Registration Statement is a
Form <FONT STYLE="white-space:nowrap">S-1</FONT> Shelf, (x)&nbsp;for a period of up to three (3)&nbsp;days following the date on which the Company files information with the SEC that must be incorporated by a post-effective amendment to the Form <FONT
STYLE="white-space:nowrap">S-1</FONT> Shelf; <U>provided</U> that such post-effective amendment must be filed promptly following such date, or (y)&nbsp;for a period of up to ten (10)&nbsp;days following the date on which the Company files a
post-effective amendment to the Form <FONT STYLE="white-space:nowrap">S-1</FONT> Shelf to convert it into a Form <FONT STYLE="white-space:nowrap">S-3</FONT> Shelf, (B)&nbsp;during the pendency of a stop order issued by the SEC suspending the use of
any registration statement of the Company or proceedings initiated by the SEC with respect to any such registration statement under Section&nbsp;8(d) or 8(e) of the Securities Act or (C)&nbsp;if, based on the good faith judgment of the Board of
Directors, such postponement or suspension is necessary in order to avoid materially detrimental disclosure of material <FONT STYLE="white-space:nowrap">non-public</FONT> information that the Board of Directors, after consultation with outside
counsel to the Company, has in good faith determined (1)&nbsp;would be required to be made in any Shelf Registration Statement so that such Registration </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Statement does not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading,
(2)&nbsp;would not be required to be made at such time but for the filing or continued use of such Registration Statement, and (3)&nbsp;the Company has a bona fide business purpose for not disclosing publicly, and the Company delivers to the
Shareholders participating in such registration notice (a &#147;<B>Suspension Notice</B>&#148;) of the Company&#146;s determination to postpone or suspend use of the Shelf Registration Statement, as applicable; <U>provided</U> that, in each case,
the Shareholders requesting a Shelf Take-Down shall be entitled, at any time after receiving a Suspension Notice or similar notice and before such Shelf Take-Down is commenced, to withdraw such request and, if such request is withdrawn, the Company
shall pay all expenses incurred by the Shareholders, including fees of one legal counsel (subject to the caps contained herein), in connection with such withdrawn registration and such Shelf Take-Down shall not count against the number of
Underwritten Shelf Take-Downs permitted pursuant to <U>Section</U><U></U><U>&nbsp;2(d)</U>. If Shareholders otherwise withdraw a request for a Shelf Take-Down, other than following the receipt of a Suspension Notice, the Shareholders shall pay all
expenses incurred by the Shareholders, including fees of legal counsel, in connection with such withdrawn registration and such Shelf Take-Down shall not count as an Underwritten Shelf Take-Down; <U>provided</U> that, at the option of the
Shareholders, the Company shall pay all expenses incurred by the Shareholders, including fees and one legal counsel (subject to the caps contained herein), in connection with such withdrawn registration if such Shelf Take-Down counts against the
number of Underwritten Shelf Take-Downs pursuant to <U>Section</U><U></U><U>&nbsp;2(d)</U>. The Company shall provide prompt written notice to the Shareholders (an &#147;<B>End of Suspension Notice</B>&#148;) of (x)&nbsp;the fact that the
circumstances giving rise to such Suspension no longer exist, (y)&nbsp;the Company&#146;s decision to commence such Shelf Take-Down following such Suspension and (z)&nbsp;the commencement of such Shelf Take-Down. Notwithstanding the provisions of
this <U>Section</U><U></U><U>&nbsp;2(i)(i)</U>, with respect to <U>Section</U><U></U><U>&nbsp;2(i)(i)(C)</U>, the Company shall not effect any Suspension(s) more than two (2)&nbsp;times during any <FONT STYLE="white-space:nowrap">12-month</FONT>
period or for a period in the aggregate exceeding ninety (90)&nbsp;days in any <FONT STYLE="white-space:nowrap">12-month</FONT> period. No Shareholder shall effect any sales of shares of Common Stock pursuant to a Shelf Registration Statement at any
time after it has received a Suspension Notice from the Company and prior to receipt of an End of Suspension Notice. The Company may not effect any other Registration Statement during the term of any Suspension. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Each Shareholder agrees that, except as required by Law, it shall treat as confidential the receipt of any Suspension Notice;
<U>provided</U> that in no event shall such Suspension Notice contain any material nonpublic information of the Company (other than the existence of such Suspension Notice). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Supplements and Amendments</U>. The Company shall supplement and amend any Shelf Registration Statement if required by the Securities
Act or the rules, regulations or instructions applicable to the registration form used by the Company for such Shelf Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Subsequent Holder Notice</U>. If a Person becomes entitled to the benefits of this Agreement as a Shareholder pursuant to
<U>Section</U><U></U><U>&nbsp;7</U> after a Shelf Registration Statement becomes effective under the Securities Act, the Company shall, as promptly as practicable, following delivery of written notice to the Company of a request for such
Person&#146;s name to be included as a selling securityholder in the prospectus related to the Shelf Registration Statement: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) if required and permitted by Law, file with the SEC a supplement to the related
prospectus or a post-effective amendment to the Shelf Registration Statement so that such Person is named as a selling securityholder in the Shelf Registration Statement and the related prospectus in such a manner as to permit such Person to deliver
a prospectus to the purchaser of the Registrable Securities in accordance with Law; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) if, pursuant to
<U>Section</U><U></U><U>&nbsp;3(a)(ii)</U>, the Company shall have filed a post-effective amendment to the Shelf Registration Statement that is not automatically effective, use its reasonable best efforts to cause such post-effective amendment to
become promptly effective under the Securities Act; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) promptly notify the Shareholders after the effectiveness under the
Securities Act of any post-effective amendment filed pursuant to <U>Section</U><U></U><U>&nbsp;3(a)(ii)</U>; <U>provided</U> that the Company shall not be required to file more than one (1)&nbsp;post-effective amendment or supplement to the related
prospectus pursuant to this <U>Section</U><U></U><U>&nbsp;2(k)</U> for any fiscal quarter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3. <U>Registration
Procedures</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Filing and Other Procedures</U>. If and whenever the Company is required to use its reasonable best efforts to
effect the registration of any Registrable Securities under the Securities Act as provided in <U>Section</U><U></U><U>&nbsp;2</U>, the Company shall effect such registration to permit the sale of such Registrable Securities in accordance with the
intended method(s) of disposition thereof, and pursuant thereto the Company shall cooperate in the sale of the securities and shall, as promptly as practicable: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) prepare and file with the SEC as promptly as reasonably practicable, but no later than five (5)&nbsp;days after a request for an
Underwritten Shelf Take-Down, subject to the postponement provisions herein, the post-effective amendments and supplements to a Shelf Registration Statement, and the Prospectus used in connection therewith or any free writing prospectus (as defined
in SEC rules) as may be required by applicable securities Laws or reasonably requested by the Shareholders or any managing underwriter(s), to effect such registration and, subject to the efforts standard herein, cause such Registration Statement to
become effective, and provide copies of all such documents proposed to be filed or furnished to (A)&nbsp;counsel of the Shareholders, and provide such legal counsel a reasonable opportunity to review and comment on such documents (other than
Exchange Act reports incorporated by reference thereto not related to such offering), and (B)&nbsp;the other representative(s) on behalf of the Shareholders included in such Registration Statement (to be chosen by the Shareholders) and any managing
underwriter(s), and the representative(s) and the managing underwriter(s) and their respective counsel shall have the reasonable opportunity to review and comment thereon, and the Company will make such changes and additions thereto as may
reasonably be requested by such counsel and the representative(s) and the managing underwriter(s) and their respective counsel prior to such filing, unless the Company reasonably objects to such changes or additions; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) prepare and file with the SEC such <FONT STYLE="white-space:nowrap">pre-and</FONT>
post-effective amendments and supplements to a Shelf Registration Statement, and the Prospectus used in connection therewith or any free writing prospectus (as defined in SEC rules) as may be required by applicable securities Laws or reasonably
requested by the Shareholders or any managing underwriter(s) to maintain the effectiveness of such registration and to comply with the provisions of applicable securities Laws with respect to the disposition of all securities covered by such
registration statement during the period in which such Registration Statement is required to be kept effective, and before filing such amendments or supplements, provide copies of all such documents proposed to be filed or furnished to counsel of
such Shareholders, which documents shall be subject to the review and comment of such counsel (other than Exchange Act reports incorporated by reference thereto not related to such offering); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) furnish to each Shareholder of the securities being registered and each managing underwriter without charge, such reasonable number of
conformed copies of such Registration Statement and of each such amendment and supplement thereto (in each case including all exhibits other than those which are being incorporated into such Registration Statement by reference and that are publicly
available), such reasonable number of copies of the Prospectus contained in such Registration Statement and any other Prospectus filed under Rule&nbsp;424 under the Securities Act in conformity with the requirements of the Securities Act, and such
other documents, as the Shareholders and any managing underwriter(s) may reasonably request; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) use its reasonable best efforts to
register or qualify all Registrable Securities under such other securities or &#147;blue sky&#148; Laws of such jurisdictions as the Shareholders and any managing underwriter(s) may reasonably request; <U>provided</U> that the Company shall not for
any such purpose be required to qualify generally to do business as a foreign company in any jurisdiction where it would not otherwise be required to qualify but for this <U>Section</U><U></U><U>&nbsp;3</U>, or to consent to general service of
process in any such jurisdiction, or to be subject to any tax obligation in any such jurisdiction where it is not then so subject; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v)
as promptly as reasonably practicable, notify the Shareholders and any managing underwriter(s) at any time when the Company becomes aware that a Prospectus relating thereto is required to be delivered under the Securities Act, of the occurrence of
any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the
statements therein not misleading in light of the circumstances under which they were made, and, to, as promptly as is reasonably practicable, prepare and furnish without charge to the Shareholders and any managing underwriter(s) a reasonable number
of copies of a supplement to or an amendment of such Prospectus as may be necessary so that, as thereafter delivered to the purchaser of such securities, such Prospectus shall not include an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances under which they were made; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) provide and cause to be maintained a transfer agent and registrar for all Registrable Securities covered by such Registration Statement
not later than the effective date of such Registration Statement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) use its reasonable best efforts to list all Registrable
Securities covered by such Registration Statement on the principal securities exchange on which any such class of securities is then listed and cause to be satisfied all requirements and conditions of such securities exchange to the listing of such
securities that are reasonably within the control of the Company; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) notify each Shareholder and any managing underwriter(s), as soon as is reasonably
practicable after it shall receive notice thereof, of the time when such Registration Statement, or any post-effective amendments to the Registration Statement, shall have become effective, after it shall receive notice thereof; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) to make available to each Shareholder whose Registrable Securities are included in such Registration Statement and any managing
underwriter(s) as soon as reasonably practicable after the same is prepared and distributed, filed with the SEC, or received by the Company, an executed copy of each letter written by or on behalf of the Company to the SEC or the staff of the SEC
(or other governmental agency or self-regulatory body or other body having jurisdiction, including any domestic or foreign securities exchange), and any item of correspondence received from the SEC or the staff of the SEC (or other governmental
agency or self-regulatory body or other body having jurisdiction, including any domestic or foreign securities exchange), in each case relating to such Registration Statement, it being understood that each Shareholder receiving such material from
the Company that is confidential shall and shall cause its Affiliates and representatives to keep such materials confidential. The Company shall as soon as reasonably practicable (A)&nbsp;notify the Shareholders and any managing underwriter(s) of
the effectiveness of such Registration Statement or any post-effective amendment or the filing of the prospectus supplement contemplated herein, (B)&nbsp;respond reasonably and completely to any and all comments received from the SEC or the staff of
the SEC, with a view towards causing such Registration Statement or any amendment thereto to be declared effective by the SEC as soon as reasonably practicable, and (C)&nbsp;file an acceleration request following the resolution or clearance of all
SEC comments or, if applicable, following notification by the SEC that any such Registration Statement or any amendment thereto will not be subject to review; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) advise each Shareholder and any managing underwriter(s), promptly after it shall receive notice or obtain knowledge thereof, of
(A)&nbsp;the issuance of any stop order, injunction or other order or requirement by the SEC suspending the effectiveness of such Registration Statement or the initiation or threatening of any proceeding for such purpose and use its reasonable best
efforts to prevent the issuance of any stop order, injunction or other order or requirement or to obtain its withdrawal if such stop order, injunction or other order or requirement should be issued, (B)&nbsp;the suspension of the registration of the
subject shares of the Registrable Securities in any state jurisdiction and (C)&nbsp;the removal of any such stop order, injunction or other order or requirement or proceeding or the lifting of any such suspension; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) in connection with a customary due diligence review, make available for inspection by one representative on behalf of each Shareholder
whose Registrable Securities are included in such registration statement and any managing underwriter(s), and any attorney, accountant or other agent retained by, or other representative of, any such Shareholder or underwriter, at reasonable times
and in a reasonable manner, all pertinent financial and other records and corporate documents of the Company, and cause the Company&#146;s officers, directors and employees to supply all information reasonably requested by any such Shareholder,
underwriter(s), attorney, accountant or agent to conduct a reasonable investigation within the meaning of Section&nbsp;11 of the Securities Act that is customary for a participant in a securities </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
offering in connection with such registration statement; <U>provided</U> that the foregoing investigation and information gathering shall be coordinated on behalf of such parties by one
(1)&nbsp;firm of counsel designated by and on behalf of such parties, and that any information that is not generally publicly available at the time of delivery of such information shall be kept confidential by such parties pursuant to customary
confidentiality agreements; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii) if requested by any Shareholder or any managing underwriter(s), as promptly as is reasonably
practicable, incorporate in a prospectus supplement or post-effective amendment such information as such Shareholder or managing underwriter(s) reasonably requests to be included therein, including with respect to the Registrable Securities being
sold by such Shareholder, the purchase price being paid therefor by any underwriter(s) and with respect to any other terms of an underwritten offering of the Registrable Securities to be sold in such offering, and as promptly as is reasonably
practicable, make all required filings of such prospectus supplement or post-effective amendment; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii) reasonably cooperate with each
Shareholder and any managing underwriter(s) participating in the disposition of such Registrable Securities and their respective counsel in connection with any filings required to be made with FINRA; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiv) in the case of an underwritten offering, (1)&nbsp;enter into such customary agreements (including an underwriting agreement in
customary form), (2)&nbsp;take all such other customary actions as the managing underwriter(s) reasonably request in order to expedite or facilitate the disposition of such Registrable Securities (including causing senior management and other
Company personnel to reasonably cooperate with the Shareholder(s) whose Registrable Securities are included in a Registration Statement and the underwriter(s) in connection with performing customary due diligence and the customary marketing of such
offering, including management presentations, investor calls and road show presentations, subject to the limitations on marketed offerings contained herein) and (3)&nbsp;cause its counsel to issue opinions of counsel addressed and delivered to the
underwriter(s) in form, substance and scope as are customary in underwritten offerings, subject to customary limitations, assumptions and exclusions; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xv) if requested by the managing underwriter(s) of an underwritten offering, use its reasonable best efforts to cause to be delivered, upon
the pricing of any underwritten offering, and at the time of closing of a sale of Registrable Securities pursuant thereto, &#147;comfort&#148; letters from the Company&#146;s independent registered public accountants addressed to the underwriter(s),
and otherwise in customary form and covering such financial and accounting matters as are customarily covered by &#147;comfort&#148; letters of the independent registered public accountants delivered at pricing or closing, as applicable, in
connection with primary underwritten public offerings; <U>provided</U> that such recipients furnish such written representations or acknowledgements as are customarily required to receive such comfort letters; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvi) the Company agrees not to file or make any amendment to any Registration Statement with respect to any Registrable Securities, or any
amendment of or supplement to the prospectus, or any free writing prospectus, which amendment refers to any Shareholder covered thereby by name, or otherwise identifies such Shareholder, without the consent of such Shareholder, such consent not to
be unreasonably withheld or delayed, unless such disclosure is required by Law, in which case the Company shall provide written notice to such Shareholders no less than two (2)&nbsp;Business Days prior to the filing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Conditions to Registration Rights</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) As a condition precedent to the obligations of the Company to file any Registration Statement, each Shareholder shall furnish in writing
to the Company such information regarding such Shareholder (and any of its Affiliates), the Registrable Securities to be sold and the intended method of distribution of such Registrable Securities reasonably requested by the Company as is reasonably
necessary for inclusion in the Registration Statement relating to such offering pursuant to the Securities Act; <U>provided</U> that the Company shall only use such information in connection with such registration or related offering.
Notwithstanding the foregoing, in no event will any party be required to disclose to any other party any personally identifiable information or personal financial information in respect of any individual. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Each Shareholder agrees that,&nbsp;upon receipt of any notice from the Company of the happening of any event of the kind described in
(x)<U>&nbsp;Section</U><U></U><U>&nbsp;3(a)</U><U>(ii)</U> or <U>(v)</U>, such Shareholder shall forthwith discontinue its disposition of Registrable Securities pursuant to the registration statement relating to such Registrable Securities until
such Shareholder&#146;s receipt of the copies of the supplemented or amended prospectus contemplated by <U>Section</U><U></U><U>&nbsp;3(a)</U><U>(ii)</U> or <U>(v)</U>; (y)&nbsp;clause&nbsp;(A) of <U>Section</U><U></U><U>&nbsp;3(a)(x)</U>, such
Shareholder shall discontinue its disposition of Registrable Securities pursuant to such registration statement until such Shareholder&#146;s receipt of the notice described in clause&nbsp;(C) of <U>Section</U><U></U><U>&nbsp;3(a)(x)</U>; and
(z)&nbsp;clause&nbsp;(B) of <U>Section</U><U></U><U>&nbsp;3(a)(x)</U>, such Shareholder shall discontinue its disposition of Registrable Securities pursuant to such registration statement in the applicable state jurisdiction(s) until such
Shareholder&#146;s receipt of the notice described in clause&nbsp;(C) of <U>Section</U><U></U><U>&nbsp;3(a)(x)</U>. The length of time that any registration statement is required to remain effective shall be extended by any period of time that such
registration statement is unavailable for use pursuant to this paragraph; <U>provided</U> that in no event shall any Registration Statement be required to remain effective after there are no longer any Registrable Securities outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) If requested by the managing underwriter(s), each Shareholder that (A)&nbsp;beneficially owns at least 5% of the Common Stock (on an <FONT
STYLE="white-space:nowrap">As-Converted</FONT> Basis) and (B)&nbsp;was offered the opportunity to participate in a marketed underwritten offering, shall enter into a customary lockup agreement not to exceed ninety (90)&nbsp;days in respect of such
underwritten offering by the Company; <U>provided</U> that the Company shall cause each of its executive officers and directors and shall use its reasonable best efforts to cause any other holders of Common Stock that beneficially own at least 5% of
the Common Stock (on an <FONT STYLE="white-space:nowrap">As-Converted</FONT> Basis) (excluding any passive investors) and were offered the opportunity to and elects to participate in such Marketed Deal, to enter into lockup agreements that contain
restrictions that are no less restrictive than the restrictions contained in the lockup agreements executed by the Shareholders; <U>provided</U>, <U>further</U>, that if such lockup agreement is released or waived for any of the Company&#146;s
executive officers or directors or other holders of Common Stock that beneficially own at least 5% of the Common Stock (on an <FONT STYLE="white-space:nowrap">As-Converted</FONT> Basis), the Shareholders shall receive a comparable release or waiver
on a pro rata basis. The Shareholders acknowledge that (i)&nbsp;the Company may be subject to a <FONT STYLE="white-space:nowrap">lock-up</FONT> with the managing underwriter(s) in connection with any underwritten offering by the Company, whether or
not a Shareholder participated in the last Underwritten Shelf Take-Down, and (ii)&nbsp;the Company will use its reasonable best efforts to cause itself not to be subject to any <FONT STYLE="white-space:nowrap">lock-up</FONT> with the requesting
underwriter(s) in a Block Trade. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4. <U>Indemnification</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Indemnification by the Company</U>. The Company agrees to indemnify, hold harmless and reimburse, to the fullest extent permitted by
Law, each Shareholder, its Affiliates, partners, officers, directors, employees, advisors, representatives and agents and each Person, if any, who controls such Shareholder within the meaning of the Securities Act or the Exchange Act, against any
and all losses, penalties, liabilities, claims, damages and expenses, joint or several (including reasonable and documented attorneys&#146; fees and any expenses and reasonable and documented costs of investigation) (&#147;<B>Losses</B>&#148;), as
incurred, to which the Shareholders or any such indemnitees may become subject under the Securities Act or otherwise, insofar as such Losses (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based
upon (i)&nbsp;any untrue statement or alleged untrue statement of any material fact contained in the Registration Statement under which such Registrable Securities were registered and sold under the Securities Act, any Prospectus contained therein,
or any amendment or supplement thereto, or arising out of or based upon any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading; <U>provided</U> that the Company shall not be liable in any such case to the extent that any Loss arises out of or is based upon an untrue statement or alleged statement or omission or alleged omission made in
such Registration Statement, any such Prospectus, amendment or supplement in reliance upon and in conformity with written information about a Shareholder that is furnished to the Company by such Shareholder or its authorized representative expressly
for use therein, it being understood and agreed that the only such information furnished by any Shareholder for any purpose of this Agreement (including <U>Section</U><U></U><U>&nbsp;4(b)</U>) consists of the number of shares of Common Stock owned
by such Shareholder, the number of Registrable Securities proposed to be sold by such Shareholder and the name and address of such Shareholder or (ii)&nbsp;any violation (or alleged violation) by the Company of the Securities Act, the Exchange Act,
any state securities laws or any rule or regulation thereunder in connection with any registration or offering hereunder. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such Shareholder
or any indemnified party and shall survive the transfer of such securities by such Shareholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Indemnification by the
Shareholders</U>. Each Shareholder agrees to indemnify, hold harmless and reimburse, to the fullest extent permitted by Law (in the same manner and to the same extent as set forth in <U>Section</U><U></U><U>&nbsp;4(a)</U>), the Company, its
Affiliates, officers, directors, and each Person, if any, who controls any of the foregoing within the meaning of the Securities Act or the Exchange Act, with respect to any untrue statement or alleged untrue statement of a material fact in or
omission or alleged omission to state a material fact from such Registration Statement, any Prospectus contained therein, or any amendment or supplement thereto, to the extent, but only to the extent, that such untrue statement or alleged untrue
statement or omission or alleged omission was made in reliance upon and in conformity with written information about such Shareholder furnished to the Company by such Shareholder or its authorized representative expressly for inclusion therein, it
being understood and agreed that the only such information furnished by any Shareholder consists of the information described as such in <U>Section</U><U></U><U>&nbsp;4(a)</U>; <U>provided</U> that a Shareholder shall not be liable for any amounts
in excess of the net </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
proceeds received by such Shareholder from sales of Registrable Securities pursuant to the Registration Statement to which the claims relate; <U>provided</U>, <U>further</U>, that the obligations
of the Shareholders shall be several and not joint and several. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Company or any indemnified party and shall survive the transfer of such
securities by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Notices of Claims, etc.</U> Promptly after receipt by an indemnified party of notice of the
commencement of any action or proceeding involving a claim referred to in the preceding paragraphs of this <U>Section</U><U></U><U>&nbsp;4</U>, such indemnified party shall, if a claim in respect thereof is to be made against an indemnifying party,
give written notice to such indemnifying party of the commencement of such action or proceeding; <U>provided</U> that the failure of any indemnified party to give notice as provided herein shall not relieve the indemnifying party of its obligations
under the preceding paragraphs of this <U>Section</U><U></U><U>&nbsp;4</U>, except to the extent that the indemnifying party is prejudiced by such failure to give notice. In case any such action or proceeding is brought against an indemnified party,
unless in such indemnified party&#146;s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, such indemnified party shall permit such indemnifying party to assume the
defense of such claim with counsel reasonably satisfactory to the indemnified party; <U>provided</U> that any person entitled to indemnification hereunder shall have the right to employ separate counsel and to participate in the defense of such
claim, but the fees and expenses of such counsel shall be at the expense of such person unless&nbsp;(i) the indemnifying party has agreed to pay such fees or expenses, (ii)&nbsp;the indemnifying party&nbsp;shall have failed to assume the defense of
such claim and employ counsel reasonably satisfactory to such person within a reasonable time after receipt of notice of such claim from the person entitled to indemnification hereunder or (iii)&nbsp;in the indemnified party&#146;s reasonable
judgment (based upon advice of its counsel) there may be material legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party or a conflict of interest may exist
between it or other indemnified parties and the indemnifying party with respect to any such claim. If such defense is not assumed by the indemnifying party as permitted hereunder, the indemnifying party will not be subject to any liability for any
settlement made by the indemnified party without its consent. If such defense is assumed by the indemnifying party pursuant to the provisions hereof, such indemnifying party shall not settle or otherwise compromise, except with the consent of the
indemnified party, unless (x)&nbsp;such settlement or compromise (i)&nbsp;contains a full and unconditional release of all indemnified parties of all liability in respect of or arising out of all such claims or proceedings that are the subject
matter of such proceeding and all claims and proceedings in respect of which the indemnified party could have been subject to claims or proceedings based upon the actions or inactions underlying such claims or proceedings, (ii)&nbsp;imposes no
liability or obligation on the indemnified party, (iii)&nbsp;does not contain any statement of wrongdoing, culpability, malfeasance or fault by or on behalf of the indemnified party and (iv)&nbsp;provides only for a cash payment that is paid in full
by the indemnifying party or (y)&nbsp;the indemnified party otherwise consents in writing. An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim will not be obligated to pay the fees and expenses of more than
one counsel (plus local counsel) for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party, a conflict of interest may exist between such indemnified party and any
other of such indemnified parties with respect to such claim, in which event the indemnifying party shall be obligated to pay the reasonable fees and disbursements of such additional counsel or counsels. The indemnifying party shall not be liable
for any settlement of any proceeding effected without its prior written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party from and against
any loss or liability by reason of such settlement or judgment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Contribution</U>. If the foregoing indemnity is held by a Governmental Entity of
competent jurisdiction to be unavailable to the Company or any Shareholder, or is insufficient to hold harmless an indemnified party, then the indemnifying party shall contribute to the amount paid or payable by the indemnified party as a result of
the Loss in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, and the relative benefits received by the indemnifying party and the indemnified party, as well as any other relevant
equitable considerations. No indemnified party guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any indemnifying party who was not guilty of such
fraudulent misrepresentation. In connection with any registration statement filed with the SEC by the Company, the relative fault of the indemnifying party on the one hand and of the indemnified party on the other shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party, and by such
party&#146;s relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. Notwithstanding the provisions of this <U>Section</U><U></U><U>&nbsp;4</U>, no Shareholder shall be required to
contribute an amount greater than the net proceeds received by such Shareholder from sales of Registrable Securities pursuant to the Registration Statement to which the claims relate (after taking into account the amount of damages which such
Shareholder has otherwise been required to pay by reason of any and all untrue or alleged untrue statements of material fact or omissions or alleged omissions of material fact made in any Registration Statement or Prospectus or any amendment thereof
or supplement thereto related to such sale of Registrable Securities). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>No Exclusivity</U>. The remedies provided for in this
<U>Section</U><U></U><U>&nbsp;4</U> are not exclusive and shall not limit any rights or remedies which may be available to any indemnified party at Law or in equity or pursuant to any other agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5 <U>Covenants Relating to Rule</U><U></U><U>&nbsp;144</U>. The Company shall use its reasonable best efforts to (x)&nbsp;timely
file all reports and other documents required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations promulgated by the SEC thereunder (provided, that if the Company is not required to file such reports, it
will, upon the request of any Shareholder, make publicly available such information as necessary to permit sales pursuant to Rule 144 under the Securities Act), and (y)&nbsp;take such further action as any Shareholder may reasonably request in
writing, in each case, to the extent required from time to time to enable such Shareholder to, if permitted by the terms of this Agreement, the applicable Investment Agreement and the Registrable Securities, transfer such Registrable Securities
without registration under the Securities Act within the limitations of the exemptions provided by (a)&nbsp;Rule&nbsp;144 or Regulation&nbsp;S under the Securities Act, as such rules may be amended from time to time, or (b)&nbsp;any successor rule
or regulation hereafter adopted by the SEC. Upon the written request of any Shareholder, the Company will deliver to such Shareholder a written statement that it has complied with such requirements, subject to its compliance with such requirements.
The Company shall, upon any request by a Shareholder in connection with a sale, transfer or other disposition by any Shareholder of any Registrable Securities permitted by Rule&nbsp;144, (i) use its reasonable best efforts
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to promptly (and in no event longer than five (5)&nbsp;Business Days after such request) cause the removal of any restrictive legend or similar restriction on the Registrable Securities, and, in
the case of book-entry shares, make or cause to be made appropriate notifications on the books of the Company&#146;s transfer agent for such number of shares and registered in such names as the Shareholders may reasonably request and
(ii)&nbsp;provide a customary opinion of counsel and instruction letter required by the Company&#146;s transfer agent in connection with such sale, transfer or disposition of such Registrable Securities; <U>provided</U> that the taking of such
action by the Company is conditioned on the Company receiving all information and documentation reasonably necessary to support such actions and make a determination that such transfer applies with Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6. <U>Termination</U><U>; Survival</U>. The rights of each Shareholder hereunder shall terminate upon the date that all of the
Registrable Securities held by such Shareholder cease to be Registrable Securities. Notwithstanding the foregoing, the obligations of the parties under <U>Sections</U><U></U><U>&nbsp;4</U>, <U>5</U> and <U>7</U> and this
<U>Section</U><U></U><U>&nbsp;6</U> shall survive the termination hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Governing Law</U>. This Agreement, and all matters arising out of this Agreement and the transactions contemplated hereby, shall be
governed by and construed in accordance with the internal Laws of the State of Delaware without giving effect to any Laws of the State of Delaware that would cause the application of the Laws of any jurisdiction other than the State of Delaware. The
parties hereto (i)&nbsp;submit to the exclusive jurisdiction of the Delaware Court of Chancery and any state appellate court therefrom within the State of Delaware, or, if the Delaware Court of Chancery declines to accept jurisdiction over a
particular matter, any federal or state court of competent jurisdiction located in the State of Delaware in respect of the interpretation and enforcement of the provisions hereof and of any related agreement, certificate or other document delivered
in connection herewith, (ii)&nbsp;waive, and agree not to assert, any defense in any action for the interpretation or enforcement of this Agreement and any related agreement, certificate or other document delivered in connection herewith that they
are not subject to such jurisdiction or that such action may not be brought or is not maintainable in such courts or that this Agreement may not be enforced in or by such courts, that the action is brought in an inconvenient forum, or that the venue
of the action is improper, (iii)&nbsp;agrees that service in person or by certified or by nationally recognized overnight courier to its address set forth in <U>Section</U><U></U><U>&nbsp;7(i)</U> shall constitute valid in personam service upon such
party and its successors and assigns in any action commenced pursuant to this <U>Section</U><U></U><U>&nbsp;7(a)</U> and (iv)&nbsp;acknowledges that this is a commercial transaction, that the foregoing provisions for service of process and the
following provisions for waiver of jury trial have been read, understood and voluntarily agreed to by each party and that by agreeing to such provisions each party is waiving important legal rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Waiver of Jury Trial</U>. <B>EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY CLAIM,
ACTION, HEARING, CHARGE, DISPUTE, SUIT, INVESTIGATION, AUDIT OR PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO CERTIFIES AND ACKNOWLEDGES THAT (i)</B><B></B><B>&nbsp;NO
REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO </B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>
ENFORCE THE FOREGOING WAIVER, (ii)&nbsp;SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (iii)&nbsp;SUCH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (iv)&nbsp;SUCH PARTY
HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
<U>Entire Agreement</U>. This Agreement (including the documents and the instruments referred to herein), the Certificate of Designations and the Investment Agreements, and the documents referenced herein and therein, constitute the entire agreement
among the parties hereto with respect to the subject matter hereof and supersedes any and all prior discussions, negotiations, proposals, undertakings, understandings, and agreements (including any draft agreements) with respect thereto, whether
written or oral, none of which shall be used as evidence of the parties&#146; intent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Amendments and Waivers</U>. No amendment of
any provision hereof shall be valid and binding unless it is in writing and signed by the Company and the Anchor Shareholder (or, in the event that the Anchor Shareholder no longer holds Registrable Securities, Shareholders holding at least fifty
percent (50%) of the Registrable Securities then outstanding, with each share of Common Stock issued pursuant to the Investment Agreements and each share of Common Stock to be received upon conversion of the Convertible Preferred Stock issued
pursuant to the Investment Agreements, in each case, counting as one Registrable Security for this purpose (whether or not then convertible)). No waiver of any right or remedy hereunder, to the extent legally allowed, shall be valid unless the same
shall be in writing and signed by the party making such waiver. No waiver by any party of any breach or violation of, default under, or inaccuracy in any representation, warranty, covenant, or agreement hereunder, whether intentional or not, shall
be deemed to extend to any prior or subsequent breach, violation, default of, or inaccuracy in, any such representation, warranty, covenant, or agreement hereunder or affect in any way any rights arising by virtue of any prior or subsequent such
occurrence. No delay or omission on the part of any party in exercising any right, power, or remedy under this Agreement shall operate as a waiver thereof. Notwithstanding the foregoing, (i)&nbsp;no amendments may be made hereto that adversely
affect the rights of any Shareholder hereunder without the prior written consent of such Shareholder, and (ii)&nbsp;no amendments shall be made to Section&nbsp;3(b)(iii), Section&nbsp;4 or Section&nbsp;5 with respect to a Shareholder without the
prior written consent of such Shareholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Successors and Assigns</U>. The Shareholders may transfer or assign all or any portion
of their respective rights provided in this Agreement in connection with the transfer of shares of Common Stock or Convertible Preferred Stock or Warrants issued under the Investment Agreements pursuant to the terms of the Investment Agreements
without the prior written consent of the Company; <U>provided</U> that reasonably promptly following any such transfer or assignment, (i)&nbsp;the Shareholder provides a written notice to the Company stating the name and address of such transferee
and identifying the amount of Registrable Securities with respect to which the rights under this Agreement were transferred and the nature of the rights so transferred, and (ii)&nbsp;such transferee or assignee agrees in writing with the Company to
be bound by this Agreement as fully as if it were an initial signatory hereto pursuant to a written instrument in form and substance reasonably acceptable to the Company, and any such transferee may thereafter make corresponding assignments in
accordance with this <U>Section</U><U></U><U>&nbsp;7(e)</U>; <U>provided</U>, <U>further</U>, that rights under this Agreement may only be assigned to a Person that is a Permitted Reg Rights Holder or that becomes a Permitted Reg Rights Holder as a
result of a transfer of Registrable Securities concurrent with such assignment pursuant to this <U>Section</U><U></U><U>&nbsp;7(e)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Expenses</U>. Except as otherwise set forth herein (including under
<U>Section</U><U></U><U>&nbsp;2(i)</U>), (i) all Registration Expenses incurred in connection with any Registration Statement under this Agreement shall be borne by the Company, (ii)&nbsp;all Selling Expenses relating to securities registered on
behalf of the Shareholders shall be borne by the Shareholders of the Registrable Securities included in such registration and (iii)&nbsp;the obligation of the Company to bear the expenses provided for in this <U>Section</U><U></U><U>&nbsp;7(f)</U>
shall apply irrespective of whether a Registration Statement becomes effective, is withdrawn or suspended, or converted to any other form of registration and irrespective of when any of the foregoing shall occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Counterparts</U><U>, Execution</U>. For the convenience of the parties hereto, this Agreement may be executed in any number of separate
counterparts, each such counterpart being deemed to be an original instrument, and all such counterparts will together constitute the same agreement. This Agreement may be executed by facsimile, email or electronic signature covered by the U.S.
federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act, or other Law (<I>e.g.</I>, www.docusign.com or by .pdf signature) by any party and such signature shall be deemed binding for all purposes
hereof without delivery of an original signature being thereafter required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Severability</U>. If any provision of this Agreement
or the application thereof to any person (including the officers and directors of the parties hereto) or circumstance is determined by a court of competent jurisdiction to be invalid, void or unenforceable, the remaining provisions hereof, or the
application of such provision to persons or circumstances other than those as to which it has been held invalid or unenforceable, will remain in full force and effect and shall in no way be affected, impaired or invalidated thereby, so long as the
economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination, the parties hereto shall negotiate in good faith in an effort to agree upon a suitable and
equitable substitute provision to effect the original intent of the parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Notices</U>. All notices and other communications
hereunder shall be in writing and shall be deemed duly delivered (i)&nbsp;four (4)&nbsp;Business Days after being sent by registered or certified mail, return receipt requested, postage prepaid, (ii)&nbsp;one (1)&nbsp;Business Day after being sent
for next Business Day delivery, fees prepaid, via a reputable nationwide overnight courier service or (iii)&nbsp;when sent, if delivered by email (<U>provided</U> that no &#147;error message&#148; or other notification of <FONT
STYLE="white-space:nowrap">non-delivery</FONT> is generated), in each case to the intended recipient as set forth below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If to a
Purchaser, at such Purchaser&#146;s address referenced in <U>Schedule A</U>. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="91%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">If to the Company, as follows:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">New York Community Bancorp, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">102 Duffy Avenue</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Hicksville, New York 11801</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Attn:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">R. Patrick Quinn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Senior Executive Vice President, General Counsel and Corporate</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#8195;Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Email: Patrick.Quinn@flagstar.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">One Manhattan West </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">New York, NY
10001 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Attention: Sven Mickisch, Michael Zeidel, Matthew Nemeroff, Christopher Barlow </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Email: sven.mickisch@skadden.com, michael.zeidel@skadden.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">matthew.nemeroff@skadden.com, christopher.barlow@skadden.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any party may, from time to time, by written notice to the other parties, designate a different address, which shall be substituted for the
one specified above for such party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Specific Performance</U>. The parties hereto agree that irreparable damage would occur in the
event that any of the provisions of this Agreement were not performed in accordance with their specific terms. It is accordingly agreed that the parties hereto shall be entitled to specific performance of the terms hereof, this being in addition to
any other remedies to which they are entitled at Law or equity. Each of the parties hereto hereby further waives any (i)&nbsp;defense in any action for specific performance that a remedy at Law would be adequate and (ii)&nbsp;requirement under Law
to post security or a bond as a prerequisite to obtaining equitable relief. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Interpretation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(i) The parties have participated jointly in negotiating and drafting this Agreement. In the event that an ambiguity or a
question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of
this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(ii) The table of contents and headings contained herein are for reference purposes only and shall not
affect in any way the meaning or interpretation hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(iii) Whenever the words &#147;include,&#148; &#147;includes&#148;
or &#147;including&#148; are used in this Agreement, they shall be deemed to be followed by the words &#147;without limitation.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(iv) References to &#147;the date hereof&#148; mean the date of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(v) Notwithstanding anything herein to the contrary, neither the Company nor Purchaser nor any of their respective subsidiaries
shall be required to take any action that is prohibited by Law or inconsistent with any requirement or directive of any Governmental Entity. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(vi) Any reference herein to any statute, includes all amendments thereto and all rules and regulations promulgated thereunder.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(vii) All references to &#147;dollars&#148; or &#147;$&#148; herein are to
United States dollars. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(viii) The definitions contained herein are applicable to the singular as well as the plural forms
of such terms and to the masculine as well as to the feminine and neutral genders of such term </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(ix) The word
&#147;extent&#148; in the phrase &#147;to the extent&#148; shall mean the degree to which a subject or other thing extends and such phrase shall not mean simply &#147;if.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>Limitations on Subsequent Registration Rights</U>. From and after the date of this Agreement, the Company shall not, without the prior
written consent of the Anchor Shareholder (or, in the event that the Anchor Shareholder no longer holds Registrable Securities, Shareholders holding at least fifty percent (50%) of the Registrable Securities then outstanding, with each share of
Common Stock issued pursuant to the Investment Agreements and each share of Common Stock to be received upon conversion of the Convertible Preferred Stock issued pursuant to the Investment Agreements, in each case, counting as one Registrable
Security for this purpose (whether or not then convertible)), enter into any agreement (a &#147;<B>Permitted Agreement</B>&#148;) with any holder or prospective holder of any securities of the Company giving such holder or prospective holder any
registration rights the terms of which are senior to or conflict with the registration rights granted to the Shareholders hereunder, including, for clarity, allowing any other holder of Common Stock to have registration rights in the nature or
substantially in the nature of those set forth in this Agreement that would have priority over the Registrable Securities with respect to the inclusion of such securities in any Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <U>Further Assurances</U>. From and after the Closing, subject to the terms of the applicable Certificate of Designations, the Company
will take such actions as reasonably necessary to effect any conversion of the Convertible Preferred Stock upon the reasonable request of the applicable Purchaser in connection with any registration or any offering and sale pursuant hereto involving
the Common Stock underlying such Convertible Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Pages Follow] </I></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed as of the
date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>COMPANY:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">NEW YORK COMMUNITY BANCORP, INC.<B> </B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ R. Patrick Quinn</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">R. Patrick Quinn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">General Counsel&nbsp;&amp; Corporate Secretary</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>11
<FILENAME>d763888dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;&#8195;


<IMG SRC="g763888snap106a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">


<IMG SRC="g763888snap106b.jpg" ALT="LOGO">
&#8195;&#8195;&#8195;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 Duffy Avenue, Hicksville, NY 11801 &#149; Phone: (516) <FONT STYLE="white-space:nowrap">683-4420</FONT>
<B>&#149; </B>flagstar.com </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>NEWS RELEASE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Investor Contact:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>FOR IMMEDIATE RELEASE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Salvatore J. DiMartino</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(516) <FONT STYLE="white-space:nowrap">683-4286</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Media Contact:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Steven Bodakowski</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(248) <FONT STYLE="white-space:nowrap">312-5872</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NEW YORK COMMUNITY BANCORP, INC. CLOSES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OVER $1 BILLION EQUITY INVESTMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STRENGTHENING BALANCE SHEET AND LIQUIDITY POSITION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Former Treasury Secretary Steven Mnuchin, Incoming CEO Joseph Otting, Milton Berlinski, and Allen Puwalski Appointed to NYCB Board of
Directors </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>HICKSVILLE, N.Y., March 11, 2024 - </B>New York Community Bancorp, Inc. (NYSE: NYCB) (&#147;NYCB&#148; or the &#147;Company&#148;)
announced today it completed the previously announced transactions resulting in individual investments aggregating to approximately $1.05 billion in the Company by Liberty Strategic Capital (&#147;Liberty&#148;), funds managed by Hudson Bay Capital
Management (&#147;Hudson Bay&#148;), funds managed by Reverence Capital Partners (&#147;Reverence Capital&#148;), and other investors (collectively, the &#147;Investors&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Chairman, President and Chief Executive Officer, Sandro DiNello stated, &#147;The completion of this major equity raise demonstrates the confidence
these strategic investors have expressed in the turnaround currently underway at the Company and allows us to execute on our strategy from a position of strength. Our Company enters this next phase with an enhanced balance sheet and liquidity
position.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Former Treasury Secretary Steven Mnuchin, newly appointed Lead Independent Director of the Board and Founder and CEO of Liberty, stated,
&#147;We are pleased to be part of NYCB&#146;s new chapter. We believe that this transaction has strengthened the Company&#146;s balance sheet and liquidity position and look forward to working with management and the dedicated workforce of NYCB to
deliver shareholder value.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Berlinski, a newly appointed member of the Board and Managing Partner of Reverence Capital, added, &#147;We are
happy to be investing alongside these strong investors. We believe NYCB has a tremendous opportunity to reposition itself as a regional bank and return to growth and profitability and we look forward to working with incoming CEO Joseph Otting and
the management team.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;&#8195;


<IMG SRC="g763888snap106a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">


<IMG SRC="g763888snap106b.jpg" ALT="LOGO">
&#8195;&#8195;&#8195;</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the transactions, the Board has been reduced to ten members and the Company has added four
new directors to the Board: Secretary Steven Mnuchin, former Comptroller of the Currency Joseph Otting; Milton Berlinski, Managing Partner of Reverence Capital; and Allen Puwalski, at the recommendation of Hudson Bay. Mr.&nbsp;DiNello, Marshall Lux,
Lawrence Savarese, Peter Schoels, David Treadwell and Jennifer Whip remain members of the Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Description of Transactions and Issued Securities
</U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transactions involve the creation and issuance of additional common stock, as well as new equity securities of the Company, namely two new
series of preferred stock (Series B and Series C) that were issued upon the closing, as well as a new series of preferred stock (Series D) issuable upon exercise of certain warrants issued to the Investors. Preferred stock is being issued in
connection with the capital raise in part due to the fact that the Company does not have a sufficient amount of authorized but unissued shares of common stock under our Amended and Restated Certificate of Incorporation of the Company (the
&#147;Certificate of Incorporation&#148;) to permit the Company to issue only common shares to the Investors. Accordingly, we need the approval of our stockholders, as described in further detail below, in order to amend our Certificate of
Incorporation to increase our total authorized shares of common shares and to permit the issuance of an amount of common stock that is 20% or more of our total common stock in compliance with the rules of the New York Stock Exchange
(&#147;NYSE&#146;&#146;). Additionally, our issuance of <FONT STYLE="white-space:nowrap">non-voting</FONT> preferred stock facilitates the Investors&#146; ability to make immediate larger equity investments in the Company in a manner that complies
with applicable banking laws and regulations, including the rules and limitations of Regulation Y of the Bank Holding Company Act of 1956, as amended (collectively, the &#147;Control Limitations&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon receipt of antitrust clearance (as described below) and the Share Issuance Approval (as defined below), and the related amendment of our Certificate of
Incorporation, (i)&nbsp;the Series C preferred stock will automatically convert into common stock for each Investor that acquired Series C preferred stock at closing to the greatest extent permissible under the Control Limitations (unless any such
Investor obtains the prior <FONT STYLE="white-space:nowrap">non-objection</FONT> of the Federal Reserve Board to acquire an amount of our common stock above the Control Limitations) and (ii)&nbsp;the dividend payable on the Series B preferred stock
will be eliminated, other than participating with common stock dividends on a pro rata basis and, therefore, holders of Series B preferred stock at such time will have no economic rights beyond those which holders of our common stock receive. In
addition, if the Requisite Stockholder Approvals are not obtained within 180 days of the closing, the Investors will receive cash-settled warrants that become exercisable 60 days after issuance (alternatively, these warrants will be cancelled if the
Requisite Stockholder Approvals are obtained during such <FONT STYLE="white-space:nowrap">60-day</FONT> period). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;&#8195;


<IMG SRC="g763888snap106a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">


<IMG SRC="g763888snap106b.jpg" ALT="LOGO">
&#8195;&#8195;&#8195;</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Below is a summary further describing the specific securities being issued as part of the transactions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">76,630,965 shares of our common stock, at a price per share of $2.00. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">192,062 shares of a new series of preferred stock, par value $0.01 per share, of the Company designated as Series
B Noncumulative Convertible Preferred Stock (the &#147;Series B Preferred Stock&#148;), at a price per share of $2,000. Each share of Series B Preferred Stock cannot convert in a holder&#146;s hands but is automatically convertible into 1,000 shares
of our common stock in the event of a transfer by the holder thereof consistent with the rules and limitations of Regulation Y (a &#147;Reg Y Transfer&#148;). Holders of shares of Series B Preferred Stock shall not have the right to vote such shares
on any matter submitted to a vote of the stockholders of the Company, other than certain matters expressly permitted by the associated Certificate of Designations, and all of which shares of Series B Preferred Stock represent the right (on an as
converted basis) to receive approximately 192&nbsp;million shares of our common stock. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">256,307 shares of a new series of preferred stock, par value $0.01 per share, of the Company designated as Series
C Noncumulative Convertible Preferred Stock (the &#147;Series C Preferred Stock&#148;), at a price per share of $2,000. Each share of Series C Preferred Stock is automatically convertible into 1,000 shares of our common stock upon the occurrence of
certain events (including (i)&nbsp;a portion upon the expiration or termination of any applicable waiting period (or extension thereof) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, with respect to such holder&#146;s
acquisition or ownership of our common stock and (ii)&nbsp;the remaining portion upon receipt of the Share Issuance Approvals (as defined below)). In addition, in connection with Reg Y Transfers, the Series C Preferred Stock is automatically
convertible into 1,000 shares of our common stock. Holders of shares of Series C Preferred Stock shall not have the right to vote such shares on any matter submitted to a vote of the stockholders of the Company, other than certain matters expressly
permitted by the associated Certificate of Designations, and all of which shares of Series C Preferred Stock represent the right (on an as converted basis) to receive approximately 256 million shares of our common stock. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Warrants affording the holder thereof the right, until the seven-year anniversary of the issuance of such
warrant, to purchase for $2,500 per share, shares of a new class of non-voting, common-equivalent preferred stock of the Company, par value $0.01 per share (the &#147;Series D NVCE Stock&#148;). Each share of Series D NVCE Stock is convertible into
1,000 shares of our common stock (or, in certain limited circumstances, one share of Series C Preferred Stock) in a Reg Y Transfer, and all of which shares of Series D NVCE Stock represent the right (on an as converted basis) to receive
315&nbsp;million shares of our common stock. The warrants will not be exercisable for 180 days after closing. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;&#8195;


<IMG SRC="g763888snap106a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">


<IMG SRC="g763888snap106b.jpg" ALT="LOGO">
&#8195;&#8195;&#8195;</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of the transactions, if all shares are converted into common stock, the Company will issue a
total of approximately 525&nbsp;million shares of common stock and the Investors will own approximately 39.6% of the Company on a fully diluted basis. Additionally, the warrants can be exercised for up to 315&nbsp;million shares of common stock;
however, given the net share settlement feature of the warrant the amount actually issued will be less than the full 315&nbsp;million shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Matters to be Submitted to Stockholders of the Company </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company plans to submit to its stockholders for their (a)&nbsp;adoption and approval amendments to the Certificate of Incorporation to (i)&nbsp;effect at
least a <FONT STYLE="white-space:nowrap">1-3</FONT> reverse stock split of our common stock (the &#147;COI Reverse Stock Split Amendment&#148;), for among other reasons, to make the bid price more attractive to a broader group of institutional and
retail investors, (ii)&nbsp;increase the number of authorized shares of the Company&#146;s common stock to at least 1,700,000,000 (or, in the event of the approval of the Certificate of Incorporation Reverse Stock Split Amendment, at least
566,670,000) (the &#147;COI Authorized Share Amendment&#148;) and (iii)&nbsp;exempt certain Investors and their respective affiliates from the application of a provision of the Certificate of Incorporation that prohibits any person who beneficially
owns, directly or indirectly, more than 10% of the then-outstanding shares of our common stock from voting any such shares of common stock in excess of such 10% threshold (the &#147;COI Exemption Amendment&#148; and, collectively with the COI
Reverse Stock Split Amendment and the COI Authorized Share Amendment, the &#147;COI Amendments&#148;); and (b) approval of the issuance of shares of our common stock in excess of 19.9% of the total voting power of the Company&#146;s securities (the
&#147;Share Issuance&#148;) in accordance with the rules of the NYSE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The requisite vote of our stockholders necessary to duly and validly (a)&nbsp;adopt
and approve the COI Reverse Stock Split Amendment and the COI Authorized Share Amendment requires the affirmative vote of a majority of votes cast by the holders of shares of Common Stock, at a duly held meeting of the Company&#146;s stockholders,
(b)&nbsp;adopt and approve the COI Exemption Amendment requires the affirmative vote of the holders of a majority of the outstanding shares of our common stock entitled to vote on the COI Exemption Amendment and (c)&nbsp;approve the Share Issuance
requires the affirmative vote of a majority of votes cast by holders of shares of our common stock at a duly convened meeting of stockholders of the Company at which a quorum is present (the &#147;Share Issuance Approval&#148; and, together with the
adoption and approval of the COI Exemption Amendment, the &#147;Requisite Stockholder Approvals&#148;). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;&#8195;


<IMG SRC="g763888snap106a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">


<IMG SRC="g763888snap106b.jpg" ALT="LOGO">
&#8195;&#8195;&#8195;</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Grant of Employment Inducement Awards </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NYCB also has announced the grant of employment inducement awards to Joseph Otting in connection with the commencement of his employment with NYCB, which
became effective as of March&nbsp;6, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board approved the employment inducement awards on March&nbsp;6, 2024 as a material inducement to enter
into an offer of employment in reliance on the employment inducement award exception to New York Stock Exchange Listing Rule 303A.08 that requires shareholder approval of equity-based compensation plans. Listing Rule 303A.08 requires the public
announcement of such an award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The inducement award consists of an option to acquire 15,000,000 shares of the Company&#146;s common stock, with an
exercise price of $2.00 per share, and vesting in 12 quarterly installments commencing on March&nbsp;6, 2024, with accelerated vesting upon a change in control of the Company prior to the final vesting date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The inducement awards are being made outside of the New York Community Bancorp, Inc. 2020 Omnibus Incentive Plan (the &#147;Plan&#148;) and the Company&#146;s
shareholder-approved equity compensation plan, but will generally be subject to the same terms and conditions as apply to awards granted under the Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Advisors </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jefferies LLC is acting as exclusive
financial advisor and sole placement agent to NYCB. Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP is serving as legal counsel to NYCB. Sullivan&nbsp;&amp; Cromwell LLP is serving as legal counsel to Liberty Strategic Capital. Schulte
Roth&nbsp;&amp; Zabel LLP is serving as legal counsel to Hudson Bay Capital. Latham&nbsp;&amp; Watkins LLP is acting as legal counsel to Jefferies LLC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About New York Community Bancorp. Inc. </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York
Community Bancorp, Inc. is the parent company of Flagstar Bank, N.A., one of the largest regional banks in the country. The Company is headquartered in Hicksville, New York. At December&nbsp;31, 2023, the Company had $113.9&nbsp;billion of assets,
$85.8&nbsp;billion of loans, deposits of $81.4&nbsp;billion, and total stockholders&#146; equity of $8.4&nbsp;billion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Flagstar Bank, N.A. operates 420
branches, primarily in the Northeast and Midwest. Flagstar Mortgage operates nationally through a wholesale network of approximately 3,000 third-party mortgage originators. In addition, the Bank has 134 private banking teams located in over ten
cities in the metropolitan New York City region and on the West Coast, which serve the needs of <FONT STYLE="white-space:nowrap">high-net</FONT> worth individuals and their businesses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York Community Bancorp, Inc. has market-leading positions in several national businesses, including multi-family lending, mortgage origination and
servicing, and warehouse lending. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;&#8195;


<IMG SRC="g763888snap106a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">


<IMG SRC="g763888snap106b.jpg" ALT="LOGO">
&#8195;&#8195;&#8195;</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Flagstar Mortgage is the seventh largest bank originator of residential mortgages for the <FONT
STYLE="white-space:nowrap">12-months</FONT> ending December&nbsp;31, 2023 and the industry&#146;s fifth largest <FONT STYLE="white-space:nowrap">sub-servicer</FONT> of mortgage loans nationwide, servicing 1.4&nbsp;million accounts with
$382&nbsp;billion in unpaid principal balances. Additionally, the Company is the second largest mortgage warehouse lender nationally based on total commitments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About Liberty Strategic Capital </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Liberty Strategic
Capital is a Washington, D.C.-based private equity firm focused on strategic investments in technology, financial services and fintech, and new forms of content. The firm was founded in 2021 and is led by Steven T. Mnuchin, the 77th Secretary of the
Treasury. Our leadership team combines decades of public service and private sector experience, creating unique insight into the intersection of capital, technology, and government regulation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About Hudson Bay Capital Management </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hudson Bay
Capital Management is a global investment management firm operating in Greenwich, New York, Miami, Boston, London and Dubai. Hudson Bay Capital&#146;s team seeks to achieve outstanding performance by uncovering market inefficiencies and undervalued
investment opportunities that are uncorrelated to each other and to market indices while maintaining a focus on risk management, portfolio construction and capital preservation. Hudson Bay Capital has been managing assets on behalf of pension plans,
sovereign wealth funds, endowments, foundations, high net worth individuals and families since 2006. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About Reverence Capital </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reverence Capital Partners is a private investment firm focused on three complementary strategies: (i)&nbsp;Financial Services-Focused Private Equity,
(ii)&nbsp;Opportunistic, Structured Credit, and (iii)&nbsp;Real Estate Solutions. Today, Reverence manages in excess of $8&nbsp;billion in AUM. Reverence focuses on thematic investing in leading global Financial Services businesses. The firm was
founded in 2013, by Milton Berlinski, Peter Aberg and Alex Chulack, after distinguished careers advising and investing in a broad array of financial services businesses. The Partners collectively bring over 100 years of advisory and investing
experience across a wide range of Financial Services sectors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Forward Looking Statements </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release may include forward-looking statements by the Company pertaining to such matters as our goals, intentions, and expectations regarding, among
other things, the convertibility of the shares of preferred stock and exercisability of the warrants issued in connection with this capital raise transaction; the Company&#146;s seeking (and the Company&#146;s ability to obtain) approval of its
stockholders of any necessary amendments of the Com pony&#146;s organizational documents or approvals of the issuance of shares of common stock or preferred </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;&#8195;


<IMG SRC="g763888snap106a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">


<IMG SRC="g763888snap106b.jpg" ALT="LOGO">
&#8195;&#8195;&#8195;</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stock in connection with this capital raise transaction; receipt of any required regulatory approvals or <FONT STYLE="white-space:nowrap">non-objections</FONT> in connection with this capital
raise transaction; revenues, earnings, loan production, asset quality, capital levels, and acquisitions, among other matters; our estimates of future costs and benefits of the actions we may take; our assessments of probable losses on loans; our
assessments of interest rate and other market risks; and our ability to achieve our financial and other strategic goals, including those related to our merger with Flagstar Bancorp, Inc., which was completed on December&nbsp;1, 2022, the purchase
and assumption of certain assets and liabilities of Signature Bridge Bank beginning March&nbsp;20, 2023 (the &#147;Signature Transaction&#148;), and our transition to a $100&nbsp;billion plus bank. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements are typically identified by such words as &#147;believe,&#148; &#147;expect,&#148; &#147;anticipate,&#148; &#147;intend,&#148;
&#147;outlook,&#148; &#147;estimate,&#148; &#147;forecast,&#148; &#147;project,&#148; &#147;should,&#148; and other similar words and expressions, and are subject to numerous assumptions, risks, and uncertainties, which change over time.
Additionally, forward-looking statements speak only as of the date they are made; the Company does not assume any duty, and does not undertake, to update our forward-looking statements. Furthermore, because forward-looking statements are subject to
assumptions and uncertainties, actual results or future events could differ, possibly materially, from those anticipated in our statements, and our future performance could differ materially from our historical results. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our forward-looking statements are subject to the following principal risks and uncertainties: general economic conditions and trends, either nationally or
locally; conditions in the securities markets; changes in interest rates; changes in deposit flows, and in the demand for deposit, loan, and investment products and other financial services; changes in real estate values; changes in the quality or
composition of our loan or investment portfolios; changes in future allowance for credit losses requirements under relevant accounting and regulatory requirements; the ability to pay future dividends at currently expected rates; changes in our
capital management and balance sheet strategies and our ability to successfully implement such strategies; changes in competitive pressures among financial institutions or from <FONT STYLE="white-space:nowrap">non-financial</FONT> institutions;
changes in legislation, regulations, and policies; the success of our blockchain and fintech activities, investments and strategic partnerships; the restructuring of our mortgage business; the impact of failures or disruptions in or breaches of the
Company&#146;s operational or security systems, data or infrastructure, or those of third parties, including as a result of cyberattacks or campaigns; the impact of natural disasters, extreme weather events, military conflict (including the
Russia/Ukraine conflict, the conflict in Israel and surrounding areas, the possible expansion of such conflicts and potential geopolitical consequences), terrorism or other geopolitical events; and a variety of other matters which, by their nature,
are subject to significant uncertainties and/or are beyond our control. Our forward-looking statements are also subject to the following principal risks and uncertainties with respect to our merger with Flagstar Bancorp, which was completed on </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;&#8195;


<IMG SRC="g763888snap106a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">


<IMG SRC="g763888snap106b.jpg" ALT="LOGO">
&#8195;&#8195;&#8195;</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
December&nbsp;1, 2022, and the Signature Transaction; the possibility that the anticipated benefits of the transactions will not be realized when expected or at all; the possibility of increased
legal and compliance costs, including with respect to any litigation or regulatory actions related to the business practices of acquired companies or the combined business; diversion of management&#146;s attention from ongoing business operations
and opportunities; the possibility that the Company may be unable to achieve expected synergies and operating efficiencies in or as a result of the transactions within the expected timeframes or at all; and revenues following the transactions may be
lower than expected. Additionally, there can be no assurance that the Community Benefits Agreement entered into with NCRC, which was contingent upon the closing of the Company&#146;s merger with Flagstar Bancorp, Inc., will achieve the results or
outcome originally expected or anticipated by us as a result of changes to our business strategy, performance of the U.S. economy, or changes to the laws and regulations affecting us, our customers, communities we serve, and the U.S. economy
(including, but not limited to, tax laws and regulations). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">More information regarding some of these factors is provided in the Risk Factors section of
our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2022, Quarterly Reports on Form 10- Q for the quarters ended March 31, 2023, June 30, 2023, and September 30, 2023 and in other Securities
and Exchange Commission (&#147;SEC&#148;) reports we file. Our forward-looking statements may also be subject to other risks and uncertainties, including those we may discuss in this Amendment, during investor presentations, or in our other SEC
filings, which are accessible on our website and at the SEC&#146;s website, <U>www.sec.gov</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Important Information and Where You Can Find It
</U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release may be deemed to be solicitation material in respect of a charter amendment and other approvals by the stockholders of the
Company. In connection with the Requisite Stockholder Approvals, NYCB will file with the SEC a preliminary proxy statement and a definitive proxy statement, which will be sent to the stockholders of NYCB, seeking certain approvals related to the
issuances of shares of common stock issued under each investment agreement and to be issued upon the conversion of shares of the preferred stock issued under the investment agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">INVESTORS AND SECURITY HOLDERS OF NYCB AND THEIR RESPECTIVE AFFILIATES ARE URGED TO READ, WHEN AVAILABLE, THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS
FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH THE TRANSACTION, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT NYCB AND THE TRANSACTION. Investors and security holders will be
able to obtain a free copy of the proxy statement, as well as other relevant documents filed with the SEC containing information about NYCB, without charge, at the SEC&#146;s website (<U>http://www.sec.gov</U>). Copies of documents filed with the
SEC by NYCB can also be obtained, without charge, by directing a request to Investor Relations, New York Community Bancorp, Inc., 102 Duffy Avenue, Hicksville, New York 11801 or by telephone <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">(516-683-4420).</FONT></FONT> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&#8195;&#8195;&#8195;


<IMG SRC="g763888snap106a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">


<IMG SRC="g763888snap106b.jpg" ALT="LOGO">
&#8195;&#8195;&#8195;</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Participants in the Solicitation of Proxies in Connection with Proposed Transaction </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NYCB and certain of their respective directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in respect of
the Requisite Stockholder Approvals under the rules of the SEC. Information regarding NYCB&#146;s directors and executive officers is available in its definitive proxy statement for its 2023 annual stockholders meeting, which was filed with the SEC
on April 21, 2023, and certain of its Current Reports on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> Other information regarding the participants in the solicitation of proxies in respect of such stockholder approvals and a description of
their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement and other relevant materials to be filed with the SEC. Free copies of these documents, when available, may be obtained as described in
the preceding paragraph. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Not an Offer of Securities </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in this press release is for informational purposes only and shall not constitute, or form a part of, an offer to sell or the solicitation of
an offer to sell or the solicitation of an offer to buy any securities. The securities that are the subject of the private placement have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the U.S.
absent registration or an applicable exemption from registration requirements. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>nycb-20240307.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 3/14/2024 9:37:18 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:nycb="http://www.mynycb.com/20240307"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.mynycb.com/20240307"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" namespace="http://fasb.org/us-gaap/2023" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" namespace="http://fasb.org/us-types/2023" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nycb-20240307_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nycb-20240307_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nycb-20240307_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="nycb_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nycb_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nycb_BifurcatedOptionNotesUnitSecuritiesMember" name="BifurcatedOptionNotesUnitSecuritiesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember" name="FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>nycb-20240307_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 3/14/2024 9:37:21 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="nycb-20240307.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="nycb-20240307.xsd#nycb_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="nycb_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="nycb-20240307.xsd#nycb_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="nycb_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="nycb-20240307.xsd#nycb_BifurcatedOptionNotesUnitSecuritiesMember" xlink:type="locator" xlink:label="nycb_BifurcatedOptionNotesUnitSecuritiesMember" />
    <link:loc xlink:href="nycb-20240307.xsd#nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember" xlink:type="locator" xlink:label="nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="nycb_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nycb_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="nycb_BifurcatedOptionNotesUnitSecuritiesMember" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember" order="26" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="30.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="51.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="52.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="53.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>nycb-20240307_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 3/14/2024 9:37:18 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="nycb-20240307.xsd#nycb_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="nycb_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nycb_DocumentAndEntityInformationTable" xlink:to="nycb_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="nycb_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="nycb_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="nycb-20240307.xsd#nycb_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="nycb_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="nycb_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="nycb_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="nycb_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:loc xlink:href="nycb-20240307.xsd#nycb_BifurcatedOptionNotesUnitSecuritiesMember" xlink:type="locator" xlink:label="nycb_BifurcatedOptionNotesUnitSecuritiesMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nycb_BifurcatedOptionNotesUnitSecuritiesMember" xlink:to="nycb_BifurcatedOptionNotesUnitSecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nycb_BifurcatedOptionNotesUnitSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Bifurcated Option Notes Unit Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nycb_BifurcatedOptionNotesUnitSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Bifurcated Option Notes Unit Securities [Member]</link:label>
    <link:loc xlink:href="nycb-20240307.xsd#nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember" xlink:type="locator" xlink:label="nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember" xlink:to="nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fixed To Floating Rate Series A Noncumulative Perpetual Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fixed To Floating Rate Series A Noncumulative Perpetual Preferred Stock [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>nycb-20240307_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 3/14/2024 9:37:18 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="nycb-20240307.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="nycb-20240307.xsd#nycb_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="nycb_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="nycb_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="nycb-20240307.xsd#nycb_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="nycb_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationTable" xlink:to="nycb_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="nycb-20240307.xsd#nycb_BifurcatedOptionNotesUnitSecuritiesMember" xlink:type="locator" xlink:label="nycb_BifurcatedOptionNotesUnitSecuritiesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="nycb_BifurcatedOptionNotesUnitSecuritiesMember" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="nycb-20240307.xsd#nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember" xlink:type="locator" xlink:label="nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="52.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nycb_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="53.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g763888snap106a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g763888snap106a.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  @&!@<&!0@'!P<*"0@*#18.#0P,#1L3%! 6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MY>PVD,\QGF=DC5K:1=S+NW#)7'&QORH V;2ZBO;2*ZA+&*50Z%E*D@].#R*
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M1B2(-9A^?3Y'Y']T^] &QX3O'D\4>(M+FE5K?47N6M''\)61@Z_B'5O_ -5
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ML;9;2 6Y4H8A&-NT]1CIB@!UO8VEGG[-;10Y 4^6@7(&<#CZG\Z )Z "@ H
E* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g763888snap106b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g763888snap106b.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( "\ IP,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /?Z &2RI!$TLAPBC)-9U*D:4'.>R*C%R?*BM;:I:W=P8(7S
M(%WD$=NE<V'QU'$R<:;U-JF'J4H\TEH7*[3G"@!DLT4$9DFD6-!U9S@#\: *
MPU;3C;-<B^MS K;6D$HV@^F?6@"S#-'/$LL,BR1L,JRG((]C0 ^@ H * "@
MH * "@ H * "@ H * "@ )P,GBC8#F]=UJVXM8Y-^#E]O/X5\IG.80E^X@[]
M_P#(]?!X2?QM6,3S9M(\00W,@(5D5BH_N$<C_/I7FTYSR_$PG/LG\F>CRQQ.
M&<(^?WH[J"XBN8P\3AE-?;4,13KQYJ;NCYJ=.4':2)>E;D'@?QFU"^\2>/\
M0O!-E>BWM9E5Y'#84L[$9;'4 +T]Z #QOX(MO ?P/U+3;;4&O5FU"*=I"H7!
M.U<<'_9_6@#T[X7?\DP\._\ 7HM '4FY@$GEF:,/_=W#- #S(@?874-Z9YH
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MP_T+PKK-]JNF12I=7H(E+R%@<MN. >G- '4T % !0 4 % !0 4 % !0 4 %
M'+>(OASX4\5ZBM_K>E?:KI4$8?[1*F%&2!A6 [F@#+B^"_P^AE25/#X#HP92
F;N<\CV+T =VB)%&L<:A448"@8 % #J "@ H * "@ H * "@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140454002995520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 07, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nycb_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000910073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  07,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NEW YORK COMMUNITY BANCORP, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-31565<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">06-1377322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">102 Duffy Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Hicksville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(516)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">683-4100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nycb_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NYCB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nycb_BifurcatedOptionNotesUnitSecuritiesMember', window );">Bifurcated Option Notes Unit Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nycb_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Bifurcated Option Note Unit Securities SM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NYCB PU<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember', window );">Fixed To Floating Rate Series A Noncumulative Perpetual Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_nycb_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Fixed-to-Floating Rate Series A Noncumulative Perpetual Preferred Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NYCB PA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nycb_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nycb_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nycb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nycb_BifurcatedOptionNotesUnitSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nycb_BifurcatedOptionNotesUnitSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>20
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M='@//GL?)=-[*CG_5U/\!%!+ P04    " #B,&Y8EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( .(P;E@<.&7J/P$
M #P"   /    >&PO=V]R:V)O;VLN>&ULC5'+;L) #/R5U7Y $U"+5$2XE#Z0
MJA:5BON2=8C%/B*O RU?7R=15*1>>O)Z;(UG9A?G2,=]C$?UY5U(A:Z9FWF6
MI;(&;])-;"#(I(KD#4M+ARPU!,:F&H"]RZ9Y/LN\P:"7BY%K0]EU$QE*QA@$
M[( =PCG]SKM6G3#A'AWR=Z'[MP.M/ ;T> %;Z%RK5,?S2R2\Q,#&;4N*SA5Z
M,@QV0(SE'WC;B?PT^]0C;/8?1H04>I8+8864N-_H^8UH/($L#UW+\0D= ZT,
MPS/%ML%PZ&C$179EH\]AK$.(<_I/C+&JL(15+%L/@8<<"5PG,*0:FZ15,!X*
M/:XH$ZQZ#"PAJ748J&2W<RJGUW9PS2+W*D.:HPQH;0?AHUH+%0:P;W(@"2[)
ME1M27>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    " #B,&Y8)!Z;
MHJT   #X 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P
M#(6O$N4 -5"I0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=N
MH+;S)$9K!LIDR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFB
MG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6
M<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ XC!N
M6&60>9(9 0  SP,  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O
M$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1
ML.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3K
MU3.T<F^I>.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY8
M4(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"
MJ;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R
M]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>
M?P%02P$"% ,4    " #B,&Y8!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .(P;E@SE)\U[@   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( .(P;EB97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ XC!N6"4]AMUW!0  JAD  !@
M         ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( .(P;EB?H!OPL0(  .(,   -              "  ;H-  !X;"]S='EL
M97,N>&UL4$L! A0#%     @ XC!N6)>*NQS     $P(   L
M ( !EA   %]R96QS+RYR96QS4$L! A0#%     @ XC!N6!PX9>H_ 0  / (
M  \              ( !?Q$  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M .(P;E@D'INBK0   /@!   :              "  >L2  !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( .(P;EAED'F2&0$  ,\#   3
M              "  = 3  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )
-  D /@(  !H5      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d763888d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="d763888d8k.htm">d763888d8k.htm</File>
    <File>nycb-20240307.xsd</File>
    <File>nycb-20240307_def.xml</File>
    <File>nycb-20240307_lab.xml</File>
    <File>nycb-20240307_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>26
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d763888d8k.htm": {
   "nsprefix": "nycb",
   "nsuri": "http://www.mynycb.com/20240307",
   "dts": {
    "inline": {
     "local": [
      "d763888d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "nycb-20240307.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "nycb-20240307_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "nycb-20240307_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nycb-20240307_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 2,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 4,
   "entityCount": 1,
   "segmentCount": 3,
   "elementCount": 31,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 29
   },
   "report": {
    "R1": {
     "role": "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-03-07_to_2024-03-07",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d763888d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-03-07_to_2024-03-07",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d763888d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "nycb_BifurcatedOptionNotesUnitSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.mynycb.com/20240307",
     "localname": "BifurcatedOptionNotesUnitSecuritiesMember",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bifurcated Option Notes Unit Securities [Member]",
        "terseLabel": "Bifurcated Option Notes Unit Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "nycb_DocumentAndEntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.mynycb.com/20240307",
     "localname": "DocumentAndEntityInformationLineItems",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "nycb_DocumentAndEntityInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.mynycb.com/20240307",
     "localname": "DocumentAndEntityInformationTable",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "nycb_FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.mynycb.com/20240307",
     "localname": "FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed To Floating Rate Series A Noncumulative Perpetual Preferred Stock [Member]",
        "terseLabel": "Fixed To Floating Rate Series A Noncumulative Perpetual Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.mynycb.com//20240307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>27
<FILENAME>0001193125-24-067332-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-067332-xbrl.zip
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M&J&NA)#. 5GWY12;!$R:#U_&"V;9<7 3C<%-0-LC"RZ-]U7#RJ#)@.OY &R
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MWWL,0"RHI=P4[P-@ATQR4N%XXC8^L#G^VJU3T4GJ5*0]IU*&E2*U6D.O=.H
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MP>UJ@4=S*;?L7+[9[*?A+7P>%>/X[?\'4$L#!!0    ( .(P;EAPW^^[?^4
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MZ9_G@[.EVO_O+7>[ST+N#N(TCY*KIRMVS_O <PV.SN+X[@MP?G1V?G0!SMT
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M!(^9@E4%/X_YK=N_#<4YDCMUD3B:[0O1&)9AC\;7<Y[SF_Z5XI]F/\"'..A
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M,U!6WZU76 &)*/[9 CRBI^"(L'/@5++<@<P@%/_C];9&)/9KQ[4^+O&D3@V
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M0\LTU0.)$#D_!ZHL%5Y<MNYJ>G*%'"A(R1K*1YHA<& %^7A&4@&V5$TL=*B
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MA%X47<%">XS3;LH\$/036O7N%V":R7>. 9>[D9ZO="$?WR6PG9F'\11]KW$
M+4UTQZ"=8_4K\[R%D;#(.F>8PAQQ\+Z1-"B[!1-L N5@& 0_!PN08!]'=!2/
MPYC!8)XB?ZM&>DVBQQ:!MVNPCW?GV#5?8;K/+2YTC?7>Q@-9ZVMA'^[-=8*,
MA=C;^$H3T4$08A+32L]3GB7-*K+WS<T_;?^M9,X9(W"^/?==X8HC!ZYXR!!5
M3:6R%G#%1<0&E% 68*T#-5T34P&$;(+%Z,H :R#+4(="@J1#C@RW89Z96\T'
MAT?[8L95J_DP3:&!>LM*^IRZZ< "V5BUIX.&VE,#,MA[Z;]YR3 #2A3,14C0
M+WH;\).=EWO^WJM7OAL5G@NJTH]Z^=K_:?O5@Z=1[W4^!0MJF[05KMEA>AN*
M^F8^=Y:WD$5M/>(_B]^:RJ)U<98.%RALLDS*0OJ1-7C-E_B:C"A-9U$B6F!4
MYO! 3/<3OR>!-W$N\C"N8GD4&JRW,2X-$BS0-4\&*;<61L*KON8,X@/8K<E"
M/(/&X#! *8?UOB-U4GES515!NQR_6$"JIUS/.I4=E4T60F?#-@N7?ZR 1GJZ
MX9=77?CEVV-@JF:+R[]D&RV6>*^)V=)4I[.D&B=(=#&.Q>5;B?V8BE4J-M!^
ML-Z;X!ME O;]CY<6UZ&+1ZYA%"UP\AIH=SJZ9UD*;E[,?.AQJ$J)]=%UC-*,
MX:US]+'+D BJ;_#=#6_Z\?F%78'Q 4^%I;CA/[?>*,PPYCJM,N"U. JJ)WQO
M8^D1;W.DM#C?'X-9WB7G>41VGO.CL_.C"U"<@\OCTY,+;W!RZ/TY.#\?G%P>
M'UVL"57/+E/US,E\/2;MQ2#WREP':GUM1QO=LV#0$H";A@%%U>XDY&#RC2K]
MZ.0DM7%NYR-[&Q1>,RE)3CJV#BNNGF?7,:U WDOB)>),J/)/7Q0;APJ13PBC
M7ZK[ WW(-17DU^&5)FXZT3D[XY#4*>=Z&UC$I#M,4Y25J/.H8./V.L4B507J
MD,+XQ8EAYB:P@!I1,HK+,8<D,9HYLE*^N2J4TSXIKQZ^K:[[M8+A%!3$#D;>
M59C VQ(_@P+TRHF(H14XU^#=9UA[8Q3\KX/!F:7A:=4M3]JJY+/N)-%$LG!]
M4W+48ICHCB-:"=]>%7Z=P92'TVCD_082@M!$"GW+N^C!<'27 KJX4%(?QI;[
MN,1  G]B57U;]=BU!66YH')%A+#@48! 9\6[PEF&(9Z=9<9E>&S"UTOV2.*T
M?]]B#J[B=(AD?!S+0 >,*B;Y[UF*0CQRDD[VA)$S419DZ^(TW084!P]$;."9
M&?AA^;0ONS*$VZ0XN11!SSZ#]VWNUMO A2S :QUE8%D50E8Q+.12VE_>+5&&
MY:)#N"Z::A_S BFJ<;VLL0;,:"A#-1LN9]LB5\MU9TMKPM%^J:$>T8=9B#T7
M3/14+:?4&#JK69$HIL.0X<(5G. K51U/;T.+G)1(UD40EO2PY9*RMB%6<O27
MKT&!PBLD^(L0S(OK?Y58P(F6 UA;XQ3^FL1I.K:$BHP/F*-QE =Y@>XAZBJ\
M&;VPM=S4J"+*0X+_9MJM',(6@?$$,?B'0C3@B(QY8WRQ(U6=Q;^#^R$U#YH_
MH@L->TF-L$3-V'R?U_<:[ILUUJVN1 SN+K$Y&[B!@FZ9P&(#-[R.9GEO@UQF
ME!<.;<#<]N%6A13/4; 1/D_')F$R-@%Z]"2O4D/*(M5[5,]6Q? M3<BV 7,*
MAT);2/&8 _FHPI9?_+F_><.W[HO&H%&:9*;.$<VO!";N*3H*=2B"4T0JX2X$
MHVX4F=DS97%;+7_C")K$SJ%KVOP@@CT.1S'8"NJ @.>,Y0 TI/253ANY4Y9L
M96(YY980$2K(41A/R >8AJ!)87MC83.Q6@B9:LYZ5SPKH_Y0E$:PN?-FZ=,B
M1Y_%E#4:<4<1G3F6E\+5EK$I6B9>$B92%@\8!CT."VK2C/>ZO>8BN[E@+[+7
M-, ,W\'AY[#--;IJ3@K;<*/ UVCAF+4D@RE/40']VF<UC8%O;&>+)?TP]U>*
M(-96V#[O:'JT3^9)(^WL:CI*K?%3#9^][L)G7\=/9 F%8O<:9H@<$=&@8E-,
M @=7R'905"T0_.=^&F2D%@Z)&"/-<G5FCROUSF/=P,814[RP,<-NS/,+LT6P
MIESM$3LF\[<_S9C4[J/H?M1424XC%&56CP F, ]%%' 44%'ST3]";;U*UDIL
M%M5,Z^M/+#L+Q"J4V[?HVA@E#-9RJ=H Z8$%?B%Y7>1VT,L?]JN8.+WJED]I
MF<5<XQ7EZ$JG&?DA'%:50T%N]GU\;L895XUZO^9TDS="[I\@650OH6:'\&YU
M=_ !Z%?O1]CD1GT>/@9_+]B#Z68ESD-CB$FY)^CNS"*ZCM9])C_*?;45;F"N
M PH9A#=I7&H)F985Q]MGB<!5N[+];3+#:,UQKZ2TS26%]N!!]_NE7&I3ICW*
MQKD#UY 4:H),*?S;_#J,N2T&,RGZ\B/YMD 6/+#6P)51W]RFV6>NPH9M40H;
M4Y[2EH,MCD$^9C:Y+HMQ>@M?BEN&3,?_*D/T.(TS21$:7+XT1E*1G*,3V$DF
M3,:R3#;C$<&A&JF,?,\-6_#YSW0KA^S#8MX\*;(T5I 2XFV2##+^YL\TB\?>
M1_9L3[,KV.><8ZXU,JH;A6PJ*DE1V%:U, ^/ +PG1MJ<]4HA6=UQT7!/6#4P
M=8XY(R@5#?.)<V$D*M<WT1J?+U*T@A0-P.L9,#O*HB$K4[J6(LTXLQSF79KJ
M.2_C4 !F6]N[*NO3I@V3=._6$?F+K7^HGU?$"^7 8H5"T= L08C6B7+B,ZIT
MWSPZJ%"'T8OO?SSP!J.'!V#<8^UOK*5OV#V-^H*BD7 ,CM&MX_03ALZOPF1T
M)TA.-1UJ0_<V7!7*0(U"HO9PCY*_D8\NSD^9TG@Z"\F0^ OF/1\S2NN;)/!6
MGSI[YD!=-<Y4'-R"2L7VEV5!*8XQQ7K'9(Q@B6P94Z&L$D+?#FK[K/UH0J[*
M"!/E2;BH$PI<Q_VT#"UTYA%_W6/SN>\RG_MY@S7_Y[P*9$Y_';%_#R:7!/*$
MN"&RR*6L$%^.[9E@4BV24<6*9-5[."4)!MB"9SCIM\9FX7A:J,=<R&/<?'L#
MN[3)GB2BVT '33FLX10N&D :]:86HQRW$/6E<OT@"WQ_A\Q?Q'8WS E6I%'K
M9,HCJ9?8HRJ L>!6[,!)?JA,",Y/&U3C^0VQ&]QQ"O/%IZNB<H.!\_LYW;2;
M9F[EUVQ*82%T8JQ4304#Q]-OIES?.K>3?.;YZ",$5+)P[V2E5\E5JGBE&00O
M3HMDI%FZN;$RZ?9C*OTY*"\3G7-52.VXQA"C$U-O5]K?4.7-]15L=['1=K];
M;^XH'G@W[S(),^ZMAR=*EN;YEO,9O/FNHB#$'5 )%08S],\8!(K;XZG&V'[J
M8FQ?%V.;4',&T!NX%7#[:D] :4S46SKI5Q6UOD33B,W"JM"SSARSQZT/*6',
MA5&FOX'9(7;_ ]Q 2FG!"9EBII>35]C[F$FR4#N5&5A;UPU,WY00_)\@ 3?N
MSN[=ML<DUC JA$-D-'PPHSZ3HD-=96D+4QYEH._7\LI\$I[C+S_0+W/E]%5N
M G.#]Z\4DICB+?@(]/EX*T[3SQ120BHORM_+_>AF 2QBQA  HUKTE28%E$>P
MY@%"RQ(P)M3ZH;8(R*N'V<"(44AFXPUIY^H , I'D*N^6TXAV3[[S#"!Q]PU
M(:K=T!ZE1\V!-#\/'?=TC8I7+NW89T[0-],NGI!N*0_<;O$5?A%"S(![4E]A
M4%GO82.H,44+YK1FE[@>/G.(S0XQCLW\USP:>GA&0#JR%\UMJ3?B1[E<#7[
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MXC%19AI=<!9CBKIN7YY=_,XKE#M+A B_G_S=[1U_>W>NQ-Y[!A[L?8V?:M*
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M5I-&M(RK!FYL=3G?(J0KYVO61:::YJ&8:SW"N3#??&3-=F/T.IW?MNHUAU3
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M*1Y%88(('Q;S[Q@D7WW?S(V4R[XQ:F:^X@A846!41/A#K2X1:LZ524MN*QY
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M&4[P:$CCG.!CKNG283#Z#*>=<SN$E(9(:4"EK3&I,0Z8M= Q\+,MS&;P#L/
M^Q2;UV$\?!HH(+0<=FSTZ=;1<7@C9E4<?0X=/L<*NRN^6@BZ5:=G%?\"HP5
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MAI" MK:.6IVHK_<6G*5@ZRE;MW:>J@:)M35I3J?,6Q7N/R!T$('#!4*:Q)E
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MPE7MIU2YZ]\O2JTCL&\4S2+Q77CCS="9S)&+W2K\]7F\"[+T@6G!1MN>6L[
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MZ7I<A%/%P/<2[[E\$2I51A=&.=H'8UV$>AN#D6ZG?A.:?NUY:D9,85IAN:(
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MP3#)@&],"$'1DBK^YE[>9-:$>IFOLT8 MY*$L(RYC9F(Y08\:1SP)<I2J*S
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MY3(#Z\!$M;BA?=F(ARL(/'3N7D4JUWQB^=&SE.=N/5)MSBUT#+76GZC GN-
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MBY#<#!@TETPFG3RD7,A&ON^Q]/;C,@1,49'*</!6XW'3:Z$TVR5-,L0BPK,
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MKE<7A\%?GQOS_0?;;\#UB"TGLXQA6/<=_3?O6_HPC/PQCAYZ'/X:!8V"+&N
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M9D0NG0^NT^$</\ DS/)81_$'J!=Y$'XGM3@;#+F2N+-Z6)6R.Q:>9(>GR%B
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M^)6V&5I-3<T!44TJ62G$7J<75A./U\35T"-VI!C_8FGX#B]/J^D0[@^\/*[
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MK>)\F9VOU]MQ;N=?[\ R8YD8/2Y79J"=*<Y(HEFAO'&S>J1L<ZLNY"H#HC#
M %S#A,%1&AJ1N5%ZYO@KAX?A\_T7X?Y/!XM>^D8E],9E3B4O\Y#'SQR$/QW
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ML0_<'0NI*A+(9LZ<9ON0I97;#BNOP'"?98S'"]$JI'20CALQ WU(LH]1G7!
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MBN=U-4+6I"YE+-%#KNH[3NX9Z)*0E\@D?\19TL6<CEO_B =Z=0&D0'0*:ID
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M5Y>?YE+ZHD,>"-F;507+KJ(=>MV#40_)?M":+<N==;(;J]\ARSWI6-@ 4!O
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ME$WC2)=D070CI*--Y*O( &/1;/#!V22?D'#@C,?GN</1K/7T (>%T*O"&!A
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M&)'9E \@*],8>EWE(#$U*XP),"*CEK(*KDQLLQ$(WXFB":IL.S8KZ^K%:60
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ML9?@.M<C=%VW&\U7[: &Z)^:86[X!L9N()!\U!EQ43%.D?<C1V'CP%N.AK!
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MWC'A7*ZF0JWIY](J+==@:>>A0" X;Y4=GUYD=L44I!7,*0K/?I<PS3])#GX
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MP[V0S::0 Q"57UP'@*'G<\9SGO4R5E*#>,L 6]/ 9$5@QB FKP$&U:B&(";
M(* 8"_D.,B((NT[&G/4"0/382"K+3%(0B, JJ]8/$X_',XJ,(:XG'FY'6["*
MUN[KEAOY2(UX1J $RQ@<A?V-1QGHQ?@=5K0:;*K*R7(,/>(R B^'5.+V3J_
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M439 "WGK)=^!5LCTXULP;X0V24F#.?+C">,#?_WA#WUP7LPY\:CP8&A'6V
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M%-[H-UAIZ\$_+S#+=VH9UFG3P6?(/8>0-+C&'1<*5@JGNHP,.ZY&0L(IY"$
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M!! UHM3^95[=GH9#HO"GH(8+T^\N&8[RXBUN(TK6?'HQ8U)^Q2 @7X-8CO2
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M1/P:(<AP6Y<-?20:+H#Z*RVN<%6%IW6:%@-Q/?E&OF/AIE8=9A2_EU&A.S2
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M/^BZC=5*>G"6Z^Q@<O0CYGM:D0&?Y7,3X-DHQS1@'Q_,&<4Y\1*RY>DXWJE
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M/B;^)5?Y#EX_3 LH3@M@*+DDRD?'PD#L^='Q_XH,@5O$!2A&WWASHPNY%GT
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M=5OA&F?3)W"2+5I38:U<O!$M;24\"M[EE:;(X3"GPM)TMO@M[89'09$1'=K
M88/QK2I_))AZCOT+9D>+"/4P";:0@XMAK7.[!Q\HG"QC$J5 U*1/N#SLJQ\.
MK/MAXY2U*$7][.W-QB4BK 1$Q6$\#GJ@<$-X>P$Q%A"DT%316.;$\=FAD\I/
M@H6N*FB5SPWPZJ3%U\+"M(#9GL/I@;^G8'<NX;/I1-6A4.U).P#]A,O)-GB
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M8\[T;X,[U,WPA\!OTQQ64FQO@? M;O4VX^LFT0@FAC,^D5F2X)05+'J5K\;
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M$2&&T*$61^Q3I ^YSH+L1'S2N&(G.@QH3)]*G(,,0RQOTHV,R7$;? X3+N)
M;#B0C2I/1&JFE\>:&:_ ROV(DE%<CMG+B0[2D15%SE7MG*[M8.KA:G4IL.5?
M)S\C=GGR;L($5DN8#9(1K&Y#U%KA3H.US[ LQ_06^;7?O[ N+:*Z99Q;Q7W6
M2.*@)-O!,KY;3!,M?$R PM6KDK +V/)P&HV\WX!#,-N1O.FR%CT9=AB3CQ@)
M)95C;!.-2_1-\"=6(;A5HUTC*/,%53!B5@Q>!9@HK4!8.' QQ$NSS+A CXVC
M>C$?<9Q.)&NQ!S=Q.@QBWV/W"%HC5$3)?\]29.*1$\>R-XS,M+(@/1>WZ3X@
MUWH@; /OS, JR:<].94A#)/BYI)3/OL,=KX9;7L+"5F @3P">R(J!,!B6,BC
M=+Z\>T(1RT6&<*TT547FA8=[F/?LN0;$PVJJYL#EK%3DBEQSFUL3#B!(7?6(
M/LQ"; E@'+**G%)]Z%"SPE$,D2'3A2<X9EBJXI[M+<UR4CQ99T$@Z4E+DK*T
M(7QM-!YO08#"$A+\10CJQ>W?)99VHN8 :M8XA;\F<9J.+:8BY0/V:!SE05Z@
MX8VR"@>C!5ODICX*41Y21G&F#?8A'!&83Q"#Y2W@ P[+F!7CP@:J9(M_!^,A
M3@^J/R(+#:))#<1$[=AB;X+O-8R;-5:TKFHRZ.!@NR0V=P-W!= PH<PV,.!M
M-,NWM\@9@?S"=C[L;0^&*J2@COR7\'DZ-C&8L?'YHQ5YDQJ@%JGHXXY+E;3
MQX#Q5+@*;;.4QQP;:-/]Z7#G<V_GCH?NB<2@69KXJ X[+:X1)B JN@JUDX>C
M3BJ&CU2F']B.:0;4%.*V(G_C#)K8;GO+XKN=#\+8XW 4@ZZ@+@AXSU@N0,<[
M8Z/+YD[!LA7<Y2@> WX"'X7QA&R :0B2%(XWECP3TL5?"NZ4Y"Z;5);X0U8:
MP>'.F[E/LQQ]%E,@:H09IE8P6A:%U):Y*:@F)@D#"XOU"Y,>AP4ULL:Q[F^Y
M.&]A_ACI:SIG#=?@8';8ZAH]M2 J;O!2X&O4< PM26'*4Q1 O_983*/_"EO^
M8K$_[+TDGK@"V^<33:_V23UA=DIXOQ4CKB>C%(V?JNOLQ<9U]G5H2193*,2O
M88;)*,(:5*2*<>7@!G$0BJH&@O]\GP89B843PLI(LUS=V>-*$?18]V)QV!0?
M; S:&_7\RAP1K#-79\1NRO(O?YLQT-U'D?THJ9*<9BC"K.[]2V ?BBA@#Z""
MZZ-_A%I[E?B8Z"RJU]/7WUAVO(E%J"]%QJH"79C!(I<J-Y#>3(@WBU87F1VT
M^)->-<U.4]VR*2VUF,O&HAQ-Z30C.X1=JG(IR&#?Q^;FX$A5J?=K1C=9(V3^
M27*,ZHK3;!#.US<''P&+]6$83J[7Y_'][P_*I+ Z/++QT.AB4N8)FCNSB)XC
MNL_D1[FOCL(=['5 +H/P+HU+S2'3LF)X^\P12+4;V]XF-8QHCF<EI6,NP<E'
M][8_+-Q2VS)M43;NW=\,U ]GS%?YFOEM&',S 0;9\^5'\FV!P'B@K8$IH[ZY
M3[//7,4-QZ(4@*8\I2,'1QR=? QZ<EL6X_0>OA2S#(&._RY#M#B-,4D>&B1?
M&B/02,[>"6R;$B9C(9.-A<0H1PU^D;GON6X+OO\9B>6$;5B$E$B*+(U5E@HA
M.DD\%7_S9YK%8^\C6[;GV0V<<XZXUB%H:DHAJXJ*4U2ZK"+,XR<5/C#MVMSU
MNL^$Q2OW"/)"HH%1=<P=04%^V$_<"\-1;K,*DOC\D$ -LC< G^<<W%$6#5F8
MTK/D:<:=93?ORE#/91F'DK.VNW^HHCYMV@Y)AW/MD;_:_1_U\PI[(1]8>%'(
M&AI ""/G44[A<2LR=S4XMM#$2%?[>.SUOT49V .(?F?1O.'8- H*<D/"_3=&
M>X[C3N@SOPF3T5RR0M4^Z)-\XT"O2;Y"(>YZ&*/DK^2CJ\MSQC>>SD+2(/Z"
M#<_'G/'U32)WZV^=O7,@IQIW*L:2 FSE6!8H5$?IF)R\8])"L-RVC*GH5G&?
M;WNS?19[M"$W9831\21L@K)3.&[P''>-,AC1F4=P=C\:U?V04=TO&]3X/Q=5
M,W/<:\"&/4+RLP=/$!_L%B^6;R_'/D6PJ1;@J,)(LFI'G/(&DRN$ES<)MF;,
M_!/SFBMYC1MA;X":-F&31(0:")\I^S.<(DB3\\9-DUD;QR-$#9I< \A*Y)\C
M#!@!X USRM32&?"DPR/"ERBBRG.Q9"BVW"0P5"94&D '5-<&Z/ *CCB%_>)K
M5:4$8>LD6I_3Y[EIY]9>9E/L"O,EQDK4Z/([16?<?K/E>NC<CNZ9]Z-Q$%#Y
MPX.CE%XE2*D<E6823)P644A#NH5.,E_21C5J 'OC9:-SKC"IW=.J$Y+V +2#
M"6BH&.=:#5:XG"9+:PZ]<Z! X=V RR3,N,D<WBA9FN>[SF>P\D/Y(9V BH\P
MF,VX+Q8FU@'-GZIS[>7&N?9USK4)=6H N8%' 8^O-@&4Q$2YI:-]55;KB1N-
MD#&L:C_KSC%GW/J0(L5<9&4U.] GQ&Z&0+V916C!#9EBB)>C5O$<P;AC/@.3
M,@-MZ[8!]ILB@?\5)&"_S47_];W#_<,CCP"M85:8!Y'1]$&-^DR"#F65)2U,
MJ95)H[^5)?-->(F__$"_S)6U5QD$]@;'KQ2EF$(P^ CD^7@W3E/J-T=-KBEP
M+^/18 $0,>/8OQ$M^DD3^\DCH'F R60)*!.*?B@M C+G83?05122VGA'TKDZ
M 72_4:Y5SRW-D#"??6<8CV/NJA#5SF@_I%/-L;3R#AV[M$.%,->VTS.GG#?3
M_)Q2W%*>N-WN*_PB\)CD)DO B$BQ,:J<8<.H,;D)%K87YWQH>.<P2#Y[Z,!F
M+&R>#;T\HPPZTA?-L._Q\8_RN)I\GV$Y#UX_?V&YQL6D<QHIV4N^%:C_D:;3
M++T7(%UC#*$7\9ZD0TQ!=<IP9_7.N#RE,A6]GNR92('ALVRN;CH-5H\-ROA>
M!#-7=#O46TI4,O:J%*%M )F#_FJ2-U*+R9?].+7&;2*&<H#8AIKK\I2D1B&3
M'DW/2,H'Q4:&PX7(_.P,T@UA4M7\L&DSN$$F:@:T>VI QK(F(<S+(_^3"QQ#
MEI.L) E'V"<.A8=$%>]1'-AA6 -NT[QA'$1A7$-WF[1VOD;R6FL4CNTM5T,$
M&H,&[YN":%44"C8U_#%K0)"J5$Z=)O8QK6+.OY_3P6OHEQ98V.-6L207CS5U
M)C45A5P8K9.I;5';"5$&LLS8I-^4G%5]?WN+3MA5K0.LHL=.T-#HK<&/US-6
MJ3KX6O@2D6ORMRYJ4=(X9QU#+8Y+5)N*ZPH77PX<0_BAA8Z[3>K]*+WA6?*$
M"+&A212AX+1GE\N0D8B)#!-RE)P5K4Z$BHZHBF!2B]4S%,,]1]FR6@Y49^>[
M4&]X+S".F<)JUS?$]E:;*^+!=P-="NYU(,W=DM2MKY245ZM,WM98+7:$M\T"
M-$*I:HQSRM#GGT7#4N7W<(RQ@D49F.";/9S$P@/E((,=#<69/TFSVB27O-?*
M[C/II&@.8U]2K4967@/[N2<14ZH^_1 '-T#&C/0"WSM3&9/]G.(;S/6!R:1$
M;8/]VOI[IH_3T=E9<O5 UXXSOKJ&2L^M\9P0XGI(@(1-*8"1E2DTN&Y\#G,I
M7JDQ ID]2#N6CABWAMTLD:,E;@36'UTR!)UA?J6B##HVX*G0 $P*G?NK'?D5
MQ[_QZZ_^J>7S5ZKDX+C-Y=6-:TET[#$8D#DFSW+JE2I/ULQ#5$/H?BL9X</)
MZ3&FF1#^"7YP(H.<XG-418C=Q9V+'KLL."[>HYVY[DKY(1Q3NG1]'*,][_=T
M;D$9QYB^NQ"3A_H-8[_K<FHD7)XW@\EA3V W_E9HOZ[1,N@Q"F>-RU#W=A",
M><JBF\@UP&EK6OWD2RG2"\+MG(5\\3C).GONMI,<FX;49*%V8U6V[6,Z#;U/
M*8@<^BE\JUM64-#YGH/3UJ7!Y;<T/V[%P:'[IUN.^6KC]GKTM Z\1H)9A%&V
M3KH'+&"4$<]3N+D._9U'.8NVUZ8@<AGDQ//Z0UA6J6J7<P9NF,'=#JIOR;66
M^WO[!PLB096J9\?J[],,?@O 9K%]<<_4K7F/_WGY[)F___JU?WATN&C:TD>'
M#GQ9&/71I#$\]U\=OO)?O'B]: AJA,OQ,M-09'O+&LY]W@)/PP0Q>ET6Z@X>
MIA=6,,M#I[^6ZJ%5WZI+>4J7F??1 5=381"&6,&FU7+.+'OE\-!_M?_:WW]Y
ML&C1MV%,*RXRRG69DR&RO77@OSR WQX^6_0[N-SR<DJ9V8QP1.+])@UBANZJ
M-3N>!E^B:3D%/?PNC'NX'6&&B$$3RE>6ZGO=!@D4LB*67+R)35'[=;M#\EMD
M9L_X )0)WNBX<7FE.\QRRF]O69@H2DVC!RYB#%'7]<N+J]^90KE#(DSM>^D?
M[A_X^X<+.?;!._!HZS5VJ@D#+E_O9<-ZV0:MMY!9SM*LF=3WD1W+M1</J-:I
M<:]/>M[!"__@Y;[__-716IL-,LUJG#DIR>%VPS[KY9Q 9U"5XCP_('DI43G]
M?ONW5?"(9FG54AH>[/N'(!"?[2_"U%G!6MM;X9<P&T6Y]BYJ3[WES(TF(,C(
MNCOGB.]9"IH3=N"T$WIL90NG@*P(QJ[<1]<9=J#Z@]9YN.]+DR"EYZ(%=\4+
M((%HX@=D!GH'/S_;)XM,ZM4HNDLK;I6DQ ^ VKWXD0_1EW ,5_?NASBE1&&Q
M:)1A<XE^/<$7ZL,&)*-R2@;2'6'TS$+LLETCKDO[7A.%EQI(VI$:5 Q3RH^U
M,!1F"+M&(@$W#<-OE.!+3J!J.9;DW[I9SRL*+3@9/M/5> S77.?.:A4=IS(S
MB_GJ;B2GL2/3;+>(<[X1_D%RVUJM6D[']I:8V!(#TV>CHAZI>YGK)ZT>A[G#
MUT[>.9U7?\'!PA$=&G,<@B;>>- 77L;:X"(/H-VVS7(S6F-2O 8-PCF9:(B<
MG;"U1RX;(B"BA9&_#J@Z(];-"/* 4]?)CJ,D0]@@E12.::H%G$BK@M.X 27/
MM^("&Z8)"N]Q. 2B8'03YU*$5J$D*KQ#8+R$0?(#\6*39883(CTJY8[0N.=3
MF .54^KFZ::>@C52FT)8386_;GG"+)0TG5!A#^?RH^RX4^^QV#D?U!BX37*'
MZ1]#X6Z5K%&7 5%N%<ZU*>ETW$\[7V1@AQW+(<YW)E#TJ?I#W0N^'!WLEQ<J
MWYSBHAEL(I@ZI(7@DSB0+]]R/'_(FX%%8$ULB.ELN^,H+IU/90 @Y23*<DK/
MFI0Y5UR+#]),H<3_8B8, >E/IU'!W@[<'8.4)3+'Q,JL,F6?Y9-=2"@S8!2G
M(L(#A77^DBQ(!XS(3Q^2M&,\&\1-3L4T(C&KLR/H/6O+I>TM5S#A@_HTVK>C
MQ<!<5S-75="8J!T0>*FU.[XJ.F(NX-U"@M\89+%Z"0:7+8[0YS),2W::T_EH
MZ-LIL8"'R5^,3-;7F=<6^E1]-J\W/IL5?I(U4Y=4_J"I8Q5$]-!A8,6OOL:F
MPEH*;'NO3'>\YS%Q3[,J#1:,R'/J>U;'9FUS.Y&/AE+!5C):*S!R'@I4GW.1
M&%)K:\09U75]B>PK5LE%2^:9N#*LNWZ:4]V NE9612Y8!A'DDF(^[M4421Q-
MYIMF#MR7H]I43[TYSY6;?*^&HE,/TAI+K)9&CB,U6"3O PK-^QBBWT.E==\[
MGR;1L,SQ$S0Y4*6/ P'ML6-7SN\.7MA&+)'6_;V.^K>8Q,$A6"<TFCM&A]HX
M:CZY1WV &\NK2+WZEZ\2;UHIO'(9P*76?!LT2/Q4>C368Z@-8+A<2(!8N%@K
M%413="E$!>6X3QC >PK*U$U L""S.!S3'Z@4T!\A&GE#BE:PG2^WDLVR]R!F
M\C1$\#WC(R'\W9JG3K:&\FEX$TA0+5DM57>V5O^]Q=K_CEVB:A]9RNMRRS6#
MW#3/8B? P2'A$AWOX?E[\?*-^#J>*Y'!M9ST(D8'4#GM%CHPY99]"C##!7.O
MOYTI<M805^4L,EMTB<6[GN8K6J6:Z!K:)?Z2U#<5&[-=PS;@J("I+](*35JG
M<(WFR%2W-#<A<7[>4J4<KXIC;=5<U73/"9;[5\_*CM3_.+CSODH%>8-,\D>4
MQEV,Y=AYC]39=V7BHR <"NJ3 (%6C-PB5=YRSN0Q[<:XU18?=)7XTMB^@?,>
M#::0];IY'16!+T\[(%#)O18]PYJ)5YG(K=46W*XV5^@*;EFJ4:9ZMO,D!,%/
MC<'&=Y'QA*!0Y>Q6)4JY_[N)[ \5*L18HT)44TP<[W0=1:(AMI5F+1T'O'L-
MR!2WY%'@R+H"A= A'L=%3<[14R5:9$.I4%> B'-O9Y3&<4@IWGAU.^LQV^G<
M8Q*1,-CCE2[-C>T5E/86:8MMR&:J=:O;<U>E_8Z7A_SL=@U5%:=Y<1#S9[0?
M:]CY;N&Q[?['T9;!;"ON%,_10C")0OE;'[1KA=XV9Z*<A=)^%T6[LK>14N?&
M*0,+HC8@5?QUR K52_S,@#1H861E?,CZ"-&],HLE5@59."IEF'+*^ Q6C2:N
M/J@:;@O$F1$BI%PM%F65)-K<=K8ZB9P"'VN)NX9"$L[QD3!H#5?<7R0V;4S:
MGI7OA?86S8 >'T:2[+*HJQ>JJ@0=@ (.&T;6P6XB1E3.QG1D-)P:LZ3JS23Y
MG\AHE.A(&H4>FG4PP:J*P;Z4T 'JD%DY*T8$%0#,=(?ES*B/!R5FO>&ATN;U
M%+D'-J:<HFEMY[W:WKQ/DBO;C!YI0PHB?RFP%S8>C;>0T1!1;+H8A?B4Y$GK
MQ$S27 0K$P,,&(ER!.+ W8:!*G^TY7SOZ:8-'>QO?%#?WHX^2Y,&=,;EFE2U
M"P9S^0,U*[^N5M5_[:I3O@ 3P EL>AN)$NN'+%%(TQ%3,-<0FX15K]65.]+
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M_BFVTD,/_#10R=YRU['.I]M9Q^&=J%5Q]#ETP"HKT+6XM!!$JPX(*XP)SD\
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M1RH:YY=7'B',<G2W5GYD9;/ ";[%Y>&;).O*JB%"-]Q(B1<+RST8%5)/-'I
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M%QZ=-EA+05PZ((>E9EC9NA[?/<$">C?/=F^Q*4.#;F_I;:I:,7XC_FTH74U
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M<7V>[Y*H>6#ZOM&YIZXS<&JP&36;P'RF6(BP&XEE4@.N2:7D'(,U\/.=2*&
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MV"?GM)FCS#[U0S;/F(WQKNK(=?"#?+R^N'++0OL_2/2T3P^RCA,Q.67>"T@
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M)8-1O08OTX8JWR[1?PFQ'8^::PP914HEN*7,XDMG7?<K]:W;VQ 6Z/B7@I'
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M>I=AJ@J1.+H*]U%)#5ZIFY;=BLE?Q)JNW=MS>@P%*RO?C1T$FKY5Z:Z0DYW
M\\+:=XV6(X7-6"1,"@==GJ%;"(\Y5G ;*5$D\U]8+?^$>Q$>/MMXB[Z][6]'
MQUMW];:/GK0W>I@L3VP%!U]<_>GR7"T6)7:[,5?:^_("#3/C#*\39-1[&!PV
MLQ,N%"P=-Q!7SF9IXN%1_,QDGS4)YQ'JRZ3PLM3EX+H$1-4=(+KP<$[&TXY!
M**!$#1(IJ)>+5FY;4-C[3&$6]!PGH!:&&@U(D#4UR"W,&QNBZ(1=@A]HK0S
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M0<?FTP09:R;I)*<*)?*RL=BUC+W0.V$\YF/\-\%R*2%B_M8X=5X2 %IHW!X
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MLW'BE$3]A77=<,;A*Q<R>"I2,/(TT7:6[3)6E/(3]:BJ5?-PA!VY.Z/Y"LI
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M;;6Q)F>R.2Q%M@4X 2@7X3H\@GI#J-_> @E=E@P0_!447]FK44@$!3>&LG:
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M^'E9*3?YV*PTCAX@:QT$HI(Q5^5D V?MZL,NFH JU Q[],7M)WA2:<""1?L
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MAW,;>D*:]F:F&8@[ECHTSAYY3%:F#>#T)P-,]<!M.V15J3W'_8P/'"\VX0,
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MP6^ZM=A$L;#5JYSGP67JEU!B" 'AP 50X>RX9C5A94V*X8+I7V85R\E*KAV
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M)3BOT=YNC>5JM]AT>1%=UZ%57WYQEY?S-*.(SD/X%^O-!<SWQB:C_OSXPI/
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M.XT7U4G6Y YJ'05&\F%[A'15P?C)&U>_ -05QFZ ^(&D>$K(- R?< !X[SD
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M&2T$YPXZ,EOK1U2@T7$@=T )#(*\*A$KU+JBK?@V3\QU_TQ=B8 ;7[XKQ,,
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MT3X24F3G>BBEGV3 J00$*C64E^V& S'>L:H<Q]O>$%,;\"OQ[Q!%C<X4A@6
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MXZC".C@2Y3'(';RJJHOQQ\'F!@A(=!YGBR3ZV_V=^[O1'&X?^O  /ZS?WQ#
M&;52@,=X4K@UVH["@3QZ],O@X4^_JE'L%_EY J*)C;C>E\DT*9$ACYX&\ZFB
M"7:P@=^,DJRXV$:Q<I]/<U@#_2@W$OA;%(_AV$SP\HPNTOJ,Y@ ;/ZNB*JEA
M9^"&A8]M;M#<\)E4,TCC/$CX *"Q.# +/E>T??594<&QA&_%\*9#&%-5XYEW
M< O.)VZ-.[;DX>[CP?W[]_'_T&4'><!O_Q&7)0'/]=13EH?6E\"*X)'LTE$_
MLXH:P/+5%TF2ZWW<W, !TK>M# 5[V_I*M<ETU*_3(.]S'AM/-HWJ4Z<"]2>=
M>,0*HLC@CH,ZMC/"!09!@=G#QI[B^MN-+;5G0 81;DLU+M,1+#<>SC2_5H/$
MFRX V&&#Z 17X>6[HR&O XP73@=:_#)@.;?@@<_2*JEXP^67LT6]B#/X@BEU
MH+^-P$@0%XDG%T]KU /FO/#= O^,"C)/3XMB0K]"S4'-]+P15+PY93).4C#N
M\(/58@K'+$WR,;%C7IRE('^X1?@^O"'''_/B(DLFI\F$OVUN+KF"S.=P]U#@
MIW#/%!?5D^BKJ^^@85CT[(/?;^O#\QVPWZ-%946%)\0CIJH2UD9G<99%9_%Y
M$OQYEL0(<%W'W)PU ]N5I<0,;>]W'!=L+2E5T+US6 <\.GC^0)5513Y0_XXF
M*>Q_G<%VER"B]J<Q5AO"5&&" _L#*GKZ()DN<D5M;LB?Z8T#$"$0&98_?L5.
M]!*^ NIY#DJY8@E/17_29@Q$I<ES9!I;:3[.%A,: ,T%KHN2"GY@)\S:#]2U
MX3V$Q^HL'OFK'GBDQRTJ$R0>U##)1-_ZT1+SU023@EE5-(WVM;0W]+RX8"TV
MCN$-;$709T0;P-:"-4<Z#Q>LR/ DTH+1FIJ7PQ!I=>NSLEB<\L597.3PU[-T
MCI\^+Z@HJG+4MB/9T'A,CZ;=N0"E,\!3,2^+<] )$SP2\+"XEK6RLB6KR <A
M+^K-#=Z:A-8$+-\:#D5:X+*2EH<AD"'DKJ?I BUK\SQ96Q@(SYBD2DVQ0V#L
MC="\4U+0D-5B!*HMC4N8\, 8RD4.JHL,7K+MX>.*:<!]"M=CX"8(]['5E# Z
MNQ#5#KJ<7_<VZ7-<8&H57Q=\'#S+B2]:\&MGH/AWUJFC\O$9[*=:^%!91:_A
MPL:>OL=XF<.E/H[VXWE:PPVX!6[T-E$T\G%__7K?[KC;%S@3!9X!&RO$N\Y1
M.Z]SVYZ]? =.M''YS](ZN5?-XW'R!.[1,I[_\'RONB=6-AY!_/1S<#6KM&JJ
M]+@F$:[A97P&XOD<E 3--E_,1HQQMR8W.Z_.YF8[F2R)15W5\ _1[HN<%$9<
M=9KK'5_%<XQLPY,%C8.5.1ZBCN=L[8F]W?7 K1?F ^@\L/FQFC?BGKBYH1X9
ML7]NOP>OV+_)*VBM%W.84?(I*<>@0_%;UC$(WL9.QD'SA?8+[0O!5C&_(+;'
M]S8&ZW;O@G5?1*V\R% B3\IXTC#]HE@<([J\E!50(,$]NUG&L@?K;>&ZCK#9
M3KQZ<_'0.C0JJR+^/+C>90I>/-[9\ ]\ ::X%UEL]4.,?Z$['5R8,:[*QX14
MSAQI)2MTJ+.J@-]?\M6+*@/,*'O^T/Q"'RCBJC)JC +GIXK)=MI>Y^WVHHA+
M<ML.R)0KRH;>)DT],A^;F(\%<1MT$*V]N\@S7!7\,]IM,%!GL\&J_',!#ZG8
MC)\L,HP5+&"A2QC[A%8/VVZ0@8GAJ:_O ;O%651ICC,YB"^;8HJCC]$\%G,6
M!2HZQK@F_?H8)#.^M/9J1#\8R1W%^4=8*C1%JSJM%^P5B]4SEN8.)HH[L/\B
MQ2H+.,%'JX4#(_1U?(&RAC*8@>TY6>/2^2&OS0T=\VI:!HUP;E_(+-HZ3M!*
MCEYLT\6SRD?WUWK(5IM,Z\'K^ZJ<0/. \,(?1&!?BK?"SAXH0,1+E-PZI)9G
MTE]J^P))"E#X#C0N[0H*;DMRXIN1K]8E!?OQIFNZW[>FT9=;TF]73 ]NNJ0'
M_[?$%/0PZ/G6-1OSWV1NFQO69J%(9BSF-UGMF&6 C]D43(=_0N;ZJ.4SW4Z!
MET9H217 E41!_'&,X18_2=&1-5BK"+?FBY8'&HZ2,?KKZQZ[GVR]'?&1'NE:
MY:+OOKVZ=+!-PQB-LKD1?&*-!W[(21#7U<@VYEAM5Y]],)%_C&?"3_(?/J /
MMM)M@K9C]']]6S[\!(HJ/TVBO7'=JMJ4IZ4_BRNS^^O#1P-RA[!B%],P:,;F
M%$'E6DGP>\&(KA,'-2@76<(Y)/ ,%QG?*Z PRP+<M%,*R9*S0+[@&C>?64-0
M"<99A!7R=;O;,"X690W3F\S27#* <'G%IYBW&K ')"%YF6]17LJ?8;4V-]BA
MF":8"<L&M%ZP6N!2PVMA_3"P -=O=*J'(YY"+=%]>.N"_R*_HEBTB\=523:]
MI]Y>E*<@K?]+2[].T5N2-+ZJIK^-,:D'=S&I+R):Q/33<EK5J0"C<^#4T[B8
M('ZEG*0Y6F@#TE,#I:,&FQOBK'/>AW)B'!(@1(!DFEK4QAJ5V!O02;/%+-J;
M86"]L2)_>_"8A1X>DZU9&7!OE[[,S-'^^V@8G\+6F1Q,]/K]-3(P:YPD&N48
M$)O@V 1 +DV_FK$ZZR&@JFMFK@;./0B@.69))&.,]Y%;'<9V*+213;]31J"8
M=859RV0.#TPD/U-'61)7=?3@[\:?@__+[^G$05?B!?X5@W%T[634-D7.*.@J
MAF(3P@7;VVM\_4RL%!^>>Q$_?(P.YG(&&N:PR-A[HL2PBF*/80F$\W/4%9Y>
ML[A5./^&(B1(P'DZ6:#)$6O0*/Z(.!K)X0\HM Z6W#BU?\ZP/ )6'>2)"VM-
MMAW_J/7?Y@8KP $MZZ)R"7^$68FMTC1&UJ(IN[KKKF2,+).V!R)MW\3\VE7L
M;9]>X%9ZA3K#\Z3E\K/(63KE:>5 &N!ZE"9_6U^@J":P#EN[#^X_._Y@)^<&
M^O-C&#?YS6"TWR/KYPE5B-1GSWZ$;SS?IH0!(^3L:T$OZG@0YU\ZW>]!E$[%
MY@4CI((#R+_GC8Q^+^ 7, =$C!0C1"1R%D&C4Q#94TKV"^&P"T&#KE5#E07=
M48OV5-7<_EE24J+L83;>#E,LD1P)!]6B3)_].FWR)*THF8)/H])7_#+ZGLEY
M6BPJ1$O)]3P%=]1_  <VX92@=F1K3P4K.T9#P%#0D[C'E*EWU-"/'M[?$_!:
MX&6#<[VMO6K<M<IVK^5]);23&YS[LW'_*)D/[B-B'S&C*AE.\X6M& P!!1O6
MXWK8-ZP0BN8P;R+#-K,K!C%BLA3$M,.X0'1IJ=!7[>LIT*DLDULD]HG"*M7B
MUV#>[9154A-VO*CJ>V[WW'/<&T X$B1GQ*_)]<CCHW.9Y)QEGJ#7.A$#H/N3
MQG9P.[#60\>I[W>R4RU)>TF.V[VT46S81=0_<'4K,PA1ON.X.O-"RIW'8W/#
MG8\N05OC3=(NH*W.Y+(0?E - )<)0S?;XA[*FE>H7SQ/8QB#R!N<J$8 M7G3
M#58MFG"J\F90(RSA&&_S>6LM4/!435^%PM9D._*G'UZ1C4OO.H40_0\B_RA9
M:6LQ_.8M#P.N*E9XFQNKYVW:UM7#8?C)&PJR*@C,6& $,4-NT&,Q"KA,QAE8
M\+;/%08UQ@QI%+-[P*4]434':Q[G!/;\2#CD!S R"?K"'\HDGORUD"4U8.!P
MB?" X^/@\WVS+OC@N\F:V#']E=R3).?+3WY3V:8S?+'R)>0-H[%15QO$TW80
M<NCW$3I7@)RW,.CX\"[H>(/5A(>CWY_T>OT&SIW$908_THU(FIQ2OP9Z&G?9
MC6U6EKE_6X61BT)&"9S<1-V[7?<K!X%ZGY1@/4:%L'=*@K54R?48:D\=>G;9
M2RI0P6U/]YJHN.Q1@DJ )Y<EIZ@@P@>6R0R,R<E3AZ[%(8 N[AY#&$OR@D 6
MH4BFKGRRH"K8GYY6IM;+K+17+H8*"3VRN)+:6F,PRU,2>ZVIP?76(S*,[JD#
M\BY97LDO$5A/S7(0Y2#/8P?TJ% 3CHKB(T9F*!,[AH]A$'%*WH?_$JY+B-DT
M-/M@MP9!ET)*8%[9%"WPBJS%'Y905(YP0PQ13_=WG@$<EL3H,5BO!+/K',!"
M#CL6DL9*!]V8]RJV^127:^NE?+7MM.HNDCK&V!7+=6$!(VYX "*4_2T;-:M2
MT$AQB<;";.Y/#"Y=;V84CD59@OT;)]L8&XC/8_@VZJFI7'N^2FFW= QN%@M2
M2UJ*\R);@);)-$L*U<_D OK'IZI<"3W3S&:=?H]O*EOBU-"R!TE*Y(]H@"V,
M6A"U2N[0I5_P*:9+TU^R'I'4)-J,+YU(>#H:.59HYHZ1"]>,+;&YQ ]$$_C5
M1Z8 "SY*BD8%1D*4-.@BTK4L,IU7#]>&YHF)@,.XN9C.>0MZZH/HGPNX>IUQ
MB;0!9@DPYX#:(,&T@X[,P!(?#_>-W6DM3/S.2TK H>-]F$_ U"QI1B9UO6<R
MWTQ]$&W9S7UY^/9H3U4<ZY=S-,6F_C", ?K5(+[)O)[#OMEQCXOY)?[;B %6
MV555 D/$DYIDR?P, X7X45%DE^JS.#NC^."B/:6;@/$.M&PEC4FL?O,E^RM0
M=2,0&G=R\'%9? 'S45$6K2[Q WAC+/+:U>>25,PI_H^IF_:(H-H2,E:,U(OG
M4,S3G&MSXP7>!3]BG"RYJ$0P,3P,RK^N$Z'$7LPGG&$2M+=#-X\$J>#$G<,A
M3MZW!W*J8A@Q*ZG.%5%E G!/@8S .2_AZ(,EFM*[./A%XZR2+$L8X>Z4.^]1
M8Q?,O%&1HP#B[\NZ<EF+)>N)"'!]>.C$AKIBX"L8*B-UE@&+<UG$:-<4%Z*8
MIJ)?[,3K)+?*1I],$;WS)*/"T(SGEQ634_J@*3P<(7E#]=$3@)56'H4,5E1J
M4/V"#:TJPT6P+_24A97F+I55F3(,#_GAK03-VNC#;27[ZBI_'8/,MIPY>/Y%
M@H>'E7Z*#D8>=PB&M\^!+@-53[6>C2^EM&PP7W-$X-[.BDM\OL@^/@(,* ;[
MR"G&WTT6./1MNV4&)M2Z,VUGP 1/&L*_@R@VW!57X95?PKT"_^#:<R.+7*9;
M7@XV-UIO3F5UF2+<XX3*M.U'=D!+1_%D(K75*QP/6](=BGEXE?J5MSR4.==H
MP"1FM#I-2\Q8/DK::3F+\4*"ZV:)-S?T1J*ZW]H5>X\C(_!""JX4ISG5;!@=
M/8C&2/EA^XE;(Q"C=[/X+P%N]4J^3G:0IEQMB<!2'-C"D[B2B*&JSQJ$*R+)
M+RQ^)S7$KI+Z!F<BX%MI:4Z_%Y8R"TK,<<9PF12+4=VYW1_TV(_/DFP:G<0?
MDWL'B-F Q[6G8K5!0=/B;W;YGZUQG*;$L">#W@*XNGF5&NM80(QG+;J G@0F
M"U:;_6WW,1.SF&4  0!GOW>&^+"_[=YWW^-W69>G[\MA&# X$W2TSZ2L+F V
MD FG,/MQS=K;ZLV( KOF5!=9DEVV\<!89:34_NV%WCVZBX)]>2_+GLC6!(JG
MU:K6'"[*:=])WPXMXBY77[SJ.2&P.+L<Y,&LV=NKFL.R"=(RE27"00HNWZK6
M*<C^A&5#TV]N5"[UZ9[:E[TDV_(L':7RBB^6RFS?N_6Z]UW(B!Z<BXE^8'BM
M-VVTUIDM,IH#<CCP?U1[Z1 EZ<5-NTX#W>J\CQB8$3/;  X(_8#4#B3D1/&
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MNAM\#SMS[W?B;C/0>TD*#<'&@I>C8OLR.W.PWIU1&K5U-_HJ.'BR^.UOL!:
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MY8X'6H_2=CIGE_0V;A$7P,6Z,=9*+(E,U..,%:6$D[DACFV8I+SV&ARS.@&
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MVK(![G,_!9>2.A)SP8?]T>7D/#@OY9FH56=UELX56;S-3B&GC[]<W?+XE61
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M]FR[Z.'PO3OX$W[YZN3-Z^?_'U!+ P04    " #B,&Y8\&>J)G55  !6SP$
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M,"?8S^$ MXFD7:4[*AN#?R8Y4 YL8H4;6J5EEM+'RS*=IF4)Y$H[J3_<MP<
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M@%"G,_EV/9;?W7DLK]RP%H1FWJLC;")8?!^3UQ'7D\5L<54A,L>(2&PA092
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M]6^0#@EG+6)C.VITX_3%P.L+3]T9RG]'9U1??SDNBI=P:1CV?ON)@J;58:.
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M2YDQY]U5U$CZ4=(?:']Y8\T*3?XLW525'Z@W@T;'U5C"0J1O=AH$$Z-J>F=
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M3:X^3*KC+GTUNQ9W!<50/51V\#9-)L/!H=.62Y_[,OYC&4GD\!'4D'BD6W
M.'"K9E>UX0 E,^X'JLISHREO9C=\-'8#642Q"ZBG)(F66YP&)MD\I28Z C8"
M!3P]1643)!C5,^*;2P$ _ TV8Z'WIY533Z(6)90?5AJ<@AY8RVSAQR0"C1.
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MJE2,? [RJ -Y5!1_5G& W0=)U%X YVM+M<C>0M?!-:?Y!DA]U-;X_E@!\I?
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MO@[14G:/+82]$0UC;4';;$CK@OJ6+8IL*9ME&D<DHP(.%@L&<790DLU7)5=
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M\_+YARR?1[,'KX)^#^X_B-,RSE^]?'/T65U\F4S*\^<_[CQ-T@=!-$O.4GA
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M/CSY^/[SX9N0"#98+/-B&:5E4&8T4WVB/$>PW\,SZ&[*FY\/WCM[0LMU'N7
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M\04]$UV;)\2\K?ER5B88D(<6*B5PV69I<_]*JY5<I'=/?+V67Q";U=N:@UW
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M.S 8*'W!$SQL(5Y9AXZ8;J6\H0KAM3J8N0[O:;_'L40F2=-3'6=FZN>ANZL
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MAC)UQB12%6C(J 23?3:)Y6\7T+?>U8&FC&CGI"-)X_^#D^0I[$T2^CG,$2M
M4;85#C=<XTVAI5%%V0N%W/9[U81_B?;4JLM%-ENF)1X<,@K,Q[9&7=*'"YZB
MT;8IEK;R^6#OPA&!$_(FMBJ7;.M,>/%X*^4'F(XIR$^=-/%WRS-2X <4& @_
M:B<)G/\1)?U.\V@I?4#39(K^$: 1[)M+#-1^#G!F)86FB3+"1K*M2!KPFYR&
M.J>N#)MT7>:[, -!>J+Y*#FCKK8JBEAX-NK60*G<A@$Q)R)9L3HC?H:F5NO,
M>L8+7$ :,"I-=CR+*482SFXE.X2M,DY=9>VWJS>JZH+B+L1*WH15CQ36^5J;
M6PGC>(@LJ(!IP-E6?0%HI%.<S_I&Q&G\\!S&DV,P'-]M'EBP1:^=9LO%):QA
ML5-K\[:%HPC*XX<L.-9U@^[(442.GV8E!5PB 7#).-2#XGE+Z'(;4W9 RJBP
MT%*#LP(S[O>T-.SFYS8$S3$G5<_'VQ@3 F?BC%3E_[8/)WY&P^&7J*048J+%
M[6#FZW,*%W&^B,LE9I8KQG(=J^!.B$ RVXYC78=O2^?NQ"UR9$,RR7R1&02B
M[M?"(ZJK(Y*S-\; ^/6*E\>JX# M]&>4%!VA4GPYQY"1*]*1I&8@IE*+O>-H
MFV0R^E1.1WK1T'6B:FN=!0DRUO/L9JYXNI4R,:O:"C5.P<$E;:SB6\1^GMQC
M/U_7UOP72>^3A$V7MZ!>;(N/=(C,R&-NN>:R'"?2/0H*F<M4YK)M1DTKC$%D
MV^+0^^RTQ1& X1?#=Q,K;0,9'!BL8V./:S^("=K2@A1K<& T@P0/5:%T[ VF
MT3=^R""2Z.], H<F(E EDV&%VK?\C< 9Y821SU>5S8O'R2(AIHX6[11Y(_HI
M9E+&5#]G4.7"*IT$8R$>GL5IS$5!R83JU)X:*Z:HQRNE?(YFPAF%-YI'PK)P
MYW%&%/*XS(9A@#$M:M93,*;+X+5*D<9:Q6[4EEZ6!,90@HQRE@4,J%GRWYS(
MOW[82"V32 \910$&,8H]-L[.4I)M&S]HG(&JQ\#.8.QL:X!F6L(@"JA6,-LY
MUBO4-85R"3N;@G:E\\0GC8N VTOEL^PU&*ED'?J$:;.LH<63@,D!EGV9IX%Z
M*8K*F!LN@AY"@>>@I6,7>+ 4S9GPD;EY*69&)*80C$Y,L>!?4YJ:CU*YZO=>
M@S()UX3!43K>"8.]W<?!F^5TN@KVX4PLP1!YEXS_+"[ $(VM!^SM_;B[%P;[
MF,V%SWX>')QCB.?AEWB\I-""CU/02%&?.<0I/P_0/,RS'3!B0'7*_M=T%IW!
M3/,=.-4O5/;D.%O@87H>_$ST.H-Q+H%09_HA0&\Y#&<'-(LT=9Y!.YVX\S?E
M/E7](MYV#A/2-2I]8+(*IJ_=+DDKT62"9I0*21(XL5 E?4!'#T99]J>_EF>6
MNXG+H5T]3#W99+9$:I%U^)23E"K#U\R'ZX]1-68)3&&*E'9J_A2\(F;SDNZ]
M P8;!CV=1E^V)HE\(:SD7JZULQP!/\$E3*C)(Y!P@3%"TUAB$,#>QO)@E:I.
MJFS(RHY+0V0YGB]F$8?-K8L]UZ'G$ACEK?XN8>C1BI$Q#"7$@#?)[ ]*7.(0
M [/G"_Y D/.2$]XGV7A)H8OHV^ K:W&B?).RGW2 IXYN;8[/R]B:7:;&9=.\
M&.M2N'@MZN9-RZ)PJ743.R8]:DUA^^B+6WC.?(U5U*1#PB@>4[6L2%&%\/+"
MG2PK*Y90H*3G-)JC@\! -5S%VES%3 >+KSQ[4=#E=E9< TD=6*'YI[+30Q40
M(77)[0Z7@C$6F?UF 1\XY!E$NO"8RL@0*=:!^S)SXCPHN_1ZQ85'&E&9"+P4
M;H&5Y!14Q8TJ)8X]N56E_72CR=%[T=P4!5RV:0O):R/,%/7[H1@&3E*_2ZG*
M<NC@FHAB?*)*M 1%06>W5<I93] 1R;&SZ@X+8G9*=QEP4!&U<K74:_8WUX8T
M9.FOI]4<US84)ZM XI@ 20G0]LF4Z<BH:#:^X0DY*CFIFJZRSH07'*&]FQ+L
M0.H-K/:$F-3>3S\^XX16B6@;X.6Z+A)>9M6K#-T0:FM[D#V\CRZQ72VKTZ;P
MHE@>Z#^A?.JI("#H,9CSG3H%4)DGNMY I2+_)GMS1;)"58@/XDJ0(>6J:+C-
M*CK>[UGT4!WK*!K_N5S8MPZ="%[K\:>\FEJ^>#B>% 3C^"A[B48K9W2:^'G+
MOEF<Z?M[G.D:R_D*D^>)*<!Y7-83\]O/D=M]33^HPO!"!T2M-JIH3S:0$&/-
M"W.2R\S]R)3D>J"4KBV%^PL4N]PS!X6?,AK,(3*%:*4,;:@.C7YJ8!XJ;]9"
MI:1J^<RV2)=4+,H8HU&A\MW1@6$-@B$24X[)X?-6VW0[F#].7:%]NVK_>+W:
M3W]30H[6+G.KWD.:>;F1Z,6-\M.J7862TK*%GNP^Q6%I-6@2*Q"'RDE.231,
M)=031E!>QE(UF*47Q4RA]3>.I8J?RJWCWRWRM"]:FT1+Q@U;'HZ6;#;38>KR
MMHD=#"&O4JFP*"ZQMJ"(<&<5]I[L/4&CS%H&C E.1'=VMRP%6G6,- KEHC.;
M<4DFUTU/6XBCN!,H[!'[J7F9+=_>G0NGJI9@P#\BDWJY+EX1K9&NN2N218A(
M'3Q[<;XJ,-TF5,#:6+&H.0-FFSS7B0)!T.8AK!(&):4*5S%H#@:=RQ0]?B\$
M?8&Q:>N:]*@[0E*(I\BXMAF"U"6K%;EII1^-'4&.^Z)6N!;0Y\OU'11#H(IT
MQ:(+/>E2?79*M6J#BR0ST<1BR5KO,YP=,PV0[6%WR2M9E-=1_/[ORZ-7QY3U
M("CF@K#]5+!!\D.@_A2,9E'ZY\M'1Z_^W[>KY#Z]5W)OF"$<?8 9G'XX/#D)
M?GMW>'SX\2WR $_Z,?;V041KTBDB%HN5XS>&(9)**%]E(@;V]C;LGEN>2_M<
M=+S :W^)0)T.@\>[C[^O'3QK)39M-4];)7M)P8\/-N\^__W7;#[?UFW^AVLV
MF__I\=::S9NVOD^(.#\<_A;\_O'XO^#[7W[Y]</1Z>_!Z_T/!Q^//X7!T8>#
M'1975^DLO/?,WUH8OM]B;V'5R??UZGE+HU_=>5AHZ?7'T]./O\ TOP14\#KX
MVR[]U]81N/*HM4]Z5#P*CG>"3^QG"_XW^MFVT'?Y&NV//T3S^/DW/H=3A'%K
M7E"^Z1_1?/%"LVPTT,9YC"X:7Y-E%I[?H@J ZLX)B1HL)_D)=1VTC%O$D:/R
M^/4&X",?W_P.7[X[_>7]J_\/4$L#!!0    ( .(P;EA=1>E\U4X  "_J 0 0
M    9#<V,S@X.&1E>#,S+FAT;>U]YW,;5[;G=U3A?^C2O'E%U#8I4K(<)(UJ
M*8JV^)XL:4E:'N_6?F@ %V1;C6ZX RGL7[\GW=0!@0GD#*=F1@30X89S3_B=
M]/K]Z:\?WKQ^?[C_[DV_]_KTZ/3#X9O#?VX_WWG^^BE_@J^?RN_!Z[>?WOT1
MO/WEX-.'3\?_>/+[^Z/3PR?!R>D?'P[_\22)4[5]KN*S\_+EQRR?1LF3-T&_
M!_<?J+14^9O7[XZ^Z(LOXW%Y_O+'G1=Q^B2(DO@LA0>H2?F$7O-97S:-\K,X
MW2ZSV<O=6?DJD,_#K"RS*7\UR=)RNXC_GWJY9S]/HFF<S%^>QE-5!!_597"<
M32-XT_Z'HU\^_N-)CH-\\N;U6YCK^Z.W1Z<!3#AX_?3MF]=//^.,VP;P_2T-
MX/#@M].C3Q^#+X?')_CODF'L/;O!<8QH9V@@!X?'IT<_'QWLGQX&GWX.WAV>
MP!7[.+*394.ZR:UQ1@2CT"^^?9)PWGMR>'QT>!(<]'L?/WT\^.W7WS[ ,GPY
M# X^??R"B_3VPV'P^?CPY\/CX\-W,*Q/!_^]F8$Z"W2W._/Q\/?@CT_'_PU+
M\NNOOWT\.@6FL/_QX-/QYS X^GBP<V4:+M6W<CM.Q_"JE]_]?;UQ+AU5&$3!
M*,MG61Z5<98&67X6I?#L<1"EXT!]BXLR3L^""EZ?!^6Y"GY1J<JC)#AP;OH0
M70;9A'X^*:-2X8=W*HDNHUP%6_!UO_>??]O[[H=7KW][X]SW^NEO;_#['U\-
MPB!.@V@$(QE'Z4@%EW%Y3L^;Y=E%7,#%!3[T1(U*^GMO]WD8['VW1Z/<>[&'
MU^8JFX3!.(,%P _#>3!2>1E/YO!C5+X,NDFQBXM=:^6/TGYO^8SPF_VI@G?P
MBA^K E=P'!S0V..1+.=1ZNP2;%H11'Q72+=U/N;M'+;!O,G=-+PLFLT2>,4P
M40%<%M(U;[,H'],.QCDL=Y:WWHV[&IA-I7O<[>SWQE4R#Z)Q-L-1X,63+$FR
M2R2F7!594C&YI<&O43XZ_\]T6,Q>?1\&SW:??1<&HUQ%1'=14*@\5C2$S[F:
MJ#R'QYV4V>AKVZC&J@"I21.'%>+AG? ##H*/63JJIE4"EU[@;>D%+C'.O?9D
MGL1.<.>']?CPY-.'+X?O0J+88%;E116E95!F-%-SI+K.H+\I[WXY^. =,5JM
M\R@'CK4*T?1[S15V240.&=XT3.+B'.:R8+O"8!;EP4645"KXC]V=W;U@!L,H
M8#@J["+/2?P-'PI_C14,>@K*5$$7ZGVF$<VR2Y47\"^]4,%A@P_P7C6=T9-(
MKX"O_JI IZ(3A8</KX\OXD2=X>5)/(U+^:'? P(M\UA8#;Z^F*E1# N>Y?!@
M(2!^K&8\2&],X<4B3G,[=(/RF3DCGZ.C': 5LT(T@_UI5J7EAH30_H)3[!]9
M2\!7/;;!ECD YA'FPGZ/KG1.11 734(>[P2G,) R*V'/TVHZ!$K%+:[*\RPG
MX4AT*R*I_A*9&%R2),%0!2^>/0^??__3!OB)I0O:=MQY^D>HY&@'/X,!\^:=
MFL1I3/0NE_!/^T50%8J/>BR'W_)Q/)*%S/,\@LWQ?YXJT"32,SA=59JH O@)
M_CZ" <.<@@P/SF5<P$%2?U4@:A:>FUN1T(90]L=_5D4)G+ ,#B_@_RU]P+R8
M*&4RS DF,:P)*"Q$8R.MRL G^8?7]\O1T58TP*]VT%Z\6Y9@YS:9Q$D,Y\N9
M%$X&MH54$EAXF!+)F"B=!Y^!E9*" 7_3%LDW))% NR*= "0[<$(8FOY4GN=9
M=78.XESA+],L!Y4O1M5XJL9QA"<DI)W/LP3^@C,G'Q)8R.$\I,<5HF6.LND4
M7BA7T"C#H*A&Y\[BRZ"V(B'0& <(3Q@;0F9BQ1$(0Y'GN4O ^EA6%$"==$O[
M](Q\(DF#*\6_X%6C"-[/,HF^@\<8N0D;$9TI(BNX<I:!JB5,,#+K?'FN:)7-
M"EZ":"_.XQE>=I&1$E2H497#I' 14:O%B43\>G.*!CMW+G4LB1DMLM]C_HRK
M&1RW$MT$1JTBW$QDH8LX*.^@9;^6YQXPA3"?52C7M8H$RO6XPJ69 &T,^!PB
M40+CK@J4@UM[X>[N[B!X??0&9$H9P\B)!%\_/7H3; WE%GS47Q6L/NT=/"MV
M?G@;%2A[8E#JX2EC4"+&*%GT,V+W6OA?NNUHV<[RT!.0L(=_ZO-GV9"K^EDN
M$P!+P16E1<03ZCQ97=!81T J.1%--2Q@:915'^E@P%)I74H,/K%!6L>(6VCD
MUM-W1U^ PPEPU>\%]-_7LZ HYXGR"4Y-&_2&7\W@/&P/0;G_NCU4, GU,DHN
MHWGQ! CWZ0Q?\OXX.#GZWT"^SY_HYQ*P]O)O/]%_G@2_'[T[??^/)WN[NW\W
M9OC!X<?3P^,[@=9NZ,A85>*$R?H#:J#-XP)F &YT"4_"K?+V3E@<:BG]WA(U
MQ3LRUIK7Y@ <NFI$!V&U0T?V"9[?N"@J,1^RJ@0-"KAF>K8!7<?:HN9XUE<S
M^(]G.[N[&QW;^X-@?]389C:JHO1K\#Y+</UPL6>X[_O,R_9^>O$]"3LQ^@>T
MX#&8'_%TEI"(8</ZC/1D4.,V.DL?#7#GN JVL-&A5P4:F47P+IHW9H ;,HY0
M'1"1'8%M%9Q$9973UR=PKJ*Y$<L!?4A!Q,<@[H:PO;A'<5J4<5FQ;4EJ"^C$
M<3G'A8 1]7M_9#F(/AP<_D6'3#3D,3[:.=UP6-'J!_8.5L8HR0HT7#:F!=0
M*\< +5IH 70U_X9^S[UCH675!DN,R8)TL*2]/0:3-KDBS%Q;3X*#N_1[*X%^
MK=-V<<"BF@DOX.<^);1"GCS)LRE+$=0&X-_-KTN_1XM ^@ZH'WEV$26M:Q7)
MCT8-SS-0VEGIH]E[H@R!9%2]4U;5XQ3!1-'1V:)WCM!R09>A"$[@"66P%_ZP
MNXOJ(_Y/B\H([*M\RN $Z.N*U?MI]">\@4\U?@L&#SZ![^GWSH'-*V9^[>\E
MP<]VIR+6WMQ\7*;O7X']C=?K!\)=S&XB'@P<LS+ZJM*&K4?VE $#S3[HI=TD
M#]:C:E('<.6F2<'&5\0H/TT8/H/)E %=N.P<=JH4K6=,YTMSYL;[@##U"]'\
M'RI8OVQ81O"HC3+8)"J*-J !:.,+6XHG;"FZHLO 4&2.SW)5LKELS@@L5!$7
M)<V;J.0\N]0F,[[1-42)5N7!VMKFQ^T]"PYV?MXYW@D\)/+9LQ<[S[;^&FP]
M'P1BLP#EC6!+T"+6GI"-4AO(39C;(LA'E6APP<J(N#X"^TCLM/VS7!'+O0=3
M6'0Z2B4J.V[ <NP2E0Y@:T4I^OU]F%U=I3<<T>'66T;WRE6B+M" 'D6S&)E^
MP:I#CG@!,F8Z#K"-@X 0\KDPA9J)Q8LHR*4,!-@CRB"T_[,\#.))D&9M/\(!
MR15PZQ*%,SX@01&@O_(>PU.Q&W-C$\,'??SCY!#_)I8_)HO^:*57]'O+WP&3
M3#.0*'F$VDSMC9W+*KXH=V=O=-IFJAT;&G3L9U2@\T<V2"OG8(K!A7B"<K@U
M$K<00C"LC("&$<]@1+_MG.P$_!;M*CKCORV %ZAO(S ;SASQ<S.3AGTHLB!!
M1DYF J)72'<K4RC3>#>)IE>9+<E*1%AF'0A+@VL$+IOX<58^$1EWMW$DS_3(
M'V&O*ZPF//SNR1RI_,;> 2RMWVMY$3&U]0ZZP_KE&<-X+(=*\Y ;&'/*AL7K
MGS]]/#6[?PY<:[N812/U,LTN\VCVY,W2"[(+E6_#L[9'Z#!&ZQ7O>"/_(&E\
M!7THLIP#C9I/IP=H>\,O1?!+GE4S-%UW2.,+BAB(),IU9)'P?^%+I)38!1%I
M$EU$<,LPD<63=\X6B8E^[VKB$5Y/<B(J;(P!32DR.YS,X:FC[(S#HE"?F2E2
M:N!OHPAJ> >-0;B<C05M([IQ#;SG,-%9!5\6:@.JU<^H>_/;1=MHH#$>? /&
M*)@0-KI"W,':K\":FB?,145#D))_;<J5?F_F7'DK.H\Q?4@=:!/W,+Y.B4<D
M/DG FK&*S:4:DB8@PZ6W;)V7Y>SETZ>7EY<[Z1PV%!0&QF=KA^1MDF6(-ISU
M>Y_S;,(^1V(:^06\\!4Z>L@D DV*O#QLT/*;V;U#WU#$"1Z5*!C'Q0A>$:6C
M.<RSO$1+M5-5O?Y4%TTJ:)M3Z(X&..J*2[]@"+RG9\BETDW:X@ZAMII<XL0F
M0@7=2B*>3 34DM@G#^.M_TI1FG4T@Z.0-KHBVFO8[RTV1(U*L*(QJH\Q+"F%
MCYCX'SCU6>TA'@-I=Z*V(2A'[%=M',$0OSC/+N'TY?R9SR1"?(Z;%.?;[UUF
M53)VXEK(%^OM5I0&2^7OX;=M7CZ6M^SI)3,<PT@Q1 %'EY)2 L>_S.,AAU+2
MR& 9JJ0DQP(Z)ZQ#V5"9[W]>8XVT[YE<?30IUF79<#A6&.E**T%C)I:K1UT?
MJX1SU%90-AH=)"H:V^6CJ"("(T; (M)QQ)X5>P 6OKM[Q38*:M3VX?IQ$M;M
M&>I NB*:HO*$HD%(P74$P+ZQ)Z K])K#NU;0#S;.=9@=G*)Y/FGQMT1LN<-/
M!H!_3WBY@8QA8.=.D$=F G2 4V5&*TT)[*=@*GV>Y#F3AD8%&\*^7CHO&!02
M;.W;Y]=X^JM@ZZW\2- LV&VJF.5X#&;5,(E''N'"U0?V:N:E8.#K22I%JM,9
MZ>$4F5ID(QST&+;<7%,, F98H-LJ=%X\^[L.W=(S<!SZKF6#CP2F2W!T!P =
MJS;'[BM\P=8[=Y5AT<!,*O16\(ATY!>-A;RL+W;_CL]#-GR5%S.P#=/A6 I-
M#'P4S"YNE(Q;DB*6 ]' "*(ID/Y&.5D%G CD!YM_7=S, 0.9746PE=&9(;4Q
M&'SS&B!H=*16ZT ;!Z!5.EN?,L^4&R9(U^C?@"O(00<L8LQ(^;S >/&1HH^D
M8$=Y$K,K4#N46+XYB@O_M((LAOWYJP)[1$=?MSQQ746@[L C-M8M8,]@:!@1
M@HH(:4FN,F 8T'65@9T'B_ ]?T3X;H4=^$DGCNJ_+'G%C67PHA5 :&TV7.&=
M/N6?(W+IUXV^%4/$@Z,O6Z.!/36;8=?.9.;$"UIM-3>.YH<P^*\J5?;3B9J5
M"FU^_16QN'? 3+TO45XC+YX#9PW)'E;IB&  _W$8I/,JT%97&(BYY9A:[#06
MAXY6QCS?/LD4U^W#ID2*#X)?,/N E."@=?H!,$W#RPMM<G2KVY?P+B97#,)#
M!],H <K&$!R-.,VBV" I*6P<2"ET>[.X\:(2MHQJ8OFSB/>(<G:,1-)#]^1B
MUR@'.\$AKG[[A)D<*)7)^/-UDIFY 9Z<C4$)(Y &^29(:,7:H,@Q6N_6-W!6
M(D) _1[*F(CGR; .6!J%-X1Q R_D+*OTS!PQDF9@HYCT*YU=LLG ]]I:U8]1
MOT<'8,8+23R-*"8=)=68LQO;MV=+?1O!(3-PGPG=KF\.TYN<+8.;?<ICF"]<
M?H3.>WHD Y*H6,=I12I/%A+9PYMX,*&AU< AU=;QW0O^U99=$.P]__O]&)Q%
M)&XFEPAD1[1QV7&HG7J?\PR(V@LSNF:>U/G&)[>F/MZ23842B)*1VO*JEAL-
M_=[=Z.RA ZCY>*S$6MH\D!9SRP4"*.@CT/(+[Z:<6!R)!A4Z[:5^KPG%;82'
M_ZS&I(X>*_192(CZXN#U7\C[X 2OUY]Q,B] 0]HD-?,0.:,1>'[9'LQN4J0F
M/ %08$H2WDDVPD_3*HTIVH/@2 7&A:6#,_.&5S9ORGZ)*2F*WJSQHA3CY$&V
M.>(/OG7O","(2D>@S USH)=SH!<UBW(B?W233&+,P695,BY+15:OO(,\4RGF
MQE6Y38P+B,! $@YLHITSD7$V11M]Q+C42.8PS,:@YWQ3^2@F,$*_!%,5@;+E
M%\7Y5^,IB&:@8]))0HQ[$*@A#/Z$2?* $W46%ZRVA)P&J$*=JY'EG/U81M]H
M2=CS4\XY8_!2,GK,\BV<1QCX:QOEP[A$NM3+P+GL*IELV[=[?OF-IHTP"M=Z
M] 2,);0S@[5/$=E>(Y81 S0*=!&/0^%U HN76&C"N-DP?='QPDGT^9"J52A.
MS:20[4K#\HO?;$+$&!G&:Z<110G,1)OB_2C+A+5;P]JI^ %Z?D"[8TK6Z/)&
M-^CDN#-[Z3T<U.V3$;QS^S@#"LR"?3PT.8BOX&B*UAV%R18VH^F'[SM-?C=!
MX0%B2]\]8DNW1W]D$Z^6R^X<J-9C*M4@R'?.*9'G*I'@'Q0\\:C"P"7F2ZPV
M%=74RRTN_9SC_WBV\\-S@_A&9V? >%#%6IIFHOT@QN$OCB6Q_P08)W?T+*DH
M"\#/5NX<1,NKD<TY[QXJRDOC1$Y8NFHF:#V'S2Q9Q*!K#>ENF88W[-$5A^VO
MF(S7#'8&!G%^C2UWAKM!;91(7))/&FES32KWH\87),SU>[A&+B6K;[/8U/P*
M:AGAM=SRRR@F)YL@&>A=A-FJM."X PH]&3A9Q2(HVI..>! Z>RD:_56!GJ7'
MX94_\'.69UP3PMG>I7)8=ON^[&<KUGJ-30WJ>^ID07%4QB2>P+-7RH)RCZM3
MTD7G/=E]U;.A+((61JEWUG)KKLF&J"WB6LZS3L]ADIBZ!@PU6-T2_YBEVW"[
M6.+:F5\O=25P\)I/:YN$MW\6X_7C1:_Q,M1KKW*[GKG)!,P2)2&![&ZWH#I1
M10,>AQT98FQRJ;.9+3+0,G&'(8B Y:Q#)F"XV]EQ#JS-. ZZ=<LWK<B:@32K
M!.SM_;3S@F44/"C9<*A06[996T:U<L.1(W,EE8Q!J>K&A]8+K=F[T>S$$ZVD
MLEF982T_79X+>([C&A+GC5N8H):%O# #>9/(_7]5*:H+W?&;+'NTNJ#A!;;%
M)"TR=ZJ:%5T5"3DJ+TJ_%L&?_$[A\)U\7<7T$HROPZ@DM$*EMHT8C9C29)Q5
MDN=MK_+B$#CZ!Z/R14M*8A"W8YTS#SJ4*<2(QYB=.Q0UQ/*C495A(YOU(;I<
MOWA5 IIWXL(LO(D>8(-%+PL&O<# I\I_58)5EC[EG$V=CMV:&C4.2.R47[G)
MQ8E52X$%4N!POL#F$[PB#,"^R*G6H2"X-FH>)Y[-)-0?B#N>PK_3+"_/(KH!
MSO.8_\BS;U2%2O*!R;RGD^#RFVP(IJ+.'""E4$>1\:5YCDX$?;&-\7=J+N+!
M0<2-5%,=KN7CB)=PL(H,';R;9,X?['F2@XR.N)ORBX"%MVFW" ;=MS)(4Z"$
MN9;V#6UZK.UUE#";9^4Z8B#]?_I[,R?7=X<XH9'QE(K<E2J94U*+Y?&"!MO:
M':VR?(/,@U:,"E"1KYA"R=H1%A_RJ%7&[/=6,-)]VVU%\!91 Q_HJ!?E7/QF
M'S^1QXVN_+C&1'(WU;%C5F\[9C6^N6%TO/E=\/'+P6'@&L$/$$Y]\0BGWLKA
M)R6G77.P>DZ6$[H0IZ"]CEAM_+,:G[%/;JS U$1?5H4.#-0B0(L$U4(39,,+
MN4%6!XH:?(%#^9TTD(5%7E>I^+%15PRKG2V;1V5+P3BHV%/JE(I"LT[ -:EW
M#9RD]<LDCH9Q@AKBB,O0@<XXA\>.R#<\HU?W>ZXC5\ ;_DD'<WGU86SE_N?
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M2!V( ,SU@OJF@;&*-<]*SC5<*6__*H+B_A #K+:;>2+D$.!OK>WC[K$"_'6
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M(A0[T%.F.3S!%*NZ5 F<U>6/\IX$7+$\!T6HYHO4OO]&Q4Z/%^8Z.CLN"^-
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M(!7ER/^!*BQO-7SS)2,'UXFGM#5XF"BO^DU;97;&."81/II_P(WB! &>@I1
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M_=&D2<'AC='5<C,'"0"#6(R3K$#^"%Q6: A_1U,@CXTG@VT32Y(K* G7IM=
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MC!R@)2<8B_XBUC1>*5*56AW -Y8;DIHN7V4B _;VUNRE5)YS,R7RB,!K?XW
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MH)()LQA8^)<[_\3G(2^>>==_,1$U3(>$AJ8%/@EZ%]=+QBV1VLVP)C!/@=*
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M+V1^9_F#+3O5<(5]V3;I7R>T"VMTAWU SS/ME:Z':4-AN $;L,-HD+-^N[F
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MD/+J;DT!G1+IUB"@4(1&;E1WO*[0':7[H_,P$7T:^Q$@=R;[W><RLM@8%JF
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M<X GC?!]FOG[J "1S^YI6%&8D:'E*<YO2A'!&/[@.N(X9L 72W417\!2)L3
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MU/@-*+C J*UQ)($(8 AB<;+6$E-2KT:%!Z)G *SE).#HQ8497(,!C%*R^G3
M6FN-40GT#V8,="+:@]&'4FG%*W&A?8Q_GTSY SD.*BY ,LK"BB)*T3O%5S9*
MZ/!-S2ER2=D\IE87=H"'3R/1H<CDIQ#9B/5S%[HDW+HJ>CA612_Q^+&M)GG)
M;0_3.7,L"^V6!-?>L@5)F,Z.O7[$B6H_/8%G*RSG6SK93?6O_=1R;6-CFTEG
M55-(.OC&MXLKV:H:?W?$JSOUB0VI1X*%#F4 PRBDHG:!K0H9&=QV%D4-*MSC
MK4J[Z(=0GG1*Q5@,_*; :O=-6*GL^]<%7RTA0E)IV&[\*/Z2(K.?(, /9U6
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M3 \\'.OH?285)DZ"#Y9EQ#H-AH +)'T%C49=!Y@5(M%6ZC2R;<R8N0IV@)>
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M@1$74P:@XD4^SP'B1M6*JTYRK_S.,"X%L>6IB'P[N(2-KH0?Q-+0$0;!<(A
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M_/3KSN'>G_#AEY.O^]O_'U!+ P04    " #B,&Y8^@AH;5PH  #KJ0  $0
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M$=H.-?8D$70 M9U)D $ZI'U-.R\E3SX01L/@7#>-" F--!$9;!WF+=+G<2+
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M3&SQ]/4&?>P_B6)U68Y6*P]J7U!Z+-*-C"(O!Z8Q"%.P.G2&"PGB)HG5P];
M#OMT96WP&%%5FL=W2ZEJY:#^^O&6/H;RE,\^4#_TRR<IR"3NO(:/4\QQS3WB
M[?G8XOG8XOG8XC_[V*+!<?68(;;NO($.B5'HV6"D5'FB:R7((2AY@B2,.&9+
M5BL<=(0*J62$O=[?*.M6/(0U!\O@5BPU>/"V=OC+LE-*1_2C'#V[81CE3NXN
M1RAEOC =@*@NY"C%Y:;@A:"HOD="^Z,&_IXD<XR<#<0XQ#A=["!6F5%"?!).
M<2DC);,\=3:Y&03;TAPF 23)R3<UQT3VG)L".LA IPA!F.2FX=T?Y?,# U\O
MC8? F2)=W_7H;G8VA!_\NF&4/RSZU?8YBV2LV8?M4X!=@BDG99]HQ"F:80IN
MI779A\G,Q<BZF$(79N1"$N^-DX1G' :@1B-TIF56K6 R%<(:#T8=U'</;,A!
MBDRFC2\G]"P*U\?5>&9:L]/FJ&YMXB%$EUYKV$D4698P?V!"L&S9&\0H1@YV
M-U%UV&@_'!H@AD(-@0-223%H['#VTT2B03Q.DYPP % Q69CE)IZ8TFQ2CK)T
MB4.!APFXX$G:0;G-;5H;0+DF6ZP<&ID@;L3+7 _>[.VA=4D6IC4C2X#[<MCH
M@W2]=U4#UW>U\OKP,#A\0UWO+).F4<R,48YENEC0Q''0-S4%36(MX$)0&M$9
MIA:R(5=X- JCD.(F*6723!(Q)0<S85#37:C]D-Y[V1G#>. 5*N_%,6;@'V#4
M_WR"@B!6&)7,4 G(;2 OIS> 2$M2RDSF3P%S$(FT^IZ3Y9@*N)OD&1KSY&;=
MXP[0E-C-<;%NFS0+8G/?!HK=(WH0.\TF\"P*@&6ZM&B9<;Y+!.&8+S_VLCA^
M@1<Q_.@>MBC20>ZE?2F<$Y]T$L=P!:=E;/=W5EBVY$]N7KK2<M3?UMX6!" -
M;E9U!GHMW;#9O, &/_:[#-99+D9?BX*U[XL\_MIMW9NT\4,B5'L$.]H0,8N0
M+0>)@_K&U4%''>3(,(\XQ1 6.AS"WV4-@0G\5C\H1]X?P0@\TM2$/>-N3J<,
MK=N!2\[@QNAF^(3?HDD#(J]T:K@$/3:9%;I>Y !-<:(B3"E51/L-5/<CZ:L5
M8$%O(<2Z=5BSE1Z>UM+0R[,D_/UQ(D(AYAVQ4<)MQ_<.C+;5P,[)FTF9K5&+
M_0'"K"7**ESNZ$+&>*Q*M+D'S\4W&;R0XM]YDN93Q%LL4.%C..N!=5_29<E8
MD3E@]RS&EJZSBNP0UB^L+]$>"-!<#E9_!BB> 8IG@.(_&Z!@A_(C.<,@2%K3
M690L2""W8TRKI3\;F-6OG\Q_I!H&((\2SMDMRNY0;H89J2I&&A8CE3Q2T#GE
M,@-K3B,IIIZR:,V[T"@6RO :IN=P- %+]6JEKP82H^C)FR0[GU0 %2YBBAUR
M\:*G,:=,V0G6EKQ ]ZX+S'UUJ)S B?!.&E+=(O<6UH%!B52M$!0ET4\9L5E:
MZ@;S@#BSS1ZO;QX$6;\SZY]OR'D3%R'7OK@!,U4<[!TT:GM'[  Y]>_7!_%U
M(6><[?:I8@KFDJE8LP-%6$1M?=LEJV*6]\%1*ZI#6?8@[P4/&.8/93G_, JO
M+)^)/M,F.S%Q2VD3?^JOG;O]:)<]L'5YJA67D<M@@XUC]0^_R!XWQ4DP464?
M;!V9 I\@>!:#<1A%#-*8[45VTSK.L]T.!BI2*9UFVW8I&D$*PPZ\?2E/:<G@
MXE0JF[X;(M9AFQA"@T^0>+>.2HSD<M3Y5 [9:,8*+LNIGIMJFL'J[(G.- [[
MN<9OT)H&:7,-'.R;D?C9ARM6R5RM>/MDUTD*DY:YLCT""JLDZ',,=F]*@&@?
M Q\H#\TNM$8AB%$SC'X ;1CEU21+9K.(G#>S%"2R,8/<1<C@L)\,+&T,[T+-
MI>V>)/?_-U0.=%YY<=&D*)8!XR08T3&(<DUGD,BJ,:(U0O+X:"%U$F&U)VEY
M:6RD,.J@FNC>8OT*H%$CG>E =#'W,A"72H[!33"VCYS.WHNS*)E"[]?8.Z8'
MFNXC-::\Y#S6*O*:S:,HO -&\EIHILF4DOL?T<K&^G0UK">11QFFAB79Q&__
MOV5?/:KQU=)U(, E:(*IW]P7F=UB<J5IL%CQE?9*U'DZ'NR# +AGU]=XUS\1
MA]IQ5"N;Q$]H]*#$LG$D)>B49P2<Q<7**6,:RS8V:GSJ;P0;97WKK%Q*RJ5\
M(QVR=,&'ZB[_6XN)DD.C0K@N0*GXNAEM330R<:H&5'"$B7_ E2(/RN=B$SD4
M+^KU@]I;?LI65D2%J;7*$#UY<?2Z=K3R<Y1(@DVY/!8ISA=']=JKTH,F^YG
M.A\*,!GQ1K+2JTMO_GR+80UYP$)07%#PU?X>&+"8"3[!6 W0G-!=2#J;E5*"
M^51T-H)US,+A'"A9*TA^";^/0205+7*8&>F(;)(F^1AQCSFLA](RHH,X+ .V
M>BAY0-9)-@G3X2ZF8BT0D39M@U.&H9A49:(44)C9/'UT"NH'KW "=PB4VZH
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M>WU;L6JR\$I/+;Y?U?S<0>XCC8@MIQ91X=/G=Z/+HE+,7'J+<L/+*7AE[-<
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M"!>ZDO[DH53JX'AB:F)JOH,Y" '1U28Y!\/.8M8SJX2LYG< J,<&C!3$\IM
MW/+V;"!K]MDJ=+=D6<+MYR%<F#/F6,XR3WJSL, XV4P<0)6T)?_-('G!_40S
M *-S0+&4M_.)XN'G_HI4XE_!B4/8*ZC):3_3</YJV-N"+GB,":M#N<SZV?!6
M[[_\N ([@#NN,N5QS%DFZ1KB&8A:2/>-GYWHD4[*CT9N29Z\J,7V(YFG0C.
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M\YO3S3?FG_D%I2[Y!U!+ 0(4 Q0    ( .(P;E@I3 8TJD$  #=\ 0 .
M          "  0    !D-S8S.#@X9#AK+FAT;5!+ 0(4 Q0    ( .(P;EAP
MW^^[?^4  &QM!0 1              "  =9!  !D-S8S.#@X9&5X,3 Q+FAT
M;5!+ 0(4 Q0    ( .(P;EB%)V>$1,\  %7K!  1              "  80G
M 0!D-S8S.#@X9&5X,3 R+FAT;5!+ 0(4 Q0    ( .(P;EAZNGRH1>0  /B#
M!0 1              "  ??V 0!D-S8S.#@X9&5X,3 S+FAT;5!+ 0(4 Q0
M   ( .(P;EA66BP2ZV,  +M( @ 1              "  6O; @!D-S8S.#@X
M9&5X,3 T+FAT;5!+ 0(4 Q0    ( .(P;ECP9ZHF=54  %;/ 0 0
M      "  84_ P!D-S8S.#@X9&5X,S$N:'1M4$L! A0#%     @ XC!N6+%?
M$DJ^50  _04" !               ( !*)4# &0W-C,X.#AD97@S,BYH=&U0
M2P$"% ,4    " #B,&Y8747I?-5.   OZ@$ $               @ $4ZP,
M9#<V,S@X.&1E>#,S+FAT;5!+ 0(4 Q0    ( .(P;EAS;P_PX$8  $2\ 0 0
M              "  1<Z! !D-S8S.#@X9&5X,S0N:'1M4$L! A0#%     @
MXC!N6/R_A9M37   XEL" !               ( !)8$$ &0W-C,X.#AD97@T
M,2YH=&U02P$"% ,4    " #B,&Y8^@AH;5PH  #KJ0  $0
M@ &FW00 9#<V,S@X.&1E>#DY,2YH=&U02P$"% ,4    " #B,&Y8O?<D!D,$
M  !E$0  $0              @ $Q!@4 ;GEC8BTR,#(T,#,P-RYX<V102P$"
M% ,4    " #B,&Y8!.M*IR &  "O-P  %0              @ &C"@4 ;GEC
M8BTR,#(T,#,P-U]D968N>&UL4$L! A0#%     @ XC!N6":!5*Y<"   EET
M !4              ( !]A % &YY8V(M,C R-# S,#=?;&%B+GAM;%!+ 0(4
M Q0    ( .(P;EA\NWW?U@4  +H[   5              "  849!0!N>6-B
G+3(P,C0P,S W7W!R92YX;6Q02P4&      \ #P"U P  CA\%

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>d763888d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:nycb="http://www.mynycb.com/20240307"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nycb-20240307.xsd" xlink:type="simple"/>
    <context id="duration_2024-03-07_to_2024-03-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910073</identifier>
        </entity>
        <period>
            <startDate>2024-03-07</startDate>
            <endDate>2024-03-07</endDate>
        </period>
    </context>
    <context id="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910073</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-07</startDate>
            <endDate>2024-03-07</endDate>
        </period>
    </context>
    <context id="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_nycb-BifurcatedOptionNotesUnitSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910073</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nycb:BifurcatedOptionNotesUnitSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-07</startDate>
            <endDate>2024-03-07</endDate>
        </period>
    </context>
    <context id="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_nycb-FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910073</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nycb:FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-07</startDate>
            <endDate>2024-03-07</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-621">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-03-07_to_2024-03-07"
      id="Hidden_dei_EntityCentralIndexKey">0000910073</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="duration_2024-03-07_to_2024-03-07"
      id="Hidden_dei_CurrentFiscalYearEndDate_duration_2024-03-07_to_2024-03-07">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-657">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-658">2024-03-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-659">NEW YORK COMMUNITY BANCORP, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-660">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-661">1-31565</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-662">06-1377322</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-663">102 Duffy Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-664">Hicksville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-665">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-666">11801</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-667">(516)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-668">683-4100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-669">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-670">true</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-671">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-672">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-673">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-674">NYCB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-675">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_nycb-BifurcatedOptionNotesUnitSecuritiesMember"
      id="ixv-676">Bifurcated Option Note Unit Securities SM</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_nycb-BifurcatedOptionNotesUnitSecuritiesMember"
      id="ixv-677">NYCB PU</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_nycb-BifurcatedOptionNotesUnitSecuritiesMember"
      id="ixv-678">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_nycb-FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember"
      id="ixv-158">Fixed-to-Floating Rate Series A Noncumulative Perpetual Preferred Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_nycb-FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember"
      id="ixv-679">NYCB PA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2024-03-07_to_2024-03-07_us-gaap-StatementClassOfStockAxis_nycb-FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember"
      id="ixv-680">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-03-07_to_2024-03-07" id="ixv-681">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
